Citrus Sinensis ID: 039228
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 356 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.772 | 0.272 | 0.372 | 2e-52 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.716 | 0.248 | 0.369 | 3e-47 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.679 | 0.234 | 0.371 | 3e-47 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.721 | 0.262 | 0.295 | 8e-33 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.716 | 0.213 | 0.300 | 4e-26 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.530 | 0.277 | 0.329 | 2e-25 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.575 | 0.174 | 0.305 | 7e-25 | |
| Q9S7I6 | 1151 | LRR receptor-like serine/ | no | no | 0.530 | 0.164 | 0.339 | 9e-25 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.592 | 0.298 | 0.325 | 1e-24 | |
| Q9LFH9 | 715 | L-type lectin-domain cont | no | no | 0.660 | 0.328 | 0.303 | 1e-24 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 206 bits (524), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 127/341 (37%), Positives = 175/341 (51%), Gaps = 66/341 (19%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
+K+ + P TL K Y L AT+GF N++G GSF VY+ + + VV
Sbjct: 669 RKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVV 728
Query: 101 AIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------------ 136
A+KVL++Q +GA KSFMAEC++LK+I HRNLV+ ++
Sbjct: 729 AVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGS 788
Query: 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLD 169
IAIDVAS LDYLH HC E I HCD KPSNVLLD
Sbjct: 789 LDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLD 848
Query: 170 NDLFAHIGDFELARFR---QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYG 226
+DL AH+ DF LAR E S Q SS GVR TIGY A +Y +G + S NGD Y++G
Sbjct: 849 DDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFG 908
Query: 227 ILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRK 286
ILLLEM T ++P + +F G+ L+++ + A P R++DIV+ +L+ +
Sbjct: 909 ILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVG--------- 959
Query: 287 TKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327
+ECL + +G C S +R+ V +L S+
Sbjct: 960 ---FPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISI 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 119/322 (36%), Positives = 163/322 (50%), Gaps = 67/322 (20%)
Query: 61 KEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAEC 120
K Y+ L K T GF NLIG G+F AV++G VAIKVL++ +GA+KSF+AEC
Sbjct: 706 KISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAEC 765
Query: 121 KALKNICHRNLVRFISI------------------------------------------- 137
+AL I HRNLV+ ++I
Sbjct: 766 EALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTL 825
Query: 138 --------AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189
AIDVASAL YLH +C I HCD KPSN+LLD DL AH+ DF LA+ +
Sbjct: 826 GLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFD 885
Query: 190 NPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
T Q SS GVR TIGY A +Y +G S GD Y++GI+LLE+ T ++P + +F
Sbjct: 886 RDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDG 945
Query: 247 LNLHNFARMAFPNR-VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAA 305
L LH+F + A R +DI D +L G + + +ECL + R+G +
Sbjct: 946 LTLHSFTKSALQKRQALDIT------DETILRGAYAQHF------NMVECLTLVFRVGVS 993
Query: 306 CSMGSSQDRMNVPNAVHDLQSV 327
CS S +R+++ A+ L S+
Sbjct: 994 CSEESPVNRISMAEAISKLVSI 1015
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 120/323 (37%), Positives = 161/323 (49%), Gaps = 81/323 (25%)
Query: 61 KEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAEC 120
K YE L AT F NLIG G+F V++G+ +VA+KVL++ GA+KSFMAEC
Sbjct: 699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758
Query: 121 KALKNICHRNLVRFIS-------------------------------------------- 136
+ K I HRNLV+ I+
Sbjct: 759 ETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSL 818
Query: 137 -------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF----- 184
IAIDVASAL+YLH HC + + HCD KPSN+LLD+DL AH+ DF LA+
Sbjct: 819 TPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYD 878
Query: 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244
R+ N Q SS GVR TIGY A +Y +G + S GD Y++GILLLEM + +KP D F
Sbjct: 879 RESFLN--QFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFA 936
Query: 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGA 304
GD NLH++ + +L+G S+ N+ E L ++++G
Sbjct: 937 GDYNLHSYTK-------------------SILSGCTSS----GGSNAIDEGLRLVLQVGI 973
Query: 305 ACSMGSSQDRMNVPNAVHDLQSV 327
CS +DRM AV +L S+
Sbjct: 974 KCSEEYPRDRMRTDEAVRELISI 996
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 93/315 (29%), Positives = 148/315 (46%), Gaps = 58/315 (18%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMA 118
P+ Y+ L+ AT GF +LIG G F VY+GV N VA+KVL + S SF
Sbjct: 647 PRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLR-NNTKVAVKVLDPKTALEFSGSFKR 705
Query: 119 ECKALKNICHRNLVRFIS-----------------------------------------I 137
EC+ LK HRNL+R I+ I
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNI 765
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS--- 194
DVA + YLHH+ ++HCD KPSN+LLD+++ A + DF ++R Q V +
Sbjct: 766 CSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDS 825
Query: 195 ----SSNGVR-RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL 249
S++G+ ++GY A +Y +G ST+GD Y++G+LLLE+V+ R+P D + +L
Sbjct: 826 VSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSL 885
Query: 250 HNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMG 309
H F + +P+ + I+ L L + E ++ M+ +G C+
Sbjct: 886 HEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWR-------EVILEMIELGLVCTQY 938
Query: 310 SSQDRMNVPNAVHDL 324
+ R ++ + H++
Sbjct: 939 NPSTRPDMLDVAHEM 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 93/309 (30%), Positives = 136/309 (44%), Gaps = 54/309 (17%)
Query: 9 LEYRLESHRFLHDCSMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLL 68
LE E H D + N +N KL + ++PLR K + LL
Sbjct: 828 LEMYAEGHGNSGDRTANNTNW--KLTGVKEALSINLAAFEKPLR--------KLTFADLL 877
Query: 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH 128
+AT+GF +LIG G F VY+ + AV K++ + QG + FMAE + + I H
Sbjct: 878 QATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQG-DREFMAEMETIGKIKH 936
Query: 129 RNLVRFIS-----------------------------------------IAIDVASALDY 147
RNLV + IAI A L +
Sbjct: 937 RNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAF 996
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
LHH+C I+H D K SNVLLD +L A + DF +AR + T S + + T GY
Sbjct: 997 LHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMD--THLSVSTLAGTPGYVP 1054
Query: 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267
+Y ST GD Y+YG++LLE++T ++P D GD NL + + R+ D+ +
Sbjct: 1055 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRISDVFDP 1114
Query: 268 VLLNDNKVL 276
L+ ++ L
Sbjct: 1115 ELMKEDPAL 1123
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 116 bits (291), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
Y+ L + T GF NL+G G F VY+GV R V A+K L I + F AE + +
Sbjct: 329 YDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREV-AVKQLKIGGSQGEREFKAEVEII 387
Query: 124 KNICHRNLVRFIS---------------------------------------IAIDVASA 144
+ HR+LV + +A A
Sbjct: 388 SRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARG 447
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
+ YLH C I+H D K SN+LLDN A + DF LA+ QE+ T S+ V T G
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR-VMGTFG 506
Query: 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE-GDLNLHNFAR 254
Y A +Y ++S D Y+YG++LLE++T RKP+D GD +L +AR
Sbjct: 507 YMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWAR 557
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 115 bits (287), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 60/265 (22%)
Query: 53 LTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQ 110
L L+ PKE L +ATD F N+IG S VY+G + + V+A+KVL+++
Sbjct: 853 LKLKRFEPKE----LEQATDSFNSANIIGSSSLSTVYKGQLE-DGTVIAVKVLNLKEFSA 907
Query: 111 GASKSFMAECKALKNICHRNLVRFISIA-------------------------------- 138
+ K F E K L + HRNLV+ + A
Sbjct: 908 ESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGS 967
Query: 139 --------IDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR---FRQE 187
+ +AS +DYLH I+HCD KP+N+LLD+D AH+ DF AR FR++
Sbjct: 968 LLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRED 1027
Query: 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG-- 245
S T +S++ TIGY A ++ +V+T D +++GI+++E++T+++P E
Sbjct: 1028 GS--TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQ 1085
Query: 246 DLNLHNFARMAFPN------RVMDI 264
D+ L + N RV+D+
Sbjct: 1086 DMTLRQLVEKSIGNGRKGMVRVLDM 1110
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S7I6|RPK2_ARATH LRR receptor-like serine/threonine-protein kinase RPK2 OS=Arabidopsis thaliana GN=RPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (286), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 78/230 (33%), Positives = 109/230 (47%), Gaps = 41/230 (17%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
++++++AT F NLIG G F A Y+ + VVAIK LSI + F AE K L
Sbjct: 864 FDNVVRATGNFNASNLIGNGGFGATYKAEISQD-VVVAIKRLSIGRFQGVQQFHAEIKTL 922
Query: 124 KNICHRNLVRFIS-------------------------------------IAIDVASALD 146
+ H NLV I IA+D+A AL
Sbjct: 923 GRLRHPNLVTLIGYHASETEMFLVYNYLPGGNLEKFIQERSTRDWRVLHKIALDIARALA 982
Query: 147 YLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
YLH C +LH D KPSN+LLD+D A++ DF LAR + ++ GV T GY
Sbjct: 983 YLHDQCVPRVLHRDVKPSNILLDDDCNAYLSDFGLARL---LGTSETHATTGVAGTFGYV 1039
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256
A +Y + VS D Y+YG++LLE+++ +K +D F N N + A
Sbjct: 1040 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFVSYGNGFNIVQWA 1089
|
Key regulator of anther development (e.g. lignification pattern), including tapetum degradation during pollen maturation (e.g. germination capacity). Together with RPK1, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (286), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 83/255 (32%), Positives = 117/255 (45%), Gaps = 44/255 (17%)
Query: 39 GFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRA 98
G KR G S Q L N+ YE L+KAT+GF NL+G G F VY+G+ R
Sbjct: 343 GASKRSG-SYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGR- 400
Query: 99 VVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS---------------------- 136
VVA+K L I + F AE + L I HR+LV +
Sbjct: 401 VVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYF 460
Query: 137 ----------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180
IA A L YLH C I+H D K SN+LL+++ A + DF
Sbjct: 461 HLHGEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFG 520
Query: 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240
LAR + + + G T GY A +Y +++ D +++G++LLE++T RKP+D
Sbjct: 521 LARLALDCNTHITTRVIG---TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 577
Query: 241 FMFE-GDLNLHNFAR 254
GD +L +AR
Sbjct: 578 TSQPLGDESLVEWAR 592
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (285), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 87/287 (30%), Positives = 127/287 (44%), Gaps = 52/287 (18%)
Query: 60 PKEY-YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA 118
PKE+ Y+ L T F +IG G+F VY+G+ +VA+K S Q F++
Sbjct: 361 PKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLS 420
Query: 119 ECKALKNICHRNLVRFIS--------------------------------------IAID 140
E + ++ HRNLVR I +
Sbjct: 421 ELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLG 480
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
VASAL YLH C+ ++H D K SN++LD A +GDF LAR + +P + + G
Sbjct: 481 VASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAG-- 538
Query: 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260
T+GY A +Y L S D ++YG ++LE+V+ R+PI E DLN+ PN
Sbjct: 539 -TMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPI----EKDLNVQRHNVGVNPNL 593
Query: 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACS 307
V + L + KV A +S + K L+ +G ACS
Sbjct: 594 VEWVWG--LYKEGKVSAAADSRLEGKFDEGEMWRVLV----VGLACS 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 356 | ||||||
| 255576770 | 851 | serine-threonine protein kinase, plant-t | 0.735 | 0.307 | 0.462 | 1e-71 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.758 | 0.259 | 0.434 | 4e-69 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.806 | 0.150 | 0.419 | 2e-68 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.806 | 0.280 | 0.402 | 1e-66 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.752 | 0.277 | 0.438 | 4e-66 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.811 | 0.284 | 0.415 | 4e-66 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.811 | 0.281 | 0.425 | 9e-66 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.811 | 0.282 | 0.417 | 2e-64 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.755 | 0.267 | 0.408 | 4e-64 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.814 | 0.282 | 0.409 | 2e-63 |
| >gi|255576770|ref|XP_002529272.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223531261|gb|EEF33104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 276 bits (706), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 146/316 (46%), Positives = 197/316 (62%), Gaps = 54/316 (17%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
Y+S+LKAT+GF +LIG GSF +VY+ + D + +AIKVL++Q +GASKSFMAEC+AL
Sbjct: 527 YKSILKATNGFSAESLIGAGSFGSVYKVILDEDGPALAIKVLNLQHRGASKSFMAECEAL 586
Query: 124 KNICHRNLVRFIS----------------------------------------------- 136
K+I HRNLV+ I+
Sbjct: 587 KSIRHRNLVKIITSCTSIDFQGNDFKALVYEYMPNGNLENWLHLGSGIGVAPFETNSLSL 646
Query: 137 -----IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191
IAID+ +ALDYLHH C+ I+HCD KPSNVLLD D+ AHIGDF LA+F +++NP
Sbjct: 647 LQRIDIAIDIGNALDYLHHQCERPIIHCDLKPSNVLLDIDMVAHIGDFGLAKFLPQLANP 706
Query: 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251
QSSS GVR TIGY +Y LGSEVST+GD Y+YGILLLEM+T +KP D F G+ NLH+
Sbjct: 707 AQSSSMGVRGTIGYAPPEYGLGSEVSTSGDVYSYGILLLEMMTGKKPTDDNFTGNHNLHS 766
Query: 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSS 311
RMA P+ V +IV+ +LL ++ N + +S+++CLI M+++G ACSM S
Sbjct: 767 ICRMALPDEVSEIVDPILLQGDE--TNNNQGSMEPKAADSKVKCLISMIKVGIACSMESP 824
Query: 312 QDRMNVPNAVHDLQSV 327
QDRM++ NA+ +L +
Sbjct: 825 QDRMDISNALTNLHYI 840
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 268 bits (684), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 145/334 (43%), Positives = 199/334 (59%), Gaps = 64/334 (19%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
Y+ L KAT GF NLIG G F +VY+G+ + VVA+KV+ + +GA KSF AEC+AL
Sbjct: 703 YDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEAL 762
Query: 124 KNICHRNLVRFIS----------------------------------------------- 136
+NI HRNLV+ ++
Sbjct: 763 RNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSL 822
Query: 137 -----IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV--- 188
IAIDVASALDYLHHHC + I+HCD KPSN+LLDND+ AH+GDF LARF E
Sbjct: 823 PQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGR 882
Query: 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248
S+P+QSSS G++ TIGY A +Y +G++VS GD Y+YGILLLEM T ++P + MF LN
Sbjct: 883 SHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLN 942
Query: 249 LHNFARMAFPNRVMDIVNLVLLN----DNKVLAGTNSNM--LRKTKMNSRLECLIFMVRI 302
LHNF +MA P R+ DI++ L+ + + A +SN+ +++ KM+ ECLI ++RI
Sbjct: 943 LHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMH---ECLISILRI 999
Query: 303 GAACSMGSSQDRMNVPNAVHDLQSVNNILLPETV 336
G +CS+ S ++RM + A+ +LQ + ILL V
Sbjct: 1000 GVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 265 bits (678), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 148/353 (41%), Positives = 207/353 (58%), Gaps = 66/353 (18%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
+ +R PS+ + ++ I Y+ L KAT GF NLIG G F +VY+G + VV
Sbjct: 713 RVKREPSQT--SASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVV 770
Query: 101 AIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------------ 136
A+KV+ + +GA KSF AEC+AL+NI HRNLV+ ++
Sbjct: 771 AVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGS 830
Query: 137 ----------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLL 168
IAIDVASALDYLHHHC + I+HCD KPSN+LL
Sbjct: 831 LENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILL 890
Query: 169 DNDLFAHIGDFELARFRQEV---SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNY 225
DND+ AH+GDF LARF E S+P+QSSS G++ TIGY A +Y +G++VS GD Y+Y
Sbjct: 891 DNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSY 950
Query: 226 GILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN----DNKVLAGTNS 281
GILLLEM T ++P + MF LNLHNF +MA P R+ DI++ L+ + + A +S
Sbjct: 951 GILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSS 1010
Query: 282 NM--LRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332
N+ +++ KM+ ECLI ++RIG +CS+ S ++RM + A+ +LQ + ILL
Sbjct: 1011 NLAHMKREKMH---ECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILL 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 259 bits (662), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 138/343 (40%), Positives = 208/343 (60%), Gaps = 56/343 (16%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
KK + + QP +L + P+ YE LL ATDGF NLIG GSF +V++G+ ++ VV
Sbjct: 679 KKDKPAASQP---SLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVV 735
Query: 101 AIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------------ 136
A+KVL++ +GASKSFMAEC+ALK+I HRNLV+ ++
Sbjct: 736 AVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGN 795
Query: 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLD 169
IAI +ASAL+YLHH CQ I+HCD KPSN+LLD
Sbjct: 796 LEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLD 855
Query: 170 NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILL 229
++ AH+GDF LARF E SN Q+SS G++ TIGY A +Y +G +VST GD Y+YGILL
Sbjct: 856 TNMTAHVGDFGLARFHSEASN--QTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILL 913
Query: 230 LEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKM 289
LEM T ++P+D MF+ LNLH++A+MA P+R++++V+ +L+ + + + ++ +
Sbjct: 914 LEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGP 973
Query: 290 NSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332
+ CL+ ++++G ACS+ ++RM++ + V +L + + LL
Sbjct: 974 HEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 258 bits (658), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 142/324 (43%), Positives = 190/324 (58%), Gaps = 56/324 (17%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
Y+SLL+ATDGF NLIGVGSF +VY+G+ D + +A+KVL++ +GASKSF+AEC+AL
Sbjct: 628 YQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEAL 687
Query: 124 KNICHRNLVRFIS----------------------------------------------- 136
+NI HRNLV+ ++
Sbjct: 688 RNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNF 747
Query: 137 -----IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN- 190
IAIDVA ALDYLHH CQ I+HCD KPSNVLLD ++ H+GDF +A+F E +
Sbjct: 748 LQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATR 807
Query: 191 --PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248
QSSS G+R TIGY A +Y +GSEVST+GD Y++GILLLEM T ++P + MF+ LN
Sbjct: 808 VPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLN 867
Query: 249 LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSM 308
+HNF + A P RV +I + VLL + + T S R + ECLI + IG ACS
Sbjct: 868 IHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQR-RMASSHDAQECLISIFGIGLACSA 926
Query: 309 GSSQDRMNVPNAVHDLQSVNNILL 332
++R N+ +A +L SV +I L
Sbjct: 927 ELPRERKNITDAAAELNSVRDIFL 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 258 bits (658), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 143/344 (41%), Positives = 207/344 (60%), Gaps = 55/344 (15%)
Query: 40 FKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAV 99
+ RR +Q L+L+ +PK YE LLKAT+GF NLIG G F +VY+G+ D + V
Sbjct: 676 YLSRRKRKEQSSELSLKEPLPKVSYEMLLKATNGFSSDNLIGEGGFGSVYRGILDQDDTV 735
Query: 100 VAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS----------------------- 136
VAIKVL++Q +GASKSF+AEC+AL+N+ HRNL++ I+
Sbjct: 736 VAIKVLNLQTRGASKSFVAECEALRNVRHRNLLKIITSCSSVDFQGNEFKALVYEFMPNG 795
Query: 137 -----------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173
I IDVASAL+YLHH L++HCD KPSN+LLD ++
Sbjct: 796 SLEILEKWLYSHNYFLDLLQRLNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDENMV 855
Query: 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMV 233
AH+ DF +A+ E + TQ+ + T+GY A +Y LGS+VS GD Y+YGI LLEM+
Sbjct: 856 AHVSDFGIAKLLGEGHSITQTMT---LATVGYMAPEYGLGSQVSIYGDIYSYGIPLLEMI 912
Query: 234 TRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAG--TNSNMLRKT---- 287
TR++P D MFEG LNLH FARMA P +V++IV+ LL+ V AG +N+++ T
Sbjct: 913 TRKRPTDNMFEGTLNLHGFARMALPEQVLNIVDPSLLSSGNVKAGRMSNTSLENPTSSSG 972
Query: 288 KMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331
++ + +EC+ +++IG +CS +DR+ + +A+ +L S+ IL
Sbjct: 973 EIGTLVECVTSLIQIGLSCSRELPRDRLEINHAITELCSIRKIL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 9e-66, Method: Compositional matrix adjust.
Identities = 149/350 (42%), Positives = 203/350 (58%), Gaps = 61/350 (17%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
KK R S P T + + YE LL+AT+GF NLIG GSF +VY+G+ + A V
Sbjct: 678 KKSRPASGSPWESTFQ----RVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAV 733
Query: 101 AIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------------ 136
A+KV ++ +GASKSFMAEC AL NI HRNLV+ ++
Sbjct: 734 AVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGS 793
Query: 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLD 169
IAIDVASALDYLH+HCQ I+HCD KPSNVLLD
Sbjct: 794 LEEWLHPAQISDEAHRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLD 853
Query: 170 NDLFAHIGDFELARFRQEVSNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYG 226
DL AH+GDF LAR + S+ Q+SS G++ TIGY A +Y LGSEVS GD Y+YG
Sbjct: 854 GDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYG 913
Query: 227 ILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRK 286
ILLLE+ T R+P D +F+ LNLHNFA+ A P V ++++ VL+ + + +G S R
Sbjct: 914 ILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDASR--RM 971
Query: 287 TKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL-PET 335
+ + + +ECL +V++G ACS ++RM + + +L+ + +ILL P+T
Sbjct: 972 SHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1021
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 252 bits (643), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 146/350 (41%), Positives = 201/350 (57%), Gaps = 61/350 (17%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
KK R S P T + + YE LL+AT GF NLIG GSF +VY+G+ + A V
Sbjct: 676 KKSRPASGSPWESTFQ----RVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAV 731
Query: 101 AIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------------ 136
A+KV ++ +GASKSFMAEC AL NI HRNLV+ ++
Sbjct: 732 AVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGS 791
Query: 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLD 169
IAIDVASALDYLH+HCQ + HCD KPSNVLLD
Sbjct: 792 LEEWLHPVQISDEAHVRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLD 851
Query: 170 NDLFAHIGDFELARFRQEVSNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYG 226
D+ AH+GDF LAR + S+ Q+SS G++ TIGY A +Y LGSEVS GD Y+YG
Sbjct: 852 GDMTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYG 911
Query: 227 ILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRK 286
ILLLE+ T R+P + +F+ LNLHNFA+ A P V ++++ VL+ + + +G S R
Sbjct: 912 ILLLEVFTGRRPTNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDASR--RM 969
Query: 287 TKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL-PET 335
+ + + +ECL +V++G ACS ++RM + + +L+ + +ILL P+T
Sbjct: 970 SHIGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 132/323 (40%), Positives = 192/323 (59%), Gaps = 54/323 (16%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
YE L +AT GF N IG GSF +VY+ + + +VA+KV ++ +GASKS+MAEC AL
Sbjct: 678 YEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAECAAL 737
Query: 124 KNICHRNLVRFIS----------------------------------------------- 136
NI HRNLV+ ++
Sbjct: 738 INIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQGNLNLI 797
Query: 137 ----IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS--- 189
+AIDVASALDYLH+HCQ ++HCD KPSNVLLD D+ AH+GDF LARFR E S
Sbjct: 798 QRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPEASVQL 857
Query: 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL 249
+ Q+SS G++ T+GY A +Y +G+EVST GD Y+YGILLLE++T + P D F+ LNL
Sbjct: 858 SSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEGLNL 917
Query: 250 HNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMG 309
H + +MA P+RV+++V+ +LL + + + S+ +++ + LECL+ ++ +G +CS+
Sbjct: 918 HKYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIMEVGVSCSVD 977
Query: 310 SSQDRMNVPNAVHDLQSVNNILL 332
++R N+ N V +L + ILL
Sbjct: 978 LPRERTNISNVVAELHRIRGILL 1000
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 249 bits (635), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 148/361 (40%), Positives = 198/361 (54%), Gaps = 71/361 (19%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
KKR+ S L L+ + P+ YE L KATDGF NLIGVGSF +VY+G D + +V
Sbjct: 675 KKRKEHSSDTL---LKESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLV 731
Query: 101 AIKVLSIQCQGASKSF------------------MAECKAL------------------- 123
AIKVL++Q +GASKSF + C ++
Sbjct: 732 AIKVLNLQRRGASKSFKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGS 791
Query: 124 -----------------KNICHRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNV 166
+ NL+ I+IAIDVA+ALDYLHHHC I+HCD KPSN+
Sbjct: 792 LEKWLHPTQETHDDQQINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNI 851
Query: 167 LLDNDLFAHIGDFELARFRQEVSNPT-QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNY 225
LLD D+ H+GDF LAR QE S P+ +SSS G++ T GY A +Y G EVS +GD Y+Y
Sbjct: 852 LLDKDMIGHLGDFGLARIFQEFSEPSLESSSAGIKGTTGYAAPEYGQGREVSIDGDVYSY 911
Query: 226 GILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLR 285
GILLLEM+T ++PID FE LNLH FA+MA P+ V++I + VLL++ +
Sbjct: 912 GILLLEMMTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSERHL---------- 961
Query: 286 KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRA 345
S ECL +V+IG ACSM S +DRM++ V +L V + + + NN+
Sbjct: 962 -ENAASMEECLTSLVKIGVACSMDSPRDRMDMSRVVRELLMVRDTF--QGTARRPENNKY 1018
Query: 346 P 346
P
Sbjct: 1019 P 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 356 | ||||||
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.373 | 0.131 | 0.528 | 1.6e-49 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.558 | 0.194 | 0.386 | 1.9e-49 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.337 | 0.239 | 0.544 | 2.6e-34 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.519 | 0.183 | 0.425 | 6.2e-34 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.547 | 0.198 | 0.280 | 8.9e-34 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.337 | 0.116 | 0.528 | 4.7e-32 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.516 | 0.182 | 0.422 | 8.2e-32 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.502 | 0.174 | 0.407 | 9.1e-30 | |
| TAIR|locus:2026408 | 540 | RPK1 "receptor-like protein ki | 0.325 | 0.214 | 0.401 | 4.8e-23 | |
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.300 | 0.247 | 0.375 | 8e-22 |
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 360 (131.8 bits), Expect = 1.6e-49, Sum P(3) = 1.6e-49
Identities = 73/138 (52%), Positives = 97/138 (70%)
Query: 131 LVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR----FRQ 186
L+ ++I IDVAS LDYLH HC E I HCD KPSNVLL++DL AH+ DF LAR F +
Sbjct: 811 LLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDK 870
Query: 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
E S Q SS GVR TIGY A +Y +G + S +GD Y++G+LLLEM T ++P D +F G+
Sbjct: 871 E-SFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGN 929
Query: 247 LNLHNFARMAFPNRVMDI 264
L LH++ ++A P +V +I
Sbjct: 930 LTLHSYTKLALPEKVFEI 947
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 1.9e-49, Sum P(2) = 1.9e-49
Identities = 80/207 (38%), Positives = 118/207 (57%)
Query: 128 HRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
H NL R ++I +DVA ALDYLH H E ++HCD K SNVLLD+D+ AH+GDF LAR +
Sbjct: 810 HLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVD 869
Query: 188 VSNPTQ--SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG 245
++ Q +SS G TIGY A +Y +G ST+GD Y+YGIL+LE+VT ++P D F
Sbjct: 870 GTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRP 929
Query: 246 DLNLHNFARMAFPNRVMDIXXXXXXXXXXXXAG-TNSNMLRKTKMNSRLECLIFMVRIGA 304
DL L + + RV D+ TN++ R+ EC+++++R+G
Sbjct: 930 DLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRIT-----ECIVWLLRLGL 984
Query: 305 ACSMGSSQDRMNVPNAVHDLQSVNNIL 331
+CS R + + +L ++ L
Sbjct: 985 SCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 2.6e-34, Sum P(2) = 2.6e-34
Identities = 67/123 (54%), Positives = 84/123 (68%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT-- 192
++IAIDVASAL+YLH +C + + HCD KPSNVLLD+DL AH+ DF LAR T
Sbjct: 321 VNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFL 380
Query: 193 -QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251
Q SS GVR TIGY A +Y +GS+ S GD Y++G+LLLEM T +KP D F G NLH
Sbjct: 381 NQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHG 440
Query: 252 FAR 254
+ +
Sbjct: 441 YTK 443
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 6.2e-34, Sum P(2) = 6.2e-34
Identities = 85/200 (42%), Positives = 113/200 (56%)
Query: 131 LVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR---QE 187
L+ ++IAIDVAS LDYLH HC E I HCD KPSNVLLD+DL AH+ DF LAR E
Sbjct: 810 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869
Query: 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247
S Q SS GVR TIGY A +Y +G + S NGD Y++GILLLEM T ++P + +F G+
Sbjct: 870 ESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNF 929
Query: 248 NLHNFARMAFPNRVMDIXXXXXXXXXXXXAGTNSNMLRKTKMNSRLECLIFMVRIGAACS 307
L+++ + A P R++DI G +ECL + +G C
Sbjct: 930 TLNSYTKSALPERILDIVDESILHI-----GLRVGF-------PVVECLTMVFEVGLRCC 977
Query: 308 MGSSQDRMNVPNAVHDLQSV 327
S +R+ V +L S+
Sbjct: 978 EESPMNRLATSIVVKELISI 997
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 266 (98.7 bits), Expect = 8.9e-34, Sum P(2) = 8.9e-34
Identities = 59/210 (28%), Positives = 109/210 (51%)
Query: 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189
+L++ ++I DVA + YLHH+ ++HCD KPSN+LLD+++ A + DF ++R Q V
Sbjct: 758 DLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE 817
Query: 190 NPTQS-------SSNGVR-RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241
+ S++G+ ++GY A +Y +G ST+GD Y++G+LLLE+V+ R+P D
Sbjct: 818 ETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDV 877
Query: 242 MFEGDLNLHNFARMAFPNRVMDIXXXXXXXXXXXXAGTNSNMLRKTKMNSRLECLIFMVR 301
+ +LH F + +P+ + I L + E ++ M+
Sbjct: 878 LVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWR-------EVILEMIE 930
Query: 302 IGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331
+G C+ + R ++ + H++ + L
Sbjct: 931 LGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 4.7e-32, Sum P(2) = 4.7e-32
Identities = 65/123 (52%), Positives = 86/123 (69%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT-- 192
++IAIDVASAL+YLH HC + + HCD KPSN+LLD+DL AH+ DF LA+ + +
Sbjct: 824 LNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFL 883
Query: 193 -QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251
Q SS GVR TIGY A +Y +G + S GD Y++GILLLEM + +KP D F GD NLH+
Sbjct: 884 NQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHS 943
Query: 252 FAR 254
+ +
Sbjct: 944 YTK 946
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 360 (131.8 bits), Expect = 8.2e-32, P = 8.2e-32
Identities = 85/201 (42%), Positives = 117/201 (58%)
Query: 131 LVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR----FRQ 186
L+ ++IAIDVAS LDYLH HC E I HCD KPSN+LLD+DL AH+ DF LAR F Q
Sbjct: 809 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQ 868
Query: 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
E S Q SS GVR TIGY A +Y +G + S +GD Y++G+L+LEM T ++P + +F G+
Sbjct: 869 E-SFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGN 927
Query: 247 LNLHNFARMAFPNRVMDIXXXXXXXXXXXXAGTNSNMLRKTKMNSRLECLIFMVRIGAAC 306
L+++ + A P RV+DI +G LECL ++ +G C
Sbjct: 928 FTLNSYTKAALPERVLDIADKSILH-----SGLRVGF-------PVLECLKGILDVGLRC 975
Query: 307 SMGSSQDRMNVPNAVHDLQSV 327
S +R+ A +L S+
Sbjct: 976 CEESPLNRLATSEAAKELISI 996
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 341 (125.1 bits), Expect = 9.1e-30, P = 9.1e-30
Identities = 81/199 (40%), Positives = 114/199 (57%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT-- 192
++IAIDVASAL YLH +C I HCD KPSN+LLD DL AH+ DF LA+ + T
Sbjct: 831 LNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFH 890
Query: 193 -QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251
Q SS GVR TIGY A +Y +G S GD Y++GI+LLE+ T ++P + +F L LH+
Sbjct: 891 IQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHS 950
Query: 252 FARMAFPNR-VMDIXXXXXXXXXXXXAGTNSNMLRKTKMN--SRLECLIFMVRIGAACSM 308
F + A R +DI T+ +LR + +ECL + R+G +CS
Sbjct: 951 FTKSALQKRQALDI--------------TDETILRGAYAQHFNMVECLTLVFRVGVSCSE 996
Query: 309 GSSQDRMNVPNAVHDLQSV 327
S +R+++ A+ L S+
Sbjct: 997 ESPVNRISMAEAISKLVSI 1015
|
|
| TAIR|locus:2026408 RPK1 "receptor-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 229 (85.7 bits), Expect = 4.8e-23, Sum P(2) = 4.8e-23
Identities = 49/122 (40%), Positives = 72/122 (59%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
IA+DVA AL YLH C +LH D KPSN+LLDN+ A++ DF L++ + +
Sbjct: 362 IALDVARALSYLHEQCSPKVLHRDIKPSNILLDNNYNAYLSDFGLSKL---LGTSQSHVT 418
Query: 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF---EGDLNLHNFA 253
GV T GY A +Y + VS D Y+YGI+LLE+++ ++ +D F E N+ ++A
Sbjct: 419 TGVAGTFGYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPSFSSHENGFNIVSWA 478
Query: 254 RM 255
M
Sbjct: 479 HM 480
|
|
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 208 (78.3 bits), Expect = 8.0e-22, Sum P(2) = 8.0e-22
Identities = 42/112 (37%), Positives = 69/112 (61%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ IA+DV L+YLH HC I+H D K SN+LLD++ A I DF LA V P ++
Sbjct: 241 MKIALDVTRGLEYLHEHCHPAIIHRDLKSSNILLDSNFNAKISDFGLA----VVDGP-KN 295
Query: 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
++ + T+GY A +Y L +++ D Y +G++LLE++ +KP++ + G+
Sbjct: 296 KNHKLSGTVGYVAPEYLLNGQLTEKSDVYAFGVVLLELLLGKKPVEKLAPGE 347
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 356 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-17 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-06 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.001 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.001 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.003 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.003 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.004 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.004 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 7e-20
Identities = 42/194 (21%), Positives = 71/194 (36%), Gaps = 48/194 (24%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF---- 134
+G G F VY VAIK++ + + + E + LK + H N+V+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCD 160
+ I + + L+YLH + I+H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRD 117
Query: 161 PKPSNVLLDNDLF-AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD-YDLGSEVST 218
KP N+LLD+D + DF L++ +S + T Y A + S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKL----LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 219 NGDAYNYGILLLEM 232
D ++ G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 56/216 (25%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF 134
++ +G GSF VY +VAIKV+ + + + + E K LK + H N+VR
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 135 I-------------------------------------SIAIDVASALDYLHHHCQELIL 157
+ SAL+YLH I+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IV 119
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYDLGS 214
H D KP N+LLD D + DF LAR + + ++ T Y A L LG
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVG--TPEYMAPEVL---LGK 171
Query: 215 EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250
D ++ G++L E++T + P F GD L
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP----FPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 53/202 (26%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK--SFMAECKALKNICHRNLVRFISI 137
+G GSF VY+ +VA+K+L + + + K + E + L+ + H N+VR I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 138 AID-------------------------------------VASALDYLHHHCQELILHCD 160
D + L+YLH + I+H D
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHRD 123
Query: 161 PKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA----LDYDLGSEV 216
KP N+LLD + I DF LA+ + SS T Y A L G+
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL----LKSSSSLTTFVGTPWYMAPEVLLG---GNGY 176
Query: 217 STNGDAYNYGILLLEMVTRRKP 238
D ++ G++L E++T + P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 5e-16
Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 46/202 (22%)
Query: 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVRFI 135
L+G GSF +VY + ++A+K + + ++ E + L ++ H N+VR+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 136 ---------------------SIA------------------IDVASALDYLHHHCQELI 156
S++ + L YLH + I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---I 122
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV 216
+H D K +N+L+D+D + DF A+ ++ + S VR T + A + G E
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS--VRGTPYWMAPEVIRGEEY 180
Query: 217 STNGDAYNYGILLLEMVTRRKP 238
D ++ G ++EM T + P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 41/206 (19%), Positives = 76/206 (36%), Gaps = 55/206 (26%)
Query: 76 LINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRN 130
L +G G+F VY+G + VA+K L + F+ E + ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 131 LVRFI--------------------------------------SIAIDVASALDYLHHHC 152
+V+ + S A+ +A ++YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LD 209
+H D N L+ +L I DF L+R ++ + G + I + A L
Sbjct: 123 ---FIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 210 YDLGSEVSTNGDAYNYGILLLEMVTR 235
+ ++ D +++G+LL E+ T
Sbjct: 177 E---GKFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 43/207 (20%), Positives = 75/207 (36%), Gaps = 56/207 (27%)
Query: 76 LINLIGVGSFDAVYQGV----FDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRN 130
L +G G+F VY+G + VA+K L + + F+ E +K + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 131 LVRFI--------------------------------------SIAIDVASALDYLH-HH 151
+VR + +A+ +A ++YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---L 208
+H D N L+ +L I DF L+R E + G I + A L
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-YRKRGGGKLP-IKWMAPESL 176
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVTR 235
+ ++ D +++G+LL E+ T
Sbjct: 177 KD---GKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 56/207 (27%)
Query: 76 LINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNICHRN 130
L +G G+F VY+G D VA+K L + F+ E + ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 131 LVRFI---------------------------------------SIAIDVASALDYLHHH 151
+V+ + S A+ +A ++YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---L 208
+H D N L+ +L I DF L+R ++ + G + I + A L
Sbjct: 123 N---FIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVTR 235
+ ++ D +++G+LL E+ T
Sbjct: 177 KE---GKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 51/203 (25%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
F L +G G F V++G++ NR VAIK+L + F E +ALK + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 134 F---------------------------------------ISIAIDVASALDYLHHHCQE 154
I +A VA + YL ++
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY--TALDYDL 212
+H D N+L+ DL + DF LAR +E SS+ + I Y TA +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKE---DVYLSSD---KKIPYKWTAPEAAS 177
Query: 213 GSEVSTNGDAYNYGILLLEMVTR 235
ST D +++GILL EM T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 52/193 (26%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISI- 137
IG G F V G + + VA+K L A+++F+AE + + H NLV+ + +
Sbjct: 13 TIGKGEFGDVMLGDYRGQK--VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 138 --------------------------------------AIDVASALDYLHHHCQELILHC 159
A+DV ++YL ++ +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN 219
D NVL+ DL A + DF LA+ + + + +TA + + ST
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 220 GDAYNYGILLLEM 232
D +++GILL E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 53/198 (26%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISI-- 137
IG G F AV QG + + VA+K I+C +++F+ E + + H+NLVR + +
Sbjct: 14 IGEGEFGAVLQGEYTGQK--VAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 138 ------------------------------------AIDVASALDYLHHHCQELILHCDP 161
++DVA ++YL + ++H D
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 162 KPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGD 221
N+L+ D A + DF LAR + + + + +TA + + S+ D
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNS-------KLPVKWTAPEALKHKKFSSKSD 179
Query: 222 AYNYGILLLEMVTR-RKP 238
++YG+LL E+ + R P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 18/114 (15%)
Query: 132 VRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191
V+F ++ AL+YLH I+H D KP N+LLD HI DF +A
Sbjct: 102 VKFW--ICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV-----T 151
Query: 192 TQSSSNGVRRTIGYTALD----YDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241
+ + T GY A + V D ++ G+ E + ++P
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 43/196 (21%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF- 134
L+ +G G F V++G+++ N VA+K L K F+AE + +K + H L++
Sbjct: 10 LLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLY 67
Query: 135 --------ISIAIDV---ASALDYLHH------HCQELI------------------LHC 159
I I ++ S L+YL +LI +H
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 160 DPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVST 218
D NVL+ + + DF LAR ++++ + G + I +TA + L + S
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 219 NGDAYNYGILLLEMVT 234
D +++GILL E+VT
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 46/204 (22%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIK--VLSIQCQGASKSFMAECKALKNICHRNL 131
+ L +LIG G+F VY+G+ VAIK L + A KS M E LKN+ H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 132 VRFI-------SIAI------------------------------DVASALDYLHHHCQE 154
V++I S+ I V L YLH ++
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQ 118
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
++H D K +N+L D + DF +A +VS V T + A + S
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----DASVVGTPYWMAPEVIEMS 174
Query: 215 EVSTNGDAYNYGILLLEMVTRRKP 238
ST D ++ G ++E++T P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 48/217 (22%), Positives = 79/217 (36%), Gaps = 74/217 (34%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
F ++ IG G F VY+ VAIKV+ ++ + + + E + LK H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 134 FIS--------------------------------------IAIDVASALDYLH-HHCQE 154
+ + ++ L+YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--- 118
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
I+H D K +N+LL +D + DF L+ Q S R T+ +G+
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLS---------AQLSDTKARNTM--------VGT 160
Query: 215 ------EVSTNGDAYNY-------GILLLEMVTRRKP 238
EV NG Y+Y GI +E+ + P
Sbjct: 161 PYWMAPEV-INGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 59.4 bits (142), Expect = 7e-10
Identities = 57/267 (21%), Positives = 98/267 (36%), Gaps = 59/267 (22%)
Query: 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CH 128
+ ++ +G GSF VY +R +VA+KVL+ + + F+ E + L ++
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 129 RNLVRFI----------------------------------------SIAIDVASALDYL 148
N+V+ I + SAL+YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 149 HHHCQELILHCDPKPSNVLLDNDLF-AHIGDFELARFRQE--VSNPTQSSSNGVRRTIGY 205
H I+H D KP N+LLD D + DF LA+ + ++ + + T GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 206 TALDYDLGSE---VSTNGDAYNYGILLLEMVTRRKPIDF---MFEGDLNLHNFARMAFPN 259
A + LG S++ D ++ GI L E++T P + L + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 260 RVMDIVNLVLLNDNKVLAGTNSNMLRK 286
+ +K + +L K
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (143), Expect = 9e-10
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 63/216 (29%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHRNLVRF 134
+ +G G++ VY+ +VA+K L + +G + + E LK + H N+V+
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 135 ISIAIDVAS-------------------------------------ALDYLHHHCQELIL 157
+ + L Y H H IL
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---IL 120
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D KP N+L++ D + DF LAR P ++ ++ V T+ Y A + LGS
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARA---FGIPLRTYTHEV-VTLWYRAPEILLGS--- 173
Query: 218 TNGDAYNYGI-------LLLEMVTRRKPIDFMFEGD 246
Y+ + + EM+T KP+ F GD
Sbjct: 174 ---KHYSTAVDIWSVGCIFAEMIT-GKPL---FPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVR----- 133
+G GS+ VY+G L +VA+K + ++ +GA + + E LK++ H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 134 ---------FISIAIDVASALDY----LHHH---------------C-QELILHCDPKPS 164
F + D+ +D L H C Q +LH D KP
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQ 132
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAY 223
N+L+ + DF LAR + S P+++ SN V T+ Y D LGS E ST+ D +
Sbjct: 133 NLLISERGELKLADFGLARAK---SVPSKTYSNEV-VTLWYRPPDVLLGSTEYSTSLDMW 188
Query: 224 NYGILLLEMVTRR 236
G + EM T R
Sbjct: 189 GVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 2e-09
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 68/221 (30%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
+I IG GSF VY + + +K + + + + E K LK + H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 134 F-----------------------------------------ISIAIDVASALDYLHHHC 152
+ + + + AL YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
ILH D KP N+ L ++ +GDF +++ + ++ +G T Y L
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-------VVG-TP--YYL 170
Query: 213 GSEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
E+ YNY G +L E+ T + P FEG+
Sbjct: 171 SPEL-CQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 49/205 (23%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF 134
I IG G++ VY+ +VA+K + ++ +G + + E K L+ + H N+VR
Sbjct: 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 135 ISIAID---------------------------------------VASALDYLHHHCQEL 155
I + L YLH +
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--- 120
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
ILH D K SN+L++ND + DF LAR + ++ +N V T+ Y + LG+
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADYTNRV-ITLWYRPPELLLGAT 177
Query: 216 VSTNG-DAYNYGILLLEMVTRRKPI 239
D ++ G +L E+ KPI
Sbjct: 178 RYGPEVDMWSVGCILAELFL-GKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 75/257 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLNR----AVVAIKVLSIQCQGASKS-FMAECKALKNICHRN 130
I +G G F V +D VA+K L+ + +S F E + L+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 131 LVRFISI----------------------------------------AIDVASALDYLHH 150
+V++ + + + +DYL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE------VSNPTQSSSNGVRRTIG 204
Q I H D N+L++++ I DF LA+ E V P +S I
Sbjct: 128 --QRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP-------IF 177
Query: 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH---NFARMAFPNR- 260
+ A + S+ S+ D +++G+ L E+ T GD + F RM +
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTY---------GDPSQSPPAEFLRMIGIAQG 228
Query: 261 VMDIVNLV-LLNDNKVL 276
M + L+ LL + + L
Sbjct: 229 QMIVTRLLELLKEGERL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 47/204 (23%)
Query: 78 NLIGVGSFDAVYQGV-FDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF 134
N IG G+F VY V D ++A+K + IQ K E K L+ + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGE-LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 135 ISI-------------------------------------AIDVASALDYLHHHCQELIL 157
+ + + L YLH H I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIV 121
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D KP+N+ LD++ +GDF A + + + T Y A + G +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 218 TNG---DAYNYGILLLEMVTRRKP 238
+G D ++ G ++LEM T ++P
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 46/201 (22%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRN 130
D + + +G GS+ VY+G +N +VA+KV+ +Q + G + + E LK + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 131 LVR--------------FISIAIDVASALD-----------------------YLHHHCQ 153
+V F + D+ +D Y+H Q
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---Q 121
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
ILH D KP N+L+ + + DF LAR + S P+ + SN V T+ Y D LG
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAK---SVPSHTYSNEV-VTLWYRPPDVLLG 177
Query: 214 S-EVSTNGDAYNYGILLLEMV 233
S E ST D + G + +EM+
Sbjct: 178 STEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 6e-09
Identities = 46/214 (21%), Positives = 77/214 (35%), Gaps = 67/214 (31%)
Query: 78 NLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQCQGASKS----FMAECKALKNICHRN 130
+G G+F VY+G D VA+K L + AS+ F+ E + +K + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57
Query: 131 LVRFI----------------------------------------------SIAIDVASA 144
+VR + S AI +A
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG---VRR 201
++YL +H D N L+ DL I DF L+R + + + G +R
Sbjct: 118 MEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIR- 172
Query: 202 TIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR 235
+ A + ++ D +++G+LL E+ T
Sbjct: 173 ---WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 44/202 (21%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLV------ 132
+G G++ V++G L +VA+K + ++ +GA + + E LKN+ H N+V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 133 ---RFISIAID-VASALDYLHHHCQEL------------------------ILHCDPKPS 164
R +++ + + S L +C L ILH D KP
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAY 223
N+L++ + DF LAR + S PT++ SN V T+ Y D LGS E ST D +
Sbjct: 133 NLLINEKGELKLADFGLARAK---SVPTKTYSNEV-VTLWYRPPDVLLGSTEYSTPIDMW 188
Query: 224 NYGILLLEMVTRRKPIDFMFEG 245
G +L EM T R MF G
Sbjct: 189 GVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 50/195 (25%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVR----- 133
+G GS+ VY+G+ +N +VA+KV+S++ + G + + E LK + H N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 134 ---------FISIAIDVAS-----------------------ALDYLHHHCQELILHCDP 161
F + D+A L Y+H + ILH D
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDL 129
Query: 162 KPSNVLLDNDLFAHIGDFELARF--RQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVST 218
KP N+L+ +++G+ +LA F + S P+Q+ S+ V T+ Y D LG+ + S+
Sbjct: 130 KPQNLLI-----SYLGELKLADFGLARAKSIPSQTYSSEV-VTLWYRPPDVLLGATDYSS 183
Query: 219 NGDAYNYGILLLEMV 233
D + G + +EM+
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 40/201 (19%)
Query: 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHR 129
+ LI +G G F V+ G ++ N V A+K L + +SF+ E + +K + H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM-SPESFLEEAQIMKKLRHD 61
Query: 130 NLVRFISIA-----------IDVASALDYLHH------HCQELI---------------- 156
LV+ ++ + S LD+L L+
Sbjct: 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 157 --LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
+H D + +N+L+ + L I DF LAR + + ++ G + I +TA + L
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 215 EVSTNGDAYNYGILLLEMVTR 235
+ D +++GILL E+VT+
Sbjct: 179 RFTIKSDVWSFGILLTELVTK 199
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 46/196 (23%)
Query: 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISI 137
+ +G G + VY+GV+ VA+K L + F+ E +K I H NLV+ + +
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 138 ---------------------------------------AIDVASALDYLHHHCQELILH 158
A ++SA++YL ++ +H
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVST 218
D N L+ + + DF L+R T ++ G + I +TA + ++ S
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 219 NGDAYNYGILLLEMVT 234
D + +G+LL E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 45/197 (22%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVR 133
L +G G F V+ G ++ VA+K L G ++F+ E + +K + H LV+
Sbjct: 10 LERKLGAGQFGEVWMGTWN-GTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 134 FISIAIDV------------ASALDYLHH------HCQELI------------------L 157
++ + S LD+L +L+ +
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D N+L+ +L I DF LAR + + ++ G + I +TA + +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 218 TNGDAYNYGILLLEMVT 234
D +++GILL E+VT
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 47/199 (23%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLVR--- 133
+G GSF V + A+KVL I + + + E L I H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 134 -FIS---------------------------------IAIDVASALDYLHHHCQELILHC 159
F + A ++ AL+YLH I++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYR 117
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN 219
D KP N+LLD D + DF LA+ E+S+ S +N T Y A + LG
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAK---ELSS-EGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 220 GDAYNYGILLLEMVTRRKP 238
D ++ G+LL EM+T + P
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVR-- 133
++ +G G++ VY+G L +VA+K + ++ + GA + + E LK++ H N+V
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 134 ------------FISIAIDVASALD----YLHHHCQEL----------------ILHCDP 161
F + D+ LD ++ H +L +LH D
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 162 KPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNG 220
KP N+L++ + DF LAR + S PT++ SN V T+ Y D LGS + ST
Sbjct: 131 KPQNLLINERGELKLADFGLARAK---SIPTKTYSNEV-VTLWYRPPDILLGSTDYSTQI 186
Query: 221 DAYNYGILLLEMVTRR 236
D + G + EM T R
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 57/215 (26%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRN 130
D + LI +IGVG+ VY + N VAIK + + +CQ + E +A+ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 131 LV----------------RFIS---------------------IAI---DVASALDYLHH 150
+V ++S IA +V L+YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
+ Q +H D K N+LL D I DF ++ +++ + VR+T T
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTR-KVRKTFVGTP--C 171
Query: 211 DLGSEVSTNGDAYN-------YGILLLEMVTRRKP 238
+ EV Y+ +GI +E+ T P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 40/191 (20%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISIA- 138
+G G F V+ G ++ VAIK L + ++F+ E + +K + H LV+ ++
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 139 ----------IDVASALDYLHHHCQELI------------------------LHCDPKPS 164
+ S LD+L + + +H D + +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 131
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYN 224
N+L+ +L + DF LAR + + ++ G + I +TA + L + D ++
Sbjct: 132 NILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 225 YGILLLEMVTR 235
+GILL E+ T+
Sbjct: 189 FGILLTELTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 43/209 (20%), Positives = 73/209 (34%), Gaps = 63/209 (30%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSI-----QCQGASKSFMAECKALKNICHRNLVR 133
L+G GSF +VY+G+ + A+K +S+ Q A K E L + H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 134 FISIAID-------------------------------------VASALDYLHHHCQELI 156
++ + + L+YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNT 123
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV 216
+H D K +N+L+D + + DF +A+ Q ++ + Y + EV
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFKGSP--YWMAPEV 172
Query: 217 STNGDAYNY-------GILLLEMVTRRKP 238
Y G +LEM T + P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRFISI- 137
+G G++ VY+G +VA+K + + +G + + E +K + H N+VR +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 138 ----------------------------AIDVASALDYLHH------HCQE-LILHCDPK 162
A+D + + + C E +LH D K
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK 127
Query: 163 PSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STNGD 221
P N+L++ + DF LAR P + SN V T+ Y A D LGS ST+ D
Sbjct: 128 PQNLLINKRGELKLADFGLAR---AFGIPVNTFSNEV-VTLWYRAPDVLLGSRTYSTSID 183
Query: 222 AYNYGILLLEMVTRR 236
++ G ++ EM+T R
Sbjct: 184 IWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 49/229 (21%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
+ L+ +G G F V+ G ++ + V AIK L Q + ++F+AE +K + H L
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLK-QGSMSPEAFLAEANLMKQLQHPRL 63
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
VR I +A +A + ++ +
Sbjct: 64 VRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---R 120
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+ +H D + +N+L+ L I DF LAR + + ++ G + I +TA +
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 214 SEVSTNGDAYNYGILLLEMVTR-RKPIDFMFEGDL--NLHNFARMAFPN 259
+ D +++GILL E+VT R P M ++ NL RM P+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 53/233 (22%), Positives = 84/233 (36%), Gaps = 72/233 (30%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI---QCQGASKSFMAECKALKNIC 127
F + IG G F VY+ + L+ VVA+K + I A + + E LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 128 HRNLVRFISIAID-----------------------------------------VASALD 146
H N++++++ I+ + SAL+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 147 YLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE--------VSNPTQSSSNG 198
++H I+H D KP+NV + +GD L RF V P S
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-LNLH 250
+ Y+ S D ++ G LL EM + P F GD +NL+
Sbjct: 178 IHEN------GYNFKS------DIWSLGCLLYEMAALQSP----FYGDKMNLY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 34/106 (32%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R I A + L++LH Q I++ D KP NVLLD+ I D LA V
Sbjct: 96 RAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA-----VELKG 147
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
G T GY A + G + D + G L EM+ R P
Sbjct: 148 GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 61/208 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQCQGASKS-FMAECKALKNICHRNL 131
+ +IG G F V +G L VAIK L + F+ E + H N+
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 132 VRFISI-----------------AID---------------------VASALDYLHHHCQ 153
+R + ++D +AS + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG---VRRT----IGYT 206
+H D N+L++++L + DF L+R R E S T ++ G +R T I Y
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVT 234
++ D +++GI++ E+++
Sbjct: 184 KF--------TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 66/210 (31%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLS----------IQCQGASKSFMAECK--ALKNI 126
LIG G++ AVY+G VVA+K+++ IQ + A +++ + NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA---LLSQLRQSQPPNI 64
Query: 127 -------------------CH----RNLVR-------FISIAI-DVASALDYLHHHCQEL 155
R L++ +IS+ I +V AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
++H D K +N+L+ N + DF +A + S + + Y + E
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS----------SKRSTFVGTPYWMAPE 171
Query: 216 VSTNGDAYNY-------GILLLEMVTRRKP 238
V T G Y+ GI + EM T P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 47/221 (21%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNL 131
+ I IG G++ VY+G +VA+K + ++ + G + + E LK + H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 132 VRFISI--------------AIDVASALD---------------YLHHHCQEL------- 155
V + ++D+ LD YL+ Q +
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+LH D KP N+L+DN + DF LAR P + ++ V T+ Y A + LGS
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVYTHEV-VTLWYRAPEVLLGSP 177
Query: 216 -VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
ST D ++ G + EM T++ +F GD + R+
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKP----LFHGDSEIDQLFRI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 46/211 (21%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHRNL 131
F + IG G++ VY+ L VVA+K L + +G + + E LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 132 VRFISI----------------------------AIDVASALDYLHHHCQEL-------I 156
V+ + + I + YL Q L +
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV 216
LH D KP N+L++ + + DF LAR P ++ ++ V T+ Y A + LG +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEV-VTLWYRAPEILLGCKY 177
Query: 217 -STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
ST D ++ G + EMVTRR +F GD
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRA----LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISIA- 138
+G G F V+ G ++ VAIK L ++F+ E + +K + H LV ++
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 139 ----------IDVASALDYL------HHHCQELI------------------LHCDPKPS 164
+ S LD+L + +L+ +H D + +
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYN 224
N+L+ ++L I DF LAR + + ++ G + I +TA + L + D ++
Sbjct: 132 NILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 225 YGILLLEMVTR 235
+GILL E+VT+
Sbjct: 189 FGILLTELVTK 199
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 56/226 (24%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHR 129
D F +I IG G++ VY+ +VA+K L + +G + + E K L+ + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 130 NLVRFISIAIDVASALD-------------YLHH----------------HCQELI---- 156
N+V I D ALD Y+ H H + +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 157 -----------LHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTIG 204
LH D K SN+LL+N + DF LAR + E S P +N V T+
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY---TNKV-ITLW 182
Query: 205 YTALDYDLGSEVSTNG-DAYNYGILLLEMVTRRKPIDFMFEGDLNL 249
Y + LG E D ++ G +L E+ T++ +F+ + L
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKP----IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 42/204 (20%)
Query: 77 INLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNL 131
I ++G G+F VY+GV+ + + VAIKVL + A+K + E + ++ H ++
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 132 VR-----------FISIAIDVASALDYLHHHCQEL-----------------------IL 157
VR I+ + + LDY+ +H + ++
Sbjct: 72 VRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLV 131
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D NVL+ I DF LA+ + + + G + I + AL+ L +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 218 TNGDAYNYGILLLEMVT-RRKPID 240
D ++YG+ + E++T KP +
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 40/193 (20%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRFISIA 138
+G G++ V++G L +VA+K + ++ + GA + + E LK++ H N+V I
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 139 --------------------IDVASALDYLHH-------------HCQEL-ILHCDPKPS 164
+D + +H+ +C +LH D KP
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQ 133
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAY 223
N+L++ + DF LAR + S PT++ SN V T+ Y D LG SE ST D +
Sbjct: 134 NLLINERGELKLADFGLARAK---SVPTKTYSNEV-VTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 224 NYGILLLEMVTRR 236
G + EM + R
Sbjct: 190 GVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 41/202 (20%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
+ L+ +G G F V+ G ++ N VA+K L ++F+ E +K + H L
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKL 63
Query: 132 VRFISIA------------IDVASALDYLHHH------CQELI----------------- 156
VR ++ + S LD+L +LI
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 157 -LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+H D + +NVL+ L I DF LAR + + ++ G + I +TA +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 216 VSTNGDAYNYGILLLEMVTRRK 237
+ D +++GILL E+VT K
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R + S L++LH Q I++ D KP NVLLDND I D LA ++
Sbjct: 98 RACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----G 150
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
QS + G T G+ A + G E + D + G+ L EM+ R P
Sbjct: 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 45/215 (20%)
Query: 67 LLKATDGFPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQG--ASKSFMAEC 120
+LK T+ + ++G G+F VY+G++ + + VAIK+L+ + G A+ FM E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 60
Query: 121 KALKNICHRNLVRFISIAIDV-----------ASALDYLHHH------------CQEL-- 155
+ ++ H +LVR + + + LDY+H H C ++
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 156 ---------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
++H D NVL+ + I DF LAR + + + +++G + I +
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 178
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPID 240
AL+ + + D ++YG+ + E++T KP D
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 44/196 (22%), Positives = 74/196 (37%), Gaps = 44/196 (22%)
Query: 80 IGVGSFDAVYQGVF---DLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLVRFI 135
+G G+F +V +GV+ VA+K L K F+ E + + H +VR I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 136 SI------------------------------------AIDVASALDYLHHHCQELILHC 159
+ A VA + YL + +H
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHR 119
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN 219
D NVLL N A I DF ++R S+ ++++ G R + + A + + S+
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG-RWPLKWYAPECINYGKFSSK 178
Query: 220 GDAYNYGILLLEMVTR 235
D ++YG+ L E +
Sbjct: 179 SDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 57/233 (24%), Positives = 86/233 (36%), Gaps = 76/233 (32%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRFISI 137
+G G+F VY+ VVA+K + + + G + + E K LK + H N+V I +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 138 AI----------------------DVASALD-----------------------YLHHHC 152
A+ D++ L+ YLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH--- 132
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTIGYTAL--- 208
+ ILH D K +N+L+DN I DF LAR + NP G R+ YT L
Sbjct: 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK---YTNLVVT 189
Query: 209 -----------DYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250
+ + V D + G + EM TRR PI +G ++
Sbjct: 190 RWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR-PI---LQGKSDID 234
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 45/153 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIK-----VLSIQCQGASKSFMAECKALKNICH 128
+ +G G++ VY+ +VAIK G + + + E K L+ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 129 RNLV---------RFISIAIDVAS----------------------------ALDYLHHH 151
N++ I++ + L+YLH +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184
ILH D KP+N+L+ +D + DF LAR
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 18/107 (16%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
+ + A DVA +DYL Q+ +H D N+L+ + A I DF L+R QEV
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY--- 177
Query: 193 QSSSNGVRRTIG-----YTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
V++T+G + A++ S +TN D ++YG+LL E+V+
Sbjct: 178 ------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 46/199 (23%)
Query: 79 LIGVGSFDAVYQGVFDL---NRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLVRF 134
+IG G F V +G L VAIK L + + F++E + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 135 ISI-----------------AID---------------------VASALDYLHHHCQELI 156
+ A+D +A+ + YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQE-VSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+H D N+L++++L + DF L+RF ++ S+PT +SS G + I +TA + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 216 VSTNGDAYNYGILLLEMVT 234
++ D ++YGI++ E+++
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 46/221 (20%), Positives = 75/221 (33%), Gaps = 74/221 (33%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRA---VVAIKVLSIQCQGASKSF 116
P+E Y++L K IG G+ VY+ +RA VAIK + ++ Q
Sbjct: 17 PRELYKNLEK----------IGEGASGEVYKAT---DRATGKEVAIKKMRLRKQNKELII 63
Query: 117 MAECKALKNICHRNLVRFIS--------------------------------------IA 138
E +K+ H N+V + +
Sbjct: 64 N-EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122
Query: 139 IDVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ-SSS 196
+V L+YLH + +H D K N+LL D + DF A Q +
Sbjct: 123 REVLQGLEYLHSQNV----IHRDIKSDNILLSKDGSVKLADFGFA---------AQLTKE 169
Query: 197 NGVRRTIGYT----ALDYDLGSEVSTNGDAYNYGILLLEMV 233
R ++ T A + + D ++ GI+ +EM
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 54/197 (27%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLV--- 132
L+ IG G F V G + N+ VA+K I+ +++F+AE + + H NLV
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 133 -------------------------------------RFISIAIDVASALDYLHHHCQEL 155
+ ++DV A++YL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+H D NVL+ D A + DF L + E S+ TQ + + + +TA + +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASS-TQDTG---KLPVKWTAPEALREKK 175
Query: 216 VSTNGDAYNYGILLLEM 232
ST D +++GILL E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 50/202 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVR 133
+ +G G F V+ G + + VAIK++ +GA F+ E K + + H NLV+
Sbjct: 8 FLKELGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 134 F--------------------------------------ISIAIDVASALDYLHHHCQEL 155
+ + DV A++YL +
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+H D N L+ D + DF LAR+ V + +SS G + + + + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 216 VSTNGDAYNYGILLLEMVTRRK 237
S+ D +++G+L+ E+ + K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 42/195 (21%), Positives = 81/195 (41%), Gaps = 40/195 (20%)
Query: 79 LIGVGSFDAVYQGVFDL---NRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLVRF 134
+IG G F V++G+ + VAIK L + + F++E + H N++R
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 135 ISIAIDVA-----------SALD-YLHHHCQEL-----------------------ILHC 159
+ ALD YL H E +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN 219
D N+L++++L + DF L+R ++ T ++S G + I +TA + + ++
Sbjct: 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG-KIPIRWTAPEAIAYRKFTSA 190
Query: 220 GDAYNYGILLLEMVT 234
D +++GI++ E+++
Sbjct: 191 SDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 31/155 (20%), Positives = 52/155 (33%), Gaps = 47/155 (30%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFM-AECKALKNICHRNLVR 133
++ IG GSF V + + ++ K + K + +E L+ + H N+VR
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 134 FI-------------------------------------------SIAIDVASALDYLHH 150
+ I + AL H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 151 --HCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
+LH D KP+N+ LD + +GDF LA+
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 62/219 (28%)
Query: 77 INLIGVGSFDAVYQGVFDLNRA-VVAIKVLSIQC--QGASKSFMAECKALKNIC---HRN 130
+ IG G++ VY+ DLN VA+K + + +G S + E LK + H N
Sbjct: 4 LAEIGEGAYGTVYKAR-DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 131 LVRF------------ISIAI-------DVA------------------------SALDY 147
+VR + + + D+A +D+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
LH H I+H D KP N+L+ +D I DF LAR + + V T+ Y A
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-----EMALTSVVVTLWYRA 174
Query: 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ L S +T D ++ G + E+ RR+P+ F G
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELF-RRRPL---FRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 45/215 (20%)
Query: 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVL-SIQCQGASKSFMAE-- 119
+LK T+ F I ++G G+F VY+G++ + VAIK L A+K + E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 120 ----------CKALKNICHRNLVRFISIAIDVASALDYLHHH------------CQEL-- 155
C+ L IC + V+ I+ + LDY+ H C ++
Sbjct: 62 VMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 156 ---------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
++H D NVL+ I DF LA+ ++ + + G + I +
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWM 178
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPID 240
AL+ L + D ++YG+ + E++T KP D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 51/224 (22%), Positives = 81/224 (36%), Gaps = 55/224 (24%)
Query: 73 GFPLINLIGVGSFDAVYQGVFDLNR-----AVVAIKVLSIQCQGASKSFMAECKALKNIC 127
+ + IG G++ VY+ + A+ K Q G S+S E L+ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 128 HRNLVRFISIAID-----VASALDY--------LHHHCQ--------------------- 153
H N+V + + ++ V DY + H Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 154 ------ELILHCDPKPSNVLLDNDLFAH----IGDFELARFRQEVSNPTQSSSNGVRRTI 203
+LH D KP+N+L+ + IGD LAR P + + V TI
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL-ADLDPVVVTI 179
Query: 204 GYTALDYDLGSEVSTNG-DAYNYGILLLEMVTRRKPIDFMFEGD 246
Y A + LG+ T D + G + E++T PI F+G
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI---FKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 45/209 (21%), Positives = 68/209 (32%), Gaps = 66/209 (31%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSI---QCQGASKSFMAECKALKNICHRNLVRF-- 134
IG GSF AVY VVAIK +S Q + + E + L+ + H N + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHC 159
+I L YLH H + +H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHR 139
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV--- 216
D K N+LL + DF A + +P S + Y + EV
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSA----SLVSPANS----------FVGTPYWMAPEVILA 185
Query: 217 ------STNGDAYNYGILLLEMVTRRKPI 239
D ++ GI +E+ R+ P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R + A ++ L+ LH QE I++ D KP N+LLD+ I D LA V P
Sbjct: 103 RAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA-----VHVPE 154
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ G T+GY A + + + D + G LL EM+ + P
Sbjct: 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 10/106 (9%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS-NPTQSS 195
IA+ V L YLH + I+H D KPSN+L++ G +L F VS S
Sbjct: 105 IAVAVLKGLTYLHE--KHKIIHRDVKPSNILVN-----SRGQIKLCDF--GVSGQLVNSL 155
Query: 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241
+ T Y A + G++ S D ++ G+ L+E+ T R P
Sbjct: 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 45/206 (21%), Positives = 79/206 (38%), Gaps = 50/206 (24%)
Query: 78 NLIGVGSFDAVYQGVF---DLNRAVVAIKVLS-IQCQGASKSFMAECKALKNICHRNLVR 133
+IG G F VY G D + A+K L+ I + F+ E +K+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 134 FISIAID---------------------------------------VASALDYLHHHCQE 154
+ I + VA ++YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR--FRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+H D N +LD + DF LAR + +E + + G + + + AL+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWMALESLQ 175
Query: 213 GSEVSTNGDAYNYGILLLEMVTRRKP 238
+ +T D +++G+LL E++TR P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 34/156 (21%), Positives = 55/156 (35%), Gaps = 48/156 (30%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALKNICHR 129
L+ IG G++ V V VAIK +S I K + E K L+++ H
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA----KRILREIKLLRHLRHE 59
Query: 130 NLVRFISIAIDVASA--------LDYLHH---------------HCQEL----------- 155
N++ + I + + + H Q
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 156 ----ILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
++H D KPSN+L++++ I DF LAR
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 45/147 (30%)
Query: 79 LIGVGSFDAVYQGVFD--LNRAV-VAIKVL-SIQCQGASKSFMAECKALKNICHRNLVRF 134
+G GSF V +G + + + VA+K L S + F+ E + ++ H NL+R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 135 ISI--------------------------------------AIDVASALDYLHHHCQELI 156
+ A+ +A+ + YL +
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELAR 183
+H D N+LL +D IGDF L R
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 7/144 (4%)
Query: 121 KALKNICHRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180
+ K I +N +I D+ + L+Y+H H I H D KP N+++D + +I D+
Sbjct: 115 EIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYG 171
Query: 181 LARF---RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRK 237
+A + ++ + R T+ Y LD G+ V+ GD + G +L+ +
Sbjct: 172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231
Query: 238 PIDFMFEGDLNLHNFARMAFPNRV 261
P F + NL + A+ F R+
Sbjct: 232 PWK-GFGHNGNLIHAAKCDFIKRL 254
|
Length = 294 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 54/204 (26%)
Query: 76 LINLIGVGSFDAV----YQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
+ +G G F V ++G +D VAIK++ + + F+ E K + + H L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKL 61
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
V+ + + DV + YL
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK-- 119
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+H D N L+D+ + DF L+R+ V + +SS G + + ++ + L
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 214 SEVSTNGDAYNYGILLLEMVTRRK 237
S+ S+ D + +G+L+ E+ + K
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 41/202 (20%)
Query: 77 INLIGVGSFDAV----YQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNL 131
I ++G G F V Y D +VA+K L +C Q + + E LK + H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 132 VRF--------------ISIAIDVASALDYLHHH----CQELI----------------- 156
V++ I + + S DYL H Q L+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV 216
+H D NVLLDND IGDF LA+ E + +G Y A++ ++
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKF 187
Query: 217 STNGDAYNYGILLLEMVTRRKP 238
S D +++G+ L E++T
Sbjct: 188 SYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-05
Identities = 39/152 (25%), Positives = 55/152 (36%), Gaps = 43/152 (28%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
D F I +G GSF V + A+K+LS I + + E + L++I H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 129 RNLVRFIS-------------------------------------IAIDVASALDYLHHH 151
LV A V AL+YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS- 119
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
I++ D KP N+LLD+D + I DF A+
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 12/112 (10%)
Query: 144 ALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTI 203
LD+LH H ++H D KP N+L+ + + DF LAR Q + V T+
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTL 173
Query: 204 GYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
Y A + L S +T D ++ G + EM RRKP +F G ++ ++
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 32/120 (26%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 115 SFMAECKALKNICHRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174
+F E + + L++F A DVA+ + YL ++ +H D NVL+ +L +
Sbjct: 105 AFAKEHGTASTLTSQQLLQF---ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS 158
Query: 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
I DF L+R + T R + + A++ S +T D +++G+LL E+V+
Sbjct: 159 KIADFGLSRGEEVYVKKTMG-----RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQCQ-GASKSFMAE-- 119
+LK T+ + ++G G+F VY+G++ + + VAIKVL A+K + E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 120 ----------CKALKNICHRNLVRFISIAIDVASALDYLHHH------------CQEL-- 155
C+ L IC + V+ ++ + LDY+ + C ++
Sbjct: 62 VMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 156 ---------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
++H D NVL+ + I DF LAR + T+ ++G + I +
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWM 178
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPID 240
AL+ L + D ++YG+ + E++T KP D
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202
LD+LH +C I+H D KP N+L+ + + DF LAR Q + V T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS-----CQMALTPVVVT 170
Query: 203 IGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
+ Y A + L S +T D ++ G + EM RRKP+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 31/106 (29%), Positives = 48/106 (45%), Gaps = 8/106 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R + A ++ L+ LH +E ++ D KP N+LLD+ I D LA V P
Sbjct: 103 RALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-----VKIPE 154
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
S G T+GY A + + + D + G L+ EM+ + P
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 21/121 (17%)
Query: 134 FISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH--IGDFELARFRQ----- 186
F+SI + + ++Y+H + +LH D KP N+LL LF I D+ A F++
Sbjct: 115 FLSIFHKICATIEYVH---SKGVLHRDLKPDNILLG--LFGEVVILDWGAAIFKKLEEED 169
Query: 187 ----EVSNPTQSSSN-----GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRK 237
+V S+ + T Y A + LG S + D Y G++L +M+T
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 238 P 238
P
Sbjct: 230 P 230
|
Length = 932 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 19/40 (47%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 144 ALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
AL Y+H +I H D KPSN+LL++D + DF LAR
Sbjct: 119 ALKYIH--SGNVI-HRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 47/197 (23%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSI--QCQGASKSFMAECKALKNICHRNLV----- 132
IG G++ VY+ L +VAIK + + + +G K+ + E K LK + H N++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 133 --------------------------------RFISIAIDVASALDYLHHHCQELILHCD 160
S + L + H H ILH D
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRD 123
Query: 161 PKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STN 219
KP N+L++ + + DF LAR +P + ++ V T Y A + LG + ST
Sbjct: 124 LKPENLLINTEGVLKLADFGLAR---SFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTP 179
Query: 220 GDAYNYGILLLEMVTRR 236
D ++ G + E+++RR
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 12/115 (10%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
+A + S + YLH + I+H D KPSN+L+++ I DF ++R + +P SS
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
Query: 197 NGVRRTIGYTA---LDYDL--GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
TI Y + ++ DL G+ GD ++ G+ +LE R P +GD
Sbjct: 230 G----TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 50/208 (24%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNL 131
F +N IG G++ VY+ + +VA+K + + + G S + E L N+ H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 132 VRFISIAI----------------DVAS-----------------------ALDYLHHHC 152
V + + D+AS L YLH +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
I+H D K SN+LL + I DF LAR P + + V T+ Y A + L
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLAR---TYGLPAKPMTPKV-VTLWYRAPELLL 181
Query: 213 GSEVSTNG-DAYNYGILLLEMVTRRKPI 239
G T D + G +L E++ KP+
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLA-HKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 31/144 (21%), Positives = 54/144 (37%), Gaps = 43/144 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
F ++ +G GS+ +VY+ + VVAIKV+ ++ + + E LK +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62
Query: 134 F-------------------------------------IS-IAIDVASALDYLHHHCQEL 155
+ I+ I L+YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDF 179
+H D K N+LL+ + A + DF
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADF 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 57/211 (27%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVR---- 133
IG G++ VY+ + +A+K + ++ + G + + E LK + H N+VR
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 134 ----------FISIAIDVASALD------------------------YLHHHCQELILHC 159
F + +D+ +D Y H H +LH
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHR 126
Query: 160 DPKPSNVLLD---NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-E 215
D KP N+L+D N L + DF LAR P ++ ++ V T+ Y A + LGS
Sbjct: 127 DLKPQNLLIDRRTNAL--KLADFGLAR---AFGIPVRTFTHEV-VTLWYRAPEILLGSRH 180
Query: 216 VSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
ST D ++ G + EMV ++ +F GD
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKP----LFPGD 207
|
Length = 294 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 46/198 (23%), Positives = 75/198 (37%), Gaps = 51/198 (25%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISIA 138
IG G+F VY+GV N V S + F+ E + LK H N+V+ I +
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 139 --------------------------------------IDVASALDYLHHHCQELILHCD 160
+D A+ ++YL +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 161 PKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT-IGYT---ALDYDLGSEV 216
N L+ + I DF ++R E + S+G+++ I +T AL+Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY---GRY 172
Query: 217 STNGDAYNYGILLLEMVT 234
++ D ++YGILL E +
Sbjct: 173 TSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 7e-05
Identities = 46/224 (20%), Positives = 74/224 (33%), Gaps = 80/224 (35%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNICHRNLV 132
+ ++G GS VY+ + A+K + + K + E K L++ +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 133 RF---------ISI----------------------------AIDVASALDYLH--HHCQ 153
+ ISI A + LDYLH H
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-- 120
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
I+H D KPSN+L+++ I DF G+ + + LD
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADF------------------GISKVLE-NTLDQCN- 158
Query: 214 SEVST---------NGDAYNY-------GILLLEMVTRRKPIDF 241
+ V T G++Y+Y G+ LLE + P
Sbjct: 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 62/213 (29%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHRNLVRFISI 137
IG G++ VY+ L +VA+K L + +G + + E LK + H N+VR + +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 138 AID------VASALD----------------------YLHHHCQEL-------ILHCDPK 162
V LD YL+ Q + +LH D K
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK 126
Query: 163 PSNVLLDNDLFAHIGDFELAR--------FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
P N+L+D + + DF LAR + EV T+ Y A + LGS
Sbjct: 127 PQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV------------TLWYRAPEILLGS 174
Query: 215 -EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ ST D ++ G + EMV RR +F GD
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRP----LFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 76 LINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRNL 131
L IG G F VYQGV+ + VA+K + + F+ E ++ H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 132 VRFISIAID 140
V+ I + +
Sbjct: 70 VKLIGVITE 78
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 37/162 (22%), Positives = 56/162 (34%), Gaps = 44/162 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKAL-KNICHR 129
F +IG GSF V AIK+L + + K E + L + H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 130 NLVRFIS-------------------------------------IAIDVASALDYLHHHC 152
+++ A ++ AL+YLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH--- 119
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ I+H D KP N+LLD D+ I DF A+ S+P +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 11/120 (9%)
Query: 115 SFMAECKALKNICHRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174
+F + + L+ F + DVA +DYL Q+ +H D N+L+ + A
Sbjct: 98 AFAIANSTASTLSSQQLLHFAA---DVARGMDYLS---QKQFIHRDLAARNILVGENYVA 151
Query: 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
I DF L+R ++ T R + + A++ S +TN D ++YG+LL E+V+
Sbjct: 152 KIADFGLSRGQEVYVKKTMG-----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 45/156 (28%), Positives = 57/156 (36%), Gaps = 48/156 (30%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKAL-KNICHRNLV--- 132
IG GSF V + A+KVL I + K MAE L KN+ H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 133 ------------------------------------RFISIAIDVASALDYLHHHCQELI 156
RF A ++ASAL YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLH---SLNI 117
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
++ D KP N+LLD+ + DF L + E S T
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 60/221 (27%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSI----------QCQGASKSFMAECKALKNICH 128
LIG G++ VY + ++A+K + + + + K+ +E + LK++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 129 RNLVRF---------ISIAID----------------------------VASALDYLHHH 151
N+V++ +SI ++ V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD-- 209
+ ILH D K N+L+D D I DF +++ ++ + + ++ ++ + A +
Sbjct: 126 -SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD--NDQNMSMQGSVFWMAPEVI 182
Query: 210 YDLGSEVSTNGDAYNYGILLLEMVTRRKP------IDFMFE 244
+ S D ++ G ++LEM R+P I MF+
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 50/198 (25%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVRF--- 134
IG G F V+ G + L + VAIK + +GA + F+ E + + + H LV+
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHC 159
+ + +DV + YL ++H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 160 DPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN 219
D N L+ + + DF + RF V + +SS G + + +++ + S+ S+
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 220 GDAYNYGILLLEMVTRRK 237
D +++G+L+ E+ + K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 44/190 (23%), Positives = 77/190 (40%), Gaps = 40/190 (21%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----- 134
+G G F V+ ++ VA+K + +F+AE +K + H LV+
Sbjct: 14 LGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 135 ------ISIAIDVASALDYL------HHHCQELI------------------LHCDPKPS 164
I+ + S LD+L +LI +H D + +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYN 224
N+L+ L I DF LAR + + ++ G + I +TA + + D ++
Sbjct: 132 NILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 225 YGILLLEMVT 234
+GILL+E+VT
Sbjct: 189 FGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 50/223 (22%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIK---VLSIQCQGASKSFMAECKALKNICHRN 130
F + IG G F VY+ L+ VA+K + + A + E LK + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 131 LVRF---------ISIAIDVASALDY-----------------------------LHHHC 152
++++ ++I +++A A D L H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
++H D KP+NV + +GD L RF S+ T ++++ + T Y + +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKT-TAAHSLVGTPYYMSPERIH 179
Query: 213 GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-LNLHNFAR 254
+ + D ++ G LL EM + P F GD +NL++ +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 41/202 (20%), Positives = 78/202 (38%), Gaps = 51/202 (25%)
Query: 77 INLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQGASKSFMA---ECKALKNICHR 129
+ L+G G F V++G++ D + VAIK IQ + ++F A+ ++ H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 130 NLVRFISI-------------------------------------AIDVASALDYLHHHC 152
+VR + I + +A + YL H
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
++H + N+LL +D I DF +A + + + + I + AL+ L
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYFYSEHKTPIKWMALESIL 184
Query: 213 GSEVSTNGDAYNYGILLLEMVT 234
+ D ++YG+ + EM++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 66/209 (31%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK----------SFMAECK-- 121
F L+ IG GSF VY+ + VVAIKV+ ++ ++ F+++C+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE---EAEDEIEDIQQEIQFLSQCRSP 59
Query: 122 --------ALKNI-------------CHRNLVRFI-----SIAI---DVASALDYLHHHC 152
LK C +L++ IA +V L+YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVLLGLEYLH--- 115
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+E +H D K +N+LL + GD +LA F VS Q +S +R + + +
Sbjct: 116 EEGKIHRDIKAANILLSEE-----GDVKLADF--GVS--GQLTSTMSKRNT-FVGTPFWM 165
Query: 213 GSEVSTNGDAYNY-------GILLLEMVT 234
EV Y+ GI +E+
Sbjct: 166 APEVIKQS-GYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 52/234 (22%), Positives = 85/234 (36%), Gaps = 65/234 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAEC----KALKNICHR 129
F ++N IG GSF V++ V ++ V A+K + + ++ E + L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSS 59
Query: 130 NLVRF---------ISIAIDVAS------------------------------ALDYLHH 150
++R+ ++I ++ A L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH- 118
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
+ ILH D K N+ LD IGD +A+ S + TI T Y
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--------LLSDNTNFANTIVGTP--Y 166
Query: 211 DLGSEV------STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258
L E+ + D + G++L E T + P D +G L L R FP
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL-KIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
S + +LH + ILH D K SN+LL+N I DF LAR
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/125 (24%), Positives = 59/125 (47%), Gaps = 11/125 (8%)
Query: 114 KSFMAECKALKNICHRNL--VRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND 171
K F+ +C+ + + L + + +AI +A + YLH ++H D N ++D +
Sbjct: 97 KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153
Query: 172 LFAHIGDFELAR--FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILL 229
L I D L+R F + R + + AL+ + E S+ D +++G+LL
Sbjct: 154 LQVKITDNALSRDLF----PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209
Query: 230 LEMVT 234
E++T
Sbjct: 210 WELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R +I + + AL YLH ++ I+H D P+N++L D I DF LA+ +Q S T
Sbjct: 114 RIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT 171
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
V TI Y+ + D + +G +L +M T + P
Sbjct: 172 S-----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 144 ALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF----RQEVSNPTQSSSNGV 199
AL+YLH + I+H D KP N+L+D++ + DF L++ RQ N + +
Sbjct: 105 ALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
T Y A + LG S D ++ G +L E +
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 38/154 (24%), Positives = 59/154 (38%), Gaps = 49/154 (31%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIK-------VLSIQCQGASKSFMAECKALKNI 126
+ I IG G++ V + + VAIK V ++ +K + E K L++
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL-----AKRTLRELKILRHF 61
Query: 127 CHRNLVRFISI-------AIDVASALDY----LHH--HCQEL------------------ 155
H N++ I DV +D LHH H +
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 156 ------ILHCDPKPSNVLLDNDLFAHIGDFELAR 183
++H D KPSN+L++ D IGDF +AR
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 59/212 (27%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS---------KSFMAECKALKNICHR 129
LIG GSF +VY G+ + ++A+K + + AS + E LK + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 130 NLVRFISIAID---------------VASALD----------------------YLHHHC 152
N+V+++ ++D VA+ L+ YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--- 123
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
I+H D K +N+L+DN I DF +++ + +N + +NG R ++ + + +
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE--ANSLSTKTNGARPSLQGSV--FWM 179
Query: 213 GSEV------STNGDAYNYGILLLEMVTRRKP 238
EV + D ++ G L++EM+T + P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/114 (27%), Positives = 46/114 (40%), Gaps = 21/114 (18%)
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197
A ++ L +LH I++ D K NVLLD++ I DF + + +
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---------EGILG 149
Query: 198 GVRR-----TIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
GV T Y A + D + G+LL EM+ + P FEGD
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 36/140 (25%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRFISI 137
IG G+ V++ VA+K ++++ G + E KAL+ H +V+ + +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 138 ---------------------------AIDVASALDYLH------HHCQEL-ILHCDPKP 163
+ A Y+ + I+H D KP
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKP 127
Query: 164 SNVLLDNDLFAHIGDFELAR 183
+N+L+ D I DF LAR
Sbjct: 128 ANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 127 CHR-NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185
CH+ +L R A ++ L +LH + I++ D K N+LLD D I DF + +
Sbjct: 90 CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK-- 144
Query: 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ + + T Y A + LG + +T+ D +++G+LL EM+ + P
Sbjct: 145 --ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 15/153 (9%)
Query: 89 YQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNIC-HRNLVRFISIAIDVASALD 146
Y G F L+ + +I + C+G S S + K + L + IA V L
Sbjct: 64 YYGAF-LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK---IAESVLKGLS 119
Query: 147 YLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
YLH I+H D KPSN+LL + DF ++ E+ N + G T Y
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTG---TSFYM 170
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
A + G S D ++ G+ LLE+ R P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 8/142 (5%)
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197
A ++ AL++LH + I++ D K NVLLD D + D+ + + E P ++S
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTST 155
Query: 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG-DLNLHNFARMA 256
T Y A + G E + D + G+L+ EM+ R P D + + D+N ++
Sbjct: 156 FCG-TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 257 FPNRVMDIVNLVLLNDNKVLAG 278
+ + I + + + VL G
Sbjct: 215 ILEKPIRIPRFLSVKASHVLKG 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 62/200 (31%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA-----SKSFMAECKALKNICHRNLVRF 134
IG G+F V+ G + VA+K C+ F+ E + LK H N+VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 135 ISIAI--------------------------------------DVASALDYLH-HHCQEL 155
I + + A+ ++YL HC
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT-IGYT---ALDYD 211
+H D N L+ I DF ++R E + +S+ G+++ + +T AL+Y
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNY- 170
Query: 212 LGSEVSTNGDAYNYGILLLE 231
S+ D +++GILL E
Sbjct: 171 --GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 41/164 (25%), Positives = 57/164 (34%), Gaps = 58/164 (35%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAE 119
P+E YE LI IG G++ VY+ +VAIKV+ ++ + E
Sbjct: 1 PQEDYE----------LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE 50
Query: 120 CKALKNICHRNLVRFI-------------------SIAIDVASA---------------- 144
LK H N+V + S+ D+
Sbjct: 51 ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRE 109
Query: 145 ----LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184
L YLH I H D K +N+LL D GD +LA F
Sbjct: 110 TLKGLAYLHE--TGKI-HRDIKGANILLTED-----GDVKLADF 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 62/218 (28%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIK---VLSIQCQGASKSFMAECKALKNICHRNLVRFI- 135
IG G F VY+ L+R VA+K + + A + + E LK + H N+++++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 136 --------SIAIDVASALDY-----------------------------LHHHCQELILH 158
+I +++A A D + H ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE-VS 217
D KP+NV + +GD L RF S+ T ++ + V Y + E +
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLV-------GTPYYMSPERIH 179
Query: 218 TNG-----DAYNYGILLLEMVTRRKPIDFMFEGD-LNL 249
NG D ++ G LL EM + P F GD +NL
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 132 VRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
V++IS +VA ALDYLH H I+H D KP N+L+ N+ + DF L++
Sbjct: 107 VKYIS---EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 70 ATDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKS-FMAECKAL 123
D L+ +G G+F VY+G++ D VA+K L C +S F+ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 124 KNICHRNLVRFISIAID 140
H+N+VR I ++ +
Sbjct: 64 SKFNHQNIVRLIGVSFE 80
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 62/217 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN 130
D + +I +G G+F VY+ A K++ I+ + + FM E L H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 131 LVRFISI-----------------AID---------------------VASALDYLHHHC 152
+V A+D + AL++LH H
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
++H D K N+LL D GD +LA F VS +S+ IG Y +
Sbjct: 123 --KVIHRDLKAGNILLTLD-----GDVKLADF--GVSAKNKSTLQKRDTFIGTP---YWM 170
Query: 213 GSEV----STNGDAYNY-------GILLLEMVTRRKP 238
EV + + Y+Y GI L+E+ P
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 27/128 (21%), Positives = 56/128 (43%), Gaps = 9/128 (7%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
IAI +A AL +LH C ++ + P +++D H+ + S+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA- 843
Query: 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256
Y A + +++ D Y +G++L+E++T + P D F ++ +AR
Sbjct: 844 --------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895
Query: 257 FPNRVMDI 264
+ + +D+
Sbjct: 896 YSDCHLDM 903
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 139 IDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198
+ SA+ Y+H + ILH D K N+ L +GDF +++ + S +
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK----ILGSEYSMAET 160
Query: 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240
V T Y + + G + + D + G +L E++T ++ D
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 41/197 (20%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRFISI 137
IG G++ V++ +VA+K + + +G S + E LK + H+N+VR +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 138 ---------------------------AIDVASALDYLHH------HC-QELILHCDPKP 163
ID ++ C +LH D KP
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP 127
Query: 164 SNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STNGDA 222
N+L++ + + DF LAR P + S V T+ Y D G+++ ST+ D
Sbjct: 128 QNLLINKNGELKLADFGLAR---AFGIPVRCYSAEV-VTLWYRPPDVLFGAKLYSTSIDM 183
Query: 223 YNYGILLLEMVTRRKPI 239
++ G + E+ +P+
Sbjct: 184 WSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 56/197 (28%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK-SFMAECKALKNICHRNLVRFISI 137
L+G G+F V++G ++ VA+K K F++E + LK H N+V+ I +
Sbjct: 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 138 --------------------------------------AIDVASALDYLH-HHCQELILH 158
A+D A+ + YL +C +H
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT-IGYTA---LDYDLGS 214
D N L+ + I DF ++R QE + SS+G+++ I +TA L+Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--QE--DDGIYSSSGLKQIPIKWTAPEALNY---G 169
Query: 215 EVSTNGDAYNYGILLLE 231
S+ D ++YGILL E
Sbjct: 170 RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP-TQSS 195
I+I V L YL + I+H D KPSN+L+++ G+ +L F VS S
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-----GEIKLCDF--GVSGQLIDSM 154
Query: 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
+N T Y + + G+ + D ++ G+ L+EM R PI
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
RF S I +A L+YLH + I++ D K NVLLD++ + D+ + + E P
Sbjct: 99 RFYSAEISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG 150
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
++S T Y A + G + + D + G+L+ EM+ R P D + D
Sbjct: 151 DTTSTFCG-TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
++I V L YL Q I+H D KPSN+L+++ + DF ++ S +
Sbjct: 108 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMA 159
Query: 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
N T Y + + G+ S D ++ G+ L+E+ R PI
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 34/173 (19%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
DG PLI + F+ + G DLN+ + A G + + + + L
Sbjct: 78 DGDPLIMV-----FEYMKHG--DLNKFLRA--------HGPDAMILVDGQPRQAKGELGL 122
Query: 132 VRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191
+ + IA +AS + YL + +H D N L+ +L IGDF ++R
Sbjct: 123 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------- 171
Query: 192 TQSSSNGVRRTIGYTAL-------DYDLGSEVSTNGDAYNYGILLLEMVTRRK 237
S R G+T L + + + +T D +++G++L E+ T K
Sbjct: 172 -DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 15/116 (12%)
Query: 151 HCQEL-ILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
HC + ++H D KP N+L+D I D L R S P +S ++ + T+ Y A
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR---AFSIPVKSYTHEI-VTLWYRAP 180
Query: 209 DYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN----LHNFARMAFPN 259
+ LGS ST D ++ G + EM R++P +F GD LH F + P
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMS-RKQP---LFPGDSELQQLLHIFKLLGTPT 232
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 72/228 (31%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAE 119
P+E++E +I +G G+F VY+ + A KV+ + + + +M E
Sbjct: 3 PEEFWE----------IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE 52
Query: 120 CKALKNICHRNLVRFISI-----------------AIDVA-------------------- 142
L + H N+V+ + A+D
Sbjct: 53 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQT 112
Query: 143 -SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRR 201
AL+YLH + I+H D K N+L D GD +LA F N + ++R
Sbjct: 113 LEALNYLH---ENKIIHRDLKAGNILFTLD-----GDIKLADFGVSAKN-----TRTIQR 159
Query: 202 TIGYTALDYDLGSEV-----------STNGDAYNYGILLLEMVTRRKP 238
+ Y + EV D ++ GI L+EM P
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R I A ++ L+ L +E I++ D KP N+LLD+ I D LA V P
Sbjct: 103 RAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA-----VQIPE 154
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ G T+GY A + + + + D + G L+ EM+ + P
Sbjct: 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
++I V L YL + I+H D KPSN+L+++ + DF ++ S +
Sbjct: 108 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMA 159
Query: 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
N T Y + + G+ S D ++ G+ L+EM R PI
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 16/49 (32%), Positives = 24/49 (48%)
Query: 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184
IA +A L LH ++ H D P N+L+D+ I D+E A +
Sbjct: 90 DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 48/219 (21%), Positives = 78/219 (35%), Gaps = 62/219 (28%)
Query: 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHRN 130
F ++ +G GS+ +VY+ + A+K L Q + + E + L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 131 LVRF-----------------------------------------ISIAIDVASALDYLH 149
++ + I I + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG---YT 206
++ ILH D K +N+LL + IGD +++ ++ TQ IG Y
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ---------IGTPHYM 168
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG 245
A + G S D ++ G LL EM T P FE
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 148 LHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
+HH H + +I H D K +N+LL ++ +GDF F + + + S+ V RT +
Sbjct: 156 VHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFG---FSKMYAA---TVSDDVGRT--FC 206
Query: 207 ALDYDLGSEV------STNGDAYNYGILLLEMVTRRKPID 240
Y + E+ S D ++ G+LL E++T ++P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 25/97 (25%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
++YLH + +I+H D K +N+L D+ +GDF ++ Q + SS G++ G
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC----SSGTGMKSVTG 169
Query: 205 ---YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ + + G D ++ G ++EM+T + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 133 RFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
R + A ++ L+ LH +E I++ D KP N+LLD+ I D LA V P
Sbjct: 103 RAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA-----VEIPE 154
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ G T+GY A + + + D + G L+ EM+ + P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 140 DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199
++A ALD+LH I++ D KP N+LLD + + DF L++ + S
Sbjct: 106 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG-- 160
Query: 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG 245
T+ Y A + + + D +++G+L+ EM+T P F+G
Sbjct: 161 --TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 356 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.49 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.34 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.04 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.84 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.84 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.33 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.79 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.74 | |
| PLN02236 | 344 | choline kinase | 95.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.17 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.7 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.17 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.68 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.53 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 91.98 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.74 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 91.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.14 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.65 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 89.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.24 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.19 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 88.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 88.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 88.71 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 86.7 | |
| PTZ00296 | 442 | choline kinase; Provisional | 86.4 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 86.13 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=343.30 Aligned_cols=250 Identities=32% Similarity=0.536 Sum_probs=211.4
Q ss_pred cCChhhHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---
Q 039228 58 AIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--- 134 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--- 134 (356)
....|++.++..+|++|.-.+.||+|+||.||+|....+ ..||||.+........++|.+|+.++.+++|||+|++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999866 8999998875433214569999999999999999987
Q ss_pred -------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 135 -------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 135 -------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
+.|+.++|.||+|||+.+.++||||||||+|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 4799999999999999988899999999999999999999999
Q ss_pred cccccccccc-CCCCCccCCCCc-cccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccc-cCCccHHHHHH
Q 039228 178 DFELARFRQE-VSNPTQSSSNGV-RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF-EGDLNLHNFAR 254 (356)
Q Consensus 178 Dfg~a~~~~~-~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~-~~~~~~~~~~~ 254 (356)
|||+|+.... ... .... .||.+|++||+...+..+.++|||||||+++|++||+.|.+... .+...+..|+.
T Consensus 220 DFGLa~~~~~~~~~-----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS-----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CccCcccCCccccc-----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999975443 111 1111 78999999999999999999999999999999999999987544 33455888887
Q ss_pred HhCC-CchHHHhhhhhc-cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 255 MAFP-NRVMDIVNLVLL-NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 255 ~~~~-~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
..+. ..+.+++|+.+. ..+.. ..+...+..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~-----------------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPD-----------------EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCCh-----------------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 7664 478899999886 33321 15777899999999999999999999999999666544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.91 Aligned_cols=239 Identities=18% Similarity=0.192 Sum_probs=178.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+.|+.+.++|+|+||.||+++++.||+.||||++-... ....+-.++|+++|++|+|+|+|.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35888899999999999999999999999999996443 2334567899999999999999998
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+...+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--- 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--- 155 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc---
Confidence 347889999999999999 9999999999999999999999999999876432
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCcc-HHHHHHHhCCCchHHHhhh--h
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN-LHNFARMAFPNRVMDIVNL--V 268 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~ 268 (356)
...+..+.|.+|+|||.+.+ -.|+..+||||+||++.||++|.+-|.+.++-+.- .....-..+..+..++... .
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 23345788999999999988 67999999999999999999999999864432211 1111111122233333221 1
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.+-.-......+ ......+.....+++++..||+.||++|++-++++.
T Consensus 235 F~Gv~lP~~~~~e-----pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPE-----PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCcc-----chhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111000000011 111122345557889999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=307.62 Aligned_cols=221 Identities=24% Similarity=0.304 Sum_probs=177.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..+|+++++||+|.||+||++....++..||.|.++.. +....+.+..|+.+|++|+|||||++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34699999999999999999999999999999998743 23344678899999999999999998
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCC-CcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQ-ELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
++++.|++.||..+|+.-. .-|+||||||.||+|+.+|.+||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 5688999999999998321 1289999999999999999999999999998
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
+... .......+||+.||+||.+.+.+|+.+|||||+||++|||..-++||.+. ++.+......
T Consensus 178 l~s~----~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~------- 241 (375)
T KOG0591|consen 178 LSSK----TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIE------- 241 (375)
T ss_pred hcch----hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHH-------
Confidence 7643 34456689999999999999999999999999999999999999999742 3333222211
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.++++. --..-....|..|+..|+..||+.||+.-.++..+..
T Consensus 242 -----qgd~~~--------------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 -----QGDYPP--------------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----cCCCCC--------------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111110 0001445577899999999999999996666555544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=326.63 Aligned_cols=225 Identities=28% Similarity=0.413 Sum_probs=179.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccc--hHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..+.+.+.||+|+||+||+|.+..+ ..||||++....... .+.|.+|+.+|.+++|||||++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3455666799999999999999843 339999997543222 4689999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.|+.|||+.+. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 5689999999999999873 99999999999999997 9999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhc--CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDL--GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
. .......||+.|||||++. ...|+.++||||||+++|||+||+.||...... .... .++.
T Consensus 198 ~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~-----------~v~~ 260 (362)
T KOG0192|consen 198 K----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVAS-----------AVVV 260 (362)
T ss_pred c----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHH-----------HHHh
Confidence 2 2223378899999999999 568999999999999999999999999864331 1111 1111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
...... .+..++..+..++..||+.||..||++.+++..|+.+...+...
T Consensus 261 ~~~Rp~------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 261 GGLRPP------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred cCCCCC------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 111111 11246678899999999999999999999999999998876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=330.22 Aligned_cols=212 Identities=21% Similarity=0.264 Sum_probs=176.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..|+..++||+|||+.||.+++..+|..||+|++.+. .....+.+.+|+++.+.|+|||||++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999999999999999999753 34556789999999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||.|||+++ |||||||-.|+|++++.++||+|||+|..+....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence 348899999999999999 9999999999999999999999999998776432
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......+||+.|.|||++....++..+||||+||+||.||+|++||+.. .+.+.++..-..
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----------------~vkety~~Ik~~ 233 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----------------TVKETYNKIKLN 233 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----------------hHHHHHHHHHhc
Confidence 3344589999999999999999999999999999999999999999742 122233332222
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
++.. +........+||.++|+.||.+|||+++|+..
T Consensus 234 ~Y~~----------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 EYSM----------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred Cccc----------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2210 01223345789999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=313.96 Aligned_cols=216 Identities=21% Similarity=0.256 Sum_probs=179.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++++.++.||+|..|+||+++++.|++.+|+|.+... .....+++.+|+++++..+||+||.+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3577788999999999999999999999999999544 34456789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
-.|+.++++||.|||+ ++ ||||||||+|||++..|.+||+|||.++.+...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 2478899999999996 77 999999999999999999999999999876532
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
....++||..|||||.+.+..|+.++||||||++++|+++|+.||....... ....++++....+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------------~~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------------LDIFELLCAIVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------------CCHHHHHHHHhcC
Confidence 4567899999999999999999999999999999999999999997531111 2333444444433
Q ss_pred ccccccccccchhhhhchhhHH-HHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRL-ECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.++. .+. .+..++.+++..||+.||.+|||+.|+++.
T Consensus 298 ppP~---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPR---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCC---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3221 111 356678999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.74 Aligned_cols=216 Identities=22% Similarity=0.259 Sum_probs=170.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-------chHHHHHHHHHHhhcCCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-------ASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
.+.|.+.+.||+|+||.|-+|..+.+++.||||++++.... ....+.+|+++|++|+|||||++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688999999999999999999999999999999754211 12235699999999999999997
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC---CceEEccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND---LFAHIGDFELAR 183 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~ 183 (356)
.-++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 237899999999999999 9999999999999755 789999999999
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCC---CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV---STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
..+. .......+||+.|.|||++.+..+ ..++||||+||+||-+++|.+||........-..+.
T Consensus 328 ~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI-------- 394 (475)
T KOG0615|consen 328 VSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI-------- 394 (475)
T ss_pred cccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH--------
Confidence 7653 344566899999999999987653 347799999999999999999998644332111111
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.+.+.. ....| .+..++..+||.++|..||++|||+.|++.
T Consensus 395 --------~~G~y~f--------~p~~w----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 --------LKGRYAF--------GPLQW----DRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --------hcCcccc--------cChhh----hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111110 00111 245556789999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=305.45 Aligned_cols=164 Identities=30% Similarity=0.392 Sum_probs=146.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|+++++||+|+||.||+++.+.+++.+|+|++++.. ....+....|..+|.+++||+||.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 567999999999999999999999999999999997542 3345678899999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
.-++.+|+.||.|||+.+ ||||||||+|||||..|+++|+|||+++..-...
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 236778999999999999 9999999999999999999999999998543322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.....++||+.|||||++.+..|+..+|+||||+++|||++|.+||..
T Consensus 180 ---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 180 ---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred ---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 233448999999999999999999999999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.92 Aligned_cols=233 Identities=27% Similarity=0.395 Sum_probs=185.9
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------ 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------ 134 (356)
...+|....+.+.+...||+|.||+||+|+|- ..||||+++... .+..+.|.+|+..+++-+|-||+-|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 33667777788899999999999999999996 569999998653 3456789999999999999999976
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+.||++|+.|||.++ |||||||..||++.+++.|||+|||++.
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 669999999999999999 9999999999999999999999999997
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
...... .........|...|||||++.. .+|++.+||||||+++|||+||..||.....+...+..-.....++
T Consensus 537 vk~~w~--g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd- 613 (678)
T KOG0193|consen 537 VKTRWS--GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD- 613 (678)
T ss_pred eeeeec--cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-
Confidence 654442 2334455677889999999863 5799999999999999999999999972221211111000000010
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+ .....+|++++.+|+..||..++++||.+.+|+.+|+.+..++
T Consensus 614 --------~-------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 614 --------L-------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred --------c-------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0 0112378889999999999999999999999999999887764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=309.31 Aligned_cols=241 Identities=23% Similarity=0.292 Sum_probs=179.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.+.|+.++.||+|.||.||+|++..+|+.||+|.+.... .+...-..+||.+|++|+||||+++
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356889999999999999999999999999999997654 4556778899999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|+|++| |+|||||.+|||||++|.+||+|||+|++.....
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 348899999999999999 9999999999999999999999999999776544
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-C-CchHHHhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-P-NRVMDIVN 266 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~ 266 (356)
. ...+..+-|++|.|||.+.|. .|+.+.|+||.||||.||++|++.|.+..+-. .+.......- | +..+...+
T Consensus 273 ~---~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 273 S---APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred C---cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhcccccc
Confidence 2 224456779999999999875 69999999999999999999999997643321 2222222221 1 11111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
-.....+. ........+.+.. ...+...++|+..+|..||.+|.|+.+++..
T Consensus 349 LP~~~~~k-p~~~y~r~l~E~~----~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFK-PQQPYKRRLRETF----KDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccC-CCCcccchHHHHh----ccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00000000 0011111222221 1233456789999999999999999988753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=313.12 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=187.7
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhc-CCCChHHH---------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CHRNLVRF--------- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l--------- 134 (356)
.+...+|..++.||.|+|++|++|+.+.+++.||||++.+. .....+.+..|-.+|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55678999999999999999999999999999999999643 233345677899999999 79999997
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+|+.||+|||++| ||||||||+|||||.+|+++|+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 237889999999999999 9999999999999999999999999999875
Q ss_pred cCCCC---------CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 187 EVSNP---------TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 187 ~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
..... .......++||..|.+||++.....++.+|+|+|||++|+|+.|.+||....+ ...++....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~--- 301 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQA--- 301 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHH---
Confidence 43322 11122569999999999999999999999999999999999999999974321 111111111
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcccccc
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVF 337 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~ 337 (356)
++-.+.+ ..++...+|+.+.|..||.+|+|+.+|-+. -+.....|
T Consensus 302 -------l~y~fp~----------------------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H------pFF~~Vdw 346 (604)
T KOG0592|consen 302 -------LDYEFPE----------------------GFPEDARDLIKKLLVRDPSDRLTSQQIKAH------PFFEGVDW 346 (604)
T ss_pred -------hcccCCC----------------------CCCHHHHHHHHHHHccCccccccHHHHhhC------cccccCCh
Confidence 1111111 222356789999999999999999655432 23444556
Q ss_pred ccCCcCCcccccccc
Q 039228 338 KSLTNNRAPKLKASS 352 (356)
Q Consensus 338 ~~~~~~~~~~~~~~~ 352 (356)
+++-.+..|.+++.-
T Consensus 347 ~nlw~~~PP~l~py~ 361 (604)
T KOG0592|consen 347 ENLWQQTPPKLQPYK 361 (604)
T ss_pred hhhhhcCCCcccCCC
Confidence 666677777766653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.35 Aligned_cols=240 Identities=22% Similarity=0.238 Sum_probs=177.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRFI-------------- 135 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~-------------- 135 (356)
.+|...++||+|.||.||+|++..+|+.||||.++.... ......++|++.|+.++|+||+.++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999999999999999975532 2345688999999999999999983
Q ss_pred -----------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 136 -----------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 136 -----------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
.++.+++.||+|||.+. |+||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 36778999999999999 9999999999999999999999999999876544322
Q ss_pred ccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
. ..+-|.+|+|||.+.|. .|+...||||.||++.||+-|.+-|.+..+ -..+....+..-.....+|-+..-.+
T Consensus 159 ~----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 159 T----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred c----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCccccccc
Confidence 1 22669999999998874 599999999999999999999887764322 12233333333222222222222222
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
++...........+.... .+.....+|+..++..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~----aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFP----AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccc----cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 222111111111122222 344556899999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.16 Aligned_cols=220 Identities=24% Similarity=0.396 Sum_probs=179.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+.+++++.||+|.||.||.|.++.+ ..||+|.++.. ....+.|.+|+++|++|+|+|||++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3466788999999999999999855 69999998754 3445789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.||+.|++||++++ +|||||.+.|||++++..+||+|||+|+......
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~--- 357 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE--- 357 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc---
Confidence 679999999999999999 9999999999999999999999999999433221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........-+.-|.|||.+..+.++.+||||||||+||||+| |+.||..+... +. .+.++...
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev---------~~~le~Gy-- 421 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EV---------LELLERGY-- 421 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HH---------HHHHhccC--
Confidence 222333344667999999999999999999999999999999 99998754321 11 11122211
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.+..+..|+..+.+||..||+.+|++|||+..+...|+.+....
T Consensus 422 ----------------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 ----------------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ----------------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 12223478889999999999999999999999999998887643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.43 Aligned_cols=228 Identities=21% Similarity=0.279 Sum_probs=177.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..++|++..+||.|.-++||+|+...++..||||+++.+.. ...+.+.+|+..|+.++||||+++
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35789999999999999999999999999999999986543 335889999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..|+++++.||.|||.+| .||||||+.||||+++|.+||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 237789999999999999 9999999999999999999999999988776554
Q ss_pred CCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.........++||+.|||||++.. ..|+.|+||||||++..||.+|..||.....-..-+... ....|.......+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~~- 258 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGLD- 258 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccCC-
Confidence 333333377899999999999643 569999999999999999999999997432211111110 0000000000000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+........+.+++..||..||.+|||++++++.
T Consensus 259 ---------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 ---------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 01112334478899999999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=301.94 Aligned_cols=164 Identities=31% Similarity=0.475 Sum_probs=147.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+. .....+.+..|+.+|+.++|||||++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 357899999999999999999999999999999999765 45556778899999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC------CceEEcccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND------LFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfg~a~~ 184 (356)
..++.|++.||++||+++ ||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 337789999999999999 9999999999999764 4689999999998
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
+.. .......+|++.|||||++....|+.|+|+||+|+++|+|++|+.||+.
T Consensus 165 L~~-----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQP-----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCc-----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 763 3445568999999999999999999999999999999999999999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=307.45 Aligned_cols=236 Identities=19% Similarity=0.220 Sum_probs=177.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchH-HHHHHHHHHhhcC-CCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK-SFMAECKALKNIC-HRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l-------------- 134 (356)
-++|.+++.||.|.||.||+|+...++..||||.++.......+ .-++|+..|++|+ |||||++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45799999999999999999999999999999999755333222 2468999999999 9999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.....
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC--
Confidence 458899999999999999 999999999999999999999999999976542
Q ss_pred CCccCCCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC---ch--HH
Q 039228 191 PTQSSSNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN---RV--MD 263 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~---~~--~~ 263 (356)
...+..+.|.+|+|||++. .+-|+.+.|||++||+++|+.+-++-|.+..+-+... ....-.- |. +. ..
T Consensus 164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~-KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY-KICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH-HHHHHhCCCccccchhHHH
Confidence 3344578899999999876 4678999999999999999999999998765433221 1111111 11 11 11
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+... +.-..+ .+...........+..+..+|+.+|+++||++||||+++++.
T Consensus 240 La~~-mnf~~P-------~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASA-MNFRFP-------QVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHH-hccCCC-------cCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111 111110 111111111222455677899999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.12 Aligned_cols=226 Identities=23% Similarity=0.308 Sum_probs=175.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..++...+.||+|+||.||++.+..++...|||.+........+.+.+|+.+|.+++|||||++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3458888999999999999999998899999999876543346778999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 189 (356)
..+..||+.||.|||++| ||||||||+|||++. ++.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES-K 171 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc-c
Confidence 347789999999999999 999999999999999 79999999999987664 1
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
...........||+.|||||++.++ ....++|||||||++.||+||+.||..... .............
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~~-------- 240 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGREDS-------- 240 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccCC--------
Confidence 1222334458899999999999853 334599999999999999999999975311 0011111111000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
. +..+...+....+++..|+..||+.||||++++....-....
T Consensus 241 -~------------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 241 -L------------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -C------------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 0 011113344567999999999999999999999876554433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=305.63 Aligned_cols=212 Identities=26% Similarity=0.361 Sum_probs=176.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... ...+.+.+|+++++.++|||||.+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578999999999999999999999999999999975533 345678999999999999999998
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|||+||.|||++.+|.+|++|||+|+.+... .
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----t 154 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----T 154 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC----c
Confidence 347889999999999999 999999999999999999999999999976542 3
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
.....+.||+.|||||...+.+|+..+|+||+||++|||++|++||-. ..+.+++...+..+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----------------~si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----------------RSITQLVKSILKDPV 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----------------HHHHHHHHHHhcCCC
Confidence 445568899999999999999999999999999999999999999952 122233332222221
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. +.+....+.+++...|..||..|.++.+++..
T Consensus 218 ~~----------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KP----------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CC----------------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 10 01344457889999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.94 Aligned_cols=215 Identities=21% Similarity=0.255 Sum_probs=179.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
..|.....||+|+.|.||.|....+++.||||.+........+-+++|+.+|+..+|+|||.+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457888899999999999999999999999999998877777789999999999999999998
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..||++++.||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.... ..
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----SK 425 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc----Cc
Confidence 248899999999999999 9999999999999999999999999998765443 24
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
....+||+.|||||+.....|+++.||||||++++||+-|.+||-. +..+.......-.+. +.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~------P~l------ 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGT------PKL------ 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCC------CCc------
Confidence 5668999999999999999999999999999999999999999853 222322221111110 000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.........+.+++.+||..|+++||++.+||+.
T Consensus 490 --------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1112445578899999999999999999999973
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.76 Aligned_cols=243 Identities=21% Similarity=0.206 Sum_probs=177.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEee--ccCccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
....|..++.||+|+||.|+.|.+..+|+.||||.+. .......++..+|+++|+.++|+||+.+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3556777899999999999999999999999999987 4455667889999999999999999976
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
-.++.|+++||.|+|+.+ |+||||||+|++++.++.+||+|||+|+...
T Consensus 100 DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence 126789999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccCCCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC----ch
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN----RV 261 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----~~ 261 (356)
.. ......+..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|++-|.+...- .-........+. .+
T Consensus 177 ~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 177 KF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEEDL 252 (359)
T ss_pred cc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHHHH
Confidence 54 2334446688899999999875 467999999999999999999999999753221 111111111111 11
Q ss_pred HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 262 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+-+..........+.....-.....+ ......++|+.+||..||.+|+|++|.++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp----~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFP----NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcC----CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111110000000011111111112 223345789999999999999999998863
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.19 Aligned_cols=213 Identities=22% Similarity=0.262 Sum_probs=173.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRFIS-------------- 136 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~-------------- 136 (356)
..|+..+.||+|.||.||+|.+..+++.||+|++...... ..+.+.+|+.+|..++++||.+++.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3477789999999999999999999999999999866443 4577889999999999999988722
Q ss_pred -----------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 137 -----------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 137 -----------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+....
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---- 165 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh----
Confidence 6678999999999999 9999999999999999999999999998665432
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
.....++||+.|||||++.+..|+.++||||||++.+||++|.+|+....... +...++.+. .|.+.+
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------vlflIpk~~----PP~L~~-- 233 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------VLFLIPKSA----PPRLDG-- 233 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------EEEeccCCC----CCcccc--
Confidence 33367999999999999998899999999999999999999999987533211 000111111 111111
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+...+.+++..||+.||+.||+|.++++.
T Consensus 234 --------------------~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 --------------------DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --------------------ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 233457899999999999999999999863
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=283.09 Aligned_cols=242 Identities=22% Similarity=0.251 Sum_probs=175.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.+.|+.++.|++|.||.||+|+++.+++.||+|+++... ....-..++||.+|.+.+|||||.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456999999999999999999999999999999997543 2333457899999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..+..|++.||+|||.+. |+|||||++|+|+.+.|.+||+|||+|+..+...
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 236789999999999999 9999999999999999999999999999776542
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh-CCC-chHHHhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA-FPN-RVMDIVN 266 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~-~~~~~~~ 266 (356)
...+..+-|++|+|||.+.+. .|++..|+||+|||+.||+++++-|.+..+-+ .+....... .|. .++.-++
T Consensus 232 ----k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 232 ----KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred ----ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCcc
Confidence 234456779999999999875 58999999999999999999999998654432 222222222 121 1111000
Q ss_pred hh-hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LV-LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ..+.. .........++..+.... ..+.-.+|+...+..||.+|.|+++.++.
T Consensus 307 ~lp~~k~~-~f~~~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKM-TFSEHPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhcc-ccCCCCchhhhhhccccc--cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00000 000011111111111111 22345788999999999999999998763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=294.39 Aligned_cols=223 Identities=24% Similarity=0.249 Sum_probs=174.4
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--------------ccchHHHHHHHHHHhhcCCCChHH
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--------------QGASKSFMAECKALKNICHRNLVR 133 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 133 (356)
.+..+.|++...||+|.||.|-+|++..+++.||||++.+.. ....+...+|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999999999999999996431 122357889999999999999999
Q ss_pred H---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 134 F---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 134 l---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
| ..++.+++.||+|||.+| ||||||||+|+||+++|.+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 8 458999999999999999 9999999999999999999
Q ss_pred EEcccccccccccCCC-CCccCCCCccccccccchhhhcCCC----CCCccchHhHHHHHHHHHcCCCCCCccccCCccH
Q 039228 175 HIGDFELARFRQEVSN-PTQSSSNGVRRTIGYTALDYDLGSE----VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL 249 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~ 249 (356)
||+|||.+........ .........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||...+.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 9999999986643322 1122334588999999999987633 34678999999999999999999963211
Q ss_pred HHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 250 HNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
... ...+++..+.-. ..++.-+.+.+|+.++|..||+.|.+..+|....
T Consensus 325 ~~l--------~~KIvn~pL~fP------------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 LEL--------FDKIVNDPLEFP------------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHH--------HHHHhcCcccCC------------------CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 112222222100 1113445678999999999999999998886544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.64 Aligned_cols=224 Identities=22% Similarity=0.300 Sum_probs=170.2
Q ss_pred hcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRFI------- 135 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~------- 135 (356)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.++..+ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3567999999999999999999852 345789999987432 23346788999999999 899998751
Q ss_pred --------------------------------------------------------------------------------
Q 039228 136 -------------------------------------------------------------------------------- 135 (356)
Q Consensus 136 -------------------------------------------------------------------------------- 135 (356)
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence
Q ss_pred -------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCcccc
Q 039228 136 -------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202 (356)
Q Consensus 136 -------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 202 (356)
.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ........++
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~ 239 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLP 239 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCCCCC
Confidence 14569999999999999 99999999999999999999999999976532211 1112234456
Q ss_pred ccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccccccc
Q 039228 203 IGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNS 281 (356)
Q Consensus 203 ~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 281 (356)
..|+|||++.+..++.++|||||||++|||++ |..||....... .+.. ....+ ... .
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~---~~~~~--------~~~-~--------- 297 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQ---RLKDG--------TRM-R--------- 297 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHH---HHhcC--------CCC-C---------
Confidence 78999999999899999999999999999997 999997432111 1111 00000 000 0
Q ss_pred chhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 282 NMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 282 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 298 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 ---------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001233467899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.15 Aligned_cols=233 Identities=19% Similarity=0.195 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|++..++..||||.+... .......+.+|+.+++.++||||+++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488899999999999999999999999999998643 22334568899999999999999875
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 347789999999999999 9999999999999999999999999997543222
Q ss_pred CCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc----hH-
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR----VM- 262 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~- 262 (356)
.. ........||..|+|||++.+ ..++.++|||||||++|||++|++||..... .............. ..
T Consensus 158 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 158 PT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred Cc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHH
Confidence 11 112234678999999999865 6789999999999999999999999964321 11111111111000 00
Q ss_pred -------HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 263 -------DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 263 -------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+......... -... ........+.+++.+||+.||++|||++++++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~--------~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPV--------PFSQ----KFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCC--------chHH----hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 011100000000 0000 001123456899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.76 Aligned_cols=226 Identities=22% Similarity=0.338 Sum_probs=173.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe----EEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
..+|++.+.||+|+||.||+|.+..++. .||+|.++... ....+.+..|+.+++.++||||+++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~ 85 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 85 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCcee
Confidence 3569999999999999999999865544 48999986443 3345678899999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 457889999999999999 999999999999999999999999999876433
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... .+.. ++..
T Consensus 163 ~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~------------~~~~ 226 (316)
T cd05108 163 EKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS------------ILEK 226 (316)
T ss_pred Ccc--eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH------------HHhC
Confidence 221 11122334678999999999999999999999999999998 99998642111 1111 1111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
..... .+..+...+.+++.+||+.+|++||++.+++..|..+...-..
T Consensus 227 ~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 227 GERLP------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred CCCCC------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 00000 0012334578999999999999999999999999888765433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=285.83 Aligned_cols=240 Identities=19% Similarity=0.232 Sum_probs=172.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999999999999999987542 2334678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 347889999999999999 99999999999999999999999999986533221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh--CCCchHHHh--hhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA--FPNRVMDIV--NLV 268 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~ 268 (356)
.......|+..|+|||++.+..++.++|||||||++|||++|++||......+ .+....... .+....... ++.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccch
Confidence 12234568999999999998889999999999999999999999997532211 111111110 111100000 000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
............... ...........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSL----ERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccH----HHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 00001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=294.20 Aligned_cols=219 Identities=21% Similarity=0.262 Sum_probs=173.7
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc----Cc-cchHHHHHHHHHHhhcC-CCChHHH--------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ----CQ-GASKSFMAECKALKNIC-HRNLVRF-------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l-------- 134 (356)
...+.|.+.+.||+|+||.|+.|.+..++..||+|++... .. ...+.+.+|+.++++++ ||||+++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999999999999999987653 12 23456778999999999 9999987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARF 184 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 184 (356)
..++.|++.|++|+|++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 348999999999999999 9999999999999999 9999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCC-CC-CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSE-VS-TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. ..........
T Consensus 171 ~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki------ 235 (370)
T KOG0583|consen 171 SP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKI------ 235 (370)
T ss_pred cC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHH------
Confidence 63 1133455689999999999999877 75 789999999999999999999974 1111111111
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHH-HHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLEC-LIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
..+.+.. +... ...+..|+.+|+..||.+|+|+.+++ .-.-+.
T Consensus 236 ------~~~~~~~----------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 236 ------RKGEFKI----------------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ------hcCCccC----------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 1111100 0011 23567999999999999999999999 433333
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=288.53 Aligned_cols=241 Identities=23% Similarity=0.291 Sum_probs=168.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||.|+||.||+|....+++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999999998999999999875432 223467789999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 347789999999999999 9999999999999999999999999987543221
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh----h
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN----L 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 267 (356)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..............+.. +
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233567899999999865 45788999999999999999999999753221111111111110000000000 0
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....+.. ....+......+.. ......+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERF--TLYSPKNLRQAWNK--LSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccc--cccCCccHHHHhhc--cCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00000000000000 011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.31 Aligned_cols=228 Identities=18% Similarity=0.193 Sum_probs=181.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|.+.+.||.|||+.||++....++..+|+|++.....+..+...+|++..++++|||++++
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999999999999999988877788899999999999999999998
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+.|+.++++||.+||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 458899999999999985 679999999999999999999999999987
Q ss_pred ccccCCCC-----CccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 184 FRQEVSNP-----TQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 184 ~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
........ ..........|..|+|||.+. +...+.++|||||||++|+|+.|..||+.....+.++.-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--- 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--- 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence 54221110 111122344688999999885 4557899999999999999999999998766544332111
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
+.+..+.- ++.. ...+.+.+++..|++.||.+||++.+|+..++.+
T Consensus 255 --------v~n~q~s~-----------------P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 --------VQNAQISI-----------------PNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------eecccccc-----------------CCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111100 0000 2445788999999999999999999999998764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=298.00 Aligned_cols=234 Identities=19% Similarity=0.220 Sum_probs=169.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999999999999999753 2456789999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~---~~ 238 (391)
T PHA03212 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN---AN 238 (391)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc---cc
Confidence 457889999999999999 9999999999999999999999999997533221 11
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccC--C----ccHHHHHHHhC------CCchH
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG--D----LNLHNFARMAF------PNRVM 262 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--~----~~~~~~~~~~~------~~~~~ 262 (356)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... . ..+........ +....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 223467899999999999999999999999999999999999887432211 0 11111111110 10000
Q ss_pred HHhhhhh---ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVL---LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..++... .......... ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGS------RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCC------CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0011000 0000000000 0001111234557889999999999999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=279.91 Aligned_cols=233 Identities=21% Similarity=0.192 Sum_probs=170.7
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
.|...+++|+|+||.||+|...++++.||||..-.... ---+|+.+|+.++|||||++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 37778899999999999999999999999999754322 12369999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 186 (356)
.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 116779999999999999 9999999999999955 999999999999876
Q ss_pred cCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
..... .....|..|+|||.+.+ ..|+.+.||||.||++.||+.|++-|.+.. +...+...+...-...-.++-
T Consensus 178 ~~epn-----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 178 KGEPN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cCCCc-----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence 54322 34677999999999887 469999999999999999999999998632 223444444443322222221
Q ss_pred hhhhccccccccccccchhhhhchh-hHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMN-SRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. +. ..+. .-..+++....+.. .......+..+++.+++.++|.+|.++.+++.
T Consensus 252 ~-mn-~~y~--~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 S-MN-PNYT--EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred h-cC-cccc--cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 10 0000 00011111111111 11134446789999999999999999998875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.49 Aligned_cols=210 Identities=22% Similarity=0.241 Sum_probs=173.2
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcC-CCChHHH---------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNIC-HRNLVRF--------- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l--------- 134 (356)
....++|.++++||+|+||.|++|..+.+++.+|||++++. .....+....|.+++.-.. ||.++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34567899999999999999999999999999999999865 3455677888988888775 9999998
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+++ |||||||.+|||||..|++||+|||+++....
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 337889999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. .....+++||+.|+|||++.+..|+.++|.|||||+|||||.|..||.+..++ ++.|.
T Consensus 521 ~----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~Fds 579 (694)
T KOG0694|consen 521 Q----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDS 579 (694)
T ss_pred C----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHH
Confidence 2 23556799999999999999999999999999999999999999999753322 23333
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
.+..+... +.-+..+.++++.+.+..||++|-.+
T Consensus 580 I~~d~~~y----------------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRY----------------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCC----------------CCcccHHHHHHHHHHhccCcccccCC
Confidence 33322210 11344456889999999999999866
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.37 Aligned_cols=221 Identities=23% Similarity=0.317 Sum_probs=171.0
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+...+|+.++.||+||||.||+++++-+|+.||||++.... ......+.+|+.+|.+|+|||+|++
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 356778999999999999999999999999999999997553 3344678899999999999999998
Q ss_pred --------------------------------------------------------------------------------
Q 039228 135 -------------------------------------------------------------------------------- 134 (356)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (356)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------------------------------------HHHHHHHHHHHHHHh
Q 039228 135 -----------------------------------------------------------------ISIAIDVASALDYLH 149 (356)
Q Consensus 135 -----------------------------------------------------------------~~i~~~i~~aL~~LH 149 (356)
+.++.+|+.||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 558899999999999
Q ss_pred hcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc--------------cCCCCCccCCCCccccccccchhhhcCCC
Q 039228 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ--------------EVSNPTQSSSNGVRRTIGYTALDYDLGSE 215 (356)
Q Consensus 150 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (356)
++| ||||||||.||++|+++.+||+|||+|+... ..........+..+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998621 00111223446688999999999997654
Q ss_pred ---CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhH
Q 039228 216 ---VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSR 292 (356)
Q Consensus 216 ---~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 292 (356)
|+.|+|||||||+++||+. ||....+....+.......+|.. .++.++.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~------------------------ 843 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE------------------------ 843 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc------------------------
Confidence 9999999999999999985 56543222222222222222222 1111111
Q ss_pred HHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 293 LECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 293 ~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...=.++|.++++.||.+||||.||+.
T Consensus 844 ---~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 ---HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 112268999999999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=284.02 Aligned_cols=209 Identities=22% Similarity=0.256 Sum_probs=165.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46899999999999999999999999999999986432 2234568889999999999999997
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 347789999999999999 999999999999999999999999999755321
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... +.....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~--------i~~~~~-- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK--------ILAGKL-- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHhCCc--
Confidence 1235689999999999998899999999999999999999999964221 111111 000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~~ 323 (356)
... ......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ~~~------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFP------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCC------------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000 012235679999999999999995 7777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=289.08 Aligned_cols=243 Identities=19% Similarity=0.214 Sum_probs=169.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHHH-----------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRFI----------- 135 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~----------- 135 (356)
...++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.++||||++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 346789999999999999999999999999999999864322 2345677899999999999999872
Q ss_pred ------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 136 ------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 136 ------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 36789999999999999 999999999999999999999999999754
Q ss_pred ccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+..... ......
T Consensus 169 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~ 239 (343)
T cd07878 169 DDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVG-TPSPEV 239 (343)
T ss_pred CCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhC-CCCHHH
Confidence 321 223567999999999876 56889999999999999999999999642211 11111111110 000011
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
................+.................+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10000000000000000000000000000112346799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.31 Aligned_cols=242 Identities=23% Similarity=0.291 Sum_probs=168.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|.+.+.||.|+||.||+|....++..||+|++..... .....+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4579999999999999999999999999999999875432 234567899999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--- 157 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--- 157 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC---
Confidence 347789999999999999 9999999999999999999999999997543221
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+...... ......+........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRL-LGTPTEETWPGITSN 234 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCCChHHhhccccc
Confidence 12233567899999998865 568899999999999999999999996432111 11111111 111000000000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ....+...................+++.+||..||.+|||+.|+++
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFR-SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhh-ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0000000000000000112335679999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=279.02 Aligned_cols=244 Identities=24% Similarity=0.277 Sum_probs=175.9
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCC-hHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRN-LVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l--------------- 134 (356)
.|..++.||+|.||+||+|+.+.+|+.||+|.+..... .......+|+.+|++++|+| |+++
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47777889999999999999999999999999976543 34566789999999999999 8876
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..+..||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 247789999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
..... .......++|..|.|||++.+. .|++..||||+||+++||+++++-|.+..+-+ .+....+..-..+..
T Consensus 169 a~~ip----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 169 AFSIP----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNEK 243 (323)
T ss_pred HhcCC----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCcc
Confidence 55422 2234557789999999999987 69999999999999999999999988655422 122222211111111
Q ss_pred HHhhhhhcccccc--ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhh
Q 039228 263 DIVNLVLLNDNKV--LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVN 328 (356)
Q Consensus 263 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~ 328 (356)
.|-.-...+++.. .......-+....+ .......+++.+|++.+|.+|.|+...+.+ +..+.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~----~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILP----KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhcc----ccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1100000011110 00000000111111 111356789999999999999999999886 54443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=273.06 Aligned_cols=161 Identities=27% Similarity=0.296 Sum_probs=145.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++++.||.|+||.|.+++.+.++..+|+|++++.. ....+...+|..+|+.+.||+++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467999999999999999999999999999999997553 3445677899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 348889999999999999 999999999999999999999999999976432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.-..+||+.|+|||++...+++.++|.|||||++|||+.|.+||..
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 3358899999999999999999999999999999999999999964
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=281.98 Aligned_cols=231 Identities=23% Similarity=0.277 Sum_probs=164.6
Q ss_pred CCCCccccceecCceEEEEEEECC-CCeEEEEEEeeccCc--cchHHHHHHHHHHhhc---CCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDL-NRAVVAIKVLSIQCQ--GASKSFMAECKALKNI---CHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l----------- 134 (356)
++|++.+.||+|+||.||+|++.. ++..||+|.+..... .....+.+|+.+++.+ +||||+++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 568899999874422 2234566777777665 69999875
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 347889999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC--
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN-- 259 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~-- 259 (356)
+..... .......|++.|+|||.+.+..++.++|||||||++|||++|.+||......+ .+........ +.
T Consensus 158 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~ 231 (290)
T cd07862 158 RIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE 231 (290)
T ss_pred EeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChh
Confidence 765322 22234568999999999998899999999999999999999999997532211 1111111110 00
Q ss_pred chHHHh---hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVMDIV---NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... ...+... ....... ........+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSK-------SAQPIEK----FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCC-------CCCCHHH----HccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000000 0000000 01123345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.44 Aligned_cols=165 Identities=25% Similarity=0.250 Sum_probs=142.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999999999999998643 23345678899999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 236789999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
. .......+|..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 176 ~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 N-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred C-----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223356789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=263.81 Aligned_cols=212 Identities=19% Similarity=0.231 Sum_probs=173.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRFI----------- 135 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~----------- 135 (356)
..++|++.+.||+|.||.||+|+.+.++..||+|++.++ ......++.+|+++.+.|+||||++++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 357899999999999999999999999999999998644 233456788999999999999999983
Q ss_pred ----------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 136 ----------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 136 ----------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
.+..|++.||.|+|..+ ||||||||+|+|++..+.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 37789999999999988 9999999999999999999999999986432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||..... +.-..+.....+ ..+
T Consensus 176 -----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~~-------~~p 242 (281)
T KOG0580|consen 176 -----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVDL-------KFP 242 (281)
T ss_pred -----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHccc-------cCC
Confidence 2344568899999999999999999999999999999999999999975432 111121111111 111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........++|..|+..+|.+|.+..|+++.
T Consensus 243 -------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -------------------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------------------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1233356799999999999999999998763
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=289.76 Aligned_cols=164 Identities=26% Similarity=0.263 Sum_probs=142.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999999899999999987432 2334678889999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 236789999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
. .......+|..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 172 ~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 172 S-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred c-----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 122345689999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=282.93 Aligned_cols=213 Identities=21% Similarity=0.232 Sum_probs=164.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999999999999999986432 2223457889999999999999876
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 347789999999999999 9999999999999999999999999997643221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||..|+|||++.+..++.++|||||||++|+|++|+.||....... ..... +..+.
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~-------------~~~~~ 218 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEV-------------DRRVK 218 (285)
T ss_pred ----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHH-------------HHHhh
Confidence 1223568999999999999999999999999999999999999997532211 00010 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
.... .........+.+|+.+||+.||.+||+ ++++++
T Consensus 219 ~~~~---------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQE---------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccc---------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0000 000022335789999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=284.21 Aligned_cols=226 Identities=20% Similarity=0.292 Sum_probs=167.1
Q ss_pred cCCCCccccceecCceEEEEEEECC----------------CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHH
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL----------------NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVR 133 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 133 (356)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998642 345799999875432 33457889999999999999987
Q ss_pred H--------------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEE
Q 039228 134 F--------------------------------------------------------ISIAIDVASALDYLHHHCQELIL 157 (356)
Q Consensus 134 l--------------------------------------------------------~~i~~~i~~aL~~LH~~~~~~ii 157 (356)
+ +.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 5 147889999999999999 99
Q ss_pred ecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc--C
Q 039228 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT--R 235 (356)
Q Consensus 158 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt--g 235 (356)
||||||+|||++.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999975533221 112223445778999999988899999999999999999987 5
Q ss_pred CCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC
Q 039228 236 RKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM 315 (356)
Q Consensus 236 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 315 (356)
..||...... .........+...... ... .....++..+.+++.+||+.||++||
T Consensus 239 ~~p~~~~~~~--~~~~~~~~~~~~~~~~----~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 239 EQPYGELTDE--QVIENAGEFFRDQGRQ----VYL-------------------FRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred CCCCCcCCHH--HHHHHHHHHhhhcccc----ccc-------------------cCCCCCCHHHHHHHHHHccCCchhCc
Confidence 6677643211 1111111100000000 000 00113455788999999999999999
Q ss_pred ChHHHHHHHHH
Q 039228 316 NVPNAVHDLQS 326 (356)
Q Consensus 316 s~~~vl~~L~~ 326 (356)
|+.+|.+.|++
T Consensus 294 s~~~i~~~l~~ 304 (304)
T cd05096 294 SFSDIHAFLTE 304 (304)
T ss_pred CHHHHHHHHhC
Confidence 99999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.86 Aligned_cols=169 Identities=22% Similarity=0.288 Sum_probs=145.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|+++.+||+|+||.||+|+-+.||..+|+|++++.. ....+.+..|-.+|...++|+||++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5689999999999999999999999999999999998653 3456778899999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc--
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE-- 187 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 187 (356)
..++.+++.|+..+|..| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 347788999999999999 99999999999999999999999999853211
Q ss_pred -------------C----CCCC------------------------ccCCCCccccccccchhhhcCCCCCCccchHhHH
Q 039228 188 -------------V----SNPT------------------------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYG 226 (356)
Q Consensus 188 -------------~----~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG 226 (356)
. .+.. .......+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0000 0112346799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCc
Q 039228 227 ILLLEMVTRRKPIDF 241 (356)
Q Consensus 227 ~~l~elltg~~Pf~~ 241 (356)
||+||||.|.+||..
T Consensus 376 ~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCS 390 (550)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999974
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=275.28 Aligned_cols=217 Identities=23% Similarity=0.372 Sum_probs=171.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4588889999999999999999988999999998744 3335678899999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 347789999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.... ....... +......
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~---------~~~~~~~ 224 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYEL---------LEKGYRM 224 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH---------HHCCCCC
Confidence 11112333567999999999999999999999999999998 999986421 1111111 1111100
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.. ...++..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 225 ~~------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ER------------------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC------------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 012345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=289.80 Aligned_cols=217 Identities=21% Similarity=0.307 Sum_probs=166.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|+..+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++|+||+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3457888999999999999999998999999999864432 334678899999999999999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~ 225 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM----DPC 225 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc----ccc
Confidence 358899999999999999 9999999999999999999999999998654321 112
Q ss_pred CCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 197 NGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+....... ...
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~------------~~~ 291 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAI------------CMS 291 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHH------------hcc
Confidence 34578999999998743 23456899999999999999999999732211 111111000 000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .....+...+.+++.+||+.||++|||+.+|++.
T Consensus 292 ~~~---------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPP---------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC---------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0001334467899999999999999999999874
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=297.12 Aligned_cols=208 Identities=20% Similarity=0.274 Sum_probs=172.0
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHHH----------------------
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS---------------------- 136 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~---------------------- 136 (356)
+||+|.||+||.|++..+....|||.+........+-+..|+.+.++|+|.|||++++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999999999999999998777777788999999999999999999832
Q ss_pred ------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccccccccccCCCCCccCCC
Q 039228 137 ------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 137 ------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
+.+||+.||.|||+.. |||||||-+|+|++ -.|.+||+|||.++.+...+ ....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin----P~TE 734 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN----PCTE 734 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC----cccc
Confidence 6789999999999998 99999999999996 68999999999999876544 2345
Q ss_pred CccccccccchhhhcCC--CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 198 GVRRTIGYTALDYDLGS--EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.+.||+.|||||++..+ .|+.++|||||||++.||.||++||-+....... +..-.+-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkVGmy----- 794 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKVGMY----- 794 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhhcce-----
Confidence 58899999999999865 4889999999999999999999999754322111 1111110
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..+.++.+...+..+++++|+.+||.+||+++++++.
T Consensus 795 ----------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 795 ----------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ----------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 01123344666678899999999999999999999863
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=289.14 Aligned_cols=165 Identities=25% Similarity=0.252 Sum_probs=142.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999987432 3344678899999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 236789999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
. .......+|..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 179 ~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 179 S-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred C-----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 2 1223356799999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=290.68 Aligned_cols=221 Identities=22% Similarity=0.272 Sum_probs=167.8
Q ss_pred cCCCCccccceecCceEEEEEEE-----CCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRFI-------- 135 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~-------- 135 (356)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... ....+.+.+|+.++..+ +||||++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45699999999999999999974 3456789999986432 23346788999999999 899998752
Q ss_pred --------------------------------------------------------------------------------
Q 039228 136 -------------------------------------------------------------------------------- 135 (356)
Q Consensus 136 -------------------------------------------------------------------------------- 135 (356)
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence
Q ss_pred ------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 136 ------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 136 ------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 25679999999999999 99999999999999999999999999976543221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
........++..|+|||++.+..++.++|||||||++|||++ |..||....... .+... +.....
T Consensus 270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~------------~~~~~~ 335 (375)
T cd05104 270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM------------IKEGYR 335 (375)
T ss_pred -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH------------HHhCcc
Confidence 111222344667999999999999999999999999999998 899986432211 11111 111100
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.... ...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 336 ~~~~------------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSP------------------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCC------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0000 01233578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=279.11 Aligned_cols=219 Identities=21% Similarity=0.325 Sum_probs=170.7
Q ss_pred CCCCccccceecCceEEEEEEECCCC-----eEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNR-----AVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
++|++.+.||+|+||.||+|.....+ ..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46899999999999999999986554 7899999864432 334568899999999999999875
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
+.++.+++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 147889999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.++|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE 237 (283)
T ss_pred cEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 999999999975432211 112233456788999999988899999999999999999998 99998643211 1111
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+...... ..+..++..+.+|+.+||+.||++||++++|++.|+++
T Consensus 238 ------------~i~~~~~~------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 ------------MIRSRQLL------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------------HHHcCCcC------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11100000 00124556789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=291.58 Aligned_cols=222 Identities=23% Similarity=0.278 Sum_probs=168.2
Q ss_pred cCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l--------- 134 (356)
.++|++.+.||+|+||.||+|++... +..||+|.+.... ......+.+|+.+++.+ +|+||+++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45799999999999999999986433 3579999997543 23345688999999999 89999875
Q ss_pred --------------------------------------------------------------------------------
Q 039228 135 -------------------------------------------------------------------------------- 134 (356)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (356)
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
+.++.||+.||.|||+.+ |+||||||+|||+++++.++|+|||+++....... ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--~~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--eeec
Confidence 125678999999999999 99999999999999999999999999976533221 1112
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+... +.........
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~------------~~~~~~~~~~- 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM------------VKRGYQMSRP- 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHH------------HHcccCccCC-
Confidence 22335678999999998899999999999999999997 999997432211 11111 1110000000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
...+..+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 338 -----------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 -----------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 012335789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.75 Aligned_cols=162 Identities=24% Similarity=0.346 Sum_probs=141.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||++++..++..||+|.+..... ...+.+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999875432 334678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+. + |+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 35778999999999985 5 999999999999999999999999998754321
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12335689999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=279.07 Aligned_cols=208 Identities=20% Similarity=0.243 Sum_probs=163.3
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCccc---hHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA---SKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.+|++++||||+++
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 57899999999999984 7899999997543322 4667899999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.+++.||.|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 44778999999999984 6 889999999999999999999999999754321
Q ss_pred ccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....... +.....
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i--------~~~~~~ 240 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLI--------INKNNS 240 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------HhcCCC
Confidence 123457889999999976 6789999999999999999999999974321 1111100 000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.. .+..++..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 241 ~~------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LK------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 00134556889999999999999999999999998764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.87 Aligned_cols=238 Identities=20% Similarity=0.193 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|.+..+++.||||.+... .....+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999989999999998643 22334678899999999999999876
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 236789999999999999 9999999999999999999999999997643221
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh--
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN-- 266 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 266 (356)
........++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......-.....++..
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 158 ---SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ---cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhh
Confidence 1122334678899999998774 4789999999999999999999999743221 11111111111111111100
Q ss_pred ----hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 ----LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+..... ..+...... .........+.+|+.+||+.||++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPH----KPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCC----CCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 000000000 0001223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=286.93 Aligned_cols=210 Identities=20% Similarity=0.165 Sum_probs=165.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467999999999999999999999999999999987432 2334568899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 336789999999999999 999999999999999999999999999755321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... ....+.
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i--------~~~~~~ 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKI--------LAGRLK 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHH--------hcCCcC
Confidence 1235689999999999999999999999999999999999999963211 1111110 000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~~ 323 (356)
.+ ......+.+++.+||+.||.+||+ +.+++..
T Consensus 234 --~p------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 --FP------------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CC------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 012234679999999999999997 5666643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=285.89 Aligned_cols=205 Identities=20% Similarity=0.219 Sum_probs=160.6
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997532 2334567889999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~----~~~~~ 153 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD----GATMK 153 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----CCccc
Confidence 347789999999999999 999999999999999999999999998743221 11223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... ........ ......
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~------------~~~~~~--- 213 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELI------------LMEEIR--- 213 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHH------------HcCCCC---
Confidence 4678999999999999999999999999999999999999996321 11111110 000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
.+......+.+++.+||+.||++|| ++.++++
T Consensus 214 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0002233578999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=275.62 Aligned_cols=223 Identities=20% Similarity=0.292 Sum_probs=169.6
Q ss_pred CCCCccccceecCceEEEEEEECCCCe----EEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|++.+.||.|+||.||+|.+..++. .+++|.+..... .....+..|+..+++++||||+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 468889999999999999999876655 477777753322 223567788889999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 458889999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. ........++..|++||++.+..++.++||||||+++|||++ |..||...... ... +++...
T Consensus 164 ~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~------------~~~~~~ 227 (279)
T cd05111 164 K--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVP------------DLLEKG 227 (279)
T ss_pred c--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH------------HHHHCC
Confidence 1 112233456778999999998899999999999999999998 99998643211 111 111110
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ..+...+.+++.+||..||++|||+.++++.|..+.+.-
T Consensus 228 ~~~~~~------------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 ERLAQP------------------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CcCCCC------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 000000 012335678999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=273.52 Aligned_cols=221 Identities=20% Similarity=0.296 Sum_probs=172.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|+...+++.||||.+.... ......+.+|+.+++.++||||+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999899999999876422 2334568899999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 346789999999999999 99999999999999999999999999876543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...+... +..
T Consensus 159 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~---------~~~ 222 (267)
T cd08228 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQK---------IEQ 222 (267)
T ss_pred hh----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHH---------Hhc
Confidence 21 1122345788999999998888999999999999999999999998532211 1111111 000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
...... ........+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 223 ~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPPL-----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCC-----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000000 00123346789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=296.59 Aligned_cols=235 Identities=21% Similarity=0.175 Sum_probs=165.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|....+++.||||.+.... ....+|+.+|+.++||||+++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999999899999999885432 234579999999999999863
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFE 180 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg 180 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 225679999999999999 99999999999999654 79999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+..........
T Consensus 217 la~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTP 290 (440)
T ss_pred cchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 998654321 12235678999999998764 6899999999999999999999999743221 1122221111111
Q ss_pred chHHH--hhhhhccccccccccccchhh-hhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 260 RVMDI--VNLVLLNDNKVLAGTNSNMLR-KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 260 ~~~~~--~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....+ ..+.... ...+.... ......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 291 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYAD------IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhc------ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 11110 0000000 00000000 00000001233467899999999999999999999843
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=299.44 Aligned_cols=218 Identities=19% Similarity=0.218 Sum_probs=171.2
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..++|+||+++
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999999999999999987542 2334567889999999999988752
Q ss_pred -------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 135 -------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 135 -------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 236789999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... .......
T Consensus 186 DFGls~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~--- 255 (496)
T PTZ00283 186 DFGFSKMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMH--- 255 (496)
T ss_pred ecccCeecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHH---
Confidence 9999986543221 11223467899999999999999999999999999999999999999632 1111111
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+...... .+...+..+.+++..||+.||.+||++.+++..
T Consensus 256 ---------~~~~~~~~~---------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 ---------KTLAGRYDP---------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---------HHhcCCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111000 001234467899999999999999999999864
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=277.58 Aligned_cols=233 Identities=21% Similarity=0.302 Sum_probs=170.7
Q ss_pred CCccccceecCceEEEEEEE----CCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
|++.+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988754 34578999999875432 334678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.......
T Consensus 86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 457889999999999999 99999999999999999999999999986543221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 269 (356)
. ........++..|+|||.+.+..++.++||||||+++|+|++|..||.................. ...+.+.++...
T Consensus 163 ~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 Y-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred h-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 1 11112233466799999998888999999999999999999999998643221111110000000 011111121111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
... .+..++..+.+++..||+.+|++|||+++|++.|+.+.
T Consensus 242 ~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLP------------------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCC------------------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 100 01134557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.12 Aligned_cols=218 Identities=19% Similarity=0.319 Sum_probs=168.2
Q ss_pred CCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
++|++.+.||+|+||.||+|.+. ..+..||+|.++.... .....+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46899999999999999999875 3467899999875432 334578899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 568889999999999999 9999999999999999999999999876432211
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
........++..|+|||++.+..++.++|||||||++||+++ |..||...... ..........
T Consensus 162 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 225 (266)
T cd05064 162 ---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF----------- 225 (266)
T ss_pred ---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC-----------
Confidence 111112334678999999999999999999999999999775 99999643211 1111110000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
... .+..++..+.+++..||+.+|.+||++.+|++.|..+
T Consensus 226 ~~~-------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLP-------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC-------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 0113455788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=276.81 Aligned_cols=236 Identities=23% Similarity=0.252 Sum_probs=164.3
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhc---CCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNI---CHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l------------- 134 (356)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.+ +||||+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999999999999999987432 22234556777777665 79999875
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 347789999999999999 99999999999999999999999999976
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
..... ......++..|+|||++.+..++.++|||||||++|+|++|.+||......+ .+..............+
T Consensus 158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 158 YSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhC
Confidence 53221 1223567889999999998899999999999999999999999986432211 11111111100000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
- ................... .........+.+++.+||+.||++|||+.+++.
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 P-RDVTLPRGAFSPRGPRPVQ----SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred c-ccccccccccCCCCCCchH----HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000000000000 001123446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=278.65 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=179.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe----EEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 85 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL 85 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence 3568889999999999999999876665 578888764432 223468899999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 457789999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ........++..|+|||++.+..++.++||||||+++|||++ |..||...... ....+ +..
T Consensus 163 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~------------~~~ 226 (303)
T cd05110 163 EK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL------------LEK 226 (303)
T ss_pred cc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHC
Confidence 21 111223345678999999998899999999999999999997 89998643211 11111 110
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCcCCccc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRAPK 347 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~~~~~~ 347 (356)
..... .+..+...+.+++..||..+|++||++.+|++.|.++.+.......+..-.+...|+
T Consensus 227 ~~~~~------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 288 (303)
T cd05110 227 GERLP------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPS 288 (303)
T ss_pred CCCCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccCCcCCCCC
Confidence 00000 001233457899999999999999999999999999876654444444444444444
Q ss_pred cc
Q 039228 348 LK 349 (356)
Q Consensus 348 ~~ 349 (356)
..
T Consensus 289 ~~ 290 (303)
T cd05110 289 PN 290 (303)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=286.77 Aligned_cols=217 Identities=18% Similarity=0.211 Sum_probs=168.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+..|+.++..++||||+++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997542 2234568889999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 347789999999999999 99999999999999999999999999975432
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... ..... ... .. .+......
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i-~~~-~~----~~~~~~~~ 223 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENL-KYW-KE----TLQRPVYD 223 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHH-Hhc-cc----cccCCCCC
Confidence 2234678999999999999999999999999999999999999997432111 00000 000 00 00000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. ........+.+++.+||..+|.+||++.++++.
T Consensus 224 ~------------------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 D------------------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred c------------------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 001234467899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=293.05 Aligned_cols=219 Identities=21% Similarity=0.287 Sum_probs=175.7
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
|+...+....++-||+|+.|.||+|+.. ++.||||.++.. -..+|+-|++|+||||+.|
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 3334444556778999999999999987 789999997522 2347889999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
.+|..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++.....
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 457788999999999998 999999999999999999999999999865432
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.....+.||..|||||++.+.+.+.|+|||||||+|||||||..||.........+ ..-. + .
T Consensus 266 ----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-----GVGs-N-------s- 327 (904)
T KOG4721|consen 266 ----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-----GVGS-N-------S- 327 (904)
T ss_pred ----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-----eccC-C-------c-
Confidence 33445889999999999999999999999999999999999999997533221110 0000 0 0
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
.....+..|+..+.-|+.+||+..|..||++.+++..|+-....+..
T Consensus 328 -----------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 328 -----------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred -----------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 11222347888899999999999999999999999999887766543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=266.04 Aligned_cols=215 Identities=19% Similarity=0.218 Sum_probs=172.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++.|++.+.||+|.|+.||++.+..+|+.+|+|+++.. .....+.+.+|+++-+.|+||||+++
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356799999999999999999999999999999998643 34466889999999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEccccccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 187 (356)
-.++.||+.||.|+|.++ |||||+||+|+++.+ .--+||+|||+|..+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 126789999999999999 999999999999953 44689999999987652
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.....+..||++|||||++...+|+..+|||+.||+||-++.|.+||.+... .++...
T Consensus 166 -----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------------~rlye~ 223 (355)
T KOG0033|consen 166 -----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HRLYEQ 223 (355)
T ss_pred -----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------------HHHHHH
Confidence 3456678999999999999999999999999999999999999999964211 122222
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAV 321 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl 321 (356)
.+.+.++. ....|. ...++..+|+.+||..||.+|.|+.|.+
T Consensus 224 I~~g~yd~--------~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 224 IKAGAYDY--------PSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HhccccCC--------CCcccC----cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 22222211 111111 3334557999999999999999998765
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.08 Aligned_cols=224 Identities=22% Similarity=0.261 Sum_probs=169.8
Q ss_pred hcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRFI------- 135 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~------- 135 (356)
..++|++.+.||.|+||.||+|.... +++.||+|++.... ....+.+..|+.++.++ +|+||++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 34579999999999999999997543 35789999987432 22345678899999999 799998762
Q ss_pred --------------------------------------------------------------------------------
Q 039228 136 -------------------------------------------------------------------------------- 135 (356)
Q Consensus 136 -------------------------------------------------------------------------------- 135 (356)
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence
Q ss_pred ------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccc
Q 039228 136 ------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTI 203 (356)
Q Consensus 136 ------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 203 (356)
.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..... ........++.
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~ 239 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPL 239 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCCCCc
Confidence 24578999999999998 99999999999999999999999999986533221 11222345567
Q ss_pred cccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccc
Q 039228 204 GYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSN 282 (356)
Q Consensus 204 ~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 282 (356)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+... +.......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~------------~~~~~~~~---------- 296 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR------------LKEGTRMR---------- 296 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH------------HhccCCCC----------
Confidence 8999999999999999999999999999998 999986422111 11110 00000000
Q ss_pred hhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 283 MLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 283 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
.+......+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 297 --------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 --------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001233467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=276.78 Aligned_cols=223 Identities=22% Similarity=0.347 Sum_probs=172.9
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|.+.+.||+|+||.||++... .++..+|+|.+........+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46889999999999999999852 3456799999876555556789999999999999999986
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEE
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI 176 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 176 (356)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 236789999999999999 999999999999999999999
Q ss_pred cccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHH
Q 039228 177 GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~ 255 (356)
+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 162 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~- 236 (288)
T cd05093 162 GDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECIT- 236 (288)
T ss_pred ccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-
Confidence 99999975432211 112223445778999999998889999999999999999998 999986432111 101000
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.+. .... ...++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 237 --~~~--------~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 --QGR--------VLQR-------------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --cCC--------cCCC-------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 0000 0022345789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.55 Aligned_cols=218 Identities=27% Similarity=0.401 Sum_probs=173.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++||||+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34569999999999999999999987 78999999986655556788999999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 347789999999999999 99999999999999999999999999976533211
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......++..|++||.+.+..++.++||||||+++|+|++ |+.||...... ....... ...
T Consensus 160 ----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~------------~~~ 221 (261)
T cd05148 160 ----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQIT------------AGY 221 (261)
T ss_pred ----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHH------------hCC
Confidence 1123345678999999988889999999999999999998 89999643211 1111110 000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
... ....++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 ~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMP------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 0013445678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.94 Aligned_cols=223 Identities=23% Similarity=0.346 Sum_probs=170.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe----EEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|++.+.||+|+||.||+|.+..++. .||+|++..... .....+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 4578999999999999999999866655 489999864432 334678899999999999999864
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 457889999999999999 999999999999999999999999999866432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... .......++..|+|||...+..++.++|||||||++|||++ |..||..... ..+... +..
T Consensus 163 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~------------~~~ 226 (279)
T cd05109 163 ETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL------------LEK 226 (279)
T ss_pred cce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH------------HHC
Confidence 211 11122334678999999998889999999999999999998 9999864221 111111 111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
...... ...+...+.+++.+||+.||+.||++.++++.|+.+...
T Consensus 227 ~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 GERLPQ------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCcCCC------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 100000 012334678999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=281.52 Aligned_cols=201 Identities=22% Similarity=0.217 Sum_probs=157.1
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||+|+||.||+|.+..+++.||+|++... .......+..|+.++.+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998743 22334567889999999999999987
Q ss_pred ---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCc
Q 039228 135 ---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199 (356)
Q Consensus 135 ---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 199 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~ 153 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTNTF 153 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Cccccc
Confidence 347789999999999999 9999999999999999999999999997532211 122346
Q ss_pred cccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccccc
Q 039228 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGT 279 (356)
Q Consensus 200 ~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 279 (356)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......... ....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~------------~~~~----- 211 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQ------------EPLR----- 211 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHc------------CCCC-----
Confidence 78999999999999999999999999999999999999996321 1111111111 0000
Q ss_pred ccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHH
Q 039228 280 NSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNA 320 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 320 (356)
.+......+.+++.+||+.||.+||++.++
T Consensus 212 -----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred -----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 001223356899999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=290.68 Aligned_cols=213 Identities=19% Similarity=0.209 Sum_probs=174.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.+-|++++.||.|+.|.|-+|++..||+.+|||++.+.. ......+.+|+-+|+-+.|||++++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 456999999999999999999999999999999997542 2334568899999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 458999999999999999 99999999999999999999999999975332
Q ss_pred CCccCCCCccccccccchhhhcCCCCC-CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVS-TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......+|.+.|.+||++.|.+|. .++||||+|||||.||||+.||++ .++. .++...-
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir------------~LLlKV~ 225 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIR------------VLLLKVQ 225 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHH------------HHHHHHH
Confidence 2345568899999999999999985 789999999999999999999972 2332 2222222
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.+.+.. +-+.+.+..+|+.+|+..||..|.|+.||++.-
T Consensus 226 ~G~f~M----------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVFEM----------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcccC----------------CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 222211 113344567999999999999999999998753
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=272.49 Aligned_cols=217 Identities=20% Similarity=0.380 Sum_probs=165.6
Q ss_pred CCccccceecCceEEEEEEECCCCe--EEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
|.+.+.||+|+||.||+|.+..++. .||+|.++.. .....+.+..|+.+++.++||||+++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999877654 6899988653 23345678899999999999999874
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 236778999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
+++........ .......++..|++||+..+..++.++||||||+++|||++ |..||..... ..+..... .+
T Consensus 158 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~---~~ 230 (272)
T cd05075 158 LSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLR---QG 230 (272)
T ss_pred cccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH---cC
Confidence 99865432211 11122345678999999998899999999999999999999 8899864211 11111100 00
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
. .... ...++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 231 ~--------~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N--------RLKQ-------------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C--------CCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0000 012334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.96 Aligned_cols=224 Identities=21% Similarity=0.314 Sum_probs=181.6
Q ss_pred cCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
..+....+.||+|.||.||+|+... ....||||.++..... ..++|.+|+.+|..|+|||||+|
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 4456677899999999999998643 3478999999866555 67889999999999999999998
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc
Q 039228 135 -----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173 (356)
Q Consensus 135 -----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 173 (356)
+.|+.|||.|+.||-++. +|||||...|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 569999999999999998 999999999999999999
Q ss_pred eEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHH
Q 039228 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNF 252 (356)
Q Consensus 174 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~ 252 (356)
|||+|||+++..-...- ........-...||+||.+..++++++||||||||+|||+++ |+.||.+....+ ..+.
T Consensus 642 VKIsDfGLsRdiYssDY--Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~ 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY--YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIEC 717 (774)
T ss_pred EEecccccchhhhhhhh--hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHH
Confidence 99999999985432211 112223444778999999999999999999999999999999 999987543321 1111
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+ -+..+. ..+++|+.++.+||..||+.+|.+||+++||-..|+......
T Consensus 718 i-----------~~g~lL-------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 718 I-----------RAGQLL-------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred H-----------HcCCcc-------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1 111111 223489999999999999999999999999999999876654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=270.43 Aligned_cols=221 Identities=21% Similarity=0.278 Sum_probs=172.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|....++..||||.+.... ......+.+|+.+++.++||||+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 56889999999999999999998889999999886432 2234578899999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 346778999999999999 99999999999999999999999999876543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||.....+ ........ .....+
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-----~~~~~~ 226 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-----EQCDYP 226 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh-----hcCCCC
Confidence 221 122346788999999998888999999999999999999999998632211 11111100 000000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
... .......+.+++.+||+.||++|||+.+|++++.+..
T Consensus 227 ~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 PLP---------------------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---------------------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000 0124446789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=276.63 Aligned_cols=218 Identities=21% Similarity=0.294 Sum_probs=166.6
Q ss_pred CCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.+|.+.+.||.|+||.||+|.+..+ +..||+|.++..... ....+..|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3478889999999999999987543 578999998754332 34568889999999999999865
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
..++.|++.||.|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 236679999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QD 234 (283)
T ss_pred ceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence 999999999876533221 111223445778999999988889999999999999999998 8888864211 11
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
..... .+.... .. +..++..+.+++..||+.+|++||++++|+..|+.
T Consensus 235 ~~~~i--------~~~~~~-~~------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMI--------RNRQVL-PC------------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH--------HcCCcC-CC------------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 010000 00 01344567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=270.42 Aligned_cols=217 Identities=18% Similarity=0.350 Sum_probs=166.0
Q ss_pred CCccccceecCceEEEEEEECCC---CeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
|++.+.||+|+||.||+|....+ +..||+|.++... ......+.+|+..++.++||||+++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997653 4789999987542 2334578899999999999999875
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 236789999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCC
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .......
T Consensus 158 g~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~----- 228 (273)
T cd05035 158 GLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL----- 228 (273)
T ss_pred cceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH-----
Confidence 999865432211 11112234668999999988889999999999999999999 8899864221 1111110
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
..+... ..+..+...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 229 ----------~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 ----------RHGNRL---------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------HcCCCC---------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 00113445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=271.95 Aligned_cols=216 Identities=24% Similarity=0.399 Sum_probs=168.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4579999999999999999999764 4779999876432 235678999999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 347789999999999998 99999999999999999999999999986543221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...........
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------------ 222 (261)
T cd05072 159 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR------------ 222 (261)
T ss_pred --eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence 11223345678999999988889999999999999999998 99998642211 11111110000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.. ....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MP------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 001233457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=273.00 Aligned_cols=218 Identities=26% Similarity=0.381 Sum_probs=168.1
Q ss_pred cCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|.+.+.||+|+||.||+|.... ++..||+|.+...... ..+.+.+|+.+++.++|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568899999999999999998743 3578999998755443 45689999999999999999987
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc
Q 039228 135 -----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173 (356)
Q Consensus 135 -----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 173 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 125778999999999999 999999999999999999
Q ss_pred eEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHH
Q 039228 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNF 252 (356)
Q Consensus 174 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~ 252 (356)
++|+|||++........ ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC 236 (280)
T ss_pred EEECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 99999999875432211 111223345778999999999999999999999999999998 99998643211 11111
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
... .... .. ....+..+.+++.+||+.||++||++.+|++.|+
T Consensus 237 ~~~-----------~~~~-~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQ-----------GRLL-QR------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHc-----------CCcC-CC------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 110 0000 00 0123346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.72 Aligned_cols=217 Identities=22% Similarity=0.240 Sum_probs=169.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46999999999999999999999999999999997432 2345678889999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC-
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN- 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 190 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 347789999999999999 99999999999999999999999999976543320
Q ss_pred ------------------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC
Q 039228 191 ------------------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246 (356)
Q Consensus 191 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 246 (356)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-- 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--
Confidence 001223346789999999999999999999999999999999999999974321
Q ss_pred ccHHHHHHHhCCCchHHHhh--hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-hHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVN--LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-VPNAVHD 323 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~vl~~ 323 (356)
..... .+.. ..+.... .......+.+++.+|+. ||.+||+ +.++++.
T Consensus 236 ---~~~~~--------~i~~~~~~~~~p~------------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ---QETYN--------KIINWKESLRFPP------------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHH--------HHhccCCcccCCC------------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11110 1111 0000000 00123457889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=281.09 Aligned_cols=206 Identities=22% Similarity=0.245 Sum_probs=161.4
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997532 2334577889999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----~~~~~ 153 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----AATMK 153 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc----ccccc
Confidence 347889999999999999 999999999999999999999999998753221 11223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... +.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~------------~~~~~~--- 213 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI------------LMEDIK--- 213 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHh------------ccCCcc---
Confidence 45689999999999988999999999999999999999999964211 1111111 000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
.+......+.+++.+||+.||.+|| ++.++++.
T Consensus 214 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 -------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0002233567899999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=275.63 Aligned_cols=226 Identities=21% Similarity=0.278 Sum_probs=163.0
Q ss_pred cCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccCccch-----------HHHHHHHHHHhhcCCCChHHH--
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQCQGAS-----------KSFMAECKALKNICHRNLVRF-- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l-- 134 (356)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|+|++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999998877 67788887543322110 112233344556778877653
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEE
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI 176 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 176 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 348889999999999998 999999999999999999999
Q ss_pred cccccccccccCCCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHH
Q 039228 177 GDFELARFRQEVSNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 253 (356)
+|||+++........ .........||+.|+|||+..+..++.++|||||||++|||++|..||....... ......
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HHHHHh
Confidence 999999866432211 1112233568999999999999999999999999999999999999997543222 111111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.. +++.....+... ...++..+.+++..|++.+|++||++.+|++.|
T Consensus 247 ~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KC-------DFIKRLHEGKIK-----------------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HH-------HHHHHhhhhhhc-----------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 111111111000 013345688999999999999999999999876
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=273.81 Aligned_cols=217 Identities=22% Similarity=0.268 Sum_probs=169.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888999999999999999999999999999987542 2334678899999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------~~~ 151 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------IAK 151 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc------ccc
Confidence 347889999999999999 999999999999999999999999999754321 223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccH--HHHHHHhCCCchHHHhhhhhcccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL--HNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
...++..|+|||++.+..++.++|+||||+++|+|++|+.||.......... ...... +.+... ....
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~- 221 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDP-PVLP- 221 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH--------HhccCC-CCCC-
Confidence 3568899999999999899999999999999999999999997533221111 010000 000000 0000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ----------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ----------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00122357899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=281.24 Aligned_cols=205 Identities=20% Similarity=0.228 Sum_probs=160.1
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
+.||+|+||.||++....++..||+|++.... ......+..|+.+++.++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997532 2334567789999999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----~~~~~ 153 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----GATMK 153 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC----CCccc
Confidence 347889999999999999 999999999999999999999999998743211 11223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ......
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~------------~~~~~~--- 213 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELI------------LMEEIR--- 213 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH------------hcCCCC---
Confidence 45689999999999999999999999999999999999999964211 1111100 000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 214 -------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0002233567999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=275.01 Aligned_cols=235 Identities=20% Similarity=0.292 Sum_probs=171.3
Q ss_pred cCCCCccccceecCceEEEEEEE----CCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..+|++.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35789999999999999999984 34678999999876655556788999999999999999875
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 347789999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC--CchHHH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP--NRVMDI 264 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 264 (356)
...... .......++..|+|||++.+..++.++||||||+++|||++|..|+..... .+......... .....+
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYY-KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcce-eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHH
Confidence 322111 111112234569999999988899999999999999999998877542211 11110000000 001111
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+. +..... ......++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 236 ~~~-~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IEL-LKNNGR--------------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHH-HhcCCc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 110 000000 000113445688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.33 Aligned_cols=223 Identities=22% Similarity=0.345 Sum_probs=176.8
Q ss_pred CCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.+.+....||+|.||.||.|....- ...||||.++... ......|++|..+|+.++|||||++
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 4466778999999999999998643 2359999987653 4456789999999999999999987
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
+.++.|||+|+.||++++ +|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 668999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCc
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
|+.+....- ........-...|||||.+..+.++.++|||||||++||++| |..||......
T Consensus 849 ArDiy~~~y--yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------------- 911 (1025)
T KOG1095|consen 849 ARDIYDKDY--YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------------- 911 (1025)
T ss_pred hHhhhhchh--eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---------------
Confidence 994322111 111111233567999999999999999999999999999999 99998743211
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+++...+.+. ++..+..|+..+.+||..||+.+|++||++..|++.+..|....
T Consensus 912 --~v~~~~~~gg---------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 912 --EVLLDVLEGG---------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --HHHHHHHhCC---------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1111111000 12223478999999999999999999999999999999998654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=295.34 Aligned_cols=224 Identities=19% Similarity=0.197 Sum_probs=179.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l--------------- 134 (356)
.-++++.+.|.+|||+.||+|.+...+..||+|++-..+....+.+.+|+.+|+.|+ |+|||.+
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 446788999999999999999999888999999987777777889999999999998 9999987
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+.|+.|+++|+++||.. ++||||||||-+||||+.+|..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67999999999999998 4889999999999999999999999999986
Q ss_pred ccccCC-CC-C---ccCCCCccccccccchhhh---cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 184 FRQEVS-NP-T---QSSSNGVRRTIGYTALDYD---LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 184 ~~~~~~-~~-~---~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
...... .. . ....-...-|+.|+|||++ .+..++.|+|||+|||+||-|+....||+....-
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 422111 00 0 0000112248899999986 4678999999999999999999999999742111
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.|++- .+. ....+.....|.+||..||+.||++||++-+|+..+.++...
T Consensus 265 -------aIlng----~Y~--------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -------AILNG----NYS--------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------eEEec----ccc--------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111 110 000125566789999999999999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=269.74 Aligned_cols=220 Identities=20% Similarity=0.357 Sum_probs=170.1
Q ss_pred cCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+..... .....+..|+.++++++||||+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35799999999999999999998643 46899999875433 334578899999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.+++.||.|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 457889999999999998 999999999999999999999999999876421
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 160 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~---------- 225 (266)
T cd05033 160 EAT--YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY---------- 225 (266)
T ss_pred ccc--eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC----------
Confidence 111 11112334678999999998899999999999999999998 99998643211 1111111000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.... ...++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 --~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPP------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 012344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=277.16 Aligned_cols=238 Identities=23% Similarity=0.306 Sum_probs=168.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|.+.+.||+|+||.||+|++..++..||+|.++.... .....+.+|+.++++++||||+++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 579999999999999999999998999999999875432 233467789999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 158 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT---- 158 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc----
Confidence 336789999999999999 9999999999999999999999999997543221
Q ss_pred cCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-C-CchH-HHhhhhh
Q 039228 194 SSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-P-NRVM-DIVNLVL 269 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~-~~~~~~l 269 (356)
.......++..|+|||++.+ ..++.++|||||||++|+|+||+.||......+ .+........ + .... .+....-
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhh
Confidence 11223456889999998865 458899999999999999999999997533211 1111111110 0 0000 0000000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.............. ..........+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPL-----INHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCch-----hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 0011123445689999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=274.21 Aligned_cols=224 Identities=21% Similarity=0.287 Sum_probs=169.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCe--EEEEEEeecc-CccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQ-CQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
++|++.+.||.|+||.||+|....++. .+++|.++.. .....+.+.+|+.++.++ +||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999876654 4788887643 233446788999999999 79999976
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 135 ----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 135 ----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 236678999999999999 9999999999999999999
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~ 253 (356)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ....
T Consensus 159 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELY 228 (297)
T ss_pred EECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 999999986322110 1111222457999999988889999999999999999997 9999864321 1111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
.. +........ ...+...+.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 229 ~~---------~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 229 EK---------LPQGYRMEK------------------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HH---------HhcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 10 111000000 012334678999999999999999999999999999887654
Q ss_pred cc
Q 039228 334 ET 335 (356)
Q Consensus 334 ~~ 335 (356)
..
T Consensus 282 ~~ 283 (297)
T cd05089 282 YV 283 (297)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=274.18 Aligned_cols=223 Identities=22% Similarity=0.347 Sum_probs=172.8
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|.+.+.||+|+||.||+|... .++..+++|.+........+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999864 2456799999876555555778999999999999999875
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc
Q 039228 135 -----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173 (356)
Q Consensus 135 -----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 173 (356)
+.++.+|+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 236788999999999999 999999999999999999
Q ss_pred eEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHH
Q 039228 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNF 252 (356)
Q Consensus 174 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~ 252 (356)
++|+|||++........ ........++..|+|||++.+..++.++||||||+++|||+| |..||...... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIEC 237 (291)
T ss_pred EEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 99999999975433211 112233456788999999999999999999999999999999 99998643211 11110
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.. .+ ... .. ...++..+.+++.+||+.+|++||++.+|+++|+++....
T Consensus 238 ~~---~~--------~~~-~~------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 238 IT---QG--------RVL-ER------------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred Hh---CC--------CCC-CC------------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 00 00 000 00 0123446789999999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=274.31 Aligned_cols=160 Identities=24% Similarity=0.318 Sum_probs=131.6
Q ss_pred cccceecCceEEEEEEECC--CCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 77 INLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
...||+|+||.||+|+... +++.||+|.+.... ....+.+|+.++++++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 4589999999999999753 56899999986432 23457789999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe----CCCCceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 236789999999999999 9999999999999 466889999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
........ ........+|+.|+|||++.+ ..++.++||||+||++|+|++|++||...
T Consensus 161 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 65432211 122334678999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=268.47 Aligned_cols=216 Identities=27% Similarity=0.407 Sum_probs=168.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|++|.||+|.+..+ +.||+|.++... ...+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 46799999999999999999997654 789999987543 335678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI-- 157 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc--
Confidence 457789999999999999 9999999999999999999999999998664221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.........+..|+|||++.+..++.++|+||||+++|+|++ |+.||...... ..... ++....
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~------------~~~~~~ 222 (261)
T cd05068 158 -YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQ------------VDQGYR 222 (261)
T ss_pred -ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHcCCC
Confidence 111122233467999999998899999999999999999999 99998643211 11110 110000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
... ...++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ~~~------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPC------------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCC------------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000 01234467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=278.87 Aligned_cols=209 Identities=21% Similarity=0.248 Sum_probs=160.1
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHH---hhcCCCChHHH-------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKAL---KNICHRNLVRF------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l------------- 134 (356)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+..|+.++ +.++||||+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999999999999999997432 22345566676654 56789999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 458889999999999999 9999999999999999999999999986432211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .... +.....
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~------------~~i~~~ 216 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVF------------DSIVND 216 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHH------------HHHHhC
Confidence 122346789999999999999999999999999999999999999964221 1111 111000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
... .+......+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 EVR----------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000 0002234567899999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.34 Aligned_cols=221 Identities=22% Similarity=0.320 Sum_probs=173.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|....+++.||+|.++.. .....+.+.+|+.++++++|+|++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999999988999999988642 22335678899999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 346788999999999999 99999999999999999999999999876533
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .........
T Consensus 159 ~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~------------ 219 (267)
T cd08224 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK------------ 219 (267)
T ss_pred CC----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh------------
Confidence 21 11223457888999999998889999999999999999999999985322 111111111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
........ .........+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus 220 ~~~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEKCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00000000 000133446789999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=292.74 Aligned_cols=213 Identities=18% Similarity=0.193 Sum_probs=168.0
Q ss_pred CCCccccceecCceEEEEEEECCC-CeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLN-RAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.+|+.++||||+++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999998877 78899998765555555667889999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 236789999999999999 99999999999999999999999999986543221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ++...+.
T Consensus 225 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~------------~~~~~~~ 285 (478)
T PTZ00267 225 --LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----RE------------IMQQVLY 285 (478)
T ss_pred --cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HH------------HHHHHHh
Confidence 1223346789999999999999999999999999999999999999963211 11 1111111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.... .+..+...+.+++..||..||++||++.+++.
T Consensus 286 ~~~~~---------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYDP---------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCC---------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11100 00123345789999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=288.70 Aligned_cols=233 Identities=21% Similarity=0.280 Sum_probs=182.7
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCC----eEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNR----AVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l- 134 (356)
..+.|+...++-.+.+.||+|+||.||+|.....+ ..||+|..+.. .....+++.+|+++|++++|||||++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 33456667788888899999999999999987542 23899998752 35567889999999999999999997
Q ss_pred -------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 135 -------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 135 -------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
+.++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 458889999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHH-HH
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFA-RM 255 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~-~~ 255 (356)
|||+++..... ........-...|+|||.+....++.++|||||||++||+++ |..||.+.... .....+ ..
T Consensus 305 DFGLs~~~~~~----~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~ 378 (474)
T KOG0194|consen 305 DFGLSRAGSQY----VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKN 378 (474)
T ss_pred ccccccCCcce----eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhc
Confidence 99998754311 111111234678999999999999999999999999999999 88898754322 111111 11
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
.++. ..+...+..+..++.+||..+|++||+|.++.+.|+.+.....+.
T Consensus 379 ~~r~------------------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 GYRM------------------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CccC------------------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 1110 011134456778899999999999999999999999999887654
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=273.31 Aligned_cols=220 Identities=21% Similarity=0.341 Sum_probs=166.7
Q ss_pred hcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998642 35789999986432 2334568899999999999999976
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEE
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI 176 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 176 (356)
+.++.+++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 225678999999999998 999999999999999999999
Q ss_pred cccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHH
Q 039228 177 GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~ 255 (356)
+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 161 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRF 233 (277)
T ss_pred CCCCCccccCCccee--ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 999998754322211 11122345678999999998889999999999999999999 7889864321 111110
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
+...... .. ...++..+.+++.+||+.||++|||+.++++.|++
T Consensus 234 --------~~~~~~~-~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 --------VMEGGLL-DK------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --------HHcCCcC-CC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000000 00 01234467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=290.76 Aligned_cols=163 Identities=21% Similarity=0.317 Sum_probs=133.2
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCC------hHHH-------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN------LVRF------- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l------- 134 (356)
....++|++.+.||+|+||.||+|.+..+++.||||+++... .....+..|+.++..++|.+ ++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345678999999999999999999999899999999986432 22344566777777776543 3332
Q ss_pred ------------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCC-----------
Q 039228 135 ------------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDL----------- 172 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~----------- 172 (356)
..++.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence 3578899999999997 48 99999999999998665
Q ss_pred -----ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 173 -----FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 173 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~-------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER-------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CCCCceEEECCCCccccCc-------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999875321 122346789999999999999999999999999999999999999974
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.85 Aligned_cols=162 Identities=25% Similarity=0.366 Sum_probs=140.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||.|+||.||+|.+..++..+|+|++..... .....+.+|+++++.++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999875432 334678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 34778999999999974 6 999999999999999999999999998754321
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235678999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=283.79 Aligned_cols=167 Identities=23% Similarity=0.257 Sum_probs=141.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..++||||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997532 2334567889999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 347889999999999999 999999999999999999999999998754321110
Q ss_pred C----------------------------------ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCC
Q 039228 192 T----------------------------------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRK 237 (356)
Q Consensus 192 ~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~ 237 (356)
. ........||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 001113468999999999999999999999999999999999999
Q ss_pred CCCc
Q 039228 238 PIDF 241 (356)
Q Consensus 238 Pf~~ 241 (356)
||..
T Consensus 238 Pf~~ 241 (364)
T cd05599 238 PFCS 241 (364)
T ss_pred CCCC
Confidence 9964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.30 Aligned_cols=212 Identities=19% Similarity=0.296 Sum_probs=162.9
Q ss_pred cceecCceEEEEEEE--CCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 79 LIGVGSFDAVYQGVF--DLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999975 45678999999864432 234678899999999999999976
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~ 157 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-KAKTH 157 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee-eecCC
Confidence 457889999999999999 9999999999999999999999999997654332211 11122
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
..++..|+|||.+....++.++|+||||+++|||++ |..||...... ..... +........
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~------------i~~~~~~~~---- 219 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQM------------IESGERMEC---- 219 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHCCCCCCC----
Confidence 334578999999988889999999999999999998 99999743211 11111 111100000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
+..++..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 220 --------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 --------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01234467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.35 Aligned_cols=217 Identities=24% Similarity=0.391 Sum_probs=169.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence 45699999999999999999998766 5699999875332 34678899999999999999875
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 347789999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......++..|+|||+..+..++.++||||||+++|+|++ |..||...... ..... +......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~---------~~~~~~~ 222 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ---------VERGYRM 222 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHH---------HhcCCCC
Confidence 11223445678999999988889999999999999999999 88898643211 00000 0000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
. ....++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 223 ~------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 P------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0113455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.69 Aligned_cols=226 Identities=23% Similarity=0.301 Sum_probs=173.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+++.+|+.++++++||||+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999987432 2234578999999999999999976
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
+.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 235679999999999999 9999999999999999999999999
Q ss_pred cccccccCCC--------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC
Q 039228 181 LARFRQEVSN--------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246 (356)
Q Consensus 181 ~a~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 246 (356)
+++....... ..........||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01112234579999999999999999999999999999999999999996421111
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-ChHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-NVPNAVHDLQ 325 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~vl~~L~ 325 (356)
... .... .++.-... ....+..+.+++.+||+.||++|| +++++++.|+
T Consensus 239 i~~----~~~i-------~~P~~~~p-------------------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 ISY----RDVI-------LSPIEVAP-------------------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hhh----hhhc-------cChhhccc-------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000 0000 00000000 013344678999999999999996 6888888888
Q ss_pred Hhhhh
Q 039228 326 SVNNI 330 (356)
Q Consensus 326 ~i~~~ 330 (356)
.....
T Consensus 289 ~~lq~ 293 (932)
T PRK13184 289 PHLQG 293 (932)
T ss_pred HHHhc
Confidence 87654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=266.68 Aligned_cols=215 Identities=24% Similarity=0.303 Sum_probs=166.3
Q ss_pred ccceecCceEEEEEEECCCC---eEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNR---AVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+..|+.+++.++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999876554 7899999875433 345678899999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++......... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-~~~~ 156 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-RATT 156 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc-cccc
Confidence 458889999999999999 9999999999999999999999999998664433211 1112
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+........+ ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~------------~~---- 218 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER------------LP---- 218 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc------------CC----
Confidence 2234567999999998899999999999999999998 9999964321 111111111100 00
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.+..++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 219 --------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 --------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00123446789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=281.39 Aligned_cols=210 Identities=22% Similarity=0.234 Sum_probs=164.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCC-eEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR-AVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+... .....+.+.+|+.+++.++||||+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999876554 78999998643 22334578899999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 347889999999999999 999999999999999999999999999765321
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... . ..... +.....
T Consensus 185 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~-~~~~~--------i~~~~~ 245 (340)
T PTZ00426 185 ------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L-LIYQK--------ILEGII 245 (340)
T ss_pred ------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H-HHHHH--------HhcCCC
Confidence 2235689999999999988899999999999999999999999964211 0 00000 000000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
. .+ ......+.+++.+|++.||.+|+ +++++++.
T Consensus 246 ~--~p------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 Y--FP------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--CC------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 00 01122457899999999999995 78877654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=271.25 Aligned_cols=223 Identities=20% Similarity=0.352 Sum_probs=172.8
Q ss_pred cCCCCccccceecCceEEEEEEECC----CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999876 35889999986432 3345678899999999999999986
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
+.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 236779999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCC
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
|+++.+..... ........++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+.....
T Consensus 162 g~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~- 236 (280)
T cd05043 162 ALSRDLFPMDY--HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY- 236 (280)
T ss_pred CCcccccCCce--EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC-
Confidence 99975532211 111122345678999999998889999999999999999999 9999864211 11111111100
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
... ....++..+.+++.+||..||++|||+.+|++.|+.+.+.
T Consensus 237 -----------~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 -----------RLA------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------CCC------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 0012344678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=266.90 Aligned_cols=211 Identities=22% Similarity=0.309 Sum_probs=162.1
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999999889999999876432 2334678999999999999999986
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTGGM 155 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc--cccCCC
Confidence 447889999999999999 99999999999999999999999999875432111 111111
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ...+........
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~------------~~~~~~~~~~~~---- 217 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QT------------REAIEQGVRLPC---- 217 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HH------------HHHHHcCCCCCC----
Confidence 223457999999998889999999999999999998 88998642211 01 111111100000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
...++..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 218 --------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 --------------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0123446789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=276.98 Aligned_cols=248 Identities=22% Similarity=0.202 Sum_probs=173.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+..|+.++++++||||+++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999999999999999998643 22344668889999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 236778999999999999 9999999999999999999999999997654322
Q ss_pred CCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC----CchHHH
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP----NRVMDI 264 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~ 264 (356)
.. ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..........+. +....+
T Consensus 161 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHh
Confidence 21 112234567899999998754 5688999999999999999999999964211 011111111111 111111
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVN 328 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~ 328 (356)
.+.............. ........+.....+.+++.+||+.+|++|||+.++++. +....
T Consensus 238 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKP----KVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCC----cccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 1111000000000000 000000011234567899999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.95 Aligned_cols=216 Identities=24% Similarity=0.317 Sum_probs=166.3
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchH--HHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK--SFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
|++.+.||+|+||+||++....+++.||+|++......... ....|+.++++++||||+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67789999999999999999999999999999866443322 34569999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE----NNE 153 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS----TTS
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc----ccc
Confidence 568899999999999999 99999999999999999999999999975411 122
Q ss_pred CCCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 195 SSNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
......++..|+|||++. +..++.++|+||+|+++|+|++|..||..... .+...... ......+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~--------~~~~~~~~~~~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIE--------KILKRPLPSSS 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHH--------HHHHTHHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhh--------hcccccccccc
Confidence 333466788999999998 78899999999999999999999999975410 01111100 00100000000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ........+.+++..||+.||++||++.++++
T Consensus 224 ~----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 Q----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011257899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=266.57 Aligned_cols=213 Identities=19% Similarity=0.344 Sum_probs=164.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|++.+.||+|+||.||+|.++.+ ..+|+|.+... ......+.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4588899999999999999998754 68999987643 2334678899999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 457789999999999999 99999999999999999999999999875432211
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||++.+..++.++|+||||+++|+|++ |+.||..... ......... .. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~---~~------~~~~~- 223 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISR---GF------RLYRP- 223 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC---CC------CCCCC-
Confidence 11122334568999999988889999999999999999999 8999864211 111111100 00 00000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 --------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 --------------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01223578999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=266.42 Aligned_cols=217 Identities=22% Similarity=0.336 Sum_probs=161.4
Q ss_pred ccceecCceEEEEEEECC---CCeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+.. .+..||+|.+... .....+.+.+|+.+++.++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998643 3468999998533 23345678899999999999999986
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
+.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 346779999999999998 999999999999999999999999999754322111111
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcC-CCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
......++..|+|||++.+..++.++||||||+++|||++| .+||.... ........ .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~------------~~~~~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYL------------LQGRR 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH------------hcCCC
Confidence 12234456789999999888899999999999999999995 56664321 11111110 00000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
. ......+..+.+++..||+.+|++||++.+|++.|+++..
T Consensus 221 ~---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 L---------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 0001223467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=266.94 Aligned_cols=217 Identities=24% Similarity=0.380 Sum_probs=168.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|.... ++.||+|.+.... .....+.+|+.++++++|+||+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence 34679999999999999999999764 5789999987443 334678899999999999999876
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 347889999999999998 99999999999999999999999999976542211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +.....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~------------~~~~~~ 221 (260)
T cd05067 158 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQN------------LERGYR 221 (260)
T ss_pred --ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHH------------HHcCCC
Confidence 11123345678999999998889999999999999999999 99999643211 11111 000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
... ....+..+.+++.+||+.+|++||++++++..|+.
T Consensus 222 ~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPR------------------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000 01233468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.50 Aligned_cols=216 Identities=25% Similarity=0.419 Sum_probs=167.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.++++++|+|++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence 4578999999999999999998764 46799999875433 34678999999999999998875
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 457789999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......++..|+|||+..+..++.++|+||||+++|+|++ |..||...... ..... +......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~------------~~~~~~~ 222 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ------------VERGYRM 222 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HHcCCCC
Confidence 11122334667999999988889999999999999999999 89998642211 11111 1100000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.. ....+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 223 ~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PC------------------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CC------------------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 01233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=270.77 Aligned_cols=220 Identities=20% Similarity=0.310 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+|++.+.||+|+||.||+|.... +...+++|.+..... .....+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235789998864432 334678899999999999999975
Q ss_pred -------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCC
Q 039228 135 -------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSN 165 (356)
Q Consensus 135 -------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~N 165 (356)
+.++.+++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 246779999999999999 9999999999
Q ss_pred eEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCcccc
Q 039228 166 VLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFE 244 (356)
Q Consensus 166 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~ 244 (356)
|++++++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999754322211 11122345678999999988889999999999999999998 9999864211
Q ss_pred CCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.. +.+.+........ +..+...+.+++..||+.+|++||++.++++.|
T Consensus 236 -----~~---------~~~~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 236 -----ER---------LFNLLKTGYRMER------------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred -----HH---------HHHHHhCCCCCCC------------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 11 1111111111000 013344678999999999999999999999999
Q ss_pred HHhhh
Q 039228 325 QSVNN 329 (356)
Q Consensus 325 ~~i~~ 329 (356)
+++..
T Consensus 284 ~~~~~ 288 (290)
T cd05045 284 EKMMV 288 (290)
T ss_pred HHHHh
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.99 Aligned_cols=166 Identities=23% Similarity=0.277 Sum_probs=139.9
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.|++++.||+|+||.||+|++..+++.||+|++.... ......+..|+.+++.++||||+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999999999999999997532 2334568899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC-
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP- 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 191 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 336789999999999999 999999999999999999999999997643110000
Q ss_pred ------------------------------------------CccCCCCccccccccchhhhcCCCCCCccchHhHHHHH
Q 039228 192 ------------------------------------------TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILL 229 (356)
Q Consensus 192 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l 229 (356)
.........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 00011235799999999999988999999999999999
Q ss_pred HHHHcCCCCCCc
Q 039228 230 LEMVTRRKPIDF 241 (356)
Q Consensus 230 ~elltg~~Pf~~ 241 (356)
|||++|..||..
T Consensus 239 ~elltG~~Pf~~ 250 (381)
T cd05626 239 FEMLVGQPPFLA 250 (381)
T ss_pred HHHHhCCCCCcC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=268.56 Aligned_cols=240 Identities=21% Similarity=0.243 Sum_probs=167.1
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|++..+|..||+|.++... ......+.+|+.++++++||||+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888899999999999999999999999999987532 2233567789999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 347889999999999999 9999999999999999999999999997553321
Q ss_pred cCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||++.+. .++.++|||||||++|+|+||..||.........+..............+.......+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 112234568899999998764 4789999999999999999999986433222111111111111111000000000000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ....... ..+..........+.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~-~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKP-YPMYPAT--TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccc-cCCCCCc--chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0000000 0000111234456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=283.79 Aligned_cols=220 Identities=20% Similarity=0.177 Sum_probs=167.5
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.+++.++||||+++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999999999999999996432 2233457789999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 346789999999999999 9999999999999999999999999997653221
Q ss_pred CCCccCCCCccccccccchhhhcCC----CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS----EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .... ..+.
T Consensus 197 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~--------~~i~ 260 (370)
T cd05596 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY--------SKIM 260 (370)
T ss_pred ---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHH--------HHHH
Confidence 1122346789999999998653 378899999999999999999999964211 1111 1111
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCC--CCChHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQD--RMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~vl~~ 323 (356)
+..-....+ ........+.+++.+||+.+|.+ ||++.+++..
T Consensus 261 ~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 261 DHKNSLTFP----------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCcCCCC----------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 100000000 00022346688999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.80 Aligned_cols=218 Identities=25% Similarity=0.350 Sum_probs=166.5
Q ss_pred cCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999976 678999999864432 234568899999999999999986
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIG 177 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 177 (356)
+.++.+|+.||.|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 247889999999999999 99999999999998654 58999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
|||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~----- 232 (277)
T cd05036 162 DFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVME----- 232 (277)
T ss_pred cCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-----
Confidence 9999986532111 111112233567999999998899999999999999999997 99998743211 1111
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.+........ +..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 -------~~~~~~~~~~------------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 -------FVTGGGRLDP------------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHcCCcCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110000000 0123446789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.70 Aligned_cols=218 Identities=21% Similarity=0.314 Sum_probs=166.3
Q ss_pred CCCCccccceecCceEEEEEEEC----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46889999999999999999863 345789999987433 2334678899999999999999876
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
+.++.+++.||.|||+.+ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 126678999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.+||+|||+++....... ........++..|+|||++.+..++.++|+||||+++|||++ |..||..... ....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE 237 (283)
T ss_pred cEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 999999999976533221 111222345678999999988889999999999999999998 9999864211 11111
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
...... .... ...++..+.+++.+||+.||++||++.+|++.|..
T Consensus 238 ~~~~~~-----------~~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQ-----------LLPC-------------------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCC-----------cCCC-------------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111100 0000 01234467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=270.07 Aligned_cols=212 Identities=27% Similarity=0.418 Sum_probs=160.3
Q ss_pred ccccceecCceEEEEEEEC----CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 76 LINLIGVGSFDAVYQGVFD----LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+.+.||.|.||.||+|.+. ..+..|+||.++.... ...+.+.+|++.+++++||||+++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999998 4568899999965333 346789999999999999999997
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.|+.||+.||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 568999999999999998 99999999999999999999999999986522111
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
............|+|||.+.+..++.++||||||+++|||++ |+.||.... ....... + .....
T Consensus 159 -~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~--------~-~~~~~ 223 (259)
T PF07714_consen 159 -YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEK--------L-KQGQR 223 (259)
T ss_dssp -EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHH--------H-HTTEE
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc--------c-ccccc
Confidence 122233456778999999988889999999999999999999 789986431 1111111 0 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
. ..+..++..+.+++..||+.||++|||+.+|++.|
T Consensus 224 ~------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 L------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp T------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 00113445678999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.45 Aligned_cols=167 Identities=22% Similarity=0.248 Sum_probs=141.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|....+++.||+|++.... ......+..|+.++..++||||+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997532 2234567889999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 347889999999999999 999999999999999999999999998754321100
Q ss_pred -------------------------------CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 192 -------------------------------TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 192 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0001124579999999999999999999999999999999999999996
Q ss_pred c
Q 039228 241 F 241 (356)
Q Consensus 241 ~ 241 (356)
.
T Consensus 238 ~ 238 (363)
T cd05628 238 S 238 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.73 Aligned_cols=219 Identities=17% Similarity=0.203 Sum_probs=167.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 3579999999999999999999998899999999975544455678889999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---- 160 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI---- 160 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc----
Confidence 346789999999999998 9999999999999999999999999997653221
Q ss_pred cCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 194 SSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......++..|+|||.+. ...++.++|+|||||++|||++|..||......... .......+. .+.+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~-------~~~~~ 232 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNFQ-------PPKLK 232 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCCC-------CCCCc
Confidence 1122356788999999874 345778999999999999999999998532211100 000000000 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
........+.+++.+||..+|++||++++|++.|
T Consensus 233 --------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --------------------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --------------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0012234678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.02 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=168.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3579999999999999999999998999999999875432 234567789999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--- 158 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---
Confidence 337789999999999999 9999999999999999999999999997543221
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......++..|+|||++.+ ..++.++|||||||++|+|++|++||...... .....................+..
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence 11223456889999998865 45788999999999999999999999743221 111111111111111111111100
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ....+.................+.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccc-ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0000000000000011123445789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.69 Aligned_cols=214 Identities=21% Similarity=0.202 Sum_probs=164.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48889999999999999999998899999999864321 223457789999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 347789999999999999 9999999999999999999999999987643211
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ...... ..+....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~---------~~~~~~~- 221 (285)
T cd05605 157 ----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVE---------RRVKEDQ- 221 (285)
T ss_pred ----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHH---------HHhhhcc-
Confidence 1123467899999999998889999999999999999999999997422110 000100 0000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
... .......+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEY------------------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccc------------------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000 012334578999999999999999 67777543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=280.09 Aligned_cols=214 Identities=18% Similarity=0.246 Sum_probs=176.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
-++|..++.+|+|+||.+++++++..+..+++|.+..... .......+|+.++++++|||||.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3579999999999999999999999999999999975532 233467899999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.|+.|||+.. |+|||||+.|||+..++.++|+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 568999999999999888 999999999999999999999999999987643
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. ......+||+.|++||.+.+.+|+.|+|||||||++|||++-+++|... +....+.. .
T Consensus 160 ~----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~k------------i 218 (426)
T KOG0589|consen 160 D----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILK------------I 218 (426)
T ss_pred h----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHH------------H
Confidence 2 2455689999999999999999999999999999999999999999742 22222111 1
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..... ..+.....++..++..|++.+|..||++.+|+.+
T Consensus 219 ~~~~~~---------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYS---------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCC---------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111100 0011344468899999999999999999999987
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.62 Aligned_cols=159 Identities=23% Similarity=0.314 Sum_probs=137.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|+||+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999999999999999643 2345689999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.|++.||.|||+.+ ||||||||+|||++.++.++|+|||+++....... .
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~ 316 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--T 316 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc--c
Confidence 458899999999999999 99999999999999999999999999986533211 1
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
.......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 12234678999999999999999999999999999999999887653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=262.08 Aligned_cols=212 Identities=21% Similarity=0.306 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|++|.||+|.+..++..|++|.+... .......+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999999999999999998643 23445678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 347889999999999998 99999999999999999999999999886543221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......++..|+|||+..+..++.++|+||||+++|+|++|+.||...... .... .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~------------~~~~~ 216 (256)
T cd08529 157 ---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALIL------------KIIRG 216 (256)
T ss_pred ---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHH------------HHHcC
Confidence 122346788999999999988999999999999999999999999643211 1000 00000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .........+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFP---------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCC---------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 0001233467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=279.33 Aligned_cols=206 Identities=20% Similarity=0.238 Sum_probs=159.7
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
+.||+|+||.||++.+..++..||+|++.... ......+..|+.++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997532 2234567789999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 -----------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~ 153 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----ATM 153 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----ccc
Confidence 3478899999999997 67 9999999999999999999999999987432211 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i------------~~~~~~~- 215 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI------------LMEEIRF- 215 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHH------------hcCCCCC-
Confidence 335689999999999999999999999999999999999999964211 1111100 0000000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 ---------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 ---------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 001223567899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=269.46 Aligned_cols=217 Identities=23% Similarity=0.327 Sum_probs=167.1
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|...+.||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45788899999999999999743 3467899999876655566789999999999999999876
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 135 ----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 135 ----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 236679999999999999 9999999999999999999
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~ 253 (356)
+|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |.+||...... .....
T Consensus 162 kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIEC- 236 (280)
T ss_pred EECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHH-
Confidence 9999999875432111 111223345678999999999999999999999999999998 99998642211 11000
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+....... .+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 237 -----------~~~~~~~~------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -----------ITQGRELE------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----------HHcCccCC------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000000 00123446789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.63 Aligned_cols=215 Identities=20% Similarity=0.192 Sum_probs=161.1
Q ss_pred CCCccccceecCceEEEEEEEC---CCCeEEEEEEeecc----CccchHHHHHHHHHHhhcC-CCChHHH----------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQ----CQGASKSFMAECKALKNIC-HRNLVRF---------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l---------- 134 (356)
+|++.+.||+|+||.||+++.. .+++.||+|++... .....+.+..|+.++..++ ||||+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999998874 46799999998643 1223456788999999995 8999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 347789999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......||+.|+|||++.+. .++.++|||||||++|||++|..||....... ........... .+
T Consensus 158 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~------~~ 227 (332)
T cd05614 158 EEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILK------CD 227 (332)
T ss_pred cCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhc------CC
Confidence 221 122345789999999999765 47889999999999999999999996432211 11111111000 00
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
+.+. ......+.+++.+||+.||++|| +++++++
T Consensus 228 ~~~~----------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPFP----------------------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0000 02233567899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=281.22 Aligned_cols=208 Identities=25% Similarity=0.310 Sum_probs=166.7
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
|.-++.||.|+||.||-|++..+.+.||||.++.... +....++.|+..|++++|||++.+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556789999999999999999999999999975543 334578999999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|...
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~-------- 176 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM-------- 176 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc--------
Confidence 236778999999999999 999999999999999999999999999754
Q ss_pred cCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 194 SSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
...+.++||+.|||||++. .+.|+.++||||||++..|+.-.++|+..+..- .....+... -.|.+.
T Consensus 177 ~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIAQN--------esPtLq 246 (948)
T KOG0577|consen 177 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN--------ESPTLQ 246 (948)
T ss_pred CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHHhc--------CCCCCC
Confidence 3445699999999999986 467999999999999999999999997654211 110001110 111121
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. +-...+.+++..||+.-|.+|||..+++..
T Consensus 247 s~---------------------eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 SN---------------------EWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred Cc---------------------hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11 333457899999999999999999988754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=274.14 Aligned_cols=248 Identities=19% Similarity=0.196 Sum_probs=172.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||.|+||.||+|....+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999999999999999987542 2345677889999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 346789999999999999 999999999999999999999999999765433
Q ss_pred CCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ................+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhhhh
Confidence 3222222334578889999998865 45889999999999999999999999643211 11111111111111111110
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.............+......+..........+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000000000000011335578999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=274.60 Aligned_cols=205 Identities=20% Similarity=0.208 Sum_probs=157.7
Q ss_pred ccceecCceEEEEEEEC---CCCeEEEEEEeeccC----ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 78 NLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC----QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+.||+|+||.||+++.. .+++.||+|++.... ......+..|+.+++.++||||+++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999864 467899999987431 2233467789999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---- 154 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC----
Confidence 236779999999999999 9999999999999999999999999987432211
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... +....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~------------~~~~~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKI------------LKGKL 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHH------------HcCCC
Confidence 122335689999999999988899999999999999999999999964211 1111111 11000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
. .+......+.+++.+||+.||++|| ++.++++
T Consensus 218 ~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 N----------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 0002233568999999999999999 7787766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=278.74 Aligned_cols=156 Identities=24% Similarity=0.358 Sum_probs=134.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
...+|++.+.||+|+||.||+|....++..||+|+.... ....|+.++++++||||+++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 346799999999999999999999989999999985422 23569999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.....
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 210 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---- 210 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC----
Confidence 347889999999999999 999999999999999999999999999743221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCC
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf 239 (356)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999865554
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.83 Aligned_cols=223 Identities=21% Similarity=0.300 Sum_probs=169.6
Q ss_pred hhcCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
...++|++.+.||+|+||.||+|..... ...+|+|.+.... ......+.+|+.++.++ +|+||+++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3456799999999999999999997643 3789999987532 23345688999999999 79999865
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 137889999999999998 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred cCCCeEEeCccccccccccccce--eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 99999999999999865432211 11122334677999999988889999999999999999998 9999863211
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+... .+....... .+..+...+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 241 --~~~~~---------~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 --EELFK---------LLKEGYRME------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHH---------HHHcCCcCC------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111 111100000 0113344678999999999999999999999999887
Q ss_pred h
Q 039228 328 N 328 (356)
Q Consensus 328 ~ 328 (356)
.
T Consensus 292 ~ 292 (293)
T cd05053 292 L 292 (293)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=266.43 Aligned_cols=221 Identities=21% Similarity=0.386 Sum_probs=168.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe---EEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA---VVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|+..+.||+|+||.||+|....++. .+|+|.+.... ....+.+..|+.++++++||||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3568889999999999999999875543 79999986542 2335678899999999999999876
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 457889999999999999 999999999999999999999999999765432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... ...... +..
T Consensus 161 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~---------i~~ 225 (268)
T cd05063 161 PEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKA---------IND 225 (268)
T ss_pred cccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHH---------Hhc
Confidence 2111 11111223457999999988889999999999999999998 9999864221 111111 110
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
...... ...++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~~~~~------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPA------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCC------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 012344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=270.46 Aligned_cols=216 Identities=19% Similarity=0.203 Sum_probs=170.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..+|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++|||++++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4579999999999999999999988899999999986655556788899999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----~ 171 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----S 171 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc----c
Confidence 457789999999999999 9999999999999999999999999987543221 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+........ +.+. .
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~~~~---------~~~~-~-- 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGT---------PELQ-N-- 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhcCCC---------CCCC-C--
Confidence 1223467889999999998889999999999999999999999996422111 0000000000 0000 0
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.......+.+++.+||..+|++||++.+|+..
T Consensus 239 -----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 -----------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01233457889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=272.76 Aligned_cols=204 Identities=22% Similarity=0.218 Sum_probs=155.3
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhh-cCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKN-ICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|+++... ....+.+..|..++.. .+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999997532 2233455667777764 479999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~~~ 153 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKA 153 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----Ccc
Confidence 347889999999999999 9999999999999999999999999997542211 223
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|||++|..||..... ....... ... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i--------~~~--~~~~~-- 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSI--------LND--RPHFP-- 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--------HcC--CCCCC--
Confidence 346789999999999998999999999999999999999999974321 1111110 000 00000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH-HHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP-NAV 321 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~vl 321 (356)
......+.+++.+||+.||.+||++. +++
T Consensus 217 ----------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 ----------------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01233567899999999999999875 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=263.95 Aligned_cols=213 Identities=23% Similarity=0.327 Sum_probs=162.5
Q ss_pred cceecCceEEEEEEEC--CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------------
Q 039228 79 LIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------------- 134 (356)
.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999875 4456799999875433 234568899999999999999976
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
+.++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++.......... .....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 157 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSA 157 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce-eccCC
Confidence 457889999999999999 9999999999999999999999999997554322211 11112
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
..++..|+|||.+.+..++.++||||||+++|++++ |..||...... .... .+........
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~------------~~~~~~~~~~---- 219 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMS------------FIEQGKRLDC---- 219 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH------------HHHCCCCCCC----
Confidence 233568999999988889999999999999999996 99999743211 1111 1111100000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
+..++..+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 --------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 --------------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 013445678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=264.22 Aligned_cols=210 Identities=24% Similarity=0.390 Sum_probs=165.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|++.+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|+|++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46899999999999999999876 678999998643 234678899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 457889999999999999 9999999999999999999999999987543211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||... ......... .....
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~---------~~~~~ 217 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV---------EKGYK 217 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH---------hcCCC
Confidence 12334567999999998889999999999999999997 99998632 111111110 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.. ....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 ~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MD------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0013345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.50 Aligned_cols=214 Identities=20% Similarity=0.329 Sum_probs=165.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|++.+.||+|+||.||.|.+... ..+|+|.+.... .....+.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4688899999999999999987643 569999886432 334678999999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 458889999999999999 99999999999999999999999999875532211
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|++||++.+..++.++||||||+++|+|++ |..||...... ...... .. .....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~-----------~~-~~~~~ 221 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKV-----------SQ-GLRLY 221 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH-----------hc-CCCCC
Confidence 11122345678999999988889999999999999999999 99998643211 010100 00 00000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.. ......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RP------------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CC------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 012346789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=268.20 Aligned_cols=235 Identities=20% Similarity=0.296 Sum_probs=173.0
Q ss_pred CCCCccccceecCceEEEEEEECC----CCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 457888999999999999999753 4789999999755443 45679999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 347789999999999999 9999999999999999999999999998664
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC-chHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN-RVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 265 (356)
..... ........++..|++||.+.+..++.++||||||+++|||++|..|+......... +....... ....+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 236 (284)
T cd05038 161 EDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLL 236 (284)
T ss_pred cCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHH
Confidence 22211 11111233456799999998888999999999999999999999998643221111 00000000 011111
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
+ .+..... ......++..+.+++.+||+.+|++||||.+|+++|+.+.
T Consensus 237 ~-~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 237 E-LLKEGER--------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred H-HHHcCCc--------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1 1110000 0001134467889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=282.55 Aligned_cols=160 Identities=26% Similarity=0.356 Sum_probs=136.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CC-----ChHHH------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HR-----NLVRF------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l------------ 134 (356)
+|.+.++||+|.||.|.+|.+..|++.||||+++.. .....+...|+.+|..|+ |. |+|++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 578999999999999999999999999999999754 334456678999999997 42 67765
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--CCceEEcccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--DLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.+.+..
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 347889999999999999 999999999999964 4479999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccc
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF 243 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~ 243 (356)
... -....+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+..
T Consensus 343 q~v-------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 343 QRV-------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred Ccc-------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 321 14667889999999999999999999999999999999988887543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=272.70 Aligned_cols=202 Identities=23% Similarity=0.216 Sum_probs=156.1
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.++.+++.||+|++... .......+..|..++..+ +||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999998743 223345677888888876 69999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++..... ....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----GKTT 153 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC----CCcc
Confidence 347789999999999999 999999999999999999999999998753211 1122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i------------~~~~~~~- 215 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAI------------LNDEVVY- 215 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHH------------hcCCCCC-
Confidence 345789999999999998999999999999999999999999964221 1111111 1000000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPN 319 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 319 (356)
+......+.+++.+||+.||++||++.+
T Consensus 216 ---------------~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 216 ---------------PTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred ---------------CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 0012235689999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=274.57 Aligned_cols=205 Identities=22% Similarity=0.235 Sum_probs=158.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCC-hHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRN-LVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~n-iv~l-------------- 134 (356)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|..++..++|++ |+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999999999999999997532 234466788999999998765 5544
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--- 154 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC---
Confidence 347889999999999999 999999999999999999999999998643211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... +.....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~--------i~~~~~-- 218 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQS--------IMEHNV-- 218 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHcCCC--
Confidence 1122345689999999999999999999999999999999999999964221 111110 000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
... ......+.+++.+||..||.+||+.
T Consensus 219 ~~~------------------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYP------------------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 0122356789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=266.43 Aligned_cols=216 Identities=19% Similarity=0.238 Sum_probs=166.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 468889999999999999999998999999999976654455668889999999999999886
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----~ 161 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI----A 161 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc----c
Confidence 347889999999999999 9999999999999999999999999987553221 1
Q ss_pred CCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 195 SSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......|+..|+|||++. ...++.++|+|||||++|+|++|..||....... ........... .+....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~-------~~~~~~ 233 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQ-------PPKLKD 233 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCC-------CCcccc
Confidence 223456889999999874 4568889999999999999999999985322111 00000000000 000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+++.+||+.+|++||++++|++
T Consensus 234 --------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --------------------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --------------------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0012235678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.09 Aligned_cols=206 Identities=23% Similarity=0.241 Sum_probs=158.3
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|++..+++.||+|++.... ......+..|..++..+ +||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999999999999999987532 23345677888888865 79999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----~~~ 153 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTT 153 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC----ccc
Confidence 347889999999999999 9999999999999999999999999987532211 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~------------i~~~~~~-- 214 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFES------------ILHDDVL-- 214 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHH------------HHcCCCC--
Confidence 345689999999999998999999999999999999999999974321 111111 1110000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-------ChHHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-------NVPNAVHD 323 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~~vl~~ 323 (356)
. +......+.+++.+||+.||++|| ++.++++.
T Consensus 215 ---~-----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 ---Y-----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---C-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 001223567899999999999999 66777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=281.10 Aligned_cols=237 Identities=20% Similarity=0.201 Sum_probs=167.4
Q ss_pred cCCCCccccceecCceEEEEEEECC--CCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..+|.+.+.||.|+||.||+|.... ++..||+|.+... ....+|+.+|+.++||||+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997643 4678999987633 335689999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~-- 240 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-- 240 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccc--
Confidence 457889999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC--ccHHHHHHHh------CCCch-HH
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD--LNLHNFARMA------FPNRV-MD 263 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--~~~~~~~~~~------~~~~~-~~ 263 (356)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....... ++... ..
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 122234678999999999999999999999999999999999999996543221 1111111111 11100 00
Q ss_pred Hhhhhhccccccccc-cccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 264 IVNLVLLNDNKVLAG-TNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+....-.-....+.. ..+..+.. ......+.+++.+||..||++|||+.+++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRK------YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhc------cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000000 00000000 0123356789999999999999999999875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.84 Aligned_cols=157 Identities=24% Similarity=0.343 Sum_probs=133.8
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++.++ +||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999999999999999997542 23345677888888776 79999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----~~~ 153 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTT 153 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----Ccc
Confidence 347789999999999999 9999999999999999999999999987432211 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
....||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 346789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.15 Aligned_cols=166 Identities=23% Similarity=0.282 Sum_probs=139.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.|++++.||+|+||.||+|+...+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999999999999999987432 2334568889999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC--
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN-- 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 190 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 346789999999999999 99999999999999999999999999753211000
Q ss_pred -----------------------------------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHH
Q 039228 191 -----------------------------------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILL 229 (356)
Q Consensus 191 -----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l 229 (356)
..........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 000011235789999999999999999999999999999
Q ss_pred HHHHcCCCCCCc
Q 039228 230 LEMVTRRKPIDF 241 (356)
Q Consensus 230 ~elltg~~Pf~~ 241 (356)
|||++|+.||..
T Consensus 239 ~elltG~~Pf~~ 250 (382)
T cd05625 239 YEMLVGQPPFLA 250 (382)
T ss_pred HHHHhCCCCCCC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=263.40 Aligned_cols=217 Identities=18% Similarity=0.226 Sum_probs=167.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-----cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-----GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|.+.+.||+|++|.||.|....+++.||+|.+..... ...+.+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999998899999999864321 123567889999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 347789999999999999 9999999999999999999999999997653321
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.. ........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~---------~~~~~ 224 (263)
T cd06625 159 SS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI---------ATQPT 224 (263)
T ss_pred cc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHH---------hccCC
Confidence 11 1111235577899999999998899999999999999999999999864211 1111000 00000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .+......+.+++.+||..+|++|||+.++++.
T Consensus 225 ~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQ------------------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCC------------------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 001233457899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=262.89 Aligned_cols=215 Identities=24% Similarity=0.397 Sum_probs=167.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|.+...||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.++++++|||++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 5688999999999999999998765 469999876432 234678899999999999999876
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 357789999999999999 99999999999999999999999999976533221
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||+..+..++.++||||||+++|+|++ |..||...... ........... ..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------~~ 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR------------MP 223 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------CC
Confidence 11222345678999999998889999999999999999999 99998643211 11111100000 00
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.....+..+.+++.+||+.||++||++++|++.|+.
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001234467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=273.87 Aligned_cols=205 Identities=21% Similarity=0.227 Sum_probs=157.9
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcC-CCChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNIC-HRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l-------------- 134 (356)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ......+..|..++..+. |++|+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999999999999999987542 223345677888887774 7777765
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--- 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC---
Confidence 457889999999999999 999999999999999999999999998743211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +.....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~~--------i~~~~~-- 218 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQS--------IMEHNV-- 218 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHhCCC--
Confidence 11223466899999999999999999999999999999999999999742211 11111 000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
..+ ......+.+++.+|++.||.+|++.
T Consensus 219 ~~p------------------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYP------------------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCC------------------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 000 0223356899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=279.87 Aligned_cols=169 Identities=23% Similarity=0.289 Sum_probs=142.8
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
+....++|++.+.||+|+||.||+|.+..+++.||+|++... .......+..|+.+++.++||||+++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344567899999999999999999999999999999998642 12234567789999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 347789999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCC----CCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSE----VSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 195 ~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 195 TG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CC---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 21 11223467899999999987543 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=277.94 Aligned_cols=215 Identities=18% Similarity=0.162 Sum_probs=164.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|+++... ....+.+..|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999997542 2234567889999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 236789999999999999 99999999999999999999999999976543221
Q ss_pred CCccCCCCccccccccchhhhc------CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 191 PTQSSSNGVRRTIGYTALDYDL------GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||..... ..... .+
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~--------~i 221 (330)
T cd05601 158 ---VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYN--------NI 221 (330)
T ss_pred ---eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHH--------HH
Confidence 1222346899999999986 45678999999999999999999999964221 11111 11
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......... ........+.+|+..|+. +|.+||++.+++.
T Consensus 222 ~~~~~~~~~~----------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 222 MNFQRFLKFP----------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HcCCCccCCC----------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1000000000 000223356789999997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=269.75 Aligned_cols=221 Identities=21% Similarity=0.276 Sum_probs=168.6
Q ss_pred cCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l--------- 134 (356)
.++|.+.+.||+|+||.||+|.+. .++..||+|.++... ....+.+.+|+.+++++ +||||+++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 346999999999999999999852 345689999987543 23345788999999999 79999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 347789999999999998 99999999999999999999999999975
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+..
T Consensus 191 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~------------ 255 (302)
T cd05055 191 IMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYK------------ 255 (302)
T ss_pred ccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHH------------
Confidence 533221 111223345778999999998889999999999999999998 999986432111 1111
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+......... ......+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 256 ~~~~~~~~~~~------------------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQP------------------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCC------------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111100000 01223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=262.60 Aligned_cols=217 Identities=20% Similarity=0.267 Sum_probs=170.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||.|+||.||+|.+..+++.+++|.+........+.+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3679999999999999999999988889999999986655566789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 347889999999999999 9999999999999999999999999987654321
Q ss_pred ccCCCCccccccccchhhhcCC---CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS---EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... .........+.. ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~~~~~~~~~~-------~~- 225 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALFLISKSNFPP-------PK- 225 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCC-------cc-
Confidence 122335678889999998776 78899999999999999999999986432111 000000000000 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+..+.+++.+||..+|.+|||+.+|+.
T Consensus 226 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 -------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011134456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.22 Aligned_cols=222 Identities=21% Similarity=0.373 Sum_probs=180.4
Q ss_pred CCCCccccceecCceEEEEEEECCCC---eEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNR---AVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
...+|.++||.|.||.||.|+++..+ ..||||.++....+ ....|+.|+.||.+++||||++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999999997654 57999999866544 44679999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++++|+.|+.||.+.+ +|||||.+.|||++.+..+|++|||+++.+.+..
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 568899999999999999 9999999999999999999999999999876554
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. .....+..-...|.|||.+...+++.+||||||||+|||.++ |..||=++...+ .... +...
T Consensus 786 ~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIka------------Ie~g 850 (996)
T KOG0196|consen 786 EA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKA------------IEQG 850 (996)
T ss_pred Cc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHH------------HHhc
Confidence 22 222233334678999999999999999999999999999887 999985443221 1111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
.. ..-+.+|+..|.+||+.||+.|-..||.+.+|+.+|+++..
T Consensus 851 yR------------------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 851 YR------------------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred cC------------------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 11 11223899999999999999999999999999999988753
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=265.54 Aligned_cols=221 Identities=22% Similarity=0.386 Sum_probs=168.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCe---EEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA---VVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
++|++.+.||+|+||.||+|.+..++. .||+|.+... .....+.+..|+.+++.++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999999876543 6999998754 23345679999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 457789999999999999 9999999999999999999999999987654322
Q ss_pred CCCc-cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 190 NPTQ-SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~---------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY---------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC----------
Confidence 1111 11111112457999999998899999999999999999887 99998642211 1111111000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.. .....++..+.+++..||+.+|++||++.+|+..|+++
T Consensus 229 --~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --RL------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00013344678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=269.12 Aligned_cols=223 Identities=21% Similarity=0.300 Sum_probs=169.4
Q ss_pred cCCCCccccceecCceEEEEEEEC-------CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-------LNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.++|.+.+.||+|+||.||+|... ..+..||+|.+.... ......+.+|+.+++.+ +||||+++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456889999999999999999752 234579999986432 23446788999999999 79999986
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.||+.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 124669999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999865432211 11222345678999999988889999999999999999998 788875321
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
........ ....... ....++..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 245 -~~~~~~~~---------~~~~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 -VEELFKLL---------KEGHRMD------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -HHHHHHHH---------HcCCcCC------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11111111 0000000 0013445678999999999999999999999999887
Q ss_pred hhh
Q 039228 328 NNI 330 (356)
Q Consensus 328 ~~~ 330 (356)
...
T Consensus 297 ~~~ 299 (304)
T cd05101 297 LTL 299 (304)
T ss_pred HHh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=266.56 Aligned_cols=233 Identities=23% Similarity=0.266 Sum_probs=165.7
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|++|.||+|+...++..||+|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4888999999999999999999889999999986442 2234678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 347889999999999999 9999999999999999999999999997543221
Q ss_pred CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC--Cc----hHHH
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP--NR----VMDI 264 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~----~~~~ 264 (356)
.......+++.|+|||++.+. .++.++||||||+++|+|+||++||....... ........... .. ....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhh
Confidence 112234568889999988654 47889999999999999999999997432211 11111110000 00 0000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+... .. +.+...............+.+++.+||..||++|||+.+|+.
T Consensus 233 ~~~~~--~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKN--TF-------PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHh--hc-------cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 000000000001123446689999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=263.49 Aligned_cols=213 Identities=22% Similarity=0.343 Sum_probs=164.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 358889999999999999998864 5789999986432 234578889999999999999975
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~---~ 155 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---Y 155 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc---c
Confidence 457889999999999999 9999999999999999999999999997653221 1
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ .....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~------------~~~~~ 221 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSA------------GYRLY 221 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHc------------CCcCC
Confidence 11122233567999999998899999999999999999999 89998642211 11111000 00000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
. +..++..+.+++.+||+.+|++|||+.+|++.|
T Consensus 222 ~------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 R------------------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 012344688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=267.72 Aligned_cols=209 Identities=21% Similarity=0.192 Sum_probs=158.9
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||+|+||.||++....+++.||+|.+.... ......+..|+.++++++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999986432 1223455679999999999999976
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~ 152 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TIT 152 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----eee
Confidence 346789999999999999 9999999999999999999999999987654321 112
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ............. ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~--------~~~~----- 218 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE--------VKFE----- 218 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc--------cccc-----
Confidence 3457889999999998889999999999999999999999996432111 1111111111000 0000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.......+.+++.+||+.||++||++.++++.+
T Consensus 219 --------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 --------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --------------cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 002233568999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=264.85 Aligned_cols=217 Identities=20% Similarity=0.351 Sum_probs=165.6
Q ss_pred CCccccceecCceEEEEEEECC---CCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
|.+.+.||+|+||.||+|.+.. ++..||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998643 57899999986542 3345678899999999999998654
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 346788999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCC
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
|+++....... ........++..|++||.+.+..++.++||||||+++|+|++ |.+||..... ..........
T Consensus 158 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~-- 231 (273)
T cd05074 158 GLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG-- 231 (273)
T ss_pred cccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--
Confidence 99986533211 111122334567999999998889999999999999999999 8899864321 1111111000
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
. .+. .....+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 232 ~--------~~~--------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N--------RLK--------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C--------cCC--------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 000 0012334688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=285.86 Aligned_cols=210 Identities=23% Similarity=0.317 Sum_probs=168.9
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeecc----CccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ----CQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+...+||+|+|-+||+|.+..+|..||--.++.. .....++|..|+.+|+.|+||||+++
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456899999999999999999999987665422 33445789999999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..|++||+.||.|||++ .+||||||||.+||+|+ ..|.+||+|+|+|..+..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--- 198 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence 35999999999999998 48999999999999997 568999999999987643
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....+.||+.|||||+.. ..|+..+||||||+.++||+|+..||..................|..+..+-|+
T Consensus 199 ---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP--- 271 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP--- 271 (632)
T ss_pred ---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH---
Confidence 2333489999999999987 789999999999999999999999998654333223332222223333333332
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
++.++|.+|+.. ..+|||+.|||..
T Consensus 272 ---------------------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ---------------------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---------------------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 357899999999 9999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=267.39 Aligned_cols=233 Identities=18% Similarity=0.281 Sum_probs=169.2
Q ss_pred CCCccccceecCceEEEEEEE----CCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.|++++.||+|+||.||+|.+ ..++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999985 3467899999986443 3334678899999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 457789999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 266 (356)
.... ........++..|+|||++.+..++.++||||||+++|+|+++..|+..... .+........ .......+.
T Consensus 162 ~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 162 DKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred Cccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hhhhhcccccccccHHHHHH
Confidence 2211 1112234567789999999888899999999999999999998776532111 0000000000 000011110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
....+.. ......++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 238 ~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR---------------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc---------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 000113445789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=274.83 Aligned_cols=201 Identities=26% Similarity=0.257 Sum_probs=154.0
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHH-HHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECK-ALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|.. +++.++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999999999999999997432 222344555554 5678999999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~ 153 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----SKTT 153 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC----CCcc
Confidence 347889999999999999 999999999999999999999999998743221 1222
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ +.....-
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i--------~~~~~~~----- 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNI--------LNKPLRL----- 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHH--------HcCCCCC-----
Confidence 34568999999999999999999999999999999999999996421 11111111 1100000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
.......+.+++.+||+.||.+||++.
T Consensus 216 ---------------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 ---------------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 001233568999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=267.14 Aligned_cols=207 Identities=24% Similarity=0.250 Sum_probs=158.7
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||+|+||+||++.+..+++.||+|.+..... ...+.+..|+.+++.++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999999864322 223567789999999999999976
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----~~ 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SK 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC----cc
Confidence 347789999999999999 9999999999999999999999999997554322 12
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ............. . .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~--------~--~--- 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS--------V--T--- 219 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC--------C--C---
Confidence 234568999999999999999999999999999999999999996432111 1111111110000 0 0
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
.....+..+.+++.+||+.||++|| +++++++
T Consensus 220 ---------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 ---------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ---------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0012344678999999999999999 5556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=274.75 Aligned_cols=157 Identities=24% Similarity=0.342 Sum_probs=134.4
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|+++... ......+..|..++..+ +||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999999999999999997532 23345678899999988 69999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----GDTT 153 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC----CCcc
Confidence 457889999999999999 999999999999999999999999998742211 1122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 346789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=266.36 Aligned_cols=218 Identities=23% Similarity=0.339 Sum_probs=167.2
Q ss_pred cCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|.+.+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45789999999999999999998643 4789999986443 2334578899999999999999976
Q ss_pred -------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 135 -------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 135 -------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 226679999999999998 9999999999999999999999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
|||+++....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||...... .......
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~-- 235 (277)
T cd05032 162 DFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVI-- 235 (277)
T ss_pred CcccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHh--
Confidence 9999875533221 111223445778999999988889999999999999999998 99998632211 1111110
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+.... .. +..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ---------~~~~~-~~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ---------DGGHL-DL------------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------cCCCC-CC------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00000 00 0123446789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=272.84 Aligned_cols=205 Identities=20% Similarity=0.192 Sum_probs=159.1
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999997542 23345677888898887 69999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~ 153 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTT 153 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC----Ccc
Confidence 347789999999999999 9999999999999999999999999986432111 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ....... ...... .
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i--------~~~~~~--~--- 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSI--------LEDEVR--Y--- 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHH--------HcCCCC--C---
Confidence 335689999999999999999999999999999999999999964221 1111110 000000 0
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh-----HHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV-----PNAVH 322 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~~vl~ 322 (356)
+......+.+++.+||+.||.+||++ .++++
T Consensus 216 ---------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 ---------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00223357899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=269.95 Aligned_cols=221 Identities=22% Similarity=0.306 Sum_probs=166.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe--EEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... ......+.+|+.++.++ +||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578999999999999999999876664 45777765432 23345788899999999 89999876
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc
Q 039228 135 -----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173 (356)
Q Consensus 135 -----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 173 (356)
+.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 135678999999999999 999999999999999999
Q ss_pred eEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHH
Q 039228 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNF 252 (356)
Q Consensus 174 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~ 252 (356)
++|+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... ...
T Consensus 163 ~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AEL 232 (303)
T ss_pred EEeCccccCcccchh-----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHH
Confidence 999999998632211 11111223567999999988889999999999999999998 9999863221 111
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
... +........ .......+.+++.+||+.+|++||++.+++++|..+.+.-
T Consensus 233 ~~~---------~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 YEK---------LPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHH---------HhcCCcCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 110 000000000 0022335789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=270.27 Aligned_cols=160 Identities=24% Similarity=0.322 Sum_probs=131.1
Q ss_pred cccceecCceEEEEEEECC--CCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 77 INLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
...||+|+||.||+|+... ++..||+|.+.... ....+.+|+.+++.++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 56889999986432 23467889999999999999875
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe----CCCCceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 246789999999999999 9999999999999 567899999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
........ ........+|..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432211 122334678999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=272.85 Aligned_cols=223 Identities=21% Similarity=0.258 Sum_probs=167.8
Q ss_pred cCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRFIS------- 136 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~------- 136 (356)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 467999999999999999999852 456899999997543 22345688999999999 6899998721
Q ss_pred --------------------------------------------------------------------------------
Q 039228 137 -------------------------------------------------------------------------------- 136 (356)
Q Consensus 137 -------------------------------------------------------------------------------- 136 (356)
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence
Q ss_pred ------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 137 ------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 137 ------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 240 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGD 240 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcCC
Confidence 3558999999999999 99999999999999999999999999976532211 111222
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .+... +........
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~------------~~~~~~~~~---- 303 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRR------------LKEGTRMRA---- 303 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHH------------HhccCCCCC----
Confidence 345677999999988889999999999999999997 999986432110 11110 000000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
+......+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 304 --------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 --------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00112357899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=281.92 Aligned_cols=167 Identities=23% Similarity=0.271 Sum_probs=139.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+|+.++||||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999986432 2234567889999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC-
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN- 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 190 (356)
..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 336789999999999999 99999999999999999999999999753210000
Q ss_pred --------------------------------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHH
Q 039228 191 --------------------------------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEM 232 (356)
Q Consensus 191 --------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~el 232 (356)
..........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 000111235789999999999999999999999999999999
Q ss_pred HcCCCCCCc
Q 039228 233 VTRRKPIDF 241 (356)
Q Consensus 233 ltg~~Pf~~ 241 (356)
++|+.||..
T Consensus 238 l~G~~Pf~~ 246 (376)
T cd05598 238 LVGQPPFLA 246 (376)
T ss_pred hhCCCCCCC
Confidence 999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=268.22 Aligned_cols=225 Identities=22% Similarity=0.322 Sum_probs=167.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCC----------------eEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHH
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR----------------AVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVR 133 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 133 (356)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999876533 568999987543 234567889999999999999987
Q ss_pred H------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCC
Q 039228 134 F------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSN 165 (356)
Q Consensus 134 l------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~N 165 (356)
+ +.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 5 246789999999999999 9999999999
Q ss_pred eEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc--CCCCCCccc
Q 039228 166 VLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT--RRKPIDFMF 243 (356)
Q Consensus 166 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~~ 243 (356)
|+++.++.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY--YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcc--eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999875432211 112223445778999999988889999999999999999998 677876432
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. .........+... ..... ...+..++..+.+++.+||+.||++|||+.+|++.
T Consensus 239 ~~--~~~~~~~~~~~~~-----~~~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 239 DQ--QVIENAGHFFRDD-----GRQIY------------------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred hH--HHHHHHHhccccc-----ccccc------------------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 11 1111111000000 00000 00011233568999999999999999999999998
Q ss_pred HH
Q 039228 324 LQ 325 (356)
Q Consensus 324 L~ 325 (356)
|+
T Consensus 294 L~ 295 (296)
T cd05051 294 LQ 295 (296)
T ss_pred hc
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=279.10 Aligned_cols=224 Identities=24% Similarity=0.280 Sum_probs=170.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCChHHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNLVRFI------- 135 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~------- 135 (356)
..++|.+.+.||+|+||.||+|.+... +..||||++..... ...+.+.+|+.+++++. ||||++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356799999999999999999987432 35799999964432 33457899999999996 99999871
Q ss_pred --------------------------------------------------------------------------------
Q 039228 136 -------------------------------------------------------------------------------- 135 (356)
Q Consensus 136 -------------------------------------------------------------------------------- 135 (356)
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC
Q 039228 136 ----------------------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLD 169 (356)
Q Consensus 136 ----------------------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 169 (356)
.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 15568999999999998 99999999999999
Q ss_pred CCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCcc
Q 039228 170 NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLN 248 (356)
Q Consensus 170 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~ 248 (356)
.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~ 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-T 348 (400)
T ss_pred CCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-H
Confidence 999999999999976533221 112233456778999999998899999999999999999997 999986432211 1
Q ss_pred HHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 249 LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
+...... .... .....++..+.+++.+||+.||++||++.+|.++|+++.
T Consensus 349 ~~~~~~~------------~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKS------------GYRM------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhc------------CCCC------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1000000 0000 001134456789999999999999999999999998765
Q ss_pred h
Q 039228 329 N 329 (356)
Q Consensus 329 ~ 329 (356)
+
T Consensus 399 ~ 399 (400)
T cd05105 399 P 399 (400)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=262.78 Aligned_cols=220 Identities=21% Similarity=0.311 Sum_probs=170.0
Q ss_pred CCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
++|.+.+.||.|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 4588899999999999999987543 3578999987554 3445678999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 347789999999999999 99999999999999999999999999976543221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......++..|+|||.+....++.++||||||+++||+++ |..||....... ......... .+
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~----------~~ 227 (270)
T cd05056 163 ---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE----------RL 227 (270)
T ss_pred ---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC----------cC
Confidence 11112334567999999988889999999999999999986 999996432211 101000000 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
. ....++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 228 -~-------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -P-------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -C-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 001334467899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=271.73 Aligned_cols=204 Identities=21% Similarity=0.198 Sum_probs=155.9
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhh-cCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKN-ICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|++..++..||+|+++... ......+..|..++.. ++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997532 2234556778888775 489999986
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~ 153 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NRA 153 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC----Cce
Confidence 347789999999999999 9999999999999999999999999986432111 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||..|+|||++.+..++.++|||||||++|||++|..||..... ....... .... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~---------~~~~-~~~~-- 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESI---------RVDT-PHYP-- 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH---------HhCC-CCCC--
Confidence 346689999999999999999999999999999999999999964221 1111110 0000 0000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH-HHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP-NAV 321 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~vl 321 (356)
......+.+++.+||+.||++||++. +++
T Consensus 217 ----------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 ----------------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01223567899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=262.03 Aligned_cols=212 Identities=25% Similarity=0.366 Sum_probs=168.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457899999999999999999976 68999999975543 46789999999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 347789999999999999 99999999999999999999999999986532111
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
....+..|+|||++....++.++||||||+++|+|++ |..||...... .+...... ...
T Consensus 158 ------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~------------~~~ 217 (256)
T cd05039 158 ------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK------------GYR 217 (256)
T ss_pred ------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc------------CCC
Confidence 2234567999999988889999999999999999997 99998632111 11111100 000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.. .....+..+.+++.+||..+|++|||+.+|+++|+.+
T Consensus 218 ~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 ME------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CC------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00 0012344678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=279.89 Aligned_cols=167 Identities=20% Similarity=0.221 Sum_probs=139.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|.+.+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986432 2234567889999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC-
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN- 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 236889999999999999 99999999999999999999999999863211000
Q ss_pred -----------CC-------------------------------ccCCCCccccccccchhhhcCCCCCCccchHhHHHH
Q 039228 191 -----------PT-------------------------------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGIL 228 (356)
Q Consensus 191 -----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~ 228 (356)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00 000012468999999999999999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 039228 229 LLEMVTRRKPIDF 241 (356)
Q Consensus 229 l~elltg~~Pf~~ 241 (356)
+|||++|..||..
T Consensus 238 l~elltG~~Pf~~ 250 (377)
T cd05629 238 MFECLIGWPPFCS 250 (377)
T ss_pred hhhhhcCCCCCCC
Confidence 9999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=262.17 Aligned_cols=212 Identities=17% Similarity=0.195 Sum_probs=167.1
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+|++.+.||.|+||.||++.+..+++.||+|.++... ....+.+..|+.+++.++|+||+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999999999999999986432 3345678889999999999999876
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 347889999999999999 9999999999999999999999999997654321
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||.... ........ ....
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~------------~~~~ 216 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKV------------CQGS 216 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHH------------hcCC
Confidence 11223567889999999998889999999999999999999999996321 11111110 0000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .+......+.+++.+||+.||++||++.+|+..
T Consensus 217 ~~~---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKP---------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCC---------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 001223356799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=262.79 Aligned_cols=234 Identities=20% Similarity=0.224 Sum_probs=167.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++...||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++|||++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999999889999999986432 2233567899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 458889999999999999 99999999999999999999999999986543221
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHhhhh-
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIVNLV- 268 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~- 268 (356)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+ .......... ........+..
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccccc
Confidence 1223456788999999876 457889999999999999999999997533211 1111111000 00000010000
Q ss_pred -----hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 -----LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 -----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... ... ............+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPE----TRE-----PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcc----ccc-----CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 000 000001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=267.89 Aligned_cols=224 Identities=21% Similarity=0.306 Sum_probs=164.8
Q ss_pred CCCCccccceecCceEEEEEEECCC--------------CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN--------------RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-- 134 (356)
++|++.+.||+|+||.||+|....+ ...||+|.++... ......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 2358999987542 2334568899999999999999876
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 135 -----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 135 -----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
+.++.+++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 236789999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc--CCCCCCccccC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT--RRKPIDFMFEG 245 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~~~~ 245 (356)
++.++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999975432211 112223445678999999988889999999999999999988 66777642211
Q ss_pred CccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 246 DLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.........+... ....... .....+..+.+++.+||+.||++|||+++|++.|+
T Consensus 240 --~~~~~~~~~~~~~-----~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQ-----GRQIYLS------------------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhc-----cccccCC------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111000000 0000000 00123346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=265.16 Aligned_cols=215 Identities=21% Similarity=0.284 Sum_probs=166.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
.+.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.++.++ +|+||+++
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677999999999999999999999999999999987543 3346788999999998 69999975
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 337789999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
....... .......|+..|+|||++. +..++.++|||||||++|||++|..||...... .......
T Consensus 159 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~~- 229 (272)
T cd06637 159 AQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIP- 229 (272)
T ss_pred eeccccc----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHHh-
Confidence 7543221 1223466889999999986 345788999999999999999999998632211 1100000
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ..... ...++..+.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP-----APRLK---------------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC-----CCCCC---------------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 00000 0023345789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=266.81 Aligned_cols=168 Identities=25% Similarity=0.361 Sum_probs=139.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|....+++.||||.+.... ......+.+|+.++++++||||+++
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999999999999999986432 2223456789999999999999875
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 347789999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.................++..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 6543322111222345678889999988664 368899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=268.22 Aligned_cols=224 Identities=18% Similarity=0.265 Sum_probs=164.7
Q ss_pred CCCCccccceecCceEEEEEEECC----------------CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDL----------------NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 134 (356)
++|++.+.||+|+||.||++.+.. +...||+|++.... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999986432 34579999987543 2334678899999999999999865
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCe
Q 039228 135 ------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNV 166 (356)
Q Consensus 135 ------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NI 166 (356)
+.++.+++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 235778999999999999 99999999999
Q ss_pred EeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc--CCCCCCcccc
Q 039228 167 LLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT--RRKPIDFMFE 244 (356)
Q Consensus 167 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~~~ 244 (356)
+++.++.++|+|||+++.+..... ........++..|++||...++.++.++|+|||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999975532221 111222334678999999888889999999999999999998 7788864221
Q ss_pred CCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
. +.... ............. ......++..+.+++.+||+.||.+||++.+|++.|
T Consensus 240 ~-----~~~~~-----~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 240 E-----QVIEN-----TGEFFRDQGRQVY---------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred H-----HHHHH-----HHHHHhhcccccc---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 1 11100 0000000000000 000013445688999999999999999999999998
Q ss_pred H
Q 039228 325 Q 325 (356)
Q Consensus 325 ~ 325 (356)
+
T Consensus 295 ~ 295 (296)
T cd05095 295 L 295 (296)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=262.26 Aligned_cols=217 Identities=19% Similarity=0.220 Sum_probs=166.3
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 345666667789999999999999998899999999876665566789999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEccccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 236679999999999998 999999999999976 67999999999875532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCC--CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSE--VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. .......++..|+|||++.+.. ++.++|+||||+++|+|++|..||......... .+.....
T Consensus 162 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~-------- 227 (268)
T cd06624 162 IN----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMF-------- 227 (268)
T ss_pred CC----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhh--------
Confidence 21 1122245788999999986643 788999999999999999999998643211100 0000000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... .+......+.+++.+||+.+|.+|||+.+|+.
T Consensus 228 --~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 --KIHPE------------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --ccCCC------------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000 00123345789999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.46 Aligned_cols=213 Identities=20% Similarity=0.246 Sum_probs=168.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999999999999999987543 3344678899999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----~ 153 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----S 153 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc----c
Confidence 457889999999999999 9999999999999999999999999998665332 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..... +.........
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~------------~~~~~~~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFL------------IPKNNPPSLE 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHH------------hhhcCCCCCc
Confidence 223356788899999999888999999999999999999999999643211 00000 0000000000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ...+..+.+++.+||..+|++|||++++++
T Consensus 220 ~-----------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 G-----------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c-----------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 013345788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=265.75 Aligned_cols=212 Identities=21% Similarity=0.273 Sum_probs=164.3
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
|++.+.||.|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6788899999999999999999999999999876555556778899999999999999987
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----~~ 159 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QR 159 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----cc
Confidence 347789999999999999 9999999999999999999999999987543211 12
Q ss_pred CCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 196 SNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....++..|+|||++. +..++.++|||||||++|+|++|.+||....... ........ .+ +.+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~-~~--------~~~~ 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS-EP--------PTLA 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhc-CC--------CCCC
Confidence 23356788999999974 3457789999999999999999999986422110 00000000 00 0000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+......+.+++.+||+.||.+||++.++++
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 --------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123346789999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=272.93 Aligned_cols=245 Identities=19% Similarity=0.140 Sum_probs=172.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357799999999999999999999999999999998643 22334567889999999999999865
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 236789999999999999 99999999999999999999999999976533
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIV 265 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 265 (356)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........... +..+...+
T Consensus 171 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHh
Confidence 21 122345788999999999999999999999999999999999999643211 11111111110 01111111
Q ss_pred hhhhcccccccc----ccccchhhhh-----chhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NLVLLNDNKVLA----GTNSNMLRKT-----KMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~----~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..+........ .......... ...........+.+++.+||+.||++|||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100000000 0000000000 000011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=272.93 Aligned_cols=205 Identities=25% Similarity=0.256 Sum_probs=155.2
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHH-HHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECK-ALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999999999999999987432 122234444544 5678999999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----~~~ 153 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----GTT 153 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC----CCc
Confidence 337789999999999999 9999999999999999999999999987432211 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... +.......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~--------i~~~~~~~----- 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN--------ILNKPLQL----- 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHhCCcCC-----
Confidence 346789999999999999999999999999999999999999964211 111111 11100000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+++.+||+.||.+||++.+.+.
T Consensus 216 ---------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 ---------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0022335688999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.90 Aligned_cols=220 Identities=20% Similarity=0.373 Sum_probs=167.9
Q ss_pred CCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
++|++.+.||+|+||.||+|.+..+ +..+|+|.+.... ....+.+..|+.++++++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 5688999999999999999988643 3479999986443 2234678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 457889999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. ........++..|++||++.+..++.++|+||||+++|++++ |..||...... ..........
T Consensus 161 ~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 226 (267)
T cd05066 161 EA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY----------- 226 (267)
T ss_pred ce-eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC-----------
Confidence 11 111122233567999999998889999999999999999887 99998643211 1111111000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
... ....++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 -~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -RLP------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -cCC------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 0012334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=266.72 Aligned_cols=223 Identities=20% Similarity=0.311 Sum_probs=167.9
Q ss_pred hhcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
...++|++.+.||+|+||.||+|..+. .+..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346789999999999999999997642 346899999864432 233467889999999999999986
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
..++.|++.||.|||+++ |+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 126778999999999999 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~ 254 (356)
|+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .....
T Consensus 160 L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLK 232 (288)
T ss_pred ECcCCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 999999875432211 111122344678999999998889999999999999999998 7889864221 11111
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
. +.+...... ...++..+.+++.+||+.||++|||+.++++.|++..
T Consensus 233 ~--------~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 F--------VMDGGYLDQ-------------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H--------HHcCCCCCC-------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 011000000 0123346889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.68 Aligned_cols=212 Identities=21% Similarity=0.249 Sum_probs=166.8
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.|+..+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3677788999999999999998889999999987443 3344678899999999999999998
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----~~ 157 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IK 157 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc----hh
Confidence 347789999999999998 9999999999999999999999999987654221 11
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....++..|+|||++.+..++.++|+||||+++|||++|..||....... ... .+........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~------------~~~~~~~~~~-- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF------------LIPKNSPPTL-- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh------------hhhcCCCCCC--
Confidence 223457888999999998889999999999999999999999986432111 000 0000000000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...++..+.+++.+||+.+|++||++.+|++.
T Consensus 222 ----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01234467899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=270.32 Aligned_cols=204 Identities=25% Similarity=0.270 Sum_probs=155.9
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhh-cCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKN-ICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|+++... ......+..|..++.. ++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999999999999999997542 2234556678888875 589999986
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~ 153 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKT 153 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----Cce
Confidence 347889999999999999 9999999999999999999999999987432111 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||..|+|||++.+..++.++|||||||++|||++|..||..... .......... .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~---------~~~~~------ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMD---------NPCYP------ 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---------CCCCC------
Confidence 345689999999999998999999999999999999999999964211 0111111000 00000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH-HHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP-NAV 321 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~vl 321 (356)
......+.+++.+||+.||++||++. ++.
T Consensus 217 ----------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 ----------------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ----------------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 01223467899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=267.74 Aligned_cols=238 Identities=20% Similarity=0.183 Sum_probs=179.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3469999999999999999999998999999999976655556788899999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~----~ 170 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----S 170 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc----c
Confidence 447788999999999999 9999999999999999999999999987543321 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... .... ...... +.+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~~~-~~~~~~--------~~~~---- 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYL-IATNGT--------PELQ---- 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcCC--------cccC----
Confidence 1223457889999999988889999999999999999999999996432110 0000 000000 0000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCcCCcccccc
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRAPKLKA 350 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~~~~~~~~~ 350 (356)
........+.+++.+||..||.+||++.+|+.. +-+.....+..++-+-.|+.++
T Consensus 237 ----------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~-----~~~~~~~~~~~~~~~~~~~~~~ 291 (296)
T cd06655 237 ----------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH-----PFLKLAKPLSSLTPLILAAKEA 291 (296)
T ss_pred ----------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC-----hHhhhccccccCCccccchhhh
Confidence 001233457789999999999999999999842 2222223345555555555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=277.47 Aligned_cols=228 Identities=23% Similarity=0.364 Sum_probs=187.0
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
..|.....+....++||-|.||.||.|+|+.-.-.||||.++.. ....++|+.|+.+|+.++|||+|++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 44555555677888999999999999999988889999998743 5667899999999999999999998
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
+.++.||..|+.||..++ +|||||...|+|+.++..+|++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 346789999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.... .....+..-.+-|.|||-+..+.++.++|||+|||+|||+.| |-.||.+. ++.+ +..+
T Consensus 416 tgDT---YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq---------VY~L 478 (1157)
T KOG4278|consen 416 TGDT---YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ---------VYGL 478 (1157)
T ss_pred cCCc---eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH---------HHHH
Confidence 6543 222223333567999999999999999999999999999998 88888642 2222 2233
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+..... +..++.|+..+.+||+.||+++|.+||++.|+-+.++.+..+.
T Consensus 479 LEkgyR------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 479 LEKGYR------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred Hhcccc------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 333222 2334479999999999999999999999999999999886544
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.04 Aligned_cols=213 Identities=20% Similarity=0.282 Sum_probs=168.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||.|+||.||+|.+..++..|++|.+..... .+.+.+|+.+++.++||||+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4679999999999999999999998889999999875432 6789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 347889999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ . .. +.......
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~-~~---------~~~~~~~~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I-FM---------IPNKPPPT 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h-hh---------hccCCCCC
Confidence 12234568899999999988999999999999999999999999974322110 0 00 00000000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..........+.+++.+||+.||++|||+.+|++
T Consensus 219 ----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 ----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0001123346789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=263.51 Aligned_cols=213 Identities=20% Similarity=0.287 Sum_probs=160.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHH-HhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKA-LKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+..|+.+ ++.++||||+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478999999999999999999999999999999875432 233456666664 667789999975
Q ss_pred -------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 -------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 35788999999999987 7 999999999999999999999999998755321
Q ss_pred CCCCccCCCCccccccccchhhhcC----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .... ...
T Consensus 158 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---------~~~ 220 (283)
T cd06617 158 V-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQL---------KQV 220 (283)
T ss_pred c-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHH---------HHH
Confidence 1 1223457888999998865 45688999999999999999999998632211 1111 011
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+..... ... ....+..+.+++.+||..+|++||++.+|++
T Consensus 221 ~~~~~~-~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEEPSP-QLP-----------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HhcCCC-CCC-----------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110000 000 0023346789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=267.79 Aligned_cols=210 Identities=18% Similarity=0.220 Sum_probs=170.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
-+|++.+.||+|.||.|-+|.....|+.||||.+++..- .+.-.+.+|+++|+.|+||||+.+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 368999999999999999999988899999999975533 334467899999999999999988
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 348899999999999999 99999999999999999999999999986643
Q ss_pred CccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......++|++.|.+||++.+.+| ++.+|.|||||+||.|+.|..||++. +...++++.-.+
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~G----------- 268 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRG----------- 268 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhcc-----------
Confidence 234456899999999999999887 47899999999999999999999853 333333332211
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+.. ++-+-...-||.+||..||++|.|+.+|...
T Consensus 269 -aYrE-----------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 269 -AYRE-----------------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -cccC-----------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1110 0111123468999999999999999998754
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=273.55 Aligned_cols=207 Identities=26% Similarity=0.257 Sum_probs=156.5
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHH-HHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECK-ALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|.. +++.++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999999999999999987432 223345556655 5678999999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----~~~~ 153 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----SDTT 153 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC----CCCc
Confidence 347889999999999999 999999999999999999999999998743221 1122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||..|+|||++.+..++.++|||||||++|+|++|..||.... ........ ....+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~--------~~~~~~~~---- 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNI--------LHKPLVLR---- 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHH--------HcCCccCC----
Confidence 34668999999999999999999999999999999999999996321 11111111 11000000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
+.....+.+++.+|++.+|.+||++.+.++.+
T Consensus 217 ----------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 ----------------PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred ----------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 01223567899999999999999986444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=270.73 Aligned_cols=244 Identities=20% Similarity=0.197 Sum_probs=170.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+...||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999998889999999986432 2234567899999999999999876
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 226778999999999999 99999999999999999999999999875422
Q ss_pred CCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC---chHHH
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN---RVMDI 264 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~ 264 (356)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..... .... ...+.
T Consensus 170 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 241 (342)
T cd07879 170 ------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILK-VTGVPGPEFVQK 241 (342)
T ss_pred ------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCCHHHHHH
Confidence 1223566888999999876 46889999999999999999999999742211 01111111 1110 11111
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVNN 329 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~~ 329 (356)
+......... ...+.................+.+++.+||+.||++||++.+++.. ++.+.+
T Consensus 242 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYI---KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHH---hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1000000000 0000000000000011233457899999999999999999999854 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=275.95 Aligned_cols=171 Identities=23% Similarity=0.275 Sum_probs=143.9
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------- 134 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------- 134 (356)
.++....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999999999999999986421 2233457789999999999999987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 336789999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCCC----CCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSE----VSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 193 ~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 193 NKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CcCC---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 4221 11223467899999999987543 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.93 Aligned_cols=222 Identities=23% Similarity=0.371 Sum_probs=170.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCe----EEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 568899999999999999999876543 689998865533 334678899999999999999875
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 457889999999999998 9999999999999999999999999998665322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
... ......++..|+|||.+....++.++|+||||+++||+++ |..||...... .+........
T Consensus 164 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (279)
T cd05057 164 KEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE----------- 228 (279)
T ss_pred cce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC-----------
Confidence 211 1112223567999999988889999999999999999999 99998643211 1111111000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.... +..+...+.+++.+||..+|+.||++.++++.|.++...
T Consensus 229 ~~~~-------------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 RLPQ-------------------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCC-------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0000 002233567899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=260.58 Aligned_cols=215 Identities=21% Similarity=0.278 Sum_probs=165.8
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---------chHHHHHHHHHHhhcCCCChHHH---------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---------ASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999999888899999988643221 12467889999999999999987
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||.++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 357889999999999998 9999999999999999999999999998664
Q ss_pred cCCCCC--ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 187 EVSNPT--QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~---------~~ 224 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIF---------KI 224 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHH---------HH
Confidence 321110 1112234578899999999988899999999999999999999999974311 11100 00
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ..... +......+.+++.+||+.||.+||++.+|++
T Consensus 225 ~~~-~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GEN-ASPEI------------------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hcc-CCCcC------------------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 00000 0123346789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.86 Aligned_cols=234 Identities=21% Similarity=0.255 Sum_probs=167.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468899999999999999999998899999999864322 234568899999999999999988
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 347789999999999999 9999999999999999999999999987653322
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH--hCCCchHHHhh---
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM--AFPNRVMDIVN--- 266 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~--- 266 (356)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||...... ......... .+........+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 11223457889999999875 34678999999999999999999998642210 111111100 01111111111
Q ss_pred ---hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 ---LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........ . ...........+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~-----~----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVK-----E----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred Hhhcccccccc-----C----cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 0 00000001134557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.01 Aligned_cols=212 Identities=20% Similarity=0.224 Sum_probs=163.4
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.++++++|+|++++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 7778899999999999999999999999999864322 223457789999999999999876
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 347789999999999998 9999999999999999999999999987543221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ..... . ......
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~~-~----~~~~~~- 225 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLVK-E----VQEEYS- 225 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhhh-h----hhhhcC-
Confidence 1123468999999999999899999999999999999999999997432111 00000 00000 0 000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
......+.+|+..||+.||++||| +.++++
T Consensus 226 ---------------------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 ---------------------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---------------------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 022335679999999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=260.63 Aligned_cols=166 Identities=22% Similarity=0.303 Sum_probs=140.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999999899999999986432 1233568889999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 347889999999999998 99999999999999999999999999875532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 159 ICMS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 2111 1112234578899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.51 Aligned_cols=227 Identities=19% Similarity=0.269 Sum_probs=169.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|++++++++||||+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 469999999999999999999999999999999875422 234568899999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 3578899999999997 46 999999999999999999999999998654221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC-------------
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN------------- 259 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------------- 259 (356)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCC
Confidence 12335678899999999888899999999999999999999999864321 1111111110000
Q ss_pred --------chHHHhhhhhccccccccccccchhhhhchhhH-HHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 260 --------RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSR-LECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 260 --------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
...+..+....... +..+ ......+.+++.+||..+|++|||+.+|+..-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPP---------------PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCC---------------ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00111111110000 0000 01344678999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.39 Aligned_cols=237 Identities=25% Similarity=0.282 Sum_probs=165.8
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|++|.||+|++..+++.||||.+.... ......+.+|++++++++||||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999999889999999986442 2233578899999999999999988
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--- 154 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 154 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc---
Confidence 346778999999999999 9999999999999999999999999987553221
Q ss_pred ccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC-chHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN-RVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l 269 (356)
.......++..|+|||++.+.. ++.++||||||+++|+|+||+.||....... ...+...... +. .....+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSL- 231 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHH-
Confidence 1122234578899999887644 5888999999999999999999996432211 1112111111 10 000000000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .+ ......................+.+++.+||+.||.+|||+.+++.
T Consensus 232 ~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 P-DY---KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred H-HH---HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 00 0000000000000001122345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.90 Aligned_cols=166 Identities=28% Similarity=0.430 Sum_probs=139.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++++|.+.+.||+|+||.||+|....++..||+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46789999999999999999999998899999999865432 223467789999999999999876
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 347789999999999999 9999999999999999999999999987543211
Q ss_pred CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 112234568899999998753 5788999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.11 Aligned_cols=242 Identities=21% Similarity=0.215 Sum_probs=167.0
Q ss_pred CCCccccceecCceEEEEEEECCC--CeEEEEEEeecc--CccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLN--RAVVAIKVLSIQ--CQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
+|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+.+++++ +||||+++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478899999999999999999877 889999998643 222346788899999999 59999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 347789999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC--chHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN--RVMD 263 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~--~~~~ 263 (356)
.............|+..|+|||++.+ ..++.++||||||+++|+|++|.+||...... ..+.......- +. ....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 32222222344678999999998765 46889999999999999999999998643211 01111111100 00 0001
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.++.................... .......+.+++.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESI----FPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhh----CCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100000000000000000000000 0112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.35 Aligned_cols=212 Identities=21% Similarity=0.218 Sum_probs=162.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
|+..+.||.|+||+||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999999999999999986432 1223457789999999999999876
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 447889999999999999 9999999999999999999999999986543211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ............. ....
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~------~~~~- 225 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETE------EVYS- 225 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhccc------cccC-
Confidence 1223568999999999998899999999999999999999999997432110 0011100000000 0000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
......+.+|+..||+.||++||+ +.+++.
T Consensus 226 ---------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 ---------------------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ---------------------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 022335678999999999999999 556555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=267.00 Aligned_cols=215 Identities=20% Similarity=0.213 Sum_probs=169.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3679999999999999999999988899999999976555556778899999999999999986
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~----~ 170 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----S 170 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc----c
Confidence 357789999999999998 9999999999999999999999999987543221 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.......... .......+ .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~~~~---------~~----- 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP---------EL----- 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccCCCC---------CC-----
Confidence 1223457889999999998889999999999999999999999996422111000 00000000 00
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 236 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 ---------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000123345678999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=264.19 Aligned_cols=215 Identities=20% Similarity=0.234 Sum_probs=166.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.+.|++.+.||.|+||.||+|.+..++..|++|.+........+.+..|+.+++.++||||+++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999999999999999999987666666788899999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--- 164 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--- 164 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc---
Confidence 447889999999999998 9999999999999999999999999986432211
Q ss_pred ccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.......++..|+|||++. ...++.++|+|||||++|+|++|..||..... ........... .+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~-----~~ 233 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSE-----PP 233 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCC-----Cc
Confidence 1122355788999999884 34467899999999999999999999864211 11110000000 00
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+. ........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLS--------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCC--------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00123345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=260.17 Aligned_cols=217 Identities=23% Similarity=0.369 Sum_probs=168.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|.+.+.||.|+||.||+|.+..+ ..||||.+.... ...+.+.+|+.++++++|+||+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 356799999999999999999998654 789999987443 334678999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 347789999999999999 9999999999999999999999999987654311
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ...... ....
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~------------~~~~ 221 (261)
T cd05034 158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQV------------ERGY 221 (261)
T ss_pred --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH------------HcCC
Confidence 111112334568999999998889999999999999999998 99998642211 111100 0000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.... +...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 222 ~~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPR------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCC------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000 01223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=267.31 Aligned_cols=224 Identities=22% Similarity=0.298 Sum_probs=168.7
Q ss_pred cCCCCccccceecCceEEEEEEEC-------CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-------LNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.++|.+.+.||+|+||.||+|... .....||+|.+.... ......+..|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999863 234679999987432 23345688999999999 59999876
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 124679999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred cCCCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999765322111 11111233467999999988889999999999999999999 8899863211
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
...... +....... .+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 243 --~~~~~~---------~~~~~~~~------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 --EELFKL---------LREGHRMD------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred --HHHHHH---------HHcCCCCC------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111 00000000 0013344678999999999999999999999999999
Q ss_pred hhhh
Q 039228 328 NNIL 331 (356)
Q Consensus 328 ~~~~ 331 (356)
....
T Consensus 294 ~~~~ 297 (314)
T cd05099 294 LAAV 297 (314)
T ss_pred HHHh
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=270.37 Aligned_cols=201 Identities=25% Similarity=0.249 Sum_probs=153.5
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHH-HHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECK-ALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999987432 122344555654 6788999999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~ 153 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----EETT 153 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC----CCcc
Confidence 347789999999999999 999999999999999999999999998743211 1122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... ....... +....+. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~--------i~~~~~~--~--- 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDN--------ILHKPLQ--L--- 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHH--------HhcCCCC--C---
Confidence 34568999999999998899999999999999999999999996421 1111111 1110000 0
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
+......+.+++.+||+.||.+||++.
T Consensus 216 ---------------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 ---------------PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---------------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 002233568999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.82 Aligned_cols=217 Identities=20% Similarity=0.266 Sum_probs=165.8
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...++|.+++.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++|||||++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34678999999999999999999999999999999987432 2334678899999999999999986
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCC----CcEEecCCCCCCeEeCC---------
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQ----ELILHCDPKPSNVLLDN--------- 170 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~----~~iiH~Dlkp~NIll~~--------- 170 (356)
+.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 3478899999999998531 23999999999999964
Q ss_pred --------CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 171 --------DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 171 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3458999999997653221 1234568999999999864 458899999999999999999999996
Q ss_pred ccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHH
Q 039228 241 FMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNA 320 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 320 (356)
... .+..+....... +.+.. ......+.+|+..||..+|.+||++.++
T Consensus 245 ~~~----~~~qli~~lk~~-------p~lpi---------------------~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 245 KAN----NFSQLISELKRG-------PDLPI---------------------KGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred cCC----cHHHHHHHHhcC-------CCCCc---------------------CCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 321 111111111000 00000 0123357899999999999999999999
Q ss_pred HH
Q 039228 321 VH 322 (356)
Q Consensus 321 l~ 322 (356)
+.
T Consensus 293 L~ 294 (1021)
T PTZ00266 293 LG 294 (1021)
T ss_pred hc
Confidence 84
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=258.10 Aligned_cols=210 Identities=23% Similarity=0.329 Sum_probs=161.8
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
+.||.|+||.||+|.+.. ++.||+|.+...... ....+.+|+.++++++|+||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999987 899999998754333 45678999999999999999875
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
+.++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++........ ......
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~ 154 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDGL 154 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc--eecccc
Confidence 447778999999999999 99999999999999999999999999975432111 111112
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ..... +........
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~------------~~~~~~~~~---- 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER------------IESGYRMPA---- 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH------------HhcCCCCCC----
Confidence 233567999999988889999999999999999999 88888643211 11111 111000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+...+..+.+++.+||..+|++|||+.+|++.|+
T Consensus 217 --------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 --------------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --------------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0123446889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=259.58 Aligned_cols=216 Identities=20% Similarity=0.280 Sum_probs=168.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|+..+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 468889999999999999999998899999999876532 344678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 3477899999999999 88 99999999999999999999999999875532211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
....++..|+|||++.+..++.++||||||+++|+|++|..||............. +...+..
T Consensus 157 -----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~~ 219 (265)
T cd06605 157 -----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL------------LQYIVNE 219 (265)
T ss_pred -----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH------------HHHHhcC
Confidence 11567889999999999899999999999999999999999997543211111111 1111111
Q ss_pred ccccccccccchhhhhchhhHH-HHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRL-ECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.... ... .....+.+++.+||..||++|||+.+++..
T Consensus 220 ~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPR---------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCC---------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 000 134467899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=259.51 Aligned_cols=217 Identities=22% Similarity=0.380 Sum_probs=167.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|.+.. +..+|+|.+... ......+.+|+.+++.++|+||+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence 35679999999999999999998764 467999988643 2234678899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 347789999999999998 99999999999999999999999999976533211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......++..|+|||++.+..++.++|+||||+++|++++ |..||...... .........+..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~----------- 222 (260)
T cd05073 158 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM----------- 222 (260)
T ss_pred --ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC-----------
Confidence 11222345677999999998889999999999999999999 99998643211 111111110000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
. .....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 -~------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -P------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -C------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 001233467899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.66 Aligned_cols=242 Identities=16% Similarity=0.160 Sum_probs=161.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCC-eEEEEEEe--------------e---ccCccchHHHHHHHHHHhhcCCCCh
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNR-AVVAIKVL--------------S---IQCQGASKSFMAECKALKNICHRNL 131 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni 131 (356)
..++|++++.||+|+||.||+|..+... ..+++|.+ . .........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998764321 12222211 0 0112234567899999999999999
Q ss_pred HHH-----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC
Q 039228 132 VRF-----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN 170 (356)
Q Consensus 132 v~l-----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 170 (356)
+++ ..++.|++.||.|||+++ ||||||||+|||++.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 986 237789999999999999 999999999999999
Q ss_pred CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCC-CCccccC-Ccc
Q 039228 171 DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP-IDFMFEG-DLN 248 (356)
Q Consensus 171 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~P-f~~~~~~-~~~ 248 (356)
++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +...... ...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999986543221 222346789999999999999999999999999999999998754 4322111 111
Q ss_pred HHHHHHH------hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 249 LHNFARM------AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 249 ~~~~~~~------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+...... .++.....+.+.................+... .....+.+++.+||+.||.+|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL------GLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc------CCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111 12221111111111101100000111111110 12234677899999999999999999987
Q ss_pred H
Q 039228 323 D 323 (356)
Q Consensus 323 ~ 323 (356)
.
T Consensus 454 h 454 (501)
T PHA03210 454 L 454 (501)
T ss_pred C
Confidence 4
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=269.12 Aligned_cols=223 Identities=22% Similarity=0.307 Sum_probs=168.5
Q ss_pred cCCCCccccceecCceEEEEEEECC-------CCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-------NRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
..+|++.+.||+|+||.||+|.+.. ....||+|.+.... ....+.+.+|+.+++++ +||||+++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468999999999999999998642 22478999887432 23356788999999999 79999975
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 125679999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred cCCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 9999999999999976543211 111122334567999999999899999999999999999998 889886421
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
........ ........ ...+...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 242 -~~~~~~~~---------~~~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 242 -VEELFKLL---------KEGHRMDK------------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred -HHHHHHHH---------HcCCCCCC------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111110 00000000 012344678999999999999999999999999998
Q ss_pred hhh
Q 039228 328 NNI 330 (356)
Q Consensus 328 ~~~ 330 (356)
...
T Consensus 294 ~~~ 296 (334)
T cd05100 294 LTV 296 (334)
T ss_pred hhh
Confidence 743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.64 Aligned_cols=224 Identities=22% Similarity=0.298 Sum_probs=168.8
Q ss_pred cCCCCccccceecCceEEEEEEECC-------CCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-------NRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... ......+..|+.+++.+ +||||+++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998643 23579999987542 23345688899999999 79999876
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 135789999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence 99999999999998754321110 11112234568999999998889999999999999999998 888885321
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
....... +....... .+..+...+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 248 -~~~~~~~---------~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 -VEELFKL---------LKEGHRMD------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HHHHHHH---------HHcCCCCC------------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11000000 0013344678899999999999999999999999998
Q ss_pred hhhh
Q 039228 328 NNIL 331 (356)
Q Consensus 328 ~~~~ 331 (356)
....
T Consensus 300 ~~~~ 303 (307)
T cd05098 300 LALT 303 (307)
T ss_pred HHHh
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=256.87 Aligned_cols=212 Identities=20% Similarity=0.272 Sum_probs=167.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|++|.||++.+..+++.||+|.+.... ....+.+.+|+.++++++|+|++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999999889999999986542 2334568889999999999999976
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 357789999999999999 9999999999999999999999999997653322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.... ..........+. +
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~--------~- 219 (257)
T cd08223 157 ---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGK--------L- 219 (257)
T ss_pred ---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcC--------C-
Confidence 12234567889999999999899999999999999999999999986321 111111110000 0
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPM------------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCC------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 01233467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=263.03 Aligned_cols=219 Identities=21% Similarity=0.305 Sum_probs=167.1
Q ss_pred cCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4679999999999999999998743 568999999875432 334568899999999999999875
Q ss_pred -------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCC
Q 039228 135 -------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSN 165 (356)
Q Consensus 135 -------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~N 165 (356)
+.++.+++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 147889999999999999 9999999999
Q ss_pred eEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCcccc
Q 039228 166 VLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFE 244 (356)
Q Consensus 166 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~ 244 (356)
|+++.++.++|+|||++........ .........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999875432211 111122234567999999998899999999999999999998 8888853221
Q ss_pred CCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.+......... .... ...++..+.+++.+||+.+|++|||+.||++.|
T Consensus 239 -----~~~~~~~~~~~--------~~~~-------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 239 -----EEVIYYVRDGN--------VLSC-------------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred -----HHHHHHHhcCC--------CCCC-------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 11111110000 0000 012344678999999999999999999999998
Q ss_pred HH
Q 039228 325 QS 326 (356)
Q Consensus 325 ~~ 326 (356)
+.
T Consensus 287 ~~ 288 (288)
T cd05050 287 QR 288 (288)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=273.42 Aligned_cols=202 Identities=22% Similarity=0.220 Sum_probs=155.9
Q ss_pred ccceecCceEEEEEEE---CCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 78 NLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
+.||+|+||.||++.. ..+++.||+|++..... .....+..|+.++++++||||+++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999886 35689999999975322 223457789999999999999987
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~ 154 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----KK 154 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----Cc
Confidence 447889999999999999 9999999999999999999999999987543221 12
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... +...... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~--------i~~~~~~--~-- 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTM--------ILKAKLG--M-- 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHH--------HHcCCCC--C--
Confidence 2345689999999999988899999999999999999999999964211 111111 0000000 0
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPN 319 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 319 (356)
+......+.+++.+||+.||++||++.+
T Consensus 218 ----------------p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ----------------PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0022335678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.08 Aligned_cols=224 Identities=20% Similarity=0.253 Sum_probs=170.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56899999999999999999999889999999986543 3345678899999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 3477889999999997 56 999999999999999999999999998644221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
......++..|+|||++.+..++.++|+|||||++|+|++|..||......... ...+..+.+.+.......
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEP 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhcc
Confidence 112356889999999998888999999999999999999999999754322110 000011112222211111
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
... . .....+..+.+++.+||+.||++|||+.+|+++.
T Consensus 230 ~~~----~----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPR----L----------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCC----C----------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 0 0002445678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=256.15 Aligned_cols=209 Identities=23% Similarity=0.332 Sum_probs=159.8
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
++||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999875 568999999875432 233468899999999999999986
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 198 (356)
+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~ 153 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---SSSGL 153 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc---ccCCC
Confidence 457789999999999999 99999999999999999999999999875432211 11112
Q ss_pred ccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 199 ~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
..++..|+|||++.+..++.++||||||+++|++++ |..||...... ........ ......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~------------~~~~~~---- 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEK------------GYRMSC---- 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc------------CCCCCC----
Confidence 233567999999998889999999999999999998 99998643211 11111100 000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
...++..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 --------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 --------------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0123446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=264.95 Aligned_cols=217 Identities=23% Similarity=0.240 Sum_probs=166.6
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|....+++.||+|.+...... ..+.+..|+.+++.++||||+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999999988999999999754322 34568899999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 336789999999999999 9999999999999999999999999987543221
Q ss_pred CCC-------------------------ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcccc
Q 039228 190 NPT-------------------------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244 (356)
Q Consensus 190 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~ 244 (356)
... ........|+..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 1112235678899999999988899999999999999999999999964321
Q ss_pred CCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC----hHHH
Q 039228 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN----VPNA 320 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~~v 320 (356)
.. .+ ..+......-. ........+.+++.+||..||++||+ +.++
T Consensus 238 ~~-~~------------~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 238 DE-TF------------SNILKKEVTFP------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred HH-HH------------HHHhcCCccCC------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 10 11 11111100000 00013446789999999999999999 5555
Q ss_pred HH
Q 039228 321 VH 322 (356)
Q Consensus 321 l~ 322 (356)
+.
T Consensus 287 l~ 288 (316)
T cd05574 287 KQ 288 (316)
T ss_pred Hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=262.36 Aligned_cols=213 Identities=18% Similarity=0.210 Sum_probs=165.9
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
|.....||.|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 4445679999999999999988899999999876555556678899999999999999997
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.+|+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~ 176 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----PKRK 176 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc----ccCc
Confidence 347889999999999999 9999999999999999999999999987543221 1123
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...++..|+|||++.+..++.++|+||||+++|||++|+.||..... .......... +.+.+...
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~--------~~~~~~~~----- 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDN--------LPPRVKDS----- 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc--------CCCccccc-----
Confidence 35678899999999888899999999999999999999999863211 0100000000 01111000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
......+.+++..||..||.+|||+.++++.
T Consensus 242 ---------------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 ---------------HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---------------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0223356789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=263.45 Aligned_cols=168 Identities=27% Similarity=0.356 Sum_probs=140.8
Q ss_pred CCCccccceecCceEEEEEEECC--CCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 78999999997632 3445678889999999999999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC----CCceEEcccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN----DLFAHIGDFE 180 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 247789999999999999 999999999999999 9999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcccc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~ 244 (356)
++......... ........++..|+|||++.+. .++.++||||||+++|+|++|++||.....
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99865433221 1223345678899999988764 578999999999999999999999975433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.43 Aligned_cols=213 Identities=22% Similarity=0.304 Sum_probs=163.6
Q ss_pred ccceecCceEEEEEEECC-CC--eEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDL-NR--AVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|++|.||+|.+.. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999999865 22 3699999976555 556789999999999999999976
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 156 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-YVM 156 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc-eec
Confidence 346779999999999999 999999999999999999999999999876442221 111
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ........ . ..+ .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--~-------~~~-~--- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE--G-------ERL-E--- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc--C-------CcC-C---
Confidence 223456788999999998889999999999999999999 999986432111 11110000 0 000 0
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.....+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 ----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ----------------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00123446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=275.23 Aligned_cols=167 Identities=22% Similarity=0.254 Sum_probs=141.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|....+++.||+|++.... ......+..|+.++..++||||+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999999999999999997432 2334567889999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 347889999999999999 999999999999999999999999998754321100
Q ss_pred -------------------------------CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 192 -------------------------------TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 192 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0001123578999999999999999999999999999999999999996
Q ss_pred c
Q 039228 241 F 241 (356)
Q Consensus 241 ~ 241 (356)
.
T Consensus 238 ~ 238 (360)
T cd05627 238 S 238 (360)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.84 Aligned_cols=219 Identities=19% Similarity=0.232 Sum_probs=167.3
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc------cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ------GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+|+..+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|+.++++++|+||+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999999998999999999874321 134678899999999999999998
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 347789999999999999 99999999999998776 5999999999766443
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ........ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~--------~~~~~ 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFK--------IASAT 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHH--------HhccC
Confidence 221122223456788999999998888999999999999999999999998632211 11111000 00000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .+......+.+++.+||..+|++||++.+++.
T Consensus 228 ~~~~------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPS------------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCC------------------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 11134456788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=259.37 Aligned_cols=221 Identities=20% Similarity=0.194 Sum_probs=168.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|...+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999999998999999999875433 345678999999999999999886
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 247788999999999999 99999999999999999999999999865432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .....++..|++||.+.+..++.++||||||+++|+|++|..||...........+.......... +
T Consensus 158 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 226 (287)
T cd06621 158 SL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-----P 226 (287)
T ss_pred cc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-----h
Confidence 11 123456788999999998899999999999999999999999997542211111111111000000 0
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+..... ........+.+++.+||+.+|.+|||+.||++
T Consensus 227 ~~~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPG----------------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCC----------------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000 00022346789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=259.43 Aligned_cols=211 Identities=23% Similarity=0.328 Sum_probs=159.0
Q ss_pred ccceecCceEEEEEEECCCCe--EEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+..++. .+++|.+.... ....+.+.+|+.++.++ +||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987764 46888876432 33446788999999999 79999865
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 236678999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||..... ......
T Consensus 158 l~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~---- 223 (270)
T cd05047 158 LSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK---- 223 (270)
T ss_pred Cccccchh-----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHH----
Confidence 98532211 11111223567999999988889999999999999999997 9999864221 111111
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
+........ ...+...+.+++.+||+.+|.+|||+.+++..|+.+.
T Consensus 224 -----~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 -----LPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HhCCCCCCC------------------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100000000 0123345789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=261.56 Aligned_cols=240 Identities=19% Similarity=0.260 Sum_probs=170.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+++++.++|+||+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999999999999999986432 3334678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 347789999999999999 99999999999999999999999999976543321
Q ss_pred ccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh--CCCchHHHh--hh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA--FPNRVMDIV--NL 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~ 267 (356)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+ .+....... .+....... +.
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCc
Confidence 122335678889999999887 78999999999999999999999996432111 111111100 000000000 00
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........ ............ +..+...+.+++.+||..+|++||++++|++
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFP-EPSQPESLERRY---PGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccC-CCCCcHHHHHhc---CCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 000000000000 0123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=262.30 Aligned_cols=165 Identities=29% Similarity=0.423 Sum_probs=137.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||.|++|.||+|....+++.||+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4679999999999999999999998899999999875432 223456789999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--- 157 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS--- 157 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC---
Confidence 346779999999999999 9999999999999999999999999987542211
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11122345788999999875 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=263.61 Aligned_cols=217 Identities=20% Similarity=0.259 Sum_probs=164.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcC-CCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNIC-HRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l--------------- 134 (356)
++|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35677889999999999999999999999999987543 234457889999999996 9999985
Q ss_pred --------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 23677899999999974 7 99999999999999999999999999975532
Q ss_pred CCCCCccCCCCccccccccchhhhcCC---CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGS---EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.... .............
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~---- 227 (288)
T cd06616 161 SI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD---- 227 (288)
T ss_pred CC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC----
Confidence 21 11223578889999998766 68899999999999999999999986422 1111111110000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+.+.... .......+.+++.+||+.+|++|||+.+|+..
T Consensus 228 -~~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSE------------------EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcC------------------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00010000 01344568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=267.31 Aligned_cols=246 Identities=22% Similarity=0.209 Sum_probs=172.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+.+.||+|+||.||+|++..++..||||.+... .......+..|+.+++.++|+||+++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999999999999998643 22334567889999999999999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 336789999999999999 99999999999999999999999999975532
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC----CCchH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF----PNRVM 262 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 262 (356)
.. .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ........... +....
T Consensus 161 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 161 KG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred Cc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHhh
Confidence 21 11223457889999998865 4688999999999999999999999964321 11111111110 00000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhhh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVNN 329 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~~ 329 (356)
.+.+.......... .. ............+...+.+++.+||+.+|++|||+.++++. +..+..
T Consensus 235 ~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 FIRNEKARRYIRSL-PY---TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hcCchhhhHHHHhc-Cc---ccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000000000000 00 00000000011345567899999999999999999999987 655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=266.92 Aligned_cols=206 Identities=22% Similarity=0.241 Sum_probs=158.2
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCC-CChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICH-RNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l-------------- 134 (356)
+|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|..++..+.| ++|+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999999999999999997532 2334567788999988875 566655
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 457889999999999999 9999999999999999999999999987432211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... +.....
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~--------i~~~~~-- 218 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQS--------IMEHNV-- 218 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHhCCC--
Confidence 122335689999999999998999999999999999999999999974321 111111 110000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
... ......+.+++.+||+.+|.+|++..
T Consensus 219 ~~p------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYP------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCC------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 000 02233567899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=259.48 Aligned_cols=214 Identities=20% Similarity=0.251 Sum_probs=163.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36889999999999999999999889999999987542 2334678899999999999999988
Q ss_pred ------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 ------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+++.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 3367789999999997 47 999999999999999999999999998754321
Q ss_pred CCCccCCCCccccccccchhhhcCCC------CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSE------VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...... ...... ..
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~--------~~ 221 (286)
T cd06622 157 -----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQL--------SA 221 (286)
T ss_pred -----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHH--------HH
Confidence 122345678899999985543 478999999999999999999999642111 110000 01
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+.+. ... .....+...+.+++.+||+.+|++||++.+++..
T Consensus 222 ~~~~----~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVDG----DPP---------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred Hhhc----CCC---------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1110 000 0011344567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=259.49 Aligned_cols=218 Identities=23% Similarity=0.255 Sum_probs=171.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|++++.||.|.-|+||+++...++..+|+|++.+.... ...+...|..||+.++||.++++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 345789999999999999999999999999999999865433 34567789999999999999998
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||+|||..| ||+|||||+||||.++|++.|+||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 237788999999999999 99999999999999999999999988743210
Q ss_pred ---------------------------------C-C------------------CCCccCCCCccccccccchhhhcCCC
Q 039228 188 ---------------------------------V-S------------------NPTQSSSNGVRRTIGYTALDYDLGSE 215 (356)
Q Consensus 188 ---------------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (356)
. . .+.......++||..|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01112335678999999999999999
Q ss_pred CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHH
Q 039228 216 VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLEC 295 (356)
Q Consensus 216 ~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (356)
.+.++|+|+|||++|||+.|..||.+..... .+..++...+.-.. ..+.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~Fp~------------------~~~v 360 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLKFPE------------------EPEV 360 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCcCCC------------------CCcc
Confidence 9999999999999999999999998643221 22333333221000 0133
Q ss_pred HHHHHHHHHhhcCCCcCCCCC----hHHHH
Q 039228 296 LIFMVRIGAACSMGSSQDRMN----VPNAV 321 (356)
Q Consensus 296 ~~~l~~l~~~Cl~~dP~~RPs----~~~vl 321 (356)
.-.+.+||.+.|..||.+|-. +.||-
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 446789999999999999998 66554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=259.46 Aligned_cols=209 Identities=25% Similarity=0.414 Sum_probs=163.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence 5689999999999999999975 46889999986432 34678899999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 447889999999999998 9999999999999999999999999987543211
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.....+..|+|||++.+..++.++|+||||+++|+|++ |..||.... ...... .+.......
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~---------~~~~~~~~~ 217 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKE---------CVEKGYRME 217 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHH---------HHhCCCCCC
Confidence 12233567999999988899999999999999999997 999986422 111111 111110000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
. ...++..+.+++.+||+.+|+.||++++|++.|+.
T Consensus 218 ~------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 P------------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C------------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 01334567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=255.37 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=165.4
Q ss_pred ccceecCceEEEEEEECCC---CeEEEEEEeeccCccc-hHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQCQGA-SKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+... +..|++|.+....... .+.+..|+..++.++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999865 8899999997554333 5788899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 246788999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... ........++..|+|||.+....++.++||||||+++|+|++ |..||..... ...... +.+
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~--------~~~ 222 (262)
T cd00192 158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEY--------LRK 222 (262)
T ss_pred ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH--------HHc
Confidence 321 122334556888999999988889999999999999999999 6999875311 111111 000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.... .....++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 223 ~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRL-------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCC-------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 001133456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=257.92 Aligned_cols=221 Identities=22% Similarity=0.290 Sum_probs=170.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||.|+||.||+|....++..+|+|++.... ....+.+.+|+.+++.++|+||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998888999999986443 2345778999999999999999876
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 346789999999999999 99999999999999999999999999976654332
Q ss_pred CCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
..........++..|++||++... .++.++|+||||+++|+|++|+.||....... .+....... +. .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~--------~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-PP--------SL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-CC--------Cc
Confidence 211223445678899999998776 78899999999999999999999996432211 111111100 00 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .....+..+.+++.+||+.||++||++.+|+.
T Consensus 228 ~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 00133456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=256.60 Aligned_cols=212 Identities=19% Similarity=0.220 Sum_probs=167.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+..|+.+++.++||||+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4888999999999999999999999999999987432 2334578899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHh-----hcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLH-----HHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH-----~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
+.++.+++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 347789999999999 766 999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ........
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~------ 222 (265)
T cd08217 158 KILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKI------ 222 (265)
T ss_pred ccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHH------
Confidence 86543221 1223567889999999998889999999999999999999999997432 11111111
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........ .......+.+++.+||+.+|++||++.+|+++
T Consensus 223 ---~~~~~~~~------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 ---KEGKFRRI------------------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---hcCCCCCC------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000000 01334467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=271.21 Aligned_cols=216 Identities=21% Similarity=0.232 Sum_probs=173.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHHHHHhhcC-CCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAECKALKNIC-HRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l------------ 134 (356)
...|++.+.||+|.||.||+++.+.+|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45699999999999999999999999999999999765443 3457899999999999 9999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC----CCceEEcccccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN----DLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.|+.|||+.| |+||||||+|+|+.. ++.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 347789999999999999 999999999999963 3579999999998765
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||......... .......+
T Consensus 191 ~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~~i~~~~~--------- 255 (382)
T KOG0032|consen 191 P-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-LAILRGDF--------- 255 (382)
T ss_pred C-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-HHHHcCCC---------
Confidence 4 23445688999999999999999999999999999999999999999754322211 11111110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+... .|. .......+++..|+..||..|+|+.++++.
T Consensus 256 -~f~~~--------------~w~----~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSE--------------PWD----DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCC--------------Ccc----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 01111 111 334466899999999999999999999993
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=267.14 Aligned_cols=164 Identities=19% Similarity=0.250 Sum_probs=132.6
Q ss_pred ccccceec--CceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 76 LINLIGVG--SFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 76 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++++||+| +||+||++....+++.||+|.+.... ....+.+..|+.+++.++||||+++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999999999999999997542 2334567789999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC-
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP- 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 191 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 347889999999999999 999999999999999999999999875433211110
Q ss_pred --CccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 192 --TQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0111122356778999999876 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=261.32 Aligned_cols=216 Identities=21% Similarity=0.285 Sum_probs=168.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||.|+||.||+|.+..++..||+|.+........+.+..|+.++++++||||+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 4679999999999999999999988899999999986655566788999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 157 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence 447889999999999999 9999999999999999999999999986543221
Q ss_pred ccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.......++..|++||.+. ...++.++|+||||+++|+|++|+.||....... ....... ..+ +
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~--------~ 226 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK-SEP--------P 226 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc-CCC--------C
Confidence 1223356788999999875 3456789999999999999999999986431110 0100000 000 0
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+. ........+.+++..||+.+|.+||++.++++.
T Consensus 227 ~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLD--------------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcC--------------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 001233457889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.08 Aligned_cols=218 Identities=23% Similarity=0.309 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc--chHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--ASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|....+++.||+|.+...... ..+.+..|+.+++.++|+||+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488889999999999999999888999999999765443 56788999999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 347889999999999999 99999999999999999999999999987644332222
Q ss_pred cCCCCccccccccchhhhcCCC---CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSE---VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......++..|++||++.+.. ++.++||||||+++|+|++|..||....... ........ .. .+.+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~~-~~-----~~~~~ 228 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVGA-GH-----KPPIP 228 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHhc-CC-----CCCCC
Confidence 1122356788999999998766 8899999999999999999999996432111 00000000 00 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .......+.+++.+||+.+|.+||++.+++.
T Consensus 229 ~--------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D--------------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c--------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0022445679999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=258.66 Aligned_cols=213 Identities=21% Similarity=0.245 Sum_probs=168.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999999889999999987543 3345678899999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 156 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----I 156 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc----c
Confidence 357789999999999998 9999999999999999999999999997553221 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......++..|+|||++.+..++.++|+||||+++|||++|..||....... ... .+......
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~------------~~~~~~~~--- 219 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLF------------LIPKNNPP--- 219 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhh------------hhhcCCCC---
Confidence 1223457888999999988889999999999999999999999986432110 000 00000000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.....++..+.+++.+||+.+|++||++.+++..
T Consensus 220 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 ---------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0112455678899999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.48 Aligned_cols=220 Identities=19% Similarity=0.250 Sum_probs=177.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc--chHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--ASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.+-|.+.+.||+|.|..|-+|++.-+|..||||++.+.... ....+.+|++.|+-++|||||++
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45588999999999999999999999999999999765433 34578999999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccccccccccCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.|+.|+|+.. +|||||||+|+.+- .-|-+||+|||++..+..+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 347889999999999988 99999999999775 5688999999999765433
Q ss_pred CCCccCCCCccccccccchhhhcCCCCC-CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVS-TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
......+|++.|.|||++.+..|+ +++||||||||||.|++|++||+...+.. .+..++|-.
T Consensus 173 ----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCK 235 (864)
T KOG4717|consen 173 ----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCK 235 (864)
T ss_pred ----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccc
Confidence 334568899999999999999987 67899999999999999999998654432 223333332
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVNNIL 331 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~~~~ 331 (356)
.. .+.....++.+||..||..||.+|.+.++|... |+.+.+.+
T Consensus 236 Yt--------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 236 YT--------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred cc--------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 21 112455567899999999999999999988753 44444433
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=269.70 Aligned_cols=207 Identities=21% Similarity=0.268 Sum_probs=156.7
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------------- 134 (356)
+.||+|+||.||+|....+++.||+|++.... ....+.+..|+.++.++ +||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999997542 23345678899999888 59999886
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 153 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DTT 153 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC----Cce
Confidence 347889999999999999 9999999999999999999999999987432111 122
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC-ccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-LNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......... +......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~----- 221 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-------ILEKPIR----- 221 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-------HHhCCCC-----
Confidence 34678999999999999999999999999999999999999996432211 1111111000 0000000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
.+......+.+++.+||+.||.+||++.
T Consensus 222 ---------------~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 ---------------IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ---------------CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0001223567899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=258.44 Aligned_cols=241 Identities=19% Similarity=0.191 Sum_probs=168.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4888999999999999999999889999999987543 3335678899999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 347789999999999999 99999999999999999999999999976543221
Q ss_pred cCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC-CchHHHhhhhhcc
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP-NRVMDIVNLVLLN 271 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 271 (356)
.......++..|+|||++.+. .++.++||||+|+++|+|++|.+||..... ..........+. .....+-.-.-..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 122335678899999988654 468899999999999999999888754221 111111111111 0000000000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+.. .................+....+.+++.+||+.+|++||++++++..
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYN--KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhh--cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000000000000111334678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.22 Aligned_cols=231 Identities=19% Similarity=0.307 Sum_probs=181.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
..|....+||+|+||.||+|.+..++..||||.+...... ...|+..+++++|||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999999888999999998643221 2346889999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||....... ..
T Consensus 766 ~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--------~~ 836 (968)
T PLN00113 766 EGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--------DT 836 (968)
T ss_pred CCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--------CC
Confidence 4578899999999996544559999999999999998888775 665432211 11
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC-chHHHhhhhhccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN-RVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~ 276 (356)
...++..|+|||++.+..++.++|||||||++|||+||+.||+...........|.+..+.. ....++++.+.....
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 914 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-- 914 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC--
Confidence 23578899999999999999999999999999999999999976555555677776665533 344455554432211
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...++...+.+++.+||+.||++||||.+|+++|+++....
T Consensus 915 --------------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 915 --------------VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred --------------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 12355667889999999999999999999999999987754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=266.49 Aligned_cols=246 Identities=20% Similarity=0.223 Sum_probs=171.8
Q ss_pred HHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------
Q 039228 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------- 134 (356)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------- 134 (356)
..++....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455567899999999999999999999998889999999986432 2234567889999999999999875
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 237789999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-- 257 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-- 257 (356)
++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..+........
T Consensus 166 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 237 (345)
T cd07877 166 LARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 237 (345)
T ss_pred ccccccc-------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 9875422 1223467888999998866 56788999999999999999999999642211 11111111110
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+......+.......+.. ..+.................+.+++.+|++.||.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQ---SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHH---HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 011110000000000000 000000000000000123357899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=260.63 Aligned_cols=221 Identities=20% Similarity=0.250 Sum_probs=168.4
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
+..++..+.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++.++ +|+||+++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 33455556788999999999999999999999899999999986543 2345678899999988 69998864
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEE
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI 176 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 176 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 336778999999999999 999999999999999999999
Q ss_pred cccccccccccCCCCCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHH
Q 039228 177 GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 251 (356)
+|||++....... .......++..|+|||.+. +..++.++|+|||||++|+|++|..||...... ..
T Consensus 163 ~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~ 234 (282)
T cd06636 163 VDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----RA 234 (282)
T ss_pred eeCcchhhhhccc----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----hh
Confidence 9999987543211 1223456888999999875 346788999999999999999999999642211 00
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. .+..... ... ....++..+.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~---------~~~~~~~-~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LF---------LIPRNPP-PKL-----------------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh---------hHhhCCC-CCC-----------------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000000 000 00123446789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=260.24 Aligned_cols=213 Identities=20% Similarity=0.208 Sum_probs=165.6
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
|.....||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 4445579999999999999988899999999976555556678899999999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~ 175 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----PKRK 175 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc----cccc
Confidence 347889999999999999 9999999999999999999999999987543221 1123
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...++..|+|||++.+..++.++||||||+++|||++|+.||..... .............. ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~--------~~------- 238 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK--------LK------- 238 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCC--------cc-------
Confidence 35678999999999988899999999999999999999999863211 01000000000000 00
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........+.+++.+||+.+|++||++.+|++.
T Consensus 239 -------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 -------------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000223356789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=260.91 Aligned_cols=224 Identities=20% Similarity=0.248 Sum_probs=169.2
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.+..+....++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3445566788999999999999999999999999999999997643 22345678899999999 69999975
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 226778999999999998 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 250 (356)
|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||..... ..
T Consensus 165 l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~ 236 (286)
T cd06638 165 LVDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MR 236 (286)
T ss_pred EccCCceeecccCC----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hH
Confidence 99999987653221 12223468899999998753 4478899999999999999999999864311 11
Q ss_pred HHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 251 NFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
...... .. ..+.+. . +......+.+++.+||+.||++|||+.+|++.+
T Consensus 237 ~~~~~~-~~-----~~~~~~-~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFKIP-RN-----PPPTLH-Q-------------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhhcc-cc-----CCCccc-C-------------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 110000 00 000000 0 001223578999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=273.88 Aligned_cols=223 Identities=22% Similarity=0.272 Sum_probs=168.2
Q ss_pred hcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCChHHH--------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNLVRF-------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l-------- 134 (356)
..++|.+.+.||+|+||.||+|++. .++..||+|+++.... ...+.+..|+.+|.++. ||||+++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888999999999999999964 3457899999975422 23457889999999998 9999876
Q ss_pred -----------------H--------------------------------------------------------------
Q 039228 135 -----------------I-------------------------------------------------------------- 135 (356)
Q Consensus 135 -----------------~-------------------------------------------------------------- 135 (356)
+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 0
Q ss_pred ------------------------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 136 ------------------------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 136 ------------------------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
.++.|++.||.|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 14468999999999998 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
++.++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSN--YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccc--cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999976432221 111223456788999999998889999999999999999998 899986432111
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.+. ..+........ +..+...+.+++.+||+.+|.+||++++|++.|+.
T Consensus 350 -~~~------------~~~~~~~~~~~------------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 -QFY------------NAIKRGYRMAK------------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -HHH------------HHHHcCCCCCC------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 000 11111100000 01233467899999999999999999999999987
Q ss_pred hh
Q 039228 327 VN 328 (356)
Q Consensus 327 i~ 328 (356)
+.
T Consensus 399 ~~ 400 (401)
T cd05107 399 LL 400 (401)
T ss_pred Hh
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=277.17 Aligned_cols=212 Identities=21% Similarity=0.332 Sum_probs=170.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS--------------- 136 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~--------------- 136 (356)
+.|.|+..||.|+||.||+|..+.++...|.|++.....+..+.++-|+.||...+||+||++++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45788899999999999999999998888999998877788889999999999999999999832
Q ss_pred -----------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 137 -----------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 137 -----------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+|.+++.||.|||++. |||||||..|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~----~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK----STR 184 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch----hHH
Confidence 7889999999999998 9999999999999999999999999985332 223
Q ss_pred cCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHhh
Q 039228 194 SSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIVN 266 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 266 (356)
.....+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-..... +.-...... |..+ +
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKiaKSePPTL---l- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSEPPTL---L- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHhhcCCCcc---c-
Confidence 3445689999999999864 46799999999999999999999999643211 111111110 1111 1
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+ ..-...+.+++..||..||..||++.+|++
T Consensus 257 ---qP---------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ---QP---------------------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---Cc---------------------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 122335678999999999999999999875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=266.03 Aligned_cols=164 Identities=24% Similarity=0.280 Sum_probs=138.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+++...+++.||+|++... .....+.+..|+.++..++|+||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999999742 22234567889999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 347789999999999999 99999999999999999999999999875433221
Q ss_pred CCccCCCCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 ---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 11223468999999999863 4578899999999999999999999963
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=258.00 Aligned_cols=212 Identities=24% Similarity=0.343 Sum_probs=160.6
Q ss_pred ccceecCceEEEEEEECCCC------eEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNR------AVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+.||+|+||.||+|...... ..+|+|.+.... ......+.+|+.+++.++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986543 789999886442 2345678899999999999999976
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-----ceEEccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-----FAHIGDFEL 181 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~ 181 (356)
+.++.+++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 236779999999999998 99999999999999877 899999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCc
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
+........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~-------- 225 (269)
T cd05044 158 ARDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQH-------- 225 (269)
T ss_pred ccccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHH--------
Confidence 975532211 111222345678999999999999999999999999999998 9999863221 111111
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
+....... .....+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 226 ----~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ----VTAGGRLQ------------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----HhcCCccC------------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000000 001344567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=256.91 Aligned_cols=202 Identities=18% Similarity=0.273 Sum_probs=153.1
Q ss_pred ccceecCceEEEEEEECC------------CCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 78 NLIGVGSFDAVYQGVFDL------------NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
+.||+|+||.||+|.... ....|++|.+..........+..|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998642 234689998876555555678889999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc-------eEEcccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF-------AHIGDFE 180 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~Dfg 180 (356)
+.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 458889999999999999 999999999999986654 8999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHH-cCCCCCCccccCCccHHHHHHHhCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMV-TRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||...... .....
T Consensus 158 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~------ 221 (262)
T cd05077 158 IPITVLS--------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKERF------ 221 (262)
T ss_pred CCccccC--------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHHHH------
Confidence 9864421 12245678899999886 466889999999999999997 588887632111 00000
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
........ ......+.+|+.+||+.||++||++.+|++.|
T Consensus 222 ------~~~~~~~~--------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 ------YEGQCMLV--------------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------HhcCccCC--------------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 01123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=254.90 Aligned_cols=211 Identities=20% Similarity=0.238 Sum_probs=167.2
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||++....+++.||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999999899999999987432 2334578899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 457889999999999998 99999999999999999999999999975533211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......++..|+|||+..+..++.++|+||||+++|+|++|..||.... .. +.+...+.+
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~------------~~~~~~~~~ 216 (256)
T cd08218 157 ---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MK------------NLVLKIIRG 216 (256)
T ss_pred ---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HH------------HHHHHHhcC
Confidence 1123457888999999988889999999999999999999999986321 11 111111111
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ........+.+++.+||+.+|++||++.+|++
T Consensus 217 ~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 217 SYPP---------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCC---------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1100 00133446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.43 Aligned_cols=215 Identities=18% Similarity=0.267 Sum_probs=154.9
Q ss_pred ccceecCceEEEEEEECC--CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.++++++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 456899998865432 233578889999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 236779999999999999 99999999999999999999999999874332111
Q ss_pred ccCCCCccccccccchhhhcCC-------CCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-------EVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
........++..|+|||++.+. .++.++||||||+++|||++ |..||....... ..... .......+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~~~~~~~ 230 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VREQQLKL 230 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hhcccCCC
Confidence 1122334567889999998642 35789999999999999996 999996432211 11110 00000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.++.+.. .....+.+++..|| .+|++|||+++|+..|+
T Consensus 231 ~~~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----------------------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----------------------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111100 12234678999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=255.40 Aligned_cols=215 Identities=19% Similarity=0.219 Sum_probs=164.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|++.+.||+|+||.||.|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999999999999999986321 1224578889999999999999975
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 447889999999999999 99999999999999999999999999875532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ............
T Consensus 159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~-------- 225 (265)
T cd06652 159 ICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAIFKIATQP-------- 225 (265)
T ss_pred cccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHHHHHhcCC--------
Confidence 2111 111223457889999999988889999999999999999999999986321 111111100000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ..+......+.+++.+|+. +|++||++++|++
T Consensus 226 -~~~------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNP------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCC------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 0011333456788889984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.71 Aligned_cols=211 Identities=21% Similarity=0.257 Sum_probs=164.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
+|+..+.||+|+||.||+|....++..|++|.+.... ....+.+.+|+.+++.++|+||+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999998888999999986543 2244678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 347789999999999999 9999999999999999999999999987653322
Q ss_pred CCccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......++..|++||.+.... ++.++|+||||+++|+|++|..||..... ............ .
T Consensus 157 ----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~--------~ 220 (258)
T cd06632 157 ----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKE--------L 220 (258)
T ss_pred ----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhccc--------C
Confidence 123356788899999987766 88999999999999999999999964321 100000000000 0
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. ........+.+++.+||+.+|++||++.+++.
T Consensus 221 -~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 -PP------------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CC------------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 00122345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=254.46 Aligned_cols=213 Identities=17% Similarity=0.237 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|+..+.||.|+||.||.+....++..+++|.+.... ....+.+.+|+.++++++|+||+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999986542 3445678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 346788999999999998 99999999999999999999999999976533221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......++..|+|||++.+..++.++|+||||+++|+|++|..||.... ....... ....
T Consensus 157 ---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~------------~~~~ 216 (256)
T cd08221 157 ---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVK------------IVQG 216 (256)
T ss_pred ---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH------------HHcC
Confidence 2234567899999999988888999999999999999999999986321 1111111 1111
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.... ........+.+++.+||+.+|++||++.++++.+
T Consensus 217 ~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 NYTP---------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCC---------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0000 0012344678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=254.99 Aligned_cols=213 Identities=21% Similarity=0.361 Sum_probs=163.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+..|+.++++++|||++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468889999999999999998864 5789999886432 234678899999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---Y 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc---c
Confidence 347788999999999999 9999999999999999999999999987543221 1
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......++..|+|||++.+..++.++||||||+++|||++ |..||..... ....... .......
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~---------~~~~~~~ 221 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI---------NAGFRLY 221 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH---------hCCCCCC
Confidence 11122334678999999998889999999999999999998 9999864221 1111110 0000000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.. ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 222 ~~------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KP------------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CC------------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 01234678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.90 Aligned_cols=213 Identities=23% Similarity=0.389 Sum_probs=164.9
Q ss_pred CCccccceecCceEEEEEEECCCC----eEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNR----AVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
|++.+.||.|+||.||+|.+...+ ..||+|.+...... ..+.+..|+.++..++|+||+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999998765 89999999755433 46788999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 347788999999999999 9999999999999999999999999997654332
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ............
T Consensus 158 ~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~----------- 221 (258)
T smart00219 158 YYK---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGY----------- 221 (258)
T ss_pred ccc---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC-----------
Confidence 111 112336788999999988889999999999999999998 888886421 111111110000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
... .....+..+.+++.+||..+|++|||+.++++.|
T Consensus 222 -~~~------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLP------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCC------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 0012344678999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=261.38 Aligned_cols=223 Identities=22% Similarity=0.251 Sum_probs=169.0
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
...++..++++|.+.+.||+|+||.||+|....+++.+|+|.+.... .....+..|+.+++++ +|||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33455667889999999999999999999999999999999986432 2345677899999998 79999875
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
..++.+++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 236788999999999998 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcCC-----CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-----EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 250 (356)
|+|||++........ ......++..|+|||++... .++.++|||||||++|+|++|+.||...... .
T Consensus 169 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~ 240 (291)
T cd06639 169 LVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----K 240 (291)
T ss_pred Eeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----H
Confidence 999999876532211 12234578899999987543 3678999999999999999999998643211 1
Q ss_pred HHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 251 NFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....... ... +.+. ........+.+++.+||+.+|++||++.++++.
T Consensus 241 ~~~~~~~-~~~-----~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKIPR-NPP-----PTLL--------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHhc-CCC-----CCCC--------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100000 000 0000 001223357899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=259.05 Aligned_cols=244 Identities=23% Similarity=0.250 Sum_probs=168.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRFI------------- 135 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~------------- 135 (356)
.++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999999999999999864422 2234577899999999999999862
Q ss_pred --------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 136 --------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 136 --------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 36778999999999999 9999999999999999999999999997
Q ss_pred ccccCCCC-------CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 184 FRQEVSNP-------TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 184 ~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
........ .........+++.|+|||.+.+. .++.++|||||||++|+|++|++||....... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 65432211 11122334668889999987654 57899999999999999999999996432211 11111111
Q ss_pred hCCCchHHHhhhhhccccc--cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 256 AFPNRVMDIVNLVLLNDNK--VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+........ ......+..... ........+.+++.+||+.||.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE----RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHH----HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000000000000000 000000000000 01122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=252.55 Aligned_cols=211 Identities=19% Similarity=0.281 Sum_probs=165.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|....+++.+|+|.+.... ....+.+.+|+.+++.++|||++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4888999999999999999999999999999987542 2345678899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 347789999999999999 9999999999999854 568999999998654321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ........ .....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~--------~~~~~ 219 (256)
T cd08220 157 ----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIM--------SGTFA 219 (256)
T ss_pred ----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHH--------hcCCC
Confidence 12235678899999999988889999999999999999999999864211 11111100 00000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. .......+.+++.+||+.+|++|||+.+++..
T Consensus 220 -~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -PI------------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CC------------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 00233457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=258.76 Aligned_cols=232 Identities=22% Similarity=0.333 Sum_probs=186.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHh--hcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALK--NICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l--------------- 134 (356)
....+.+.||+|.||+||+|.|. |+.||||+|.. .+...+.+|.++.+ .|+|+||+.|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45778899999999999999998 88999999973 33466778887776 4799999998
Q ss_pred -------------------------HHHHHHHHHHHHHHhh-----cCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 -------------------------ISIAIDVASALDYLHH-----HCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~-----~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
+.++..++.||++||. +|++.|.|||||+.|||+..++.+-|+|+|+|..
T Consensus 286 LvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred EeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 5688899999999995 4667799999999999999999999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCC----C--CCccchHhHHHHHHHHHcC----------CCCCCccccCCcc
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSE----V--STNGDAYNYGILLLEMVTR----------RKPIDFMFEGDLN 248 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDiwSlG~~l~elltg----------~~Pf~~~~~~~~~ 248 (356)
.....+.-....+..+||..|||||++...- + -..+||||||.++||+.-. ++||......+.+
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 7666555556677789999999999986432 1 1457999999999999752 5788877777777
Q ss_pred HHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 249 LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
+.++..-....++...++..+..+ +++..+.++|..||..||..|-|+-.+-+.|.++.
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s~---------------------~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKSD---------------------PALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred HHHHhcceeecccCCCCCcccccC---------------------HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 766654433333333333333222 67888999999999999999999999999998886
Q ss_pred h
Q 039228 329 N 329 (356)
Q Consensus 329 ~ 329 (356)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 5
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=260.38 Aligned_cols=239 Identities=23% Similarity=0.263 Sum_probs=167.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++|+||+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 5679999999999999999999999999999999874432 223356789999999999999976
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 347889999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH---h
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI---V 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~ 265 (356)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||..... .................+ +
T Consensus 163 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 163 K----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred C----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhh
Confidence 1 1122344778999999865 4578999999999999999999999974321 111111111111000000 0
Q ss_pred hh-hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NL-VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ................ . .........+.+++.+||+.||++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNL-K----HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCch-H----HhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000000000000000 0 0001124456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=260.06 Aligned_cols=216 Identities=20% Similarity=0.214 Sum_probs=169.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++|||++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 3579999999999999999999988889999999876555556778999999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~----~ 170 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----S 170 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc----c
Confidence 347789999999999999 9999999999999999999999999987543222 1
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......+++.|++||.+.+..++.++|+||||+++|++++|+.||........ .... ..... +.+.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~---~~~~~------~~~~---- 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI---ATNGT------PELQ---- 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh---hcCCC------CCCC----
Confidence 22234578889999999888899999999999999999999999964321110 0000 00000 0000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........+.+++.+||..+|++||++.+++.+
T Consensus 237 ----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 ----------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001233457889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=261.73 Aligned_cols=251 Identities=20% Similarity=0.204 Sum_probs=174.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|+||.||+|....++..||+|.+.... ....+.+..|+.+++.++||||+++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4888999999999999999999889999999987543 3445678999999999999999887
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 237788999999999999 9999999999999999999999999998654432
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. ........++..|+|||++.+. .++.++|+||||+++|+|++|.+||...... ...............+.....
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 158 DE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhhc
Confidence 11 1122335678899999999887 7899999999999999999999999754321 111111111100000000000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVNN 329 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~~ 329 (356)
..............................+.+++.+||+.+|++||++.+++.. ++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000000000000000011234567899999999999999999999974 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=260.55 Aligned_cols=211 Identities=24% Similarity=0.263 Sum_probs=164.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
...|.+.+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4568889999999999999999988899999999864322 233568899999999999999876
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 347789999999999999 999999999999999999999999998754321
Q ss_pred CCccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
....++..|+|||++. ...++.++||||||+++|||++|..||...... ..... +...
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~--------~~~~ 229 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYH--------IAQN 229 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHH--------HhcC
Confidence 2345678899999874 356888999999999999999999998632110 00000 0000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. ..... .......+.+++.+||+.+|++||++.+|+..
T Consensus 230 ~-~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 D-SPTLS-----------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C-CCCCC-----------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00000 01234567899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=258.73 Aligned_cols=202 Identities=18% Similarity=0.229 Sum_probs=152.9
Q ss_pred ccceecCceEEEEEEECCCCe-------EEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRA-------VVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+.||+|+||.||+|.....+. .||+|.+........+.+..|+.+++.++|||++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999999865443 488888865555555678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc--------eEEcccccccc
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF--------AHIGDFELARF 184 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfg~a~~ 184 (356)
+.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 447889999999999999 999999999999987665 68999998864
Q ss_pred cccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCC-CCCCccccCCccHHHHHHHhCCCchH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRR-KPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||...... ....
T Consensus 158 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~----------- 216 (258)
T cd05078 158 VLP--------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQ----------- 216 (258)
T ss_pred cCC--------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHH-----------
Confidence 321 123456788999999976 45789999999999999999985 555421110 0000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
...... ..+ ......+.+++.+||+.||++|||++++++.|
T Consensus 217 -~~~~~~--~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 -FYEDRH--QLP------------------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -HHHccc--cCC------------------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 000 01123578999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.87 Aligned_cols=218 Identities=21% Similarity=0.366 Sum_probs=177.1
Q ss_pred CCccccceecCceEEEEEEECC----CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
....+.||.|.||.||+|++.. .+-.||||..+... .+..+.|+.|.-+|++++||||+++
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 4456789999999999999743 24569999988654 3456789999999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
.-++.||+.||+|||+.. +|||||...|||+.....+||+|||+++.+....-.
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 337889999999999998 999999999999999999999999999988654422
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......-..-|||||.+....++.+||||-|||.+||++. |..||.+....+.... +. .
T Consensus 548 ---kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~--------------iE---n 607 (974)
T KOG4257|consen 548 ---KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH--------------IE---N 607 (974)
T ss_pred ---hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE--------------ec---C
Confidence 2223344667999999999999999999999999999987 9999986544332110 00 0
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
-..+.-+++|+..|..|+.+||.++|.+||.+.++...|..+..
T Consensus 608 ---------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 ---------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 01122344899999999999999999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=255.88 Aligned_cols=216 Identities=19% Similarity=0.268 Sum_probs=163.2
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc------cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ------GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+|++.+.||.|+||.||+|... +++.+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999874 678999999864321 123468889999999999999886
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 347789999999999999 9999999999999999999999999987653211
Q ss_pred C--CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 190 N--PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 190 ~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. ..........++..|+|||++.+..++.++|+||||+++|+|++|..||....... ........ ... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~-----~~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAH--RGL-----MP 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhc--cCC-----CC
Confidence 1 11122234567889999999998889999999999999999999999996432110 00000000 000 00
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+. ......+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLP----------------------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----------------------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 123345789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.05 Aligned_cols=221 Identities=24% Similarity=0.259 Sum_probs=172.8
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHHHH----------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRFIS---------- 136 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~---------- 136 (356)
..+-++.-..+||.|.||.||.|.+.++|...|+|-+.... ....+.+.+|..++..++|||+|++++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34556788889999999999999999999999999886432 344567889999999999999999821
Q ss_pred ---------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 137 ---------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 4568999999999999 9999999999999999999999999998775543
Q ss_pred CCCccCCCCccccccccchhhhcCC---CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS---EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
...........||+.|||||++.+. ....+.||||+||++.||+||+.||.....+....-.......
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--------- 1459 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--------- 1459 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC---------
Confidence 2223344568899999999999763 3567889999999999999999999764333211111111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
++.+.....+-.+++..||..||..|+++.||++.
T Consensus 1460 ----------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11222334455789999999999999999887764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=264.41 Aligned_cols=241 Identities=20% Similarity=0.230 Sum_probs=170.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+.+++++ +||||+++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 56799999999999999999999988999999988532 223345677899999999 99999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 237789999999999999 99999999999999999999999999986543322
Q ss_pred C-CccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CC-chHHH-
Q 039228 191 P-TQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PN-RVMDI- 264 (356)
Q Consensus 191 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~-~~~~~- 264 (356)
. .........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .........- +. ....+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHH
Confidence 1 1122334568899999998754 457889999999999999999999996432211 1111111100 00 00000
Q ss_pred ---hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 265 ---VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 265 ---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+..+......... .. ..........+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~----~~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRK----PL----DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhccccccc----ch----hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00 00011235578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=254.19 Aligned_cols=219 Identities=21% Similarity=0.298 Sum_probs=163.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc----------cchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ----------GASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
+|.+.+.||.|+||.||+|....+++.||+|.+..... ...+.+..|+.+++.++|||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999999988899999998863211 112457789999999999999886
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 336789999999999998 999999999999999999999999999754
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCCC--CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSE--VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
..... ........++..|+|||.+.... ++.++|+||||+++|++++|..||.... ....... ........
T Consensus 159 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~ 231 (272)
T cd06629 159 DDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFK-LGNKRSAP 231 (272)
T ss_pred ccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHH-hhccccCC
Confidence 32211 11223356788999999987654 7899999999999999999999985321 1111110 00000000
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+.... ....+..+.+++.+||..+|++||++.+|++.
T Consensus 232 ~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPPDV----------------------SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCccc----------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000 01234567899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=254.34 Aligned_cols=236 Identities=17% Similarity=0.163 Sum_probs=164.4
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l----------------- 134 (356)
|++.+.||+|+||.||+|....++..||+|.++.... ........|+.++.++. |+|++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6778899999999999999998899999999875422 22234557888898885 9999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 447889999999999999 999999999999999 9999999999976533221
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.....++..|+|||++.. ..++.++|||||||++|||++|..||..... .................+. ..+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~ 228 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVL-KKFRK 228 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHH-Hhhcc
Confidence 122456889999997654 5578899999999999999999999964322 1111111111111111110 00000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ....+..............+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000 0000000000011111244668899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.34 Aligned_cols=222 Identities=20% Similarity=0.161 Sum_probs=167.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468999999999999999999999999999999875432 234567889999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 346789999999999998 999999999999999999999999998742111000
Q ss_pred -----------CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 192 -----------TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 192 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.........++..|+|||++.+..++.++|+||||+++|||++|..||..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~---- 228 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQV---- 228 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH----
Confidence 00111234568889999999888899999999999999999999999863211 1111110
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
...... .. ......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 229 ----~~~~~~-~~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ----ISDDIE-WP----------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----HhcccC-CC----------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 00 0000233457899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=252.71 Aligned_cols=211 Identities=22% Similarity=0.232 Sum_probs=165.7
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999999889999999997542 2345678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 347789999999999998 9999999999999999999999999987553321
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...... ........ . .. ....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~--------~~-~~~~ 220 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-Q--------ET-ADVL 220 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH-h--------cc-cccc
Confidence 223355788899999998888999999999999999999999999743321 01111100 0 00 0000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh--HHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV--PNAV 321 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~~vl 321 (356)
.+...+..+.+++.+||+.||.+||++ ++++
T Consensus 221 ------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 ------------------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------------------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011233567899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=254.66 Aligned_cols=238 Identities=19% Similarity=0.172 Sum_probs=165.9
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-----chHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-----ASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999988999999999754322 33557789999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 347889999999999999 99999999999999999999999999976543221
Q ss_pred CCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...... ..+..............+.+...
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 158 ----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred ----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 1122345778999998854 45788999999999999999998887642211 11111111110000000000000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
............ .............+.+++.+||+.+|++|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPP----TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCC----cchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000 0000001133457889999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=252.66 Aligned_cols=202 Identities=20% Similarity=0.342 Sum_probs=155.7
Q ss_pred ccceecCceEEEEEEECCCC----------eEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNR----------AVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 36899999999999998765 45888887644333 5788899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-------ceEEccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-------FAHIGDFELAR 183 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~Dfg~a~ 183 (356)
+.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 347789999999999998 99999999999999887 79999999997
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC--CCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS--EVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...... ....+..
T Consensus 157 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~------ 220 (259)
T cd05037 157 TVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ------ 220 (259)
T ss_pred cccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh------
Confidence 5432 1123456789999998876 78899999999999999999 57777543211 1111100
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
....... .....+.+++.+||..+|.+|||+.+|++.|.
T Consensus 221 -----~~~~~~~---------------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -----DQHRLPM---------------------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----cCCCCCC---------------------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 00135789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.50 Aligned_cols=216 Identities=16% Similarity=0.245 Sum_probs=165.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC----cc----chHHHHHHHHHHhhcC-CCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC----QG----ASKSFMAECKALKNIC-HRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~E~~~l~~l~-h~niv~l------- 134 (356)
-+.|.-.+.||+|..++|-++..+.++..+|+|++.... .+ ..+.-.+|+.+|+++. ||+|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 345777889999999999999999999999999986321 11 1234567999999975 9999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..|..++..|+.|||... ||||||||+|||+|++.+++|+|||++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeec
Confidence 348899999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhc------CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDL------GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
+..+. .....+||++|+|||.+. ...|+..+|+|++||++|.++.|.+||-.. ...-
T Consensus 173 l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQml---------- 235 (411)
T KOG0599|consen 173 LEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQML---------- 235 (411)
T ss_pred cCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHH----------
Confidence 75533 234588999999999874 346889999999999999999999998421 0000
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
++--.+.+.+. .-...|. +......+|+.+||+.||.+|.|++++++.
T Consensus 236 -----MLR~ImeGkyq--------F~speWa----dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 -----MLRMIMEGKYQ--------FRSPEWA----DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----HHHHHHhcccc--------cCCcchh----hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 01111111111 0011111 334456899999999999999999999863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=253.93 Aligned_cols=214 Identities=21% Similarity=0.245 Sum_probs=151.9
Q ss_pred cceecCceEEEEEEECC--CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------------
Q 039228 79 LIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------------- 134 (356)
.||+|+||.||+|.... ....+|+|.+..... .....+.+|+.+++.++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997543 346788988764332 234568899999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~ 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--Y 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh--e
Confidence 246789999999999999 99999999999999999999999999864322111 1
Q ss_pred cCCCCccccccccchhhhcC-------CCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 194 SSSNGVRRTIGYTALDYDLG-------SEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||....... .+........ ..+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~----~~~~ 231 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD----IKLP 231 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC----ccCC
Confidence 11123445678999998743 356789999999999999999 788886432111 1111111000 0000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.+.+ .......+.+++..|| .||++|||+++|++.|.
T Consensus 232 ~~~~----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000 0123335567888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=251.90 Aligned_cols=214 Identities=17% Similarity=0.247 Sum_probs=150.9
Q ss_pred cceecCceEEEEEEECCC--CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------------
Q 039228 79 LIGVGSFDAVYQGVFDLN--RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------------- 134 (356)
.||+|+||.||+|....+ ...+++|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 689999999999975433 3456777766443 2345678999999999999999986
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~--~~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED--YIE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch--hhh
Confidence 246778999999999998 9999999999999999999999999986422111 111
Q ss_pred CCCCccccccccchhhhcC-------CCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 195 SSNGVRRTIGYTALDYDLG-------SEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
......++..|+|||++.. ..++.++||||||+++|||++ |..||..... .........+....+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQVKLFK 231 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcccccCC
Confidence 2223567889999998743 245788999999999999997 5778753221 11111111111111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+.+.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~~----------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLEL----------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCC----------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 11224677889999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=255.80 Aligned_cols=234 Identities=25% Similarity=0.269 Sum_probs=164.9
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
|++.+.||.|++|.||+|.+..++..||+|++.... ......+.+|+.+++.++|||++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999999899999999987543 2234568889999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---- 153 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---- 153 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc----
Confidence 347789999999999998 9999999999999999999999999997543221
Q ss_pred cCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CCc-hHHHh--hhh
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PNR-VMDIV--NLV 268 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~-~~~~~--~~~ 268 (356)
.......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...... ..+........ +.. ....+ .+.
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 111223457889999987654 4688999999999999999999999643211 11111111111 110 00000 000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....... ................+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPK-------WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhccc-------ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0000000001123346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.91 Aligned_cols=217 Identities=18% Similarity=0.265 Sum_probs=166.1
Q ss_pred CCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
++|++...||.|+||.||+|+.+. +.+.|++|.+...... ..+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568899999999999999999753 3468999988654333 45678999999999999999987
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 236789999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCC
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~--- 233 (275)
T cd05046 162 SLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA--- 233 (275)
T ss_pred ccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---
Confidence 9987442211 112233456778999999988888999999999999999998 88898632211 11111000
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.. +.... ...++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 234 ~~--------~~~~~------------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GK--------LELPV------------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC--------cCCCC------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 00000 0123446789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=253.53 Aligned_cols=216 Identities=21% Similarity=0.272 Sum_probs=171.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+|+..+.+++|+||+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468899999999999999999999999999999876543 345778999999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-- 155 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-- 155 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC--
Confidence 4588899999999999 98 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......... ........
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~--------~~~~~~~~ 223 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAI--------CDGPPPSL 223 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHH--------hcCCCCCC
Confidence 11235678899999999988899999999999999999999999975432 1111111111 10000000
Q ss_pred cccccccccchhhhhchhhHHH-HHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLE-CLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .+..+.+++.+||+.+|++||++.++++.
T Consensus 224 -------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 012 34568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=253.93 Aligned_cols=235 Identities=22% Similarity=0.268 Sum_probs=168.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+|++.+.||.|++|.||+|++..++..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58899999999999999999999999999999875533 234567789999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 347889999999999999 9999999999999999999999999997543221
Q ss_pred ccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC---chHHHhhh-
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN---RVMDIVNL- 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 267 (356)
.......++..|++||++.+. .++.++|+||||+++|+|++|+.||....... ............ ....+.+.
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCc
Confidence 112234567889999988654 56889999999999999999999997533211 111111111100 11111100
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+... .+.................+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPT-------FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhccc-------ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000000001111234556789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=257.41 Aligned_cols=241 Identities=23% Similarity=0.238 Sum_probs=166.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++.... .....+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 3579999999999999999999998899999999975432 223456789999999999999875
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 457889999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHHHhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMDIVN 266 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 266 (356)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... ............ .......
T Consensus 161 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 ----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhh
Confidence 112234567889999998764 46889999999999999999999997432211 111111110000 0000000
Q ss_pred hh-hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LV-LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. ............. .+....+.. .....+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYN-QLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccch-hhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000000 000000000 02446789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.35 Aligned_cols=164 Identities=21% Similarity=0.265 Sum_probs=137.6
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+++++.+++.||+|++... .......+..|+.++..++|+||+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999999999999999998642 12223457789999999999999876
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 347789999999999999 9999999999999999999999999987543221
Q ss_pred CCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 157 --TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred --cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 11223356899999999986 34678999999999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=260.58 Aligned_cols=238 Identities=20% Similarity=0.221 Sum_probs=168.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI--------------- 135 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~--------------- 135 (356)
..+|.+.+.||.|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46799999999999999999999999999999999766656667788999999999999999753
Q ss_pred ----------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccc
Q 039228 136 ----------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFE 180 (356)
Q Consensus 136 ----------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg 180 (356)
.++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence 36678999999999999 99999999999997 56678999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
++..+...... ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....... ..+.
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~ 237 (342)
T cd07854 161 LARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILE-SVPV 237 (342)
T ss_pred cceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCC
Confidence 99765332111 111223456888999998754 567889999999999999999999996432211 1111111 0110
Q ss_pred c----hHHH---hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 R----VMDI---VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~----~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .... +...+.......... ...........+.+++.+||..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRP--------LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCC--------HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000 000000000000000 00000123346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=265.00 Aligned_cols=164 Identities=22% Similarity=0.269 Sum_probs=138.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||++++..+++.||+|++... .......+..|+.++..++|+||+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998642 12233457789999999999999876
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 336789999999999999 99999999999999999999999999976533221
Q ss_pred CCccCCCCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 12223568999999999875 4678899999999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.82 Aligned_cols=245 Identities=20% Similarity=0.219 Sum_probs=170.2
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
+...+++|++.+.||.|+||.||+|.+..++..||+|.+... .....+.+..|+.+++.++||||+++
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678899999999999999999999999999999988543 22334678899999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 336789999999999999 99999999999999999999999999874321
Q ss_pred CCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ...............++...
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 161 ------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence 1123456788999998765 56889999999999999999999999643210 11111111111001111110
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...............................+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000000000011234578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=254.10 Aligned_cols=214 Identities=23% Similarity=0.356 Sum_probs=163.9
Q ss_pred CCCccccceecCceEEEEEEECC-CCeEEEEEEeeccC----------ccchHHHHHHHHHHhh-cCCCChHHH------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDL-NRAVVAIKVLSIQC----------QGASKSFMAECKALKN-ICHRNLVRF------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l------ 134 (356)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ......+..|+.++.+ ++||||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 67899999885321 2233457788887764 799999986
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGD 178 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~D 178 (356)
+.++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 3467799999999996 66 99999999999999999999999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||... ........
T Consensus 158 fg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~--- 224 (269)
T cd08528 158 FGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATK--- 224 (269)
T ss_pred ccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHH---
Confidence 99997643321 223456788999999999888999999999999999999999998632 11111111
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+.+........ ......+.+++.+||+.||++||++.+|.++|.
T Consensus 225 -----~~~~~~~~~~~------------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -----IVEAVYEPLPE------------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HhhccCCcCCc------------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01100000000 012345789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.12 Aligned_cols=216 Identities=22% Similarity=0.295 Sum_probs=165.9
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
..+++|++.+.||.|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +|+||+++
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999988889999999875533 346788999999998 69998764
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 237778999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
++....... .......++..|+|||++.. ..++.++||||||+++|+|++|..||...... ........
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~- 232 (275)
T cd06608 159 VSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR- 232 (275)
T ss_pred cceecccch----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhc-
Confidence 987543221 12233567889999998753 34678899999999999999999999632111 01111000
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. .+.+ .........+.+++.+||..||++|||+.+|++
T Consensus 233 ---~~-----~~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 ---NP-----PPTL--------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---cC-----CCCC--------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0000 000123456789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=266.61 Aligned_cols=155 Identities=27% Similarity=0.299 Sum_probs=127.4
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhc---CCCChHHH-------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNI---CHRNLVRF------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l------------------- 134 (356)
||+|+||.||+|++..+++.||+|++..... .....+..|..++... +||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999864321 2233455677777665 69999876
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~ 153 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----KTT 153 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----CCc
Confidence 347889999999999999 9999999999999999999999999987532211 122
Q ss_pred CCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 197 NGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
....||..|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 346789999999998754 478999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.03 Aligned_cols=201 Identities=20% Similarity=0.292 Sum_probs=151.0
Q ss_pred cceecCceEEEEEEECC------------------------CCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH
Q 039228 79 LIGVGSFDAVYQGVFDL------------------------NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 134 (356)
.||+|+||.||+|.... ....||+|++..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999998532 124689999875544445678889999999999999986
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---- 172 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---- 172 (356)
+.++.||+.||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 458889999999999998 99999999999997543
Q ss_pred ---ceEEcccccccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHH-HcCCCCCCccccCCc
Q 039228 173 ---FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEM-VTRRKPIDFMFEGDL 247 (356)
Q Consensus 173 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~el-ltg~~Pf~~~~~~~~ 247 (356)
.++++|||++..... .....++..|+|||.+.+ ..++.++||||||+++||| ++|..||.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~--------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS--------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccceeeecCCcccccccc--------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 479999998753321 112346778999998865 5688999999999999998 47999986432111
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.... +....... . .....+.+++.+||+.+|++|||+.+|++.|
T Consensus 230 -~~~~------------~~~~~~~~-~-------------------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KERF------------YEKKHRLP-E-------------------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHH------------HHhccCCC-C-------------------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111 11100000 0 1112478899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=269.90 Aligned_cols=222 Identities=22% Similarity=0.296 Sum_probs=177.5
Q ss_pred cCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+...+.+.||+|.||.|++|.|... ...||||.+...... ....|++|+.+|.+|+|+|++++
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV 188 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMV 188 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHH
Confidence 34566778999999999999999753 357999999755443 56789999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
.+++.||+.|+.||..++ +|||||...|+|+.....+||+|||+.+-+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 348899999999999999 999999999999999999999999999988766
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
...... .....-...|.|||.+....++.++|||+|||++|||+| |..||.+.... .+...+|.
T Consensus 266 ed~Yvm-~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD~ 330 (1039)
T KOG0199|consen 266 EDMYVM-APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNIDA 330 (1039)
T ss_pred CcceEe-cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhccc
Confidence 554322 222334678999999999999999999999999999999 88998753211 12222332
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.- ....+..|++.+.+++..||..+|++|||+..|.+.+-...
T Consensus 331 ~e------------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 331 GE------------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred cc------------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 11 11223379999999999999999999999999986554433
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=254.28 Aligned_cols=239 Identities=20% Similarity=0.196 Sum_probs=164.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcC-CCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNIC-HRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+. ||||+++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999999999999999864422 23457888999999995 5999876
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFEL 181 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~ 181 (356)
..++.||+.||.|||+.+ |+||||+|+||+++. ++.++|+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 336789999999999999 999999999999998 89999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
+....... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||....... .............
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPV----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPT 232 (295)
T ss_pred ceecCCCc----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 87543221 11122345788999998865 457899999999999999999999996422111 1111111100000
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...+....-...........+.... .........+.+++.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLS----RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHH----HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000000000000000 001134456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=255.49 Aligned_cols=207 Identities=25% Similarity=0.230 Sum_probs=163.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999999889999999986432 2334678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 347789999999999999 999999999999999999999999998765322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .........+. ..+.
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~------~~~~- 218 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILEGK------VRFP- 218 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC------ccCC-
Confidence 2234678899999999888889999999999999999999999864221 11110000000 0000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAV 321 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl 321 (356)
......+.+++.+||..||.+|| ++++++
T Consensus 219 ---------------------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 ---------------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---------------------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01223567999999999999999 556655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=261.42 Aligned_cols=241 Identities=21% Similarity=0.215 Sum_probs=167.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999999999999986432 2234568899999999999999865
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 347789999999999999 9999999999999999999999999997543
Q ss_pred cCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. .....++..|++||.+.+ ..++.++|+||||+++|++++|..||...... ............ ....+.
T Consensus 170 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~ 240 (343)
T cd07880 170 SE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGT-PSKEFV 240 (343)
T ss_pred cC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCC-CCHHHH
Confidence 21 123456888999999876 45788999999999999999999999743211 011111111000 000100
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.............................+...+.+++.+|++.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000000000000011123446789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=252.77 Aligned_cols=237 Identities=22% Similarity=0.261 Sum_probs=167.1
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|||++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999999889999999998653 3344678899999999999999876
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 347889999999999999 99999999999999999999999999986544321
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH--hhhh-
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI--VNLV- 268 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 268 (356)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .................+ ....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 11223456788999997765 45789999999999999999999999643321 111111111100000000 0000
Q ss_pred hccccccccccccchhhhhchhhHHH-HHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLE-CLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....... ......... ..... +...+.+++.+||..+|.+||++.++++
T Consensus 234 ~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKP-KKPYKRRLR----EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccc-cccchhHHH----HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 000000000 01111 2567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=255.41 Aligned_cols=217 Identities=18% Similarity=0.229 Sum_probs=162.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||.++.... .....+..|+.++.+.. ||||+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34679999999999999999999998899999999975432 23455677887666665 9999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 ------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+++.||.|||+ .+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 2478899999999997 47 9999999999999999999999999987553221
Q ss_pred CCCccCCCCccccccccchhhhcCCC----CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSE----VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .. ... .++
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~-~~~--------~~~ 232 (296)
T cd06618 170 -----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FE-VLT--------KIL 232 (296)
T ss_pred -----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HH-HHH--------HHh
Confidence 112234678899999987554 788999999999999999999998642111 10 000 011
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..... ... ....+...+.+++.+||+.||++||++.+++..
T Consensus 233 ~~~~~-~~~----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 QEEPP-SLP----------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred cCCCC-CCC----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 000 000233467899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=250.41 Aligned_cols=236 Identities=23% Similarity=0.257 Sum_probs=168.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
|++.+.||.|++|.||+|....+++.+++|.+..... .....+..|+.++++++|+||+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 5677899999999999999988899999999875432 234678889999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----~ 153 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----R 153 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc----c
Confidence 347789999999999999 9999999999999999999999999997654322 1
Q ss_pred CCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC---CchHHHhhhhhc
Q 039228 195 SSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP---NRVMDIVNLVLL 270 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 270 (356)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ .+......... .....+.+....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhh
Confidence 11224567889999998776 78899999999999999999999986432111 11111111000 000000000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ...-...............+.+++..||+.||.+||++.+++.
T Consensus 233 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFS-----FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhh-----hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0000000001112245667899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=260.66 Aligned_cols=242 Identities=19% Similarity=0.216 Sum_probs=167.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|.+...||+|++|.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 367899999999999999999999999999999998643 22334567789999999999999876
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 236678999999999999 9999999999999999999999999997543
Q ss_pred cCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+.... .........+.
T Consensus 170 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~-~~~~~~~~~~~ 240 (343)
T cd07851 170 DE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM-NLVGTPDEELL 240 (343)
T ss_pred cc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-HhcCCCCHHHH
Confidence 21 223456888999998865 36788999999999999999999999642211 0111111 11110001111
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.................................+.+++.+||+.+|++|||+.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1000000000000000000000000011234578899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=252.99 Aligned_cols=212 Identities=18% Similarity=0.188 Sum_probs=165.1
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
|...+.||.|++|.||+|....+++.+++|.+........+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4555789999999999999988899999999875555555678899999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.+++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ....
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----~~~~ 173 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----PRRK 173 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----cccc
Confidence 348889999999999999 9999999999999999999999999886543221 1122
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......... ..+.+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~------- 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDN-----LPPKLK------- 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhc-----CCCCCc-------
Confidence 35578899999999888899999999999999999999999863211 1111100000 000000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||..+|++||++.++++
T Consensus 237 -------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00023346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=249.21 Aligned_cols=212 Identities=21% Similarity=0.265 Sum_probs=165.1
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.+++.++|+||+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4888999999999999999999999999999986542 2334578899999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 346788999999999999 99999999999999875 46999999997654321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......|++.|+|||+..+..++.++|+||||+++|+|++|..||.... ........... .+.
T Consensus 157 ---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~--------~~~ 220 (257)
T cd08225 157 ---ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQG--------YFA 220 (257)
T ss_pred ---ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc--------cCC
Confidence 11223457889999999988889999999999999999999999986321 11211111111 000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... ......+.+++.+||..+|++|||+.+|++.
T Consensus 221 ~~~-------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PIS-------------------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCC-------------------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0223357899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=266.88 Aligned_cols=216 Identities=18% Similarity=0.252 Sum_probs=164.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeec--cCccchHHHHHHHHHHhhcC-CCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI--QCQGASKSFMAECKALKNIC-HRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l------------- 134 (356)
...|++++.||+||.+.||++..... +.||+|.+.. .+.....-|.+|+..|.+|+ |.+||++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34699999999999999999987654 6777776542 23344567999999999997 8899987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..+..||+.|+.++|.+| |||.||||.|+|+- .|.+||+|||.|..+.....
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 347889999999999999 99999999999986 57899999999987765443
Q ss_pred CCccCCCCccccccccchhhhcCCC-----------CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSE-----------VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
......-+||+.||+||.+.... .+.++||||||||||+|+.|+.||.. +.... .
T Consensus 515 --sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~-----a 580 (677)
T KOG0596|consen 515 --SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQI-----A 580 (677)
T ss_pred --ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHH-----H
Confidence 23344568999999999886432 56789999999999999999999963 11111 1
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+..+.++.-.-.++.. ....+++.++..||..||++||++.+||+
T Consensus 581 Kl~aI~~P~~~Iefp~~-----------------~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDI-----------------PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCC-----------------CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12233444222122110 01112789999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=257.45 Aligned_cols=213 Identities=25% Similarity=0.294 Sum_probs=164.9
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
|...+.||+|+||.||+|++..++..||+|.+..... .....+.+|+.+++.++|||++++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 7778899999999999999998899999999874322 234568889999999999999876
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 347789999999999999 99999999999999999999999999864322
Q ss_pred cCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 194 SSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....++..|+|||++. ...++.++|||||||++|+|++|..||....... .... +......
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~------------~~~~~~~ 242 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH------------IAQNESP 242 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHH------------HHhccCC
Confidence 12345788899999974 4568899999999999999999999986421100 0101 1110000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
... .......+.+++.+||+.+|.+||++.+|++.+-...
T Consensus 243 ~~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 TLQ------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCC------------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0123345789999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=246.09 Aligned_cols=168 Identities=29% Similarity=0.355 Sum_probs=141.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCC----eEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR----AVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
...|+.++.||+|.||.||+|..+.++ ..+|||.++.+ .........+|+.+++.++|||++.+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 456999999999999999999766553 37899999754 33445678899999999999999987
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC----CceEEcc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND----LFAHIGD 178 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~D 178 (356)
..|+.||+.|+.|||++= |+||||||.|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 347889999999999987 9999999999999876 9999999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
||+++.+.....+ ......++-|..|.|||.+.|. .|+.+.|||++|||+.||+|-.+-|...
T Consensus 180 lGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999987654432 2234557789999999999875 5899999999999999999999888653
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=252.57 Aligned_cols=212 Identities=20% Similarity=0.243 Sum_probs=165.8
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
-|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3778889999999999999998889999999986432 2334578899999999999999976
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~----~~ 157 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----IK 157 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch----hh
Confidence 457889999999999999 9999999999999999999999999987553221 11
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ..... +.......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~~~~--- 220 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL---------IPKNNPPT--- 220 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH---------HhcCCCCC---
Confidence 22345788899999998888899999999999999999999998642111 00000 00000000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.....+..+.+++.+||+.+|.+||++.+++..
T Consensus 221 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ---------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001234467899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=241.02 Aligned_cols=216 Identities=17% Similarity=0.220 Sum_probs=163.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-CccchHHHHHHHHHHhhc-CCCChHHHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNI-CHRNLVRFIS------------- 136 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~------------- 136 (356)
++.+.+..||.|.-|.|++++...+|...|||.+... +.+..++++..++++..- +.|.||+.++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4566778899999999999999999999999999754 445567888888876654 4899998621
Q ss_pred ------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 137 ------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 137 ------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+...++.||.||.++. .|||||+||+|||+|+.|++||+|||.+-++...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---- 245 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---- 245 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc----
Confidence 3345889999998754 3999999999999999999999999999876543
Q ss_pred ccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......|-+.|||||.+.- ..|+.++||||||++++||.||+.||.....+..-+..... ..| +.+
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP--------P~L 315 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP--------PLL 315 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC--------CCC
Confidence 23344667889999998853 46889999999999999999999999864333211211111 111 111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... ......+.+++..||..|+.+||...++++.
T Consensus 316 ~~~--------------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGH--------------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Ccc--------------------cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 110 0123357899999999999999999998864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=249.70 Aligned_cols=215 Identities=18% Similarity=0.199 Sum_probs=165.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-----CccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-----CQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.+|.+.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.++++++|+||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999999999999999997532 12234578889999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 447789999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||..... ...... ....
T Consensus 159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~---------~~~~ 224 (264)
T cd06653 159 ICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFK---------IATQ 224 (264)
T ss_pred cccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHH---------HHcC
Confidence 2111 1112235678899999999988899999999999999999999999964211 111100 0000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... +......+.+++.+||. +|..||++.+++.
T Consensus 225 ~~~~~~------------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPML------------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCC------------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000000 01233467899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=262.97 Aligned_cols=225 Identities=22% Similarity=0.289 Sum_probs=180.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+...+.+.||+|.||.|.++.... +..||||+++..... ....|..|+++|.+++||||+++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456788999999999999999874 599999999865443 34789999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.||.||+.|++||.+.. +|||||.+.|+|+|.++++||+|||+++-+-...-
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y- 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY- 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-
Confidence 569999999999999998 99999999999999999999999999986543322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc--CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT--RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......+-...|||+|.+..+++++++|+|+||+++||+++ ...||..+.+++ ..+-....++..-.
T Consensus 693 -y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~------- 762 (807)
T KOG1094|consen 693 -YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGR------- 762 (807)
T ss_pred -eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCc-------
Confidence 233345666789999999999999999999999999999865 788987554332 22222222222111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
...+..++-|+..+.++++.||..+-.+||++++|...|++.
T Consensus 763 ----------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 ----------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112233347888899999999999999999999999988764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=254.10 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=167.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||.|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999999889999999997543 2233567789999999999999974
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 347789999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-- 257 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-- 257 (356)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..... ...+........
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 162 LARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 9976543221 11122345778999998865 3578899999999999999999999964221 111111111110
Q ss_pred -CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 258 -PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 258 -~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.....+.......... ................+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMK-----PKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred Chhhcccccccccccccc-----cccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000000000 0000000000000123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=255.51 Aligned_cols=238 Identities=24% Similarity=0.271 Sum_probs=164.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999998899999999864322 234568889999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+|+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 246789999999999998 999999999999985 5679999999997543221
Q ss_pred CCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh-
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV- 268 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (356)
.......++..|+|||++.+ ..++.++||||||+++|+|+||..||......+ .+...... .........+..
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~ 232 (294)
T PLN00009 158 ---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRI-LGTPNEETWPGVT 232 (294)
T ss_pred ---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCCChhhccccc
Confidence 11223456889999998866 357889999999999999999999996432211 11111100 000000000000
Q ss_pred hcccccc-ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKV-LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
-..+... ........... ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLAT----VVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHH----hCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00000000000 00122345789999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=245.08 Aligned_cols=209 Identities=22% Similarity=0.248 Sum_probs=166.2
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... ......+..|+.+++.++|+||+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4888999999999999999999899999999987542 2334567889999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 246778999999999999 999999999999999999999999999765432
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...... .+.....
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~--------------- 214 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQ--------------- 214 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh---------------
Confidence 112245678899999999888999999999999999999999999643211 1111100
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... .........+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 215 RGKYP---------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred cCCCC---------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 001134456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=245.02 Aligned_cols=212 Identities=21% Similarity=0.263 Sum_probs=167.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
+|.+.+.||+|++|.||++.+..++..+++|++........+.+.+|+.+++.++|+|++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999998889999999976655456788999999999999999876
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 347889999999999998 99999999999999999999999999876543221
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||...... ....... ........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~------------~~~~~~~~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIA------------TNGPPGLR 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHH------------hcCCCCcC
Confidence 23456788999999998888999999999999999999999998642110 0000000 00000000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||+.||.+|||+.++++
T Consensus 219 ----------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 ----------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----------------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00012346789999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=252.68 Aligned_cols=209 Identities=19% Similarity=0.233 Sum_probs=163.5
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
...||+|+||.||+|....++..||+|.+..........+.+|+.+++.++|+||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 4579999999999999998999999999865544455678899999999999999987
Q ss_pred --------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCcc
Q 039228 135 --------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200 (356)
Q Consensus 135 --------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 200 (356)
..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----~~~~~~~ 177 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRRKSLV 177 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----ccccccc
Confidence 347889999999999999 9999999999999999999999999987543221 1123356
Q ss_pred ccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccc
Q 039228 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTN 280 (356)
Q Consensus 201 gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 280 (356)
++..|++||.+.+..++.++|+||||+++|+|++|..||..... ...........+.... .
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~--------~--------- 238 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLK--------N--------- 238 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccC--------C---------
Confidence 78899999999888889999999999999999999999863211 1111111111111000 0
Q ss_pred cchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 281 SNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+++.+||+.+|.+||++.+|+.
T Consensus 239 -----------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 -----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -----------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0022335678999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=250.86 Aligned_cols=213 Identities=22% Similarity=0.291 Sum_probs=164.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcC---CCChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNIC---HRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l-------------- 134 (356)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ |||++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4788899999999999999999899999999987542 334567888999999987 9999976
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 457889999999999999 9999999999999999999999999997654322
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ......... ..+.+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~-----~~~~~~~ 224 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKS-----KPPRLED 224 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccC-----CCCCCCc
Confidence 12233467889999998865 44688999999999999999999999643211 100000000 0000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+ ..+..+.+++.+||+.||++||++.+++..
T Consensus 225 ~---------------------~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 N---------------------GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c---------------------cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 123457899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=251.45 Aligned_cols=216 Identities=20% Similarity=0.245 Sum_probs=169.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..+.|++...||.|++|.||+|.+..++..|++|.+..... ..+.+..|+.+++.++|+|++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 46679999999999999999999998889999999975544 45678899999999999999875
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 448889999999999998 99999999999999999999999999865432211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......++..|++||++.+..++.++|+||||+++|+|++|..||..... ...... +.......
T Consensus 172 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~~~~~~---------~~~~~~~~ 235 (286)
T cd06614 172 ---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----LRALFL---------ITTKGIPP 235 (286)
T ss_pred ---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---------HHhcCCCC
Confidence 11234467889999999888899999999999999999999999863211 111000 00000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. .....++..+.+++.+||+.+|.+||++.+|+..
T Consensus 236 ~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 L-----------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C-----------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0001234567899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=252.70 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=170.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHh--hcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALK--NICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l-------------- 134 (356)
.....+.++||+|.||.||+|... ++.||||+++. ...+.|.+|-+|.+ .++|+||++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 456778889999999999999987 69999999973 34567888877766 5789999998
Q ss_pred --------------------------HHHHHHHHHHHHHHhhc------CCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHH------CQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
.+++..+++||+|||+. .+++|+|||||+.|||+.+++++.|+|||+|
T Consensus 284 wLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 34788899999999974 2456999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCC-CC-----CccchHhHHHHHHHHHcCCCCCCccccC--CccHHHHHH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE-VS-----TNGDAYNYGILLLEMVTRRKPIDFMFEG--DLNLHNFAR 254 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~~ 254 (356)
..+...... .....-+||..|||||++.+.. +. .+.||||+|.++|||++.-.-+...... ...+..-+.
T Consensus 364 l~~~p~~~~--~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 364 LRLEPGKPQ--GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred EEecCCCCC--cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 988644332 2333478999999999997642 11 3579999999999999864433210000 111111111
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
....+.++.+-.+.... ++.....|... ..+..|.+.+..||..||+.|-|+.=+.+.+.++...-
T Consensus 442 --~hPt~e~mq~~VV~kK~--RP~~p~~W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 --NHPTLEEMQELVVRKKQ--RPKIPDAWRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred --CCCCHHHHHHHHHhhcc--CCCChhhhhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11222222221111110 11111112222 34556889999999999999999999999888876544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=248.86 Aligned_cols=234 Identities=24% Similarity=0.245 Sum_probs=163.8
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhc---CCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNI---CHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l-------------- 134 (356)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++++ +|||++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999998889999999974322 2234566788777665 59998876
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 347789999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CCchHHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PNRVMDI 264 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 264 (356)
.... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||...... ..+........ +......
T Consensus 158 ~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred cCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence 3321 112234688899999999989999999999999999999999998743221 11111111111 1000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........ ....................+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRS------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchh------hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 00000000001111234456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=245.99 Aligned_cols=164 Identities=25% Similarity=0.324 Sum_probs=143.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
-++|..+++||+|.||.|.+++.+.+++.+|+|++++.-- .....-+.|-++|+..+||.+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4679999999999999999999999999999999986532 333456779999999999999877
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..+-.+|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++..-..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-- 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-- 321 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc--
Confidence 225568999999999998 999999999999999999999999999853222
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
......++||+.|+|||++....|+.++|.|.+||++|||++|+.||..
T Consensus 322 --g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 322 --GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred --cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 2345569999999999999999999999999999999999999999974
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=266.84 Aligned_cols=241 Identities=20% Similarity=0.216 Sum_probs=173.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
+...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|+|||++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 556678999999999999999999999999997543 3456778899999999999999998
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--CCC--ceEEcccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD--NDL--FAHIGDFELA 182 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~Dfg~a 182 (356)
+.++.++..||.|||+++ ||||||||.||++. .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 558889999999999999 99999999999994 323 5699999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC---C
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF---P 258 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---~ 258 (356)
+.+++.. ....++||..|.+||... ...|+..+|.|||||++|++.||..||-..... .+..+...... +
T Consensus 172 rel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p-k~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 172 RELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP-KNNKEIMWHIITKKP 245 (732)
T ss_pred ccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc-cccchhhhhhhccCC
Confidence 9776533 456689999999999998 488999999999999999999999999643222 11111111111 1
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC--ChHHHHHHHHHhhh
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM--NVPNAVHDLQSVNN 329 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~~vl~~L~~i~~ 329 (356)
....-..++...+... +...+.- .-...+.....+-..+..++..+|.+|. ...+....+..|..
T Consensus 246 ~~v~i~~~~~eNgpv~----~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVE----WSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCcee----eeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111111111111100 0000000 0011112333455667777888999999 88888888887764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=250.15 Aligned_cols=234 Identities=15% Similarity=0.171 Sum_probs=155.2
Q ss_pred CceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH---------------------------
Q 039228 84 SFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF--------------------------- 134 (356)
Q Consensus 84 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l--------------------------- 134 (356)
++|.||.++...+++.||||++... .....+.+..|+.+++.++|+||+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666667899999998754 33455688999999999999999997
Q ss_pred ------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC---CccCCCCc
Q 039228 135 ------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP---TQSSSNGV 199 (356)
Q Consensus 135 ------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~ 199 (356)
..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+......... ........
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 337789999999999999 999999999999999999999999998754322110 11122334
Q ss_pred cccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH----HHhhhhhcccc
Q 039228 200 RRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM----DIVNLVLLNDN 273 (356)
Q Consensus 200 ~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~~ 273 (356)
.++..|+|||++.. ..++.++|+|||||++|||++|..||....... ...+......+..+. ......+....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCCcCccc
Confidence 56778999999876 357899999999999999999999997532211 111111111110000 00000000000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. ......................+.+++.+||+.||++|||++++++.
T Consensus 248 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 248 S--SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred c--cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00000000000011112334567899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=243.96 Aligned_cols=212 Identities=20% Similarity=0.319 Sum_probs=167.9
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|.+.+.||.|+||.||++.+..++..||+|.+..... ...+.+..|+++++.++|||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 48888999999999999999998899999999875433 455678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 347789999999999998 9999999999999999999999999997654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......+++.|+|||...+..++.++|+||+|+++|+|++|..||.... ............ .
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~ 220 (258)
T cd08215 158 ----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ--------Y 220 (258)
T ss_pred ----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC--------C
Confidence 12233567889999999988889999999999999999999999986422 111111110000 0
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. .. +......+.+++.+||..+|++|||+.++++.
T Consensus 221 ~-~~------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 P-PI------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C-CC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 00223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=253.63 Aligned_cols=212 Identities=25% Similarity=0.319 Sum_probs=163.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
+.|...+.||.|+||.||+|++..++..||+|.+... .......+.+|+.+++.++|+|++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477788999999999999999988999999998643 22334567889999999999999886
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 346788999999999998 99999999999999999999999999875432
Q ss_pred CccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||....... ..........+ .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~ 233 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------A 233 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC---------C
Confidence 12345788999999974 3567889999999999999999999986421110 00001000000 0
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.. .......+.+++.+||+.+|++||++.+|+..--
T Consensus 234 ~~---------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 LQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cC---------------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 0123345789999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=256.66 Aligned_cols=249 Identities=16% Similarity=0.204 Sum_probs=161.7
Q ss_pred ccceec--CceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVG--SFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
..||+| +||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999999899999999987542 2234678889999999999999975
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC--
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT-- 192 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-- 192 (356)
..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 247889999999999999 9999999999999999999999998654322111100
Q ss_pred -ccCCCCccccccccchhhhcCC--CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--------CCch
Q 039228 193 -QSSSNGVRRTIGYTALDYDLGS--EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--------PNRV 261 (356)
Q Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--------~~~~ 261 (356)
........++..|+|||++.+. .++.++|||||||++|+|++|..||.................+ +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0111122345679999998763 4789999999999999999999999754321111000000000 0000
Q ss_pred HHHhhhh------hccccccccccccchh-hhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH--HHHHhhhh
Q 039228 262 MDIVNLV------LLNDNKVLAGTNSNML-RKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH--DLQSVNNI 330 (356)
Q Consensus 262 ~~~~~~~------l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~--~L~~i~~~ 330 (356)
..+.+.. +...... ......+. ..........+...+.+|+.+||+.||++|||+.++++ .+..+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVA-AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhc-cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 0000000 0000000 00000000 00011112346667899999999999999999999974 34444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=245.05 Aligned_cols=234 Identities=23% Similarity=0.247 Sum_probs=166.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
|+..+.||+|++|.||+|....+++.||+|.+.... ....+.+..|+.+++.++|+|++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999999989999999997653 3345678889999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 153 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---- 153 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc----
Confidence 347788999999999999 99999999999999999999999999976543221
Q ss_pred CCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHHHhhhh--h
Q 039228 195 SSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMDIVNLV--L 269 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--l 269 (356)
......++..|+|||.+.+. .++.++||||||+++|||++|..||...... ..+.......... ......... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223456789999998766 7889999999999999999999998643211 1111111111000 000000000 0
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... .......... .......+.+++.+||..||++||++.+|+.
T Consensus 233 ~~~~~---~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFP---KFPPKDLEKV----LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccc---ccCccchHHh----cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0000000001 1122456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=244.90 Aligned_cols=215 Identities=21% Similarity=0.264 Sum_probs=169.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|.+.+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999998899999999875542 445778899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 447889999999999998 999999999999999999999999999866443211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......++..|++||.+.+...+.++||||||+++|+|++|..||.... ........ +.......
T Consensus 158 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~--------~~~~~~~~ 223 (260)
T cd06606 158 --EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYK--------IGSSGEPP 223 (260)
T ss_pred --ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHh--------ccccCCCc
Confidence 11234567889999999988889999999999999999999999997533 11111000 00000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ........+.+++.+|++.+|++||++.+++.
T Consensus 224 ~------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 E------------------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred C------------------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 01123456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=251.82 Aligned_cols=208 Identities=25% Similarity=0.308 Sum_probs=160.5
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
|...+.||+|+||.||+|++..++..|++|.+..... .....+..|+.+++.++|||++++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 6667789999999999999998999999999874322 233567889999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 347789999999999999 9999999999999999999999999985321
Q ss_pred cCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 194 SSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......++..|+|||++. ...++.++||||||+++|+|++|..||....... ..........+. ..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~---------~~ 241 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSPT---------LQ 241 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC---------CC
Confidence 122356788999999974 4568889999999999999999999986432110 000000000000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ---------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ---------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00122357789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=245.57 Aligned_cols=212 Identities=19% Similarity=0.230 Sum_probs=160.9
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||.|+||.||+|++..+++.|++|.+..... ...+.+.+|+.++++++||||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999865433 345678899999999999999987
Q ss_pred ---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC----CccC
Q 039228 135 ---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP----TQSS 195 (356)
Q Consensus 135 ---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----~~~~ 195 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 347889999999999999 999999999999999999999999998754322110 0112
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....++..|++||.......+.++|+||||+++|++++|..||..... ..... .........
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~------------~~~~~~~~~ 220 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQ------------NILNGKIEW 220 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------------HHhcCCcCC
Confidence 2335577889999999888889999999999999999999999964321 11111 000000000
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
+ ........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 221 -------------~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -------------P-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------------C-ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 00011346789999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=262.12 Aligned_cols=212 Identities=21% Similarity=0.238 Sum_probs=170.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc--chHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--ASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
....|.+...||+|.|+.|.+|++..++..||||++.+..-. ....+.+|+++|..++|||||++
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 457799999999999999999999999999999999765433 23458899999999999999998
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
-.++.|++.|++|||.++ |||||||++||||+.+.++||+|||++.++...
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc--
Confidence 237889999999999999 999999999999999999999999999987643
Q ss_pred CCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-. . +-+..+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----~------------Lr~rvl 268 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----E------------LRPRVL 268 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----c------------ccchhe
Confidence 33445889999999999998876 58899999999999999999999843211 1 111111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+.+. ++.-....+.+++.+.+-.+|.+|++++++.+
T Consensus 269 ~gk~r----------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKYR----------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeec----------------ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111 01112224568899999999999999998865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=253.67 Aligned_cols=244 Identities=18% Similarity=0.179 Sum_probs=164.2
Q ss_pred cCCCC-ccccceecCceEEEEEEECCCCeEEEEEEeeccCccc--------------hHHHHHHHHHHhhcCCCChHHH-
Q 039228 71 TDGFP-LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--------------SKSFMAECKALKNICHRNLVRF- 134 (356)
Q Consensus 71 ~~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l- 134 (356)
.++|. +.+.||.|+||.||+|.+..+++.||||.+....... ...+.+|+.+++.++|+||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4577999999999999999889999999986432211 1257789999999999999886
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 447889999999999999 999999999999999999999999
Q ss_pred ccccccccCCC----------CCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCcc
Q 039228 180 ELARFRQEVSN----------PTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248 (356)
Q Consensus 180 g~a~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~ 248 (356)
|++........ ..........++..|+|||++.+. .++.++|+|||||++|+|++|..||......+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~ 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-Q 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 99976541110 001112233467889999998764 46889999999999999999999997432211 1
Q ss_pred HHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 249 LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+..............+-...............+ .............+.+++.+||+.+|++||++.+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP----KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCc----ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111000000000000000000000000000 0000001123456789999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=242.51 Aligned_cols=211 Identities=26% Similarity=0.302 Sum_probs=167.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|++++++++|||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47889999999999999999998889999999975543 345678999999999999999876
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 457889999999999999 99999999999999999999999999986643321
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
......++..|+|||...+..++.++|+||+|+++|+|++|..||.... ......... .... ...
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~---------~~~~-~~~ 219 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIV---------QDDH-PPL 219 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh---------ccCC-CCC
Confidence 1233567889999999988888999999999999999999999986322 111111000 0000 000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+++.+||..+|++|||+.+++.
T Consensus 220 ------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ------------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0123346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=256.13 Aligned_cols=211 Identities=21% Similarity=0.231 Sum_probs=165.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
-+.|..-++||+||||.||-+....||+.+|.|.+.+.. .......++|-.+|.+++.+.||.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888999999999999999999999999999986432 2233456789999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.+|+.||.+||+.+ ||+|||||+|||+|+.|+++|+|+|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 558899999999999999 999999999999999999999999999876543
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. .....+||.+|||||++.++.|+...|.|||||++|||+.|+.||....+.. . .+-+|..
T Consensus 341 ~-----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k-------------~eEvdrr 401 (591)
T KOG0986|consen 341 K-----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-K-------------REEVDRR 401 (591)
T ss_pred C-----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-h-------------HHHHHHH
Confidence 3 2233589999999999999999999999999999999999999996432211 0 0112222
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
...+... -+....++..++....|..||.+|-...
T Consensus 402 ~~~~~~e---------------y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEE---------------YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred Hhcchhh---------------cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2211110 0013334567788888999999997543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=243.69 Aligned_cols=237 Identities=22% Similarity=0.221 Sum_probs=162.7
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcC-CCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNIC-HRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l----------------- 134 (356)
|++.+.||+|+||.||+|....+++.|+||.+...... ......+|+..+++++ |+||+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67788999999999999999888899999998654322 2234567999999999 9999988
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 336778999999999999 9999999999999999999999999997553321
Q ss_pred cCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh-hcc
Q 039228 194 SSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV-LLN 271 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~ 271 (356)
......++..|+|||++.+ ..++.++|+||||+++++|++|++||......+ .........-+.....+.+.. +..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1223457888999998754 457899999999999999999999986432211 111111100000000000000 000
Q ss_pred ccc-cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNK-VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .............. ......+.+++.+||+.+|++|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLI----PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHc----ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000 00000000000000 0113467899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-34 Score=243.89 Aligned_cols=219 Identities=22% Similarity=0.262 Sum_probs=161.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHh-hcCCCChHHHHHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALK-NICHRNLVRFISIA----------- 138 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~i~----------- 138 (356)
++.+-+..||.|+||+|++-.++.+|+..|||.+..... ...++++.|.+... .-+.||||++++.+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 445567789999999999999999999999999976544 45678889988654 45689999994421
Q ss_pred ------------------------------HHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 139 ------------------------------IDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 139 ------------------------------~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
.-.+.||.||-..- .|||||+||+|||++..|.+||+|||.+..+...
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 12568999998743 4999999999999999999999999999765432
Q ss_pred CCCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
...+.-.|-..|||||.+.. ..|+.+||+||||++|||+.||..|+.....- + +-+-
T Consensus 222 -----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---f-------------eql~ 280 (361)
T KOG1006|consen 222 -----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---F-------------EQLC 280 (361)
T ss_pred -----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---H-------------HHHH
Confidence 22334567788999998863 35899999999999999999999998743221 1 1111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....++++. ++. .....+....+..++..|+-.|-.+||...++.++
T Consensus 281 ~Vv~gdpp~-------l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVIGDPPI-------LLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHcCCCCe-------ecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111110 000 00112345578899999999999999999998764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=247.38 Aligned_cols=206 Identities=21% Similarity=0.235 Sum_probs=150.8
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHH---hhcCCCChHHH------------------
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKAL---KNICHRNLVRF------------------ 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l------------------ 134 (356)
.||+|+||.||++.+..+++.||+|.+..... .....+..|..++ ...+||||+.+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999998899999999864322 1122334444433 34478998764
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~------~ 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK------K 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc------C
Confidence 457889999999999999 999999999999999999999999998644321 1
Q ss_pred CCCccccccccchhhhc-CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 196 SNGVRRTIGYTALDYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
.....|+..|+|||.+. +..++.++|+|||||++|+|++|..||........ ......... ....+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~------~~~~~----- 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------VNVEL----- 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc------CCcCC-----
Confidence 12346789999999986 45688999999999999999999999974332211 111110000 00000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
+......+.+++.+||+.||.+|| +++++++.
T Consensus 219 -----------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -----------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 012344678999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=243.67 Aligned_cols=206 Identities=21% Similarity=0.218 Sum_probs=159.2
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||.|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999999889999999987542 2334678899999999999999987
Q ss_pred ---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCc
Q 039228 135 ---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199 (356)
Q Consensus 135 ---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 199 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~~~ 152 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWTF 152 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----ccccc
Confidence 347789999999999998 9999999999999999999999999997654321 12234
Q ss_pred cccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccccc
Q 039228 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGT 279 (356)
Q Consensus 200 ~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 279 (356)
.++..|++||.+.+..++.++|+||||+++|+|++|..||.....+. ...... +.........
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~~~~~~~~~~------ 215 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND--------ILKGNGKLEF------ 215 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------HhccCCCCCC------
Confidence 57888999999988889999999999999999999999997543211 111110 0100000000
Q ss_pred ccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 280 NSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
+......+.+++.+||+.+|++||+ +.++++
T Consensus 216 ------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 ------------PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ------------CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0122446789999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=245.22 Aligned_cols=215 Identities=25% Similarity=0.310 Sum_probs=167.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcC-CCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNIC-HRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l------------- 134 (356)
++|.+.+.||+|+||.||+|....+++.||+|++.... ......+..|+.++++++ ||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46899999999999999999999899999999986532 233456788999999999 9999988
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 447889999999999999 99999999999999999999999999986543221
Q ss_pred CC----------------ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 039228 191 PT----------------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 191 ~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 254 (356)
.. ........++..|+|||......++.++|+||||++++++++|..||..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~-- 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTF-- 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHH--
Confidence 10 1223345678899999999888899999999999999999999999974321 1000
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh----HHHHH
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV----PNAVH 322 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~~vl~ 322 (356)
..+..... .. .......+.+++.+||+.+|.+||++ .+++.
T Consensus 232 -------~~~~~~~~--~~------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -------QKILKLEY--SF------------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------HHHHhcCC--CC------------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000000 00 00223457899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-34 Score=250.05 Aligned_cols=212 Identities=21% Similarity=0.293 Sum_probs=171.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHH-----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI----------------- 135 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~----------------- 135 (356)
-|.++++||+|+||.||+|.++.+|+.+|||.+... .+.++++.|+.+|++.+.|++|+++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 377889999999999999999999999999998754 3468899999999999999999983
Q ss_pred ---------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 136 ---------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 136 ---------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
.++.+.+.||+|||... -||||||..|||++.+|..||+|||.|..+.. +..
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD----TMA 184 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD----TMA 184 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh----hHH
Confidence 26778899999999887 89999999999999999999999999976543 234
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
..+.+.||+.|||||++..-.|+.++||||||++..||..|++||...-.-. .. ..+|.+. .+.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----AI--FMIPT~P--------PPT-- 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----AI--FMIPTKP--------PPT-- 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----ee--EeccCCC--------CCC--
Confidence 4567899999999999999999999999999999999999999996422110 00 0011100 000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...++.-...+-+++..||-.+|++|-|+.++++.
T Consensus 249 --------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 --------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 01122344467789999999999999999998864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=245.49 Aligned_cols=203 Identities=23% Similarity=0.232 Sum_probs=154.2
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||+|+||+||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999899999999986432 2233456789999999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~~ 152 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----KKIK 152 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC-----Cccc
Confidence 346789999999999999 999999999999999999999999998765321 1122
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...++..|++||++.+..++.++||||||+++|+|++|+.||....... ............ ....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----------~~~~---- 217 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEM----------AVEY---- 217 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccccc----------cccC----
Confidence 3456788999999988889999999999999999999999996432211 111111100000 0000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPN 319 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 319 (356)
.......+.+++.+||+.||.+||++.+
T Consensus 218 --------------~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 218 --------------PDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --------------CccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0022335689999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=259.69 Aligned_cols=158 Identities=27% Similarity=0.383 Sum_probs=139.1
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------------- 134 (356)
.++||+|.||+||-|.++.+|+.||||++.+.. ......+.+|+.+|+++.||.||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 358999999999999999999999999997543 3445678999999999999999986
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC---CceEEcccccccccccCCCCCc
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND---LFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||+|+++++.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----- 720 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----- 720 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh-----
Confidence 236779999999999999 9999999999999643 36899999999987653
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.....++||+.|+|||++.+..|...-|+||.||++|.-++|..||++.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 3445689999999999999999999999999999999999999999753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=259.54 Aligned_cols=220 Identities=22% Similarity=0.353 Sum_probs=176.8
Q ss_pred CCccccceecCceEEEEEEECCC----CeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.+..++||+|+||+||+|.+-.. +.+||+|++... ......+++.|+-+|.+++|||++++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 45567899999999999998543 357899998643 34456789999999999999999998
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.|+.||++|+.|||.+. +|||||...|||+.....+||.|||+++.+......
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 458899999999999998 999999999999999999999999999987654432
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.. .....-.+-|||-|.+....|+.++|||||||++||++| |..|+++...++ +.+++....
T Consensus 855 y~--~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------I~dlle~ge- 917 (1177)
T KOG1025|consen 855 YS--APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------IPDLLEKGE- 917 (1177)
T ss_pred cc--ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------hhHHHhccc-
Confidence 21 122233567999999999999999999999999999999 999987654322 112221111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
....++.|...+.-++.+||..|++.||+++++...+.+....
T Consensus 918 -----------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 -----------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1223447888999999999999999999999999998887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=237.02 Aligned_cols=169 Identities=27% Similarity=0.353 Sum_probs=142.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeec--cCccchHHHHHHHHHHhhcCCCChHHHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI--QCQGASKSFMAECKALKNICHRNLVRFIS------------ 136 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~------------ 136 (356)
.+.|.-..+||+|.||.||+|+.+.+++.||+|++-. +........++|+++|..|+|+|++.++.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3457778899999999999999999999999987632 23344456789999999999999998733
Q ss_pred ---------------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 137 ---------------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 137 ---------------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+..++..||.|+|... |+|||+||.|+||+.+|.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 4556899999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.+....+.........+-|+.|.+||.+.+. .|+++.|||.-||++.||+||.+-+.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 7766555444445556679999999998874 6899999999999999999999988653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=242.64 Aligned_cols=220 Identities=20% Similarity=0.183 Sum_probs=164.0
Q ss_pred CCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC----ccchHHHHHHHHHHhhc-CCCChHHH----------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC----QGASKSFMAECKALKNI-CHRNLVRF---------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l---------- 134 (356)
+|++.+.||+|+||.||++... .++..||||.+.... ....+.+..|+.++.++ +||||+++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 356889999986432 22345678899999999 59999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 336779999999999998 99999999999999999999999999876533
Q ss_pred CCCCCccCCCCccccccccchhhhcCCC--CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSE--VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. ........++..|++||...+.. .+.++|+||||+++|+|++|..||...... ..........
T Consensus 158 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~--------- 224 (288)
T cd05583 158 EE---EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRI--------- 224 (288)
T ss_pred cc---ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHH---------
Confidence 21 11122345788999999987655 778999999999999999999998632111 1111111110
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
...... ........+.+++.+||+.||++|||+.++.+.|+..
T Consensus 225 ---~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 ---LKSKPP----------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---HccCCC----------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000000 0012334578899999999999999999888877553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=236.86 Aligned_cols=210 Identities=20% Similarity=0.197 Sum_probs=159.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
+|.+.+.||+|+||.||++.+..++..+++|+++... ......+..|+.+++.++||||+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888999999999999999998776777777765321 2233456789999999999999987
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 236678999999999999 999999999999985 569999999987653
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......++..|+|||...+..++.++|+||||+++|+|++|..||.... .........
T Consensus 157 ~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~--------- 218 (260)
T cd08222 157 GSC----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV--------- 218 (260)
T ss_pred CCc----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH---------
Confidence 321 12223557888999999988888999999999999999999999986321 111111100
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... .........+.+++.+||..+|++||++.++++
T Consensus 219 ---~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 ---EGPTP---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---cCCCC---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000 001134456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=239.93 Aligned_cols=211 Identities=18% Similarity=0.174 Sum_probs=157.2
Q ss_pred HHhhcCCCCccccc--eecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh-cCCCChHHH---------
Q 039228 67 LLKATDGFPLINLI--GVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN-ICHRNLVRF--------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l--------- 134 (356)
.....++|.+.+.+ |+|+||.||++....++..+|+|.+........ |+..... .+||||+++
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677777776 999999999999999999999999874422211 2222221 269999876
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFR 185 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 185 (356)
..++.|++.||.|||+.+ ++||||+|+||+++.++ .++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 458899999999999999 99999999999999888 9999999998754
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
... ....++..|+|||++.+..++.++||||||+++|+|++|..||............+.... ..
T Consensus 161 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------ 225 (267)
T PHA03390 161 GTP--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------ 225 (267)
T ss_pred CCC--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------
Confidence 321 124578899999999988899999999999999999999999974433322222221111 00
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-hHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-VPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~vl~ 322 (356)
.. . ........+.+++.+||+.+|.+||+ ++++++
T Consensus 226 --~~----~----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 --KL----P----------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --cC----C----------------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0 00123345789999999999999996 688874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=240.01 Aligned_cols=207 Identities=19% Similarity=0.155 Sum_probs=153.5
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHHHH-HhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAECKA-LKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l------------------- 134 (356)
+.||.|+||.||+|....+++.||+|.+...... ....+..|..+ ....+|+|++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999888999999998644221 12234455444 445689999987
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--------~ 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--------N 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc--------c
Confidence 347889999999999998 99999999999999999999999999874322 2
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....++..|++||.+.+..++.++||||||+++|+|++|..||..... ....... ...... ..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~--------~~~~~~-~~--- 213 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNI--------LSRRIN-WP--- 213 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------HhcccC-CC---
Confidence 234578889999999888889999999999999999999999964221 1111000 000000 00
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
......+...+.+++.+||+.+|++||++.++.+.|
T Consensus 214 ------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 214 ------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000012345678999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=240.39 Aligned_cols=205 Identities=19% Similarity=0.207 Sum_probs=150.8
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHH---HHHhhcCCCChHHH------------------
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAEC---KALKNICHRNLVRF------------------ 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~h~niv~l------------------ 134 (356)
.||+|+||.||+|.+..+++.||+|.+...... ....+..|. ..++...||||+++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999988999999998654221 112233443 34455679999865
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~------~ 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK------K 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc------C
Confidence 447889999999999999 999999999999999999999999998754321 1
Q ss_pred CCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 196 SNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
.....|+..|+|||++.++ .++.++||||+|+++|+|++|+.||........ ......... ....+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~------~~~~~~---- 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------MAVELP---- 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc------cCCCCC----
Confidence 1234678999999998754 688999999999999999999999975322111 110000000 000000
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
......+.+++.+|+..+|.+|| ++.++++
T Consensus 220 ------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 ------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01234678999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=217.10 Aligned_cols=239 Identities=21% Similarity=0.223 Sum_probs=166.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.|...++||+|.||+||+|+...+++.||+|.+.... .......++|+-+|+.++|.|||++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999999999999999987543 3345678999999999999999998
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|+++||.|+|+++ +.|||+||.|.||+.+|++||+|||+++.++...
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv---- 155 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---- 155 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence 236678999999999999 9999999999999999999999999998765322
Q ss_pred cCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......+-|..|.+|.++.+.+ |++..|+||-||++.|+.. |++.|.+.. -+..+....+..-...-.++-.-.-.+
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCCccccCC
Confidence 2333456699999999998755 8889999999999999988 566565432 222333333332211111111111111
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
++..-+.. +. .-.|.+..+.....=.+++.+.+.-+|..|.+++..++
T Consensus 235 dyk~yp~y-pa--ttswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIY-PA--TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCc-cc--cchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11100000 00 00011111222223346777777889999999988765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=240.90 Aligned_cols=215 Identities=22% Similarity=0.249 Sum_probs=158.4
Q ss_pred CCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC----ccchHHHHHHHHHHhhc-CCCChHHH----------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC----QGASKSFMAECKALKNI-CHRNLVRF---------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l---------- 134 (356)
+|++.+.||.|+||.||.|... .++..||+|++.... ....+.+..|+.++.++ +|+||+++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999874 367899999987432 22345678899999999 58999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 235668999999999999 99999999999999999999999999976533
Q ss_pred CCCCCccCCCCccccccccchhhhcCC--CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGS--EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ........
T Consensus 158 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~----------- 222 (290)
T cd05613 158 DE---VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISR----------- 222 (290)
T ss_pred cc---ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHH-----------
Confidence 21 1122235678899999998753 4678899999999999999999998632111 11111111
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
..+..... .+......+.+++.+||+.||++|| ++.+++.
T Consensus 223 -~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 223 -RILKSEPP----------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -HhhccCCC----------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11110000 0002233568999999999999998 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=254.94 Aligned_cols=206 Identities=21% Similarity=0.191 Sum_probs=163.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh-cCCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN-ICHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l-------------- 134 (356)
.++.|.+...+|.|+|+.|-.+.+..+++..++|++..... ...+|+.++.. -+||||+++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 36778999999999999999999999999999999975522 22346655444 469999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe-CCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL-DNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..|+.+|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 248899999999999999 9999999999999 69999999999999865433
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
....+-|..|.|||++....|+.++|+||||++||+|++|+.||.....+ ..+.. ....+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---RIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---hhcCCccc---------
Confidence 22345588899999999999999999999999999999999999754433 11111 11111111
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........+|+.+||+.||.+||+|.++...
T Consensus 533 ---------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ---------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---------------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1333456799999999999999999998753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=234.65 Aligned_cols=215 Identities=18% Similarity=0.160 Sum_probs=163.6
Q ss_pred hcCCCCcc-ccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 70 ATDGFPLI-NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
.+++|.+. ++||-|-.|.|-.+..+.|++.+|+|++.. .....+|+++.-.. .|||||.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46778764 579999999999999999999999999752 24566788876665 49999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFEL 181 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~ 181 (356)
-.|..||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 348889999999999999 99999999999996 456799999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCch
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV 261 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
|+..... ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-..-. ..+..-.+..+
T Consensus 211 AK~t~~~-----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI---- 279 (400)
T KOG0604|consen 211 AKETQEP-----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRI---- 279 (400)
T ss_pred ccccCCC-----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHh----
Confidence 9865432 223346679999999999999999999999999999999999999964322 11111111000
Q ss_pred HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 262 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..+.+. +-+++| .+..+...++|...|+.+|.+|.|+.+++.
T Consensus 280 -------~~gqy~--------FP~pEW----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 280 -------RTGQYE--------FPEPEW----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -------hccCcc--------CCChhH----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 001100 111111 155566788999999999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=229.83 Aligned_cols=200 Identities=25% Similarity=0.233 Sum_probs=156.7
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
||.|+||.||++....+++.+|+|.+..... .....+..|+.+++.++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999988889999999875432 234578899999999999999997
Q ss_pred ---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCc
Q 039228 135 ---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199 (356)
Q Consensus 135 ---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 199 (356)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~ 153 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----SRTNTF 153 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----CcccCC
Confidence 347788999999999998 9999999999999999999999999997653321 122345
Q ss_pred cccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccccc
Q 039228 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGT 279 (356)
Q Consensus 200 ~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 279 (356)
.++..|++||...+...+.++|+||||+++|++++|..||..... ....... ....+ ..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~--------~~~~~--~~------ 212 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKI--------LKDPL--RF------ 212 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH--------hcCCC--CC------
Confidence 678899999999888889999999999999999999999964221 1111110 00000 00
Q ss_pred ccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHH
Q 039228 280 NSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPN 319 (356)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 319 (356)
+......+.+++.+||..||++||++.+
T Consensus 213 ------------~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 ------------PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------------CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0022346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=263.75 Aligned_cols=170 Identities=24% Similarity=0.289 Sum_probs=147.5
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeec---cCccchHHHHHHHHHHhhcCCCChHHH-------
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI---QCQGASKSFMAECKALKNICHRNLVRF------- 134 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l------- 134 (356)
.++....++|.++++||+|+||.|.+++.+.+++.||+|++++ .......-|..|-.+|..-+.+-|+.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4555667899999999999999999999999999999999986 234445678889999998888888877
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.+|+.||.-||+.| +|||||||+|||||..|++||+|||.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHh
Confidence 236778999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhc----C-CCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDL----G-SEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
+...+ .......+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||.
T Consensus 225 m~~dG---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 225 MDADG---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cCCCC---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 76544 34455688999999999985 3 568999999999999999999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=255.86 Aligned_cols=233 Identities=19% Similarity=0.127 Sum_probs=143.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCC----CeEEEEEEeeccCccch---HHHHHH-----H-----------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQCQGAS---KSFMAE-----C----------------- 120 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~---~~~~~E-----~----------------- 120 (356)
..++|.+.+.||+|+||.||+|++..+ +..||+|.+........ ..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 567899999999999999999999988 89999998753221110 000000 0
Q ss_pred --------------HHHhhcCCCChH--------------------HHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCe
Q 039228 121 --------------KALKNICHRNLV--------------------RFISIAIDVASALDYLHHHCQELILHCDPKPSNV 166 (356)
Q Consensus 121 --------------~~l~~l~h~niv--------------------~l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NI 166 (356)
..+..-.++..+ .+..++.|++.||.|||+.+ |+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence 000000011000 01357889999999999999 99999999999
Q ss_pred EeCC-CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCC----------------------CCCCccchH
Q 039228 167 LLDN-DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS----------------------EVSTNGDAY 223 (356)
Q Consensus 167 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDiw 223 (356)
|++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9985 68999999999986543221 223346788999999965432 233456999
Q ss_pred hHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHH
Q 039228 224 NYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVR 301 (356)
Q Consensus 224 SlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 301 (356)
||||++|||+++..|++. ....+..... ......+.... ..... ...... ............+
T Consensus 364 SlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~-~~~~~------~~~~~~--~~~~d~~~~~~~d 428 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLV-EPRAS------PDLRRG--FEVLDLDGGAGWE 428 (566)
T ss_pred HHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhh-ccccc------hhhhhh--hhhccccchHHHH
Confidence 999999999997776532 1111111110 00111110000 00000 000000 0000001123458
Q ss_pred HHHhhcCCCcCCCCChHHHHHH
Q 039228 302 IGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 302 l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
|+.+||+.||.+|||+.++++.
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999873
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=261.99 Aligned_cols=110 Identities=33% Similarity=0.470 Sum_probs=98.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||+++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999987432 2233578889999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+.++.||+.||.|||..+ ||||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 457889999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=243.69 Aligned_cols=164 Identities=25% Similarity=0.309 Sum_probs=143.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHHHH----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRFIS---------- 136 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~---------- 136 (356)
...+++++..||-||||.|-++..+.....+|+|++++. .....+.+..|-.+|...+.|.||+++.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 445788888999999999999998876666899988643 4555677899999999999999999833
Q ss_pred ---------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 137 ---------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
++..++.|++|||.++ ||+|||||+|+++|.+|.+||.|||+|+.+....
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 4455889999999999 9999999999999999999999999999876543
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
..-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||..
T Consensus 575 -----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 575 -----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred -----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 23358999999999999999999999999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.85 Aligned_cols=241 Identities=19% Similarity=0.244 Sum_probs=171.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRFIS------------ 136 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~------------ 136 (356)
..++|++.+.+|+|.+++||.|....+++.++||+++.. ..+.+.+|+.+|+.|. ||||+++++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999999888999999999733 3567889999999998 999999833
Q ss_pred ------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCCCC
Q 039228 137 ------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 137 ------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
++.+++.||.|+|+.| |+|||+||.|++||. .-.++|+|+|+|.+......
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 5668999999999999 999999999999994 56799999999987654332
Q ss_pred CccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh--
Q 039228 192 TQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV-- 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 268 (356)
-+..+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||....++...+...+.-.-.+.+...+...
T Consensus 189 ----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 189 ----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 223445677889998865 5578889999999999999999999965444444444444333333333322211
Q ss_pred -hcccccccc--ccccchhhhhchhhHHH-HHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 -LLNDNKVLA--GTNSNMLRKTKMNSRLE-CLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 -l~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.+.+...- ..-..|. .......+. ...+.++++.+.|..|-.+|+|+.|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~-~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWS-RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHH-HhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111110000 0000000 000001111 1235678999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=234.21 Aligned_cols=165 Identities=25% Similarity=0.301 Sum_probs=138.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcC-CCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNIC-HRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l------------ 134 (356)
..+|..+.+||+|+||.|.+|..+.+.+.+|||++++.- ..+.+--..|-++|.-.. -|.++++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 456999999999999999999999999999999997542 222333445666666553 5677766
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.+|+.||-+||++| ||+||||.+|||+|.+|++||+|||+++.--.
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-- 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-- 502 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc--
Confidence 347788999999999999 99999999999999999999999999974221
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.......++||+.|+|||++...+|+..+|.|||||+||||+.|++||++.
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 123445689999999999999999999999999999999999999999854
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=224.54 Aligned_cols=249 Identities=17% Similarity=0.192 Sum_probs=173.7
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHHHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRFIS-------------------- 136 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-------------------- 136 (356)
+.||+|+|+.|-.++...++..||||++.+.......++.+|+.++.+.+ |+||++++.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 57999999999999999999999999998887777889999999999886 999999833
Q ss_pred -----------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEcccccccccccCCC---CCc
Q 039228 137 -----------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIGDFELARFRQEVSN---PTQ 193 (356)
Q Consensus 137 -----------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~---~~~ 193 (356)
+..+|+.||.|||.+| |.||||||+|||..... -+||+||.+..-...... ..+
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 6778999999999999 99999999999996544 479999988754322211 223
Q ss_pred cCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCch-HHHhhh
Q 039228 194 SSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV-MDIVNL 267 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 267 (356)
......+|+..|||||+.. ...|+.+.|.|||||++|-|+.|.+||.+....+..+.+- ..-..- ..+...
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG---e~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG---EVCRVCQNKLFES 317 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC---CccHHHHHHHHHH
Confidence 3345577889999999763 2358899999999999999999999998876654332110 000000 001111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH--HHHHhh--hhhccccccccCCcC
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH--DLQSVN--NILLPETVFKSLTNN 343 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~--~L~~i~--~~~~~~~~~~~~~~~ 343 (356)
.-.+.++ +-++.|. ....+-.+++...+..++.+|-++.+++. ....+. ..++.+..+...+++
T Consensus 318 IQEGkYe--------FPdkdWa----hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r~~s~ 385 (463)
T KOG0607|consen 318 IQEGKYE--------FPDKDWA----HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQRNSST 385 (463)
T ss_pred HhccCCc--------CChhhhH----HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcccccCccc
Confidence 1111111 1122222 22334456777778899999999998887 223322 334555554444443
Q ss_pred C
Q 039228 344 R 344 (356)
Q Consensus 344 ~ 344 (356)
+
T Consensus 386 ~ 386 (463)
T KOG0607|consen 386 M 386 (463)
T ss_pred h
Confidence 3
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=253.85 Aligned_cols=228 Identities=23% Similarity=0.312 Sum_probs=173.1
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECC-------CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCChHHH--
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDL-------NRAVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNLVRF-- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l-- 134 (356)
.++...++..+.+.||.|.||.|++|.... ....||||.++.... ...+.+..|+.+|+.+. |+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 344455666777899999999999998531 146899999874433 45577899999999985 9999987
Q ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 039228 135 ---------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKP 163 (356)
Q Consensus 135 ---------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp 163 (356)
+.++.||+.|++||++.. +|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 347789999999999988 99999999
Q ss_pred CCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCcc
Q 039228 164 SNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFM 242 (356)
Q Consensus 164 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~ 242 (356)
.|||+..+..+||+|||+|+................ -...|||||.+....|+.++|||||||+||||+| |..||.+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999985433222111111111 2455999999999999999999999999999999 88998642
Q ss_pred ccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 243 FEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. ..++.++ +..... +..+..|..++.++|..||+.+|++||++.++.+
T Consensus 526 ~~-~~~l~~~------------l~~G~r------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PP-TEELLEF------------LKEGNR------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred Cc-HHHHHHH------------HhcCCC------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 10 1111111 111111 1223367778899999999999999999999999
Q ss_pred HHHHhh
Q 039228 323 DLQSVN 328 (356)
Q Consensus 323 ~L~~i~ 328 (356)
.++...
T Consensus 575 ~~~~~l 580 (609)
T KOG0200|consen 575 FFEKHL 580 (609)
T ss_pred HHHHHH
Confidence 999954
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=233.15 Aligned_cols=239 Identities=20% Similarity=0.222 Sum_probs=166.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC--CC----hHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH--RN----LVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l--------- 134 (356)
.+++|.+...+|+|.||.|-.+.+..++..||||+++... ...+...-|+++|+++.+ |+ +|++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4788999999999999999999999999999999987432 233556679999999842 21 1111
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---------------
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--------------- 170 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------------- 170 (356)
..++.|++.+++|||+.+ ++|-||||+|||+-+
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 347889999999999999 999999999999932
Q ss_pred -----CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccC
Q 039228 171 -----DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG 245 (356)
Q Consensus 171 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~ 245 (356)
+..++|+|||.|.+-.+.. ...+.|..|.|||++.+-+++..+||||+||||+|+.||...|....
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-- 313 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-- 313 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC--
Confidence 3358999999998654322 34677999999999999999999999999999999999999987532
Q ss_pred CccHHHHHHH---hCCCchHHHh------hhh-hc--cccccc---cc-cccchhhhhchhhHHHHHHHHHHHHHhhcCC
Q 039228 246 DLNLHNFARM---AFPNRVMDIV------NLV-LL--NDNKVL---AG-TNSNMLRKTKMNSRLECLIFMVRIGAACSMG 309 (356)
Q Consensus 246 ~~~~~~~~~~---~~~~~~~~~~------~~~-l~--~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 309 (356)
+.....+.+. .+|..+..-. ... +. .....+ +. ....-+.. .+.....+...|.+|+.++|..
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~-~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK-YMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH-HhccCcHHHhHHHHHHHHHHcc
Confidence 2221122222 2222111111 000 00 000000 00 00001111 1122235566799999999999
Q ss_pred CcCCCCChHHHHH
Q 039228 310 SSQDRMNVPNAVH 322 (356)
Q Consensus 310 dP~~RPs~~~vl~ 322 (356)
||.+|+|+.|++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=221.63 Aligned_cols=163 Identities=25% Similarity=0.338 Sum_probs=137.5
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRFIS-------------- 136 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-------------- 136 (356)
+.+--+.||-|+||.||.+.+..+|+.||+|.+... +-...+++.+|+++|..++|.|++..++
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455567899999999999999999999999998633 2334578999999999999999998733
Q ss_pred ---------------------------HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 137 ---------------------------IAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 137 ---------------------------i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
++.||++||.|||+.+ |+||||||.|.|++++..+||+|||+++.-+...
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 5678999999999999 9999999999999999999999999998543322
Q ss_pred CCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.......+-|..|.|||.++|. .|+.+.||||.||++.|++..+..|..
T Consensus 211 ---~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 211 ---RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ---hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 1222335568899999999885 589999999999999999999888863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=219.90 Aligned_cols=202 Identities=26% Similarity=0.271 Sum_probs=157.8
Q ss_pred CceEEEEEEECCCCeEEEEEEeeccCccc-hHHHHHHHHHHhhcCCCChHHH----------------------------
Q 039228 84 SFDAVYQGVFDLNRAVVAIKVLSIQCQGA-SKSFMAECKALKNICHRNLVRF---------------------------- 134 (356)
Q Consensus 84 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l---------------------------- 134 (356)
+||.||+|.+..+++.+|+|++....... .+.+.+|+..+++++|+|++++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999888999999997654444 6789999999999999999987
Q ss_pred ---------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccc
Q 039228 135 ---------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205 (356)
Q Consensus 135 ---------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 205 (356)
+.++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~ 152 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGTPEY 152 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCCcCC
Confidence 347788999999999998 9999999999999999999999999998654321 22335568889
Q ss_pred cchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhh
Q 039228 206 TALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLR 285 (356)
Q Consensus 206 ~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 285 (356)
++||...+..++.++|+||||+++++|++|..||....... ........ .......
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~------------~~~~~~~----------- 208 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGK------------PKPPFPP----------- 208 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhc------------cCCCCcc-----------
Confidence 99999988889999999999999999999999986421111 11111100 0000000
Q ss_pred hhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 286 KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 286 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||..+|++||++.++++
T Consensus 209 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 -----PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -----ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00003346789999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-31 Score=240.16 Aligned_cols=225 Identities=21% Similarity=0.278 Sum_probs=167.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-------ccchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-------QGASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
..++|-++..||+|||+.||+|.+...++.||+|+-.... ....+...+|.++.+.|+||.||++
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3457889999999999999999998888999999975332 1223456789999999999999997
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFEL 181 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~ 181 (356)
..|+.||+.||.||.+.. +||||-||||.|||+- ..|.+||+|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 348899999999999984 7899999999999994 568999999999
Q ss_pred ccccccCCCC---CccCCCCccccccccchhhhcCC----CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 039228 182 ARFRQEVSNP---TQSSSNGVRRTIGYTALDYDLGS----EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 182 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 254 (356)
+++++..... .........||.+|++||.+.-+ .++.++||||+||++|.++.|+.||....... ....
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dILq 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DILQ 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HHHh
Confidence 9998665432 23345667899999999988643 47889999999999999999999996432211 1111
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. .++...-...+. -+....+...+|.+||++.-++|.+..++..
T Consensus 696 eN------TIlkAtEVqFP~-----------------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 EN------TILKATEVQFPP-----------------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hh------chhcceeccCCC-----------------CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 10 011110000000 0122224468999999999999998777653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=223.95 Aligned_cols=184 Identities=20% Similarity=0.164 Sum_probs=140.7
Q ss_pred cCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------------------
Q 039228 83 GSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------------------- 134 (356)
Q Consensus 83 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------------------- 134 (356)
|.+|.||++.+..+++.||+|.+.... .+..|...+....||||+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999987542 23345555556679999987
Q ss_pred ---------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccc
Q 039228 135 ---------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205 (356)
Q Consensus 135 ---------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 205 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~y 148 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEAVENMY 148 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCCcCccc
Confidence 347789999999999999 999999999999999999999999987654321 1123446779
Q ss_pred cchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhh
Q 039228 206 TALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLR 285 (356)
Q Consensus 206 ~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 285 (356)
+|||...+..++.++|+||+|+++|||++|..|+........ ......+.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~~~~~--------------- 198 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTTLNIP--------------- 198 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccccCCc---------------
Confidence 999999888899999999999999999999988753211000 00000000
Q ss_pred hhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH
Q 039228 286 KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 286 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
......+.+++.+|++.||++||++.
T Consensus 199 -------~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 199 -------EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -------ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 01223567899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=211.56 Aligned_cols=181 Identities=22% Similarity=0.276 Sum_probs=142.9
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-CccchHHHHHHHHHHhh-cCCCChHHHH---------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKN-ICHRNLVRFI--------- 135 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~--------- 135 (356)
+....++..-+..||+|++|.|-+-++..+|+..|+|.+... .....+++++|+++..+ ...|.+|+++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334455667778899999999999999999999999999744 23445678889887554 5689999872
Q ss_pred -------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 136 -------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 136 -------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
.|+..+..||.|||++- .+||||+||+||||+.+|.+|++|||.+-.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 26778999999999953 599999999999999999999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhcC----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLG----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 254 (356)
+...- ..+.-.|-..|||||.+.. ..|+.++||||||+++.||.+++.||+........+.+.+.
T Consensus 199 L~dSi-----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSI-----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhh-----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 64322 1222345678999998753 36899999999999999999999999876555444444443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=220.67 Aligned_cols=166 Identities=23% Similarity=0.321 Sum_probs=142.5
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhc-CCCChHHH----------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CHRNLVRF---------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l---------- 134 (356)
...++|.++.+||+|+|..|.+++++.|.+.+|+|+++++ ..++......|-.+..+. +||.+|-+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3567899999999999999999999999999999999754 334455666777766654 68998876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..+..+|..||.|||++| ||+||||.+|+|+|..|++||+|+|.++..-.
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 235567999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
. ......++||+.|.|||.+.+..|+..+|.|+|||+++||+.|+.||+-
T Consensus 404 ~----gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 404 P----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C----CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 2 2344568999999999999999999999999999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=227.97 Aligned_cols=231 Identities=20% Similarity=0.289 Sum_probs=179.0
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH----
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF---- 134 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l---- 134 (356)
.++.....+++....+-+|.||.||.|.+.+. .+.|-+|.++.. +......++.|.-.+..+.|||+.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 45555667788889999999999999987643 244566666533 23345678899999999999999986
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
..++.|++.|++|||+++ +||.||...|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 347789999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.+||+|=.+++-+....-. ......-.+..||+||.+.+..|+.++|+|||||++|||+| |+.|+.+.. -.+
T Consensus 434 qVkltDsaLSRDLFP~DYh--cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----PfE 506 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYH--CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----PFE 506 (563)
T ss_pred eEEeccchhccccCccccc--ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----HHH
Confidence 9999999999865433221 11122233667999999999999999999999999999999 999986432 112
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+......+ ....++.+|+.+|..+|.-||...|++||+++|++..|.+...++
T Consensus 507 m~~ylkdG---------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 MEHYLKDG---------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHHHHhcc---------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 11111111 012233489999999999999999999999999999999987766
Q ss_pred c
Q 039228 332 L 332 (356)
Q Consensus 332 ~ 332 (356)
.
T Consensus 560 t 560 (563)
T KOG1024|consen 560 T 560 (563)
T ss_pred h
Confidence 4
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=249.60 Aligned_cols=208 Identities=25% Similarity=0.293 Sum_probs=159.4
Q ss_pred CCccccceecCce-EEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH-----------------
Q 039228 74 FPLINLIGVGSFD-AVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l----------------- 134 (356)
|.-.+++|.|..| .||+|... ++.||||++-. +...-..+|+..|+.-+ |||||++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4445678999887 57999987 78999999753 23345678999998775 9999997
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---C--CceEEcccccccccc
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---D--LFAHIGDFELARFRQ 186 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~ 186 (356)
+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 346788999999999998 999999999999975 2 578999999999887
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcC-CCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
........ ..+..||-+|+|||.+....-+.++||||+||++|+.++| ..||......+.++..-.. .+.
T Consensus 663 ~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~-----~L~--- 733 (903)
T KOG1027|consen 663 GGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY-----TLV--- 733 (903)
T ss_pred CCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc-----cee---
Confidence 66544333 5678899999999999998888899999999999999995 9999754333222111000 000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+... .++ +..+||.+|++.+|..||++.+|+.
T Consensus 734 --~L~~~--------------------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 --HLEPL--------------------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --eeccC--------------------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00000 122 4578999999999999999999973
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=226.19 Aligned_cols=243 Identities=20% Similarity=0.194 Sum_probs=174.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC------CChHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH------RNLVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l--------- 134 (356)
...+|.+....|+|-|++|..|.+...|+.||||++..... ..+.=+.|+.+|++|+. -|+++|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 45679999999999999999999998899999999975432 23455678888888842 245554
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELAR 183 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 183 (356)
..++.|+..||..|-..+ |+|.||||+|||+++. ..+||||||.|.
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccc
Confidence 237889999999999999 9999999999999864 567999999997
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc-cHHHHHHHhCCCch-
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL-NLHNFARMAFPNRV- 261 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~- 261 (356)
+..... ...+.-+..|.|||++.|-+|+...|+||.||+|||+.||+..|.+.....+ .+.--+...+|..+
T Consensus 586 ~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 586 FASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 654322 2224456779999999999999999999999999999999999987554332 12222222333322
Q ss_pred --HHHhhhhhccccccccc---------------------cccchhhh--hchhhHHHHHHHHHHHHHhhcCCCcCCCCC
Q 039228 262 --MDIVNLVLLNDNKVLAG---------------------TNSNMLRK--TKMNSRLECLIFMVRIGAACSMGSSQDRMN 316 (356)
Q Consensus 262 --~~~~~~~l~~~~~~~~~---------------------~~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 316 (356)
.+++|..+-.++...+. .....+.. ..+.+.....+.|.+|+..|+..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 12333333222111000 01111111 123445577889999999999999999999
Q ss_pred hHHHHH
Q 039228 317 VPNAVH 322 (356)
Q Consensus 317 ~~~vl~ 322 (356)
..+.|+
T Consensus 740 ~nqAL~ 745 (752)
T KOG0670|consen 740 VNQALK 745 (752)
T ss_pred HHHHhc
Confidence 998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=229.65 Aligned_cols=165 Identities=24% Similarity=0.296 Sum_probs=119.8
Q ss_pred hcCCCCccccceecCceEEEEEEEC----------------CCCeEEEEEEeeccCccchHHH--------------HHH
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD----------------LNRAVVAIKVLSIQCQGASKSF--------------MAE 119 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 119 (356)
..++|.+.++||+|+||.||+|... ..++.||||.+........+.| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999999752 2346799999865433222222 345
Q ss_pred HHHHhhcCCCCh-----HH-------------------------------------------------------------
Q 039228 120 CKALKNICHRNL-----VR------------------------------------------------------------- 133 (356)
Q Consensus 120 ~~~l~~l~h~ni-----v~------------------------------------------------------------- 133 (356)
+.++.+++|.++ ++
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666655543 11
Q ss_pred --------HHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccc
Q 039228 134 --------FISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205 (356)
Q Consensus 134 --------l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 205 (356)
+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .......+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCcce
Confidence 1236778999999999998 99999999999999999999999999975432211 111123347899
Q ss_pred cchhhhcCCCC----------------------CCccchHhHHHHHHHHHcCCC-CCC
Q 039228 206 TALDYDLGSEV----------------------STNGDAYNYGILLLEMVTRRK-PID 240 (356)
Q Consensus 206 ~aPE~~~~~~~----------------------~~~sDiwSlG~~l~elltg~~-Pf~ 240 (356)
+|||.+..... ..+.||||+||++|+|++|.. ||.
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99998754321 124699999999999999875 664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=232.94 Aligned_cols=221 Identities=21% Similarity=0.269 Sum_probs=173.7
Q ss_pred HHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH--------
Q 039228 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF-------- 134 (356)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l-------- 134 (356)
+..+...++-|++.+.||.|.+|.||+++...+++.+|+|+....... .+++..|..+|+.+. |||++.+
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344455677899999999999999999999999999999998755433 467788999998875 8999987
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcc
Q 039228 135 ------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGD 178 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 178 (356)
..|+.+++.||.+||++. ++|||||-.|||++.++.+||.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 347889999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCC-----CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHH
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-----EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 253 (356)
||++..++.. ....+...||+.|||||++... .|+..+|+||||++..||.-|.+|+..+-. ...+.
T Consensus 167 FGvSaQldsT----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF 238 (953)
T KOG0587|consen 167 FGVSAQLDST----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALF 238 (953)
T ss_pred eeeeeeeecc----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhc
Confidence 9999876533 3455668899999999998643 477889999999999999999999864321 11111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.++.+. .+. ...+..-.+.+.++|..||..|-+.||++.++++
T Consensus 239 --~IpRNP----PPk--------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 --LIPRNP----PPK--------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --cCCCCC----Ccc--------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111100 000 0111244557789999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=217.73 Aligned_cols=95 Identities=33% Similarity=0.495 Sum_probs=80.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-----CC---ChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-----HR---NLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~---niv~l-------- 134 (356)
.++|.+.++||.|.|++||+|.+..+.+.||+|+.+.. ....+..+.||++|++++ |+ .||+|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999999999999999998633 344567788999999884 32 45655
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
..|+.||+.||.|||..+ .|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 348999999999999976 49999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=209.91 Aligned_cols=238 Identities=20% Similarity=0.181 Sum_probs=169.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..+|.-+..+|.|.- .|-.|.+.-.++.||+|.+... .....++..+|..++..++|+||+++
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 446777888999988 7888888888899999987533 23445778899999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
-.++.|++.|+.|||+.| |+||||||+||++..++.+||.|||+|+.-+..
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc
Confidence 237889999999999999 999999999999999999999999999754321
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH---hC-CC-chHH
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM---AF-PN-RVMD 263 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~---~~-~~-~~~~ 263 (356)
...+..+.|..|.|||++.+..+...+||||+||++.||++|..-|.+. ..+.+|.+. .- ++ ...+
T Consensus 172 -----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 172 -----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred -----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHH
Confidence 2344577899999999999988999999999999999999999988732 222222211 11 11 1111
Q ss_pred Hhhhhh------ccccccccccccchhhhhchhhHH---HHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVL------LNDNKVLAGTNSNMLRKTKMNSRL---ECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
-+.+.. .+.+.. ......+-+-.++...+ .......+++.+||-.||++|.++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111110 011100 11111111111111111 12234678999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=226.19 Aligned_cols=161 Identities=23% Similarity=0.357 Sum_probs=139.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--------ccchHHHHHHHHHHhhcC---CCChHHHH----
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--------QGASKSFMAECKALKNIC---HRNLVRFI---- 135 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~---- 135 (356)
..+|..++.+|.|+||.|++|.++.++..|+||.+.++. ......+-.|++||..++ |+||++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456999999999999999999999999999999987542 111223557999999998 99999983
Q ss_pred ----------------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 136 ----------------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 136 ----------------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
-|+.|++.|+++||..| |||||||-+|+.++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 28899999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCCC-CccchHhHHHHHHHHHcCCCCCC
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS-TNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
+..... .....++||..|.|||++.|.+|- ..-|||++|++||.++....||-
T Consensus 717 aa~~ks------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKS------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcC------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 975432 344568999999999999998874 55799999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=226.65 Aligned_cols=171 Identities=24% Similarity=0.262 Sum_probs=141.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.-|..++.||-|+||+|.+++-..|+..||+|.+.+.+ ......+..|-+||...+.+-||+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34778889999999999999999999999999997543 2334567789999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC---
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV--- 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 188 (356)
..++.++..|+++.|..| +|||||||+|||||.+|++||+|||++.-+...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 235678999999999999 999999999999999999999999998532110
Q ss_pred -----CC------------------------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHH
Q 039228 189 -----SN------------------------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMV 233 (356)
Q Consensus 189 -----~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ell 233 (356)
++ .........+||..|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 00 0112234567999999999999999999999999999999999
Q ss_pred cCCCCCCccccC
Q 039228 234 TRRKPIDFMFEG 245 (356)
Q Consensus 234 tg~~Pf~~~~~~ 245 (356)
.|++||-.....
T Consensus 866 ~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 866 VGQPPFLADTPG 877 (1034)
T ss_pred hCCCCccCCCCC
Confidence 999999654443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=193.80 Aligned_cols=216 Identities=16% Similarity=0.191 Sum_probs=155.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l---------------- 134 (356)
+.|.+.+.||+|-||.+-+++++.+++.+++|.++... ...+.|.+|...--.|. |.||+.-
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45999999999999999999999999999999997553 34577888887655554 8899875
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--CCCceEEcccccccccccCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD--NDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ +||||||.+||||- +...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~---- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT---- 175 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc----
Confidence 337888999999999998 99999999999994 455899999999874332
Q ss_pred CccCCCCccccccccchhhhcC---C--CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDLG---S--EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
......-+..|.+||.... + ...+.+|+|.||+++|.++||.+||+.....+....+|....-....
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----
Confidence 1122333556889997643 2 24678899999999999999999998655555555444332211110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+...+. .....+..+..+-+..+|++|=-..++-++
T Consensus 248 -~~P~~F~-------------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 -ALPKKFN-------------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -cCchhhc-------------------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1100100 122245677888899999999444444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=190.45 Aligned_cols=173 Identities=25% Similarity=0.395 Sum_probs=147.0
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH------------------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF------------------------ 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l------------------------ 134 (356)
||.|++|.||++....+++.+++|++...... ....+.+|+..++.++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888899999998755332 34678899999999999999876
Q ss_pred --------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCCCCCccCCCCc
Q 039228 135 --------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVSNPTQSSSNGV 199 (356)
Q Consensus 135 --------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 199 (356)
..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~ 153 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLKTI 153 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhhcc
Confidence 347789999999999998 999999999999999 89999999999976543221 12234
Q ss_pred cccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccc
Q 039228 200 RRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAG 278 (356)
Q Consensus 200 ~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 278 (356)
.+...|++||..... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999877 788999999999999999
Q ss_pred cccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 279 TNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 035789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=205.81 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=170.0
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECC---CCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH--------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF-------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l-------- 134 (356)
+....+.|..+++||.|.|++||+|.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34456679999999999999999999877 78899999986432 3467889999999986 6788776
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEccccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 187 (356)
..++..++.||.++|..| ||||||||+|+|.+ ..+.-.|.|||+|...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHh
Confidence 347788999999999999 99999999999997 456778999999972110
Q ss_pred CC----------------------------------------CCCccCCCCccccccccchhhhcCC-CCCCccchHhHH
Q 039228 188 VS----------------------------------------NPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYG 226 (356)
Q Consensus 188 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG 226 (356)
.. ...........||++|.|||++... ..+++.||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0001112345699999999998764 478899999999
Q ss_pred HHHHHHHcCCCCCCccccCCccHHHHHHHhC----------CCc--hHHH----hhhhhccccccccccccchhhh----
Q 039228 227 ILLLEMVTRRKPIDFMFEGDLNLHNFARMAF----------PNR--VMDI----VNLVLLNDNKVLAGTNSNMLRK---- 286 (356)
Q Consensus 227 ~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----------~~~--~~~~----~~~~l~~~~~~~~~~~~~~~~~---- 286 (356)
|+++-+++++.||-...++-..+.+.+...- .+. +++- ..+.+...+.... ...+...
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~--~~~~~~~~q~n 343 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH--IESIYKSRQPN 343 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC--hhhcccccccc
Confidence 9999999999999766555444444332221 122 1110 0000000000000 0000000
Q ss_pred hchhhHHH-HHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 287 TKMNSRLE-CLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 287 ~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.....-.+ .+..+.+++.+|++.||.+|.|+++.|+.
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111112 22367899999999999999999998863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=187.53 Aligned_cols=156 Identities=17% Similarity=0.143 Sum_probs=114.1
Q ss_pred ChHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchh
Q 039228 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD 209 (356)
Q Consensus 130 niv~l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (356)
..-.++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++...... ...|++.|+|||
T Consensus 15 ~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---------~~~g~~~y~aPE 74 (176)
T smart00750 15 NEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---------QSRVDPYFMAPE 74 (176)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc---------cCCCcccccChH
Confidence 34456789999999999999875 999999999999999 9999765331 125789999999
Q ss_pred hhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhch
Q 039228 210 YDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKM 289 (356)
Q Consensus 210 ~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 289 (356)
++.+..++.++|||||||++|||+||+.||.........+...... ........ .
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~-------------~ 129 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG------------MPADDPRD-------------R 129 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH------------hccCCccc-------------c
Confidence 9999999999999999999999999999986432211111111111 11000000 0
Q ss_pred hhHHHHH--HHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 290 NSRLECL--IFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 290 ~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
....... ..+.+++.+||+.+|.+||++.++++.+..+...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0001122 2588999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-26 Score=219.69 Aligned_cols=218 Identities=18% Similarity=0.243 Sum_probs=171.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI-------------- 135 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-------------- 135 (356)
..++|.+++.+|.|.+|.||+|+++.++...|+|+++.......+-+..|+-+++..+||||+.++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 356799999999999999999999999999999999988777788888999999999999999982
Q ss_pred -----------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 136 -----------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 136 -----------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
.++++.+.||+|||+.+ =+|||||-.||++++.|.+|++|||.+..+.. .
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita----t 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA----T 165 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh----h
Confidence 26788999999999999 89999999999999999999999999865432 2
Q ss_pred ccCCCCccccccccchhhh---cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYD---LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......+.||+.|||||+. ..+.|...+|||++|++..|+-.-++|.... ...+........ ..++.-
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hpmr~l~LmTkS-----~~qpp~ 236 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HPMRALFLMTKS-----GFQPPT 236 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----chHHHHHHhhcc-----CCCCCc
Confidence 3445568999999999976 3567899999999999999998888874311 111111111000 011111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..+. ..-...+-+++..|+-.+|.+||+++.++.
T Consensus 237 lkDk-------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDK-------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCC-------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1110 122335678999999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=188.89 Aligned_cols=162 Identities=30% Similarity=0.404 Sum_probs=138.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
|.+.+.||.|++|.||+|....++..+|+|.+...... ..+.+.+|+..+++++|+|++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988899999999866544 56788999999999999999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~---~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA---A 154 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---c
Confidence 236778999999999998 99999999999999999999999999986543320 1
Q ss_pred CCCCccccccccchhhh-cCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 195 SSNGVRRTIGYTALDYD-LGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335567889999998 666788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=222.07 Aligned_cols=156 Identities=14% Similarity=0.147 Sum_probs=107.2
Q ss_pred ChHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-------------------CCceEEcccccccccccCCC
Q 039228 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-------------------DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 130 niv~l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+...++.++.||+.||.|||+++ |+||||||+||||+. ++.+|++|||+++.......
T Consensus 78 ~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~ 154 (793)
T PLN00181 78 DAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSE 154 (793)
T ss_pred cHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccc
Confidence 45566789999999999999999 999999999999954 44556666666653211000
Q ss_pred ------------CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC
Q 039228 191 ------------PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 191 ------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
..........||+.|+|||++.+..++.++|||||||++|||++|.+|+.... ..+........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~ 231 (793)
T PLN00181 155 RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP 231 (793)
T ss_pred cchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC
Confidence 00001122457889999999999999999999999999999999988864211 011111111000
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.. .........++.+||+.+|.+||+|.+|++
T Consensus 232 --------~~~-----------------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 232 --------PQI-----------------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --------hhh-----------------------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 000 011123457888999999999999999976
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=186.78 Aligned_cols=142 Identities=22% Similarity=0.124 Sum_probs=113.3
Q ss_pred hcCCCCccccceecCceEEEEEEECC-CCeEEEEEEeecc-----CccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDL-NRAVVAIKVLSIQ-----CQGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
..++|.+.+.||+|+||+||+|.+.. +++.||||++... .......+.+|+.+|++++|+|+++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 45779999999999999999999876 6788899986532 11234568899999999999999841
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCC-CCCCeEeCCCCceEEcccccccccccCCCCCc--
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDP-KPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ-- 193 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-- 193 (356)
..++.+++.||.|||+.| |+|||| ||+|||++.++.++|+|||+++.+........
T Consensus 96 VmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~ 172 (365)
T PRK09188 96 VRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA 172 (365)
T ss_pred EEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh
Confidence 357788999999999999 999999 99999999999999999999987644321111
Q ss_pred --cCCCCccccccccchhhhcCC
Q 039228 194 --SSSNGVRRTIGYTALDYDLGS 214 (356)
Q Consensus 194 --~~~~~~~gt~~y~aPE~~~~~ 214 (356)
.......+++.|.|||++...
T Consensus 173 ~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 173 AYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhhccCccCCcccCChh
Confidence 111356778889999988643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=180.50 Aligned_cols=228 Identities=21% Similarity=0.199 Sum_probs=162.6
Q ss_pred CCCccccceecCceEEEEEEECCCC-eEEEEEEeeccCccchHHHHHHHHHHhhcCC----CChHHH-------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNR-AVVAIKVLSIQCQGASKSFMAECKALKNICH----RNLVRF------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l------------- 134 (356)
+|++.+.||+|+||.||.|.+..++ ..+|+|............+..|+.++..+.. +++..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999988764 6899999875533332367778888877762 111111
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-----CceEEccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-----LFAHIGDFELAR 183 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg~a~ 183 (356)
+.|+.|++.+|.+||+.| ++||||||+|++++.. ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 668999999999999999 9999999999999854 468999999998
Q ss_pred ccc--cCCCC----CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 184 FRQ--EVSNP----TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 184 ~~~--~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
... ..... .........||..|.++....+...+.+.|+||++.++.+++.|..||........ .........
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhh
Confidence 322 22111 11113456799999999999999999999999999999999999999965432211 111111110
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
... ... .. ...+..+..+...+-..+..++|....+...|.......
T Consensus 255 ~~~----~~~-~~----------------------~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLL----TDR-FG----------------------DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhc----ccc-cc----------------------CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 000 00 012234455555566689999999999999998886653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=170.26 Aligned_cols=194 Identities=20% Similarity=0.208 Sum_probs=130.2
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCC-CC----------hHHH-----
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICH-RN----------LVRF----- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~n----------iv~l----- 134 (356)
+.....||.|+++.||.+++..|++.+|+|++..... ...+.+.+|.-....+.+ .| ++.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 5667899999999999999999999999999864332 234556666655544433 11 1111
Q ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecC
Q 039228 135 ------------------------------------------------------ISIAIDVASALDYLHHHCQELILHCD 160 (356)
Q Consensus 135 ------------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~D 160 (356)
+.+..|++..+++||..| ++|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 335578899999999999 99999
Q ss_pred CCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcC--------CCCCCccchHhHHHHHHHH
Q 039228 161 PKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG--------SEVSTNGDAYNYGILLLEM 232 (356)
Q Consensus 161 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlG~~l~el 232 (356)
|+|+|++++.+|.+.|+||+.....+.... . ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE-----G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee-----c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999998765433211 0 223467899997643 2468889999999999999
Q ss_pred HcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcC
Q 039228 233 VTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQ 312 (356)
Q Consensus 233 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 312 (356)
++|..||........... .+ ..+ .+.++.+..||...|+.||+
T Consensus 244 WC~~lPf~~~~~~~~~~~-----------------~f-~~C-------------------~~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-----------------DF-SRC-------------------RDMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-----------------GG-TTS-------------------S---HHHHHHHHHHT-SSGG
T ss_pred HHccCCCCCCCccccccc-----------------cc-hhc-------------------CCcCHHHHHHHHHHccCCcc
Confidence 999999986533221100 00 011 14555788999999999999
Q ss_pred CC
Q 039228 313 DR 314 (356)
Q Consensus 313 ~R 314 (356)
+|
T Consensus 287 ~R 288 (288)
T PF14531_consen 287 DR 288 (288)
T ss_dssp GS
T ss_pred cC
Confidence 88
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=192.27 Aligned_cols=221 Identities=15% Similarity=0.122 Sum_probs=161.4
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeecc--Ccc----chHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQG----ASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
....++|.|++|.|+.+........++.|.+... ... ....+..|+-+-..+.|||++..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998888877665565666654311 111 11225567777788899997754
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
-.++.|++.|+.|+|..| |.|||+|++|+++..+|.+||+|||.+..+.......
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 126778999999999999 9999999999999999999999999998765554444
Q ss_pred ccCCCCccccccccchhhhcCCCCCCc-cchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTN-GDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||......+..+.. .....+.....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~~~~~~~~~~------ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NNYSDQRNIFE------ 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hcccccccccc------
Confidence 456677899999999999999998765 69999999999999999999765544433200 00111100000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.........+.....++.++|+.||.+|.|+++|++
T Consensus 549 ---------------~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 ---------------GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---------------ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 001111244556678999999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=161.00 Aligned_cols=167 Identities=22% Similarity=0.309 Sum_probs=136.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l---------------- 134 (356)
-+|++.++||+|+||+++.|...-+++.||||.-+.... ..++..|.+..+.|. .++|..+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 469999999999999999999999999999998764432 346677777777665 3444433
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-----CceEEcccccccccccC
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-----LFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.-++|+|++. +|+|||||+|+||... ..+.|+|||+|+.....
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 447889999999999999 9999999999999743 35889999999976544
Q ss_pred CCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccc
Q 039228 189 SNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF 243 (356)
Q Consensus 189 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~ 243 (356)
... .........||..||+-....+.+.+.+.|+=|||-++++.|-|..||.+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 332 1233455779999999999999999999999999999999999999998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=156.56 Aligned_cols=170 Identities=23% Similarity=0.329 Sum_probs=135.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC----CChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH----RNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l----------- 134 (356)
..+.|.+++.||+|+||.+|.|....+|..||||+-+.. .....+..|.++...|++ |+|-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356799999999999999999999999999999996533 223467778888777764 333332
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 188 (356)
+-++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+..-..
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 346778999999999999 999999999999973 446789999999876443
Q ss_pred CCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcccc
Q 039228 189 SNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244 (356)
Q Consensus 189 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~ 244 (356)
... .........||..|.+-....+...+.+.|+=|+|.++.+..-|..||++...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 321 12334457799999998888888888999999999999999999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=188.61 Aligned_cols=232 Identities=21% Similarity=0.208 Sum_probs=157.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChH----HHHH----HHHHH
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLV----RFIS----IAIDV 141 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv----~l~~----i~~~i 141 (356)
...+|..++.|..|++|.||.++++.+.+.+|+|+ ++... +.+- ++.....|.+| .++. .-.++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvvgDc~tllk~~g~lPvdm 152 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVVGDCATLLKNIGPLPVDM 152 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCcceechhhhhcccCCCCcchh
Confidence 35689999999999999999999999999999954 32211 1111 44444555553 1111 12345
Q ss_pred HHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC-----------CCccCCCCccccccccchhh
Q 039228 142 ASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN-----------PTQSSSNGVRRTIGYTALDY 210 (356)
Q Consensus 142 ~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~ 210 (356)
+.+++|||+.+ |+|||+||+|.+|..-|++|++|||+.+..-.... ...-....++||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 88999999999 99999999999999999999999999975422111 12233456789999999999
Q ss_pred hcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchh
Q 039228 211 DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMN 290 (356)
Q Consensus 211 ~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 290 (356)
+....|+..+|+|++|+++||.+.|..||.....+ +++...+..+. .|++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-----------------elfg~visd~i-------------~wpE 279 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----------------ELFGQVISDDI-------------EWPE 279 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-----------------HHHhhhhhhhc-------------cccc
Confidence 99999999999999999999999999999753221 11111111111 0111
Q ss_pred hHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCcCCc
Q 039228 291 SRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRA 345 (356)
Q Consensus 291 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~~~~ 345 (356)
.+...+.+..+++.+.|+.+|..|--... .++--.+.+.....|.+|-.+++
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~g---a~evk~h~ff~~LDw~~llRqka 331 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGG---ALEVKQHGFFQLLDWKSLLRQKA 331 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccch---hhhhhhccceeecccchhhhhhc
Confidence 12233445678888889999999964332 22222333333444454444443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-19 Score=161.74 Aligned_cols=222 Identities=24% Similarity=0.334 Sum_probs=162.0
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---chHHHHHHHHHHhhcCCC-ChHHH---------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---ASKSFMAECKALKNICHR-NLVRF--------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l--------------- 134 (356)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999987 78899998754333 356789999999999988 68776
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 188 (356)
..++.+++.++.|+|..+ ++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 346778999999999999 99999999999999888 7999999999855433
Q ss_pred CCCCc--cCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccC--CccHHHHHHHhCCCch
Q 039228 189 SNPTQ--SSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEG--DLNLHNFARMAFPNRV 261 (356)
Q Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~ 261 (356)
..... .......|+..|++||.+.+ ..++...|+||+|++++++++|..||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 32111 13456788999999999987 57889999999999999999999997543221 01111111111000
Q ss_pred HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 262 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........ .........+.+++..|+..+|..|.++.+....
T Consensus 234 ------~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ------SLASPLSP--------------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ------ccccccCc--------------cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 0001223456789999999999999998887765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-21 Score=178.76 Aligned_cols=93 Identities=29% Similarity=0.464 Sum_probs=78.1
Q ss_pred HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC--CCccCCCCccccccccchhhhcC
Q 039228 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN--PTQSSSNGVRRTIGYTALDYDLG 213 (356)
Q Consensus 136 ~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~ 213 (356)
.++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+......... ........-.||..||+||.+.+
T Consensus 363 ~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 363 DIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred HHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 367788888888 66 99999999999999999999999999875543321 11223455779999999999999
Q ss_pred CCCCCccchHhHHHHHHHHHc
Q 039228 214 SEVSTNGDAYNYGILLLEMVT 234 (356)
Q Consensus 214 ~~~~~~sDiwSlG~~l~ellt 234 (356)
..|+.++||||||++++|+++
T Consensus 437 ~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 437 QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhcchhhHHHHHHHHHH
Confidence 999999999999999999997
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=180.42 Aligned_cols=214 Identities=16% Similarity=0.165 Sum_probs=149.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccc---hHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGA---SKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~---~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
+|...+.||++.|=.|.+|++.++ .|+||++-+.. .-. .++.+.|++ ...++|||.+++
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 677888999999999999998754 49999985443 222 234445555 566789999887
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc--ccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR--QEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~--~~~~~ 190 (356)
.-|+.|++.||..+|..| |+|||||.+||||+.=..+.|+||..-+.. ...+.
T Consensus 101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 127889999999999999 999999999999999999999999876532 22221
Q ss_pred C-CccCCCCccccccccchhhhcCC----------C-CCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhC
Q 039228 191 P-TQSSSNGVRRTIGYTALDYDLGS----------E-VSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 191 ~-~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
. ..........-.+|.|||.+... . .+++-||||+||++.|+++ |++||... .+..+....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~- 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN- 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-
Confidence 1 11111222234579999987542 1 5678899999999999998 78888621 111111111
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.......+...- + ..+.++++.|++.||.+|-++++.++.-
T Consensus 252 ~~~~e~~Le~Ie------------------------d--~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 252 ADDPEQLLEKIE------------------------D--VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCHHHHHHhCc------------------------C--ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 111111111110 1 1467899999999999999999999873
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.9e-19 Score=159.91 Aligned_cols=152 Identities=18% Similarity=0.157 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--CCC--ceEEcccccccccccC--CCCCccCCCCccccccccchhh
Q 039228 137 IAIDVASALDYLHHHCQELILHCDPKPSNVLLD--NDL--FAHIGDFELARFRQEV--SNPTQSSSNGVRRTIGYTALDY 210 (356)
Q Consensus 137 i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~~--~~~~~~~~~~~~gt~~y~aPE~ 210 (356)
++.|+++|+.|||.+| |.|||+|++|||+. +++ .+.|+|||++---+.. ..+.....-..-|....||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 7789999999999999 99999999999993 443 4689999998532211 1111222223446677899999
Q ss_pred hcCCC------CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchh
Q 039228 211 DLGSE------VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNML 284 (356)
Q Consensus 211 ~~~~~------~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 284 (356)
....+ --.++|.|+.|.+.||+++...||-...+...+...+.+..+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--------------------------- 475 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--------------------------- 475 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC---------------------------
Confidence 86532 125789999999999999999999642211112221111111
Q ss_pred hhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 285 RKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 285 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+..+..++..+.+|+...|+.||.+|++..=...
T Consensus 476 ----Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 476 ----PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ----CCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1111245556778999999999999998654333
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-19 Score=155.16 Aligned_cols=142 Identities=14% Similarity=0.156 Sum_probs=108.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchH---H------HHHHHHHHhhcCCCChHHH------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK---S------FMAECKALKNICHRNLVRF------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l------ 134 (356)
..++|++.++||.|+||.||++.. ++..+|||++......... . +.+|+..+.++.|++|..+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357899999999999999999655 3568999999744332222 2 5789999999999987765
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
-....+++.+|..+|..| ++|||++|+||+++.+| ++|+|||...
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 123568999999999999 99999999999999988 9999999886
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMV 233 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ell 233 (356)
....... ...+.....+..++|+||||+++....
T Consensus 183 ~~~e~~a----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 183 CTAQRKA----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccchhh----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 4321110 011344455667899999999876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-19 Score=154.61 Aligned_cols=211 Identities=19% Similarity=0.264 Sum_probs=150.0
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
..++-+|.....|+.|+|++. |..+++|+++... ......|..|...|+-+.||||+.+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 445557888999999999997 5567788876432 2334678889999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+|++|++|||+.. +-|.---|.+..++||++.+.+|+ .+-+++.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfs------- 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFS------- 340 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceee-------
Confidence 457889999999999974 223344688999999999888764 2222211
Q ss_pred ccCCCCccccccccchhhhcCCCCC---CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVS---TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
....+..-.+.|++||.+...+-+ .++|+|||++++||+.|...||.....-.....-... .+
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale-------------gl 406 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE-------------GL 406 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-------------cc
Confidence 111122336789999999765533 4689999999999999999999765433222111110 01
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
. ..+++.....+..|+.-|.+.||.+||.++.|+-.|++.
T Consensus 407 r------------------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 R------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred c------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1 011123334567899999999999999999999988875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.3e-19 Score=167.23 Aligned_cols=150 Identities=25% Similarity=0.217 Sum_probs=120.4
Q ss_pred cceecCceEEEEEEE---CCCCeEEEEEEeeccCcc--chHHHHHHHHHHhhcC-CCChHHH------------------
Q 039228 79 LIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQCQG--ASKSFMAECKALKNIC-HRNLVRF------------------ 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l------------------ 134 (356)
++|.|.||.|++++- ...+..+|+|++++.... .......|..++...+ ||.+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987653 234688999988644221 1124556788888887 8988876
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..+..+++.|++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 124567899999999999 99999999999999999999999999986543221
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27899999999998 567889999999999999999999974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.5e-18 Score=144.67 Aligned_cols=103 Identities=19% Similarity=0.140 Sum_probs=81.2
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCcc--c-------h-----------------HHHHHHHHHHhhcCCCC
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--A-------S-----------------KSFMAECKALKNICHRN 130 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 130 (356)
...||+|+||.||+|... +|+.||||+++..... . . .....|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 7899999999754211 0 0 12234888888886554
Q ss_pred hHH-----------------------------------HHHHHHHHHHHHHHH-hhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 131 LVR-----------------------------------FISIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 131 iv~-----------------------------------l~~i~~~i~~aL~~L-H~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.. +..++.|++.+|.++ |+.+ |+||||||+||+++ ++.+
T Consensus 81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 311 145788999999999 6888 99999999999998 4789
Q ss_pred EEcccccccc
Q 039228 175 HIGDFELARF 184 (356)
Q Consensus 175 kl~Dfg~a~~ 184 (356)
+|+|||+|..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=141.37 Aligned_cols=104 Identities=18% Similarity=0.102 Sum_probs=84.8
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccc--------------------------hHHHHHHHHHHhhcCCCC
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--------------------------SKSFMAECKALKNICHRN 130 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 130 (356)
...||+|+||.||+|.+. +|+.||||+++...... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 78999999987542110 112356888888888776
Q ss_pred hHHH-----------------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCce
Q 039228 131 LVRF-----------------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 131 iv~l-----------------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+... ..++.+++.+|.++|+ .| |+||||||+||+++ ++.+
T Consensus 81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 5321 4578899999999999 88 99999999999999 8899
Q ss_pred EEccccccccc
Q 039228 175 HIGDFELARFR 185 (356)
Q Consensus 175 kl~Dfg~a~~~ 185 (356)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-17 Score=140.21 Aligned_cols=163 Identities=16% Similarity=-0.017 Sum_probs=115.5
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccCccc----hHHHHHHHHHHhhcCC-CChHHH---------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA----SKSFMAECKALKNICH-RNLVRF--------------- 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~h-~niv~l--------------- 134 (356)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|.| ++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence 4567899999999997765 46788877776443311 1257889999999964 445443
Q ss_pred -----------HHHHHHHHHHHHHHhhcCCCcEEecCC-CCCCeEeCCCCceEEcccccccccccCCCC----Cc-----
Q 039228 135 -----------ISIAIDVASALDYLHHHCQELILHCDP-KPSNVLLDNDLFAHIGDFELARFRQEVSNP----TQ----- 193 (356)
Q Consensus 135 -----------~~i~~~i~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----~~----- 193 (356)
..++.+++.+|.++|..| |+|||| ||+|||++.++.++|+|||++......... ..
T Consensus 83 ~~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ 159 (218)
T PRK12274 83 AAMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH 159 (218)
T ss_pred ccHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence 346788999999999999 999999 799999999999999999999854322110 00
Q ss_pred cCCCCccccccccchhhhcCC-CCC-CccchHhHHHHHHHHHcCCCCCCcc
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVS-TNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~-~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
....-...++.|++|+...-- ..+ ...+.++.|.-+|.++|+..|+-..
T Consensus 160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 000011235667777643221 222 4568899999999999999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=152.45 Aligned_cols=168 Identities=21% Similarity=0.293 Sum_probs=118.1
Q ss_pred HHHHHHHHHHHHHHhhcCCCcE-EecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcC
Q 039228 135 ISIAIDVASALDYLHHHCQELI-LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213 (356)
Q Consensus 135 ~~i~~~i~~aL~~LH~~~~~~i-iH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (356)
..+.++|+.||.|||+.. | .|+.+++.|+++|....+||+|||+....... ..............|.|||.+.+
T Consensus 51 ~s~~rdi~~Gl~ylh~s~---i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~--~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 51 LSFIRDISKGLAYLHNSP---IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET--AEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred HHHHHHHHHHHHHHhcCc---ceeeeeeccccceeeeeEEEEechhhhccccccc--ccccccchhHHHHhccCHHHhcc
Confidence 457789999999999875 5 89999999999999999999999998876431 11111122234567999999876
Q ss_pred CC-------CCCccchHhHHHHHHHHHcCCCCCCccccCCcc--HHHHHHHhCCCchHHHhhhhhccccccccccccchh
Q 039228 214 SE-------VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN--LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNML 284 (356)
Q Consensus 214 ~~-------~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 284 (356)
.. .+.+.||||||++++|+++...||+........ +...+.... ...+.+....
T Consensus 126 ~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~--------~~~~rP~i~~--------- 188 (484)
T KOG1023|consen 126 ALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGG--------SNPFRPSIEL--------- 188 (484)
T ss_pred cccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcC--------CCCcCcchhh---------
Confidence 41 466799999999999999999999864433221 111111100 0001111000
Q ss_pred hhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 285 RKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 285 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.. +....+..++..||..+|.+||++.++-..++.+....
T Consensus 189 ------~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 189 ------LN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ------hh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 00 22336789999999999999999999999999887754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-16 Score=161.96 Aligned_cols=164 Identities=18% Similarity=0.195 Sum_probs=124.0
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC---CCChHHH--------
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC---HRNLVRF-------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l-------- 134 (356)
+.......|.|.+.||+|+||.||.|.... ++.||+|+-+..... +|.-=.+++.+|+ -+.|..+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 334455679999999999999999999987 899999996543221 1111223333333 1112222
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-------CCCceEEcc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-------NDLFAHIGD 178 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~D 178 (356)
+.+..+++.-++.||..+ |||+||||+|+||. +..-++|+|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 457789999999999999 99999999999994 345689999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCC
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~P 238 (356)
||.+--+.-..+ .......++|-.+-.+|...|.+++...|.|.|+.+++.||.|+.-
T Consensus 845 fG~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999965433222 3455667889999999999999999999999999999999999653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=131.21 Aligned_cols=102 Identities=19% Similarity=0.263 Sum_probs=81.0
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-----CCCChHHHH--------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-----CHRNLVRFI-------------- 135 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~-------------- 135 (356)
.-...||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ +||||++++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3456899999999995 6666555 69998765444567899999999999 579999871
Q ss_pred --------------------------HHHHHHHHHH-HHHhhcCCCcEEecCCCCCCeEeCC----CCceEEcccccc
Q 039228 136 --------------------------SIAIDVASAL-DYLHHHCQELILHCDPKPSNVLLDN----DLFAHIGDFELA 182 (356)
Q Consensus 136 --------------------------~i~~~i~~aL-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg~a 182 (356)
.++.+++.++ +|||+++ ||||||||+|||++. ++.++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 1356777777 8999999 999999999999973 347999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-14 Score=129.56 Aligned_cols=115 Identities=18% Similarity=0.133 Sum_probs=89.5
Q ss_pred HHhhcCCCCccccceecCceEEEEEE-ECCCCeEEEEEEeeccCcc------------------------chHHHHHHHH
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGV-FDLNRAVVAIKVLSIQCQG------------------------ASKSFMAECK 121 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~ 121 (356)
+......|.+.+.||.|+||.||+|. +..+|+.||+|++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444468899999999999999999 6667899999998743210 0123567999
Q ss_pred HHhhcCCCChH--H---------------------------------HHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCe
Q 039228 122 ALKNICHRNLV--R---------------------------------FISIAIDVASALDYLHHHCQELILHCDPKPSNV 166 (356)
Q Consensus 122 ~l~~l~h~niv--~---------------------------------l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NI 166 (356)
++.++.+.++. + ...++.+++.+|.+||..+ .|+||||||+||
T Consensus 103 ~L~~L~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred HHHHHHhcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 98888653221 1 1368899999999999876 399999999999
Q ss_pred EeCCCCceEEcccccccc
Q 039228 167 LLDNDLFAHIGDFELARF 184 (356)
Q Consensus 167 ll~~~~~~kl~Dfg~a~~ 184 (356)
+++ ++.++|+|||.+..
T Consensus 181 li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEE-CCCEEEEEChhhhc
Confidence 999 88999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=124.53 Aligned_cols=116 Identities=23% Similarity=0.199 Sum_probs=89.6
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc----------------------chHHHHHHHHHH
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG----------------------ASKSFMAECKAL 123 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 123 (356)
.+......|.+.+.||.|+||.||+|... +++.||||++...... ....+..|..++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 33344444888899999999999999875 6799999987643210 011356788888
Q ss_pred hhcCCCCh--HH---------------------------HHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 124 KNICHRNL--VR---------------------------FISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 124 ~~l~h~ni--v~---------------------------l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
..+.|+++ .. ...++.+++.++.++|+.+ |+|+||+|+||+++.++.+
T Consensus 88 ~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 88 KALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred HHHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcE
Confidence 88776632 11 1347889999999999999 9999999999999999999
Q ss_pred EEccccccccc
Q 039228 175 HIGDFELARFR 185 (356)
Q Consensus 175 kl~Dfg~a~~~ 185 (356)
+|+|||.+...
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=119.69 Aligned_cols=100 Identities=22% Similarity=0.245 Sum_probs=80.9
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.||+|+||.||+|.+. +..|++|....... ....++.+|+.++..+.|+++...
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999954 67899998643211 112457789999999987764321
Q ss_pred ---------H-----HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ---------I-----SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ---------~-----~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
+ .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 1 68899999999999999 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=120.81 Aligned_cols=100 Identities=21% Similarity=0.213 Sum_probs=81.7
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCcc--------chHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--------ASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|+.++..+.|+++...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 4678999986532211 12357789999999988776532
Q ss_pred ------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 ------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 267889999999999999 99999999999999 7889999999886
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=117.65 Aligned_cols=104 Identities=22% Similarity=0.183 Sum_probs=76.8
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCcc--chHHH----------------------HHHHHHHhhcCCCC--
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG--ASKSF----------------------MAECKALKNICHRN-- 130 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n-- 130 (356)
.+.||+|+||.||+|.+. +++.||||++...... ....+ ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 6799999998643211 01111 24454444432221
Q ss_pred --------------------------h------HHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 131 --------------------------L------VRFISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 131 --------------------------i------v~l~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
+ -....++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+
T Consensus 81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CCceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEE
Confidence 0 1225588899999999999 88 99999999999999 8999999
Q ss_pred cccccccc
Q 039228 178 DFELARFR 185 (356)
Q Consensus 178 Dfg~a~~~ 185 (356)
|||.+...
T Consensus 157 Dfg~a~~~ 164 (187)
T cd05119 157 DVPQAVEI 164 (187)
T ss_pred ECcccccc
Confidence 99999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=137.25 Aligned_cols=109 Identities=20% Similarity=0.165 Sum_probs=84.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEe-ecc-Cc------cchHHHHHHHHHHhhcCCCChHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVL-SIQ-CQ------GASKSFMAECKALKNICHRNLVRF------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l------- 134 (356)
....|...+.||+|+||.||+|.+... .+++|+. ... .. ...+++.+|+.++..++|++++..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 344566788999999999999988644 3444432 111 11 123467899999999999987653
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 347789999999999999 9999999999999 578899999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-15 Score=147.50 Aligned_cols=220 Identities=23% Similarity=0.226 Sum_probs=156.6
Q ss_pred cCCCCccccceecCceEEEEEEECC-CCeEEEEEEeeccC--ccchHHHHHHHHHHhhcC-CCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-NRAVVAIKVLSIQC--QGASKSFMAECKALKNIC-HRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l------------ 134 (356)
...|.+.+.||.|+|+.|-...... ....+|+|.+.... .........|..+-..+. |+|++.+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457788889999999998877633 34566777765443 223344556777777777 9999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHh-hcCCCcEEecCCCCCCeEeCCCC-ceEEccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLH-HHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFR 185 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 185 (356)
-.++.|+..++.|+| +.+ +.|+||||+|.+++..+ .++++|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 236788999999999 888 99999999999999999 9999999999866
Q ss_pred ccCCCCCccCCCCccc-cccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 186 QEVSNPTQSSSNGVRR-TIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.... ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|...... ..
T Consensus 176 ~~~~-g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~- 251 (601)
T KOG0590|consen 176 RNKN-GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR--FT- 251 (601)
T ss_pred cccC-CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc--cc-
Confidence 5421 11233344566 9999999999874 45678899999999999999999998665544333333222100 00
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... .......++..+++..+|..|.+.+++-.
T Consensus 252 ---~~~~~----------------------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ---QLPWN----------------------SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cCccc----------------------cCChhhhhcccccccCCchhccccccccc
Confidence 00000 11113457778888889999998777643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-12 Score=113.52 Aligned_cols=102 Identities=16% Similarity=0.141 Sum_probs=80.4
Q ss_pred ccce-ecCceEEEEEEECCCCeEEEEEEeeccC-------------ccchHHHHHHHHHHhhcCCCChH--HH-------
Q 039228 78 NLIG-VGSFDAVYQGVFDLNRAVVAIKVLSIQC-------------QGASKSFMAECKALKNICHRNLV--RF------- 134 (356)
Q Consensus 78 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv--~l------- 134 (356)
..|| .||.|+||.+... +..++||.+.... ......+.+|+.++.+|+|++|. +.
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888899988775 6789999885321 12234678899999999887741 11
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
...+.+++.+|.+||..| |+||||||.|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 124668999999999999 99999999999999889999999998863
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=100.82 Aligned_cols=104 Identities=23% Similarity=0.226 Sum_probs=83.8
Q ss_pred ccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCC--ChHHH-------------------
Q 039228 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHR--NLVRF------------------- 134 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l------------------- 134 (356)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.++..++|. +++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45689999999999999863 7899999865433 45688899998888753 44433
Q ss_pred -----------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -----------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -----------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.+++.+|++||......++|+|++|.||+++..+.+++.|||.+.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 78 ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred eecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 3467789999999998533349999999999999998999999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-11 Score=108.53 Aligned_cols=102 Identities=19% Similarity=0.312 Sum_probs=75.0
Q ss_pred HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCC
Q 039228 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215 (356)
Q Consensus 136 ~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (356)
+|+.||+.||.|||+. .++|+|+++..+.|++..+|-+|++--.....-...............+-++|.+||+-....
T Consensus 180 kw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn 258 (458)
T KOG1266|consen 180 KWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN 258 (458)
T ss_pred HHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc
Confidence 4888999999999997 588999999999999999998887532221110000001111222344567899999877777
Q ss_pred CCCccchHhHHHHHHHHHcCCCC
Q 039228 216 VSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 216 ~~~~sDiwSlG~~l~elltg~~P 238 (356)
.+..+|||+||....+|..|..-
T Consensus 259 ~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 259 TTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred cccchhhhhhhHHHHHHHHheec
Confidence 78899999999999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.5e-12 Score=120.01 Aligned_cols=164 Identities=25% Similarity=0.249 Sum_probs=123.5
Q ss_pred CCCcccccee--cCceEEEEEEE--CCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcC-CCChHHH-----------
Q 039228 73 GFPLINLIGV--GSFDAVYQGVF--DLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNIC-HRNLVRF----------- 134 (356)
Q Consensus 73 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l----------- 134 (356)
.|.+.+.+|. |.+|.||.+.. ..+...+|+|.-+.. ......+=.+|+.....++ |+|.++.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4677888999 99999999998 778899999984322 2222333345555555554 7777764
Q ss_pred --------------------------HHHHHHHHH----HHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEccccccc
Q 039228 135 --------------------------ISIAIDVAS----ALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELAR 183 (356)
Q Consensus 135 --------------------------~~i~~~i~~----aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 183 (356)
+.++.+... ||.++|+.. ++|-|+||.||++..+ ...+++|||+..
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeE
Confidence 446667777 999999998 9999999999999988 899999999998
Q ss_pred ccccCCCCCc-cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 184 FRQEVSNPTQ-SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 184 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
.+........ .......|...|++||...+ -++..+|+|++|.++.+..+|..+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 7655442211 11123356778999998854 57889999999999999998877653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.5e-10 Score=107.64 Aligned_cols=139 Identities=17% Similarity=0.234 Sum_probs=103.0
Q ss_pred EEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHHHH--------------------------------H
Q 039228 90 QGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS--------------------------------I 137 (356)
Q Consensus 90 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~--------------------------------i 137 (356)
.|..+.++.+|.|...+...........+-++.|+.++||||+++++ .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~G 109 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLG 109 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHH
Confidence 46666778899999887665544455777889999999999999832 3
Q ss_pred HHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCC
Q 039228 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217 (356)
Q Consensus 138 ~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (356)
+.||+.||.|||+.+ .++|++|.-+.|+++..|..||++|.++........ .......-..|..|+.+....
T Consensus 110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcCccc--
Confidence 568999999999765 499999999999999999999999998864432221 111112223456666543322
Q ss_pred CccchHhHHHHHHHHHcCC
Q 039228 218 TNGDAYNYGILLLEMVTRR 236 (356)
Q Consensus 218 ~~sDiwSlG~~l~elltg~ 236 (356)
...|.|-||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3459999999999999993
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.3e-09 Score=96.80 Aligned_cols=186 Identities=15% Similarity=0.094 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhc--
Q 039228 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-- 212 (356)
Q Consensus 135 ~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-- 212 (356)
+.+++.++.+.+-||++| .+-+|+.++|+|+++++.+.|.|-..-..- .+.......+|...|.+||...
T Consensus 120 lrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-----~ng~~~~cpVg~~eftPPElQ~~~ 191 (637)
T COG4248 120 LRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-----ANGTLHLCPVGVSEFTPPELQTLP 191 (637)
T ss_pred HHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec-----cCCceEecccCccccCCHHHhccc
Confidence 668889999999999999 999999999999999999999875443221 1123344567888999999765
Q ss_pred ---CCCCCCccchHhHHHHHHHHHcC-CCCCCccccCCc---cHH-HHHHHhCCCchHHHhhhhhccccccccccccchh
Q 039228 213 ---GSEVSTNGDAYNYGILLLEMVTR-RKPIDFMFEGDL---NLH-NFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNML 284 (356)
Q Consensus 213 ---~~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 284 (356)
+..-+...|.|.||+++++++.| +.||.+...... ... ......+...-. ....+... +.
T Consensus 192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~--~~~g~~p~--------P~-- 259 (637)
T COG4248 192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD--QRRGLKPP--------PR-- 259 (637)
T ss_pred cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh--ccCCCCCC--------CC--
Confidence 34456788999999999999886 999987543221 111 111111110000 00000000 00
Q ss_pred hhhchhhHHHHHHHHHHHHHhhcCC--CcCCCCChHHHHHHHHHhhhhhcc--ccccccCCcCC
Q 039228 285 RKTKMNSRLECLIFMVRIGAACSMG--SSQDRMNVPNAVHDLQSVNNILLP--ETVFKSLTNNR 344 (356)
Q Consensus 285 ~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~~vl~~L~~i~~~~~~--~~~~~~~~~~~ 344 (356)
+... .-.+..+..+..+|+.. ++.-|||++..+..|.++.+++.+ ...+-.++++.
T Consensus 260 -~~P~---~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl 319 (637)
T COG4248 260 -SIPL---SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHL 319 (637)
T ss_pred -CCCh---hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCC
Confidence 0000 01222456677888765 367899999999999999998844 34433355544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.7e-10 Score=106.21 Aligned_cols=47 Identities=21% Similarity=0.244 Sum_probs=39.0
Q ss_pred HHHHHHH-HHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 137 IAIDVAS-ALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 137 i~~~i~~-aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
++..++. .+..+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 261 ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 261 LAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 3444444 467889988 9999999999999999999999999997553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.4e-10 Score=92.30 Aligned_cols=103 Identities=19% Similarity=0.111 Sum_probs=78.1
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
.+.|+.|.++.||++... +..|++|+...... ....+..|+.+++.+.+.++++-
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccc
Confidence 457899999999999875 67899999754322 12345678888888765444321
Q ss_pred ------HHHHHHHHHHHHHHhhcC--CCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 ------ISIAIDVASALDYLHHHC--QELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ------~~i~~~i~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 235678999999999986 11259999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.7e-10 Score=109.39 Aligned_cols=162 Identities=15% Similarity=0.250 Sum_probs=101.3
Q ss_pred hhcCCCCccccceecCce---EEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCC-ChHHH----HHHHHH
Q 039228 69 KATDGFPLINLIGVGSFD---AVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHR-NLVRF----ISIAID 140 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l----~~i~~~ 140 (356)
....+|+..+.+|..+-| .+|.+.....+.....|..-. ..+.....-+++++|. ++.+- +.=+.+
T Consensus 34 ~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~~~------~~ld~~~~~~~~lr~~~~vs~aTe~~f~nl~~ 107 (700)
T KOG2137|consen 34 KESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSAVV------WMLDKRASSLQQLRGLDGVSKATEDGFANLGN 107 (700)
T ss_pred ccccccccccceeecCCCchhhhhhhhccCccCccccceeee------eecChhhhHHHHHhcccchhhcccHhhhhhhc
Confidence 446678887777765544 566666554444432221110 0011112223333331 11111 222334
Q ss_pred HHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC-----CCccCCCCccccccccchhhhcCCC
Q 039228 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN-----PTQSSSNGVRRTIGYTALDYDLGSE 215 (356)
Q Consensus 141 i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (356)
++.||.|+|... .+||++|.|++|.++.++..||+.|+++........ ..............|.|||++.+..
T Consensus 108 v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 668999999865 499999999999999999999999999865433111 1111222233456799999999988
Q ss_pred CCCccchHhHHHHHHHHHcCCCC
Q 039228 216 VSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 216 ~~~~sDiwSlG~~l~elltg~~P 238 (356)
.+.++|+||+|+++|.+..|..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccceeeeeEEEEEecCCcc
Confidence 89999999999999999954443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.84 E-value=1e-08 Score=100.65 Aligned_cols=35 Identities=26% Similarity=0.270 Sum_probs=30.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeec
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI 107 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~ 107 (356)
..|+. +.||+|++|+||+|+.+.+|+.||||+...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP 154 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRP 154 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCc
Confidence 35776 789999999999999998789999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.3e-09 Score=103.13 Aligned_cols=163 Identities=21% Similarity=0.204 Sum_probs=114.8
Q ss_pred HHhhcCCCCccccceecCceEEEEEEEC-CCCeEEEEEEeeccCccchHH--HHHHHHHHhhcC-CCChHHH--------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFD-LNRAVVAIKVLSIQCQGASKS--FMAECKALKNIC-HRNLVRF-------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l-------- 134 (356)
....+.+|..+..||.|.|+.|+..... .++..|++|.+.........+ -..|+.+...+. |.+++.+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678999999999999999988765 678899999876443322222 123444444332 4444442
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARF 184 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 184 (356)
+.+..+++.++.++|+.. ++|+|++|+||++..+ +..+++|||.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 456778999999999988 9999999999999876 8889999999864
Q ss_pred cccCCCCCccCCCCccccccc-cchhhhcCCCCCCccchHhHHHHHHHHHcCCCC
Q 039228 185 RQEVSNPTQSSSNGVRRTIGY-TALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~P 238 (356)
+...... ....+..| .++.......+..+.|++|||..+.+..+|..-
T Consensus 417 ~~~~~~~------~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 417 LAFSSGV------FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cceeccc------ccccccccccchhhccccccccccccccccccccccccCccc
Confidence 3221110 01112233 355555667788999999999999999998654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.2e-08 Score=85.78 Aligned_cols=104 Identities=20% Similarity=0.137 Sum_probs=74.7
Q ss_pred cccceecCceEEEEEEECC------CCeEEEEEEeeccC------------c----------cchHHH----HHHHHHHh
Q 039228 77 INLIGVGSFDAVYQGVFDL------NRAVVAIKVLSIQC------------Q----------GASKSF----MAECKALK 124 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 124 (356)
...||.|--+.||.|.... .+..+|||+++... . ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 24799999985321 0 001122 26888888
Q ss_pred hcCCCC-----hH------------------------------HHHHHHHHHHHHHHHH-hhcCCCcEEecCCCCCCeEe
Q 039228 125 NICHRN-----LV------------------------------RFISIAIDVASALDYL-HHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 125 ~l~h~n-----iv------------------------------~l~~i~~~i~~aL~~L-H~~~~~~iiH~Dlkp~NIll 168 (356)
++.--+ ++ .+..+..+++.+|..| |..+ |||+||++.||++
T Consensus 82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~ 158 (197)
T cd05146 82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLW 158 (197)
T ss_pred HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 774211 00 0134567899999988 8888 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 039228 169 DNDLFAHIGDFELARF 184 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~ 184 (356)
+ ++.+.|+|||.+..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 7 46799999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-09 Score=108.53 Aligned_cols=170 Identities=21% Similarity=0.232 Sum_probs=118.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..+++.+.+.+-+|.++.++.+.-..++...++|+..... ....+....+-.++-...+|.+++.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4567888889999999999988776666555555543211 1111222222222222233333321
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
......+..+++|||... ++|+|++|.|+++..++..+++|||.........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccccc
Confidence 124456788999999987 8999999999999999999999998443221100
Q ss_pred ----------------------CC-----CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 190 ----------------------NP-----TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 190 ----------------------~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.. .........+|+.|.+||...+......+|+|++|++++|.++|.+||+..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 012234567899999999999999999999999999999999999999743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9e-07 Score=73.91 Aligned_cols=101 Identities=21% Similarity=0.235 Sum_probs=72.4
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEe-eccCc--c-----chHHHHHHHHHHhhcCC-----CChHHH----------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVL-SIQCQ--G-----ASKSFMAECKALKNICH-----RNLVRF---------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~--~-----~~~~~~~E~~~l~~l~h-----~niv~l---------- 134 (356)
..+++|+-+.+|.+.+. +..+++|.= ++.-. . ...+..+|++++.++.- |-+.-+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 445666653 22111 1 12345678888887642 211110
Q ss_pred ---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++..+-.-+.-||..| |||+||.++||++..++ +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 357788888999999999 99999999999998765 88999999963
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.6e-06 Score=78.96 Aligned_cols=130 Identities=18% Similarity=0.233 Sum_probs=100.5
Q ss_pred ceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------------------------
Q 039228 85 FDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------------------ 134 (356)
Q Consensus 85 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------------------ 134 (356)
-.+.|++....+|..|++|+++............-++..+++.|+|+|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789999999999999999964433333334455788999999999998
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 568899999999999999 88899999999999998999987777654432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCC
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~P 238 (356)
... +.+.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 210 11111 1345888999999999999654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.9e-06 Score=71.89 Aligned_cols=103 Identities=27% Similarity=0.310 Sum_probs=76.2
Q ss_pred ccccceecCceEEEEEEECCCCeEEEEEEe-eccC-------ccchHHHHHHHHHHhhcC-----CCChHH---------
Q 039228 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVL-SIQC-------QGASKSFMAECKALKNIC-----HRNLVR--------- 133 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~-----h~niv~--------- 133 (356)
....|-+|+-+.|+++.+. |+...||.- .+.. .-..++..+|+++|.++. -|-+.-
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999987 677777753 2221 112356778998888763 222111
Q ss_pred ------------H--------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEccccccc
Q 039228 134 ------------F--------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIGDFELAR 183 (356)
Q Consensus 134 ------------l--------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~ 183 (356)
+ ..++..|-..+.-||..+ |||+||..+||++..++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 1 357788999999999999 99999999999996544 45899999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=68.08 Aligned_cols=92 Identities=22% Similarity=0.232 Sum_probs=62.3
Q ss_pred EEEEEEECCCCeEEEEEEeeccC--------------c-------c-----chHHHHHHHHHHhhcCCCCh--HHH----
Q 039228 87 AVYQGVFDLNRAVVAIKVLSIQC--------------Q-------G-----ASKSFMAECKALKNICHRNL--VRF---- 134 (356)
Q Consensus 87 ~Vy~~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~h~ni--v~l---- 134 (356)
.||.|.... +..+|||+..... . . ......+|.+.|.++..-++ .+.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998854 5899999985320 0 0 01245679999999875432 221
Q ss_pred -----------------------------HHHHHHHHHHHHH-HhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -----------------------------ISIAIDVASALDY-LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.+++..+.. +|..| |+|+||.+.||+++++ .+.|+|||.+.
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcce
Confidence 3466777775555 57888 9999999999999987 89999999885
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=70.27 Aligned_cols=105 Identities=17% Similarity=0.186 Sum_probs=77.4
Q ss_pred ccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCCh--HHH--------------------
Q 039228 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNL--VRF-------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni--v~l-------------------- 134 (356)
+.|+.|.++.||++.... |..+++|....... .....+..|+.++..+.+.++ .++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 47899999764322 134567889998888764221 211
Q ss_pred -------------------HHHHHHHHHHHHHHhhcC-------------------------------------------
Q 039228 135 -------------------ISIAIDVASALDYLHHHC------------------------------------------- 152 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~------------------------------------------- 152 (356)
..++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 145778888999988531
Q ss_pred ----------CCcEEecCCCCCCeEeCC--CCceEEccccccc
Q 039228 153 ----------QELILHCDPKPSNVLLDN--DLFAHIGDFELAR 183 (356)
Q Consensus 153 ----------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 183 (356)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 123799999999999998 6678999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.7e-05 Score=68.19 Aligned_cols=106 Identities=20% Similarity=0.129 Sum_probs=75.8
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc----------------------cchHHHHHHHHHHhhcCCC-
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ----------------------GASKSFMAECKALKNICHR- 129 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 129 (356)
-..+...||.|.-+.||.|.... +..+|||.-..... -......+|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 35677899999999999999874 58999997532110 0112346788888888422
Q ss_pred -ChHHH----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 130 -NLVRF----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 130 -niv~l----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
.+.+. -.++..|+.-+.-+-..| |||+|+++-||+++++|.+.++||=
T Consensus 171 ~~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 171 VKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred CCCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 11111 235556666666555778 9999999999999999999999996
Q ss_pred cc
Q 039228 181 LA 182 (356)
Q Consensus 181 ~a 182 (356)
-+
T Consensus 248 Q~ 249 (304)
T COG0478 248 QA 249 (304)
T ss_pred cc
Confidence 55
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.2e-05 Score=68.47 Aligned_cols=45 Identities=27% Similarity=0.214 Sum_probs=39.5
Q ss_pred HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-------CCceEEccccccc
Q 039228 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-------DLFAHIGDFELAR 183 (356)
Q Consensus 136 ~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~~~~kl~Dfg~a~ 183 (356)
.++.+++..+.-||..| |+|+|++++|||++. ++.+.|+||+.+.
T Consensus 142 ~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 142 MLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 35567899999999999 999999999999975 4688999999885
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.7e-05 Score=65.67 Aligned_cols=100 Identities=13% Similarity=0.075 Sum_probs=75.1
Q ss_pred ceecCceEEEEEEECCCCeEEEEEEeeccC------ccchHHHHHHHHHHhhcCCCChH--HH-----------------
Q 039228 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQC------QGASKSFMAECKALKNICHRNLV--RF----------------- 134 (356)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv--~l----------------- 134 (356)
-|+||.+-|+..... |..+-+|.-.... .-....|.+|+..|.+|..-++. +.
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 478999999997765 3467778753110 22456899999999888532222 11
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc--eEEcccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF--AHIGDFELARF 184 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 184 (356)
-.++.+++..+.-||..| +.|+|+.+.||+++..+. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 146778999999999999 999999999999986666 89999987763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00057 Score=60.08 Aligned_cols=124 Identities=21% Similarity=0.192 Sum_probs=81.6
Q ss_pred hcccCChhhHHHHHhhcCCCCccccce---ecCceEEEEEEECCCCeEEEEEEeeccCccc-------------------
Q 039228 55 LRNAIPKEYYESLLKATDGFPLINLIG---VGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA------------------- 112 (356)
Q Consensus 55 ~~~~~~~~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------- 112 (356)
...-+...+...+....++..+....| .|.-+.||+|... ++..+|+|++.......
T Consensus 28 ~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~ 106 (268)
T COG1718 28 VDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN 106 (268)
T ss_pred hhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence 334455566666666666666666555 5666689998863 46899999996432111
Q ss_pred hH-----HHHHHHHHHhhcCCC------------ChHH-----------------------HHHHHHHHHHHHHHHhh-c
Q 039228 113 SK-----SFMAECKALKNICHR------------NLVR-----------------------FISIAIDVASALDYLHH-H 151 (356)
Q Consensus 113 ~~-----~~~~E~~~l~~l~h~------------niv~-----------------------l~~i~~~i~~aL~~LH~-~ 151 (356)
.. ....|+.-|+++.-. |++- ...+..+++..+.-|-. .
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 01 123466666655211 1110 03456677777777766 6
Q ss_pred CCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 152 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+ +||+||+.-|||+. ++.+.|+|||-|.
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV 214 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAV 214 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECcccc
Confidence 6 99999999999999 8899999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=1.8e-05 Score=77.33 Aligned_cols=150 Identities=15% Similarity=0.062 Sum_probs=110.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCC-hHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN-LVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l--------------- 134 (356)
+..+...+-+++|+++.+++.+...+...+ .+.+... .....++++|.+++||| .++.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 344556667899999999998876553333 5554422 34456889999999999 4433
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..+++.-+.+|++||+.. =+|+| ||+..+ +..+.+||+....+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 124445667899999864 48888 777654 678999999887554322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCC
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf 239 (356)
......+++.++|||+...+.+....|.|++|+--.+|.-|.+|-
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 344577899999999999999999999999998777887777764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00037 Score=68.47 Aligned_cols=36 Identities=28% Similarity=0.425 Sum_probs=31.2
Q ss_pred HhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 148 LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+-..| +.|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33456 9999999999999999999999999987553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00011 Score=63.87 Aligned_cols=47 Identities=32% Similarity=0.388 Sum_probs=42.5
Q ss_pred HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEcccccccc
Q 039228 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIGDFELARF 184 (356)
Q Consensus 135 ~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 184 (356)
-.++.+++..+.-||..| |+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 121 ~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 121 RELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 567889999999999999 99999999999999877 889999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=57.57 Aligned_cols=108 Identities=19% Similarity=0.207 Sum_probs=70.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHH---------HHHHHHHhhcC---CCChHHH---
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSF---------MAECKALKNIC---HRNLVRF--- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l--- 134 (356)
..++|.+.+++-......|.+-... +..+++|..........+.| .+.+..+.+++ -..+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888877777766654 68899998764332221111 12222222221 1111111
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
-.+...+..++.-||..| +.|+|..|.|+++++++ +++.||+..+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 023456889999999999 99999999999999655 8899998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0017 Score=54.19 Aligned_cols=104 Identities=23% Similarity=0.246 Sum_probs=70.1
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHH-----------H--------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR-----------F-------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------l-------- 134 (356)
....+.|++|.+|.||++.+. |..+|+|+=... .....+..|+++|..+..-++.+ +
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L 99 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcch
Confidence 345678999999999999987 668999985432 33467888999888776433221 1
Q ss_pred ---H-----HHHHHHHHHHHHHhhcCCCcEEecCCC-CCCeEeCCCCceEEcccccccc
Q 039228 135 ---I-----SIAIDVASALDYLHHHCQELILHCDPK-PSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ---~-----~i~~~i~~aL~~LH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~Dfg~a~~ 184 (356)
. .-...++.+---|-..| |-|..|. |..++|..++.+.|+||..|+.
T Consensus 100 ~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 1 11233444444455666 8888886 4445555555899999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0025 Score=54.64 Aligned_cols=101 Identities=25% Similarity=0.378 Sum_probs=73.1
Q ss_pred CCCCccccceecCc-eEEEEEEECCCCeEEEEEEeec---cCc------------------cchHHHHHHHHHHhhcC--
Q 039228 72 DGFPLINLIGVGSF-DAVYQGVFDLNRAVVAIKVLSI---QCQ------------------GASKSFMAECKALKNIC-- 127 (356)
Q Consensus 72 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~-- 127 (356)
.+++.++.||.|.. |.||++... |+.+|+|++.. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 999999987 78999999421 100 11224667777666554
Q ss_pred -CCCh--HHH------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCC
Q 039228 128 -HRNL--VRF------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPK 162 (356)
Q Consensus 128 -h~ni--v~l------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlk 162 (356)
+.++ |+. ..-+.+|.+-|..+|..| |+-+|++
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~ 191 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLG---IVPRDVK 191 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCC---eeeccCc
Confidence 2233 222 123456888899999999 9999999
Q ss_pred CCCeEeCCCCceEEcccccc
Q 039228 163 PSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 163 p~NIll~~~~~~kl~Dfg~a 182 (356)
+.|.. .-+|+|||.+
T Consensus 192 ~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccccc-----CCEEEecccC
Confidence 99987 3478999865
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0037 Score=54.63 Aligned_cols=47 Identities=19% Similarity=0.227 Sum_probs=35.4
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
++.|+.|..+.||+..... ..+++|..... .....+..|..+++.+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~ 48 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLA 48 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHH
Confidence 4578999999999999874 48899997543 34456777888777764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0036 Score=55.14 Aligned_cols=27 Identities=19% Similarity=0.026 Sum_probs=24.8
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.006 Score=54.71 Aligned_cols=27 Identities=26% Similarity=0.310 Sum_probs=24.5
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 79999999999999877 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.012 Score=62.06 Aligned_cols=164 Identities=15% Similarity=0.144 Sum_probs=103.6
Q ss_pred HHHHHHHHhhcCCCChHHH-----------------------------------------HHHHHHHHHHHHHHhhcCCC
Q 039228 116 FMAECKALKNICHRNLVRF-----------------------------------------ISIAIDVASALDYLHHHCQE 154 (356)
Q Consensus 116 ~~~E~~~l~~l~h~niv~l-----------------------------------------~~i~~~i~~aL~~LH~~~~~ 154 (356)
...|...+..+.|+|++.+ ..+..++..||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 3456777888899999876 225567889999999985
Q ss_pred cEEecCCCCC---CeEeCCCCceEEc--ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCc--cchHhHHH
Q 039228 155 LILHCDPKPS---NVLLDNDLFAHIG--DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN--GDAYNYGI 227 (356)
Q Consensus 155 ~iiH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDiwSlG~ 227 (356)
..|.-+..+ +.-.+..+.+.++ ||+..+.+...... .....+..+.++|......+..+ .|+|.+|.
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccc-----hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 555544444 3444556666666 88887755432211 11222445677777766555444 69999999
Q ss_pred HHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhc
Q 039228 228 LLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACS 307 (356)
Q Consensus 228 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 307 (356)
....+..|..+-... .....+++.. ....+......|+
T Consensus 381 l~~~~~~~~~i~~~~----------------~~~~~~l~~~--------------------------~~~~~~d~~~~~~ 418 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS----------------AVPVSLLDVL--------------------------STSELLDALPKCL 418 (1351)
T ss_pred HHhhhhhcCcccccc----------------cchhhhhccc--------------------------cchhhhhhhhhhc
Confidence 999998876652210 0001111110 0003457788999
Q ss_pred CCCcCCCCChHHHHHHHHHhhh
Q 039228 308 MGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 308 ~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
..++++|+++.+++...-.-..
T Consensus 419 ~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 419 DEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred chhhhhccchhhhhhchhcccc
Confidence 9999999999999987644333
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.018 Score=50.69 Aligned_cols=29 Identities=21% Similarity=0.302 Sum_probs=25.8
Q ss_pred cEEecCCCCCCeEeCC-CCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDN-DLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 3899999999999997 5789999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.02 Score=52.46 Aligned_cols=28 Identities=36% Similarity=0.510 Sum_probs=25.6
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.|.||++++++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 8999999999999988777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.02 Score=52.60 Aligned_cols=106 Identities=19% Similarity=0.200 Sum_probs=72.4
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----------------ccc---h--HHHHHHHHHHhhcC---
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----------------QGA---S--KSFMAECKALKNIC--- 127 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~---~--~~~~~E~~~l~~l~--- 127 (356)
-+.+++.||-|.-+-||.+.+.. |++.++|.-.... ... . -...+|...|+.|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 46788899999999999998865 4788888643110 000 0 12345777777662
Q ss_pred -----------CCChHHH---------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 128 -----------HRNLVRF---------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 128 -----------h~niv~l---------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
|--|..+ -.++..+..-+--|.++| +||+|..--||++++++.++++||=-
T Consensus 172 fpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 172 FPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechH
Confidence 1112222 124444555566788889 99999999999999999999999954
Q ss_pred c
Q 039228 182 A 182 (356)
Q Consensus 182 a 182 (356)
.
T Consensus 249 m 249 (465)
T KOG2268|consen 249 M 249 (465)
T ss_pred h
Confidence 4
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.081 Score=52.23 Aligned_cols=30 Identities=30% Similarity=0.440 Sum_probs=26.9
Q ss_pred EEecCCCCCCeEeC----CCCceEEccccccccc
Q 039228 156 ILHCDPKPSNVLLD----NDLFAHIGDFELARFR 185 (356)
Q Consensus 156 iiH~Dlkp~NIll~----~~~~~kl~Dfg~a~~~ 185 (356)
++|+|=.|.||++. .++.+.+.|||+...+
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 99999999999998 4778999999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.06 Score=50.62 Aligned_cols=29 Identities=28% Similarity=0.324 Sum_probs=25.4
Q ss_pred cEEecCCCCCCeEeCC-CCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDN-DLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 183 (356)
.++|+|+++.||++++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 3899999999999986 5789999999884
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.093 Score=50.17 Aligned_cols=50 Identities=20% Similarity=0.054 Sum_probs=35.5
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeecc-----C--ccchHHHHHHHHHHhhc
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-----C--QGASKSFMAECKALKNI 126 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l 126 (356)
.+.||.|.++.||++....+++.|+||.-... . ....++...|...|..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l 87 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQ 87 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHH
Confidence 35789999999999998755468999984311 0 12345677788877765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.063 Score=49.75 Aligned_cols=28 Identities=32% Similarity=0.469 Sum_probs=24.9
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+||+|+.|.||+++.+...-|+||+.+.
T Consensus 189 liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 189 VIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCCCCCCCcEEEECCceEEEEeccccc
Confidence 9999999999999977666899999884
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.08 Score=48.85 Aligned_cols=29 Identities=38% Similarity=0.509 Sum_probs=26.0
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 39999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.14 Score=44.14 Aligned_cols=96 Identities=23% Similarity=0.269 Sum_probs=61.1
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccC----------------ccchHHHHHHHHHHhhcC------CCChHHH
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC----------------QGASKSFMAECKALKNIC------HRNLVRF 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 134 (356)
...||+|+.-.||.--.. ....||+..... ....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999975433 556789886543 223456677777666655 4455554
Q ss_pred HH----------------------------HH------HHHHHH----HHHHhhcCCCcEEecCCCCCCeEeCC--CC--
Q 039228 135 IS----------------------------IA------IDVASA----LDYLHHHCQELILHCDPKPSNVLLDN--DL-- 172 (356)
Q Consensus 135 ~~----------------------------i~------~~i~~a----L~~LH~~~~~~iiH~Dlkp~NIll~~--~~-- 172 (356)
++ ++ ..+..+ ..||-..+ |+.+|++|.||++.. ++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCce
Confidence 11 11 123333 35777777 999999999999963 22
Q ss_pred ceEEcc
Q 039228 173 FAHIGD 178 (356)
Q Consensus 173 ~~kl~D 178 (356)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.006 Score=65.91 Aligned_cols=80 Identities=11% Similarity=-0.017 Sum_probs=68.5
Q ss_pred EEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcC
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR 235 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg 235 (356)
.+|+++|+-|.+|..+..++++++|+.++. ++.....+...+++.|+.++....-.++.++|+|+.|+.+|+.-.|
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk----np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIK----NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred chhhhhhhhccceecCCccccccccccccc----CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 689999999999999999999999999833 2334455667778889999999888888889999999999999888
Q ss_pred CCCC
Q 039228 236 RKPI 239 (356)
Q Consensus 236 ~~Pf 239 (356)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 8776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.064 Score=46.70 Aligned_cols=40 Identities=23% Similarity=0.218 Sum_probs=33.3
Q ss_pred HHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 142 ASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 142 ~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|-+..
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 56788889542 34999999999999999999999997754
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.24 Score=47.18 Aligned_cols=50 Identities=18% Similarity=0.192 Sum_probs=34.6
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEee----c--cCccchHHHHHHHHHHhhc
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLS----I--QCQGASKSFMAECKALKNI 126 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~--~~~~~~~~~~~E~~~l~~l 126 (356)
...||.|.-..||++.+..+++.|+||.-. . +..-..++..-|...|+.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~ 89 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLE 89 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHH
Confidence 467899999999999985445679999742 1 1123345666677777765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.33 Score=51.23 Aligned_cols=55 Identities=9% Similarity=0.130 Sum_probs=37.3
Q ss_pred cccceecCceEEEEEEECCCC--eEEEEEEeeccCc-cchHHHHHHHHHHhhcC-CCCh
Q 039228 77 INLIGVGSFDAVYQGVFDLNR--AVVAIKVLSIQCQ-GASKSFMAECKALKNIC-HRNL 131 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni 131 (356)
...++.|.++.+|+.....++ ..+++|+...... .....+.+|+.+|+.+. |+++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v 101 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV 101 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC
Confidence 567899999999998775432 4677777643221 22346788999998885 5543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.17 Score=43.25 Aligned_cols=56 Identities=20% Similarity=0.230 Sum_probs=45.8
Q ss_pred ChHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 130 niv~l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
....-.+|+.+++..+.+|++.-...+.-.|++++|+-++++|.+|+.|...+...
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 33444678999999999999854444888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.27 Score=46.20 Aligned_cols=104 Identities=20% Similarity=0.250 Sum_probs=68.6
Q ss_pred ccccceecCceEEEEEEECCCCeEEEEEEeecc---------------------Cccc----h-HHHHHHHHHHhhcCCC
Q 039228 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---------------------CQGA----S-KSFMAECKALKNICHR 129 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------------------~~~~----~-~~~~~E~~~l~~l~h~ 129 (356)
+-..|..|.-+.||.|.... |..+|||+++.+ +... . -....|++-|.+|+..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44567788889999998764 577999998532 0011 1 1234677778877533
Q ss_pred ChH-------H-------H---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 130 NLV-------R-------F---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 130 niv-------~-------l---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
.|. + + ..+..+++.-+.-|-+.+ .+||.||.--|+|+. +|.+
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEE
Confidence 221 1 0 234455666666665544 399999999999987 5678
Q ss_pred EEccccccc
Q 039228 175 HIGDFELAR 183 (356)
Q Consensus 175 kl~Dfg~a~ 183 (356)
.|+|.+-+.
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 899988764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.45 Score=44.80 Aligned_cols=48 Identities=15% Similarity=0.086 Sum_probs=32.7
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEee----c---cCccchHHHHHHHHHHhhc
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLS----I---QCQGASKSFMAECKALKNI 126 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~---~~~~~~~~~~~E~~~l~~l 126 (356)
.||.|....||++....+++.|+||.-. . ...-...+..-|...|+..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~ 56 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQ 56 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHh
Confidence 5799999999999986544689999742 1 1123345556677777654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.27 Score=46.02 Aligned_cols=47 Identities=28% Similarity=0.335 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
+.++.+.+.-++-+... .+.-|||+.-.||||+ +|++.|+||.+++.
T Consensus 324 lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 324 LSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred HHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence 55666666666655553 4588999999999999 99999999999983
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.99 E-value=0.55 Score=43.83 Aligned_cols=28 Identities=25% Similarity=0.291 Sum_probs=24.7
Q ss_pred EEecCCCCCCeEeCC-CCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDN-DLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 183 (356)
++|.|+.+.||++++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 689999999999974 5789999999884
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.1 Score=46.15 Aligned_cols=29 Identities=24% Similarity=0.421 Sum_probs=25.3
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.||++++++..-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999977666799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.53 E-value=0.24 Score=45.45 Aligned_cols=30 Identities=33% Similarity=0.319 Sum_probs=26.4
Q ss_pred CcEEecCCCCCCeEeCCC----CceEEccccccc
Q 039228 154 ELILHCDPKPSNVLLDND----LFAHIGDFELAR 183 (356)
Q Consensus 154 ~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 183 (356)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 348999999999999974 889999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.22 E-value=0.11 Score=44.23 Aligned_cols=27 Identities=26% Similarity=0.292 Sum_probs=24.7
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.+|+|+.|.||++++++ ++|+||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 68999999999998877 8899999885
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.13 Score=45.63 Aligned_cols=29 Identities=21% Similarity=0.299 Sum_probs=26.1
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.74 E-value=0.19 Score=46.39 Aligned_cols=49 Identities=27% Similarity=0.428 Sum_probs=29.5
Q ss_pred HHHHHHHHHHHH-hhcCCCcEEecCCCCCCeEeCCCC------------------ceEEccccccccc
Q 039228 137 IAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDL------------------FAHIGDFELARFR 185 (356)
Q Consensus 137 i~~~i~~aL~~L-H~~~~~~iiH~Dlkp~NIll~~~~------------------~~kl~Dfg~a~~~ 185 (356)
++.||+.-.-.. ...+-...+|-||||+|||+-+.. .++|.||.+++..
T Consensus 284 ifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 284 IFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 555655433222 222223489999999999994332 3456777777643
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=91.49 E-value=0.092 Score=41.21 Aligned_cols=30 Identities=20% Similarity=0.107 Sum_probs=26.1
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeec
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSI 107 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~ 107 (356)
...||.|+.|.||+|+... |+.||||+.+.
T Consensus 16 ~~PlasASiaQVh~a~l~~-g~~VaVKV~rP 45 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKD-GEEVAVKVQRP 45 (119)
T ss_pred cchhhheehhhheeeeecc-cchhhhhhcch
Confidence 3589999999999999876 69999999763
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.14 E-value=0.35 Score=44.44 Aligned_cols=28 Identities=25% Similarity=0.222 Sum_probs=24.5
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3899999999999987 668899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.65 E-value=0.17 Score=43.82 Aligned_cols=28 Identities=36% Similarity=0.521 Sum_probs=20.3
Q ss_pred EEecCCCCCCeEe-CCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLL-DNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll-~~~~~~kl~Dfg~a~ 183 (356)
++|.|+.|.||++ +.++.++|+||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 7899999999999 889999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.44 Score=43.15 Aligned_cols=28 Identities=32% Similarity=0.338 Sum_probs=26.4
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.|.|++.++.+.++|+||..|.
T Consensus 155 ~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 155 PCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eecCCCCccceEEcCCCcEEEEecccCC
Confidence 8999999999999999999999998875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=89.84 E-value=0.83 Score=41.78 Aligned_cols=48 Identities=21% Similarity=0.287 Sum_probs=32.0
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
+-.+.++-|....+|+.. .+++.+.||+-. ......|..|..-|+.|.
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~ 67 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALA 67 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHH
Confidence 345578889999999877 556889999865 233456777888777773
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.24 E-value=0.32 Score=44.20 Aligned_cols=30 Identities=27% Similarity=0.517 Sum_probs=25.0
Q ss_pred cEEecCCCCCCeEeCCCCc-eEEcccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLF-AHIGDFELARF 184 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~ 184 (356)
.++|+|+.|.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997554 46999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.19 E-value=0.27 Score=45.68 Aligned_cols=32 Identities=28% Similarity=0.571 Sum_probs=24.2
Q ss_pred cEEecCCCCCCeEeCCC------------------CceEEcccccccccc
Q 039228 155 LILHCDPKPSNVLLDND------------------LFAHIGDFELARFRQ 186 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~------------------~~~kl~Dfg~a~~~~ 186 (356)
..+|-||||+|||+-+. -.++|.||.+++..+
T Consensus 299 nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 299 NFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred eeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 48999999999999432 245788888887543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=88.89 E-value=0.37 Score=41.35 Aligned_cols=28 Identities=25% Similarity=0.330 Sum_probs=24.1
Q ss_pred EEecCCCCCCeEeCCCC-----ceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDL-----FAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~-----~~kl~Dfg~a~ 183 (356)
++|||+.+.||++..++ .+.|.||..+.
T Consensus 122 l~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 122 LNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 89999999999997543 58899999885
|
subfamily of choline kinases |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.77 E-value=0.31 Score=47.62 Aligned_cols=78 Identities=10% Similarity=0.007 Sum_probs=44.7
Q ss_pred CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHHHhhhhhccccccccccccchhhhhchhhHHHH
Q 039228 218 TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLEC 295 (356)
Q Consensus 218 ~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (356)
+++||||+|.++.++.-|..-+..... .+........+.. ....+.-.. ...-++
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~--s~~l~~i~k~~~~d~~~~~~a~e~---------------------~~~~~~ 166 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTE--SEYLEILLKYYTDDQELLSTAMEH---------------------LIQLLA 166 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHH--HHHHHHHHHhccCchhHHHHHHHH---------------------HHHHhh
Confidence 599999999999999998776543211 1111111121211 111111100 112256
Q ss_pred HHHHHHHHHhhcCCCcCCCCChH
Q 039228 296 LIFMVRIGAACSMGSSQDRMNVP 318 (356)
Q Consensus 296 ~~~l~~l~~~Cl~~dP~~RPs~~ 318 (356)
...+..+...|+-..|..||...
T Consensus 167 d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 167 DKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred hHhHHHHhccCCccccccccchh
Confidence 66778899999999998877543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.71 E-value=0.34 Score=45.15 Aligned_cols=28 Identities=43% Similarity=0.583 Sum_probs=25.3
Q ss_pred EEecCCCCCCeEeCCCCc-eEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLF-AHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~ 183 (356)
+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=86.70 E-value=0.39 Score=44.36 Aligned_cols=28 Identities=25% Similarity=0.216 Sum_probs=26.3
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.+.|++++.++.+.++||..+.
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 9999999999999999899999999885
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.40 E-value=3.5 Score=40.15 Aligned_cols=27 Identities=26% Similarity=0.379 Sum_probs=23.2
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|.|+-+.|||.+.++ ++|+||..|.
T Consensus 286 fCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 286 FCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred EEeCCCCccceeecCCC-EEEEeecccc
Confidence 78999999999887554 9999998774
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.13 E-value=1.1 Score=42.69 Aligned_cols=31 Identities=35% Similarity=0.528 Sum_probs=23.9
Q ss_pred ccceecCceEEEEEEEC---------------CCCeEEEEEEeecc
Q 039228 78 NLIGVGSFDAVYQGVFD---------------LNRAVVAIKVLSIQ 108 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~---------------~~~~~vavK~~~~~ 108 (356)
..||.|.-..||+|..+ .+.+.+|+|+.+..
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~ 240 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN 240 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc
Confidence 36899999999998742 23578999998743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 356 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 356 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 5e-44 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-34 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-32 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-30 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-27 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-27 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-27 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-26 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-26 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-26 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-26 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-25 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-24 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-24 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-21 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-21 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-21 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 9e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 6e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-16 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-14 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 8e-14 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-13 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-13 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-12 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-12 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-12 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-11 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-11 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-11 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-11 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-11 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-11 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-11 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-11 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 5e-11 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-11 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-11 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-11 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-11 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-11 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-10 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-10 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-10 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-10 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-10 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-10 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-10 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-10 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-10 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-10 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-10 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 9e-10 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-09 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-09 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-09 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-09 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-09 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-09 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-09 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-09 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-08 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-08 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-08 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-08 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-08 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-08 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-08 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-07 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-07 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-07 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-07 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-07 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-07 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-07 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-07 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 7e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-07 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-07 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 9e-07 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-06 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-06 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-06 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-06 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-06 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-06 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-06 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-06 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-06 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 9e-06 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-05 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-05 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-05 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-05 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-05 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-05 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-05 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-05 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-05 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-05 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-05 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-05 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-05 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-05 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-05 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-05 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-05 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-05 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-04 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-04 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-04 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-04 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-04 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-04 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-04 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-04 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-44
Identities = 71/298 (23%), Positives = 117/298 (39%), Gaps = 70/298 (23%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKA 122
L A+D F N++G G F VY+G + +VA+K L + QG F E +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 123 LKNICHRNLVRFI-----------------------------------------SIAIDV 141
+ HRNL+R IA+
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 142 ASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS--SNGV 199
A L YLH HC I+H D K +N+LLD + A +GDF LA+ + + + V
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDYKDTHVTTAV 195
Query: 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF---EGDLNLHNFARMA 256
R TIG+ A +Y + S D + YG++LLE++T ++ D + D+ L ++ +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDR 314
+ L L D + + + ++++ C+ S +R
Sbjct: 256 LKEK-----KLEALVDVDLQGNYKDEEVEQ------------LIQVALLCTQSSPMER 296
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 71/293 (24%), Positives = 108/293 (36%), Gaps = 65/293 (22%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
L +AT+ F LIG G F VY+GV + A VA+K + + + F E + L
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 124 KNICHRNLVRFI-----------------------------------------SIAIDVA 142
H +LV I I I A
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202
L YLH I+H D K N+LLD + I DF +++ E+ T S+ V+ T
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ-THLSTV-VKGT 204
Query: 203 IGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF-EGDLNLHNFARMAFPNRV 261
+GY +Y + ++ D Y++G++L E++ R I +NL +A + N
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG- 263
Query: 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDR 314
+ +V D + LRK C SS+DR
Sbjct: 264 -QLEQIV---DPNLADKIRPESLRK------------FGDTAVKCLALSSEDR 300
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 59/241 (24%)
Query: 64 YESLLKATDGF------PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS---- 113
+ L T+ F N +G G F VY+G +N VA+K L+ +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELK 74
Query: 114 KSFMAECKALKNICHRNLVRFI-------------------------------------- 135
+ F E K + H NLV +
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 136 --SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193
IA A+ +++LH + +H D K +N+LLD A I DF LAR ++ +
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ--T 189
Query: 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFA 253
++ + T Y A + G E++ D Y++G++LLE++T +D E L +
Sbjct: 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIK 247
Query: 254 R 254
Sbjct: 248 E 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 54/233 (23%), Positives = 83/233 (35%), Gaps = 57/233 (24%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
E+L + L+ + G F V++ VA+K+ IQ + S E +L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK-QSWQNEYEVYSL 72
Query: 124 KNICHRNLVRFI----------------------------------------SIAIDVAS 143
+ H N+++FI IA +A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMAR 132
Query: 144 ALDYLHHHCQEL-------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
L YLH L I H D K NVLL N+L A I DF LA + + + +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE--AGKSAGDT 190
Query: 197 NGVRRTIGYTA---LDY--DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244
+G T Y A L+ + + D Y G++L E+ +R D +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 51/205 (24%), Positives = 78/205 (38%), Gaps = 50/205 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVR 133
+ IG GSF VY+G + VA+K+L++ ++F E L+ H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 134 F-------------------------------------ISIAIDVASALDYLHHHCQELI 156
F I IA A +DYLH I
Sbjct: 85 FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYDLG 213
+H D K +N+ L D IGDF LA + S + +I + A +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAPEVIRMQDS 199
Query: 214 SEVSTNGDAYNYGILLLEMVTRRKP 238
+ S D Y +GI+L E++T + P
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 55/208 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
+ IG GSF V++ + + + VA+K+L Q A F+ E +K + H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 134 F----------------------------------------ISIAIDVASALDYLHHHCQ 153
F +S+A DVA ++YLH+
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RN 157
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDY 210
I+H + K N+L+D + DF L+R + T SS T + A L
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGTPEWMAPEVLR- 212
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ D Y++G++L E+ T ++P
Sbjct: 213 --DEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 36/212 (16%), Positives = 69/212 (32%), Gaps = 64/212 (30%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA--SKSFMAECKALKNICHRNLVR 133
+ + +++G + + +KVL ++ S+ F EC L+ H N++
Sbjct: 14 FLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 134 FI-----------------------------------------SIAIDVASALDYLHHHC 152
+ A+D+A + +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA----- 207
+ LI +V++D D+ A I ++ Q S G + A
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEALQ 181
Query: 208 -LDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
D + D +++ +LL E+VTR P
Sbjct: 182 KKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 62/214 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ----GASKSFMAECKALKNICHRNL 131
L +IG+G F VY+ + VA+K ++ E K + H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 132 VRF------------------------------------ISIAIDVASALDYLHHHCQEL 155
+ ++ A+ +A ++YLH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 156 ILHCDPKPSNVLLDNDLFAH--------IGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
I+H D K SN+L+ + I DF LAR E T+ S+ G + A
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG---AYAWMA 182
Query: 208 ---LDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ + S+ S D ++YG+LL E++T P
Sbjct: 183 PEVIRASMFSKGS---DVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 41/239 (17%), Positives = 87/239 (36%), Gaps = 68/239 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-------KSFMAECKALKNICH 128
IG G F V++G +++VVAIK L + + F E + N+ H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 129 RNLVRFI------------------------------------SIAIDVASALDYLHHHC 152
N+V+ + +D+A ++Y+ +
Sbjct: 83 PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQ 141
Query: 153 QELILHCDPKPSNVLLDN-----DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
I+H D + N+ L + + A + DF L++ S +G+ + A
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-------SVSGLLGNFQWMA 194
Query: 208 ---LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263
+ + + D Y++ ++L ++T P F+ +++ ++ F N + +
Sbjct: 195 PETIGAE-EESYTEKADTYSFAMILYTILTGEGP----FDE----YSYGKIKFINMIRE 244
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 52/236 (22%), Positives = 76/236 (32%), Gaps = 65/236 (27%)
Query: 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECK-- 121
D L+ LIG G + AVY+G L+ VA+KV S ++F+ E
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFA---NRQNFINEKNIY 59
Query: 122 ALKNICHRNLVRFI-----------------------------------------SIAID 140
+ + H N+ RFI +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 141 VASALDYLH------HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF----RQEVSN 190
V L YLH H + I H D NVL+ ND I DF L+ R
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 191 PTQSSSNGVRRTIGYTA-------LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239
+++ TI Y A ++ D Y G++ E+ R +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 50/202 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF- 134
+ ++G G+F V + + VAIK + + + K+F+ E + L + H N+V+
Sbjct: 12 VEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLY 67
Query: 135 -------------------------------------ISIAIDVASALDYLHHHCQELIL 157
+S + + + YLH + ++
Sbjct: 68 GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 158 HCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV 216
H D KP N+LL I DF A Q +++ G + + A + GS
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKG---SAAWMAPEVFEGSNY 180
Query: 217 STNGDAYNYGILLLEMVTRRKP 238
S D +++GI+L E++TRRKP
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP 202
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-24
Identities = 45/213 (21%), Positives = 68/213 (31%), Gaps = 57/213 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVR 133
+ LIG G F VY G + VAI+++ I+ + K+F E A + H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 134 F--------------------------------------ISIAIDVASALDYLHHHCQEL 155
F IA ++ + YLH +
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS-NGVRRTIGYTA------- 207
ILH D K NV DN I DF L + + + + A
Sbjct: 151 ILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 208 --LDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ S + D + G + E+ R P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 45/238 (18%), Positives = 79/238 (33%), Gaps = 61/238 (25%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI 135
++G G F + V+ +K L + ++F+ E K ++ + H N+++FI
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 136 --------------------------------------SIAIDVASALDYLHHHCQELIL 157
S A D+AS + YLH I+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN----------PTQSSSNGVRRTIGYTA 207
H D N L+ + + DF LAR + P + V + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 208 ---LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF----EGDLNLHNFARMAFP 258
++ E D +++GI+L E++ R + LN+ F P
Sbjct: 191 PEMINGRSYDEKV---DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 44/222 (19%), Positives = 76/222 (34%), Gaps = 58/222 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECK--ALKNICHRNLVR 133
L+ +G G + V++G + VA+K+ S + KS+ E + + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILG 66
Query: 134 FI----------------------------------------SIAIDVASALDYLH---- 149
FI I + +AS L +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 150 -HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA- 207
+ I H D K N+L+ + I D LA + +N +N T Y A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 208 --LD---YDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244
LD + D + +G++L E+ R + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 45/220 (20%), Positives = 69/220 (31%), Gaps = 54/220 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI 135
++ IG G + V+ G + VA+KV + AS E + H N++ FI
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFI 97
Query: 136 ----------------------------------------SIAIDVASALDYLH-----H 150
+A S L +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA--- 207
+ I H D K N+L+ + I D LA +N N T Y
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 208 LDYDLGS---EVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244
LD L + D Y++G++L E+ R + E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 45/216 (20%), Positives = 72/216 (33%), Gaps = 58/216 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECK--ALKNICHRNLVR 133
L IG G F V++G + VA+K+ S + + +S+ E + + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILG 100
Query: 134 FI----------------------------------------SIAIDVASALDYLH---- 149
FI +A+ AS L +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 150 -HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA- 207
+ I H D K N+L+ + I D LA ++ + N T Y A
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 208 --LDYDLGS---EVSTNGDAYNYGILLLEMVTRRKP 238
LD + E D Y G++ E+ R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 54/213 (25%)
Query: 76 LINLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQCQG---ASKSFMAECKALKNICHRN 130
+++ +G G VY D LN VAIK + I + K F E + H+N
Sbjct: 15 IVDKLGGGGMSTVYLAE-DTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 131 LV-------------------------------------RFISIAIDVASALDYLHHHCQ 153
+V I+ + + + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
I+H D KP N+L+D++ I DF +A+ +S + + +N V T+ Y + + G
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 214 SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
D Y+ GI+L EM+ P F G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 45/213 (21%), Positives = 73/213 (34%), Gaps = 54/213 (25%)
Query: 76 LINLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRN 130
L L+G G VY+ D R +VA+K++S E + + +
Sbjct: 38 LRRLVGRGGMGDVYEAE-DTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 131 LV-------------------------------------RFISIAIDVASALDYLHHHCQ 153
+V R ++I + SALD H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
H D KP N+L+ D FA++ DF +A ++ + T+ Y A +
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 214 SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
S + D Y +L E +T P ++GD
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 43/269 (15%), Positives = 80/269 (29%), Gaps = 72/269 (26%)
Query: 25 NQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDG-------FPLI 77
+ +HS+ ++L + QP R++ R + + F +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL 62
Query: 78 NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNIC-HRNLVRF 134
+ +G GS+ V++ + + A+K +G +AE + + + H VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 135 IS-------------------------------------IAIDVASALDYLHHHCQELIL 157
D AL +LH ++
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN-GVRRTIGYTALDYDLGSEV 216
H D KP+N+ L +GDF L E+ G Y + E+
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEG---DPRY------MAPEL 227
Query: 217 STNGDAYNY-------GILLLEMVTRRKP 238
Y G+ +LE+ +
Sbjct: 228 LQGS--YGTAADVFSLGLTILEVACNMEL 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 47/236 (19%), Positives = 88/236 (37%), Gaps = 56/236 (23%)
Query: 48 KQPLRLTLRNAIPKEYYESLLKATDGFP----------LINLIGVGSFDAVYQGVFDLNR 97
L TL PK ++ + + + + +G G + VY+GV+
Sbjct: 186 ADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS 245
Query: 98 AVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------------- 134
VA+K L + + F+ E +K I H NLV+
Sbjct: 246 LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGD 178
+ +A ++SA++YL +H + N L+ + + D
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVAD 361
Query: 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
F L+R ++ T ++ G + I +TA + ++ S D + +G+LL E+ T
Sbjct: 362 FGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-16
Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 58/218 (26%)
Query: 76 LINLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQCQG---ASKSFMAECKALKNICHRN 130
L ++G G V+ D +R VA+KVL F E + + H
Sbjct: 16 LGEILGFGGMSEVHLAR-DLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 131 LV-----------------------------------------RFISIAIDVASALDYLH 149
+V R I + D AL++ H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP-TQSSSNGVRRTIGYTAL 208
+ I+H D KP+N+++ + DF +AR + N TQ+++ V T Y +
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSP 188
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ G V D Y+ G +L E++T P F GD
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 56/242 (23%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVV 100
+ P + + L A+PK+ + L D L IG G+F V+ G + +V
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWV--LNHED-LVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 101 AIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------------------- 134
A+K F+ E + LK H N+VR
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 135 -------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181
+ + D A+ ++YL C +H D N L+ I DF +
Sbjct: 203 LRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 182 ARFRQEVSNPTQSSSNGVRRT-IGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVTR-R 236
+R E ++ ++S G+R+ + +TA L+Y S+ D +++GILL E +
Sbjct: 260 SR---EEADGVYAASGGLRQVPVKWTAPEALNY---GRYSSESDVWSFGILLWETFSLGA 313
Query: 237 KP 238
P
Sbjct: 314 SP 315
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 38/223 (17%), Positives = 65/223 (29%), Gaps = 71/223 (31%)
Query: 76 LINLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLV 132
+ I G +Y + D +N V +K L A MAE + L + H ++V
Sbjct: 84 VKGCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 133 R----------------FI------------------------SIAIDVASALDYLHHHC 152
+ +I + +++ AL YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG 202
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+++ D KP N++L + + D +S + T G+ A
Sbjct: 203 ---LVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYGTPGFQA----- 245
Query: 213 GSEVSTNG-----DAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250
E+ G D Y G L + G
Sbjct: 246 -PEIVRTGPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 70/274 (25%)
Query: 11 YRLESHRFLHDCSMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKA 70
Y +F S+ Q L Y K G L L P ++ A
Sbjct: 215 YITSRTQF---NSLQQ--------LVAYYSKHADG-----LCHRLTTVCPTSKPQTQGLA 258
Query: 71 TDG-------FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL 123
D L +G G F V+ G ++ V AIK L + ++F+ E + +
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVM 316
Query: 124 KNICHRNLVRF--------------------------------------ISIAIDVASAL 145
K + H LV+ + +A +AS +
Sbjct: 317 KKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 146 DYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205
Y+ +H D + +N+L+ +L + DF LAR + + ++ G + I +
Sbjct: 377 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKW 430
Query: 206 TALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
TA + L + D +++GILL E+ T+ R P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 47/202 (23%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF- 134
L +G G F V+ G ++ VAIK L + ++F+ E + +K + H LV+
Sbjct: 188 LEVKLGQGCFGEVWMGTWN-GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 135 -------------------------------------ISIAIDVASALDYLHHHCQELIL 157
+ +A +AS + Y+ +
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D + +N+L+ +L + DF LAR + + ++ G + I +TA + L +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 218 TNGDAYNYGILLLEMVTR-RKP 238
D +++GILL E+ T+ R P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 42/205 (20%), Positives = 80/205 (39%), Gaps = 53/205 (25%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF- 134
L +G G F V+ ++ VA+K + + ++F+AE +K + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYN-KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 135 -------------------------------------ISIAIDVASALDYLHHHCQELIL 157
I + +A + ++ +
Sbjct: 250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYDLGS 214
H D + +N+L+ L I DF LAR + + ++ G + I +TA +++
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEAINF---G 360
Query: 215 EVSTNGDAYNYGILLLEMVTR-RKP 238
+ D +++GILL+E+VT R P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 46/226 (20%), Positives = 79/226 (34%), Gaps = 69/226 (30%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK---SFMAECKALKNICH 128
F + IG G F VY+ L+ VA+K + I +K + E LK + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 129 RNLVRFI-----------------------------------------SIAIDVASALDY 147
N++++ + + SAL++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
+H ++H D KP+NV + +GD L R + ++++ + T Y +
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYMS 204
Query: 208 LDYDLGSEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
E + + YN+ G LL EM + P F GD
Sbjct: 205 ------PER-IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD 239
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 48/209 (22%), Positives = 68/209 (32%), Gaps = 62/209 (29%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVRFI- 135
IG GSF VY+G+ VA L + S + F E + LK + H N+VRF
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 136 ----------------------------------------SIAIDVASALDYLHHHCQEL 155
S + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPP 151
Query: 156 ILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
I+H D K N+ + IGD LA ++ S + V T + A
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMA------P 199
Query: 215 EVSTNG-----DAYNYGILLLEMVTRRKP 238
E+ D Y +G+ +LEM T P
Sbjct: 200 EMYEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 43/229 (18%), Positives = 72/229 (31%), Gaps = 69/229 (30%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHR 129
+ + ++ IG GS+ + + ++ K L + + ++E L+ + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 130 NLVRFI-------------------------------------------SIAIDVASALD 146
N+VR+ + + AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 147 YLH--HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
H +LH D KP+NV LD +GDF LAR ++ ++ G T
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-G---TPY 181
Query: 205 YTALDYDLGSEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
Y + E N +YN G LL E+ P F
Sbjct: 182 YMS------PEQ-MNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 53/205 (25%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF- 134
L+ +G G F V+ G ++ VA+K L Q + +F+AE +K + H+ LVR
Sbjct: 17 LVERLGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 135 -------------------------------------ISIAIDVASALDYLHHHCQELIL 157
+ +A +A + ++ +
Sbjct: 75 AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYDLGS 214
H D + +N+L+ + L I DF LAR + + ++ G + I +TA ++Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINY---G 185
Query: 215 EVSTNGDAYNYGILLLEMVTR-RKP 238
+ D +++GILL E+VT R P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 42/223 (18%), Positives = 68/223 (30%), Gaps = 66/223 (29%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHR 129
+ + + IG GSF + IK ++I + + E L N+ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 130 NLVRFI---------------------------------------SIAIDVASALDYLHH 150
N+V++ + + AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
ILH D K N+ L D +GDF +AR ++ G T Y +
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-G---TPYYLS--- 193
Query: 211 DLGSEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
E+ YN G +L E+ T + FE
Sbjct: 194 ---PEI-CENKPYNNKSDIWALGCVLYELCTLKHA----FEAG 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 46/213 (21%), Positives = 71/213 (33%), Gaps = 60/213 (28%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVL---SIQCQGASKSFMAECKALKNICHR 129
L+ +G GSF V +G + VA+K L + A F+ E A+ ++ HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 130 NLVR-------------------------------------FISIAIDVASALDYLHHHC 152
NL+R A+ VA + YL
Sbjct: 82 NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+H D N+LL IGDF L R + + + + + A
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-KVPFAWCAP---- 193
Query: 213 GSEV------STNGDAYNYGILLLEMVTR-RKP 238
E S D + +G+ L EM T ++P
Sbjct: 194 --ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 16/122 (13%), Positives = 37/122 (30%), Gaps = 25/122 (20%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ + + V L LHH+ ++H +P +++LD + FE +
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV---- 266
Query: 195 SSNGVRRTIGYTALDY----------DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFE 244
G+ + + ++ D + G+ + + P
Sbjct: 267 ----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NT 318
Query: 245 GD 246
D
Sbjct: 319 DD 320
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 50/214 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRN 130
+ + ++ +G G++ VY+G L +VA+K + ++ + GA + + E LK++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 131 LVRFISIAIDVAS-------------------------------------ALDYLHHHCQ 153
+V I S L Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+LH D KP N+L++ + DF LAR S PT++ N V T+ Y D LG
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYDNEV-VTLWYRPPDILLG 174
Query: 214 SEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
S ST D + G + EM T R P+ F G
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR-PL---FPGS 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 59/209 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
+ + +G G + VY+GV+ VA+K L + + F+ E +K I H NLV+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 134 F---------------------------------------ISIAIDVASALDYL-HHHCQ 153
+ +A ++SA++YL +
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDY 210
+H D N L+ + + DF L+R ++ T ++ G + I +TA L Y
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
++ S D + +G+LL E+ T P
Sbjct: 187 ---NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 59/208 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
+ IG G F V+ G + LN+ VAIK + +GA + F+ E + + + H LV+
Sbjct: 12 FVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 134 F--------------------------------------ISIAIDVASALDYL-HHHCQE 154
+ + +DV + YL
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYD 211
+H D N L+ + + DF + RF V + +SS G + + + + +
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWASPEVFSF- 179
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR-RKP 238
S S+ D +++G+L+ E+ + + P
Sbjct: 180 --SRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 47/208 (22%), Positives = 79/208 (37%), Gaps = 63/208 (30%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNICHRNLVR- 133
L+ IG G F V G + VA+K + A+ ++F+AE + + H NLV+
Sbjct: 197 LLQTIGKGEFGDVMLGDY--RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 134 ---------------------------------------FISIAIDVASALDYLHHHCQE 154
+ ++DV A++YL +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 309
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYD 211
+H D NVL+ D A + DF L + S+ + + + +TA L
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKE-------ASSTQDTGKLPVKWTAPEALRE- 360
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR-RKP 238
+ ST D +++GILL E+ + R P
Sbjct: 361 --KKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 59/207 (28%)
Query: 80 IGVGSFDAVYQGVF--DLNRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRNLVR--- 133
+G G+F +V QGV+ + VAIKVL + A M E + + + + +VR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 134 ----------------------------------FISIAIDVASALDYL-HHHCQELILH 158
+ V+ + YL + +H
Sbjct: 78 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----VH 133
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-- 216
D NVLL N +A I DF L++ + ++ + + + + A E
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAP------ECIN 186
Query: 217 ----STNGDAYNYGILLLEMVTR-RKP 238
S+ D ++YG+ + E ++ +KP
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 63/221 (28%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRN 130
D + L +IG G+ V + VAIK +++ +CQ + + E +A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 131 LVRFI------------------------------------------SIAI---DVASAL 145
+V + +IA +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 146 DYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT-IG 204
+YLH + Q +H D K N+LL D I DF ++ F ++ + N VR+T +G
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAF---LATGGDITRNKVRKTFVG 188
Query: 205 YTALDYDLGSEVSTNGDAYNY-------GILLLEMVTRRKP 238
T + EV Y++ GI +E+ T P
Sbjct: 189 -TP--CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 45/215 (20%), Positives = 80/215 (37%), Gaps = 50/215 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHR 129
+ + IG G++ V++ +VA+K L +G S + E LK + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 130 NLVRFISIAIDVAS-------------------------------------ALDYLHHHC 152
N+VR + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+LH D KP N+L++ + + +F LAR P + S V T+ Y D
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEV-VTLWYRPPDVLF 174
Query: 213 GSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
G+++ ST+ D ++ G + E+ +P+ F G+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL---FPGN 206
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 59/208 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
L+ +G G F V G + + VA+K++ +G+ F E + + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWK-GQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 134 F--------------------------------------ISIAIDVASALDYL-HHHCQE 154
F + + DV + +L H
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYD 211
+H D N L+D DL + DF + R+ V + SS G + + ++A Y
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVKWSAPEVFHY- 179
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR-RKP 238
+ S+ D + +GIL+ E+ + + P
Sbjct: 180 --FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 42/223 (18%), Positives = 78/223 (34%), Gaps = 62/223 (27%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS 115
P + E LK I+ +G G+F +V +D A+VA+K L +
Sbjct: 17 PTIFEERHLK------YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 116 FMAECKALKNICHRNLVRF----------------------------------------I 135
F E + LK + +V++ +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 136 SIAIDVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ + ++YL C +H D N+L++++ I DF LA+ +
Sbjct: 131 LYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 195 SSNGVRRTIGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVT 234
G + I + A L + S D +++G++L E+ T
Sbjct: 187 REPG-QSPIFWYAPESLSD---NIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 44/223 (19%), Positives = 80/223 (35%), Gaps = 62/223 (27%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS 115
P ++ E LK + +G G+F +V +D VVA+K L + +
Sbjct: 4 PTQFEERHLK------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 116 FMAECKALKNICHRNLVRF----------------------------------------I 135
F E + LK++ H N+V++ +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 136 SIAIDVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ ++YL +H D N+L++N+ IGDF L + + +
Sbjct: 118 QYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 195 SSNGVRRTIGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVT 234
G I + A L S+ S D +++G++L E+ T
Sbjct: 174 KEPG-ESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 59/208 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNLVR 133
+ +G G F V G + + VAIK++ +G+ F+ E K + N+ H LV+
Sbjct: 28 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 134 F--------------------------------------ISIAIDVASALDYL-HHHCQE 154
+ + DV A++YL
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDYD 211
LH D N L+++ + DF L+R+ V + +SS G + + ++ L Y
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEVLMY- 195
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR-RKP 238
S+ S+ D + +G+L+ E+ + + P
Sbjct: 196 --SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 28/142 (19%), Positives = 49/142 (34%), Gaps = 47/142 (33%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNIC-HRN 130
F + IG G F +V++ V L+ + AIK G+ ++ + E A + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 131 LVRFIS-----------------------------------------IAIDVASALDYLH 149
+VR+ S + + V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 150 HHCQELILHCDPKPSNVLLDND 171
++H D KPSN+ +
Sbjct: 133 SM---SLVHMDIKPSNIFISRT 151
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 33/184 (17%), Positives = 55/184 (29%), Gaps = 45/184 (24%)
Query: 41 KKRRGPSKQPLRLTLRNAIPKEYYESLLKATDG--FPLINLIGVGSFDAVYQGVFDLNRA 98
K P KE E L+ + +G G F ++ +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 99 VVAIKVLS---IQCQGASKSFMAECKALKNICHRNLVRFISIAID--------------- 140
V A K++ + + E +++ H+++V F D
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 141 ----------------------VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGD 178
+ YLH + ++H D K N+ L+ DL IGD
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGD 184
Query: 179 FELA 182
F LA
Sbjct: 185 FGLA 188
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 39/213 (18%), Positives = 73/213 (34%), Gaps = 62/213 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRN 130
I ++G G+F VY+G++ + VAIK L + + E + ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 131 LVRFI-------------------------------------SIAIDVASALDYL-HHHC 152
+ R + + + +A ++YL
Sbjct: 79 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+H D NVL+ I DF LA+ + G + I + AL
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMAL---- 188
Query: 213 GSEV------STNGDAYNYGILLLEMVTR-RKP 238
E + D ++YG+ + E++T KP
Sbjct: 189 --ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 39/209 (18%), Positives = 69/209 (33%), Gaps = 62/209 (29%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFISIA 138
++G G++ VY G N+ +AIK + + S+ E K++ H+N+V+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 139 ID----------------------------------------VASALDYLHHHCQELILH 158
+ + L YLH + I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 159 CDPKPSNVLLDNDL-FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV- 216
D K NVL++ I DF ++ + T+ Y A E+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSK----RLAGINPCTETFTGTLQYMA------PEII 195
Query: 217 STNGDAYNY-------GILLLEMVTRRKP 238
Y G ++EM T + P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 42/214 (19%), Positives = 82/214 (38%), Gaps = 62/214 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAV----VAIKVLSIQC-QGASKSFMAECKALKNICHRN 130
+IG G F VY+G+ + VAIK L + F+ E + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 131 LVRF--------------------------------------ISIAIDVASALDYL-HHH 151
++R + + +A+ + YL + +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+H D N+L++++L + DF L+R ++ T ++S G + I +TA
Sbjct: 168 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG-KIPIRWTAP--- 219
Query: 212 LGSEV------STNGDAYNYGILLLEMVTR-RKP 238
E ++ D +++GI++ E++T +P
Sbjct: 220 ---EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 59/207 (28%)
Query: 80 IGVGSFDAVYQGVFDLNRAV--VAIKVLSIQC--QGASKSFMAECKALKNICHRNLVR-- 133
+G G+F V +G + + + V VA+K+L + +AE ++ + + +VR
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 134 ----------------------------------FISIAIDVASALDYL-HHHCQELILH 158
I + V+ + YL + +H
Sbjct: 85 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF----VH 140
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-- 216
D NVLL +A I DF L++ + N ++ ++G + + + A E
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAP------ECIN 193
Query: 217 ----STNGDAYNYGILLLEMVTR-RKP 238
S+ D +++G+L+ E + +KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 43/220 (19%), Positives = 80/220 (36%), Gaps = 56/220 (25%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS 115
P ++ E LK + +G G+F +V +D VVA+K L + +
Sbjct: 35 PTQFEERHLK------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 88
Query: 116 FMAECKALKNICHRNLVRF----------------------------------------I 135
F E + LK++ H N+V++ +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 136 SIAIDVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ ++YL +H D N+L++N+ IGDF L + + +
Sbjct: 149 QYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
G I + A + S+ S D +++G++L E+ T
Sbjct: 205 KEPG-ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 57/254 (22%), Positives = 87/254 (34%), Gaps = 84/254 (33%)
Query: 60 PKEY--YESLLKA---TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK 114
P+EY YES + D + L+ +G G + V++ + N V +K+L K
Sbjct: 19 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------K 70
Query: 115 SFMA-----ECKALKNIC-HRNLVRFISIAIDVAS------------------------- 143
E K L+N+ N++ I D S
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130
Query: 144 -----------ALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQEVS 189
ALDY H I+H D KP NV++D+ L + D+ LA F
Sbjct: 131 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR--LIDWGLAEFYHPGQ 185
Query: 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGI-------LLLEMVTRRKPIDFM 242
A Y G E+ + Y+Y + +L M+ R++P
Sbjct: 186 EYN-----------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--- 231
Query: 243 FEGDLNLHNFARMA 256
F G N R+A
Sbjct: 232 FHGHDNYDQLVRIA 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 40/232 (17%), Positives = 75/232 (32%), Gaps = 80/232 (34%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK-SFMAECKALKNICHRN 130
F I +G G F V++ ++ AIK + + + ++ M E KAL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 131 LVRFIS----------------------------------------------------IA 138
+VR+ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 139 IDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198
+ +A A+++LH ++H D KPSN+ D +GDF L
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEE 173
Query: 199 VRRTIGYTALDYDLGSEVST---------NGDAYNY-------GILLLEMVT 234
+ + +V T +G++Y++ G++L E++
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 27/149 (18%), Positives = 48/149 (32%), Gaps = 43/149 (28%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVL---SIQCQGASKSFMAECKALKNICHRN 130
+ +G G F ++ + V A K++ + + E +++ H++
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 131 LVRFISIAID-------------------------------------VASALDYLHHHCQ 153
+V F D + YLH +
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 135
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELA 182
++H D K N+ L+ DL IGDF LA
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 59/212 (27%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRNL 131
+ +IG G V G VAIK L + F++E + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
+R + + V + + YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+H D NVL+D++L + DF L+R ++ + +++ G + I +TA
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG-KIPIRWTAP----- 223
Query: 214 SEV------STNGDAYNYGILLLEMVTR-RKP 238
E S+ D +++G+++ E++ +P
Sbjct: 224 -EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 42/237 (17%), Positives = 84/237 (35%), Gaps = 56/237 (23%)
Query: 54 TLRNAIPKEYYESLLKATDGFP---------LINLIGVGSFDAVYQGVF---DLNRAVVA 101
LR + +E + F + ++G G F V G VA
Sbjct: 18 GLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 102 IKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------------------- 134
IK L + + + F+ E + H N++R
Sbjct: 78 IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 135 ------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182
+ + +AS + YL +H D N+L++++L + DF L
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
R ++ ++ G + I +T+ + + ++ D ++YGI+L E+++ +P
Sbjct: 195 RVLEDDPEAAYTTRGG-KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 40/201 (19%), Positives = 78/201 (38%), Gaps = 47/201 (23%)
Query: 80 IGVGSFDAVYQGVFDLNRAV--VAIKVLSIQCQGASKS-FMAECKALKNICHRNLVR--- 133
+G G+F +V QGV+ + + VAIKVL + A M E + + + + +VR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 134 ----------------------------------FISIAIDVASALDYL-HHHCQELILH 158
+ V+ + YL + +H
Sbjct: 404 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----VH 459
Query: 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVST 218
+ NVLL N +A I DF L++ + ++ + + + + A + + S+
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 219 NGDAYNYGILLLEMVTR-RKP 238
D ++YG+ + E ++ +KP
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP 539
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 38/205 (18%), Positives = 72/205 (35%), Gaps = 51/205 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRN 130
I +G G F V +D VA+K L + G + E + L+N+ H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 131 LVRF----------------------------------------ISIAIDVASALDYLH- 149
+V++ + A+ + +DYL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD 209
+H D NVL++++ IGDF L + + + + + A +
Sbjct: 145 RQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR-DSPVFWYAPE 199
Query: 210 YDLGSEVSTNGDAYNYGILLLEMVT 234
+ S+ D +++G+ L E++T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 42/261 (16%), Positives = 75/261 (28%), Gaps = 65/261 (24%)
Query: 24 MNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVG 83
+ + + + + ++ L + EY E + T +G G
Sbjct: 14 ASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ----PRVGRG 69
Query: 84 SFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI-------- 135
SF V++ A+K + ++ E A + +V
Sbjct: 70 SFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPW 124
Query: 136 -----------SIA------------------IDVASALDYLHHHCQELILHCDPKPSNV 166
S+ L+YLH ILH D K NV
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 181
Query: 167 LLDND-LFAHIGDFELA-RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYN 224
LL +D A + DF A + + + + + + T + A EV G +
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA------PEV-VMGKPCD 234
Query: 225 Y-------GILLLEMVTRRKP 238
++L M+ P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 37/206 (17%), Positives = 76/206 (36%), Gaps = 48/206 (23%)
Query: 76 LINLIGVGSFDAVYQGVFDL----NRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRN 130
+ ++G G F V++GV+ + V IKV+ + S A+ ++ H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 131 LVR-------------------------------------FISIAIDVASALDYLHHHCQ 153
+VR ++ + +A + YL H
Sbjct: 77 IVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
++H + NVLL + + DF +A + Q + + I + AL+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTPIKWMALESIHF 191
Query: 214 SEVSTNGDAYNYGILLLEMVTR-RKP 238
+ + D ++YG+ + E++T +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 15/133 (11%), Positives = 32/133 (24%), Gaps = 22/133 (16%)
Query: 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195
+ + L ++H P N+ + D +GD
Sbjct: 198 ILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW------------ 242
Query: 196 SNGVRRTIGYTALDY-------DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248
G R + Y + + +A+ G+ + + P + G
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 249 LHNFARMAFPNRV 261
+ P
Sbjct: 303 SWKRPSLRVPGTD 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 47/209 (22%), Positives = 79/209 (37%), Gaps = 65/209 (31%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNICHRNLVRF 134
L+ IG G F V G VA+K + A+ ++F+AE + + H NLV+
Sbjct: 25 LLQTIGKGEFGDVMLGD--YRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 135 ----------------------------------------ISIAIDVASALDYL-HHHCQ 153
+ ++DV A++YL ++
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDY 210
+H D NVL+ D A + DF L + S+ + + + +TA L
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALRE 188
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
+ ST D +++GILL E+ + R P
Sbjct: 189 ---KKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 18/115 (15%), Positives = 41/115 (35%), Gaps = 10/115 (8%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ + + V L LHH+ ++H +P +++LD + FE + S
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS 265
Query: 195 SSNG---VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ + D + ++ + DA+ G+++ + P D
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKD 316
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 40/212 (18%), Positives = 83/212 (39%), Gaps = 62/212 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAV---VAIKVLSIQCQGASKS-FMAECKALKNICHRNL 131
L ++G G F VY+GV+ ++ VA+K C +K FM+E +KN+ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 132 VRF-------------------------------------ISIAIDVASALDYL-HHHCQ 153
V+ + ++ + A+ YL +C
Sbjct: 76 VKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+H D N+L+ + +GDF L+R+ + + ++ R I + +
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMSP----- 183
Query: 214 SEV------STNGDAYNYGILLLEMVTR-RKP 238
E +T D + + + + E+++ ++P
Sbjct: 184 -ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 37/214 (17%), Positives = 76/214 (35%), Gaps = 54/214 (25%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRN- 130
+ ++ IG G V+Q V + + + AIK ++++ S+ E L + +
Sbjct: 58 YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 131 -----------------------------LVRFISIAIDVA--------SALDYLHHHCQ 153
L + SI A+ +H H
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNG--------VRRTIG 204
I+H D KP+N L+ + + + DF +A + + ++ + S G + +
Sbjct: 176 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ + S++S D ++ G +L M + P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 37/217 (17%), Positives = 72/217 (33%), Gaps = 60/217 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNL 131
+ ++ IG G V+Q V + + + AIK ++++ S+ E L + +
Sbjct: 30 YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 132 --VRFISIAID------------------------------------VASALDYLHHHCQ 153
+R I + A+ +H H
Sbjct: 89 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTIGYTA----L 208
I+H D KP+N L+ + + + DF +A + + ++ + S G T+ Y
Sbjct: 147 -GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIK 201
Query: 209 DYDLGSEVSTNGDAYNY-------GILLLEMVTRRKP 238
D E + + G +L M + P
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 34/180 (18%), Positives = 60/180 (33%), Gaps = 53/180 (29%)
Query: 40 FKKRRGPSKQPLRLTLRNAI----PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDL 95
+ + + + + LR + P+ +S +K IG GS V
Sbjct: 19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK----------IGEGSTGIVCLAREKH 68
Query: 96 NRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFIS------------------- 136
+ VA+K++ ++ Q + E +++ H N+V
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 137 --------------IAI---DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
IA V AL YLH + ++H D K ++LL D + DF
Sbjct: 129 LTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 48/206 (23%)
Query: 76 LINLIGVGSFDAVYQGVFDL----NRAVVAIKVL-SIQCQGASKSFMAECKALKNICHRN 130
I ++G G+F VY+G++ + VAIK L A+K + E + ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 131 LVRFI-------------------------------------SIAIDVASALDYLHHHCQ 153
+ R + + + +A ++YL
Sbjct: 79 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
++H D NVL+ I DF LA+ + G + I + AL+ L
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 214 SEVSTNGDAYNYGILLLEMVTR-RKP 238
+ D ++YG+ + E++T KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 40/209 (19%), Positives = 78/209 (37%), Gaps = 56/209 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQCQGASKS-FMAECKALKNICHRNL 131
L IG G F V+QG++ VAIK + + F+ E ++ H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 132 VR-------------------------------------FISIAIDVASALDYL-HHHCQ 153
V+ I A +++AL YL
Sbjct: 79 VKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---LDY 210
+H D NVL+ ++ +GDF L+R+ + + T ++ + I + A +++
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINF 191
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
++ D + +G+ + E++ KP
Sbjct: 192 ---RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 47/282 (16%), Positives = 88/282 (31%), Gaps = 57/282 (20%)
Query: 7 CLLEYRLESHRFLHDCSMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEY--Y 64
C L + + + L + R + I E Y
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377
Query: 65 ESLLKATDGFP-----LINLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQCQGASKS- 115
L IG G F V+QG++ + VAIK + +
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 116 FMAECKALKNICHRNLVR-------------------------------------FISIA 138
F+ E ++ H ++V+ I A
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 139 IDVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197
+++AL YL +H D NVL+ ++ +GDF L+R + + T ++
Sbjct: 498 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKAS 550
Query: 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
+ I + A + ++ D + +G+ + E++ KP
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 36/217 (16%), Positives = 71/217 (32%), Gaps = 60/217 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAECKALKNICHRNL 131
+ ++ IG G V+Q + + + AIK ++++ S+ E L + +
Sbjct: 11 YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 132 --VRFISIAID------------------------------------VASALDYLHHHCQ 153
+R I + A+ +H H
Sbjct: 70 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTIGYTA----L 208
I+H D KP+N L+ + + + DF +A + + ++ + S G T+ Y
Sbjct: 128 -GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEAIK 182
Query: 209 DYDLGSEVSTNGDAYNY-------GILLLEMVTRRKP 238
D E + + G +L M + P
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 47/229 (20%), Positives = 76/229 (33%), Gaps = 78/229 (34%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
F I ++G G+F V + L+ AIK + + + ++E L ++ H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 134 ------------------------FI---------------------------SIAIDVA 142
FI + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF------RQEVSNPTQSSS 196
AL Y+H I+H D KP N+ +D IGDF LA+ ++ + S
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 197 NGVRRT-IG---YTALDYDLGSEVSTNGDAYNY-------GILLLEMVT 234
+ + IG Y A +EV YN GI+ EM+
Sbjct: 184 SDNLTSAIGTAMYVA------TEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 25/211 (11%), Positives = 44/211 (20%), Gaps = 80/211 (37%)
Query: 76 LINLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQCQGASKS---FMAECKALKNICHRN 130
L+ G +Q + D L+R VA+ + Q ++ L I
Sbjct: 35 LLIFHGGVPPLQFWQAL-DTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 131 LVR-----------FI------------------------SIAIDVASALDYLHHHCQEL 155
+ R + +A+A D H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+ PS V + D + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP------------------------AT-------MPD 178
Query: 216 VSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ D G L ++ R P
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWP----LPEA 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 42/231 (18%), Positives = 69/231 (29%), Gaps = 69/231 (29%)
Query: 65 ESLLKATDGFPLINLIGVG--SFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSFMAEC 120
S L + L+ +IG G V + V ++ ++++ E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 121 KALKNICHRNLVRFI------------------------------------SIAI---DV 141
K H N+V + +IA V
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 142 ASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRR 201
ALDY+HH +H K S++L+ D G L+ R + S+G R+
Sbjct: 138 LKALDYIHHMGY---VHRSVKASHILISVD-----GKVYLSGLR--SN--LSMISHGQRQ 185
Query: 202 TIGYTALDYDLGS------EV-STNGDAYNY-------GILLLEMVTRRKP 238
+ + Y + EV N Y+ GI E+ P
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 43/204 (21%), Positives = 72/204 (35%), Gaps = 48/204 (23%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVL-SIQCQGASKSFMAECKALKNICHRNL 131
+IG G F VY G D + A+K L I G F+ E +K+ H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 132 VRF---------------------------------------ISIAIDVASALDYL-HHH 151
+ I + VA + +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+H D N +LD + DF LAR + + + G + + + AL+
Sbjct: 213 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR 235
+ +T D +++G+LL E++TR
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTR 292
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 46/204 (22%), Positives = 74/204 (36%), Gaps = 48/204 (23%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVL-SIQCQGASKSFMAECKALKNICHRNL 131
+IG G F VY G + NR AIK L I ++F+ E ++ + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 132 VR---------------------------------------FISIAIDVASALDYL-HHH 151
+ IS + VA ++YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+H D N +LD + DF LAR + + R + +TAL+
Sbjct: 145 F----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 212 LGSEVSTNGDAYNYGILLLEMVTR 235
+T D +++G+LL E++TR
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTR 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 43/206 (20%), Positives = 72/206 (34%), Gaps = 55/206 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQCQGASKS-FMAECKALKNICHRN 130
I +G G F V +D +VA+K L +S + E L+ + H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 131 LVRF--------------------------------------ISIAIDVASALDYLH-HH 151
++++ + A + + YLH H
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---L 208
+H D NVLLDND IGDF LA+ E + +G + + A L
Sbjct: 155 Y----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG-DSPVFWYAPECL 209
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVT 234
+ D +++G+ L E++T
Sbjct: 210 KE---YKFYYASDVWSFGVTLYELLT 232
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 40/233 (17%), Positives = 71/233 (30%), Gaps = 64/233 (27%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF 134
+ ++ G F VY+ + A+K L + +++ + E +K + H N+V+F
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 135 IS-----------------------------------------------IAIDVASALDY 147
S I A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRR------ 201
+H + I+H D K N+LL N + DF A + + S+
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 202 --TIGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL 249
T Y +D + D + G +L + R+ P FE L
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 49/165 (29%)
Query: 51 LRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ 110
LR + PK+ Y K IG G+ VY + VAI+ +++Q Q
Sbjct: 9 LRSIVSVGDPKKKYTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 111 GASKSFMAECKALKNICHRNLVRFIS---------------------------------I 137
+ + E ++ + N+V ++ I
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 138 AI---DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
A + AL++LH + ++H D K N+LL D + DF
Sbjct: 119 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 67/220 (30%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F + +G G F VY N+ ++A+KVL ++ +G E + ++ H N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 131 LVRF---------ISIAID----------------------------VASALDYLHHHCQ 153
++R I + ++ +A AL Y H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 134
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
++H D KP N+L+ I DF + + RRT+ T LDY L
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAP----------SLRRRTMCGT-LDY-LP 180
Query: 214 SEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
E+ G ++ G+L E + P F+
Sbjct: 181 PEM-IEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHR 129
+ + + +G G++ VY+ D +VA+K + + + G + + E LK + H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 130 NLVRFISIAIDVAS-------------------------------------ALDYLHHHC 152
N+V I + + + H H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
ILH D KP N+L+++D + DF LAR P +S ++ V T+ Y A D +
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARA---FGIPVRSYTHEV-VTLWYRAPDVLM 192
Query: 213 GSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
GS+ ST+ D ++ G + EM+T KP+ F G
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT-GKPL---FPGV 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/226 (14%), Positives = 63/226 (27%), Gaps = 60/226 (26%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ I +G G F V + A+K + Q + E + H N++R
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 134 FIS---------------------------------------------IAIDVASALDYL 148
++ + + + L+ +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 149 HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRR----TI 203
H H D KP+N+LL ++ + D V Q+ + TI
Sbjct: 151 HAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 204 GYTA---LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
Y A + D ++ G +L M+ P ++
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMV 249
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 55/219 (25%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHR 129
D + I +G G++ VY+ + + VAIK L + +G + + E LK + HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 130 NLVRFISIAID------------------------------------VASALDYLHHHCQ 153
N++ S+ + + +++ H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR- 152
Query: 154 ELILHCDPKPSNVLLDNDLFAH-----IGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
LH D KP N+LL + IGDF LAR P + ++ + T+ Y
Sbjct: 153 --CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEI-ITLWYRPP 206
Query: 209 DYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ LGS ST+ D ++ + EM+ + P+ F GD
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLM-KTPL---FPGD 241
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 27/144 (18%), Positives = 53/144 (36%), Gaps = 41/144 (28%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ ++ +G G+F VY+ A+ A KV+ + + + ++ E + L H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 134 FIS-----------------------------------IAI---DVASALDYLHHHCQEL 155
+ I + + AL++LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDF 179
I+H D K NVL+ + + DF
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADF 161
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 43/207 (20%), Positives = 70/207 (33%), Gaps = 54/207 (26%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNL 131
+IG G F VY G D + A+K L+ G F+ E +K+ H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 132 VR---------------------------------------FISIAIDVASALDYLH-HH 151
+ I + VA + YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---L 208
+H D N +LD + DF LAR + + + G + + + A L
Sbjct: 149 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVTR 235
+ S D +++G+LL E++TR
Sbjct: 205 QTQKFTTKS---DVWSFGVLLWELMTR 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 35/150 (23%), Positives = 53/150 (35%), Gaps = 44/150 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F + NL+G GSF VY+ VAIK++ + G + E K + H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 131 LVRFISIAID--------------------------------------VASALDYLHHHC 152
++ + D + + + YLH H
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELA 182
ILH D SN+LL ++ I DF LA
Sbjct: 133 ---ILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 45/220 (20%), Positives = 75/220 (34%), Gaps = 67/220 (30%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F + +G G F VY ++ ++A+KVL ++ G E + ++ H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 131 LVRFISIAID-------------------------------------VASALDYLHHHCQ 153
++R D +A+AL Y H
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
++H D KP N+LL + I DF + + R + T LDY L
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAP----------SSRRTDLCGT-LDY-LP 175
Query: 214 SEVSTNGDAYNY-------GILLLEMVTRRKPIDFMFEGD 246
E+ G ++ G+L E + + P FE +
Sbjct: 176 PEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/221 (14%), Positives = 72/221 (32%), Gaps = 72/221 (32%)
Query: 76 LINLIGVGSFDAVYQGVF-------DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH 128
+G G+F +++GV L+ V +KVL + S+SF + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 129 RNLVRF--------------------------------------ISIAIDVASALDYL-H 149
++LV + +A +A+A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAH--------IGDFELARFRQEVSNPTQSSSNGVRR 201
+ +H + N+LL + + D ++ + ++
Sbjct: 132 NTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--------KDILQE 179
Query: 202 TIGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVTR-RKP 238
I + ++ ++ D +++G L E+ + KP
Sbjct: 180 RIPWVPPECIEN--PKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 31/160 (19%), Positives = 56/160 (35%), Gaps = 50/160 (31%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFMAECKALKNICHRN 130
+ L +++G G+ V++G + AIKV + I M E + LK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVR------------------------------------------FISIAIDVASALDYL 148
+V+ F+ + DV +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 149 HHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELARF 184
+ I+H + KP N++ D + DF AR
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 43/211 (20%), Positives = 73/211 (34%), Gaps = 62/211 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLV 132
F + IG GSF V++G+ + + VVAIK++ + + + + E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 133 RFI---------------------------------SIAI---DVASALDYLHHHCQELI 156
++ IA ++ LDYLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---K 140
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT--IGYTALDYDLGS 214
+H D K +NVLL + DF +A Q + ++R +G T + +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVA---------GQLTDTQIKRNTFVG-TP--FWMAP 188
Query: 215 EVSTNGDAYNY-------GILLLEMVTRRKP 238
EV Y+ GI +E+ P
Sbjct: 189 EVIKQSA-YDSKADIWSLGITAIELARGEPP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 55/223 (24%)
Query: 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI 126
+ ++ F + +G G++ VY+G+ VA+K + + + G + + E +K +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 127 CHRNLVRFISIAIDVAS------------------------------------------A 144
H N+VR +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
L + H + ILH D KP N+L++ +GDF LAR P + S+ V T+
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA---FGIPVNTFSSEV-VTLW 173
Query: 205 YTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
Y A D +GS ST+ D ++ G +L EM+T KP+ F G
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPL---FPGT 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 7e-09
Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 52/215 (24%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV--LSIQCQGASKSFMAECKALKNICHR 129
+ + + IG G++ VY+ + A+K L + +G + + E LK + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 130 NLVRFISI---------------------------AIDVA----------SALDYLHHHC 152
N+V+ + ++ + + Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+LH D KP N+L++ + I DF LAR P + ++ + T+ Y A D +
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARA---FGIPVRKYTHEI-VTLWYRAPDVLM 173
Query: 213 GSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
GS+ ST D ++ G + EMV P+ F G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT-PL---FPGV 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 34/148 (22%)
Query: 105 LSIQ---CQGAS-KSFMAECKALKNICHRNLVRFISIAIDVASALDYLHHHCQELILHCD 160
L IQ C+ + K +M +L++ H + I I +A A+++LH ++H D
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH---IFIQIAEAVEFLHSKG---LMHRD 189
Query: 161 PKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVST-- 218
KPSN+ D +GDF L + + +V T
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 219 -------NGDAYNY-------GILLLEM 232
+G+ Y++ G++L E+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFEL 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 33/152 (21%), Positives = 51/152 (33%), Gaps = 50/152 (32%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLV 132
F L+ L+G G++ VY+G + AIKV+ + + E LK HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 84
Query: 133 RFI------------------------------------------SIAI---DVASALDY 147
+ IA ++ L +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
LH H ++H D K NVLL + + DF
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 31/160 (19%), Positives = 56/160 (35%), Gaps = 50/160 (31%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFMAECKALKNICHRN 130
+ L +++G G+ V++G + AIKV + I M E + LK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVR------------------------------------------FISIAIDVASALDYL 148
+V+ F+ + DV +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 149 HHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELARF 184
+ I+H + KP N++ D + DF AR
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 29/174 (16%), Positives = 59/174 (33%), Gaps = 46/174 (26%)
Query: 47 SKQPLRLTLRNAIPKEYYESLLKATDG---FPLINLIGVGSFDAVYQGVFDLNRAVVAIK 103
S + ++L + + F ++ +G GS+ +VY+ + +VAIK
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 104 VLSIQCQGASKSFMAECKALKNICHRNLVRFIS--------------------------- 136
+ ++ + + E ++ ++V++
Sbjct: 61 QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 137 --------IAI---DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
IA L+YLH +H D K N+LL+ + A + DF
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 58/213 (27%)
Query: 74 FPLINLIGVGSF-DAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNIC-HRN 130
F +++G G+ VY+G+FD NR V A+K + +C A + E + L+ H N
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFD-NRDV-AVKRILPECFSFADR----EVQLLRESDEHPN 79
Query: 131 LVR---------FISIAI----------------------------DVASALDYLHHHCQ 153
++R F IAI S L +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 154 ELILHCDPKPSNVLLDN-----DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA- 207
I+H D KP N+L+ + A I DF L + + S +GV T G+ A
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRRSGVPGTEGWIAP 195
Query: 208 --LDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
L D + D ++ G + +++
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 49/210 (23%), Positives = 76/210 (36%), Gaps = 51/210 (24%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIK--VLSIQCQGASKSFMAECKALKNICHRNLVRF 134
+ L+G GS+ V + +VAIK + S + K M E K LK + H NLV
Sbjct: 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 135 ISI---------------------------AIDVA----------SALDYLHHHCQELIL 157
+ + +D + + + H H I+
Sbjct: 90 LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---II 146
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV- 216
H D KP N+L+ + DF AR ++ P + + V T Y A + +G
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFAR---TLAAPGEVYDDEV-ATRWYRAPELLVGDVKY 202
Query: 217 STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
D + G L+ EM P+ F GD
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE-PL---FPGD 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 35/146 (23%), Positives = 52/146 (35%), Gaps = 43/146 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS---KSFMAECKALKNICHRN 130
F + IG GSF AVY N VVAIK +S + ++ + + E + L+ + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 131 LVRFI----------------------------------SIAI---DVASALDYLHHHCQ 153
+++ IA L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 172
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDF 179
++H D K N+LL +GDF
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 30/162 (18%), Positives = 57/162 (35%), Gaps = 58/162 (35%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRN 130
L ++G G F +V +G D VA+K + + Q + F++E +K+ H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 131 LVR------------------------------------------------FISIAIDVA 142
++R + +D+A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 143 SALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
++YL + + LH D N +L +D+ + DF L++
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 54/213 (25%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKS---FMA--ECKALKNICHRNL 131
++ +G G F VY+ +VAIK + + + +K A E K L+ + H N+
Sbjct: 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 132 VRFI---------------------------SIAIDVA----------SALDYLHHHCQE 154
+ + S+ + + L+YLH H
Sbjct: 75 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
ILH D KP+N+LLD + + DF LA+ +P ++ ++ V T Y A + G+
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKS---FGSPNRAYTHQV-VTRWYRAPELLFGA 187
Query: 215 EV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ D + G +L E++ R P GD
Sbjct: 188 RMYGVGVDMWAVGCILAELLL-RVPF---LPGD 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 51/210 (24%)
Query: 77 INLIGVGSFDAVYQGVFDLNRAVVAIK--VLSIQCQGASKSFMAECKALKNICHRNLVRF 134
I IG GS+ V++ +VAIK + S K + E + LK + H NLV
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 135 I-------------------------------------SIAIDVASALDYLHHHCQELIL 157
+ SI A+++ H H +
Sbjct: 68 LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CI 124
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV- 216
H D KP N+L+ + DF AR ++ P+ + V T Y + + +G
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFAR---LLTGPSDYYDDEV-ATRWYRSPELLVGDTQY 180
Query: 217 STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
D + G + E+++ P+ + G
Sbjct: 181 GPPVDVWAIGCVFAELLSGV-PL---WPGK 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 51/224 (22%), Positives = 80/224 (35%), Gaps = 57/224 (25%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA--ECKALKNICHR 129
+ + IG G+F V++ VA+K + ++ + A E K L+ + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 130 NLVRFISIAIDVA---------------------------------------------SA 144
N+V I I A +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR-FRQEVSNPTQSSSNGVRRTI 203
L Y+H + ILH D K +NVL+ D + DF LAR F ++ +N V T+
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV-VTL 192
Query: 204 GYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
Y + LG D + G ++ EM T R PI +G+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI---MQGN 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 39/152 (25%), Positives = 60/152 (39%), Gaps = 43/152 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLV 132
L + +GVG+F V G L VA+K+L+ I+ E + LK H +++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 133 R----------------FIS-------------IAIDVA--------SALDYLHHHCQEL 155
+ ++S + A SA+DY H H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--- 131
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
++H D KP NVLLD + A I DF L+ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 28/163 (17%), Positives = 52/163 (31%), Gaps = 59/163 (36%)
Query: 76 LINLIGVGSFDAVYQGVF---DLNRAVVAIKVL--SIQCQGASKSFMAECKALKNICHRN 130
L ++G G F +V + D + VA+K+L I + F+ E +K H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 131 LVRFI-------------------------------------------------SIAIDV 141
+ + + +D+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 142 ASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
A ++YL + +H D N +L D+ + DF L+R
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 67/216 (31%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH-- 128
F ++ IG GSF V + + + A+K ++ + ++ E + ++ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 129 ------------------------------RNLVRF------ISIAIDVASALDYLHHHC 152
+ V F + I ++ ALDYL +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR 135
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN-GVRRTIGYTALDYD 211
I+H D KP N+LLD HI DF +A + TQ ++ G T Y A
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAG---TKPYMA---- 182
Query: 212 LGSEV--STNGDAYNY-------GILLLEMVTRRKP 238
E+ S G Y++ G+ E++ R+P
Sbjct: 183 --PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 28/159 (17%), Positives = 52/159 (32%), Gaps = 47/159 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS----IQCQGASKSFMAECKALKNICHRNL 131
+ +L+G GS+ V + + A+K+L + + E + L+ + H+N+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 132 VR---------------------------FISIA-----IDVA--------SALDYLHHH 151
++ S+ + A L+YLH
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190
I+H D KP N+LL I +A +
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 34/157 (21%), Positives = 52/157 (33%), Gaps = 43/157 (27%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN 130
F + ++G G+F V+ L + A+K + S E LK I H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 131 LVRFI-------------------------------------SIAIDVASALDYLHHHCQ 153
+V + V SA+ YLH +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 154 ELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQE 187
I+H D KP N+L + + I DF L++ Q
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202
LD+LH H ++H D KP N+L+ + + DF LAR S +S V T
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV--T 182
Query: 203 IGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ Y A + L S +T D ++ G + EM RKP+ F G
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL---FRGS 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 12/104 (11%)
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202
LD+LH +C I+H D KP N+L+ + + DF LAR S + V T
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVV--T 182
Query: 203 IGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ Y A + L S +T D ++ G + EM RKP+ F G+
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL---FCGN 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 17/111 (15%)
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAH----IGDFELARFRQEVSNPTQSSSNG 198
+ YLH + +LH D KP+N+L+ + I D AR ++P + ++
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL---FNSPLKPLADL 192
Query: 199 VRR--TIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
T Y A + LG+ + D + G + E++T +PI F
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI---FHCR 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 36/275 (13%), Positives = 75/275 (27%), Gaps = 65/275 (23%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAV-----VAIKVLSIQCQGASKSFMAECKALKN 125
+ + +L+G G+F VY+ +KV + LK
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 126 ICHRNLVRF------------------------------------------ISIAIDVAS 143
++F IS A+ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 144 ALDYLHHHCQELILHCDPKPSNVLLDNDLFAH-----------IGDFELARFRQEVSNPT 192
++ +H I+H D KP N +L N + D + + P
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF--PK 238
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH-N 251
+ T G+ ++ + D + + M+ G+
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRK 286
F R+ + + ++ +LN + ++LR+
Sbjct: 299 FRRLPHLDMWNEFFHV-MLNIPDCHHLPSLDLLRQ 332
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 43/152 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLV 132
L + +GVG+F V G +L VA+K+L+ I+ E + LK H +++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 133 R----------------FIS-------------IAIDVA--------SALDYLHHHCQEL 155
+ ++S + + S +DY H H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
++H D KP NVLLD + A I DF L+ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 33/151 (21%), Positives = 55/151 (36%), Gaps = 42/151 (27%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLV 132
+ +G GSF V + VA+K +S ++ E LK + H +++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 133 R------------------------FIS----IAIDVA--------SALDYLHHHCQELI 156
+ +I + D A++Y H H I
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---I 129
Query: 157 LHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
+H D KP N+LLD++L I DF L+ +
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 25/157 (15%), Positives = 50/157 (31%), Gaps = 49/157 (31%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMA-----ECKALKN 125
+ ++ +G G+F V+ V V +K + + + E L
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 126 ICHRNLVR---------FISIAID-----------------------------VASALDY 147
+ H N+++ F + ++ + SA+ Y
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184
L I+H D K N+++ D + DF A +
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 34/165 (20%), Positives = 54/165 (32%), Gaps = 64/165 (38%)
Query: 76 LINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKS----FMAECKALKNI 126
+ +G GSF VY+GV D VAIK ++ + AS F+ E +K
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEF 85
Query: 127 CHRNLVR-----------------------------------------------FISIAI 139
++VR I +A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 140 DVASALDYLH-HHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
++A + YL+ + +H D N ++ D IGDF + R
Sbjct: 146 EIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 25/155 (16%), Positives = 49/155 (31%), Gaps = 50/155 (32%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSI---------QCQGASKSFMAECKALKNIC-HR 129
+G G V + + A+K++ + + Q ++ + E L+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 130 NLVRFI-------------------------------------SIAIDVASALDYLHHHC 152
N+++ I + + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
I+H D KP N+LLD+D+ + DF +
Sbjct: 145 ---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 31/166 (18%), Positives = 54/166 (32%), Gaps = 53/166 (31%)
Query: 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK-SFMAECKALKNIC 127
+ + + +G G F V + + VAIK + ++ + E + +K +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 128 HRNLVR----------------------------------------------FISIAIDV 141
H N+V ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 142 ASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFELARF 184
+SAL YLH + I+H D KP N++L L I D A+
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 42/230 (18%), Positives = 71/230 (30%), Gaps = 67/230 (29%)
Query: 18 FLHDCSMNQSNHSNKLNLEEYGFKKRR-----------GPSKQPLRLTLRNAIPKEYYES 66
++ D S N + +N E G KRR + + Y
Sbjct: 76 YIEDHSGNGT----FVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPK 131
Query: 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--------IQCQGASKSFMA 118
L+ D + + +G G+ V VAI+++S + + +
Sbjct: 132 ALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 119 ECKALKNICHRNLVRFI------------------------------------SIAIDVA 142
E + LK + H +++ +
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 143 SALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEVS 189
A+ YLH + I+H D KP NVLL + D I DF ++ E S
Sbjct: 250 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 43/206 (20%), Positives = 69/206 (33%), Gaps = 52/206 (25%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALKNIC 127
+ + IG G+ V + VAIK LS + A E +K +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA----YRELVLMKCVN 82
Query: 128 HRNLVRFISIAIDVASALDY-------------LHH---------HCQEL---------- 155
H+N++ +++ S ++ L L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 156 -----ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
I+H D KPSN+++ +D I DF LAR T T Y A +
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TRYYRAPEV 197
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTRR 236
LG N D ++ G ++ EM+
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 48/221 (21%), Positives = 73/221 (33%), Gaps = 71/221 (32%)
Query: 76 LINLIGVGSFDAVYQG-VFDLNRA----VVAIKVLSIQCQGASKS----FMAECKALKNI 126
+G G+F V + F L + VA+K+L A M+E K + ++
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHL 106
Query: 127 -CHRNLVRF--------------------------------------------------- 134
H N+V
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 135 ISIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193
+ + VA + +L +C +H D NVLL N A IGDF LAR SN
Sbjct: 167 LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YI 221
Query: 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
N R + + A + + D ++YGILL E+ +
Sbjct: 222 VKGNA-RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 22/105 (20%)
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
+ L+++H+ +++ D KP+N+LLD I D LA + S +S G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVG-- 352
Query: 201 RTIGYTALDYDLGSEVSTNGDAYN-------YGILLLEMVTRRKP 238
T GY A EV G AY+ G +L +++ P
Sbjct: 353 -THGYMA------PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 32/214 (14%), Positives = 69/214 (32%), Gaps = 60/214 (28%)
Query: 20 HDCSMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINL 79
+ + + + + E + + GP + + Y+ ++
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF-YQKYD----------PKDV 101
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSI--------QCQGASKSFMAECKALKNIC-HRN 130
IG G V + V A+K++ + Q + ++ E L+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 131 LVRFI-------------------------------------SIAIDVASALDYLHHHCQ 153
++ I SI + A+ +LH +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN- 220
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187
I+H D KP N+LLD+++ + DF + +
Sbjct: 221 --IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 29/139 (20%)
Query: 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH------IGDFELAR 183
V+ I+ + LDY+H C I+H D KP NVL++ I D A
Sbjct: 131 IYVK--QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 184 F-RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242
+ + +N Q+ Y + + LG+ D ++ L+ E++T DF+
Sbjct: 187 WYDEHYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFL 234
Query: 243 FEGD------LNLHNFARM 255
FE D + + A++
Sbjct: 235 FEPDEGHSYTKDDDHIAQI 253
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 34/147 (23%), Positives = 52/147 (35%), Gaps = 44/147 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLV 132
L+ IG G+F V L VAIK++ + K F E + +K + H N+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 133 R-------------------------FIS------------IAIDVASALDYLHHHCQEL 155
+ ++ + SA+ Y H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELA 182
I+H D K N+LLD D+ I DF +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 42/231 (18%), Positives = 69/231 (29%), Gaps = 89/231 (38%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALK-----NI-- 126
F I LIG G F V++ ++ IK + ++ E KAL NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVH 68
Query: 127 ---------------------------------CHR-NLVRFI--------------SIA 138
C + L ++I +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 139 IDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198
+ +DY+H +++ D KPSN+ L + IGDF L ++G
Sbjct: 129 EQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---------SLKNDG 176
Query: 199 VRRT-IG---YTALDYDLGSEVSTNGDAYNY-------GILLLEMVTRRKP 238
R G Y + E + Y G++L E++
Sbjct: 177 KRTRSKGTLRYMS------PEQ-ISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 48/207 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNICHRN 130
D F I+ +G G+ V++ + V+A K++ ++ + A + E + L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 131 LVRF---------ISI----------------------------AIDVASALDYLHHHCQ 153
+V F ISI +I V L YL +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS-NPTQSSSNGVRRTIGYTALDYDL 212
I+H D KPSN+L++ G+ +L F VS S +N T Y + +
Sbjct: 153 --IMHRDVKPSNILVN-----SRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 213 GSEVSTNGDAYNYGILLLEMVTRRKPI 239
G+ S D ++ G+ L+EM R PI
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 48/223 (21%), Positives = 76/223 (34%), Gaps = 68/223 (30%)
Query: 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALK 124
+KA D + ++ +IG G+F V R V A+K+LS + + S F E +
Sbjct: 66 MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 125 NICHRNLVR----------------FIS------------IAIDVA--------SALDYL 148
+V+ ++ + A ALD +
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 149 HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
H +H D KP N+LLD + DF + + G+ R TA+
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM---------KMNKEGMVRC--DTAV 230
Query: 209 ---DYDLGSEV-STNGDAYNY---------GILLLEMVTRRKP 238
DY + EV + G Y G+ L EM+ P
Sbjct: 231 GTPDY-ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 26/123 (21%), Positives = 46/123 (37%), Gaps = 32/123 (26%)
Query: 140 DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199
V ++ Y+H+ I H D KPSN+L+D + + DF + + +
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV----------DKK 206
Query: 200 RRTI-G---YTA-------LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248
+ G + Y+ G++V D ++ GI L M P F ++
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYN-GAKV----DIWSLGICLYVMFYNVVP----FSLKIS 257
Query: 249 LHN 251
L
Sbjct: 258 LVE 260
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 43/202 (21%), Positives = 67/202 (33%), Gaps = 47/202 (23%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F ++G GSF V AIK+L I + E + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 131 LVR------------FI-----------------SIAIDVA--------SALDYLHHHCQ 153
V+ F S SAL+YLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN-GVRRTIGYTALDYDL 212
I+H D KP N+LL+ D+ I DF A+ S +++S G T Y + +
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG---TAQYVSPELLT 205
Query: 213 GSEVSTNGDAYNYGILLLEMVT 234
+ D + G ++ ++V
Sbjct: 206 EKSACKSSDLWALGCIIYQLVA 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 51/266 (19%), Positives = 83/266 (31%), Gaps = 63/266 (23%)
Query: 27 SNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFD 86
++ L + R S + + + + F + L+G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-FEYLKLLGKGTFG 162
Query: 87 AVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRNLV----------- 132
V A+K+L I + + E + L+N H L
Sbjct: 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222
Query: 133 ----------------------------RFISIAIDVASALDYLHHHCQELILHCDPKPS 164
RF ++ SALDYLH +++ D K
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSALDYLHSEKN--VVYRDLKLE 278
Query: 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA----LDYDLGSEVSTNG 220
N++LD D I DF L + + ++ T Y A D D G V
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG----TPEYLAPEVLEDNDYGRAV---- 330
Query: 221 DAYNYGILLLEMVTRRKPIDFMFEGD 246
D + G+++ EM+ R P F
Sbjct: 331 DWWGLGVVMYEMMCGRLP----FYNQ 352
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 45/218 (20%), Positives = 73/218 (33%), Gaps = 52/218 (23%)
Query: 62 EYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKS 115
E +S + + IG G+ V + VAIK LS + A
Sbjct: 52 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--- 108
Query: 116 FMAECKALKNICHRNLVRFISIAIDVASALDY-------------LHH---------HCQ 153
E +K + H+N++ +++ + ++ L
Sbjct: 109 -YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 167
Query: 154 EL---------------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNG 198
L I+H D KPSN+++ +D I DF LAR T
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-- 225
Query: 199 VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRR 236
T Y A + LG N D ++ G ++ EMV +
Sbjct: 226 ---TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 32/152 (21%), Positives = 55/152 (36%), Gaps = 39/152 (25%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQGASKSFMAECKALKNICH 128
+ +G G++ +V + + VAIK LS Q + +K E LK++ H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 129 RNLVRFISIAIDVASALDY-------------LHH---------HCQEL----------- 155
N++ + + +S ++ L Q L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 156 ----ILHCDPKPSNVLLDNDLFAHIGDFELAR 183
++H D KP N+ ++ D I DF LAR
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 32/145 (22%), Positives = 51/145 (35%), Gaps = 41/145 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLVRF 134
L+ +G G++ V V + VA+K++ + + ++ E K + H N+V+F
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 135 I-------SIAI----------------------DVA--------SALDYLHHHCQELIL 157
+ A + + YLH I
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GIT 127
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELA 182
H D KP N+LLD I DF LA
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLA 152
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 44/226 (19%), Positives = 74/226 (32%), Gaps = 74/226 (32%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNIC-HR 129
+ + IG G++ +V + V + ++A+K + K + + +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 130 NLVRF----------------------------------------IS-IAIDVASALDYL 148
+V+F + I + AL++L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 149 HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ-SSSNGVRRTIG--- 204
+ + I+H D KPSN+LLD G+ +L F +S Q S R G
Sbjct: 142 KENLK--IIHRDIKPSNILLDRS-----GNIKLCDF--GIS--GQLVDSIAKTRDAGCRP 190
Query: 205 YTALDYDLGSEV---STNGDAYNY-------GILLLEMVTRRKPID 240
Y A E S + Y+ GI L E+ T R P
Sbjct: 191 YMA------PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 44/231 (19%), Positives = 73/231 (31%), Gaps = 67/231 (29%)
Query: 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALK 124
L+ D F ++ +IG G+F V V A+K+++ + +G F E L
Sbjct: 58 LQRDD-FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 125 NICHRNLVR----------------FIS-----------------------IAIDVASAL 145
N R + + + +A ++ A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAI 175
Query: 146 DYLHHHCQELILHCDPKPSNVLLDNDLFAHI--GDFELARFRQEVSNPTQSSSNG----- 198
D +H +H D KP N+LLD HI DF + + G
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 199 ---VRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ + +G G E D + G+ EM + P F D
Sbjct: 231 SPEILQAVGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTP----FYAD 273
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 46/261 (17%), Positives = 87/261 (33%), Gaps = 71/261 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F ++ +IG G+F V V A+K+L+ + + + F E L N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 131 LVR----------------FIS-----------------------IAIDVASALDYLHHH 151
+ + +A ++ A+D +H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQL 194
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+H D KP N+L+D + + DF E S + G T Y + +
Sbjct: 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG---TPDYISPEIL 248
Query: 212 LGSEVSTNG-----DAYNYGILLLEMVTRRKPIDFMFEGDLN-------LHNFARMAFPN 259
E D ++ G+ + EM+ P F + +++ R FP
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP----FYAESLVETYGKIMNHKERFQFPT 304
Query: 260 RVMDI----VNLV--LLNDNK 274
+V D+ +L+ L+ +
Sbjct: 305 QVTDVSENAKDLIRRLICSRE 325
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 32/145 (22%), Positives = 51/145 (35%), Gaps = 41/145 (28%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRNLVRF 134
L+ +G G++ V V + VA+K++ + + ++ E K + H N+V+F
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 135 I-------SIAI----------------------DVA--------SALDYLHHHCQELIL 157
+ A + + YLH I
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GIT 127
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELA 182
H D KP N+LLD I DF LA
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLA 152
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 43/226 (19%), Positives = 73/226 (32%), Gaps = 73/226 (32%)
Query: 78 NLIGVGSF-DAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL-KNICHRNLVR-- 133
++G GS V+QG F R V A+K + I + E K L ++ H N++R
Sbjct: 21 KILGYGSSGTVVFQGSFQ-GRPV-AVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYY 75
Query: 134 -------FISIAI----------------------------------DVASALDYLHHHC 152
F+ IA+ +AS + +LH
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 153 QELILHCDPKPSNVLLDNDLFAH-------------IGDFELARFRQEVSNPTQSSSNGV 199
I+H D KP N+L+ I DF L + + +++ N
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 200 RRTIGYTALDYDLGSEVSTNGDAYNY-------GILLLEMVTRRKP 238
T G+ A + S G + ++++ K
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 40/150 (26%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQGASKSFMAECKALKNICHRNL 131
+ + +G G++ AV V A VAIK L Q + +K E + LK++ H N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 132 VRFISIAIDVASALDY-------------LHH----------HCQEL------------- 155
+ + + + D+ L Q L
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 156 --ILHCDPKPSNVLLDNDLFAHIGDFELAR 183
I+H D KP N+ ++ D I DF LAR
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 31/164 (18%), Positives = 52/164 (31%), Gaps = 50/164 (30%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--------IQCQGASKSFMAECKA 122
D + + +G G+ V VAIK++S + + + E +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 123 LKNICHRNLVRFI------------------------------------SIAIDVASALD 146
LK + H +++ + A+
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 147 YLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQE 187
YLH + I+H D KP NVLL + D I DF ++ E
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 46/215 (21%), Positives = 73/215 (33%), Gaps = 54/215 (25%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICHRN 130
F ++G G F V + A K L I+ + + E + L+ + R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 131 LV---------------------------------------RFISIAIDVASALDYLHHH 151
+V R + A ++ L+ LH
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+E I++ D KP N+LLD+ I D LA E T G T+GY A +
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVG---TVGYMAPEVV 357
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ + D + G LL EM+ + P F+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 38/162 (23%), Positives = 54/162 (33%), Gaps = 58/162 (35%)
Query: 76 LINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKS-FMAECKALKNICHR 129
LI +G G+F VY+G D + VA+K L C + F+ E + H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 130 NLVRF--------------------------------------------ISIAIDVASAL 145
N+VR + +A D+A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 146 DYL-HHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELAR 183
YL +H +H D N LL A IGDF +AR
Sbjct: 154 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 32/148 (21%), Positives = 48/148 (32%), Gaps = 43/148 (29%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI 135
+ IG G+F L + +VA+K + ++ E +++ H N+VRF
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFK 82
Query: 136 -------SIAI----------------------DVA--------SALDYLHHHCQELILH 158
+AI D A S + Y H I H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICH 139
Query: 159 CDPKPSNVLLDNDLFAH--IGDFELARF 184
D K N LLD I DF ++
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 42/211 (19%), Positives = 69/211 (32%), Gaps = 58/211 (27%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSF---MAECKALKNICH 128
D F I +G GSF V + A+K+L Q K + E + L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 129 RNLVR----------------FIS---------------------IAIDVASALDYLHHH 151
LV+ +++ A + +YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---- 207
+++ D KP N+L+D + + DF A+ V T + + T A
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT----LCGTPEALAPEII 210
Query: 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
L V D + G+L+ EM P
Sbjct: 211 LSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 38/162 (23%), Positives = 54/162 (33%), Gaps = 58/162 (35%)
Query: 76 LINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKS-FMAECKALKNICHR 129
LI +G G+F VY+G D + VA+K L C + F+ E + H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 130 NLVRF--------------------------------------------ISIAIDVASAL 145
N+VR + +A D+A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 146 DYL-HHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELAR 183
YL +H +H D N LL A IGDF +AR
Sbjct: 195 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 22/109 (20%), Positives = 45/109 (41%), Gaps = 8/109 (7%)
Query: 126 ICHRNLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185
+ +L+ + + VA +++L +H D N+LL I DF LAR
Sbjct: 190 LTLEHLICY---SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT 234
+ + + R + + A + + D +++G+LL E+ +
Sbjct: 244 YKDPDYVRKG--DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 48/225 (21%), Positives = 73/225 (32%), Gaps = 67/225 (29%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
D F ++G G F V+ + A K L+ ++ + + M E K L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 129 RNLV-------------------------------------------RFISIAIDVASAL 145
R +V F + S L
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGL 302
Query: 146 DYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205
++LH I++ D KP NVLLD+D I D LA + T+ + T G+
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG----TPGF 355
Query: 206 TA----LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
A L + V D + G+ L EM+ R P F
Sbjct: 356 MAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP----FRAR 392
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 33/166 (19%), Positives = 56/166 (33%), Gaps = 62/166 (37%)
Query: 76 LINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN 130
L +G G+F V+ + ++ +VA+K L + A + F E + L + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 131 LVRFI----------------------------------------------------SIA 138
+VRF ++A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 139 IDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
VA+ + YL H +H D N L+ L IGDF ++R
Sbjct: 165 SQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 35/167 (20%), Positives = 54/167 (32%), Gaps = 63/167 (37%)
Query: 76 LINLIGVGSFDAVYQG-----VFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN 130
L +G G+F V+ ++ +VA+K L A K F E + L N+ H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 131 LVRFI-----------------------------------------------------SI 137
+V+F I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 138 AIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
A +AS + YL H +H D N L+ +L IGDF ++R
Sbjct: 139 ASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 28/179 (15%), Positives = 53/179 (29%), Gaps = 53/179 (29%)
Query: 46 PSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVL 105
P + ++ +YY+ ++ +G G+F V++ V V K +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYD----------ILEELGSGAFGVVHRCVEKATGRVFVAKFI 84
Query: 106 SIQCQGASKSFMAECKALKNICHRNLVRF------------------------------- 134
+ + E + + H L+
Sbjct: 85 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 144
Query: 135 -------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH--IGDFELARF 184
I+ L ++H H I+H D KP N++ + + I DF LA
Sbjct: 145 KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 38/148 (25%), Positives = 55/148 (37%), Gaps = 38/148 (25%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFMAECKALKNICHRNLV 132
+ ++ IG G++ V +LN+ VAIK +S + Q + + E K L H N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 133 RFISIAI--------DVASALDY----LHH----------HCQEL--------------- 155
I DV D L+ H
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183
+LH D KPSN+LL+ I DF LAR
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 39/224 (17%), Positives = 67/224 (29%), Gaps = 71/224 (31%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS-KSFMAECKALKNIC-HR 129
D I +G G++ V + + ++A+K + K + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 130 NLVRF---------ISI-------------------------------AIDVASALDYLH 149
V F + I A+ + AL++LH
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF---RQEVSNPTQSSSNGVRRTIGYT 206
++H D KPSNVL++ G ++ F V + + G Y
Sbjct: 127 SKLS--VIHRDVKPSNVLINAL-----GQVKMCDFGISGYLVDDVAKDIDAG---CKPYM 176
Query: 207 ALDYDLGSEV---STNGDAYNY-------GILLLEMVTRRKPID 240
A E N Y+ GI ++E+ R P D
Sbjct: 177 A------PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 42/283 (14%), Positives = 99/283 (34%), Gaps = 66/283 (23%)
Query: 50 PLRLTL-----RNAIPK-EYY-----ESLLKATDGFPLINLIGVGSFDAVYQ--GVFDLN 96
P RL++ R+ + + + + L + +N++ + ++ VF +
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEYRKMFDRLSVFPPS 384
Query: 97 RAVVAI--KVLSIQCQGASKS----FMAEC--KAL--KNICHRNLVRFISIAIDVASALD 146
I +LS+ KS + + +L K + + SI +++ L+
Sbjct: 385 ---AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK-ESTISIPSIYLELKVKLE 440
Query: 147 ---YLHHHCQELILH-------CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSS 196
LH + ++ H LD ++HIG L
Sbjct: 441 NEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG-HHLKNIEHP------ERM 490
Query: 197 NGVRRTIGYTALDYD-LGSEVSTNGDAYNYGILLLEMVTR----RKPI---DFMFEGDLN 248
R + LD+ L ++ + A+N +L + + + I D +E +N
Sbjct: 491 TLFRMV--F--LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
Query: 249 -LHNFARMAFPNRV----MDIVNLVLLNDNKVLAGTNSNMLRK 286
+ +F N + D++ + L+ +++ + +++
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 3e-05
Identities = 37/252 (14%), Positives = 81/252 (32%), Gaps = 67/252 (26%)
Query: 145 LDY----LHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF-RQEVSNPTQSSS--N 197
+D+ + ++++ + + + D + D + ++E+ + S +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDA---FVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 198 GVRRTIGYTALDYDLGSEVST----NGDAYNYGILLLEMVTR-RKP--IDFMFEGDLN-L 249
G R T L E+ NY L+ + T R+P + M+ + L
Sbjct: 63 GTLRLFW-TLLSK--QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 250 HN----FARMAFPNRVMDIVNL--VLLNDNK---------------VLAGTNSNMLRKTK 288
+N FA+ R+ + L LL +A ++ K
Sbjct: 120 YNDNQVFAKYNVS-RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA---LDVCLSYK 175
Query: 289 MNSRLECLIFMVRIG------------------AACSMGSSQDRM-NVPNAVHDLQSVNN 329
+ +++ IF + + + S D N+ +H +Q+
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 330 ILLPETVFK-SL 340
LL ++ L
Sbjct: 236 RLLKSKPYENCL 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 34/174 (19%), Positives = 52/174 (29%), Gaps = 73/174 (41%)
Query: 76 LINLIGVGSFDAVYQGV-------FDLNRAVVAIKVLSIQCQGASKS----FMAECKALK 124
L +G G+F V VA+K+L A++ ++E + +K
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMK 129
Query: 125 NI-CHRNLVRFI------------------------------------------------ 135
I H+N++ +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 136 -----SIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
S A VA ++YL C +H D NVL+ D I DF LAR
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 33/159 (20%), Positives = 60/159 (37%), Gaps = 45/159 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
+ + ++ ++G GSF V + + + A+KV++ + + + E + LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+++ I V S + Y+H H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 152 CQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQE 187
I+H D KP N+LL + D I DF L+ Q+
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 33/157 (21%), Positives = 59/157 (37%), Gaps = 48/157 (30%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALK 124
+ + ++ +G G++ +V VA+K LS I + E + LK
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YRELRLLK 83
Query: 125 NICHRNLVRFISIAIDVASALDY-------------LHH--HCQEL-------------- 155
++ H N++ + + S ++ L++ CQ+L
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 156 ---------ILHCDPKPSNVLLDNDLFAHIGDFELAR 183
I+H D KPSN+ ++ D I DF LAR
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 26/159 (16%), Positives = 50/159 (31%), Gaps = 45/159 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
+D + + +G G+F V + V A K+++ + + E + + + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+VR + ++ Y H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 152 CQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQE 187
I+H + KP N+LL + DF LA +
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 47/225 (20%), Positives = 80/225 (35%), Gaps = 49/225 (21%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHR 129
+ F L +L+G G++ V +VAIK + + + E K LK+ H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 130 NLVRFISIAI--------DVASALDY----LHH----------HCQEL------------ 155
N++ +I +V + LH H Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 156 ---ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
++H D KPSN+L++++ + DF LAR E + + + + A +
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 213 GSEVSTNGDAYNYGI-------LLLEMVTRRKPIDFMFEGDLNLH 250
EV Y+ + +L E+ R+PI F G H
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI---FPGRDYRH 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 33/145 (22%), Positives = 44/145 (30%), Gaps = 43/145 (29%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI---- 135
IG GS+ V V R A K + F E + +K++ H N++R
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 136 ---------------------------------SIAIDVASALDYLHHHCQELILHCDPK 162
I DV SA+ Y H + H D K
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLK 133
Query: 163 PSNVLLDN---DLFAHIGDFELARF 184
P N L D + DF LA
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAAR 158
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 37/206 (17%), Positives = 68/206 (33%), Gaps = 50/206 (24%)
Query: 23 SMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGV 82
+ + + ++ ++ + + S + D + + +LIG
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 83 GSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALKNICHRNLVRFIS 136
GS+ V + L + VVAIK + I C+ + E L + H ++V+ +
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLD 119
Query: 137 IAIDVASALDY-------------LHH-----------HCQEL---------------IL 157
I + + H + L IL
Sbjct: 120 I-VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGIL 178
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELAR 183
H D KP+N L++ D + DF LAR
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 46/160 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNIC 127
+D + ++G GSF V + A+KV+S ++ + +S + E + LK +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 128 HRNLVRFI-------------------------------------SIAIDVASALDYLHH 150
H N+++ I V S + Y+H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 151 HCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQE 187
+ I+H D KP N+LL++ D I DF L+ +
Sbjct: 145 NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 31/174 (17%), Positives = 51/174 (29%), Gaps = 73/174 (41%)
Query: 76 LINLIGVGSFDAVYQGV-------FDLNRAVVAIKVLSIQCQGASKS----FMAECKALK 124
L +G G+F V VA+K+L A++ ++E + +K
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMK 95
Query: 125 NI-CHRNLVRFI------------------------------------------------ 135
I H+N++ +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 136 -----SIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
S +A ++YL C +H D NVL+ + I DF LAR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 35/170 (20%), Positives = 55/170 (32%), Gaps = 45/170 (26%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRFI-- 135
++G G+ V + + A+K++ Q E + L HRN++ I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 136 -----------------------------------SIAIDVASALDYLHHHCQELILHCD 160
+ DVASALD+LH+ I H D
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRD 136
Query: 161 PKPSNVLL---DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
KP N+L + I DF+L + + S T +A
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKL-NGDCSPISTPELLTPCGSA 185
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 31/174 (17%), Positives = 56/174 (32%), Gaps = 44/174 (25%)
Query: 45 GPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV 104
G S + T I + Y+ + D + +G G+ V++ F V+A+K
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQ--AEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 105 LSIQCQGAS-KSFMAECKALKNIC-HRNLVRF---------ISI---------------- 137
+ K + + + +V+ + I
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRM 117
Query: 138 ------------AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
+ + AL YL + ++H D KPSN+LLD + DF
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 34/174 (19%), Positives = 54/174 (31%), Gaps = 69/174 (39%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMA-------------- 118
L + IG GS+ V + + A+KVLS + Q
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 119 ---------ECKALKNICHRNLVRFISIAIDVA--------------------------- 142
E LK + H N+V+ + + +D
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 143 ------------SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184
++YLH+ I+H D KPSN+L+ D I DF ++
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 31/174 (17%), Positives = 50/174 (28%), Gaps = 73/174 (41%)
Query: 76 LINLIGVGSFDAVYQGV-------FDLNRAVVAIKVLSIQCQGASKS----FMAECKALK 124
L +G G F V VA+K+L A++ ++E + +K
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMK 141
Query: 125 NI-CHRNLVRFI------------------------------------------------ 135
I H+N++ +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 136 -----SIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
S +A ++YL C +H D NVL+ + I DF LAR
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 33/198 (16%), Positives = 57/198 (28%), Gaps = 62/198 (31%)
Query: 39 GFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRA 98
G G L + + + ++ YE L +IG G F V + +
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYE----------LCEVIGKGPFSVVRRCINRETGQ 50
Query: 99 VVAIKV-----LSIQCQGASKSFMAECKALKNICHRNLVRFI------------------ 135
A+K+ + +++ E + H ++V +
Sbjct: 51 QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110
Query: 136 -----------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLL---D 169
+ AL Y H + I+H D KP VLL +
Sbjct: 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKE 167
Query: 170 NDLFAHIGDFELARFRQE 187
N +G F +A E
Sbjct: 168 NSAPVKLGGFGVAIQLGE 185
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 31/180 (17%), Positives = 53/180 (29%), Gaps = 52/180 (28%)
Query: 46 PSKQPLR-LTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKV 104
P+ R +T + +Y ++G G F V++ +A K+
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 105 LSIQCQGASKSFMAECKALKNICHRNLVRF------------------------------ 134
+ + + E + + H NL++
Sbjct: 122 IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 135 --------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI--GDFELARF 184
I + + ++H ILH D KP N+L N I DF LAR
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 26/156 (16%), Positives = 48/156 (30%), Gaps = 45/156 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
T+ + L +G G+F V + V L A +++ + + E + + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+VR + A+ + H
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 152 CQELILHCDPKPSNVLL---DNDLFAHIGDFELARF 184
++H + KP N+LL + DF LA
Sbjct: 130 G---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 23/198 (11%), Positives = 53/198 (26%), Gaps = 53/198 (26%)
Query: 27 SNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFD 86
++ + P + +++ ++Y+ + +G G+F
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD----------IHEELGTGAFG 171
Query: 87 AVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134
V++ A K + + ++ E + + + H LV
Sbjct: 172 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168
+ V L ++H + +H D KP N++
Sbjct: 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMF 288
Query: 169 DNDLFAHI--GDFELARF 184
+ DF L
Sbjct: 289 TTKRSNELKLIDFGLTAH 306
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 26/159 (16%), Positives = 50/159 (31%), Gaps = 45/159 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
+D + + +G G+F V + V A K+++ + + E + + + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+VR + ++ Y H +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 152 CQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQE 187
I+H + KP N+LL + DF LA +
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 48/223 (21%), Positives = 75/223 (33%), Gaps = 79/223 (35%)
Query: 76 LINLIGVGSFDAVYQGVFDLN--RAVVAIKVLSIQCQGASKS----FMAECKALKNI-CH 128
++IG G+F V + + R AIK + + ASK F E + L + H
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHH 85
Query: 129 RNLVRFI----------------------------------------------------- 135
N++ +
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 136 SIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
A DVA +DYL +H D N+L+ + A I DF L+R
Sbjct: 146 HFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 196
Query: 195 SSNGVRRTIGYTA---LDYDLGSEVSTNGDAYNYGILLLEMVT 234
R + + A L+Y S +TN D ++YG+LL E+V+
Sbjct: 197 KKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVS 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 33/208 (15%), Positives = 62/208 (29%), Gaps = 48/208 (23%)
Query: 20 HDCSMNQSNHSNKLNLEEYGFKKRRGPSKQPLRLTLRNAIPKEYYESLLKATDGFPLINL 79
H + + + + + L I ++L +D F + +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---SDFFEVESE 60
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI---- 135
+G G+ VY+ + A+K ++ K E L + H N+++
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 136 ---------------------------------SIAIDVASALDYLHHHCQELILHCDPK 162
+ A+ YLH + I+H D K
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 163 PSNVLL---DNDLFAHIGDFELARFRQE 187
P N+L D I DF L++ +
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 31/156 (19%), Positives = 54/156 (34%), Gaps = 45/156 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
++ + + +G G++ V + AIK++ ++ + E LK + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+++ I V S + YLH H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 152 CQELILHCDPKPSNVLLDN---DLFAHIGDFELARF 184
I+H D KP N+LL++ D I DF L+
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 41/194 (21%), Positives = 65/194 (33%), Gaps = 50/194 (25%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALK 124
D + + +LIG GS+ VY VAIK ++ I C+ + E L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----LREITILN 80
Query: 125 NICHRNLVRFISIAI--------DVASALDY----LHH-----------HCQEL------ 155
+ ++R + I ++ L+ L H + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 156 ---------ILHCDPKPSNVLLDNDLFAHIGDFELAR--FRQEVSNPTQSSSNGVRRTIG 204
I+H D KP+N LL+ D + DF LAR ++ +N
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 205 YTALDYDLGSEVST 218
L L S V T
Sbjct: 201 NKNLKKQLTSHVVT 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 31/156 (19%), Positives = 59/156 (37%), Gaps = 45/156 (28%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICH 128
+ + ++ ++G GSF V + + + A+KV++ + + + E + LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N+++ I V S + Y+H H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 152 CQELILHCDPKPSNVLLDN-DLFAHI--GDFELARF 184
I+H D KP N+LL++ + I DF L+
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 31/171 (18%), Positives = 45/171 (26%), Gaps = 70/171 (40%)
Query: 76 LINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQGASKS----FMAECKALKNI 126
+ +G F VY+G VAIK L A F E +
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARL 69
Query: 127 CHRNLVRFI--------------------------------------------------- 135
H N+V +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 136 --SIAIDVASALDYL-HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
+ +A+ ++YL HH +H D NVL+ + L I D L R
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 35/157 (22%), Positives = 57/157 (36%), Gaps = 47/157 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ + +G G V+ V + VAIK + + + K + E K ++ + H N+V+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 134 FISI--------AIDVASALDY-------------LHH----------HCQEL------- 155
I DV S + L + H +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 156 --------ILHCDPKPSNVLLD-NDLFAHIGDFELAR 183
+LH D KP+N+ ++ DL IGDF LAR
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 46/219 (21%), Positives = 73/219 (33%), Gaps = 59/219 (26%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
+ F + L+G G+F V A+K+L I + + E + L+N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 RNLVR----------------FIS---------------------IAIDVASALDYLHHH 151
L + + ++ SAL+YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA---- 207
+++ D K N++LD D I DF L + + G T Y A
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCG---TPEYLAPEVL 177
Query: 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
D D G V D + G+++ EM+ R P F
Sbjct: 178 EDNDYGRAV----DWWGLGVVMYEMMCGRLP----FYNQ 208
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 49/209 (23%), Positives = 73/209 (34%), Gaps = 58/209 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSF---MAECKALKNICH-- 128
F ++ +G GSF V+ N A+KVL + K E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 129 ------------------------------RNLVRFISI-----AIDVASALDYLHHHCQ 153
R RF + A +V AL+YLH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD- 126
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA----LD 209
I++ D KP N+LLD + I DF A+ V + T + + T Y A
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT----LCGTPDYIAPEVVST 177
Query: 210 YDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ D +++GIL+ EM+ P
Sbjct: 178 KPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 67/231 (29%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS------IQCQGASKSFMAECKALKNIC 127
+ L+ +G G++ V++ + VVA+K + Q E L +
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT----FREIMILTELS 66
Query: 128 -HRNLVRFISIAI-----DVASALDY----LHH----------HCQEL------------ 155
H N+V +++ DV DY LH H Q +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 156 ---ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+LH D KPSN+LL+ + + DF L+R + T + + D +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 213 GSE-VST----------NGDAYNYGI-------LLLEMVTRRKPIDFMFEG 245
++ V+T Y GI +L E++ KPI F G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPI---FPG 233
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 5/71 (7%)
Query: 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189
++ I++ AL+YL + H D KP N+LLD+ F +
Sbjct: 137 EDIK--LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 190 NPTQSSSNGVR 200
++ S G++
Sbjct: 192 QIYRTKSTGIK 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 20/121 (16%)
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
+ AL++LH I++ D K N+LLD++ + DF L++ G
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG-- 222
Query: 201 RTIGYTA------LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254
TI Y A D V D ++ G+L+ E++T P F D ++ A
Sbjct: 223 -TIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVDGEKNSQAE 273
Query: 255 M 255
+
Sbjct: 274 I 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 32/167 (19%), Positives = 56/167 (33%), Gaps = 56/167 (33%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-------------IQCQGASKSFM 117
+ + + +G G++ V + AIKV+ + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 118 AECKALKNICHRNLVRFI-------------------------------------SIAID 140
E LK++ H N+++ +I
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHI--GDFELARF 184
+ S + YLH H I+H D KP N+LL+N + +I DF L+ F
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 28/155 (18%), Positives = 50/155 (32%), Gaps = 46/155 (29%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA-ECKALKNICHR 129
+ + + +G G F V++ V ++ K ++ +G + + E L HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHR 61
Query: 130 NLVRF--------------------------------------ISIAIDVASALDYLHHH 151
N++ +S V AL +LH H
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 152 CQELILHCDPKPSNVLLDNDLFAH--IGDFELARF 184
I H D +P N++ + I +F AR
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 3/50 (6%)
Query: 144 ALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193
L LH ++H D P N+LL ++ I DF LAR +N T
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 30/159 (18%), Positives = 51/159 (32%), Gaps = 48/159 (30%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFMAECKALKNICHR 129
D F +G G+F V+ + IK ++ + Q + AE + LK++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 130 NLVRFI-----------------------------------------SIAIDVASALDYL 148
N+++ + + +AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 149 HHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARF 184
H ++H D KP N+L + I DF LA
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 32/119 (26%), Positives = 49/119 (41%), Gaps = 21/119 (17%)
Query: 132 VRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191
F A ++A L +L I++ D K NV+LD++ I DF + +
Sbjct: 444 AVFY--AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 192 TQSSSNGVRRTIGYTA----LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
T + G T Y A G V D + +G+LL EM+ + P FEG+
Sbjct: 499 T-KTFCG---TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 545
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 32/156 (20%), Positives = 52/156 (33%), Gaps = 54/156 (34%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALK--------- 124
F + IG G+F + G VAIK+ ++ + E + K
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIP 68
Query: 125 ---------------------------NICHRNLVRF-----ISIAIDVASALDYLHHHC 152
++C R F + IAI + S ++Y+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 153 QELILHCDPKPSNVLL-----DNDLFAHIGDFELAR 183
+++ D KP N L+ HI DF LA+
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 36/173 (20%), Positives = 57/173 (32%), Gaps = 63/173 (36%)
Query: 80 IGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA----ECKALKNIC-HRNLVRF 134
+G GSF + V + A+K++S K A E ALK H N+V+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 135 I-------------------------------------SIAIDVASALDYLHHHCQELIL 157
I + SA+ ++H ++
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VV 128
Query: 158 HCDPKPSNVLL---DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
H D KP N+L +++L I DF AR + N +T +T
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--------DNQPLKTPCFTL 173
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 17/65 (26%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEVSNPT 192
I V LDYLH C+ I+H D KP N+LL + + + +
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 193 QSSSN 197
+ S
Sbjct: 208 SAVST 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 5/63 (7%)
Query: 130 NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189
VR +A + AL +LH + + H D KP N+L N F + + + + V
Sbjct: 123 PHVR--HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 190 NPT 192
N +
Sbjct: 178 NTS 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 21/111 (18%)
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN-GV 199
+A L +L I++ D K NV+LD++ I DF + ++ + + + + G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCG- 183
Query: 200 RRTIGYTA----LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
T Y A G V D + +G+LL EM+ + P FEG+
Sbjct: 184 --TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 224
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 356 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.2 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 90.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 88.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 86.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 84.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.31 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.31 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=375.46 Aligned_cols=230 Identities=27% Similarity=0.398 Sum_probs=175.4
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
+...+++.+.+.||+|+||+||+|++. ..||||+++... ....+.|.+|+.+|++++|||||++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEE
Confidence 344578899999999999999999875 359999987443 3345679999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 568999999999999998 999999999999999999999999999866433
Q ss_pred CCCCccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
.. ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... .+...+.....
T Consensus 186 ~~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~------- 255 (307)
T 3omv_A 186 SG--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYA------- 255 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCC-------
T ss_pred Cc--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCC-------
Confidence 22 122345689999999999864 458999999999999999999999997432111 11111111110
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.+.+. .....++..+.+|+.+||+.||++||||.+|++.|+.+.+.++
T Consensus 256 ~p~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 256 SPDLS-------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCCST-------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCCcc-------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 00000 0111455678899999999999999999999999999887664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=374.97 Aligned_cols=225 Identities=21% Similarity=0.309 Sum_probs=179.7
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|.+.+.||+|+||.||+|++. .++..||||+++.......+.|.+|+.+|++++|||||++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46889999999999999999975 3578999999987666667789999999999999999987
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEE
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHI 176 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 176 (356)
+.++.||+.||.|||+++ ||||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 347889999999999999 999999999999999999999
Q ss_pred cccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHH
Q 039228 177 GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~ 255 (356)
+|||+|+....... ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... .+...+..
T Consensus 170 ~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQ 245 (299)
T ss_dssp CCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHH
T ss_pred CCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 99999986543321 222344678999999999999999999999999999999999 89999753211 11111111
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
. .. .. .+..++..+.+|+.+||+.||++||||++|++.|+.+.+..+.
T Consensus 246 ~-----------~~-~~------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 246 G-----------RV-LQ------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp T-----------CC-CC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred C-----------CC-CC------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 0 00 00 0114556788999999999999999999999999998876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=372.28 Aligned_cols=240 Identities=20% Similarity=0.258 Sum_probs=187.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++++.||+|+||+||+|++..+++.||||++++. .....+.+.+|+++|++++|||||++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999753 23345779999999999999999997
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 458899999999999999 99999999999999999999999999987653322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......+||+.|+|||++.+..|+.++||||+||++|||+||+.||..... .. ++...+.
T Consensus 188 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~------------~~~~i~~ 248 (311)
T 4aw0_A 188 --QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GL------------IFAKIIK 248 (311)
T ss_dssp --CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH------------HHHHHHH
T ss_pred --cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HH------------HHHHHHc
Confidence 2234457899999999999999999999999999999999999999964211 11 1111111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCcCCcccc
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRAPKL 348 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~~~~~~~ 348 (356)
..+.. +......+.+|+.+||+.||++|||++|++..-.=..+-......|+.+.+..+|.+
T Consensus 249 ~~~~~----------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 249 LEYDF----------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp TCCCC----------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred CCCCC----------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 11100 001223568999999999999999999975432222233344456778877777764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=375.14 Aligned_cols=222 Identities=22% Similarity=0.318 Sum_probs=172.3
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|.+.+.||+|+||.||+|++. .+++.||||+++.......+.|.+|+.+|++++|||||++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46888899999999999999975 3578999999987666667889999999999999999987
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 135 ----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 135 ----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.|+.||+.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 358889999999999998 9999999999999999999
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~ 253 (356)
||+|||+++....... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...+
T Consensus 198 Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCI 273 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHH
T ss_pred EEcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 9999999986543321 222344678999999999999999999999999999999999 89999753211 111111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
... .... .+..++..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 274 ~~g------------~~~~------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQG------------RELE------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHT------------CCCC------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcC------------CCCC------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 110 0000 1114555788999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=368.91 Aligned_cols=220 Identities=20% Similarity=0.276 Sum_probs=174.7
Q ss_pred CCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
+++++.+.||+|+||.||+|++. .+++.||||+++... ....+.|.+|+.++++++|||||++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35778889999999999999974 356899999997543 3345789999999999999999987
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
+.|+.||+.||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 247889999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.+||+|||+++....... ........||+.|+|||++.++.|+.++|||||||++|||+| |..||...... .+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHH
T ss_pred CEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence 999999999987644322 223345678999999999999999999999999999999999 89999753211 1111
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.+.. .... ..+..++..+.+|+.+||+.||++||||++|++.|+++.
T Consensus 259 ~i~~-----------~~~~-------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 MIRN-----------RQVL-------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHT-----------TCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHc-----------CCCC-------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1111 0000 011245667889999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=371.10 Aligned_cols=214 Identities=19% Similarity=0.219 Sum_probs=175.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+.|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.+|+.++|||||++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 469999999999999999999999999999999987666666778999999999999999997
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PR 226 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----CC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC----Cc
Confidence 458899999999999999 9999999999999999999999999998764332 22
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ......+....+.. +.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~--------~~----- 291 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPR--------LK----- 291 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCC--------CS-----
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCC--------CC-----
Confidence 3457899999999999999999999999999999999999999964211 11111111111100 00
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+|+.+||..||++|||+.|+++
T Consensus 292 ---------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 ---------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00123345789999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=372.94 Aligned_cols=213 Identities=20% Similarity=0.248 Sum_probs=167.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|++++|||||++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999997543 2345678999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 458899999999999999 9999999999999999999999999998654321
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... .... +...+
T Consensus 180 ----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~------------~~~i~ 238 (350)
T 4b9d_A 180 ----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNL------------VLKII 238 (350)
T ss_dssp ----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH------------HHHHH
T ss_pred ----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHH------------HHHHH
Confidence 12234679999999999999999999999999999999999999997421 1111 11111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~---------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 239 SGSFPP---------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HTCCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCC---------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100 00123345789999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=367.29 Aligned_cols=223 Identities=19% Similarity=0.164 Sum_probs=175.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.+.|++.+.||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4568889999999999999999999999999999975432 2469999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccCCCC-
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEVSNP- 191 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~- 191 (356)
..++.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 458999999999999999 99999999999999887 6999999999876543221
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........+||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+....... + .. .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~-~-~~--------~- 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP-P-PI--------R- 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC-C-GG--------G-
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC-C-Cc--------h-
Confidence 1222344689999999999999999999999999999999999999997543322 111111110 0 00 0
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
..+..++..+.+++.+||+.||++|||+.||++.|..+....
T Consensus 277 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 ------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 001133446789999999999999999999999998887664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=355.19 Aligned_cols=211 Identities=21% Similarity=0.280 Sum_probs=157.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+|++++|||||++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997542 2345678999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 165 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--- 165 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence 568899999999999999 999999999999999999999999999865432
Q ss_pred CccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.... ....... +..
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~--------i~~---- 226 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKN--------ISN---- 226 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HHH----
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH--------HHc----
Confidence 22334789999999999998876 579999999999999999999996421 1111111 110
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... . +......+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~-----~-----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 GVYT-----L-----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TCCC-----C-----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC-----C-----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0 0012335679999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=357.67 Aligned_cols=210 Identities=24% Similarity=0.305 Sum_probs=164.3
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
++.+.||+|+||.||+|.+..++..||+|++.... ....+.|.+|+.+|++++|||||++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999999999999999997442 3345679999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 458899999999999875 45999999999999984 79999999999985432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ...........+.. +
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~~-----~--- 248 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVK-----P--- 248 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCC-----C---
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCCC-----C---
Confidence 22334689999999999875 69999999999999999999999996422 11111111110000 0
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~------------------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASF------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0012234689999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=360.96 Aligned_cols=241 Identities=23% Similarity=0.245 Sum_probs=171.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|.+.+.||+|+||.||+|++. |+.||||+++.... ....+..|+..+.+++|||||++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35788899999999999999985 79999999974321 12233456667778999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcC-----CCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 -----------------------ISIAIDVASALDYLHHHC-----QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||+|||+++ .++||||||||+||||+.++.+||+|||+|+...
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 568899999999999871 1239999999999999999999999999998765
Q ss_pred cCCCCCccCCCCccccccccchhhhcCC------CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGS------EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
..............||+.|+|||++.+. .++.++|||||||++|||+||.+||.........+..... ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~--~~~~ 237 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SDPS 237 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SSCC
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc--ccch
Confidence 5443333334457899999999999764 3678999999999999999998887543222111100000 0001
Q ss_pred hHHH----hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 261 VMDI----VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 261 ~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
...+ ....+.+..+. .....+++..+.+|+.+||+.||++||||.+|++.|+++.++
T Consensus 238 ~~~~~~~~~~~~~rp~~p~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCG-------------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCc-------------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 11111111110 001125667889999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=372.01 Aligned_cols=214 Identities=19% Similarity=0.221 Sum_probs=175.8
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+.|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++|||||++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 469999999999999999999999999999999987766666789999999999999999997
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PR 303 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----CC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC----cc
Confidence 458899999999999999 9999999999999999999999999998764332 23
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+....+.. +. .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~--------~~-~--- 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPR--------LK-N--- 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCC--------CS-C---
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCC--------Cc-c---
Confidence 345789999999999999999999999999999999999999996421 111111111111100 00 0
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+|+.+||..||++|||+.|+++
T Consensus 370 ----------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 ----------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ----------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0122345789999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=364.60 Aligned_cols=232 Identities=20% Similarity=0.223 Sum_probs=183.9
Q ss_pred HHHHHhhcCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccCc-cchHHHHHHHHHHhhcCC-CChHHH--
Q 039228 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQCQ-GASKSFMAECKALKNICH-RNLVRF-- 134 (356)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l-- 134 (356)
...|....++|++.+.||+|+||.||+|.+..+ ++.||||.+..... ...+.|.+|+.+|.+++| ||||++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 455667778999999999999999999998643 46899999975433 335679999999999976 899987
Q ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCC
Q 039228 135 ----------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPK 162 (356)
Q Consensus 135 ----------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlk 162 (356)
+.++.||+.||.|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 247789999999999999 9999999
Q ss_pred CCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCc
Q 039228 163 PSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDF 241 (356)
Q Consensus 163 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~ 241 (356)
|+|||+++++.+||+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999986643322 223345778999999999999999999999999999999998 9999975
Q ss_pred cccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHH
Q 039228 242 MFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAV 321 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl 321 (356)
..... .+...+... ..... +..++..+.+++.+||+.||++||||++|+
T Consensus 291 ~~~~~-~~~~~i~~g------------~~~~~------------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil 339 (353)
T 4ase_A 291 VKIDE-EFCRRLKEG------------TRMRA------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339 (353)
T ss_dssp CCCSH-HHHHHHHHT------------CCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHHH-HHHHHHHcC------------CCCCC------------------CccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 43221 111111111 11010 113445678999999999999999999999
Q ss_pred HHHHHhhhhh
Q 039228 322 HDLQSVNNIL 331 (356)
Q Consensus 322 ~~L~~i~~~~ 331 (356)
+.|+.+.++-
T Consensus 340 ~~L~~llq~~ 349 (353)
T 4ase_A 340 EHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=354.88 Aligned_cols=214 Identities=23% Similarity=0.346 Sum_probs=157.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|++++.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|+.+|++++|||||++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999975543 344678999999999999999975
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcc
Q 039228 135 ------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGD 178 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 178 (356)
+.++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 347889999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC--------ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHH
Q 039228 179 FELARFRQEVSNPT--------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLH 250 (356)
Q Consensus 179 fg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 250 (356)
||+|+.+....... .......+||+.|||||++.+..|+.++|||||||++|||++ ||....+ ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence 99998765432211 112344679999999999999999999999999999999996 7753111 000
Q ss_pred HHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 251 NFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... .+.+ ... +.........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~---------~~~~----~~~---------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLT---------DVRN----LKF---------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH---------HHHT----TCC---------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---------HHhc----CCC---------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0000 000 0011122334568999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=360.69 Aligned_cols=244 Identities=21% Similarity=0.195 Sum_probs=173.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+|+.++|||||++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999999999999999997543 2334678899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 458899999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMD 263 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~ 263 (356)
.............+||+.|+|||++.+. .++.++||||+||++|||++|++||......+ .+.......... ....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHhh
Confidence 4333333445568899999999998875 46899999999999999999999997532211 111221111111 1000
Q ss_pred Hhhh-hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNL-VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+.. .............+.-.....+ .....+.+|+.+||..||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYP----GADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHST----TCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCC----CCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000000000000000000111 12335689999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.21 Aligned_cols=206 Identities=22% Similarity=0.239 Sum_probs=157.7
Q ss_pred CCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|++++.||+|+||+||+|+.. .+++.||||+++... ......+.+|+.+|++++|||||++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999974 467899999997542 2233568899999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 458899999999999999 9999999999999999999999999998653322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .+.. ...+
T Consensus 181 ----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~------------~~i~ 239 (304)
T 3ubd_A 181 ----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETM------------TMIL 239 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHHH
T ss_pred ----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHH------------HHHH
Confidence 223457899999999999999999999999999999999999999974221 1111 1111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
...... +...+..+.+|+.+||+.||++|||+
T Consensus 240 ~~~~~~----------------p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 240 KAKLGM----------------PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HCCCCC----------------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred cCCCCC----------------CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111000 00223356899999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=337.14 Aligned_cols=171 Identities=22% Similarity=0.283 Sum_probs=139.8
Q ss_pred HHhhcCCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH--------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF-------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l-------- 134 (356)
+....+.|++.+.||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+.+|+.+ +||||+++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3345678999999999999999999874 457899999986442 345788999999998 69999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEccccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARFRQE 187 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||+|||++| ||||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 458899999999999999 9999999999999876 8999999999986533
Q ss_pred CCCC------------------------CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 188 VSNP------------------------TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 188 ~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.... ........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2110 01122345799999999999875 4899999999999999999999999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=349.62 Aligned_cols=215 Identities=16% Similarity=0.166 Sum_probs=172.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+.+|+.++|||||++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3679999999999999999999999999999999987666666788999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC--CceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND--LFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 458899999999999999 9999999999999854 899999999998764322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...... .....+ ......
T Consensus 312 ----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i-----------~~~~~~ 374 (573)
T 3uto_A 312 ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV-----------KSCDWN 374 (573)
T ss_dssp ----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH-----------HTTCCC
T ss_pred ----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH-----------HhCCCC
Confidence 223467999999999999999999999999999999999999999743211 111110 000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... .. .......+.+|+.+||..||.+|||+.|+++
T Consensus 375 ~~~------------~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDD------------SA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCS------------GG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc------------cc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 0022335679999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=346.35 Aligned_cols=213 Identities=18% Similarity=0.200 Sum_probs=164.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHH---HHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMA---ECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l---------- 134 (356)
.++|+++++||+|+||.||+|+++.+|+.||||++++.. ......+.+ ++.+++.++|||||++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999999999999999997432 122233333 4567778899999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 458899999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......+ .......
T Consensus 345 ~------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~----------- 405 (689)
T 3v5w_A 345 K------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRM----------- 405 (689)
T ss_dssp C------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHH-----------
T ss_pred C------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHh-----------
Confidence 2 2334789999999999974 579999999999999999999999997533222 1111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
.+...... +......+.+|+.+||..||.+|++ ++||++
T Consensus 406 -i~~~~~~~----------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 406 -TLTMAVEL----------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -HHHCCCCC----------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -hcCCCCCC----------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01000000 0022235689999999999999998 566653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=319.37 Aligned_cols=241 Identities=29% Similarity=0.444 Sum_probs=191.2
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
++...+++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 44557889999999999999999999965 578999999876666667789999999999999999986
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 568999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC-ccHHHHHHHh-CCCchH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-LNLHNFARMA-FPNRVM 262 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~~~~~~~-~~~~~~ 262 (356)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... ....+.
T Consensus 189 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 189 GTELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp CSSSSC--CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccc--cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 543221 122334668999999999988899999999999999999999999997544322 2333332211 111222
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.++++.+... ....++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 267 ~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADK------------------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTC------------------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccc------------------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2222222111 1236778899999999999999999999999999988754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.60 Aligned_cols=230 Identities=20% Similarity=0.287 Sum_probs=183.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4579999999999999999999999999999999876666667789999999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 458899999999999999 9999999999999999999999999998664332211
Q ss_pred ----------ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 193 ----------QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 193 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------~~~~~ 237 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------GLNVR 237 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------SBCHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------hhhhh
Confidence 111124678999999999999999999999999999999999999986533221110 00111
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
...+..... .++..+.+++.+||+.||++|||+.+|++.|+.+...+..
T Consensus 238 ~~~~~~~~~----------------------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 238 GFLDRYCPP----------------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHTCCT----------------------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCC----------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 112211111 2223578999999999999999999999999999987644
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.87 Aligned_cols=245 Identities=29% Similarity=0.490 Sum_probs=194.3
Q ss_pred cCChhhHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--
Q 039228 58 AIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-- 134 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-- 134 (356)
....+++.++....++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++||||+++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456778899999999999999999999999999864 578999999875432 223468899999999999999987
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhc---CCCcEEecCCCCCCeEeCCCC
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHH---CQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~---~~~~iiH~Dlkp~NIll~~~~ 172 (356)
..++.+++.||.|||+. + |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCC
Confidence 45889999999999999 7 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccc---cCCccH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF---EGDLNL 249 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---~~~~~~ 249 (356)
.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||+... ......
T Consensus 172 ~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp CEEECCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred CEEeccCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 999999999986643221 22334568999999999988889999999999999999999999996321 223344
Q ss_pred HHHHHHhCCC-chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 250 HNFARMAFPN-RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 250 ~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
..+....... ....+.+..+.... ...++..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNY------------------KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSC------------------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHhhchhhhhhcChhhcccc------------------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4554444322 33333333332222 236778899999999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.89 Aligned_cols=228 Identities=21% Similarity=0.341 Sum_probs=174.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh--cCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN--ICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 56799999999999999999998 4799999998643 34556667777666 899999986
Q ss_pred --------------------------HHHHHHHHHHHHHHh--------hcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 --------------------------ISIAIDVASALDYLH--------HHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
+.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 568899999999999 777 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCC------CCCCccchHhHHHHHHHHHcC----------CCCCCcccc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS------EVSTNGDAYNYGILLLEMVTR----------RKPIDFMFE 244 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwSlG~~l~elltg----------~~Pf~~~~~ 244 (356)
+++.................||+.|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9986654433222233445789999999999876 455789999999999999999 888865544
Q ss_pred CCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 245 GDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
.................. +.+... .....++..+.+++.+||+.||++|||+.+|++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~----~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQR----PNIPNR-----------------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp SSCCHHHHHHHHTTSCCC----CCCCGG-----------------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCC----CCCChh-----------------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 443333332222111000 000000 00115667889999999999999999999999999
Q ss_pred HHh
Q 039228 325 QSV 327 (356)
Q Consensus 325 ~~i 327 (356)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.60 Aligned_cols=257 Identities=15% Similarity=0.167 Sum_probs=185.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCC-----CeEEEEEEeeccCccc-----------hHHHHHHHHHHhhcCCCChHH
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLN-----RAVVAIKVLSIQCQGA-----------SKSFMAECKALKNICHRNLVR 133 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 133 (356)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999765 5789999987543211 123445666777888999987
Q ss_pred H-----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--C
Q 039228 134 F-----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD--N 170 (356)
Q Consensus 134 l-----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~ 170 (356)
+ +.++.||+.||.|||+.+ |+||||||+|||++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 5 568899999999999999 99999999999999 8
Q ss_pred CCceEEcccccccccccCCCCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc
Q 039228 171 DLFAHIGDFELARFRQEVSNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247 (356)
Q Consensus 171 ~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 247 (356)
++.+||+|||+++.+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... .
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-P 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-H
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-H
Confidence 9999999999998765432211 12224456999999999999999999999999999999999999999753322 2
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.........+...+..+++..+... .++..+.+++..||+.||.+||++.+|++.|+.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAA---------------------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTT---------------------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccc---------------------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 2222233333334455555544211 2344688999999999999999999999999999
Q ss_pred hhhhcc----ccccccCCcCCccccccc
Q 039228 328 NNILLP----ETVFKSLTNNRAPKLKAS 351 (356)
Q Consensus 328 ~~~~~~----~~~~~~~~~~~~~~~~~~ 351 (356)
.+.+.. ...+.-..|...+....+
T Consensus 328 ~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 355 (364)
T 3op5_A 328 LKAIGSKDDGKLDLSVVENGGLKAKTIT 355 (364)
T ss_dssp HHHTTCCCCCCCCC--------------
T ss_pred HHHcCCCcCCccceEeccCCccchhhhh
Confidence 876532 344554555554444433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.69 Aligned_cols=215 Identities=19% Similarity=0.222 Sum_probs=174.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4579999999999999999999999999999999987666667788999999999999999986
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCcc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 194 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----S 171 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----C
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----c
Confidence 458899999999999999 9999999999999999999999999997654322 2
Q ss_pred CCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccc
Q 039228 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNK 274 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 274 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........+. +.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~---------~~---- 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE---------LQ---- 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC---------CS----
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC---------CC----
Confidence 2334678999999999999999999999999999999999999996422110 000000000000 00
Q ss_pred cccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 275 VLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||+.||++|||+.++++
T Consensus 238 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 ----------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00123345789999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=317.58 Aligned_cols=224 Identities=22% Similarity=0.347 Sum_probs=170.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeE----EEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAV----VAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|++.+.||+|+||.||+|++..+++. ||+|.+... .....+.+.+|+.++++++||||+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 35699999999999999999998777665 577777533 23445789999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 558899999999999999 999999999999999999999999999876443
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ........+|..|+|||++.+..++.++|||||||++|||++ |..||...... .+... +..
T Consensus 171 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~------------~~~ 234 (327)
T 3poz_A 171 EK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI------------LEK 234 (327)
T ss_dssp CC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH------------HHT
T ss_pred cc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHH------------HHc
Confidence 22 122233556889999999999999999999999999999999 99999753221 11111 111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ...+...+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 235 ~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 235 GERLPQ------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TCCCCC------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCC------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 110000 0123346789999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.69 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=190.8
Q ss_pred cCChhhHHHHHhhcCCCCcc------ccceecCceEEEEEEECCCCeEEEEEEeeccC----ccchHHHHHHHHHHhhcC
Q 039228 58 AIPKEYYESLLKATDGFPLI------NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC----QGASKSFMAECKALKNIC 127 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~ 127 (356)
....+++.++...+++|... +.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34667888889999988877 8899999999999986 47899999986432 234567899999999999
Q ss_pred CCChHHH----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 128 HRNLVRF----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 128 h~niv~l----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
||||+++ +.++.+++.||.|||+.+ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 9999986 457889999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 247 (356)
++.++.+||+|||++........ ........||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-
T ss_pred EcCCCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-
Confidence 99999999999999986543221 122334678999999998865 58899999999999999999999997644332
Q ss_pred cHHHHHHH--hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 248 NLHNFARM--AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 248 ~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.+..+... .....+.++++..+... ....+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDA-------------------DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCC-------------------CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhhhhhhhhhhhcccccccc-------------------chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11122111 11223334444333211 2366778999999999999999999999999999
Q ss_pred Hhhhh
Q 039228 326 SVNNI 330 (356)
Q Consensus 326 ~i~~~ 330 (356)
++..+
T Consensus 303 ~l~~s 307 (307)
T 2nru_A 303 EMTAS 307 (307)
T ss_dssp HHC--
T ss_pred HHhcC
Confidence 98653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=313.75 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=178.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++. ++.||||++.... ........|+.++++++||||+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 567999999999999999999986 7999999997543 233456679999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhc----------CCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHH----------CQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~----------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCC
Confidence 45889999999999998 7 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCC-----CCCCccchHhHHHHHHHHHcCCCCCCccccCCcc-HHHHHH
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-----EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN-LHNFAR 254 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~~ 254 (356)
+++....... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||......... +....
T Consensus 177 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~- 253 (322)
T 3soc_A 177 LALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI- 253 (322)
T ss_dssp TCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-
T ss_pred cccccccccC--ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-
Confidence 9987654322 2223346789999999999863 4566889999999999999999999764432211 11110
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.......++........... .....+ ....++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 -GQHPSLEDMQEVVVHKKKRP-------VLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp -CSSCCHHHHHHHHTTSCCCC-------CCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -ccCCchhhhhhhhhcccCCC-------Cccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111222222111111000 000000 0114566789999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=308.55 Aligned_cols=239 Identities=18% Similarity=0.273 Sum_probs=177.4
Q ss_pred cCCCCccccceecCceEEEEEE----ECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGV----FDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|+ ...+++.||||++........+.+.+|+.++++++||||+++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4679999999999999999999 456789999999986666666789999999999999999976
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 458889999999999999 9999999999999999999999999998664
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc-h-HHH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR-V-MDI 264 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~-~~~ 264 (356)
..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||..... ............. . ..+
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 166 QDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---HHHHHHCTTCCTHHHHHHH
T ss_pred CCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---HHHhhhcCccccchhHHHH
Confidence 33211 1222334567789999999999999999999999999999999999864211 1111111100000 0 011
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
......... ...+..++..+.+++.+||+.||++|||+.+|++.|+++.+.+
T Consensus 242 ~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGR---------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCC---------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCc---------------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111110000 0011244557889999999999999999999999999998765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=308.78 Aligned_cols=228 Identities=23% Similarity=0.313 Sum_probs=168.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567999999999999999999874 7899999987543 2334678899999999999999987
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||.|||+.+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 458889999999999875 459999999999999999999999999997543
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 191 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~--------- 255 (309)
T 3p86_A 191 STF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKC--------- 255 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSC---------
T ss_pred ccc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC---------
Confidence 221 2233467899999999999999999999999999999999999999743211 1111100000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
..... +..+...+.+++.+||+.||.+|||+.+|++.|+.+.+...++
T Consensus 256 --~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 256 --KRLEI------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp --CCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred --CCCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 00000 0123346789999999999999999999999999998876544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=312.07 Aligned_cols=225 Identities=20% Similarity=0.311 Sum_probs=175.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCC---eEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR---AVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+..++ ..||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457999999999999999999997544 469999997543 3345678999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 568899999999999999 999999999999999999999999999876443
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...... ..
T Consensus 205 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~------------~~ 269 (325)
T 3kul_A 205 PDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSV------------EE 269 (325)
T ss_dssp --C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH------------HT
T ss_pred ccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH------------Hc
Confidence 221 122233456778999999998899999999999999999999 99999643211 111111 11
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ...++..+.+++..||+.||.+|||+.+|++.|+.+.+..
T Consensus 270 ~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 270 GYRLPA------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCC------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 000000 0133446789999999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=311.36 Aligned_cols=213 Identities=22% Similarity=0.280 Sum_probs=171.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4678999999999999999999999999999999997542 3345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 458899999999999999 9999999999999999999999999997654321
Q ss_pred CCccCCCCccccccccchhhhcCCCCC-CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVS-TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... .... .....
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~------------~~~i~ 227 (328)
T 3fe3_A 169 ----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKEL------------RERVL 227 (328)
T ss_dssp ----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH------------HHHHH
T ss_pred ----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHH------------HHHHH
Confidence 22346789999999999988775 78999999999999999999997422 1111 11111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...... +......+.+|+.+||..||.+|||+.++++.
T Consensus 228 ~~~~~~----------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 RGKYRI----------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCCCC----------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred hCCCCC----------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100 00122356799999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.81 Aligned_cols=230 Identities=23% Similarity=0.312 Sum_probs=175.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999999999999999986432 2334678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS- 165 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence 558899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .........+ .... ..
T Consensus 166 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~----~~- 236 (294)
T 4eqm_A 166 --LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSVP-NVTT----DV- 236 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-HHHHHSSCCC-CHHH----HS-
T ss_pred --ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhccCC-Ccch----hc-
Confidence 1223346789999999999999999999999999999999999999974321110 0000000000 0000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-ChHHHHHHHHHhhhhhccc
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-NVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~vl~~L~~i~~~~~~~ 334 (356)
....+..+.+++.+||+.||.+|| +++++.+.|+.+.......
T Consensus 237 ---------------------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 237 ---------------------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp ---------------------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred ---------------------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 012344678999999999999999 8999999999887655443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.34 Aligned_cols=225 Identities=20% Similarity=0.292 Sum_probs=177.0
Q ss_pred cCCCCccccceecCceEEEEEEEC-------CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-------LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.++|++.+.||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+++.+ +||||+++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999974 3457899999975432 3446789999999999 89999986
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 126789999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred CCCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 9999999999999986543221 122233556889999999999999999999999999999999 99999743211
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+..... ....... +..+...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 313 ~~~~~~~------------~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 ELFKLLK------------EGHRMDK------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GHHHHHH------------TTCCCCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHh------------cCCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 1100000 113444678999999999999999999999999999
Q ss_pred hhhhc
Q 039228 328 NNILL 332 (356)
Q Consensus 328 ~~~~~ 332 (356)
.....
T Consensus 363 l~~~~ 367 (370)
T 2psq_A 363 LTLTT 367 (370)
T ss_dssp HHHHC
T ss_pred HHHhc
Confidence 87553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.22 Aligned_cols=225 Identities=23% Similarity=0.323 Sum_probs=177.6
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|++++||||+++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 345679999999999999999999998899999999875422 233568899999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 458899999999999999 9999999999999999999999999997543211
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... +...
T Consensus 268 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~------------~~~~ 331 (377)
T 3cbl_A 268 --YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREF------------VEKG 331 (377)
T ss_dssp --EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHH------------HHTT
T ss_pred --eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHcC
Confidence 1111222345778999999998889999999999999999998 99999743211 11111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
..... +..++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 332 ~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPC------------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 00000 013445678999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=303.42 Aligned_cols=233 Identities=22% Similarity=0.300 Sum_probs=171.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh--cCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN--ICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|..++.. ++||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3467999999999999999999986 799999998643 23445556665554 489999876
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhc--------CCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHH--------CQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~--------~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
+.++.+++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 45889999999999998 7 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCc------cchHhHHHHHHHHHcC----------CCCCCccc
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTN------GDAYNYGILLLEMVTR----------RKPIDFMF 243 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDiwSlG~~l~elltg----------~~Pf~~~~ 243 (356)
|++..................||+.|+|||++.+...+.. +|||||||++|||++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997664433322223345678999999999988776665 8999999999999999 56665443
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
................. +...... ......++..+.+++.+||+.||.+|||+.+|++.
T Consensus 267 ~~~~~~~~~~~~~~~~~--------~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKK--------LRPSFPN-------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSC--------CCCCCCG-------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhc--------cCccccc-------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 33323222221111000 0000000 00012677789999999999999999999999999
Q ss_pred HHHhhhhh
Q 039228 324 LQSVNNIL 331 (356)
Q Consensus 324 L~~i~~~~ 331 (356)
|+.+.++.
T Consensus 326 L~~l~~~~ 333 (337)
T 3mdy_A 326 LAKMSESQ 333 (337)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhhc
Confidence 99998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=301.82 Aligned_cols=241 Identities=20% Similarity=0.236 Sum_probs=172.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 579999999999999999999999999999999975432 334678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 458899999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+..............+-...-..
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2233457799999999998765 79999999999999999998888643222222222222221111000000000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
......... ...............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYP---ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCC---TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccc---CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000000 000000011123446789999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.13 Aligned_cols=244 Identities=20% Similarity=0.135 Sum_probs=172.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999999754 33445678899999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 348899999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH------
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM------ 262 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 262 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.............
T Consensus 218 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 218 -----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTTSC
T ss_pred -----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHcc
Confidence 2233467899999999999999999999999999999999999999753211 1111211111110000
Q ss_pred HHhhhhhccccccccccccchhhh----hchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRK----TKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
......+...........+..... ............+.+|+.+||..||++|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000000000 0001112235578899999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=306.60 Aligned_cols=230 Identities=18% Similarity=0.177 Sum_probs=179.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4679999999999999999999999999999999875432 34688999999999 89999976
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc-----eEEccccccccccc
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF-----AHIGDFELARFRQE 187 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~ 187 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 558899999999999999 999999999999998887 99999999987644
Q ss_pred CCCCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 188 VSNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 188 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... +
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~--------i 232 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQK--------I 232 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHH--------H
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHH--------H
Confidence 32211 112345789999999999999999999999999999999999999997543222 1111110 0
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.......... ......+ .+.+++..||+.||.+||++.+|++.|+.+.+..
T Consensus 233 ~~~~~~~~~~---------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 233 GDTKRATPIE---------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHSCHH---------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhhhccCCHH---------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000000 0000123 6889999999999999999999999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.49 Aligned_cols=224 Identities=22% Similarity=0.342 Sum_probs=169.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEE----EEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVV----AIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.| |+|.+... .....+.+.+|+.+++.++||||+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 467999999999999999999998777654 66666433 33456789999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 558899999999999999 999999999999999999999999999866433
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...... .+.... ..
T Consensus 171 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~------------~~ 234 (327)
T 3lzb_A 171 EK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL------------EK 234 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH------------HT
T ss_pred cc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH------------Hc
Confidence 22 122233456788999999999999999999999999999999 99999753222 111111 11
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ...+...+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 235 ~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 235 GERLPQ------------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCC------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 110000 0123345789999999999999999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.31 Aligned_cols=218 Identities=21% Similarity=0.268 Sum_probs=171.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 5789999999999999999999999999999999875432 234568899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc--
Confidence 568999999999999999 99999999999999999999999999986543221
Q ss_pred ccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||............+........
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN----------- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST-----------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC-----------
Confidence 222345678999999999988775 67899999999999999999999754333222222211110000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
. .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 -~------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -P------------------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -T------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -c------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 00223356789999999999999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=303.13 Aligned_cols=213 Identities=21% Similarity=0.215 Sum_probs=171.5
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
|...+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 6777899999999999999998899999999987666667789999999999999999986
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~ 199 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----PKRK 199 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----CCBC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----cccc
Confidence 568899999999999999 9999999999999999999999999998654322 1223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLA 277 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 277 (356)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ...........+.. +..
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~--------~~~------ 263 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK--------LKN------ 263 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCC--------CTT------
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCC--------cCc------
Confidence 46789999999999999999999999999999999999999964211 11111111100000 000
Q ss_pred ccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 278 GTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.......+.+++.+||+.||++|||+.++++.
T Consensus 264 --------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 --------------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01223357899999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.64 Aligned_cols=224 Identities=18% Similarity=0.278 Sum_probs=172.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeE----EEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAV----VAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL 91 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence 45799999999999999999999877665 7777775332 2334567789999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 568899999999999999 999999999999999999999999999876443
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~----------- 233 (325)
T 3kex_A 169 DK--QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKG----------- 233 (325)
T ss_dssp TT--CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTT-----------
T ss_pred cc--cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcC-----------
Confidence 22 122334567889999999998899999999999999999999 99999753221 111111111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ..+...+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 234 -~~~~~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 234 -ERLAQP------------------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -CBCCCC------------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -CCCCCC------------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 012224578999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.08 Aligned_cols=225 Identities=20% Similarity=0.364 Sum_probs=165.3
Q ss_pred cCCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|.+.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.++++++||||+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999986 456789999997543 3344679999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 568899999999999999 999999999999999999999999999866433
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... ........++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... ...+..
T Consensus 201 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~---------~~~i~~ 265 (373)
T 2qol_A 201 PEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDV---------IKAVDE 265 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHH---------HHHHHT
T ss_pred Ccc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---------HHHHHc
Confidence 211 111222345778999999999999999999999999999998 9999964321 111 111111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ...++..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 266 ~~~~~~------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 266 GYRLPP------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TEECCC------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCC------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111000 0134456889999999999999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.27 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=158.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 5679999999999999999999999999999999975432 334678899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 336679999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDI 264 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 264 (356)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+........ +......
T Consensus 161 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 161 PV----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp CC----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGG
T ss_pred Cc----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhh
Confidence 22 12234567999999999976 468999999999999999999999997533211 1111111111 0111000
Q ss_pred hhhh--hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLV--LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+... ....... .....+...............+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQ--RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCC--CCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhccccccc--ccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 0000000 000000000000000123346789999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.14 Aligned_cols=231 Identities=16% Similarity=0.156 Sum_probs=180.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l-------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.+ +|+|++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3567999999999999999999999999999999986432 234678899999999 68888765
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc-----eEEcccccccccc
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF-----AHIGDFELARFRQ 186 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~ 186 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+++...
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 568999999999999999 999999999999987776 9999999998765
Q ss_pred cCCCCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCcc--HHHHHHHhCCCch
Q 039228 187 EVSNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN--LHNFARMAFPNRV 261 (356)
Q Consensus 187 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~ 261 (356)
...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......... +............
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 433211 12234567899999999999999999999999999999999999999754322111 0110000000000
Q ss_pred HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 262 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.. + ...++..+.+++..||+.||++|||+.+|++.|+++.+.+.
T Consensus 243 ~~-----~----------------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 RE-----L----------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HH-----H----------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH-----H----------------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00 0 01234467899999999999999999999999999988763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=302.05 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=170.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+|+.++++++||||+++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 35789999999999999999999964 79999999864422 234678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 458899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC---chHHHhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN---RVMDIVN 266 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 266 (356)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+.......... ......+
T Consensus 174 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 ---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp ---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTT
T ss_pred ---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhc
Confidence 22233567999999999876 568999999999999999999999997644332 222222221111 1000000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... ..........+..........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQ-----RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHS-----CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhh-----cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000000000001111123346789999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=304.80 Aligned_cols=226 Identities=19% Similarity=0.329 Sum_probs=163.8
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCe---EEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRA---VVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
...++|++.+.||+|+||.||+|.+..++. .||||++... .....+.+.+|+.++++++||||+++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999877654 8999998754 33445789999999999999999875
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 135 ----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 135 ----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 347889999999999999 9999999999999999999
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~ 253 (356)
||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 177 kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~ 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYL 252 (323)
T ss_dssp EECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH
T ss_pred EEeecccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHH
Confidence 9999999986543221 122223456788999999999999999999999999999999 99999753221 111111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
. ....... ...++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 253 ~-----------~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 I-----------GGNRLKQ-------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp H-----------TTCCCCC-------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred h-----------cCCCCCC-------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 0000000 0133346789999999999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=301.57 Aligned_cols=225 Identities=27% Similarity=0.426 Sum_probs=166.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...++|++.+.||+|+||.||+|.+. ..||+|+++... ....+.+.+|+.+++.++||||+++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEE
Confidence 34578999999999999999999865 359999987543 2344678999999999999999976
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 468899999999999999 9999999999999999999999999997654322
Q ss_pred CCCccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh-CCCchHHHh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA-FPNRVMDIV 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 265 (356)
. ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||....... .+....... .......
T Consensus 175 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~-- 249 (289)
T 3og7_A 175 G--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSK-- 249 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTS--
T ss_pred c--cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhh--
Confidence 1 12233466899999999986 5678889999999999999999999997532211 111111111 1110000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
....++..+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus 250 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 -------------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 001334568899999999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.09 Aligned_cols=215 Identities=15% Similarity=0.174 Sum_probs=170.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.+.|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+|+.++||||+++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999754322 34678999999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----ceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL----FAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~ 183 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 568899999999999999 99999999999998777 79999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~-------- 229 (361)
T 2yab_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN-------- 229 (361)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH--------
T ss_pred EcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------
Confidence 654321 22346789999999999999999999999999999999999999964221 111110
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.....+.. .... .......+.+++.+||..||.+|||+.++++
T Consensus 230 ----i~~~~~~~--------~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 230 ----ITAVSYDF--------DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----HHTTCCCC--------CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhcCCCC--------Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 0000 0022335789999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=305.48 Aligned_cols=213 Identities=20% Similarity=0.214 Sum_probs=170.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999753 23345678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 457889999999999999 9999999999999999999999999997533221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..... ..... .+....+.
T Consensus 160 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~--------~i~~~~~~ 223 (337)
T 1o6l_A 160 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE--------LILMEEIR 223 (337)
T ss_dssp ---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHCCCC
T ss_pred ---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHH--------HHHcCCCC
Confidence 223457899999999999999999999999999999999999999964211 11110 01100000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~ 323 (356)
.+ ......+.+++.+||+.||.+|| ++.+|++.
T Consensus 224 --~p------------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FP------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CC------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CC------------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 02233578999999999999999 88888763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.29 Aligned_cols=224 Identities=23% Similarity=0.329 Sum_probs=173.9
Q ss_pred cCCCCccccceecCceEEEEEEE-----CCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... ......+.+|+.++++++||||+++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45799999999999999999994 4467899999996442 3344578899999999999999986
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIG 177 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 177 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 358899999999999999 99999999999999554 59999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+....
T Consensus 227 DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i--- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV--- 299 (367)
T ss_dssp CCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH---
T ss_pred CCccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---
Confidence 9999986533221 122334567889999999998999999999999999999998 9999964321 1111111
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
........ ...++..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 300 ---------~~~~~~~~------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 ---------TSGGRMDP------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ---------HTTCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------HcCCCCCC------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11000000 0133446789999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.01 Aligned_cols=220 Identities=22% Similarity=0.301 Sum_probs=169.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCC
Confidence 356899999999999999999986 689999998643 345678999999999999999976
Q ss_pred ----------------------HHHHHHHHHHHHHHhh---cCCCcEEecCCCCCCeEeCCCCc-eEEcccccccccccC
Q 039228 135 ----------------------ISIAIDVASALDYLHH---HCQELILHCDPKPSNVLLDNDLF-AHIGDFELARFRQEV 188 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~---~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 4578899999999999 66 999999999999998886 799999999754321
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 221 (307)
T 2eva_A 160 -------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT----------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-----------
T ss_pred -------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-----------
Confidence 12345899999999999999999999999999999999999999743222111110000000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
.... ...++..+.+++.+||+.||.+|||+.+|++.|+.+...+...
T Consensus 222 -~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 222 -RPPL------------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -CCCC------------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -CCCc------------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 0000 0123345789999999999999999999999999998887554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.07 Aligned_cols=228 Identities=23% Similarity=0.329 Sum_probs=176.1
Q ss_pred CCCccccceecCceEEEEEEECCCC---eEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNR---AVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++||||+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3666789999999999999975543 3799999875433 345678899999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 468889999999999999 9999999999999999999999999998654332
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
...........++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ............
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~------------ 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGR------------ 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTC------------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCC------------
Confidence 2222334456678999999999999999999999999999999996555432211 111211111111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
..... ..++..+.+++.+||+.||.+|||+.++++.|+++.+.+...
T Consensus 246 ~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 246 RLPQP------------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCCC------------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 00000 123346789999999999999999999999999999887554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=310.75 Aligned_cols=238 Identities=19% Similarity=0.240 Sum_probs=180.1
Q ss_pred cCCCCccccceecCceEEEEEEE----CCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|+.++++++||||+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999994 56789999999987666666789999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 458889999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC----CCchH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF----PNRVM 262 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 262 (356)
..... ........+|..|+|||++.+..++.++||||||+++|+|++|..||..... ....... .....
T Consensus 179 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 179 LDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLRMMGCERDVPALS 251 (327)
T ss_dssp TTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHCC----CCHHH
T ss_pred cCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc------hhhhhcccccccccHH
Confidence 33221 1223345678889999999988899999999999999999999999863211 1111100 01111
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
.+......... ......++..+.+++.+||+.||.+|||+.+|++.|+.+......
T Consensus 252 ~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 252 RLLELLEEGQR---------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHHHTTCC---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHHHhhcccC---------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 11111111000 001113455688999999999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.01 Aligned_cols=220 Identities=22% Similarity=0.358 Sum_probs=172.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccc-------hHHHHHHHHHHhhcCCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA-------SKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 468999999999999999999999999999999986443221 1678899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc-----eEEcccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF-----AHIGDFELA 182 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~a 182 (356)
+.++.|++.||.|||+.+ .+|+||||||+||+++.++. +||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 568899999999999875 45999999999999988776 999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhc--CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDL--GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
+.... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.................
T Consensus 177 ~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 245 (287)
T 4f0f_A 177 QQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE---- 245 (287)
T ss_dssp BCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS----
T ss_pred ccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc----
Confidence 74322 223356899999999983 45678899999999999999999999975433222111111110
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
....... ..++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 246 -------~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 -------GLRPTIP------------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -------CCCCCCC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -------CCCCCCC------------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0100000 13344678999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=295.42 Aligned_cols=231 Identities=19% Similarity=0.215 Sum_probs=177.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.++|++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35789999999999999999999999999999998764322 2457889999999999887654
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 568899999999999999 9999999999999 78999999999999876543
Q ss_pred CCCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc--cHHHHHHHhCCCchHH
Q 039228 189 SNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL--NLHNFARMAFPNRVMD 263 (356)
Q Consensus 189 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~ 263 (356)
.... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .+........+....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-
Confidence 3211 1233456789999999999999999999999999999999999999976443221 111111111000000
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.+. ...+..+.+++..||+.||++|||+.+|++.|+.+.+...
T Consensus 241 ----~~~----------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 ----VLC----------------------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHT----------------------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----hhh----------------------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000 0223467899999999999999999999999999987763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=319.53 Aligned_cols=226 Identities=21% Similarity=0.344 Sum_probs=179.8
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.+....++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEE
Confidence 344556789999999999999999999975 5889999997543 346789999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 458899999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
.. ........++..|+|||++.+..++.++|||||||++|||+| |+.||...... .........
T Consensus 337 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~---------- 401 (454)
T 1qcf_A 337 NE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERG---------- 401 (454)
T ss_dssp HH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHT----------
T ss_pred Cc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----------
Confidence 21 112233446788999999998899999999999999999999 99999743211 111111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.... .+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 402 --~~~~------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 --YRMP------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0000 01134557889999999999999999999999999887654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=311.83 Aligned_cols=170 Identities=23% Similarity=0.344 Sum_probs=135.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcC-CCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNIC-HRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l------------ 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.+. ||||+++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357899999999999999999999999999999998643 2344567889999999998 9999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 347889999999999999 9999999999999999999999999998653211
Q ss_pred C-----------------CCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 190 N-----------------PTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 190 ~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
. ..........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 01122344679999999999986 67899999999999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=294.33 Aligned_cols=231 Identities=19% Similarity=0.216 Sum_probs=181.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.++|++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 35789999999999999999999999999999999875432 3568899999999999886643
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 568899999999999999 9999999999999 48899999999999876543
Q ss_pred CCCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC--ccHHHHHHHhCCCchHH
Q 039228 189 SNPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD--LNLHNFARMAFPNRVMD 263 (356)
Q Consensus 189 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~ 263 (356)
.... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+.............
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 3211 112345678999999999999999999999999999999999999997643321 1111111111000000
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.+. ..++..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 241 ----~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 ----VLC----------------------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHT----------------------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHH----------------------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000 1233467899999999999999999999999999987753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=307.80 Aligned_cols=212 Identities=23% Similarity=0.252 Sum_probs=169.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 578999999999999999999999999999999997432 2234578899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 458899999999999999 9999999999999999999999999998654322
Q ss_pred CccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ......
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~i~~ 222 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKKVNS 222 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCCCCS
T ss_pred ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHHHc
Confidence 2234578999999999988776 6899999999999999999999964322110 000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.... .+......+.+|+.+||+.||.+|||+.++++.
T Consensus 223 ~~~~----------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYV----------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCC----------------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCC----------------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 000123356899999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.84 Aligned_cols=220 Identities=20% Similarity=0.346 Sum_probs=175.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|+.++++++||||+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4679999999999999999999875 5789999997543 334678999999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 160 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc---
Confidence 458899999999999999 9999999999999999999999999998653321
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~------------~~~~ 226 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST------------GFRL 226 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT------------TCCC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhc------------CccC
Confidence 122334556788999999998899999999999999999999 99999742211 11111100 0000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
... ......+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 227 ~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKP------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC------------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 000 02233578999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.34 Aligned_cols=232 Identities=20% Similarity=0.238 Sum_probs=180.6
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEE-----ECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH-
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGV-----FDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l- 134 (356)
....+....++|++.+.||+|+||.||+|. ...+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 345566677899999999999999999999 445679999999975433 3346789999999999 78999986
Q ss_pred -------------------------H------------------------------------------------------
Q 039228 135 -------------------------I------------------------------------------------------ 135 (356)
Q Consensus 135 -------------------------~------------------------------------------------------ 135 (356)
+
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 0
Q ss_pred ------------------------HHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 136 ------------------------SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 136 ------------------------~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 248 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD- 248 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc-
Confidence 16679999999999999 99999999999999999999999999986543222
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
........||+.|+|||++.+..++.++||||||+++|||++ |..||....... .+.........
T Consensus 249 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~------------ 314 (359)
T 3vhe_A 249 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR------------ 314 (359)
T ss_dssp -CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCC------------
T ss_pred -chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCC------------
Confidence 223345678899999999999999999999999999999998 999997533221 11111111100
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.... ..+...+.+++..||+.||.+|||+.+|++.|+++.+.
T Consensus 315 ~~~~------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 MRAP------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000 02233578999999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.05 Aligned_cols=173 Identities=25% Similarity=0.347 Sum_probs=147.7
Q ss_pred cCChhhHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-----CCChH
Q 039228 58 AIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-----HRNLV 132 (356)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 132 (356)
....+++.+.....++|.+.+.||+|+||.||+|++..+++.||||++... ......+..|+.+++.+. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344444555555678999999999999999999999999999999998743 233456778999999987 99999
Q ss_pred HH--------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC----
Q 039228 133 RF--------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---- 170 (356)
Q Consensus 133 ~l--------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---- 170 (356)
++ ..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp CEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 86 458899999999999999 999999999999975
Q ss_pred ---------------------CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHH
Q 039228 171 ---------------------DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILL 229 (356)
Q Consensus 171 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l 229 (356)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC-------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 78999999999975432 12346789999999999999999999999999999
Q ss_pred HHHHcCCCCCCc
Q 039228 230 LEMVTRRKPIDF 241 (356)
Q Consensus 230 ~elltg~~Pf~~ 241 (356)
|+|++|+.||..
T Consensus 250 ~ell~g~~pf~~ 261 (360)
T 3llt_A 250 AELYTGSLLFRT 261 (360)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=318.48 Aligned_cols=162 Identities=27% Similarity=0.369 Sum_probs=126.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999998643 23345678999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 458899999999999999 99999999999999999999999999987643
Q ss_pred CCCCC-----------------------ccCCCCccccccccchhhh-cCCCCCCccchHhHHHHHHHHHcC
Q 039228 188 VSNPT-----------------------QSSSNGVRRTIGYTALDYD-LGSEVSTNGDAYNYGILLLEMVTR 235 (356)
Q Consensus 188 ~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlG~~l~elltg 235 (356)
..... .......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 22110 0123456789999999986 456799999999999999999993
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=294.05 Aligned_cols=220 Identities=20% Similarity=0.334 Sum_probs=173.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.++++++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4679999999999999999998874 57899999975433 34678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--- 158 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC---
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh---
Confidence 568899999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... ....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~------------~~~~ 224 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQ------------GHRL 224 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHT------------TCCC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHc------------CCCC
Confidence 122234556778999999998889999999999999999999 999996432111 1000000 0000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
... ...+..+.+++..||+.||.+|||+.+|++.|+.+.+.
T Consensus 225 ~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 YRP------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCC------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCC------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000 01233578999999999999999999999999988754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=299.07 Aligned_cols=243 Identities=16% Similarity=0.180 Sum_probs=178.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 456999999999999999999999999999999997543 2345678899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe----CCCCceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~ 183 (356)
+.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 458899999999999999 9999999999999 788889999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhc--------CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccH---HHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDL--------GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNL---HNF 252 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~---~~~ 252 (356)
...... ......||..|+|||++. +..++.++|||||||++|||++|..||.......... ...
T Consensus 165 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 654322 223356899999999986 5788999999999999999999999996533322111 111
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.....+.....+ ......... ...... ............+.+++.+||+.||++|||+.|+++......
T Consensus 240 ~~~~p~~~~~~~-~~~~~~~~~----~~~~~~--~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGV-QKAENGPID----WSGDMP--VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEE-ECSTTCCEE----EESSCC--TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhh-hcccCCccc----cCccCC--cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111110000 000000000 000000 001122366678899999999999999999999999886543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.19 Aligned_cols=215 Identities=20% Similarity=0.227 Sum_probs=171.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999999999999999987543 334668899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--CCceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 568899999999999999 999999999999987 7899999999998654321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+.......+....
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~--------- 224 (321)
T 1tki_A 159 ----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFDE--------- 224 (321)
T ss_dssp ----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCCH---------
T ss_pred ----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCCCh---------
Confidence 1233568999999999998889999999999999999999999996422110 01111111000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
......+..+.+++.+||..||.+|||+.++++.
T Consensus 225 -------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 -------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001233467899999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.88 Aligned_cols=233 Identities=23% Similarity=0.318 Sum_probs=178.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh--cCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN--ICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l------------- 134 (356)
..++|.+.+.||+|+||.||+|.+. ++.||||++... ....+.+|..++.. ++||||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3467999999999999999999984 799999998633 34667889988887 789999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHh--------hcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 ---------------------------ISIAIDVASALDYLH--------HHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
+.++.+++.||.||| +.+ |+||||||+||+++.++.+||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 468899999999999 777 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCC------CCCccchHhHHHHHHHHHcC----------CCCCCccc
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE------VSTNGDAYNYGILLLEMVTR----------RKPIDFMF 243 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~~l~elltg----------~~Pf~~~~ 243 (356)
|++..................||+.|+|||++.+.. ++.++||||||+++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876543322112334567899999999997652 33689999999999999999 77876544
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........+....... .+...... .+ ....++..+.+|+.+||+.||++|||+.+|++.
T Consensus 272 ~~~~~~~~~~~~~~~~--------~~~~~~~~-----------~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQ--------KLRPNIPN-----------RW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTS--------CCCCCCCG-----------GG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHH--------HhCCCCcc-----------cc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4333333332222111 11111000 00 012667789999999999999999999999999
Q ss_pred HHHhhhhh
Q 039228 324 LQSVNNIL 331 (356)
Q Consensus 324 L~~i~~~~ 331 (356)
|+.+.++.
T Consensus 331 L~~i~~~~ 338 (342)
T 1b6c_B 331 LSQLSQQE 338 (342)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99997653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=299.00 Aligned_cols=214 Identities=21% Similarity=0.229 Sum_probs=164.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------------------------cchHHHHHHHHHHh
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------------------------GASKSFMAECKALK 124 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 124 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999864421 12356889999999
Q ss_pred hcCCCChHHH--------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCe
Q 039228 125 NICHRNLVRF--------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNV 166 (356)
Q Consensus 125 ~l~h~niv~l--------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NI 166 (356)
+++||||+++ ..++.|++.||.|||+.+ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 9999999986 568899999999999999 99999999999
Q ss_pred EeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCC---CCCccchHhHHHHHHHHHcCCCCCCccc
Q 039228 167 LLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE---VSTNGDAYNYGILLLEMVTRRKPIDFMF 243 (356)
Q Consensus 167 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~~l~elltg~~Pf~~~~ 243 (356)
+++.++.+||+|||++....... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCCEEEecCCCcccccccc----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999998654322 1123457899999999997765 3778999999999999999999996421
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... .+....+.... .......+.+++.+||+.||++|||+.+|++
T Consensus 245 -----~~~~~~--------~~~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 -----IMCLHS--------KIKSQALEFPD------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHHHHH--------HHHHCCCCCCS------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHHHHH--------HHhcccCCCCC------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111110 00000000000 0022345789999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.72 Aligned_cols=216 Identities=23% Similarity=0.362 Sum_probs=174.5
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 45578999999999999999999986 6899999997543 45789999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 458899999999999999 999999999999999999999999999754221
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+....
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~---------- 403 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY---------- 403 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTC----------
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC----------
Confidence 112355788999999999999999999999999999998 999997543221 111111110
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.... +..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 404 --~~~~------------------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 --KMDA------------------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCC------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0000 113455788999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=298.58 Aligned_cols=214 Identities=17% Similarity=0.189 Sum_probs=169.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
+.|.+.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4599999999999999999999999999999999754321 35678999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----ceEEcccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL----FAHIGDFELARF 184 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~ 184 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 568899999999999999 99999999999999877 899999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+...........
T Consensus 168 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~---- 237 (326)
T 2y0a_A 168 IDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYEFE---- 237 (326)
T ss_dssp CCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCCCCC----
T ss_pred CCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCCCcC----
Confidence 64322 2234568999999999999999999999999999999999999996422110 0111100000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .........+.+++.+||..||++|||+.++++
T Consensus 238 -~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 -D-----------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -H-----------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -c-----------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000122345789999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=300.50 Aligned_cols=215 Identities=22% Similarity=0.293 Sum_probs=166.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4569999999999999999999999999999999975433 345779999999999999999852
Q ss_pred --------------------------------------------------------------------------------
Q 039228 135 -------------------------------------------------------------------------------- 134 (356)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (356)
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence
Q ss_pred --HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC--------ccCCCCcccccc
Q 039228 135 --ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT--------QSSSNGVRRTIG 204 (356)
Q Consensus 135 --~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~gt~~ 204 (356)
+.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 357889999999999999 9999999999999999999999999998765432111 122344678999
Q ss_pred ccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchh
Q 039228 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNML 284 (356)
Q Consensus 205 y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 284 (356)
|+|||++.+..++.++|||||||++|+|++|..|+... ...... .... ..
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~--------~~~~----~~----------- 291 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITD--------VRNL----KF----------- 291 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHH--------HHTT----CC-----------
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHH--------hhcc----CC-----------
Confidence 99999999999999999999999999999987774310 000000 0000 00
Q ss_pred hhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 285 RKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 285 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.........+.+++.+||+.||.+|||+.++++
T Consensus 292 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 292 ----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0011233445688999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=302.73 Aligned_cols=228 Identities=21% Similarity=0.266 Sum_probs=167.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++++++||||+++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 5689999999999999999999999999999999975432 234578899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 458899999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ....... .... ...
T Consensus 168 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~-~~~~-~~~- 242 (311)
T 3ork_A 168 DSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVRED-PIPP-SAR- 242 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCC-CCCH-HHH-
T ss_pred ccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCC-CCCc-ccc-
Confidence 43221 12233467899999999999999999999999999999999999999643211100 0000000 0000 000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh-HHHHHHHHHhhhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV-PNAVHDLQSVNNIL 331 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-~~vl~~L~~i~~~~ 331 (356)
....+..+.+++.+||+.||++||++ +++.+.|..+....
T Consensus 243 -------------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 243 -------------------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp -------------------------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred -------------------------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 00233467899999999999999964 45556676665544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=297.46 Aligned_cols=223 Identities=20% Similarity=0.286 Sum_probs=165.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 346799999999999999999998653 4679999987543 2345678899999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcc
Confidence 457889999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~---------- 234 (281)
T 1mp8_A 170 TY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGE---------- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC----------
T ss_pred cc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCC----------
Confidence 21 12223456788999999998899999999999999999997 99999753322 1111111100
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.. .. ...++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 235 -~~-~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 -RL-PM------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CC-CC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC-CC------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 00 013344678999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=322.96 Aligned_cols=224 Identities=21% Similarity=0.336 Sum_probs=180.3
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
....++|++.+.||+|+||.||+|.+..++..||||+++... ...+.+.+|+.+|++++||||+++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 334567999999999999999999999888999999997543 346789999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 457889999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .... .+..
T Consensus 372 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~------------~~~~ 434 (495)
T 1opk_A 372 T---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYE------------LLEK 434 (495)
T ss_dssp C---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH------------HHHT
T ss_pred c---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHc
Confidence 1 122334456788999999998899999999999999999999 99999753221 1111 1111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
...... +..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 435 ~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 DYRMER------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCC------------------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111110 113445688999999999999999999999999988644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=301.03 Aligned_cols=239 Identities=24% Similarity=0.252 Sum_probs=168.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcC---CCChHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNIC---HRNLVRF------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++ ||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3678999999999999999999999999999999987432 122346677887777665 9999976
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcc
Q 039228 135 ------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGD 178 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 178 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 458899999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+.........
T Consensus 164 fg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~ 237 (308)
T 3g33_A 164 FGLARIYSYQ-----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGL 237 (308)
T ss_dssp CSCTTTSTTC-----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred CccccccCCC-----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 9999765422 22234678999999999999999999999999999999999999997532211 11111111110
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.....+........ .....................+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPR-----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCG-----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccc-----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000000000 000000000000001123446789999999999999999999885
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.11 Aligned_cols=227 Identities=21% Similarity=0.320 Sum_probs=173.9
Q ss_pred CCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.+|++.+.||+|+||.||+|.+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4689999999999999999997543 3468999987533 3345678999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 458889999999999999 999999999999999999999999999866443
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...... ...........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~--------- 250 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR--------- 250 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCC---------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCC---------
Confidence 3222333445667889999999999999999999999999999999 56666533221 11111111000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
... . ..++..+.+++.+||+.||++|||+.+|++.|+++...+..
T Consensus 251 --~~~-~------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 --LLQ-P------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp --CCC-C------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred --CCC-C------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 000 0 02234578999999999999999999999999999887754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=299.42 Aligned_cols=225 Identities=21% Similarity=0.336 Sum_probs=181.7
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
...++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 3466799999999999999999999999999999999754 3345778999999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 457889999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... +...
T Consensus 166 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~------------~~~~ 228 (288)
T 3kfa_A 166 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL------------LEKD 228 (288)
T ss_dssp ---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH------------HHTT
T ss_pred ---cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------Hhcc
Confidence 222334566888999999998899999999999999999999 99999743221 11111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
...... ..++..+.+++..||+.||.+|||+.+|++.|+.+.....
T Consensus 229 ~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 229 YRMERP------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCC------------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111100 1334467899999999999999999999999999887653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.80 Aligned_cols=239 Identities=21% Similarity=0.224 Sum_probs=165.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 5679999999865432 234678899999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 154 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--- 154 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence 458899999999999999 9999999999999999999999999998654221
Q ss_pred ccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+..............+-......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccc
Confidence 122335679999999999764 58999999999999999999999997532211 111211111110000000000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .........+..........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDP---NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCT---TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccc---ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000000000000123346789999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.10 Aligned_cols=236 Identities=19% Similarity=0.324 Sum_probs=172.5
Q ss_pred cCCCCccccceecCceEEEEEEECCC----CeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+ +..||||++..... .....+.+|+.+++.++||||+++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 45788899999999999999998654 34699999975432 334578899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 558899999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
.... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||...... .......
T Consensus 200 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~------------ 264 (333)
T 1mqb_A 200 DPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN------------ 264 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH------------
T ss_pred cccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHH------------
Confidence 3211 112223445788999999999999999999999999999999 99999643211 1111110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCc
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTN 342 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~ 342 (356)
....... ...++..+.+++.+||+.||++||++.+|++.|+.+.........+.....
T Consensus 265 ~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~p 322 (333)
T 1mqb_A 265 DGFRLPT------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322 (333)
T ss_dssp TTCCCCC------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCCC--
T ss_pred CCCcCCC------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcCCCc
Confidence 0000000 012344678999999999999999999999999999876654444443333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=297.26 Aligned_cols=222 Identities=20% Similarity=0.338 Sum_probs=172.7
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
...++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34567999999999999999999887 458899999975432 34678999999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 568899999999999999 9999999999999999999999999998653321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..... +....
T Consensus 175 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~------------~~~~~ 238 (283)
T 3gen_A 175 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH------------IAQGL 238 (283)
T ss_dssp --HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH------------HHTTC
T ss_pred --cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHH------------Hhccc
Confidence 122333456788999999998889999999999999999998 99999743211 11111 11110
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
..... ......+.+++.+||+.||.+|||+.+|++.|..+.+.
T Consensus 239 ~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRP------------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCC------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC------------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00000 01233578999999999999999999999999988653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=305.62 Aligned_cols=246 Identities=20% Similarity=0.309 Sum_probs=183.7
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----- 134 (356)
++....++|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34455678999999999999999999876 3568899999975432 334568899999999999999986
Q ss_pred ------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC
Q 039228 135 ------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL 172 (356)
Q Consensus 135 ------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 172 (356)
+.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 237789999999999999 99999999999999999
Q ss_pred ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHH
Q 039228 173 FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 173 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 251 (356)
.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~ 248 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQ 248 (322)
T ss_dssp CEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HH
T ss_pred eEEECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HH
Confidence 999999999986543221 122233566889999999998899999999999999999999 8999864321 11
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.... +........ ...++..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 249 ~~~~--------~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 249 VLRF--------VMEGGLLDK-------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHHH--------HHTTCCCCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHH--------HHcCCcCCC-------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 1110 000000000 0133446789999999999999999999999999887655
Q ss_pred ccccccccCCcCCcccc
Q 039228 332 LPETVFKSLTNNRAPKL 348 (356)
Q Consensus 332 ~~~~~~~~~~~~~~~~~ 348 (356)
.....+....+...|..
T Consensus 302 ~~~~~~~~~~~~~~~~~ 318 (322)
T 1p4o_A 302 FREVSFYYSEENKLPEP 318 (322)
T ss_dssp HHHHCSTTSTTC-----
T ss_pred CcccccccccccCCCCh
Confidence 44444444444444443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=306.29 Aligned_cols=214 Identities=21% Similarity=0.285 Sum_probs=168.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997432 2345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 458889999999999999 999999999999999999999999999865432
Q ss_pred CCccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....... +..
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~---------~~~ 234 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHT---------FET 234 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHH---------HHH
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHH---------Hhh
Confidence 22344678999999999864 458999999999999999999999997432221 1111110 000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-hHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-VPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~vl~ 322 (356)
..... + ......+.+|+.+||+.||.+||+ +.+|++
T Consensus 235 ~~~~~-p------------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTY-P------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCC-C------------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCC-C------------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00000 0 022345789999999999999998 666543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=303.98 Aligned_cols=240 Identities=23% Similarity=0.203 Sum_probs=174.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999999999999999997433 2334678899999999999999875
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 458899999999999999 9999999999999999999999999998665432
Q ss_pred CCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh---
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV--- 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 265 (356)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..............+.
T Consensus 183 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 183 DH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp CB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHHTCC
T ss_pred Cc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhh
Confidence 21 122344678999999998765 458999999999999999999999997543221 222222211111111000
Q ss_pred h---hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 266 N---LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 266 ~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+ ......... ... ..+..........+.+|+.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPH---KNK----VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCC---CCC----CCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCC---ccC----CCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000000 000 0000000123346789999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.03 Aligned_cols=224 Identities=21% Similarity=0.310 Sum_probs=176.4
Q ss_pred hcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
..++|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3567999999999999999999983 456899999997543 3345678899999999999999976
Q ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCC
Q 039228 135 ----------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPK 162 (356)
Q Consensus 135 ----------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlk 162 (356)
+.++.|++.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 136789999999999999 9999999
Q ss_pred CCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCc
Q 039228 163 PSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDF 241 (356)
Q Consensus 163 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~ 241 (356)
|+||+++.++.+||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999986543322 122334556788999999998889999999999999999999 9999974
Q ss_pred cccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHH
Q 039228 242 MFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAV 321 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl 321 (356)
.... .+....... ..... ...++..+.+++.+||+.||++|||+.+|+
T Consensus 256 ~~~~--~~~~~~~~~------------~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 256 IPPE--RLFNLLKTG------------HRMER------------------PDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp CCGG--GHHHHHHTT------------CCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHH--HHHHHhhcC------------CcCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 3221 111111111 00000 012344678999999999999999999999
Q ss_pred HHHHHhhhh
Q 039228 322 HDLQSVNNI 330 (356)
Q Consensus 322 ~~L~~i~~~ 330 (356)
+.|+++...
T Consensus 304 ~~l~~~~~~ 312 (314)
T 2ivs_A 304 KDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHhh
Confidence 999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.04 Aligned_cols=246 Identities=21% Similarity=0.271 Sum_probs=175.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4679999999999999999999999999999999864432 234578899999999999999865
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 458899999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh--CCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA--FPNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~ 260 (356)
.................||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+....... .+..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChh
Confidence 765443333344455678999999999876 457999999999999999999999997532211 111111111 1111
Q ss_pred hHHHhh-hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 261 VMDIVN-LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 261 ~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.....+ ..................... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRL---KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHH---HHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHh---hhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 110000 000000000000000000000 000112357899999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=296.22 Aligned_cols=240 Identities=20% Similarity=0.230 Sum_probs=166.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3679999999999999999999999999999999865432 234568899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-- 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence 458889999999999999 9999999999999999999999999998654322
Q ss_pred CccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIVNLV 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 268 (356)
.......||..|+|||++.+ ..++.++||||||+++|+|++|..||......+ .......... ...........
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhcccccccccccccc
Confidence 12234568999999999876 668999999999999999999999997533221 1111111111 11111111100
Q ss_pred -hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 -LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 -l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..............-... ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLEL----KFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHH----HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhh----hcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000000 00123446789999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=311.06 Aligned_cols=215 Identities=18% Similarity=0.169 Sum_probs=168.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4569999999999999999999999999999999975432 234578899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 458899999999999999 99999999999998 5688999999999765432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH-hCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM-AFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 267 (356)
. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ..+...... .+... .+
T Consensus 167 ~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~-----~~ 235 (444)
T 3soa_A 167 Q----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFP-----SP 235 (444)
T ss_dssp C----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCC-----TT
T ss_pred C----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCCC-----cc
Confidence 2 222346789999999999999999999999999999999999999964211 111111111 00000 00
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+ ......+.+|+.+||+.||.+|||+.++++
T Consensus 236 -------------------~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 -------------------EW----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -------------------TT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------------------cc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 022345789999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.20 Aligned_cols=216 Identities=18% Similarity=0.205 Sum_probs=169.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999999999999999997543 2334678899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC---CceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND---LFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 468899999999999999 9999999999999864 45999999999765432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+........
T Consensus 185 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~----------- 246 (362)
T 2bdw_A 185 E-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGA----------- 246 (362)
T ss_dssp C-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-----------
T ss_pred c-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC-----------
Confidence 1 22346789999999999999999999999999999999999999964211 11111111100
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..... .. .......+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~------------~~----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YDYPS------------PE----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCCT------------TG----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCc------------cc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00 00223457899999999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=303.46 Aligned_cols=234 Identities=18% Similarity=0.182 Sum_probs=170.4
Q ss_pred cCCCCccccceecCceEEEEEEECC---CCeEEEEEEeeccCcc-----------chHHHHHHHHHHhhcCCCChHHH--
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQCQG-----------ASKSFMAECKALKNICHRNLVRF-- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l-- 134 (356)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+..++.++||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999987 7889999998754321 12346678889999999999875
Q ss_pred --------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC--ce
Q 039228 135 --------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL--FA 174 (356)
Q Consensus 135 --------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~ 174 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 568999999999999999 99999999999998777 99
Q ss_pred EEcccccccccccCCCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHH
Q 039228 175 HIGDFELARFRQEVSNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 251 (356)
||+|||+++........ .........||..|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999876433221 111224467899999999999999999999999999999999999999643222211111
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
...... ..+...+...... ..++..+.+++..||+.||++|||+.+|++.|+.+.-
T Consensus 273 ~~~~~~-~~~~~~~~~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLL-DELPQSVLKWAPS---------------------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHH-HTTTHHHHHHSCT---------------------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhc-ccccHHHHhhccc---------------------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111110 0001111110000 0233467899999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.55 Aligned_cols=214 Identities=19% Similarity=0.211 Sum_probs=168.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-----ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+.|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999999999999999986431 1235678999999999999999987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc---eEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF---AHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a 182 (356)
..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 347889999999999999 999999999999986554 999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.......+....
T Consensus 181 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~~~~- 253 (351)
T 3c0i_A 181 IQLGESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNP- 253 (351)
T ss_dssp EECCTTS----CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCCCCH-
T ss_pred eEecCCC----eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCCCCc-
Confidence 8664322 123346789999999999999999999999999999999999999974211 001111110000000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.........+.+|+.+||+.||++|||+.++++
T Consensus 254 ---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 ---------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000122346789999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=299.28 Aligned_cols=241 Identities=19% Similarity=0.230 Sum_probs=173.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++... ..+.+.+|+.++++++ ||||+++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999998733 3567889999999997 9999976
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEcccccccccccCCCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--- 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 185 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---
Confidence 458899999999999999 99999999999999766 89999999998654322
Q ss_pred ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.........+.......-.....+.++.....
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2233567899999999877 6789999999999999999999999954332222222222222222222222111000
Q ss_pred cccc-----ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKV-----LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .......+...............+.+|+.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000000000000011123456789999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.13 Aligned_cols=223 Identities=20% Similarity=0.345 Sum_probs=173.0
Q ss_pred hcCCCCccccceecCceEEEEEEECC---CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 35679999999999999999999753 34579999987543 3345678999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 457889999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...........
T Consensus 167 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~--------- 232 (281)
T 3cc6_A 167 DY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDR--------- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCC---------
T ss_pred cc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCC---------
Confidence 21 12233456788999999998899999999999999999998 99999643221 11111111100
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.... ..++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 233 ---~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 ---LPKP------------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---CCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCC------------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0000 02334578999999999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=302.75 Aligned_cols=229 Identities=17% Similarity=0.173 Sum_probs=176.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4579999999999999999999999999999999976666666789999999999999999976
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 458899999999999999 999999999999999999999999998754
Q ss_pred ccCCCCC-----ccCCCCccccccccchhhhcCCC---CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 186 QEVSNPT-----QSSSNGVRRTIGYTALDYDLGSE---VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 186 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
....... ........||+.|+|||.+.+.. ++.++||||||+++|+|++|..||................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 3211100 00112245689999999987654 6889999999999999999999996433222222211111
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
...... .......+.+++.+||+.||.+|||+.+|++.|+.+....+
T Consensus 263 ----------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 263 ----------QLSIPQ------------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp ----------C--CCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred ----------cCCCCc------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 000000 01223467899999999999999999999999998865443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=297.57 Aligned_cols=226 Identities=21% Similarity=0.261 Sum_probs=178.4
Q ss_pred hcCCCCccccceecCceEEEEEEE-----CCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH--------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF-------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l-------- 134 (356)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ...+.+.+|+.+++++ +||||+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356799999999999999999985 45678999999975433 3456789999999999 89999976
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 135 -----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 135 -----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
+.++.|++.||.|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 236789999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
++.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EcCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999986644322 122334567889999999998899999999999999999999 999997543221
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
...... ......... ...+..+.+++.+||+.||.+|||+.+|++.|++
T Consensus 256 -~~~~~~------------~~~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 -KFYKMI------------KEGFRMLSP------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -HHHHHH------------HHTCCCCCC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHh------------ccCCCCCCc------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111111 111110000 1233467899999999999999999999999999
Q ss_pred hhhhh
Q 039228 327 VNNIL 331 (356)
Q Consensus 327 i~~~~ 331 (356)
+....
T Consensus 305 ~~~~~ 309 (313)
T 1t46_A 305 QISES 309 (313)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 87764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.90 Aligned_cols=240 Identities=21% Similarity=0.229 Sum_probs=165.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 567999999999999999999999999999999986432 2335678899999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 347889999999999999 99999999999999999999999999986432
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+........... .+++.
T Consensus 181 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~-~~~~~ 251 (367)
T 1cm8_A 181 -------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPP-AEFVQ 251 (367)
T ss_dssp -------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC-HHHHH
T ss_pred -------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC-HHHHH
Confidence 1234577999999999887 679999999999999999999999997532211 1111111111100 00000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..............+.................+.+|+.+||..||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000000000000000011123346789999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=305.64 Aligned_cols=227 Identities=22% Similarity=0.290 Sum_probs=177.9
Q ss_pred hcCCCCccccceecCceEEEEEEECC-------CCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDL-------NRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l------ 134 (356)
..++|.+.+.||+|+||.||+|++.. .+..||||++..... .....+.+|+.+++.+ +||||+++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 35679999999999999999999743 346899999975432 3346788999999999 89999986
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 135 -----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 135 -----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
+.++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 247889999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--- 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EcCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999986543221 122334566889999999999999999999999999999999 999986432
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
..... ..+......... ..+...+.+++.+||+.||++|||+.+|++.|++
T Consensus 299 --~~~~~---------~~~~~~~~~~~~------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 299 --VEELF---------KLLKEGHRMDKP------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp --HHHHH---------HHHHTTCCCCCC------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHH---------HHHHcCCCCCCC------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111 111111000000 1234467899999999999999999999999999
Q ss_pred hhhhhcc
Q 039228 327 VNNILLP 333 (356)
Q Consensus 327 i~~~~~~ 333 (356)
+......
T Consensus 350 ~~~~~~~ 356 (382)
T 3tt0_A 350 IVALTSN 356 (382)
T ss_dssp HHHHSCS
T ss_pred HHHHHhc
Confidence 9876643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.33 Aligned_cols=248 Identities=22% Similarity=0.262 Sum_probs=171.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHH--HhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKA--LKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 357899999999999999999987 47999999997432 3344444444 556899999876
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhc---------CCCcEEecCCCCCCeEeCCCCceEEc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHH---------CQELILHCDPKPSNVLLDNDLFAHIG 177 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~---------~~~~iiH~Dlkp~NIll~~~~~~kl~ 177 (356)
..++.|++.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 45888999999999998 8 9999999999999999999999
Q ss_pred ccccccccccCCCC----CccCCCCccccccccchhhhcC-------CCCCCccchHhHHHHHHHHHcCCCCCCccccCC
Q 039228 178 DFELARFRQEVSNP----TQSSSNGVRRTIGYTALDYDLG-------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246 (356)
Q Consensus 178 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 246 (356)
|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99999876432211 1122334578999999999987 356678999999999999999977764322211
Q ss_pred ccHHHHHHHhC-CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHH
Q 039228 247 LNLHNFARMAF-PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQ 325 (356)
Q Consensus 247 ~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~ 325 (356)
.....+..... .....++ ...+..... . ...+ .. ......++..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~-~~~~----~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDM-QVLVSREKQ-R-PKFP----EA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHH-HHHHTTSCC-C-CCCC----TT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHH-Hhhhccccc-C-CCCC----cc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 10000000111 1111111 100000000 0 0000 00 0011246667899999999999999999999999999
Q ss_pred Hhhhhhcc
Q 039228 326 SVNNILLP 333 (356)
Q Consensus 326 ~i~~~~~~ 333 (356)
++.+....
T Consensus 315 ~ll~~~~~ 322 (336)
T 3g2f_A 315 ELMMIWER 322 (336)
T ss_dssp HHHHCCCC
T ss_pred HHHHHHHh
Confidence 99877644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=307.86 Aligned_cols=217 Identities=20% Similarity=0.264 Sum_probs=165.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l----------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ......+..|..++.++ +||||+++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3567999999999999999999999999999999997542 23345688899999887 89999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 458889999999999999 999999999999999999999999999753221
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+....
T Consensus 207 ----~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~~~i 274 (396)
T 4dc2_A 207 ----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVI 274 (396)
T ss_dssp ----TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHH
T ss_pred ----CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHHHHH
Confidence 1233457899999999999999999999999999999999999999964322110000 0000011111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
+..... .+......+.+|+.+||+.||.+||++
T Consensus 275 ~~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCCCC----------------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hccccC----------------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111100 001223357899999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.06 Aligned_cols=228 Identities=22% Similarity=0.272 Sum_probs=175.2
Q ss_pred hhcCCCCccccceecCceEEEEEEE-----CCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
...++|.+.+.||+|+||.||+|.+ ..++..||||++.... ....+.+.+|+.+++++ +||||+++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999997 3456789999997442 33456789999999999 89999976
Q ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCC
Q 039228 135 -----------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDP 161 (356)
Q Consensus 135 -----------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dl 161 (356)
+.++.||+.||.|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 127789999999999999 999999
Q ss_pred CCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCC
Q 039228 162 KPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPID 240 (356)
Q Consensus 162 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~ 240 (356)
||+||+++.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999986644322 122344567889999999998899999999999999999998 999997
Q ss_pred ccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHH
Q 039228 241 FMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNA 320 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 320 (356)
...... .+...... ....... ..++..+.+++.+||+.||.+|||+.+|
T Consensus 277 ~~~~~~-~~~~~~~~------------~~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 277 GIPVDA-NFYKLIQN------------GFKMDQP------------------FYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp TCCCSH-HHHHHHHT------------TCCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCcHH-HHHHHHhc------------CCCCCCC------------------CCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 543211 11111111 1110000 1233467899999999999999999999
Q ss_pred HHHHHHhhhhhc
Q 039228 321 VHDLQSVNNILL 332 (356)
Q Consensus 321 l~~L~~i~~~~~ 332 (356)
++.|+.+.....
T Consensus 326 ~~~l~~~~~~~~ 337 (344)
T 1rjb_A 326 TSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHC----
T ss_pred HHHHHHHHHHHH
Confidence 999999877653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.18 Aligned_cols=228 Identities=19% Similarity=0.314 Sum_probs=169.2
Q ss_pred hhcCCCCccccceecCceEEEEEEECC---CCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
...++|.+.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345679999999999999999998764 45689999987543 2334678999999999999999875
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 457889999999999999 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~ 254 (356)
|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .......
T Consensus 188 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~ 263 (313)
T 3brb_A 188 VADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLL 263 (313)
T ss_dssp ECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH
T ss_pred EeecCcceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHH
Confidence 999999986543221 112233456788999999999999999999999999999999 89998643221 1111111
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
... .... ...++..+.+++.+||+.||.+|||+.+|++.|+.+.+.++.
T Consensus 264 ~~~------------~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 264 HGH------------RLKQ------------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp TTC------------CCCC------------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred cCC------------CCCC------------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 100 0000 013334678999999999999999999999999999887753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.95 Aligned_cols=231 Identities=20% Similarity=0.270 Sum_probs=177.3
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----- 134 (356)
.+....++|++.+.||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+.+++.++||||+++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445678999999999999999999987 3458999999975432 335678999999999999999986
Q ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEe
Q 039228 135 --------------------------------------------------------ISIAIDVASALDYLHHHCQELILH 158 (356)
Q Consensus 135 --------------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH 158 (356)
+.++.||+.||.|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 117889999999999999 999
Q ss_pred cCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCC
Q 039228 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRK 237 (356)
Q Consensus 159 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~ 237 (356)
|||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999986543221 122234567889999999998899999999999999999999 999
Q ss_pred CCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 238 PIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 238 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
||..... ...... +.+.... .. +..++..+.+++.+||+.||++|||+
T Consensus 276 p~~~~~~-----~~~~~~--------~~~~~~~-~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 276 PYYGMAH-----EEVIYY--------VRDGNIL-AC------------------PENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp TTTTSCH-----HHHHHH--------HHTTCCC-CC------------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCCh-----HHHHHH--------HhCCCcC-CC------------------CCCCCHHHHHHHHHHcccCcccCCCH
Confidence 9964321 111110 0000000 00 01334467899999999999999999
Q ss_pred HHHHHHHHHhhhhhcc
Q 039228 318 PNAVHDLQSVNNILLP 333 (356)
Q Consensus 318 ~~vl~~L~~i~~~~~~ 333 (356)
.+|++.|+++.+....
T Consensus 324 ~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 324 CSIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHHTTC----
T ss_pred HHHHHHHHHHHhhhhh
Confidence 9999999999876643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=306.92 Aligned_cols=227 Identities=21% Similarity=0.328 Sum_probs=166.6
Q ss_pred CCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.|.+.+.||+|+||.||+|.+..+ +..||+|.++... ....+.+.+|+.++++++||||+++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 467788999999999999997533 3568999986432 3445789999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 457889999999999999 9999999999999999999999999998654332
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...... ...........
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~---------- 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR---------- 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCC----------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 222222334567788999999999999999999999999999999 77787643222 11111111100
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
... +..++..+.+++.+||+.||++|||+.+|++.|+++...+...
T Consensus 315 -~~~-------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 -LLQ-------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -CCC-------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -CCC-------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 000 0123446789999999999999999999999999999887543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.11 Aligned_cols=218 Identities=22% Similarity=0.316 Sum_probs=163.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc----cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ----GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467999999999999999999986 78999999864422 234678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--------CCceEEcccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--------DLFAHIGDFELA 182 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~Dfg~a 182 (356)
+.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+|||++
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 568899999999999987555889999999999985 778999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 164 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~--------- 224 (271)
T 3dtc_A 164 REWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VAY--------- 224 (271)
T ss_dssp ------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHH---------
T ss_pred ccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---------
Confidence 7554321 223568999999999998899999999999999999999999997432110 000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
........... ...++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 225 ~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 GVAMNKLALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHTSCCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhhcCCCCCCC------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000000000 012334678999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.16 Aligned_cols=213 Identities=22% Similarity=0.228 Sum_probs=164.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhc-CCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l----------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .......+..|..++..+ +||||+++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999999999999999999753 223446688899999988 69999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 458899999999999999 999999999999999999999999999753222
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ....
T Consensus 178 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~------------~~~i 236 (353)
T 3txo_A 178 ----GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DL------------FEAI 236 (353)
T ss_dssp ------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH------------HHHH
T ss_pred ----CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HH------------HHHH
Confidence 12234467999999999999888999999999999999999999999743211 11 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh------HHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV------PNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~~vl~ 322 (356)
+...... + ......+.+++.+||+.||.+||++ .++++
T Consensus 237 ~~~~~~~-----p-----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 237 LNDEVVY-----P-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHCCCCC-----C-----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HcCCCCC-----C-----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111000 0 0122356789999999999999998 66654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.24 Aligned_cols=232 Identities=11% Similarity=0.104 Sum_probs=177.0
Q ss_pred cCCCCccccceecCceEEEEEEECCC--------CeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN--------RAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
.++|.+.+.||+|+||.||+|++..+ ++.||+|++... +.+.+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 36899999999999999999999873 789999998743 467899999999999999983
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 458899999999999999 9999999999999
Q ss_pred CCCC--ceEEcccccccccccCCCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccc
Q 039228 169 DNDL--FAHIGDFELARFRQEVSNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMF 243 (356)
Q Consensus 169 ~~~~--~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~ 243 (356)
+.++ .+||+|||+++........ .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 9999999999876543221 1122244578999999999999999999999999999999999999997543
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.....+........ .....+.+.... ....+..+.+++.+||+.||.+|||+.+|++.
T Consensus 273 ~~~~~~~~~~~~~~-~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 273 PNTEDIMKQKQKFV-DKPGPFVGPCGH---------------------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TCHHHHHHHHHHHH-HSCCCEECTTSC---------------------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCHHHHHHHHHhcc-CChhhhhhhccc---------------------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 22222221111100 000000000000 00123467899999999999999999999999
Q ss_pred HHHhhhhhc
Q 039228 324 LQSVNNILL 332 (356)
Q Consensus 324 L~~i~~~~~ 332 (356)
|+.+.+...
T Consensus 331 L~~~~~~~~ 339 (352)
T 2jii_A 331 LEALLQDLR 339 (352)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhcC
Confidence 999987763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.33 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=167.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999999999999999998644322 12245579999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---- 154 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT---- 154 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc----
Confidence 457889999999999999 9999999999999999999999999997543221
Q ss_pred cCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC---CCchHHHhhhhh
Q 039228 194 SSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF---PNRVMDIVNLVL 269 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 269 (356)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+........ +...........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchh
Confidence 22234567999999999876 568999999999999999999999997532211 1111111111 001101100000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH--HHHHhhhh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH--DLQSVNNI 330 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~--~L~~i~~~ 330 (356)
..... .+.................+.+|+.+||+.||.+|||+.|+++ .+..+.+.
T Consensus 234 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTYN-----YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHTC-----CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hcccc-----cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00000 0000000000011123346789999999999999999999987 44444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=297.31 Aligned_cols=228 Identities=20% Similarity=0.248 Sum_probs=167.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999999899999999997532 3345678899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 457889999999999999 9999999999999999999999999997654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.........+.......
T Consensus 188 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 253 (310)
T 2wqm_A 188 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------- 253 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT----------
T ss_pred CCC----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc----------
Confidence 322 122345689999999999999999999999999999999999999964321111111111100
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
...... ....+..+.+++.+||+.||.+|||+.+|++.|+.+.+....+
T Consensus 254 -~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 254 -DYPPLP------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -CSCCCC------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -cCCCCc------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 000000 0023346789999999999999999999999999999876544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=310.15 Aligned_cols=167 Identities=23% Similarity=0.300 Sum_probs=138.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 57899999999999999999999999999999999753 23345678999999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 458899999999999999 99999999999999999999999999987643
Q ss_pred CCCCC------------------ccCCCCccccccccchhhh-cCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 188 VSNPT------------------QSSSNGVRRTIGYTALDYD-LGSEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 188 ~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
..... ........||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32110 0123557889999999986 55679999999999999999999666554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.49 Aligned_cols=243 Identities=20% Similarity=0.167 Sum_probs=166.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 578999999999999999999999999999999997532 2344678899999999999999875
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 458889999999999999 999999999999999999999999999765322
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh---
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV--- 265 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 265 (356)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+...... .......+.
T Consensus 181 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~ 253 (371)
T 2xrw_A 181 -----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ-LGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC--CCCCCHHHHTTS
T ss_pred -----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCCCHHHHHHh
Confidence 12234678999999999999999999999999999999999999997532111 11111111 000000000
Q ss_pred ----hhhhcccccccccccc----chhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 ----NLVLLNDNKVLAGTNS----NMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ----~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...+............ ...-.............+.+|+.+||..||.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000000000 000000011122345678999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.49 Aligned_cols=227 Identities=23% Similarity=0.359 Sum_probs=174.6
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+....++|++.+.||+|+||.||+|.+..+ ..||||+++... ...+.+.+|+.+|++++||||+++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEE
Confidence 334556799999999999999999999865 779999997543 335789999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 468899999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ..
T Consensus 334 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i------------~~ 396 (452)
T 1fmk_A 334 E---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV------------ER 396 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH------------HT
T ss_pred c---eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH------------Hc
Confidence 1 112233456788999999998899999999999999999999 99999743211 111111 11
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
..... .+..++..+.+++.+||+.||++|||+.+|++.|+.+.....+
T Consensus 397 ~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 397 GYRMP------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCC------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 00000 0113455688999999999999999999999999988766543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=305.11 Aligned_cols=216 Identities=19% Similarity=0.201 Sum_probs=171.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+|+.++||||+++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4579999999999999999999999999999999986655556678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--CCceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 568899999999999999 999999999999974 5789999999998654321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+.......+. ..
T Consensus 206 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~----------~~ 270 (387)
T 1kob_A 206 ----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE----------FD 270 (387)
T ss_dssp ----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC----------CC
T ss_pred ----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC----------CC
Confidence 122346899999999999999999999999999999999999999742210 001111000000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... .......+.+++.+||+.||.+|||+.++++.
T Consensus 271 ~~~------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDA------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SST------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 00233457899999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.75 Aligned_cols=213 Identities=14% Similarity=0.103 Sum_probs=165.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHH---HHHhhcCCCChHHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAEC---KALKNICHRNLVRFI--------- 135 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~--------- 135 (356)
.++|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+ .++++++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999888999999999743 334457788999 556666899998753
Q ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhhcCCCcEE
Q 039228 136 ----------------------------------------------------------SIAIDVASALDYLHHHCQELIL 157 (356)
Q Consensus 136 ----------------------------------------------------------~i~~~i~~aL~~LH~~~~~~ii 157 (356)
.++.||+.||+|||+++ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 37789999999999999 99
Q ss_pred ecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCC-----------CCCCccchHhHH
Q 039228 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-----------EVSTNGDAYNYG 226 (356)
Q Consensus 158 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwSlG 226 (356)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 999999999999999999999999985322 1223456 899999999887 899999999999
Q ss_pred HHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhh
Q 039228 227 ILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAAC 306 (356)
Q Consensus 227 ~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 306 (356)
|++|||++|+.||........ ...+.. .. . .++..+.+|+.+|
T Consensus 301 ~il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-~----------------------~~~~~~~~li~~~ 343 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGG-------------SEWIFR-SC-K----------------------NIPQPVRALLEGF 343 (377)
T ss_dssp HHHHHHHHSSCCC------CC-------------SGGGGS-SC-C----------------------CCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccc-------------hhhhhh-hc-c----------------------CCCHHHHHHHHHH
Confidence 999999999999964321110 000000 00 0 2233578999999
Q ss_pred cCCCcCCCCChHHHHH--HHHHhhhhh
Q 039228 307 SMGSSQDRMNVPNAVH--DLQSVNNIL 331 (356)
Q Consensus 307 l~~dP~~RPs~~~vl~--~L~~i~~~~ 331 (356)
|+.||++|||+.++++ .+..+.+.+
T Consensus 344 L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 344 LRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp TCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred cCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 9999999999999996 555555443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=291.62 Aligned_cols=224 Identities=23% Similarity=0.361 Sum_probs=177.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
...++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 34567999999999999999999986 45789999987543 345788999999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence 468899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......... .
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~------------~ 227 (279)
T 1qpc_A 164 --YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERG------------Y 227 (279)
T ss_dssp --EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT------------C
T ss_pred --cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcc------------c
Confidence 122234556788999999988889999999999999999999 99998643211 111111100 0
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.... ...++..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 228 ~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 228 RMVR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCC------------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 0000 01233467899999999999999999999999999887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.33 Aligned_cols=227 Identities=22% Similarity=0.277 Sum_probs=178.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCe-----EEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRA-----VVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
...++|.+.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.+ +||||+++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 346789999999999999999999976554 799999975432 3456789999999999 89999986
Q ss_pred --------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC
Q 039228 135 --------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN 170 (356)
Q Consensus 135 --------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 170 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 236789999999999999 999999999999999
Q ss_pred CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccH
Q 039228 171 DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNL 249 (356)
Q Consensus 171 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 249 (356)
++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||....... .+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KF 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HH
T ss_pred CCeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HH
Confidence 99999999999986543322 222344567889999999998899999999999999999999 999997532221 11
Q ss_pred HHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 250 HNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
........ ..... ..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 277 ~~~~~~~~------------~~~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDGY------------QMAQP------------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTC------------CCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCC------------CCCCC------------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111111 10000 0223467899999999999999999999999998876
Q ss_pred hh
Q 039228 330 IL 331 (356)
Q Consensus 330 ~~ 331 (356)
..
T Consensus 327 ~~ 328 (333)
T 2i1m_A 327 ED 328 (333)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.23 Aligned_cols=230 Identities=21% Similarity=0.233 Sum_probs=159.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 578999999999999999999999999999999986532 2345678899999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 458899999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC-------
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN------- 259 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------- 259 (356)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..........
T Consensus 185 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 185 -------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred -------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHH
Confidence 1234678999999999887 67899999999999999999999999753221 1111111111110
Q ss_pred ----chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 260 ----RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 260 ----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....++.. +..... .-.... .......+.+|+.+||..||.+|||+.++++.
T Consensus 257 ~~~~~~~~~~~~-~~~~~~-------~~~~~~----~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQS-LTQMPK-------MNFANV----FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHT-SCCCCC-------CCHHHH----TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhc-cCCCCC-------CCHHHH----CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00011110 000000 000000 01223457899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=298.28 Aligned_cols=232 Identities=20% Similarity=0.284 Sum_probs=175.3
Q ss_pred CCCCccccceecCceEEEEEE----ECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGV----FDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+.|++.+.||+|+||.||+|+ ...+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458999999999999999999 45678999999997443 3345778999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 458889999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC--C--chH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP--N--RVM 262 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~--~~~ 262 (356)
.... .........+|..|+|||.+.+..++.++||||||+++|+|++|..|+... .........+ . ...
T Consensus 178 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 178 TDKE-YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP------MALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCC-EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH------HHHHHHHHCSCCGGGHHH
T ss_pred CCCc-ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch------hhHHhhccCCcccccCHH
Confidence 4322 112334456788899999999888999999999999999999999986421 1111111111 1 111
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVN 328 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~ 328 (356)
.+......... ......++..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 251 ~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKR---------------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCC---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCC---------------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111000 0011134456889999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=291.93 Aligned_cols=232 Identities=21% Similarity=0.306 Sum_probs=181.0
Q ss_pred cCCCCccc-cceecCceEEEEEEEC--CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLIN-LIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 34577776 9999999999999864 457889999997643 3345678999999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 568899999999999999 9999999999999999999999999998664332
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..........
T Consensus 165 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~------------ 229 (287)
T 1u59_A 165 SY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQG------------ 229 (287)
T ss_dssp CE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTT------------
T ss_pred ce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcC------------
Confidence 21 122233456889999999988889999999999999999999 9999974321 1111111110
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccc
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFK 338 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~ 338 (356)
..... +..++..+.+++..||+.||.+||++.+|++.|+.+..+......+.
T Consensus 230 ~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 230 KRMEC------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp CCCCC------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CcCCC------------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 00000 01334467899999999999999999999999999998876655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=304.00 Aligned_cols=169 Identities=18% Similarity=0.244 Sum_probs=144.3
Q ss_pred cCCCCccccceec--CceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVG--SFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+| +||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999999 99999999999999999999997543 2334678889999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 458889999999999999 99999999999999999999999999875432
Q ss_pred CCC---CCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 188 VSN---PTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 188 ~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 211 11122334578999999999987 57999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=296.45 Aligned_cols=209 Identities=23% Similarity=0.230 Sum_probs=168.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 2345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 457889999999999999 99999999999999999999999999986532
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ..++...+.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~--------~~i~~~~~~ 221 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTY--------EKILNAELR 221 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH--------HHHHHCCCC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH--------HHHHhCCCC
Confidence 12346789999999999999999999999999999999999999964211 1111 111111100
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
.. ......+.+++.+||..||.+|| ++.+|++
T Consensus 222 --~p------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 --FP------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CC------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 01223568999999999999999 7888874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.85 Aligned_cols=237 Identities=20% Similarity=0.296 Sum_probs=180.8
Q ss_pred cCCCCccccceecCceEEEEEEE----CCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+ ..+++.||||++........+.+.+|+.+++.++||||+++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45699999999999999999994 55789999999987666666789999999999999999976
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 457889999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC---c-hH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN---R-VM 262 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~-~~ 262 (356)
..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....... . ..
T Consensus 197 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 197 QDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp SSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHHHCTTCCTHHHH
T ss_pred ccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHhhccccchhhhH
Confidence 33211 112233456778999999988889999999999999999999999975321 1111111100 0 00
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
..+...+..... ......++..+.+++.+||+.||++|||+.+|++.|+.+.+++
T Consensus 270 ~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGR--------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCC--------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 000011100000 0001134557889999999999999999999999999998875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.33 Aligned_cols=234 Identities=20% Similarity=0.279 Sum_probs=177.2
Q ss_pred CCccccceecCceEEEEEEE----CCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 74 FPLINLIGVGSFDAVYQGVF----DLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
|++.+.||+|+||.||++.+ ..+++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988865 34689999999975532 335678999999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 568899999999999999 99999999999999999999999999987644321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC------chHHH
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN------RVMDI 264 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~ 264 (356)
.........+|..|+|||++.+..++.++||||||+++|+|++|..||...... .... ..... .+...
T Consensus 190 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~--~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 190 -YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLEL--IGIAQGQMTVLRLTEL 263 (318)
T ss_dssp -EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHH--HCSCCHHHHHHHHHHH
T ss_pred -ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhhh--hcccccchhHHHHHHH
Confidence 112233456788899999999888999999999999999999999998642111 0000 00110 11111
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
+....... ....++..+.+|+.+||+.||.+|||+.+|++.|+.+.+.+...
T Consensus 264 ~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 264 LERGERLP------------------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHTTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HhcccCCC------------------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 11111111 11134457889999999999999999999999999999887554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.64 Aligned_cols=210 Identities=26% Similarity=0.331 Sum_probs=166.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
+.|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 348999999999999999999999999999999975432 233578899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 458889999999999999 99999999999999999999999999975432
Q ss_pred CccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .+........+ .
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~---------~ 272 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------A 272 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------C
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------C
Confidence 12356899999999985 5678999999999999999999999986432110 00111000000 0
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+.. ......+.+++.+||+.||++|||+.+|++.
T Consensus 273 ~~~---------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 LQS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0223357899999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=289.30 Aligned_cols=220 Identities=20% Similarity=0.366 Sum_probs=174.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 457999999999999999999997 458899999975533 34678999999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 458899999999999999 9999999999999999999999999998653211
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........++..|+|||++.+..++.++||||||+++|+|++ |..||...... ......... ...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~------------~~~ 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTG------------FRL 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT------------CCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcC------------CcC
Confidence 122234556788999999998889999999999999999999 89998642211 111111000 000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
... ......+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 225 ~~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKP------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC------------------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000 02233578999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=300.99 Aligned_cols=240 Identities=20% Similarity=0.195 Sum_probs=170.4
Q ss_pred hhHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-----------chHHHHHHHHHHhhcCCCC
Q 039228 62 EYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-----------ASKSFMAECKALKNICHRN 130 (356)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n 130 (356)
....++....++|.+.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456777888999999999999999999999865 799999998543211 1367899999999999999
Q ss_pred hHHH------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 131 LVRF------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 131 iv~l------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
|+++ ..++.||+.||.|||+.+ |+||||||+||++
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9976 458899999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~ 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-N 241 (362)
T ss_dssp CTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred cCCCCEEEEecCcccccccc-----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-H
Confidence 99999999999999754322 12234567899999999877 67899999999999999999999999753211 1
Q ss_pred cHHHHHHHhCCCchHHH-----------hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC
Q 039228 248 NLHNFARMAFPNRVMDI-----------VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN 316 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~-----------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 316 (356)
.+............... +...+.... ...+..........+.+|+.+||+.||.+|||
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-----------ARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC-----------CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC-----------hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 11222221111111111 111110000 00011111123446789999999999999999
Q ss_pred hHHHHH
Q 039228 317 VPNAVH 322 (356)
Q Consensus 317 ~~~vl~ 322 (356)
+.++++
T Consensus 311 ~~ell~ 316 (362)
T 3pg1_A 311 TEQALR 316 (362)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=300.08 Aligned_cols=209 Identities=20% Similarity=0.181 Sum_probs=169.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999999999999999997432 2345678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 458899999999999999 999999999999999999999999999865321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... ..... .+....+.
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~--------~i~~~~~~ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYE--------KIVSGKVR 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHCCCC
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHH--------HHHcCCCC
Confidence 2346789999999999999999999999999999999999999964211 11110 11111000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
.+ ......+.+++.+||+.||.+||+ +.+|++
T Consensus 257 --~p------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --FP------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CC------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC------------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 00 022335789999999999999998 777765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=299.48 Aligned_cols=216 Identities=20% Similarity=0.267 Sum_probs=165.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|..++.++ +||||+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999997542 23345688899999987 89999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 457889999999999999 9999999999999999999999999997532221
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+.....
T Consensus 165 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~i~ 232 (345)
T 3a8x_A 165 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVIL 232 (345)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHH
T ss_pred ----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHHHH
Confidence 223446789999999999999999999999999999999999999964322110000 00000111111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
..... .+......+.+++.+||+.||.+||++
T Consensus 233 ~~~~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EKQIR----------------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HCCCC----------------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cCCCC----------------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 10000 000223357899999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=299.83 Aligned_cols=222 Identities=22% Similarity=0.268 Sum_probs=168.6
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-----CccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-----CQGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
...++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3456799999999999999999999999999999998643 23445788999999999999999976
Q ss_pred --------------------------------------------------------------------HHHHHHHHHHHH
Q 039228 135 --------------------------------------------------------------------ISIAIDVASALD 146 (356)
Q Consensus 135 --------------------------------------------------------------------~~i~~~i~~aL~ 146 (356)
..++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 137889999999
Q ss_pred HHhhcCCCcEEecCCCCCCeEeCCCC--ceEEcccccccccccCCCCCccCCCCccccccccchhhhcC--CCCCCccch
Q 039228 147 YLHHHCQELILHCDPKPSNVLLDNDL--FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDA 222 (356)
Q Consensus 147 ~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi 222 (356)
|||+.+ |+||||||+||+++.++ .+||+|||++..................||+.|+|||++.+ ..++.++||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999999 99999999999998766 89999999998765433322233445678999999999875 678999999
Q ss_pred HhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHH
Q 039228 223 YNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRI 302 (356)
Q Consensus 223 wSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 302 (356)
||||+++|+|++|+.||....... ... .++......... ........+.++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~-~~~------------~~~~~~~~~~~~----------------~~~~~~~~~~~l 310 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDAD-TIS------------QVLNKKLCFENP----------------NYNVLSPLARDL 310 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHH-HHH------------HHHHCCCCTTSG----------------GGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHH-HHH------------HHHhcccccCCc----------------ccccCCHHHHHH
Confidence 999999999999999997432211 111 111111100000 000223457899
Q ss_pred HHhhcCCCcCCCCChHHHHH
Q 039228 303 GAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 303 ~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.+||+.||.+|||+.++++
T Consensus 311 i~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 311 LSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=301.35 Aligned_cols=213 Identities=23% Similarity=0.272 Sum_probs=168.0
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH----------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF---------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l---------- 134 (356)
...++|.+.+.||+|+||.||+|+++.+++.||||+++... ......+..|..++..+ +||||+++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999999999999999997542 23456678899999876 89999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 457889999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ..... .
T Consensus 171 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~------------~ 229 (345)
T 1xjd_A 171 GD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH------------S 229 (345)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH------------H
T ss_pred CC----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHH------------H
Confidence 21 223456789999999999999999999999999999999999999964221 11111 0
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH-HHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP-NAV 321 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~vl 321 (356)
....... .+ ......+.+++.+||..||.+||++. +|+
T Consensus 230 i~~~~~~-----~p-----------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRMDNPF-----YP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHCCCC-----CC-----------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHhCCCC-----CC-----------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0000000 00 01223568999999999999999997 554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=296.79 Aligned_cols=225 Identities=19% Similarity=0.194 Sum_probs=161.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l--------------- 134 (356)
..+|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++.++. ||||+++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999999999999999987666666678899999999996 9999975
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
+.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 458889999999999874 45999999999999999999999999999
Q ss_pred cccccCCCCC--------ccCCCCccccccccchhhh---cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHH
Q 039228 183 RFRQEVSNPT--------QSSSNGVRRTIGYTALDYD---LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251 (356)
Q Consensus 183 ~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 251 (356)
.......... ........||+.|+|||++ .+..++.++||||||+++|+|++|..||...... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~ 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----R 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----H
Confidence 8654322111 0111245689999999998 5667889999999999999999999999642111 0
Q ss_pred HHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 252 FARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
. +......... ......+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 261 ~------------~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 I------------VNGKYSIPPH------------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------CCCCTT------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h------------hcCcccCCcc------------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0100000000 011123678999999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=295.98 Aligned_cols=232 Identities=20% Similarity=0.240 Sum_probs=180.3
Q ss_pred HHHHHhhcCCCCccccceecCceEEEEEEE-----CCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH--
Q 039228 64 YESLLKATDGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF-- 134 (356)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l-- 134 (356)
...+....++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 345555678899999999999999999985 34678999999975433 3345788999999999 68999976
Q ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCC
Q 039228 135 ----------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPK 162 (356)
Q Consensus 135 ----------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlk 162 (356)
+.++.|++.||.|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 236789999999999999 9999999
Q ss_pred CCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCc
Q 039228 163 PSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDF 241 (356)
Q Consensus 163 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~ 241 (356)
|+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEECCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999986543221 122334667889999999999999999999999999999998 9999975
Q ss_pred cccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHH
Q 039228 242 MFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAV 321 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl 321 (356)
..... .+......... .... ......+.+++.+||+.||.+|||+.+|+
T Consensus 254 ~~~~~-~~~~~~~~~~~------------~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 254 VKIDE-EFCRRLKEGTR------------MRAP------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp CCCSH-HHHHHHHHTCC------------CCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cchhH-HHHHHhccCcc------------CCCC------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 33221 11111111100 0000 02233578999999999999999999999
Q ss_pred HHHHHhhhhh
Q 039228 322 HDLQSVNNIL 331 (356)
Q Consensus 322 ~~L~~i~~~~ 331 (356)
+.|+.+.+..
T Consensus 303 ~~L~~~~~~~ 312 (316)
T 2xir_A 303 EHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhh
Confidence 9999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.89 Aligned_cols=215 Identities=20% Similarity=0.242 Sum_probs=155.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999999999999999997542 34567889999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 568899999999999999 999999999999975 889999999999865332
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.........+.......... ..+.
T Consensus 205 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~~~~- 274 (349)
T 2w4o_A 205 ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----ISPW- 274 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----CTTT-
T ss_pred ----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----CCch-
Confidence 122346789999999999999999999999999999999999999964322111111111000000 0000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+|+.+||+.||++|||+.++++
T Consensus 275 ----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 ----------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------------------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0023345789999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.15 Aligned_cols=217 Identities=22% Similarity=0.276 Sum_probs=171.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356999999999999999999999999999999997543 3345678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence 568999999999999999 99999999999999999999999999976543221
Q ss_pred ccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||............+...... . .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~-~ 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------L-N 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----------S-T
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----------c-C
Confidence 122334678999999999987765 678999999999999999999997544332222222111000 0 0
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .......+.+++.+||+.||.+|||+.++++
T Consensus 230 ~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 P-------------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T-------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 0022335678999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.40 Aligned_cols=215 Identities=17% Similarity=0.271 Sum_probs=168.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCC-------eEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR-------AVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++++++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457999999999999999999988765 5799999987666667889999999999999999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc--------eEEc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF--------AHIG 177 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~ 177 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 458899999999999999 999999999999998877 9999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCC-CCCccccCCccHHHHHHH
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRK-PIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~-Pf~~~~~~~~~~~~~~~~ 255 (356)
|||++..... .....+|..|+|||++.+ ..++.++||||||+++|+|++|.. ||... ... ........
T Consensus 164 Dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~-~~~~~~~~ 233 (289)
T 4fvq_A 164 DPGISITVLP--------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQ-RKLQFYED 233 (289)
T ss_dssp CCCSCTTTSC--------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHH-HHHHHHHT
T ss_pred cCcccccccC--------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chH-HHHHHhhc
Confidence 9999864321 123557889999999987 678999999999999999999654 44321 110 00010000
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.. .+.. .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 234 ~~----------~~~~----------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 RH----------QLPA----------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TC----------CCCC----------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred cC----------CCCC----------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00 0000 1112467899999999999999999999999888654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=301.61 Aligned_cols=218 Identities=20% Similarity=0.242 Sum_probs=161.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999999999999999997543 234678899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc--eEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF--AHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 458899999999999999 999999999999987765 999999999743221
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCc-cchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTN-GDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ........ +.....
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~--------~~~~~~ 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQR--------ILSVKY 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHH--------HHTTCC
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHH--------HhcCCC
Confidence 22234578999999999988887666 899999999999999999997543222 11111111 111000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.... .......+.+|+.+||+.||.+|||+.++++.
T Consensus 240 ~~~~------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPD------------------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCT------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCC------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 00122356899999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.00 Aligned_cols=217 Identities=18% Similarity=0.199 Sum_probs=170.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999999999999999997543 2334678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc---eEEccccccccccc
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF---AHIGDFELARFRQE 187 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 458899999999999999 999999999999986655 99999999976543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~---------- 223 (284)
T 3kk8_A 161 SE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGA---------- 223 (284)
T ss_dssp SC-----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC----------
T ss_pred Cc-----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhcc----------
Confidence 21 223466899999999999999999999999999999999999999642211 1111111000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..... .........+.+++.+||+.||++|||+.++++.
T Consensus 224 -~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 -YDYPS----------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CCCCT----------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -ccCCc----------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 0000223457899999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=296.80 Aligned_cols=208 Identities=18% Similarity=0.180 Sum_probs=159.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhc-CCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNI-CHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l-------------- 134 (356)
++|++.+.||+|+||+||+|++..+++.||||++..... ........|+..+..+ +||||+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999864322 2234455666665555 89999976
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 458899999999999999 9999999999999999999999999997654322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ...........+. .+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~--------~~-- 273 (311)
T 3p1a_A 212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPP--------EF-- 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCH--------HH--
T ss_pred ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCc--------cc--
Confidence 2233568999999999876 7899999999999999999997765421 1111110000000 00
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......+.+++.+||+.||++|||+.++++
T Consensus 274 --------------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 --------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0123346789999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=299.03 Aligned_cols=243 Identities=20% Similarity=0.236 Sum_probs=167.0
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-----cchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-----GASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999999999999999864322 123468899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 568899999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+..............+.
T Consensus 164 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 164 SPN----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp SCC----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSS
T ss_pred CCc----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhh
Confidence 322 222345689999999998764 5889999999999999999999998753221 1112222111110000000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..-..+..........-.. .........+.+|+.+||..||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLH----HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHH----HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChH----HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000000000000 0001233568899999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=286.97 Aligned_cols=214 Identities=21% Similarity=0.207 Sum_probs=170.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3569999999999999999999999999999999987666667889999999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 568999999999999999 9999999999999 788999999999997654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||.+.+. ++.++||||||+++|+|++|..||....... ...............
T Consensus 164 ----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-------- 229 (277)
T 3f3z_A 164 ----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFTFPEK-------- 229 (277)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCHH--------
T ss_pred ----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCch--------
Confidence 22345689999999998654 8999999999999999999999997432111 011111100000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||+.||++|||+.++++
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 --------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00023346789999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.09 Aligned_cols=212 Identities=19% Similarity=0.248 Sum_probs=167.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567999999999999999999999999999999986432 2234678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 458899999999999999 999999999999999999999999998644321
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...... +.....
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------~~~~~~ 224 (279)
T 3fdn_A 163 -----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKR--------ISRVEF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--------HHHTCC
T ss_pred -----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHH--------HHhCCC
Confidence 22345689999999999999999999999999999999999999974211 111000 000000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... ......+.+++.+||+.||.+|||+.+|++.
T Consensus 225 --~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFP------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCC------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCC------------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0123356799999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=305.46 Aligned_cols=246 Identities=17% Similarity=0.186 Sum_probs=181.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999999999999999997543 2345678899999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe----CCCCceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----DNDLFAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~a~ 183 (356)
+.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 458899999999999999 9999999999999 788889999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC--------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHH--
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG--------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFA-- 253 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-- 253 (356)
...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 165 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp ECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred EccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 654322 2234568999999999865 4677899999999999999999999975433222211111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
....+......+......... ..... .............+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~----~~~~~--~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPID----WSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEE----EESSC--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcc----cCccC--CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111000000000000000 00000 000111236677889999999999999999999999999998765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.54 Aligned_cols=206 Identities=19% Similarity=0.244 Sum_probs=168.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4579999999999999999999999999999999975431 123457789999999999999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 458899999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 180 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 180 LERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp CCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred CCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 54322 2233568999999999988877 78999999999999999999999642110
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........ ......+.+++.+||+.||++|||+.+|++.
T Consensus 237 -~~~~~~~~--------------------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHPP--------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCCS--------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCCC--------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0122357899999999999999999999884
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.15 Aligned_cols=225 Identities=20% Similarity=0.157 Sum_probs=173.9
Q ss_pred HHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------
Q 039228 64 YESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------ 134 (356)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------ 134 (356)
..++....++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455567789999999999999999999999999999999997421 2233457899999999999999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 457889999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCC----CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSE----VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ....
T Consensus 218 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~------- 282 (410)
T 3v8s_A 218 MNKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY------- 282 (410)
T ss_dssp CCTTS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH-------
T ss_pred eccCC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHH-------
Confidence 54322 12233567999999999998765 78999999999999999999999964211 1111
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCC--CCChHHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQD--RMNVPNAVHD 323 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~vl~~ 323 (356)
..++........+. .......+.+|+.+||..+|.+ ||++.+|++.
T Consensus 283 -~~i~~~~~~~~~p~----------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 -SKIMNHKNSLTFPD----------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHTHHHHCCCCT----------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -HHHHhccccccCCC----------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11111100000000 0012335689999999999988 9999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=292.50 Aligned_cols=215 Identities=15% Similarity=0.170 Sum_probs=169.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34699999999999999999999999999999999754321 35678999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----ceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL----FAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 568899999999999999 99999999999999887 79999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ............ .
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~-~-- 237 (321)
T 2a2a_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSYD-F-- 237 (321)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC-C--
T ss_pred ecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcccc-c--
Confidence 654322 223456899999999999999999999999999999999999999642211 111000000000 0
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
++.. .......+.+++.+||+.||++|||+.++++
T Consensus 238 --~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 --DEEF----------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CHHH----------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --Chhh----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0122345789999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=301.96 Aligned_cols=216 Identities=19% Similarity=0.290 Sum_probs=161.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCC--CChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICH--RNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++..++| |||+++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999885 578999999975432 334678899999999987 899986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 458899999999999999 99999999999997 67899999999986543221
Q ss_pred CCccCCCCccccccccchhhhcC-----------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLG-----------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...
T Consensus 163 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~-------- 229 (343)
T 3dbq_A 163 --SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK-------- 229 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH--------
T ss_pred --cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHH--------
Confidence 112334678999999999864 67889999999999999999999999643221 111
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..++++........ .....+.+|+.+||+.||.+|||+.++++.
T Consensus 230 -~~~~~~~~~~~~~~~------------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -LHAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHhcCCcccCCcc------------------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111122111111110 112357899999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=293.68 Aligned_cols=227 Identities=19% Similarity=0.267 Sum_probs=174.6
Q ss_pred hcCCCCccc-cceecCceEEEEEEE--CCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 70 ATDGFPLIN-LIGVGSFDAVYQGVF--DLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 70 ~~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 345688888 999999999999955 5567899999997543 2235678999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 568899999999999999 999999999999999999999999999865433
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... .
T Consensus 171 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~------------~ 235 (291)
T 1xbb_A 171 ENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLE------------K 235 (291)
T ss_dssp CSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH------------T
T ss_pred CCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH------------c
Confidence 221 112223445788999999988889999999999999999999 99999743211 1111111 1
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
...... +..++..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 236 ~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 236 GERMGC------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TCCCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCC------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 000000 01334467899999999999999999999999999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.30 Aligned_cols=217 Identities=19% Similarity=0.221 Sum_probs=162.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhcCCCChHHH-------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNICHRNLVRF------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l------- 134 (356)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|++++||||+++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35789999999999999999999999999999999975321 122357899999999999999987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC---CceEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND---LFAHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a 182 (356)
..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 568899999999999999 9999999999999754 45999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+..........
T Consensus 290 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~ 363 (419)
T 3i6u_A 290 KILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYN 363 (419)
T ss_dssp TSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCC
T ss_pred eecCCC-----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCC
Confidence 865432 22234678999999999853 567889999999999999999999997533222 222221111100
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ........+.+++.+||+.||.+|||+.++++
T Consensus 364 ~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 364 FIPE---------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCch---------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 00123346789999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=297.16 Aligned_cols=226 Identities=20% Similarity=0.292 Sum_probs=175.1
Q ss_pred cCCCCccccceecCceEEEEEEEC-------CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH-------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD-------LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l------- 134 (356)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++++ +||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999985 3567899999975432 3456788999999999 89999976
Q ss_pred ----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe
Q 039228 135 ----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 135 ----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll 168 (356)
+.++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 236789999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCc
Q 039228 169 DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDL 247 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 247 (356)
+.++.+||+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 9999999999999986543221 122233456788999999988889999999999999999999 99999643211
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.+...... ...... ...++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 267 ~~~~~~~~------------~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ELFKLLKE------------GHRMDK------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHH------------TCCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhc------------CCCCCC------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 000000 012344678999999999999999999999999999
Q ss_pred hhhhcc
Q 039228 328 NNILLP 333 (356)
Q Consensus 328 ~~~~~~ 333 (356)
......
T Consensus 317 ~~~~~~ 322 (334)
T 2pvf_A 317 LTLTTN 322 (334)
T ss_dssp HHHHC-
T ss_pred Hhcccc
Confidence 876644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.51 Aligned_cols=215 Identities=23% Similarity=0.347 Sum_probs=166.9
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.++++++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3467999999999999999999985 789999998743 245778999999999999999976
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 457889999999999999 999999999999999999999999999754322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ .
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~------------~ 230 (278)
T 1byg_A 171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK------------G 230 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTT------------T
T ss_pred ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc------------C
Confidence 122356788999999998899999999999999999998 99999743211 11111100 0
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
..... ...++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 231 ~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 YKMDA------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 00000 012344678999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=297.89 Aligned_cols=239 Identities=23% Similarity=0.260 Sum_probs=162.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45689999999999999999999999999999999975432 224567899999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe-----CCCCceEEcccccccccc
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL-----DNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll-----~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++....
T Consensus 112 ~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 458899999999999999 9999999999999 455669999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh-CCC-chHH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA-FPN-RVMD 263 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~-~~~~ 263 (356)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+....... .+. ....
T Consensus 189 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 189 IPI----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTST
T ss_pred Ccc----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhhh
Confidence 322 222345679999999999874 48999999999999999999999997532211 111111111 111 0000
Q ss_pred Hhh--hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVN--LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
-.. +.+...... ......... ........+.+|+.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPK---FRGKTLKRV---LGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCC---CCCCCHHHH---HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhh---hccccHhhh---cccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000000000 000000000 00013346789999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=306.62 Aligned_cols=231 Identities=19% Similarity=0.204 Sum_probs=178.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|++.+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 5789999999999999999999999999999999875432 2457889999999988654422
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+.+ ||||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 568899999999999999 9999999999999 688999999999998765433
Q ss_pred CCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 190 NPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 190 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... ........||..|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~--------~i~~ 230 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYE--------KISE 230 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHH--------HHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHH--------HHhh
Confidence 211 1223357789999999999999999999999999999999999999976433221 11110 1111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
..+..... .....++..+.+++..||+.||++||++.+|++.|+.+....
T Consensus 231 ~~~~~~~~---------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 231 KKVATSIE---------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHSCHH---------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccccccHH---------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11100000 000123446889999999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.45 Aligned_cols=230 Identities=20% Similarity=0.213 Sum_probs=169.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568999999999999999999999999999999997542 2334678899999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 458899999999999999 999999999999999999999999999754322
Q ss_pred CCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC-c-----
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN-R----- 260 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~-~----- 260 (356)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+........ +. .
T Consensus 198 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 198 -------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTTC
T ss_pred -------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHHHh
Confidence 233567999999999987 678999999999999999999999997532111 1111111111 10 0
Q ss_pred ----hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 261 ----VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 261 ----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....... +..... .............+.+|+.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQS-LPQTPR-----------KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHH-SCCCCC-----------CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhc-cCCCcc-----------hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 000000 00000011234567899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.82 Aligned_cols=241 Identities=19% Similarity=0.191 Sum_probs=173.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC--------CCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC--------HRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l-------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ |+||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999999743 334567889999999986 6678765
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCC-------
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDL------- 172 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~------- 172 (356)
..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 45889999999999998 8 99999999999999775
Q ss_pred ------------------------------------------ceEEcccccccccccCCCCCccCCCCccccccccchhh
Q 039228 173 ------------------------------------------FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210 (356)
Q Consensus 173 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (356)
.+||+|||++...... .....||+.|+|||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCChh
Confidence 7999999999865422 233568999999999
Q ss_pred hcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCcc-----HHHHHHHhCCCchHHHhhhhhccccccccccccchhh
Q 039228 211 DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN-----LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLR 285 (356)
Q Consensus 211 ~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 285 (356)
+.+..++.++|||||||++|||++|+.||......... +.......-......+..................+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754433211 1111111111010001000000000000000000000
Q ss_pred ----------hhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 286 ----------KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 286 ----------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.............+.+|+.+||+.||++|||+.+|++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001122466778899999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=291.27 Aligned_cols=227 Identities=20% Similarity=0.215 Sum_probs=166.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875432 224678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 568899999999999999 9999999999999999999999999997654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .+........+. .. ..
T Consensus 189 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-~~-----~~ 257 (309)
T 2h34_A 189 ---LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-PS-----TV 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-GG-----GT
T ss_pred ---cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-cc-----cc
Confidence 12223456899999999999999999999999999999999999999742211 111111100000 00 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-ChHHHHHHHHHhhhhhc
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-NVPNAVHDLQSVNNILL 332 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~vl~~L~~i~~~~~ 332 (356)
....+..+.+++.+||+.||++|| ++.++++.|+.+.....
T Consensus 258 ----------------------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 ----------------------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ----------------------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ----------------------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 012333578999999999999999 99999999998876653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=299.73 Aligned_cols=209 Identities=18% Similarity=0.175 Sum_probs=161.9
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------------- 134 (356)
.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5689999999999999999999999999987655566789999999999999999987
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe--CCCCceEEcccccccccccCCCCCccCC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL--DNDLFAHIGDFELARFRQEVSNPTQSSS 196 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 196 (356)
+.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-----~~ 245 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KL 245 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----BC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----cc
Confidence 457889999999999999 9999999999999 677899999999998654322 12
Q ss_pred CCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... .+... +........
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i------------~~~~~~~~~--- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNI------------LACRWDLED--- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH------------HHTCCCSCS---
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH------------HhccCCCCh---
Confidence 23568999999999998899999999999999999999999997432110 11111 111000000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.........+.+|+.+||+.||.+|||+.++++
T Consensus 310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000123346789999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=297.57 Aligned_cols=239 Identities=20% Similarity=0.226 Sum_probs=168.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4679999999999999999999999999999999865432 234567899999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 458899999999999999 9999999999999999999999999997654322
Q ss_pred CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCchHHHhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNRVMDIVNLV 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 268 (356)
.......||..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+........ ...........
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence 122335679999999999875 68999999999999999999999997533211 1111111111 11111111110
Q ss_pred -hccccccccccccchhh-hhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 -LLNDNKVLAGTNSNMLR-KTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 -l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... .+.... .............+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVR-----LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCC-----CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccc-----CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000 0000011134557889999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=302.43 Aligned_cols=234 Identities=19% Similarity=0.160 Sum_probs=166.9
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
.+|++.+.||+|+||.||+|++..+++.||||++..... ...+|+.+|+.++||||+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 469999999999999999999999999999999864422 23469999999999999975
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARF 184 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 184 (356)
..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 346789999999999999 9999999999999954 6789999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......-......
T Consensus 207 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHH
T ss_pred cccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 54322 12335789999999998765 7899999999999999999999999753221 12222222222111111
Q ss_pred Hhhhhhccccccccccccchhhhhchh-hHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMN-SRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.. . ...+.. -..+......+.. ........+.+|+.+||..||.+|||+.++++
T Consensus 281 ~~~-~-~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IRE-M-NPNYTE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHH-H-CSCCCC--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHh-h-Chhhhh--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 110 0 000000 0000000000000 00122346789999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=288.26 Aligned_cols=216 Identities=19% Similarity=0.262 Sum_probs=169.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 457999999999999999999986 7899999997543 2344678999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.|++.||.|||+.+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT--
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee--
Confidence 568899999999999864 45999999999999999999999999887532
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCC---ccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVST---NGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
......+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||....... ... ..
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~--------~~ 223 (271)
T 3kmu_A 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGM--------KV 223 (271)
T ss_dssp -------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHH--------HH
T ss_pred -------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHH--------HH
Confidence 122356789999999998766554 7999999999999999999997432111 000 01
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
.......... ..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 224 ~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 ALEGLRPTIP------------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHSCCCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HhcCCCCCCC------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1110000000 1233467899999999999999999999999998865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=316.86 Aligned_cols=227 Identities=23% Similarity=0.359 Sum_probs=179.1
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
+....++|++.+.||+|+||.||+|.+..+ ..||||+++... ...+.+.+|+.+|++++||||+++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence 334556789999999999999999999865 779999997543 335789999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 458899999999999999 999999999999999999999999999865321
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+ ..
T Consensus 417 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i------------~~ 479 (535)
T 2h8h_A 417 E---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV------------ER 479 (535)
T ss_dssp H---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHH------------HT
T ss_pred c---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH------------Hc
Confidence 1 112233456788999999998899999999999999999999 99999743211 111111 11
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
..... ....++..+.+|+.+||+.||++|||+.+|++.|+.+.....+
T Consensus 480 ~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 480 GYRMP------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCC------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 00000 0113445688999999999999999999999999988766543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.40 Aligned_cols=208 Identities=20% Similarity=0.213 Sum_probs=165.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhc-CCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNI-CHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l----------- 134 (356)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+..|..++..+ +||||+++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999997542 23456788999999987 79999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 458899999999999999 999999999999999999999999999753221
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+....
T Consensus 175 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~--------~i~~~~ 237 (353)
T 2i0e_A 175 G----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ--------SIMEHN 237 (353)
T ss_dssp T----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH--------HHHHCC
T ss_pred C----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHH--------HHHhCC
Confidence 1 223456789999999999999999999999999999999999999964211 11111 111110
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
+. .+ ......+.+++.+||..||.+||++
T Consensus 238 ~~--~p------------------~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 VA--YP------------------KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CC--CC------------------TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CC--CC------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 00 0223357899999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.13 Aligned_cols=244 Identities=19% Similarity=0.157 Sum_probs=163.9
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.....++|++.+.||+|+||.||+|.+..+++.||||++.... ........++..+..++||||+++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3455788999999999999999999999999999999986542 333566788888999999999975
Q ss_pred -----------------------------------HHHHHHHHHHHHHHh--hcCCCcEEecCCCCCCeEeCC-CCceEE
Q 039228 135 -----------------------------------ISIAIDVASALDYLH--HHCQELILHCDPKPSNVLLDN-DLFAHI 176 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH--~~~~~~iiH~Dlkp~NIll~~-~~~~kl 176 (356)
..++.+++.||.||| +.+ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 347889999999999 888 999999999999996 899999
Q ss_pred cccccccccccCCCCCccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 177 GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..+......
T Consensus 174 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~ 247 (360)
T 3e3p_A 174 CDFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRV 247 (360)
T ss_dssp CCCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred eeCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHH
Confidence 9999998654322 223456799999999987654 899999999999999999999999753221 122222222
Q ss_pred hCCC--chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 256 AFPN--RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 256 ~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .....+++....... ......-...............+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDL--YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGG--GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccc--cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2111 111111111000000 0000000000001111124557899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.09 Aligned_cols=213 Identities=17% Similarity=0.184 Sum_probs=171.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999987542 2345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 458899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||..|+|||++.+..++.++||||||+++|+|++|+.||..... ..... .+......
T Consensus 196 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~--------~~~~~~~~ 259 (335)
T 2owb_A 196 ---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL--------RIKKNEYS 259 (335)
T ss_dssp ---CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHHTCCC
T ss_pred ---ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH--------HHhcCCCC
Confidence 122345689999999999999999999999999999999999999964221 11100 00000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ......+.+++.+||+.||++|||+.++++.
T Consensus 260 --~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 --IP------------------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CC------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CC------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0122356789999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=310.81 Aligned_cols=213 Identities=20% Similarity=0.256 Sum_probs=160.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999999999999999999753 23334567889999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 -------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 4578899999999998 88 999999999999999999999999999753322
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....
T Consensus 303 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~------------~~~i 361 (446)
T 4ejn_A 303 G----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKL------------FELI 361 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH------------HHHH
T ss_pred C----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHH------------HHHH
Confidence 1 223446789999999999999999999999999999999999999964221 111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
....... +......+.+|+.+||+.||.+|| ++.++++
T Consensus 362 ~~~~~~~----------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 LMEEIRF----------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHCCCCC----------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhCCCCC----------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1000000 002233578999999999999999 9999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=304.82 Aligned_cols=215 Identities=19% Similarity=0.285 Sum_probs=162.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcC--CCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNIC--HRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l------------- 134 (356)
.+|.+.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.+|+.++ ||||+++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 459999999999999999999875 7999999997543 234567899999999997 4999976
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~- 209 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT- 209 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc-
Confidence 457899999999999999 99999999999996 58899999999986643221
Q ss_pred CccCCCCccccccccchhhhcC-----------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLG-----------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~--------- 276 (390)
T 2zmd_A 210 -SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK--------- 276 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHH---------
T ss_pred -cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHH---------
Confidence 112334678999999999875 36889999999999999999999999643211 111
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+..+++.......+. .....+.+|+.+||+.||.+|||+.+|++.
T Consensus 277 ~~~~~~~~~~~~~~~------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCccccCCCCc------------------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111222111111110 112357899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.91 Aligned_cols=237 Identities=22% Similarity=0.215 Sum_probs=170.6
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999999999999999996433 2334578899999999999999975
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 458899999999999999 999999999999999999999999999876432
Q ss_pred CCCC------ccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC-
Q 039228 189 SNPT------QSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN- 259 (356)
Q Consensus 189 ~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~- 259 (356)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+........ +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCch
Confidence 2111 111234578999999998764 678999999999999999999999997532111 1111111100 00
Q ss_pred ----------chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 ----------RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ----------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...+.+... ... ....... ........+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSL-PMY-------PAAPLEK----MFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTS-CCC-------CCCCHHH----HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccchhhHHhhcc-cCC-------CCcchhh----hcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000010000 000 0000000 00133456789999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.57 Aligned_cols=226 Identities=16% Similarity=0.130 Sum_probs=173.3
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-----
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF----- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l----- 134 (356)
.+.++....++|++.+.||+|+||.||+|++..+++.||+|++.... ......+..|+.++..++||||+++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667789999999999999999999999999999999997431 1223448889999999999999986
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 448889999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ....
T Consensus 222 a~~~~~~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~~~~--- 290 (437)
T 4aw2_A 222 CLKLMEDG---TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETY--- 290 (437)
T ss_dssp CEECCTTS---CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH---
T ss_pred hhhcccCC---CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----hHHH---
Confidence 97654322 12233467999999999987 56789999999999999999999999974221 1111
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCC--CCChHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQD--RMNVPNAVH 322 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~vl~ 322 (356)
..++........+. ........+.+|+.+||..+|++ ||+++++++
T Consensus 291 -----~~i~~~~~~~~~p~---------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 -----GKIMNHKERFQFPT---------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -----HHHHTHHHHCCCCS---------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -----HhhhhccccccCCc---------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 01111000000000 00012335688999999988888 999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.51 Aligned_cols=212 Identities=20% Similarity=0.211 Sum_probs=157.9
Q ss_pred cCCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC----ccchHHHHHHHHHHhhcCCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC----QGASKSFMAECKALKNICHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l--------- 134 (356)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.+++.++||||+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 578999999997542 2234567889999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 457889999999999999 9999999999999999999999999997543
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .... ..+..
T Consensus 173 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~--------~~i~~ 235 (327)
T 3a62_A 173 HDG----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTI--------DKILK 235 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH--------HHHHH
T ss_pred cCC----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHH--------HHHHh
Confidence 221 122346789999999999999999999999999999999999999974321 1110 01111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
.... .. ......+.+++.+||+.||.+|| ++.++++
T Consensus 236 ~~~~--~p------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 CKLN--LP------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TCCC--CC------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC--CC------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1000 00 02233578999999999999999 6667765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=291.48 Aligned_cols=235 Identities=19% Similarity=0.207 Sum_probs=166.1
Q ss_pred cCCCCcc-ccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH--------------
Q 039228 71 TDGFPLI-NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l-------------- 134 (356)
.+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568885 7899999999999999989999999999876656677899999999984 79999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc---eEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF---AHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 458899999999999999 999999999999998776 999999999765322
Q ss_pred CCC---CccCCCCccccccccchhhhcC-----CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 189 SNP---TQSSSNGVRRTIGYTALDYDLG-----SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 189 ~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...... ...+..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~ 245 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG--EACPAC 245 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc--ccchhH
Confidence 110 1112234568999999999875 457899999999999999999999997654332111000 000000
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...+........... + . .........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~i~~~~~~~-----~---~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYEF-----P---D----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCCC-----C---H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCccc-----C---c----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 001111111110000 0 0 000123346789999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.73 Aligned_cols=225 Identities=21% Similarity=0.308 Sum_probs=171.7
Q ss_pred CCCccc-cceecCceEEEEEEEC--CCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 73 GFPLIN-LIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 73 ~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++.+.. .||+|+||.||+|.+. .++..||||+++... ....+.+.+|+.+|++++||||+++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E 415 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 415 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence 344444 7999999999999875 346789999997543 3356789999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 568899999999999999 999999999999999999999999999866432211
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.. ...
T Consensus 493 -~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~------------~~~ 557 (613)
T 2ozo_A 493 -YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ------------GKR 557 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHT------------TCC
T ss_pred -eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc------------CCC
Confidence 112223345688999999998999999999999999999998 99999753221 11111111 100
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
... +..++..+.+|+..||+.||++||++.+|++.|+.+...+..
T Consensus 558 ~~~------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 558 MEC------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCC------------------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCC------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 000 113455788999999999999999999999999999877643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.44 Aligned_cols=161 Identities=23% Similarity=0.328 Sum_probs=139.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc------CCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI------CHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l---------- 134 (356)
..+|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+ +|+||+++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 46799999999999999999999999999999999743 23345677888888877 56688875
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc--eEEcccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF--AHIGDFELARF 184 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 184 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 458899999999999999 999999999999999887 99999999975
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 252 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQ-------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTC-------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC-------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 432 223357899999999999999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=291.32 Aligned_cols=215 Identities=20% Similarity=0.236 Sum_probs=154.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cch-HHHHHHHHHHhhcCCCChHHH-------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GAS-KSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ... ..+..+...++.++||||+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 35679999999999999999999999999999999975422 222 234445556888999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 45889999999999998 8 9999999999999999999999999997654
Q ss_pred cCCCCCccCCCCccccccccchhhh----cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYD----LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||.........+........+.
T Consensus 162 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 233 (290)
T 3fme_A 162 DDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--- 233 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC---
T ss_pred ccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC---
Confidence 322 12234689999999996 556788999999999999999999999974322111111111111000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ...+..+.+++.+||+.||++|||+.++++
T Consensus 234 ---------~~~------------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ---------LPA------------------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCT------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------ccc------------------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000 022345789999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.98 Aligned_cols=211 Identities=22% Similarity=0.290 Sum_probs=169.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 568999999999999999999999999999999997432 2234678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 568999999999999999 9999999999999999999999999998654321
Q ss_pred CCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..... .+.+...
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~--------~i~~~~~ 233 (476)
T 2y94_A 171 ----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFK--------KICDGIF 233 (476)
T ss_dssp ----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHH--------HHHTTCC
T ss_pred ----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHH--------HHhcCCc
Confidence 2234578999999999988776 6899999999999999999999974211 11111 1111100
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. .. ......+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~-~p-------------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 Y-TP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C-CC-------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CC-------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 00 012235689999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.43 Aligned_cols=218 Identities=20% Similarity=0.282 Sum_probs=168.1
Q ss_pred ccceecCceEEEEEEE--CCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVF--DLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|+.+|++++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 3799999999999965 4556899999997543 2335789999999999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
+.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++........ .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~ 530 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQT 530 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-ccccc
Confidence 568899999999999999 999999999999999999999999999876433221 12223
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .... .+........
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~------------~i~~~~~~~~--- 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA------------MLEKGERMGC--- 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH------------HHHTTCCCCC---
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHcCCCCCC---
Confidence 3456788999999999999999999999999999998 99999743221 1111 1111111000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
+..++..+.+|+..||+.||++||++.+|++.|+.+...+
T Consensus 594 ---------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 594 ---------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ---------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1134456889999999999999999999999999987655
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=287.79 Aligned_cols=214 Identities=20% Similarity=0.229 Sum_probs=164.2
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+.|.....||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 445566689999999999999999999999999987666666789999999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 347889999999999999 999999999999987 8999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCC--CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSE--VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||................ .
T Consensus 178 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------~ 242 (295)
T 2clq_A 178 ---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF------------K 242 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH------------C
T ss_pred ---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc------------c
Confidence 1223456899999999987643 7889999999999999999999996432111110000000 0
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... ......+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIP------------------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCC------------------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccc------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 123346789999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=286.60 Aligned_cols=212 Identities=21% Similarity=0.288 Sum_probs=171.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 346999999999999999999999889999999997543 356789999999999999853
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 457889999999999999 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+... .....
T Consensus 163 l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~- 229 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT- 229 (284)
T ss_dssp ECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH-
T ss_pred ECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH-
Confidence 99999998654322 223356899999999999999999999999999999999999886421 01100
Q ss_pred hCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 256 AFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 256 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.+....+.. .....+.+++.+||+.||.+|||+.++++.|..+....
T Consensus 230 -------~~~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 -------DLRDGIISD----------------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------HHHTTCCCT----------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------Hhhcccccc----------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111111110 12234678999999999999999999999999887654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=292.71 Aligned_cols=223 Identities=22% Similarity=0.304 Sum_probs=171.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEE--EEEEeecc-CccchHHHHHHHHHHhhc-CCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVV--AIKVLSIQ-CQGASKSFMAECKALKNI-CHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+.+.+|+.+++++ +||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 357999999999999999999998887755 99998743 233456788999999999 89999976
Q ss_pred -----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc
Q 039228 135 -----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF 173 (356)
Q Consensus 135 -----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 173 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 247889999999999999 999999999999999999
Q ss_pred eEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHH
Q 039228 174 AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNF 252 (356)
Q Consensus 174 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~ 252 (356)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 181 ~kL~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AEL 250 (327)
T ss_dssp EEECCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHH
T ss_pred EEEcccCcCcccccc-----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHH
Confidence 999999999743221 11223456788999999988889999999999999999998 9999964321 111
Q ss_pred HHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 253 ARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
... +........ ...+...+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 251 ~~~---------~~~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 251 YEK---------LPQGYRLEK------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHH---------GGGTCCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHH---------hhcCCCCCC------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111 111000000 01233467899999999999999999999999999987764
Q ss_pred c
Q 039228 333 P 333 (356)
Q Consensus 333 ~ 333 (356)
.
T Consensus 304 ~ 304 (327)
T 1fvr_A 304 T 304 (327)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.71 Aligned_cols=214 Identities=26% Similarity=0.275 Sum_probs=160.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHH-HhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKA-LKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|+++.+++.||||++..... .....+..|..+ ++.++||||+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999999999999999975432 233456677776 577899999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 347889999999999999 9999999999999999999999999998543221
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ..++...+
T Consensus 194 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~--------~~i~~~~~ 256 (373)
T 2r5t_A 194 ----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMY--------DNILNKPL 256 (373)
T ss_dssp ----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHH--------HHHHHSCC
T ss_pred ----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHH--------HHHHhccc
Confidence 223457789999999999999999999999999999999999999964211 1111 11111111
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
. .. ......+.+|+.+||+.||.+||++.+.++.+
T Consensus 257 ~--~~------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 Q--LK------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C--CC------------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred C--CC------------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0 00 02233568999999999999999986544443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=295.29 Aligned_cols=229 Identities=21% Similarity=0.216 Sum_probs=168.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999999999999997542 2334678899999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 458899999999999999 999999999999999999999999999754321
Q ss_pred CCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC-c-----
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN-R----- 260 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~-~----- 260 (356)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+ .+........ +. .
T Consensus 180 -------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 180 -------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTTC
T ss_pred -------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHH
Confidence 223567999999999877 678999999999999999999999997432111 1111111110 10 0
Q ss_pred ----hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 ----VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....+.. +.... ..............+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQS-LPQTP-----------RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHT-SCBCS-----------SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHh-CcCCC-----------CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0001100 00000 00000011133456789999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=283.41 Aligned_cols=220 Identities=15% Similarity=0.149 Sum_probs=169.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc------cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ------GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 459999999999999999999999999999999875422 235778999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----ceEEcccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL----FAHIGDFELARF 184 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~~ 184 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 568899999999999999 99999999999998877 899999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ...............
T Consensus 162 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-- 232 (283)
T 3bhy_A 162 IEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNYDFDE-- 232 (283)
T ss_dssp CC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCCCCCH--
T ss_pred ccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhcccCCcc--
Confidence 54322 123356899999999999999999999999999999999999999643211 110000000000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH--HHHHhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH--DLQSVN 328 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~--~L~~i~ 328 (356)
......+..+.+++.+||+.||.+|||+.++++ .++.+.
T Consensus 233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 233 -------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 000122345789999999999999999999997 345444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=286.86 Aligned_cols=215 Identities=21% Similarity=0.263 Sum_probs=172.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.+.|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999999999999999997543 3345788999999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 173 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence 568899999999999999 9999999999999999999999999997654322
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........+ +.+..
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~-- 241 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNP--------PTLEG-- 241 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC--------CCCCS--
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCC--------CCCcc--
Confidence 1223467899999999999999999999999999999999999999643211 11111100000 00000
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
..+..+.+++.+||+.||.+|||+.+|++..
T Consensus 242 --------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 --------------------NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp --------------------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred --------------------ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 2233578999999999999999999998854
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=292.99 Aligned_cols=214 Identities=19% Similarity=0.211 Sum_probs=145.9
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH---------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF--------------------- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l--------------------- 134 (356)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999999743 3466788999999997 9999987
Q ss_pred ----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEcccccccccccCCCCCccC
Q 039228 135 ----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 ----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 165 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN----QP 165 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----Cc
Confidence 458899999999999999 99999999999997665 89999999998654322 22
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+++.....+....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCC
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHHHHHHcCCCCC
Confidence 2345679999999999999999999999999999999999999975332110 001111122111111100
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...........+.+|+.+||+.||.+|||+.++++
T Consensus 236 ------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 ------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00001123456789999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.80 Aligned_cols=212 Identities=23% Similarity=0.299 Sum_probs=149.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999999899999999996432 2234678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 558899999999999999 9999999999999999999999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ +....
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~ 225 (278)
T 3cok_A 167 E----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVV 225 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CC
T ss_pred C----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHh
Confidence 1 12235689999999999988899999999999999999999999974322110 00000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... +......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYEM----------------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCC----------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCC----------------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000 0012335789999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=302.59 Aligned_cols=225 Identities=18% Similarity=0.122 Sum_probs=171.3
Q ss_pred hHHHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-----
Q 039228 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF----- 134 (356)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l----- 134 (356)
.+.+.....++|++.+.||+|+||.||+|+.+.+++.||||++++.. ....+.+.+|..++..++||||+++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999999999999999997432 2233457889999999999999986
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 447889999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhc-------CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-------GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 254 (356)
++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...
T Consensus 209 a~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~- 279 (412)
T 2vd5_A 209 CLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ETY- 279 (412)
T ss_dssp CEECCTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHH-
T ss_pred heeccCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HHH-
Confidence 986543221 1223467899999999987 456899999999999999999999999642211 110
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCC---CChHHHHH
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDR---MNVPNAVH 322 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~~vl~ 322 (356)
..++........+ ......+..+.+|+.+||. +|.+| |+++++++
T Consensus 280 -------~~i~~~~~~~~~p---------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 -------GKIVHYKEHLSLP---------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -------HHHHTHHHHCCCC-------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -------HHHHhcccCcCCC---------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0111100000000 0001233457899999999 99998 58888764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=286.88 Aligned_cols=215 Identities=16% Similarity=0.208 Sum_probs=168.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC----ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC----QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999999999999999997432 2345678999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 458889999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCC--CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSE--VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.... ........||..|+|||++.+.. ++.++||||||+++|+|++|..||.... ....... +
T Consensus 161 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~--------i 225 (305)
T 2wtk_C 161 PFAA--DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFEN--------I 225 (305)
T ss_dssp TTCS--SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHH--------H
T ss_pred cccc--ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHH--------H
Confidence 3221 11223456899999999997644 3779999999999999999999997421 1111110 0
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
... ... ....+...+.+++.+||+.||.+|||+.++++.
T Consensus 226 ~~~----~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 GKG----SYA----------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHC----CCC----------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hcC----CCC----------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 000233457899999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=289.26 Aligned_cols=216 Identities=20% Similarity=0.211 Sum_probs=164.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3569999999999999999999999999999999864321 122457899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc---eEEccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF---AHIGDFELAR 183 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~a~ 183 (356)
..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 458899999999999999 999999999999987654 9999999997
Q ss_pred ccccCCCCCccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+...........
T Consensus 166 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 166 ILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNF 239 (322)
T ss_dssp ECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCCC
T ss_pred eccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcccc
Confidence 653211 112356899999999974 5678899999999999999999999997543222 2222111111000
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ........+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~---------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 240 IPE---------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cch---------------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000 00123346789999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.94 Aligned_cols=224 Identities=24% Similarity=0.337 Sum_probs=168.6
Q ss_pred cCCCCccccceecCceEEEEEE-----ECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGV-----FDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|. ...++..||||.+.... ......+.+|+.++++++||||+++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4679999999999999999999 45567899999996442 3345678899999999999999986
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIG 177 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~ 177 (356)
+.++.|++.||.|||+.+ |+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 457889999999999999 999999999999984 4569999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..........
T Consensus 186 Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSG 261 (327)
T ss_dssp CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTT
T ss_pred ccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcC
Confidence 9999976543221 122234567889999999988899999999999999999998 9999864221 1111111110
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
...... ..++..+.+++.+||+.||.+|||+.+|++.|+.+...-
T Consensus 262 ------------~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 ------------GRMDPP------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ------------CCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ------------CCCCCC------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 000000 123346789999999999999999999999999887643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=283.70 Aligned_cols=210 Identities=22% Similarity=0.265 Sum_probs=169.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999999999999999986432 2234678899999999999999986
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 458899999999999999 999999999999999999999999998754321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .... .+.....
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~--------~~~~~~~- 229 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHR--------RIVNVDL- 229 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--------HHHTTCC-
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHH--------HHhcccc-
Confidence 123456899999999999999999999999999999999999999642211 1100 0111000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ......+.+++.+||+.||.+|||+.++++
T Consensus 230 -~~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -KFP------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCC------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCC------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 000 012335689999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.37 Aligned_cols=212 Identities=21% Similarity=0.215 Sum_probs=162.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
++|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46999999999999999999999999999999997553 3345788999999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccc
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 458889999999999999 9999999999999 456889999999997654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... ......||+.|+|||.+. ..++.++||||||+++|+|++|..||...... ..........+
T Consensus 179 ~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~-------- 242 (285)
T 3is5_A 179 SDE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEP-------- 242 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC--------
T ss_pred Ccc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCc--------
Confidence 321 223456899999999985 56889999999999999999999999743211 11111100000
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... ......+.+++.+||+.||.+|||+.||++
T Consensus 243 -~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 -NYAVEC-------------------RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccccc-------------------CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 012235679999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.60 Aligned_cols=212 Identities=18% Similarity=0.199 Sum_probs=159.7
Q ss_pred cCCCCcc-ccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHh-hcCCCChHHH--------------
Q 039228 71 TDGFPLI-NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALK-NICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l-------------- 134 (356)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++. ..+||||+++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 689999999999999999999999999863 245678888874 4589999985
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a 182 (356)
..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 458899999999999999 999999999999997 789999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc--cHHHHHHH-hCCC
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL--NLHNFARM-AFPN 259 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~~~~~-~~~~ 259 (356)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........ .+.
T Consensus 212 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~- 285 (400)
T 1nxk_A 212 KETTSH-----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE- 285 (400)
T ss_dssp EECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-
T ss_pred cccCCC-----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-
Confidence 865422 122346789999999999999999999999999999999999999975432211 11111111 000
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+... ....+...+.+|+.+||+.||++|||+.+|++.
T Consensus 286 ---------~~~~------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ---------FPNP------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---------CCTT------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCCc------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 000233457899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=287.22 Aligned_cols=213 Identities=17% Similarity=0.184 Sum_probs=170.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457999999999999999999999999999999987542 2345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 458899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ..... .+......
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~--------~~~~~~~~ 233 (294)
T 2rku_A 170 ---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL--------RIKKNEYS 233 (294)
T ss_dssp ---CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH--------HHHTTCCC
T ss_pred ---cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH--------HHhhccCC
Confidence 122345689999999999998999999999999999999999999964321 11110 00000000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ......+.+++.+||+.||++|||+.++++.
T Consensus 234 --~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 --IP------------------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CC------------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --Cc------------------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0122357889999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.71 Aligned_cols=244 Identities=16% Similarity=0.111 Sum_probs=170.7
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ..+|+.+++.++||||+++
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998644322 2369999999999999852
Q ss_pred ----------------------------------------------------------------HHHHHHHHHHHHHHhh
Q 039228 135 ----------------------------------------------------------------ISIAIDVASALDYLHH 150 (356)
Q Consensus 135 ----------------------------------------------------------------~~i~~~i~~aL~~LH~ 150 (356)
..++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3367899999999999
Q ss_pred cCCCcEEecCCCCCCeEeC-CCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHH
Q 039228 151 HCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGIL 228 (356)
Q Consensus 151 ~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~ 228 (356)
.+ |+||||||+||+++ .++.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||||||+
T Consensus 160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 99999999999998 68999999999998654322 22345679999999998775 48999999999999
Q ss_pred HHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhch-hhHHHHHHHHHHHHHhhc
Q 039228 229 LLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKM-NSRLECLIFMVRIGAACS 307 (356)
Q Consensus 229 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl 307 (356)
+|||++|+.||...... ..+..............+.... ..+.. ...+......+. ......+..+.+|+.+||
T Consensus 232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMN--PHYTE--VRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHC--TTC----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhC--ccccc--ccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999753221 1222222222222222211100 00000 000000000000 001123446789999999
Q ss_pred CCCcCCCCChHHHHH--HHHHhhh
Q 039228 308 MGSSQDRMNVPNAVH--DLQSVNN 329 (356)
Q Consensus 308 ~~dP~~RPs~~~vl~--~L~~i~~ 329 (356)
+.||.+|||+.|+++ .++.+..
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999985 3444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=284.76 Aligned_cols=213 Identities=23% Similarity=0.284 Sum_probs=165.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34888899999999999999999999999999987542 3345678899999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEccccccccccc
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 458899999999999874 3499999999999997 789999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
. ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..... .............
T Consensus 185 ~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~------ 247 (290)
T 1t4h_A 185 S------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVK------ 247 (290)
T ss_dssp T------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCC------
T ss_pred c------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHHhccCC------
Confidence 1 2223568999999998874 589999999999999999999999964321 1111111111000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ....+..+.+++.+||+.||.+|||+.+|++
T Consensus 248 --~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 --PASF------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CGGG------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccc------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000 0012235789999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.66 Aligned_cols=238 Identities=21% Similarity=0.230 Sum_probs=166.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999999999999999987666666789999999999999999875
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFE 180 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 347889999999999999 99999999999997 57799999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
+++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..........+.
T Consensus 167 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 243 (320)
T 2i6l_A 167 LARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESIPV 243 (320)
T ss_dssp TCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHSCC
T ss_pred cccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence 99865432211 122334567889999998865 67899999999999999999999999753221 111111111111
Q ss_pred chH----HHhhh---hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVM----DIVNL---VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~----~~~~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ++... .+...... ...-. ..........+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTE----PHKPL----TQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTS----CCCCH----HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhcCcccccccccC----CCCCh----hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00000 00000000 00000 0000123456889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.08 Aligned_cols=162 Identities=25% Similarity=0.364 Sum_probs=141.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457999999999999999999999999999999997553 3345678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+. + |+||||||+||+++.++.++|+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 45889999999999995 8 999999999999999999999999999755322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDF 241 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~ 241 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22335789999999999999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=289.30 Aligned_cols=214 Identities=21% Similarity=0.253 Sum_probs=166.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 3469999999999999999999999999999999986554455678899999999999999986
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccCCC
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 458889999999999999 9999999999999 78899999999998754321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .+.......... +.
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~---------~~ 227 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYE---------FE 227 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCC---------CC
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC---------CC
Confidence 122356899999999999999999999999999999999999999643211 111111110000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SP------------------FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00123346789999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=310.16 Aligned_cols=216 Identities=20% Similarity=0.249 Sum_probs=170.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999999999999999997432 2334668899999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 457889999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ..+..
T Consensus 339 ~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~---------~~i~~ 403 (576)
T 2acx_A 339 GQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE---------RLVKE 403 (576)
T ss_dssp TC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHH---------HHHHH
T ss_pred Cc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHH---------HHhhc
Confidence 22 1223578999999999999899999999999999999999999997543221 111111 00100
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
. ..... ......+.+|+.+||+.||.+|| ++.+|++
T Consensus 404 ~-~~~~p------------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 V-PEEYS------------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C-CCCCC------------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c-cccCC------------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 00000 02233578999999999999999 6777765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.74 Aligned_cols=225 Identities=23% Similarity=0.292 Sum_probs=163.8
Q ss_pred cCCCCccccceecCceEEEEEEECC-CC--eEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-NR--AVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. .....+.+.+|+.++++++||||+++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 4579999999999999999998643 22 36999998744 23345678999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 458889999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
.... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||..... ....... ..
T Consensus 174 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~--------~~ 239 (291)
T 1u46_A 174 NDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKI--------DK 239 (291)
T ss_dssp -CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH--------HT
T ss_pred cccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHH--------Hc
Confidence 3221 122233556788999999988889999999999999999999 9999964321 1111100 00
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
...... ....++..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 240 ~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 240 EGERLP------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SCCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCCCC------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 000000 0013344678999999999999999999999999887653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.86 Aligned_cols=211 Identities=24% Similarity=0.286 Sum_probs=167.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+..|+.+++.++||||+++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999997432 2334678899999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 347889999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ +..
T Consensus 341 ~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~--------i~~ 407 (543)
T 3c4z_A 341 AGQ----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR--------VLE 407 (543)
T ss_dssp TTC----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHH--------HHH
T ss_pred CCC----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHH--------Hhh
Confidence 322 12234578999999999999999999999999999999999999997543211 11111111 111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
... ..+ ......+.+++.+||+.||.+||++
T Consensus 408 ~~~--~~p------------------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 408 QAV--TYP------------------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCC--CCC------------------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ccc--CCC------------------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 100 000 0223356899999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.31 Aligned_cols=232 Identities=19% Similarity=0.159 Sum_probs=165.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
..+|++.+.||+|+||.||+|++..++. ||+|++...... ..+|+.+++.++||||+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3469999999999999999999987755 888887543221 2369999999999999975
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELAR 183 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 183 (356)
..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 347889999999999999 99999999999999 79999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.............
T Consensus 191 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 191 ILIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSRE 264 (394)
T ss_dssp ECCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred cccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 654322 12245679999999998765 5899999999999999999999999753221 1222222222211111
Q ss_pred HH--hhhhhc-cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DI--VNLVLL-NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~--~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+ .++... ..... ....-..... .......+.+|+.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQ---IRPHPFSKVF---RPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCC---CCCCCHHHHS---CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhcccc---ccCCcHHHhc---cccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 11 111110 00000 0000000000 0023346789999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=299.51 Aligned_cols=218 Identities=11% Similarity=0.072 Sum_probs=155.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhc--CCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNI--CHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l----------- 134 (356)
..+|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+ +||||+++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999986542 2345667785444444 69997751
Q ss_pred -------------------------------------------------H-------HHHHHHHHHHHHHhhcCCCcEEe
Q 039228 135 -------------------------------------------------I-------SIAIDVASALDYLHHHCQELILH 158 (356)
Q Consensus 135 -------------------------------------------------~-------~i~~~i~~aL~~LH~~~~~~iiH 158 (356)
. .++.||+.||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 1 34589999999999999 999
Q ss_pred cCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCC
Q 039228 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRR 236 (356)
Q Consensus 159 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~ 236 (356)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998653211 13456799999999987 67999999999999999999999
Q ss_pred CCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC
Q 039228 237 KPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN 316 (356)
Q Consensus 237 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 316 (356)
.||.......... +.... .......... ......++..+.+|+.+||+.||++|||
T Consensus 291 ~Pf~~~~~~~~~~-------~~~~~---~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 291 LPFGLVTPGIKGS-------WKRPS---LRVPGTDSLA--------------FGSCTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp CSTTBCCTTCTTC-------CCBCC---TTSCCCCSCC--------------CTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred CCCCCcCcccccc-------hhhhh---hhhccccccc--------------hhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence 9997643221100 00000 0000000000 0000123346789999999999999999
Q ss_pred hHHHHH
Q 039228 317 VPNAVH 322 (356)
Q Consensus 317 ~~~vl~ 322 (356)
+.++++
T Consensus 347 ~~e~l~ 352 (371)
T 3q60_A 347 PLEAME 352 (371)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=291.25 Aligned_cols=217 Identities=17% Similarity=0.233 Sum_probs=168.5
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhc-CCCChHHH----
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNI-CHRNLVRF---- 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l---- 134 (356)
....++|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3445679999999999999999999998899999999875431 1135678899999999 79999986
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
..++.||+.||.|||+.| |+|+||||+||+++.++.++|+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence 458899999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcC------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 255 (356)
+..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .........
T Consensus 247 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~ 319 (365)
T 2y7j_A 247 SCHLEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMIME 319 (365)
T ss_dssp CEECCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred ccccCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh
Confidence 98664322 2234678999999999863 3588999999999999999999999964211 111111111
Q ss_pred h-CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 256 A-FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 256 ~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. +.... +.+ ......+.+++.+||+.||++|||+.++++
T Consensus 320 ~~~~~~~-----~~~-----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQFSS-----PEW-----------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCCCCH-----HHH-----------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCC-----ccc-----------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00000 000 022335789999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.58 Aligned_cols=214 Identities=21% Similarity=0.262 Sum_probs=166.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++++++||||+++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 4699999999999999999999999999999999643 23345778999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 458899999999999999 99999999999995 46679999999997654321
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+.......+.....
T Consensus 179 -----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~------- 244 (486)
T 3mwu_A 179 -----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFDLP------- 244 (486)
T ss_dssp --------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSCSG-------
T ss_pred -----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCc-------
Confidence 2234578999999999876 58999999999999999999999996432110 011111111100000
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........+.+++.+||+.||.+|||+.++++.
T Consensus 245 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 ---------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001223457899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.52 Aligned_cols=218 Identities=20% Similarity=0.255 Sum_probs=168.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999999999999999997543 2345678899999999999999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcC--CCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHC--QELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 458889999999999976 2349999999999999999999999999997
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ..+.......
T Consensus 165 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~------- 231 (279)
T 2w5a_A 165 ILNHDT----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREG------- 231 (279)
T ss_dssp HC---C----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT-------
T ss_pred eecccc----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhc-------
Confidence 653321 111235678999999999999999999999999999999999999974321 1111111100
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L 324 (356)
... .. +...+..+.+++.+||+.||.+|||+.+|++.+
T Consensus 232 ----~~~-~~------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 ----KFR-RI------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ----CCC-CC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ----ccc-cC------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 000 00 002334678999999999999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=306.13 Aligned_cols=212 Identities=21% Similarity=0.256 Sum_probs=168.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++++++||||+++
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999996542 3345779999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe---CCCCceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL---DNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 458999999999999999 9999999999999 56789999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH-hCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM-AFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 267 (356)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... .....+.. .+.....
T Consensus 183 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~----- 249 (484)
T 3nyv_A 183 K-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTFELP----- 249 (484)
T ss_dssp C-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCCSG-----
T ss_pred c-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCCCCc-----
Confidence 2 1223568999999999876 6899999999999999999999999743211 11111111 0000000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.....+..+.+++.+||+.||.+|||+.++++
T Consensus 250 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 -----------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00123345789999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=288.55 Aligned_cols=215 Identities=19% Similarity=0.255 Sum_probs=165.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 4679999999999999999999999999999999986666667889999999999999999986
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---- 170 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH----
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc----
Confidence 458889999999999999 999999999999999999999999997643211
Q ss_pred ccCCCCccccccccchhhh-----cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 193 QSSSNGVRRTIGYTALDYD-----LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
........||..|+|||++ .+..++.++||||||+++|+|++|..||....... ..........+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-------- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPT-------- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC--------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcc--------
Confidence 1112335689999999998 36678999999999999999999999997432110 000000000000
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+. .....+..+.+++.+||+.||++|||+.++++
T Consensus 242 -~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -LL--------------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CS--------------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cC--------------------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00123345789999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.75 Aligned_cols=204 Identities=13% Similarity=0.061 Sum_probs=158.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCC-CChH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICH-RNLV-------------- 132 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv-------------- 132 (356)
...|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+.| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458888999999999999999999999999999873322 235778899999999987 2211
Q ss_pred -------------------------------------------------------HHHHHHHHHHHHHHHHhhcCCCcEE
Q 039228 133 -------------------------------------------------------RFISIAIDVASALDYLHHHCQELIL 157 (356)
Q Consensus 133 -------------------------------------------------------~l~~i~~~i~~aL~~LH~~~~~~ii 157 (356)
..+.++.||+.||.|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11346689999999999999 99
Q ss_pred ecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhh----------cCCCCCCccchHhHHH
Q 039228 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD----------LGSEVSTNGDAYNYGI 227 (356)
Q Consensus 158 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDiwSlG~ 227 (356)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999998765432 233556 899999999 5566888999999999
Q ss_pred HHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhc
Q 039228 228 LLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACS 307 (356)
Q Consensus 228 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 307 (356)
++|||++|+.||....... .....+.... ..+..+.+|+.+||
T Consensus 306 il~elltg~~Pf~~~~~~~-----------------~~~~~~~~~~--------------------~~~~~~~~li~~~l 348 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALG-----------------GSEWIFRSCK--------------------NIPQPVRALLEGFL 348 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGS-----------------CSGGGGSSCC--------------------CCCHHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCCcchhh-----------------hHHHHHhhcc--------------------cCCHHHHHHHHHHc
Confidence 9999999999997432211 0111111000 12245789999999
Q ss_pred CCCcCCCCChHHHHH
Q 039228 308 MGSSQDRMNVPNAVH 322 (356)
Q Consensus 308 ~~dP~~RPs~~~vl~ 322 (356)
+.||++||++.++++
T Consensus 349 ~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 349 RYPKEDRLLPLQAME 363 (413)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhhCcCHHHHHh
Confidence 999999999887754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=290.88 Aligned_cols=220 Identities=19% Similarity=0.198 Sum_probs=167.9
Q ss_pred HHHhhcCCCCcc-ccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcC-CCChHHH-------
Q 039228 66 SLLKATDGFPLI-NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNIC-HRNLVRF------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l------- 134 (356)
......+.|.+. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++..+. ||||+++
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 333445568877 88999999999999999999999999997542 334567899999999995 6999986
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDF 179 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Df 179 (356)
..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 568999999999999999 999999999999997 789999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ...........
T Consensus 179 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~- 251 (327)
T 3lm5_A 179 GMSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNISQVNVD- 251 (327)
T ss_dssp GGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-
T ss_pred ccccccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhcccc-
Confidence 9998654322 2233578999999999999999999999999999999999999996432111 00000000000
Q ss_pred chHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... .....+...+.+++.+||+.||++|||+.++++
T Consensus 252 ---------~~~------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 ---------YSE------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---------CCT------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---------cCc------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 000123345789999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=285.03 Aligned_cols=214 Identities=19% Similarity=0.269 Sum_probs=165.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+.+|+.+++.++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999999999999999997543 34678999999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 458899999999999999 9999999999999999999999999997654321
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........+.. +.
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~~- 246 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNPPPT--------FR- 246 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC--------CS-
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCCcc--------cC-
Confidence 1223456899999999999999999999999999999999999999643211 0000000000000 00
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........+.+++.+||+.||.+|||+.++++
T Consensus 247 -------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00122345789999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.98 Aligned_cols=164 Identities=24% Similarity=0.339 Sum_probs=125.5
Q ss_pred CCCc-cccceecCceEEEEEEEC--CCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPL-INLIGVGSFDAVYQGVFD--LNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.|.+ .++||+|+||.||+|++. .+++.||||++... .....+.+|+.+|+.++||||+++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3665 457999999999999976 46789999998743 234578899999999999999976
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe----CCCCceEEcc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----DNDLFAHIGD 178 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~D 178 (356)
..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 347789999999999999 9999999999999 6789999999
Q ss_pred cccccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 179 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
||+++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 176 fg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999866432211 1223446789999999999874 5899999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=292.73 Aligned_cols=216 Identities=18% Similarity=0.213 Sum_probs=164.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.++.+++.||||++...... ..+|+.++.++ +||||+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45699999999999999999999999999999999755332 34688888887 79999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC----CceEEcccccccccccC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND----LFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~~~~ 188 (356)
..++.+|+.||.|||+.+ |+||||||+|||+.+. +.+||+|||+++.....
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 458899999999999999 9999999999998432 35999999999865433
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... +...
T Consensus 174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~------------~~~i 235 (342)
T 2qr7_A 174 NG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEI------------LARI 235 (342)
T ss_dssp TC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHH------------HHHH
T ss_pred CC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHH------------HHHH
Confidence 21 223457899999999998888899999999999999999999999743221 11111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+..... ...+ ......+.+|+.+||..||++|||+.++++.
T Consensus 236 ~~~~~~~~--------~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 236 GSGKFSLS--------GGYW----NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHCCCCCC--------STTT----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCCcccC--------cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11110000 0000 0233457899999999999999999998863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=280.85 Aligned_cols=213 Identities=22% Similarity=0.261 Sum_probs=161.7
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999999899999999996432 2334678899999999999999986
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 458899999999999999 9999999999999999999999999997654321
Q ss_pred CCCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ..... .+...
T Consensus 166 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~---------~~~~~ 226 (276)
T 2h6d_A 166 -----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFK---------KIRGG 226 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---------HHHHC
T ss_pred -----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHH---------HhhcC
Confidence 1223567899999999987765 5899999999999999999999964211 11110 00000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..... ......+.+++.+||+.||.+|||+.+|++.
T Consensus 227 ~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VFYIP-------------------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCC-------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cccCc-------------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 0123357899999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.37 Aligned_cols=228 Identities=20% Similarity=0.268 Sum_probs=150.4
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999998889999999986443 2344678899999999999999986
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 347789999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC-CccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC
Q 039228 182 ARFRQEVSNP-TQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN 259 (356)
Q Consensus 182 a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (356)
+......... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .........+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCC
Confidence 9765432211 1122334678999999999865 568999999999999999999999997532221 11111111111
Q ss_pred chH-HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 260 RVM-DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 260 ~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ...+..+.. .....+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~----------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLK----------------------KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCC----------------------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhh----------------------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 100 001111100 22335789999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=301.68 Aligned_cols=214 Identities=19% Similarity=0.213 Sum_probs=165.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-------------cchHHHHHHHHHHhhcCCCChHHH---
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-------------GASKSFMAECKALKNICHRNLVRF--- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l--- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5679999999999999999999999999999999975421 234678899999999999999987
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC---ceEEc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---FAHIG 177 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 177 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 458899999999999999 99999999999998766 69999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHH-h
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM-A 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~-~ 256 (356)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+...... .
T Consensus 192 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~ 263 (504)
T 3q5i_A 192 DFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKGK 263 (504)
T ss_dssp CCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC
T ss_pred ECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC
Confidence 999998654322 223456899999999986 46899999999999999999999999743211 11111111 0
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
+...... ....+..+.+|+.+||..||.+|||+.++++.
T Consensus 264 ~~~~~~~----------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 264 YYFDFND----------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCHHH----------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccc----------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000 01223457899999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=290.93 Aligned_cols=241 Identities=19% Similarity=0.219 Sum_probs=168.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-----------CCChHHH-----
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-----------HRNLVRF----- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l----- 134 (356)
.++|.+.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++ ||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999999999999999998743 233467888999998886 7888865
Q ss_pred -------------------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeC------C
Q 039228 135 -------------------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLD------N 170 (356)
Q Consensus 135 -------------------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~------~ 170 (356)
..++.||+.||.|||++ + |+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 45889999999999998 8 99999999999994 4
Q ss_pred CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC----
Q 039228 171 DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD---- 246 (356)
Q Consensus 171 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~---- 246 (356)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp EEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 458999999999865432 223567999999999999999999999999999999999999997543211
Q ss_pred -ccHHHHHHHhC--CCchHH-------Hhhhh-hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC
Q 039228 247 -LNLHNFARMAF--PNRVMD-------IVNLV-LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM 315 (356)
Q Consensus 247 -~~~~~~~~~~~--~~~~~~-------~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 315 (356)
..+.......- +..... +.+.. ................-.........+...+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111111 100000 00000 00000000000000000011112246677899999999999999999
Q ss_pred ChHHHHH
Q 039228 316 NVPNAVH 322 (356)
Q Consensus 316 s~~~vl~ 322 (356)
|+.+|++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=301.71 Aligned_cols=214 Identities=20% Similarity=0.254 Sum_probs=163.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+.|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.+++.++||||+++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45999999999999999999999999999999997543 2335678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 458899999999999999 999999999999976 4559999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+....... ..
T Consensus 194 -----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~-----------~~ 254 (494)
T 3lij_A 194 -----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKG-----------KY 254 (494)
T ss_dssp -----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT-----------CC
T ss_pred -----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CC
Confidence 223467899999999986 56999999999999999999999999743211 111111110 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.... ..+ ...+..+.+++.+||+.||.+|||+.++++.
T Consensus 255 ~~~~------------~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 TFDS------------PEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCCS------------GGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCc------------hhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000 000 0223457899999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=294.56 Aligned_cols=218 Identities=15% Similarity=0.099 Sum_probs=169.9
Q ss_pred hhcCCCCccccceecCceEEEEEE-----ECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC---CCChHHH------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGV-----FDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC---HRNLVRF------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l------ 134 (356)
...++|.+.+.||+|+||.||+|. ...+++.||||++... ....+..|+.++..++ |+||+++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345779999999999999999994 5667899999998743 3456778888888887 8998876
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--------
Q 039228 135 ------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-------- 170 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------- 170 (356)
+.++.||+.||.|||+.+ ||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 458899999999999999 999999999999998
Q ss_pred ---CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCc
Q 039228 171 ---DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247 (356)
Q Consensus 171 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 247 (356)
++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.....+..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 89999999999976543222 2233446789999999999999999999999999999999999999864322110
Q ss_pred cHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCC-CChHHHHHHHHH
Q 039228 248 NLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDR-MNVPNAVHDLQS 326 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~~vl~~L~~ 326 (356)
. +...+... .....+.+++..|++.+|.+| |++.++.+.|+.
T Consensus 294 ~----------------~~~~~~~~---------------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 K----------------PEGLFRRL---------------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp E----------------ECSCCTTC---------------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred e----------------echhcccc---------------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 00000000 012245689999999999999 578999999998
Q ss_pred hhhhh
Q 039228 327 VNNIL 331 (356)
Q Consensus 327 i~~~~ 331 (356)
+.+..
T Consensus 337 ~l~~~ 341 (365)
T 3e7e_A 337 VFQQH 341 (365)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 87664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=289.36 Aligned_cols=218 Identities=21% Similarity=0.264 Sum_probs=164.0
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH----------
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF---------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l---------- 134 (356)
.+....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++++ +||||+++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34456788999999999999999999999899999999997543 3346788999999999 79999875
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 457889999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 039228 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 180 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 254 (356)
|++....... .......|++.|+|||++. +..++.++||||||+++|+|++|..||...... .......
T Consensus 174 g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~ 247 (326)
T 2x7f_A 174 GVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFLIP 247 (326)
T ss_dssp TTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred cCceecCcCc----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhh
Confidence 9997654321 1223456899999999987 566889999999999999999999999643211 0000000
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... +.+.. ...+..+.+++.+||..||.+|||+.++++
T Consensus 248 ~~~~--------~~~~~---------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPA--------PRLKS---------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCC--------CCCSC---------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcc--------ccCCc---------------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 00000 022336789999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=285.55 Aligned_cols=240 Identities=15% Similarity=0.161 Sum_probs=168.5
Q ss_pred cCCCCccccceecCceEEEEEEE-CCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCC------hHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF-DLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRN------LVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l--------- 134 (356)
.++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.++|++ ++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 557899999998743 234567888999999887665 5543
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---------------
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--------------- 170 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------------- 170 (356)
..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 468899999999999999 999999999999987
Q ss_pred ----CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC
Q 039228 171 ----DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246 (356)
Q Consensus 171 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 246 (356)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE-------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS-------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccCCCceEeeCcccccCcc-------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 66899999999975432 123456899999999999999999999999999999999999999753221
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhcccc-ccccccccch------hh------hhchhhHHHHHHHHHHHHHhhcCCCcCC
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDN-KVLAGTNSNM------LR------KTKMNSRLECLIFMVRIGAACSMGSSQD 313 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~------~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 313 (356)
................+......... .......... .. .........+...+.+|+.+||+.||.+
T Consensus 241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11111111111100111100000000 0000000000 00 0000011245677899999999999999
Q ss_pred CCChHHHHHH
Q 039228 314 RMNVPNAVHD 323 (356)
Q Consensus 314 RPs~~~vl~~ 323 (356)
|||+.+|++.
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=279.94 Aligned_cols=206 Identities=17% Similarity=0.200 Sum_probs=162.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+..+ +||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456999999999999999999999999999999997542 33456788999999999 89999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC----------------
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---------------- 170 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---------------- 170 (356)
..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 458899999999999999 999999999999984
Q ss_pred ---CCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCC
Q 039228 171 ---DLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246 (356)
Q Consensus 171 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 246 (356)
...+||+|||.+...... ....||..|+|||.+.+. .++.++||||||+++|+|++|.+|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---- 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred cCCceEEEEcccccccccCCc--------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence 447999999999765432 124589999999999776 5668999999999999999999876421
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...........+ ... ......+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~-------------~~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQWHEIRQGRLP-------------RIP------------------QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHHTTCCC-------------CCS------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHHHcCCCC-------------CCC------------------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111111111000 000 022335789999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=312.32 Aligned_cols=208 Identities=20% Similarity=0.209 Sum_probs=166.1
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhc-CCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNI-CHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l----------- 134 (356)
..++|++++.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||||+++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999743 233456788899999987 68999876
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 458899999999999999 999999999999999999999999999854322
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ... +...
T Consensus 496 ~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~------------~~~i 554 (674)
T 3pfq_A 496 G----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DEL------------FQSI 554 (674)
T ss_dssp T----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH------------HHHH
T ss_pred C----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHH------------HHHH
Confidence 1 223457899999999999999999999999999999999999999974221 111 1111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
+...... +......+.+|+.+||+.||++||++
T Consensus 555 ~~~~~~~----------------p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 555 MEHNVAY----------------PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HSSCCCC----------------CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HhCCCCC----------------CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1111000 00223357899999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=279.12 Aligned_cols=216 Identities=16% Similarity=0.199 Sum_probs=168.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---------cchHHHHHHHHHHhhcC-CCChHHH-----
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---------GASKSFMAECKALKNIC-HRNLVRF----- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l----- 134 (356)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++++. ||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999999999999999975431 22356789999999996 9999987
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELA 182 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a 182 (356)
..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 568899999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhc------CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDL------GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||..... .......
T Consensus 172 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~--- 241 (298)
T 1phk_A 172 CQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMI--- 241 (298)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---
T ss_pred hhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHH---
Confidence 7654322 223456899999999885 45688999999999999999999999964221 1111110
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
......... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 242 --------~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 --------MSGNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --------HHTCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------hcCCcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000000000 000123346789999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.37 Aligned_cols=219 Identities=22% Similarity=0.252 Sum_probs=165.6
Q ss_pred cCCCCccccceecCceEEEEEEEC---CCCeEEEEEEeeccC----ccchHHHHHHHHHHhhc-CCCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFD---LNRAVVAIKVLSIQC----QGASKSFMAECKALKNI-CHRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l-------- 134 (356)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+.+++.+ +||||+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 467999999999999999999984 478999999986432 22345677899999999 69999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 457889999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCccCCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .......
T Consensus 210 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~--------- 276 (355)
T 1vzo_A 210 VADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISR--------- 276 (355)
T ss_dssp CGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHH---------
T ss_pred ccCC---CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHH---------
Confidence 3322 122334678999999999986 347889999999999999999999997433221 1111111
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVHDL 324 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~~L 324 (356)
..+..... ........+.+|+.+||..||.+|| ++.++++..
T Consensus 277 ---~~~~~~~~----------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 ---RILKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---HHHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---HHhccCCC----------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11100000 0012233578999999999999999 888887643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=284.02 Aligned_cols=239 Identities=23% Similarity=0.260 Sum_probs=168.5
Q ss_pred hcCCCCccccceecCceEEEEEEEC-CCCeEEEEEEeeccCc--cchHHHHHHHHHHhhc---CCCChHHH---------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD-LNRAVVAIKVLSIQCQ--GASKSFMAECKALKNI---CHRNLVRF--------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l--------- 134 (356)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999864322 2234566788777766 89999975
Q ss_pred ----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 135 ----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 135 ----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence 458889999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
++...... .......||..|+|||++.+..++.++||||||+++|+|++|+.||....... .+...........
T Consensus 166 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~ 239 (326)
T 1blx_A 166 LARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG 239 (326)
T ss_dssp SCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred ccccccCC-----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence 99765322 12234667999999999999999999999999999999999999997532211 1111111111000
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...+........... ........... .......+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAF-HSKSAQPIEKF----VTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGS-CCCCCCCGGGT----CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhh-cccCcchhhhc----cccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000000 00000000000 0123446789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=289.89 Aligned_cols=217 Identities=19% Similarity=0.217 Sum_probs=146.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHH-HHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECK-ALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+. +++.++||||+++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4789999999999999999999999999999999975432 23345666666 7778899999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 35788999999999998 8 9999999999999999999999999997654
Q ss_pred cCCCCCccCCCCccccccccchhhh----cCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYD----LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||....... ...........
T Consensus 178 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~- 247 (327)
T 3aln_A 178 DSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGDP- 247 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCC-
T ss_pred ccc-----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCCC-
Confidence 321 12234689999999998 45678999999999999999999999997432110 00000000000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+.+.... ...+...+.+++.+||+.||++|||+.+|++
T Consensus 248 ----~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ----PQLSNSE------------------EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCS------------------SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCcc------------------cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000 0023346789999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=285.93 Aligned_cols=163 Identities=26% Similarity=0.305 Sum_probs=137.2
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCC-----hHHH--------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRN-----LVRF-------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n-----iv~l-------- 134 (356)
...++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++ |+| |+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3467899999999999999999999999999999999743 233466778898888885 554 4432
Q ss_pred ------------------------------HHHHHHHHHHHHHHhh--cCCCcEEecCCCCCCeEeC--CCCceEEcccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHH--HCQELILHCDPKPSNVLLD--NDLFAHIGDFE 180 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~--~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg 180 (356)
..++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEecc
Confidence 4588999999999994 56 99999999999994 57889999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 207 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 23467899999999999999999999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=288.49 Aligned_cols=222 Identities=19% Similarity=0.268 Sum_probs=163.4
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcC--CCChHHH------
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNIC--HRNLVRF------ 134 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l------ 134 (356)
..+....++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.++.+++ ||||+++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3334456679999999999999999999864 7899999997543 234567889999999998 4999876
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
..++.|++.||.|||+.+ |+||||||+||++++ +.+||+|||++..
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 458899999999999999 999999999999974 8999999999986
Q ss_pred cccCCCCCccCCCCccccccccchhhhcC-----------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHH
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLG-----------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 253 (356)
...... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........+
T Consensus 176 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---- 249 (313)
T 3cek_A 176 MQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---- 249 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----
T ss_pred ccCccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH----
Confidence 543221 112234568999999999875 468889999999999999999999996432211111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
..+++......... .....+.+++.+||+.||.+|||+.++++.
T Consensus 250 --------~~~~~~~~~~~~~~------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 --------HAIIDPNHEIEFPD------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------HHHHCTTSCCCCCC------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHhcccccCCcc------------------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111111100 112357899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.45 Aligned_cols=223 Identities=19% Similarity=0.280 Sum_probs=172.0
Q ss_pred hcCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 446789999999999999999998643 4689999987543 2334678999999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 457889999999999999 999999999999999999999999999865432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .........
T Consensus 545 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~----------- 608 (656)
T 2j0j_A 545 TY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG----------- 608 (656)
T ss_dssp ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHT-----------
T ss_pred cc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcC-----------
Confidence 21 12223456788999999998899999999999999999997 99999743211 111111100
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
. .... +..++..+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 609 ~-~~~~------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 E-RLPM------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp C-CCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CCCC------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0 0000 013344678999999999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=283.60 Aligned_cols=161 Identities=22% Similarity=0.311 Sum_probs=137.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCC-eEEEEEEeeccCccchHHHHHHHHHHhhcCCCC------hHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR-AVVAIKVLSIQCQGASKSFMAECKALKNICHRN------LVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l--------- 134 (356)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999998766 79999998743 234467888999999987765 4432
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEe-----------------
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLL----------------- 168 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll----------------- 168 (356)
..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 568899999999999999 9999999999999
Q ss_pred --CCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 169 --DNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 169 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE-------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS-------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCCcEEEeecCccccccc-------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5678999999999975432 123457899999999999999999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=285.97 Aligned_cols=206 Identities=20% Similarity=0.231 Sum_probs=164.8
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhcC--CCChHHH------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNIC--HRNLVRF------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l------ 134 (356)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++++++ ||||+++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 4567899999999999999999999999999999999754321 2245678999999996 5999876
Q ss_pred --------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEccccc
Q 039228 135 --------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFEL 181 (356)
Q Consensus 135 --------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~ 181 (356)
..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 458889999999999999 99999999999999 789999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
+...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 197 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~-------- 255 (320)
T 3a99_A 197 GALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI-------- 255 (320)
T ss_dssp CEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH--------
T ss_pred ccccccc------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh--------
Confidence 9865432 1223568999999999887665 678899999999999999999996321 10
Q ss_pred hHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 VMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... .. ...+..+.+++.+||+.||++|||+.+|++
T Consensus 256 ----~~~~~~--~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 ----IRGQVF--FR------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HHCCCC--CS------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hccccc--cc------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00 012235789999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.13 Aligned_cols=214 Identities=20% Similarity=0.241 Sum_probs=167.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457999999999999999999999899999999997542 2345788999999999999999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC---CceEEcccccccccccC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND---LFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 188 (356)
..++.+++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 558899999999999999 9999999999999754 47999999999765432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ........ ..
T Consensus 178 ~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-----------~~ 238 (287)
T 2wei_A 178 T-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVET-----------GK 238 (287)
T ss_dssp S-----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-----------CC
T ss_pred C-----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc-----------CC
Confidence 1 2233568999999999876 4899999999999999999999999743211 11111100 00
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
...... .....+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFDLP----------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCSG----------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCch----------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000 00122345789999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.78 Aligned_cols=216 Identities=20% Similarity=0.228 Sum_probs=156.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l---------------- 134 (356)
+.|.+.+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+.+++++ +||||+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3455678899999999987544 46799999998743 245678899999876 89999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-------------Cce
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-------------LFA 174 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~~~ 174 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.+ +.+
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 238899999999999999 9999999999999654 489
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcC-------CCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG-------SEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998765433222222345679999999999976 568999999999999999999 999996432111
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
............ +. ..........+.+++.+||+.||.+|||+.+|++
T Consensus 248 ---~~i~~~~~~~~~-------~~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFSLDE-------MK------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCCCCC-------CT------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCCccc-------cc------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111110000 00 0001245567889999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=281.27 Aligned_cols=208 Identities=21% Similarity=0.217 Sum_probs=161.3
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhc----CCCChHHH--
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNI----CHRNLVRF-- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l-- 134 (356)
.....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++.++ +||||+++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999999989999999999654321 223456799999988 89999986
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEc
Q 039228 135 ------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIG 177 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~ 177 (356)
+.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 458899999999999999 99999999999999 89999999
Q ss_pred ccccccccccCCCCCccCCCCccccccccchhhhcCCCCC-CccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 039228 178 DFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS-TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
|||++...... ......|+..|+|||++.+..+. .++||||||+++|+|++|+.||.... .
T Consensus 183 dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~----- 244 (312)
T 2iwi_A 183 DFGSGALLHDE------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E----- 244 (312)
T ss_dssp CCSSCEECCSS------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H-----
T ss_pred EcchhhhcccC------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H-----
Confidence 99999865432 12345689999999998876664 48999999999999999999996321 1
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+...... .. ......+.+++.+||+.||++|||+.++++
T Consensus 245 -------~~~~~~~--~~------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -------ILEAELH--FP------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------HHHTCCC--CC------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------HhhhccC--Cc------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111000 00 022335789999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.83 Aligned_cols=225 Identities=18% Similarity=0.221 Sum_probs=167.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccc-----------------hHHHHHHHHHHhhcCCCChHH
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGA-----------------SKSFMAECKALKNICHRNLVR 133 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 133 (356)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999999999 68999999997432111 178999999999999999998
Q ss_pred H---------------------------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeE
Q 039228 134 F---------------------------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVL 167 (356)
Q Consensus 134 l---------------------------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIl 167 (356)
+ ..++.|++.||.|||+ .+ |+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 6 4588999999999999 88 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCC-CCCC-ccchHhHHHHHHHHHcCCCCCCccccC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVST-NGDAYNYGILLLEMVTRRKPIDFMFEG 245 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwSlG~~l~elltg~~Pf~~~~~~ 245 (356)
++.++.++|+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|+|++|..||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999865332 22345689999999999877 6666 999999999999999999999753321
Q ss_pred CccHHHHHHHh-C--CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 246 DLNLHNFARMA-F--PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 246 ~~~~~~~~~~~-~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ......... . +........+.. ..............+.+++.+||+.||.+|||+.++++
T Consensus 259 ~-~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 V-ELFNNIRTKNIEYPLDRNHFLYPLT---------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-HHHHHHTSCCCCCCCSSSSSTTTTC---------------C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHhccCcCCccchhhhhcccc---------------ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111111110 0 000000000000 00000000123446789999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=284.92 Aligned_cols=227 Identities=22% Similarity=0.229 Sum_probs=165.4
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
+....++|++.+.||+|+||.||+|.+.. .||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 34456789999999999999999999863 49999987442 2334567789999999999999987
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
+.++.|++.||.|||+.+ |+||||||+||+++ ++.++|+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 568999999999999999 99999999999998 6799999999987553
Q ss_pred cCCC-CCccCCCCccccccccchhhhcC---------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 039228 187 EVSN-PTQSSSNGVRRTIGYTALDYDLG---------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256 (356)
Q Consensus 187 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (356)
.... ..........|++.|+|||++.+ ..++.++||||||+++|+|++|..||...... .........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~ 258 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMGTG 258 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHHTT
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccC
Confidence 2211 11222334568999999999874 45788999999999999999999999643211 111000000
Q ss_pred CCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 257 FPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 257 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.. +.+.. ..++..+.+++.+||..||++|||+.+|++.|+.+.+..
T Consensus 259 ~~--------~~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 MK--------PNLSQ---------------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CC--------CCCCC---------------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CC--------CCCCc---------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00000 012224689999999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.35 Aligned_cols=217 Identities=23% Similarity=0.311 Sum_probs=158.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45699999999999999999999999999999999643 3345678899999999999999753
Q ss_pred -----------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccc
Q 039228 135 -----------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179 (356)
Q Consensus 135 -----------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 179 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 357889999999999999 999999999999999999999999
Q ss_pred ccccccccCCCC----------CccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCcc
Q 039228 180 ELARFRQEVSNP----------TQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN 248 (356)
Q Consensus 180 g~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~ 248 (356)
|++......... .........|++.|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---- 233 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---- 233 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh----
Confidence 999765422110 01222346689999999999764 68999999999999999998 5532111
Q ss_pred HHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 249 LHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.......... ....+..... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~------~~~~~~~~~~------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKKLRS------VSIEFPPDFD------------------DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHS------TTCCCCTTCC------------------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccc------cccccCcccc------------------ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0111000000 0000000000 123345789999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=282.29 Aligned_cols=216 Identities=19% Similarity=0.221 Sum_probs=150.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-chHH-HHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-ASKS-FMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~-~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .... +..+..+++.++||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 56799999999999999999999989999999999755332 2223 4445557888899999986
Q ss_pred -----------------------HHHHHHHHHHHHHHhhc-CCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHH-CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 46889999999999995 8 9999999999999999999999999997553321
Q ss_pred CCccCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
......+++.|+|||++. ...++.++||||||+++|+|++|+.||.........+........+
T Consensus 180 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 248 (318)
T 2dyl_A 180 ----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP------- 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-------
T ss_pred ----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-------
Confidence 123356899999999984 4568899999999999999999999997422111111111110000
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+... ......+.+++.+||+.||.+|||+.+|++.
T Consensus 249 --~~~~~--------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 --LLPGH--------------------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCSS--------------------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCcc--------------------CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 0123357899999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=277.32 Aligned_cols=214 Identities=18% Similarity=0.168 Sum_probs=140.3
Q ss_pred cCCCCccc-cceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHH-HHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLIN-LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAE-CKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E-~~~l~~l~h~niv~l-------------- 134 (356)
.++|.+.+ +||+|+||.||+|.+..+++.||||++... .....| ...++.++||||+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 56799855 699999999999999999999999998643 122233 334667789999876
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a 182 (356)
..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 558899999999999999 999999999999976 456999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... .. .
T Consensus 179 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~-~------- 243 (336)
T 3fhr_A 179 KETTQN------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MK-R------- 243 (336)
T ss_dssp EEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred eecccc------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HH-H-------
Confidence 754321 22345679999999999888899999999999999999999999964332211000 00 0
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.+......... .....+...+.+++.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 RIRLGQYGFPN----------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------CCCT----------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhccccccCc----------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000000000 0001233467899999999999999999999973
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=286.60 Aligned_cols=214 Identities=21% Similarity=0.226 Sum_probs=152.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc-CCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI-CHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l--------------- 134 (356)
..+|.+.+.||+|+||+||... ..+++.||||++..... ..+.+|+.+|+.+ +||||+++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3468999999999999865433 34578999999865432 2356799999999 79999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-----CCceEEccccccccccc
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-----DLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++....
T Consensus 99 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 468999999999999999 999999999999943 33678999999986643
Q ss_pred CCCCCccCCCCccccccccchhhhc---CCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDL---GSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........... .
T Consensus 176 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~~~~~~~~---~ 248 (432)
T 3p23_A 176 GRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANILLGACSL---D 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHHHTTCCCC---T
T ss_pred CCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHHHhccCCc---c
Confidence 3211 12234467899999999997 4567889999999999999999 99998532111 00000000000 0
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... .......+.+|+.+||+.||.+|||+.+|++
T Consensus 249 ----~~~~--------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 ----CLHP--------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----TSCT--------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCc--------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 0133345679999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.32 Aligned_cols=242 Identities=21% Similarity=0.212 Sum_probs=169.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46899999999999999999999999999999998754 23345678999999999999999865
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCc---eEEcccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLF---AHIGDFE 180 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg 180 (356)
..++.+++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 458899999999999999 999999999999996664 8999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (356)
++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.... ....|........
T Consensus 170 ~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC---
T ss_pred ccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhccc
Confidence 998654322 2234678999999999999999999999999999999999999996421 1111111000000
Q ss_pred hHH-HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHH-----HHHHHHHhhhh
Q 039228 261 VMD-IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPN-----AVHDLQSVNNI 330 (356)
Q Consensus 261 ~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~-----vl~~L~~i~~~ 330 (356)
... .....+.+.... ...... ........+..+.+++..||..||++|||+.+ .++.++.+.+.
T Consensus 241 ~~~~~~~~~l~g~~~~-----~~~lp~-p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKF-----SSVLPT-PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ---CCSCCCCSSSCCC-----CSSSCC-SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred chhhhhhhhhcccccc-----ccccCC-chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000 000000000000 000000 00011134567889999999999999999988 56777666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=265.32 Aligned_cols=201 Identities=13% Similarity=0.053 Sum_probs=154.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++..++||||+++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999999999999999975432 234678999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||.|||+++ |+||||||+|||++.++.+||+++|.
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----------- 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----------- 175 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence 568999999999999999 99999999999999999999985442
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
++ .++.++|||||||++|||+||+.||........... ....+...
T Consensus 176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~~~~ 221 (286)
T 3uqc_A 176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDTAGQ 221 (286)
T ss_dssp -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCTTSC
T ss_pred -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHhccC
Confidence 22 367899999999999999999999975432210000 00000000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
... . ......++..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus 222 ~~~--------~----~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PIE--------P----ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCC--------H----HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCC--------h----hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000 0 00001234467899999999999999 99999999999886543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.02 Aligned_cols=208 Identities=20% Similarity=0.219 Sum_probs=168.2
Q ss_pred cCCCCccccceecCceEEEEEEECC-CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDL-NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.++++++||||+++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 68999999986433 2344578899999999999999976
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ ||||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 568999999999999999 9999999999999975 8999999999865332
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||........ +..
T Consensus 235 --------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~-------- 287 (681)
T 2pzi_A 235 --------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PED-------- 287 (681)
T ss_dssp --------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTT--------
T ss_pred --------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------ccc--------
Confidence 345689999999998765 48899999999999999999999864322110 000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-ChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-NVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~vl~~L~~i~~~ 330 (356)
. ........+.+++.+||+.||.+|| +++++.+.|..+...
T Consensus 288 ---~------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 288 ---D------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ---C------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ---c------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 0012234578999999999999999 577788888777544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=256.59 Aligned_cols=194 Identities=18% Similarity=0.239 Sum_probs=145.5
Q ss_pred cCCCCcc-ccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHH-hhcCCCChHHH--------------
Q 039228 71 TDGFPLI-NLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKAL-KNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l-------------- 134 (356)
.++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +.++||||+++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4568777 789999999999999999999999999863 24567888887 56689999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a 182 (356)
..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 458899999999999999 999999999999997 789999999998
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.... +..++.++|||||||++|+|++|..||........ . ......
T Consensus 168 ~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~-~~~~~~-- 213 (299)
T 3m2w_A 168 KETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----S-PGMKTR-- 213 (299)
T ss_dssp EECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCS--
T ss_pred cccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----h-HHHHHH--
Confidence 6322 23467889999999999999999999964321110 0 000000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
....... ............+.+++.+||+.||.+|||+.++++.
T Consensus 214 -----~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 -----IRMGQYE------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -----SCTTCCS------------SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----Hhhcccc------------CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0000001234467899999999999999999999973
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=258.62 Aligned_cols=155 Identities=23% Similarity=0.199 Sum_probs=131.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--------ccchHHHHHHHHHHhhcC---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--------QGASKSFMAECKALKNIC--------------- 127 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~--------------- 127 (356)
.++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35689999999999999999998 57999999997542 223377889999999887
Q ss_pred -----------CCChHHH-------------------------------------------------HHHHHHHHHHHHH
Q 039228 128 -----------HRNLVRF-------------------------------------------------ISIAIDVASALDY 147 (356)
Q Consensus 128 -----------h~niv~l-------------------------------------------------~~i~~~i~~aL~~ 147 (356)
||||+++ ..++.||+.||.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 6777664 3478899999999
Q ss_pred Hh-hcCCCcEEecCCCCCCeEeCCCC--------------------ceEEcccccccccccCCCCCccCCCCcccccccc
Q 039228 148 LH-HHCQELILHCDPKPSNVLLDNDL--------------------FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206 (356)
Q Consensus 148 LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 206 (356)
|| +.+ |+||||||+|||++.++ .+||+|||+++.... ....||+.|+
T Consensus 177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------~~~~gt~~y~ 244 (336)
T 2vuw_A 177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------TEEECCCCTT
T ss_pred HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------CcEEEeeccc
Confidence 99 899 99999999999999887 899999999986542 1357899999
Q ss_pred chhhhcCCCCCCccchHhHHHH-HHHHHcCCCCCC
Q 039228 207 ALDYDLGSEVSTNGDAYNYGIL-LLEMVTRRKPID 240 (356)
Q Consensus 207 aPE~~~~~~~~~~sDiwSlG~~-l~elltg~~Pf~ 240 (356)
|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999998766 889999998776 788999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-26 Score=225.46 Aligned_cols=153 Identities=15% Similarity=-0.009 Sum_probs=102.3
Q ss_pred cceecCceEEEEEEECCCCeEEEEEEeeccC----------ccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC----------QGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
..+.|++|.+..++....|+.||+|++.... ....++|.+|+++|+++ .|+||+++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777777766666678999999996542 12235689999999999 69999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..|+.||+.||+|+|++| ||||||||+|||++.+|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence 458999999999999999 9999999999999999999999999998654322
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCC
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf 239 (356)
......+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 23345789999999999976 4667899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-23 Score=205.29 Aligned_cols=159 Identities=18% Similarity=0.099 Sum_probs=119.1
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------cchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------GASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...+.||+|+||.||+|... +..+++|....... ...+++.+|+.++++++||||+++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34568999999999999544 68899998643221 113457899999999999999933
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC---cc
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT---QS 194 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~ 194 (356)
..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++......... ..
T Consensus 417 VmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~ 491 (540)
T 3en9_A 417 MMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV 491 (540)
T ss_dssp EEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred EEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence 368999999999999999 999999999999998 99999999998764321100 00
Q ss_pred CCCCccccccccchhhhcC--CCCCCccchHhHHHHHHHHHcCCCCCC
Q 039228 195 SSNGVRRTIGYTALDYDLG--SEVSTNGDAYNYGILLLEMVTRRKPID 240 (356)
Q Consensus 195 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~ 240 (356)
......||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1235779999999999976 567888899999998888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.8e-21 Score=173.74 Aligned_cols=126 Identities=17% Similarity=0.079 Sum_probs=101.6
Q ss_pred HHHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc------------------cchHHHHHHHHHHhhc
Q 039228 65 ESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ------------------GASKSFMAECKALKNI 126 (356)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 126 (356)
..+......|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.+++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556677889999999999999999 7789999999964321 1245688999999999
Q ss_pred CCCChHHH--------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccc
Q 039228 127 CHRNLVRF--------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFE 180 (356)
Q Consensus 127 ~h~niv~l--------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 180 (356)
+|+++..+ ..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 162 ~~~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 162 QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp TTSSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred cCCCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 85444332 568999999999999999 99999999999999 9999999999
Q ss_pred cccccccCCCCCccCCCCccccccccchhhhc
Q 039228 181 LARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212 (356)
Q Consensus 181 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (356)
+++. +..+.|||++.
T Consensus 238 ~a~~-----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE-----------------VGEEGWREILE 252 (282)
T ss_dssp TCEE-----------------TTSTTHHHHHH
T ss_pred CCeE-----------------CCCCCHHHHHH
Confidence 9962 33468899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.7e-18 Score=150.99 Aligned_cols=107 Identities=16% Similarity=0.087 Sum_probs=86.3
Q ss_pred CCCccccceecCceEEEEEEECCCCeE--EEEEEeeccCcc------------------------chHHHHHHHHHHhhc
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAV--VAIKVLSIQCQG------------------------ASKSFMAECKALKNI 126 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 126 (356)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998666788 999997543111 013578899999988
Q ss_pred CCCChH-------------------------------------HHHHHHHHHHHHHHHHh-hcCCCcEEecCCCCCCeEe
Q 039228 127 CHRNLV-------------------------------------RFISIAIDVASALDYLH-HHCQELILHCDPKPSNVLL 168 (356)
Q Consensus 127 ~h~niv-------------------------------------~l~~i~~~i~~aL~~LH-~~~~~~iiH~Dlkp~NIll 168 (356)
.|+++. ....++.|++.||.||| +.+ |+||||||+|||+
T Consensus 128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl 204 (258)
T 1zth_A 128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMY 204 (258)
T ss_dssp HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEE
T ss_pred HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEE
Confidence 765421 01457889999999999 898 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 039228 169 DNDLFAHIGDFELARF 184 (356)
Q Consensus 169 ~~~~~~kl~Dfg~a~~ 184 (356)
+. .++|+|||+|..
T Consensus 205 ~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 205 ID--KVYFIDMGQAVT 218 (258)
T ss_dssp SS--SEEECCCTTCEE
T ss_pred cC--cEEEEECccccc
Confidence 98 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=136.24 Aligned_cols=112 Identities=17% Similarity=0.179 Sum_probs=81.0
Q ss_pred HhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--------------cchHHH--------HHHHHHHhh
Q 039228 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--------------GASKSF--------MAECKALKN 125 (356)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~ 125 (356)
.....-|.+.+.||.|+||.||+|.+. +|+.||||+++.... ...... .+|...|.+
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 333345999999999999999999986 579999999753210 001111 235555555
Q ss_pred cCCCChHH-----------------------------HHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----
Q 039228 126 ICHRNLVR-----------------------------FISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL---- 172 (356)
Q Consensus 126 l~h~niv~-----------------------------l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---- 172 (356)
+.+.++.- ...++.|++.+|.+||+.| ||||||||.|||+++++
T Consensus 170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSC
T ss_pred HHhcCCCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccc
Confidence 43222110 0458899999999999999 99999999999998776
Q ss_pred ------ceEEccccccc
Q 039228 173 ------FAHIGDFELAR 183 (356)
Q Consensus 173 ------~~kl~Dfg~a~ 183 (356)
.+.|+||+-+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 38899999774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.3e-08 Score=90.30 Aligned_cols=112 Identities=13% Similarity=0.084 Sum_probs=84.4
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l-------------- 134 (356)
..++|.+...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 4567988889999999999999754 5889999987532223346888999998885 3333322
Q ss_pred ------------------HHHHHHHHHHHHHHhhcC--------------------------------------------
Q 039228 135 ------------------ISIAIDVASALDYLHHHC-------------------------------------------- 152 (356)
Q Consensus 135 ------------------~~i~~~i~~aL~~LH~~~-------------------------------------------- 152 (356)
..++.+++.+|..||+..
T Consensus 90 e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 90 SEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp ECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred EecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 246788999999999810
Q ss_pred ------------CCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 153 ------------QELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 153 ------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.41 E-value=2.2e-07 Score=81.76 Aligned_cols=109 Identities=18% Similarity=0.125 Sum_probs=78.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCCh-HH-H--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL-VR-F-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~-l-------------- 134 (356)
..++.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.++ ++ +
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34566544444566699999965 34578999997643 22456788888888754433 21 1
Q ss_pred -------H--------HHHHHHHHHHHHHhhcC-----------------------------------------------
Q 039228 135 -------I--------SIAIDVASALDYLHHHC----------------------------------------------- 152 (356)
Q Consensus 135 -------~--------~i~~~i~~aL~~LH~~~----------------------------------------------- 152 (356)
+ .++.+++..|..||+..
T Consensus 95 e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 95 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 1 57888999999999753
Q ss_pred --------CCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 153 --------QELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 153 --------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.25 E-value=2.5e-07 Score=83.93 Aligned_cols=154 Identities=18% Similarity=0.133 Sum_probs=95.3
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCCh-----H-----------HH-----
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNL-----V-----------RF----- 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni-----v-----------~l----- 134 (356)
.+.++.|..+.||+.. ..+++|+.... .....+.+|+.+|+.+. +..+ + .+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 45888886422 33467888999998773 2211 0 00
Q ss_pred -------------------HHHHHHHHHHHHHHhhcC-------------------------------------------
Q 039228 135 -------------------ISIAIDVASALDYLHHHC------------------------------------------- 152 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~------------------------------------------- 152 (356)
..++.+++..|..||...
T Consensus 98 i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 98 IKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp CCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred cCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 246778888888888621
Q ss_pred ------------CCcEEecCCCCCCeEeCC--CCceEEcccccccccccCCCCCccCCC----------Cccccccccc-
Q 039228 153 ------------QELILHCDPKPSNVLLDN--DLFAHIGDFELARFRQEVSNPTQSSSN----------GVRRTIGYTA- 207 (356)
Q Consensus 153 ------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~----------~~~gt~~y~a- 207 (356)
...++|+|++|.||+++. ...+.|+||+.+............... ......+...
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence 123899999999999997 566789999998754321100000000 0000001111
Q ss_pred hhhhcCCCCCCccchHhHHHHHHHHHcCCCCC
Q 039228 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPI 239 (356)
Q Consensus 208 PE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf 239 (356)
|+.... .....+.|++|.++|.+.+|..+|
T Consensus 258 ~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 258 PTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222111 112258999999999999998876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.14 E-value=2.3e-06 Score=79.34 Aligned_cols=108 Identities=11% Similarity=0.162 Sum_probs=75.3
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEee--ccCc-cchHHHHHHHHHHhhcCCCCh--HHH---------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQ-GASKSFMAECKALKNICHRNL--VRF--------------- 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~h~ni--v~l--------------- 134 (356)
...+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+...++ .++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34667899999999998865 4678888865 3221 223467789999988863222 111
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcC---------------------------------------
Q 039228 135 -----------------------ISIAIDVASALDYLHHHC--------------------------------------- 152 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~--------------------------------------- 152 (356)
..++.+++.+|..||...
T Consensus 119 vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 346788999999999731
Q ss_pred ----------------CCcEEecCCCCCCeEeCCCCc--eEEcccccccc
Q 039228 153 ----------------QELILHCDPKPSNVLLDNDLF--AHIGDFELARF 184 (356)
Q Consensus 153 ----------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 184 (356)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987653 68999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00043 Score=64.86 Aligned_cols=50 Identities=18% Similarity=0.074 Sum_probs=32.6
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCc-------cchHHHHHHHHHHhhc
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-------GASKSFMAECKALKNI 126 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l 126 (356)
.+.||.|..+.||++....+++.++||....... ....++..|..+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l 91 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ 91 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHH
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHh
Confidence 5678999999999997655568899998642211 1234566788777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0014 Score=59.19 Aligned_cols=45 Identities=11% Similarity=0.073 Sum_probs=33.0
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH 128 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 128 (356)
...++.|....||+. +..+++|+.. .......+..|..+|+.+.+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~ 68 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVG 68 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTT
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHh
Confidence 456788988999987 3567888843 22334678899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.002 Score=57.51 Aligned_cols=54 Identities=15% Similarity=0.059 Sum_probs=40.6
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
...-...+|.|..+.||+....+ |+.|.+|+...........+..|+..|+.|.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 34556788999999999998764 5889999876444343456778998888774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0035 Score=55.06 Aligned_cols=102 Identities=18% Similarity=0.116 Sum_probs=69.4
Q ss_pred cceecCce-EEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC----CChHHH-------------------
Q 039228 79 LIGVGSFD-AVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH----RNLVRF------------------- 134 (356)
Q Consensus 79 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l------------------- 134 (356)
.+..|..| .||+.....++..+++|+-.. .....+..|...|+.+.. |.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 689888777778899998653 234567789988887742 211110
Q ss_pred -----------HHHHHHHHHHHHHHhhcC---------------------------------------------------
Q 039228 135 -----------ISIAIDVASALDYLHHHC--------------------------------------------------- 152 (356)
Q Consensus 135 -----------~~i~~~i~~aL~~LH~~~--------------------------------------------------- 152 (356)
..++.+++..|.-||...
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 108 FQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 235556666777777521
Q ss_pred ----CCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 153 ----QELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 153 ----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..-++|+|+.+.||++++++.+-|+||+.+.
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0117999999999999988777899999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.021 Score=51.68 Aligned_cols=29 Identities=21% Similarity=0.203 Sum_probs=26.3
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 49999999999999878889999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.097 Score=49.89 Aligned_cols=30 Identities=13% Similarity=0.082 Sum_probs=21.4
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEee
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLS 106 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~ 106 (356)
.+.|+.|-...+|++....++..+++|+..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g 142 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYG 142 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECC
Confidence 456778888999999886545788899863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.89 E-value=0.062 Score=50.76 Aligned_cols=49 Identities=14% Similarity=0.135 Sum_probs=32.3
Q ss_pred cccceecCceEEEEEEECC-------CCeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 77 INLIGVGSFDAVYQGVFDL-------NRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
.+.|+.|....||++.... .+..+++|+.... .....+..|..+++.+.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~ 133 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLS 133 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHH
Confidence 4567888889999998753 2468889987421 11144556777766653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.90 E-value=0.099 Score=47.12 Aligned_cols=46 Identities=15% Similarity=0.101 Sum_probs=33.6
Q ss_pred ccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhc
Q 039228 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI 126 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 126 (356)
-.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L 85 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALL 85 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHH
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHH
Confidence 346789999999999875 3578889987632 245677787777766
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.82 E-value=0.13 Score=47.64 Aligned_cols=29 Identities=28% Similarity=0.345 Sum_probs=25.6
Q ss_pred cEEecCCCCCCeEeCCC----CceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDND----LFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 38999999999999876 789999999885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.12 E-value=0.055 Score=50.83 Aligned_cols=75 Identities=12% Similarity=0.069 Sum_probs=44.4
Q ss_pred cEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccc--cccccchhhhcCCC---CCCccchHhHHHHH
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRR--TIGYTALDYDLGSE---VSTNGDAYNYGILL 229 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDiwSlG~~l 229 (356)
.++|+|+.|.|||++.++ +.|+||+.+......... ..... ...|.+|+...... -....++.+....+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-----a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-----GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-----HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-----HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 499999999999999776 999999998754321100 00000 12355555543111 11123445677777
Q ss_pred HHHHcC
Q 039228 230 LEMVTR 235 (356)
Q Consensus 230 ~elltg 235 (356)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.42 E-value=0.55 Score=39.83 Aligned_cols=97 Identities=10% Similarity=-0.003 Sum_probs=53.4
Q ss_pred HHhhcCCC-ChHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCcc
Q 039228 122 ALKNICHR-NLVRFISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200 (356)
Q Consensus 122 ~l~~l~h~-niv~l~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 200 (356)
||+..+.| +==+.+.++.|.+.+|.-+-.... -..+=+.|..|++..+|.+.+.+ +.+. .
T Consensus 38 IL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------------~ 98 (229)
T 2yle_A 38 ILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------------A 98 (229)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------------
T ss_pred HHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------------c
Confidence 34444443 333457788888888876621110 01223456889999999887653 1110 1
Q ss_pred ccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCC
Q 039228 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238 (356)
Q Consensus 201 gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~P 238 (356)
....+.+||... ...+.+.=|||||+++|.-+-=..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 122456777653 2345666799999999999874444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.65 E-value=0.087 Score=47.23 Aligned_cols=43 Identities=28% Similarity=0.412 Sum_probs=31.0
Q ss_pred HHHHHHHHhhc----CCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 141 VASALDYLHHH----CQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 141 i~~aL~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+...+.++... ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 33445555532 12348999999999999987666899999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.47 E-value=0.28 Score=44.14 Aligned_cols=30 Identities=23% Similarity=0.296 Sum_probs=26.3
Q ss_pred cEEecCCCCCCeEeCCC----CceEEcccccccc
Q 039228 155 LILHCDPKPSNVLLDND----LFAHIGDFELARF 184 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 184 (356)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999874 6789999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=90.25 E-value=0.099 Score=47.66 Aligned_cols=30 Identities=23% Similarity=0.302 Sum_probs=25.6
Q ss_pred CcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 154 ELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 154 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 349999999999999965557899999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.43 E-value=0.36 Score=43.23 Aligned_cols=28 Identities=36% Similarity=0.335 Sum_probs=24.4
Q ss_pred cEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
.++|+|+.+.||+++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 488999999999999 4 889999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.39 E-value=0.27 Score=45.11 Aligned_cols=28 Identities=25% Similarity=0.387 Sum_probs=23.8
Q ss_pred cEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
.++|+|+.+.|||+++++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 389999999999998655 8999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=86.43 E-value=0.25 Score=44.83 Aligned_cols=30 Identities=27% Similarity=0.356 Sum_probs=26.8
Q ss_pred cEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
.++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=84.84 E-value=0.39 Score=42.61 Aligned_cols=29 Identities=34% Similarity=0.476 Sum_probs=24.5
Q ss_pred cEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 155 LILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 155 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999998853
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.31 E-value=0.11 Score=49.71 Aligned_cols=57 Identities=9% Similarity=0.067 Sum_probs=14.2
Q ss_pred CccccceecCceEEEEEEECCCCeEEEE------EEeeccC--ccchHHHHHHHHHHhhcCCCChHHH
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAI------KVLSIQC--QGASKSFMAECKALKNICHRNLVRF 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l 134 (356)
.+.+.|| ||.||+|.+......||+ |...... .+....+.+|..+++.++|||+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~ 209 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKI 209 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBC
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCC
Confidence 4556676 999999999765568888 6654321 2233467888899999999998863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 356 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-26 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-25 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-25 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-22 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-22 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-21 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-20 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-19 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-18 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-18 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-18 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-17 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-17 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-17 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-16 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-16 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-15 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-14 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 7e-31
Identities = 46/227 (20%), Positives = 88/227 (38%), Gaps = 55/227 (24%)
Query: 64 YESLLKATDGFP---------LINLIGVGSFDAVYQGVFDLN---RAVVAIKVL-SIQCQ 110
+E +A F + +IG G F V G L VAIK L S +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 111 GASKSFMAECKALKNICHRNLVRF------------------------------------ 134
+ F++E + H N++
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 135 --ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARF-RQEVSNP 191
+ + +A+ + YL +H D N+L++++L + DF L+RF + S+P
Sbjct: 129 QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
T +S+ G + I +TA + + ++ D ++YGI++ E+++ +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 54/224 (24%), Positives = 82/224 (36%), Gaps = 60/224 (26%)
Query: 59 IPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGAS--KSF 116
IP + IG GSF VY+G + VA+K+L++ ++F
Sbjct: 5 IPDGQIT----------VGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAF 51
Query: 117 MAECKALKNICHRNLVRFI-------------------------------------SIAI 139
E L+ H N++ F+ IA
Sbjct: 52 KNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 140 DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199
A +DYLH I+H D K +N+ L DL IGDF LA + S Q +
Sbjct: 112 QTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ--L 166
Query: 200 RRTIGYTALDYDLGSE---VSTNGDAYNYGILLLEMVTRRKPID 240
+I + A + + S D Y +GI+L E++T + P
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 4e-30
Identities = 53/254 (20%), Positives = 97/254 (38%), Gaps = 60/254 (23%)
Query: 59 IPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA 118
+P+E + L+ +G G F V+ G ++ + VA+K L Q + +F+A
Sbjct: 10 VPRETLK----------LVERLGAGQFGEVWMGYYNGHT-KVAVKSLK-QGSMSPDAFLA 57
Query: 119 ECKALKNICHRNLVRFI--------------------------------------SIAID 140
E +K + H+ LVR +A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
+A + ++ +H D + +N+L+ + L I DF LAR + + ++ G +
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAK 171
Query: 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD---LNLHNFARMAF 257
I +TA + + D +++GILL E+VT + NL RM
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 258 PNRVM-DIVNLVLL 270
P+ ++ L+ L
Sbjct: 232 PDNCPEELYQLMRL 245
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-30
Identities = 42/209 (20%), Positives = 76/209 (36%), Gaps = 46/209 (22%)
Query: 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICH 128
D F I+ +G G+ V++ + V+A K++ ++ + E + L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
+V F ++I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+ I+H D KPSN+L+++ + DF ++ + S +N T Y + +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFVGTRSYMSPERL 175
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPID 240
G+ S D ++ G+ L+EM R PI
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-29
Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 56/218 (25%)
Query: 59 IPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMA 118
IP+E L +G G F V+ G ++ VAIK L ++F+
Sbjct: 14 IPRESLR----------LEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS-PEAFLQ 61
Query: 119 ECKALKNICHRNLVRF--------------------------------------ISIAID 140
E + +K + H LV+ + +A
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
+AS + Y+ +H D + +N+L+ +L + DF LAR + + ++ G +
Sbjct: 122 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAK 175
Query: 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
I +TA + L + D +++GILL E+ T+ +
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-27
Identities = 41/203 (20%), Positives = 75/203 (36%), Gaps = 46/203 (22%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ IG G F V+ G LN+ VAIK + + F+ E + + + H LV+
Sbjct: 7 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQ 64
Query: 134 FI--------------------------------------SIAIDVASALDYLHHHCQEL 155
+ +DV + YL C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
++H D N L+ + + DF + RF V + +SS G + + + + + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 216 VSTNGDAYNYGILLLEMVTRRKP 238
S+ D +++G+L+ E+ + K
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 41/203 (20%), Positives = 75/203 (36%), Gaps = 46/203 (22%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ +G G F V G + VAIK++ F+ E K + N+ H LV+
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 63
Query: 134 FI--------------------------------------SIAIDVASALDYLHHHCQEL 155
+ DV A++YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
LH D N L+++ + DF L+R+ V + +SS G + + ++ + + S+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 216 VSTNGDAYNYGILLLEMVTRRKP 238
S+ D + +G+L+ E+ + K
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM 200
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 41/213 (19%), Positives = 82/213 (38%), Gaps = 45/213 (21%)
Query: 67 LLKATDGFPLINL-IGVGSFDAVYQGVFDL--NRAVVAIKVLSIQ-CQGASKSFMAECKA 122
L D + ++ +G G+F +V QGV+ + + VAIKVL + ++ M E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 123 LKNICHRNLVRFI-------------------------------------SIAIDVASAL 145
+ + + +VR I + V+ +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 146 DYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGY 205
YL +H D NVLL N +A I DF L++ + ++ + + + +
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKW 178
Query: 206 TALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
A + + S+ D ++YG+ + E ++ +
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-26
Identities = 41/214 (19%), Positives = 80/214 (37%), Gaps = 48/214 (22%)
Query: 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVL-----SIQCQGASKSFMAECK 121
+LK T+ F I ++G G+F VY+G++ V I V A+K + E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 122 ALKNICHRNLVRF-------------------------------------ISIAIDVASA 144
+ ++ + ++ R ++ + +A
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
++YL ++H D NVL+ I DF LA+ + + + G + I
Sbjct: 124 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIK 178
Query: 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ AL+ L + D ++YG+ + E++T
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-26
Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 50/230 (21%)
Query: 78 NLIGVGSFDAVYQGVFDLNRA---VVAIKVLS-IQCQGASKSFMAECKALKNICHRNLVR 133
+IG G F VY G N A+K L+ I G F+ E +K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 134 F---------------------------------------ISIAIDVASALDYLHHHCQE 154
I + VA + +L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 150
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
+H D N +LD + DF LAR + + + G + + + AL+
Sbjct: 151 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 215 EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264
+ +T D +++G+LL E++TR P D+N + R +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQ 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-26
Identities = 43/221 (19%), Positives = 75/221 (33%), Gaps = 53/221 (23%)
Query: 64 YESL---LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAEC 120
YE + L D + +I +G G+F VY+ + A KV+ + + + +M E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 121 KALKNICHRNLVRFI--------------------------------------SIAIDVA 142
L + H N+V+ + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRT 202
AL+YLH + I+H D K N+L D + DF ++ + T + T
Sbjct: 121 DALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK----NTRTIQRRDSFIGT 173
Query: 203 IGYTALDYDLGSE-----VSTNGDAYNYGILLLEMVTRRKP 238
+ A + + D ++ GI L+EM P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-26
Identities = 43/239 (17%), Positives = 76/239 (31%), Gaps = 53/239 (22%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHR 129
+ + ++ IG GS+ + + ++ K L + + ++E L+ + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 130 NLVRF-------------------------------------------ISIAIDVASALD 146
N+VR+ + + + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 147 YLHHH--CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
H +LH D KP+NV LD +GDF LAR N S + T
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDTSFAKAFVGTPY 179
Query: 205 YTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL--NLHNFARMAFPNRV 261
Y + + + D ++ G LL E+ P + +L + P R
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 44/220 (20%), Positives = 77/220 (35%), Gaps = 44/220 (20%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI-QCQGASKSFMAECKALKNICHRN 130
+ + L+ +G G++ V V + VA+K++ + + ++ E K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 131 LVRFI-------------------------------------SIAIDVASALDYLHHHCQ 153
+V+F + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
I H D KP N+LLD I DF LA + N + N + T+ Y A +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAPELLKR 179
Query: 214 SEVSTNG-DAYNYGILLLEMVTRRKPIDFMFEGDLNLHNF 252
E D ++ GI+L M+ P D + ++
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 42/226 (18%), Positives = 78/226 (34%), Gaps = 53/226 (23%)
Query: 49 QPLRLTLRNAIPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ 108
+ LR + PK+ Y IG G+ VY + VAI+ +++Q
Sbjct: 7 EKLRSIVSVGDPKKKYT----------RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 109 CQGASKSFMAECKALKNICHRNLVRFI--------------------------------- 135
Q + + E ++ + N+V ++
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 136 ---SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
++ + AL++LH + ++H D K N+LL D + DF P
Sbjct: 117 QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ----ITPE 169
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
QS + + T + A + D ++ GI+ +EM+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-25
Identities = 42/231 (18%), Positives = 78/231 (33%), Gaps = 50/231 (21%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
+ F + +G G F VY ++ ++A+KVL ++ G E + ++ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
N++R + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
++H D KP N+LL + I DF + S + T+ Y +
Sbjct: 126 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS------SRRTTLCGTLDYLPPEMI 176
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-LNLHNFARMAFPNRV 261
G D ++ G+L E + + P + + + FP+ V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 227
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (251), Expect = 3e-25
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 50/232 (21%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
+ + +G G + VY+GV+ VA+K L + F+ E +K I H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 132 VRF---------------------------------------ISIAIDVASALDYLHHHC 152
V+ + +A ++SA++YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
+H D N L+ + + DF L+R ++ T ++ G + I +TA +
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 213 GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264
++ S D + +G+LL E+ T ++L + + M+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRMER 237
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 9e-25
Identities = 40/212 (18%), Positives = 81/212 (38%), Gaps = 47/212 (22%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLN----RAVVAIKVLSIQC-QGASKSFMAECKALKNICH 128
+IG G F VY+G+ + VAIK L + F+ E + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 129 RNLVRFI--------------------------------------SIAIDVASALDYLHH 150
N++R + +A+ + YL +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
+H D N+L++++L + DF L+R ++ T ++S G + I +TA +
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRWTAPEA 184
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242
+ ++ D +++GI++ E++T + +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 9e-25
Identities = 50/242 (20%), Positives = 82/242 (33%), Gaps = 65/242 (26%)
Query: 60 PKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSF 116
P++ + + IG GSF AVY N VVAIK +S Q +
Sbjct: 13 PEKLFS----------DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 117 MAECKALKNICHRNLVRFI-------------------------------------SIAI 139
+ E + L+ + H N +++ ++
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 140 DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199
L YLH H ++H D K N+LL +GDF A +N
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSF 171
Query: 200 RRTIGYTALDYDLGSEVSTNG---DAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256
T + A + L + D ++ GI +E+ R+ P+ M L++ A+
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE 230
Query: 257 FP 258
P
Sbjct: 231 SP 232
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 3e-24
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 54/205 (26%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
L+ IG G F V G D VA+K + +++F+AE + + H NLV+
Sbjct: 9 LKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 64
Query: 134 FI----------------------------------------SIAIDVASALDYLHHHCQ 153
+ ++DV A++YL +
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 123
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
+H D NVL+ D A + DF L + S+ + + + +TA +
Sbjct: 124 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEALRE 174
Query: 214 SEVSTNGDAYNYGILLLEMVTRRKP 238
+ ST D +++GILL E+ + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 3e-24
Identities = 54/305 (17%), Positives = 88/305 (28%), Gaps = 65/305 (21%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI 135
L IG G F V++G VA+K+ S + + S AE + H N++ FI
Sbjct: 7 LQESIGKGRFGEVWRGK--WRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFI 63
Query: 136 ----------------------------------------SIAIDVASALDYLHHHCQEL 155
+A+ AS L +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 156 -----ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
I H D K N+L+ + I D LA ++ + N T Y A +
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 211 DLGSEVSTNGDA------YNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264
S + ++ Y G++ E+ R + L ++ M
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDL 324
V + S E L M +I C + R+ L
Sbjct: 244 VVCEQKLRPNIPNRWQSC-----------EALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 325 QSVNN 329
++
Sbjct: 293 SQLSQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-24
Identities = 34/201 (16%), Positives = 71/201 (35%), Gaps = 44/201 (21%)
Query: 78 NLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVR 133
+G G+F V +G + + + VA+K+L + +AE ++ + + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 134 FI------------------------------------SIAIDVASALDYLHHHCQELIL 157
I + V+ + YL +
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D NVLL +A I DF L++ + + + + + A + + S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 218 TNGDAYNYGILLLEMVTRRKP 238
+ D +++G+L+ E + +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQK 209
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 8e-24
Identities = 38/207 (18%), Positives = 65/207 (31%), Gaps = 39/207 (18%)
Query: 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKN 125
K + F ++G GSF V AIK+L I + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 126 ICHRNLVRFIS----------------------------------IAIDVASALDYLHHH 151
+ H V+ A + L +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+ I+H D KP N+LL+ D+ I DF A+ S +++S T Y + +
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--FVGTAQYVSPELL 182
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ D + G ++ ++V P
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 2e-23
Identities = 47/234 (20%), Positives = 71/234 (30%), Gaps = 52/234 (22%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVR 133
IG GSF VY+G+ VA L + + + F E + LK + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 134 FI-----------------------------------------SIAIDVASALDYLHHHC 152
F S + L +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 153 QELILHCDPKPSNVLLDNDLF-AHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
I+H D K N+ + IGD LA ++ S + V T + A +
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMAPEM- 184
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIV 265
+ + D Y +G+ +LEM T P P +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 6e-23
Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 61/256 (23%)
Query: 59 IPKEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNR---AVVAIKVLS-IQCQGASK 114
I +E E L IG G F V+QG++ VAIK +
Sbjct: 4 IQRERIE----------LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 53
Query: 115 SFMAECKALKNICHRNLVRF-------------------------------------ISI 137
F+ E ++ H ++V+ I
Sbjct: 54 KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197
A +++AL YL +H D NVL+ ++ +GDF L+R+ + + T ++
Sbjct: 114 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKAS 167
Query: 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRK-PIDFMFEGDL--NLHNFAR 254
+ I + A + ++ D + +G+ + E++ P + D+ + N R
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227
Query: 255 MAFPNRV-MDIVNLVL 269
+ P + +L+
Sbjct: 228 LPMPPNCPPTLYSLMT 243
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 47/210 (22%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDL---NRAVVAIKVLS---IQCQGASKSFMAECKALKN 125
L+ +G GSF V +G +D VA+K L + A F+ E A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 126 ICHRNLVRFI-------------------------------------SIAIDVASALDYL 148
+ HRNL+R A+ VA + YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 149 HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
+H D N+LL IGDF L R + ++ + + A
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRKVPFAWCAP 183
Query: 209 DYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ S D + +G+ L EM T +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 92.8 bits (230), Expect = 7e-22
Identities = 31/207 (14%), Positives = 61/207 (29%), Gaps = 48/207 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
D + + +G G+F V++ A K + + ++ E + + + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
V + V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 154 ELILHCDPKPSNVLLDNDLFAHI--GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+H D KP N++ + DF L + S T + A +
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-----KQSVKVTTGTAEFAAPEVA 197
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKP 238
G V D ++ G+L +++ P
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.3 bits (226), Expect = 2e-21
Identities = 40/204 (19%), Positives = 68/204 (33%), Gaps = 44/204 (21%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
F ++ +G GSF V+ N A+KVL + + E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 129 RNLVRFISIAID----------------------------------VASALDYLHHHCQE 154
++R D A L + +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
I++ D KP N+LLD + I DF A++ + + T Y A +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKY-------VPDVTYTLCGTPDYIAPEVVSTK 176
Query: 215 EVSTNGDAYNYGILLLEMVTRRKP 238
+ + D +++GIL+ EM+ P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 89.3 bits (221), Expect = 1e-20
Identities = 35/224 (15%), Positives = 67/224 (29%), Gaps = 52/224 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
D + ++ +G G+F V++ V V K ++ + E + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
+ I+ L ++H H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 154 ELILHCDPKPSNVLLDNDLFAHI--GDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
I+H D KP N++ + + + DF LA T + A +
Sbjct: 148 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFAAPEIV 200
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
V D + G+L +++ P F G+ +L +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNV 240
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 3e-20
Identities = 49/237 (20%), Positives = 80/237 (33%), Gaps = 46/237 (19%)
Query: 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS-IQCQGASKSFMAECKALK 124
+ + ++ IG G++ V ++N+ VAIK +S + Q + + E K L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 125 NICHRNLVRFI----------------------------------------SIAIDVASA 144
H N++ +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIG 204
L Y+H +LH D KPSN+LL+ I DF LAR + T
Sbjct: 122 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHDHTGFLTEYVATRW 177
Query: 205 YTALDYDLGSEVSTN-GDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260
Y A + L S+ T D ++ G +L EM++ R D H + P++
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 8e-20
Identities = 48/236 (20%), Positives = 79/236 (33%), Gaps = 57/236 (24%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNIC- 127
+ F L ++G GSF V+ F AIK L + + M E + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 128 HRNLVRFI-------------------------------------SIAIDVASALDYLHH 150
H L A ++ L +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 151 HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDY 210
I++ D K N+LLD D I DF + + + + +N T Y A +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKE----NMLGDAKTNTFCGTPDYIAPEI 174
Query: 211 DLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-----LNLHNFARMAFPNRV 261
LG + + + D +++G+LL EM+ + P F G + +P +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPFYPRWL 226
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 86.0 bits (212), Expect = 8e-20
Identities = 45/220 (20%), Positives = 76/220 (34%), Gaps = 52/220 (23%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNIC 127
+D + L ++G G V+ VA+KVL + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 128 HRNLVRF-----------------------------------------ISIAIDVASALD 146
H +V I + D AL+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 147 YLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
+ H + I+H D KP+N+++ + DF +AR + S + + + V T Y
Sbjct: 126 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGTAQYL 181
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD 246
+ + G V D Y+ G +L E++T P F GD
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 85.3 bits (210), Expect = 2e-19
Identities = 41/225 (18%), Positives = 79/225 (35%), Gaps = 40/225 (17%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHR 129
+ + + IG G++ VY+ + A+K + ++ +G + + E LK + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 130 NLVRFI----------------------------------SIAIDVASALDYLHHHCQEL 155
N+V+ + + L+ + +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 156 ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSE 215
+LH D KP N+L++ + I DF LAR P + ++ + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 216 VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNR 260
ST D ++ G + EMV + E D + F + PN
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 2e-19
Identities = 44/224 (19%), Positives = 75/224 (33%), Gaps = 65/224 (29%)
Query: 72 DGFPLINLIGVGSFDAVYQGVF--DLNRAVVAIKVLS-IQCQGASKSFMAECKALKNIC- 127
+ ++IG G+F V + D R AIK + + + F E + L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HRNLVRFI---------------------------------------------------- 135
H N++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 136 -SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
A DVA +DYL +H D N+L+ + A I DF L+R ++
Sbjct: 130 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE-----VYV 181
Query: 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
R + + A++ S +TN D ++YG+LL E+V+
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (209), Expect = 2e-19
Identities = 41/218 (18%), Positives = 75/218 (34%), Gaps = 42/218 (19%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNL 131
+ + IG G++ V++ +VA+K + + +G S + E LK + H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 132 VRFISIAID----------------------------------VASALDYLHHHCQELIL 157
VR + + L L +L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 158 HCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVS 217
H D KP N+L++ + + +F LAR P + S V S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 218 TNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
T+ D ++ G + E+ +P+ F G+ R+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL---FPGNDVDDQLKRI 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 3e-19
Identities = 48/221 (21%), Positives = 80/221 (36%), Gaps = 44/221 (19%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHR 129
+ F + IG G++ VY+ L VVA+K + + +G + + E LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 130 NLVRFISIAID-----------------------------------VASALDYLHHHCQE 154
N+V+ + + + L L
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
+LH D KP N+L++ + + DF LAR P ++ ++ V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 215 EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
ST D ++ G + EMVTRR F GD + R+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRI 215
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.8 bits (209), Expect = 5e-19
Identities = 40/234 (17%), Positives = 74/234 (31%), Gaps = 55/234 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI------QCQGASKSFMAECKALKN 125
+ F + +IG G F VY + A+K L Q + + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 126 ICHRNLVRFI-------------------------------------SIAIDVASALDYL 148
+V A ++ L+++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 149 HHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
H+ +++ D KP+N+LLD I D LA ++ + T GY A
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACD------FSKKKPHASVGTHGYMAP 174
Query: 209 DYDL-GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV 261
+ G ++ D ++ G +L +++ P F + H RM V
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAV 226
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 5e-19
Identities = 49/227 (21%), Positives = 81/227 (35%), Gaps = 49/227 (21%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNL 131
+ + IG G+F V++ VA+K + ++ +G + + E K L+ + H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 132 VRFISIAIDVASA------------------------------------------LDYLH 149
V I I AS L+ L+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD 209
+ + ILH D K +NVL+ D + DF LAR N + T+ Y +
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 210 YDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
LG + D + G ++ EM TR +G+ H A +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALI 234
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 8e-19
Identities = 40/232 (17%), Positives = 70/232 (30%), Gaps = 50/232 (21%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
+ F + L+G G+F V A+K+L I + + E + L+N H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 RNLVRFISIAID----------------------------------VASALDYLHHHCQE 154
L A + L +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 155 LILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGS 214
+++ D K N++LD D I DF L + ++ T Y A + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 215 EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-----LNLHNFARMAFPNRV 261
+ D + G+++ EM+ R P F L + FP +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILMEEIRFPRTL 228
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.2 bits (205), Expect = 1e-18
Identities = 38/206 (18%), Positives = 62/206 (30%), Gaps = 43/206 (20%)
Query: 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-CQGASKSFMAECKALKNICHR 129
D + +++G G+F V + +VAIK ++ + +G S E L I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 130 NLVRFI-------------------------------------SIAIDVASALDYLHHHC 152
N+V + V A+ YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 153 QELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDL 212
LD D I DF L++ S + T GY A +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----GSVLSTACGTPGYVAPEVLA 182
Query: 213 GSEVSTNGDAYNYGILLLEMVTRRKP 238
S D ++ G++ ++ P
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 1e-18
Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 54/223 (24%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-----QGASKSFMAECKALKNICHRN 130
++ +G G F VY+ +VAIK + + G +++ + E K L+ + H N
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 131 LVRFI-------------------------------------SIAIDVASALDYLHHHCQ 153
++ + + + L+YLH H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 154 ELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLG 213
ILH D KP+N+LLD + + DF LA+ + T Y A + G
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKS----FGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 214 SEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
+ + D + G +L E++ R GD +L R+
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRI 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 81.3 bits (200), Expect = 3e-18
Identities = 29/215 (13%), Positives = 65/215 (30%), Gaps = 51/215 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI---------QCQGASKSFMAECKA 122
+ + ++G G V + + A+K++ + + Q ++ + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 123 LKNI-CHRNLVRFI-------------------------------------SIAIDVASA 144
L+ + H N+++ I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 145 LDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS-SNGVRRTI 203
+ LH I+H D KP N+LLD+D+ + DF + + +
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 204 GYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
D D ++ G+++ ++ P
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 5e-18
Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 8/130 (6%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
+ A VA +++L +H D NVL+ + I DF LAR SN
Sbjct: 167 LCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223
Query: 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254
R + + A + + D ++YGILL E+ + + G NF +
Sbjct: 224 G--NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDANFYK 278
Query: 255 MAFPNRVMDI 264
+ MD
Sbjct: 279 LIQNGFKMDQ 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 2e-17
Identities = 37/207 (17%), Positives = 66/207 (31%), Gaps = 49/207 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNL 131
+ + + +G G F V++ V ++ K + ++ E L HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNI 63
Query: 132 VRF--------------------------------------ISIAIDVASALDYLHHHCQ 153
+ +S V AL +LH H
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 154 ELILHCDPKPSNVLLDNDLFAH--IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
I H D +P N++ + I +F AR + N + Y A +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----LFTAPEYYAPEVH 175
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKP 238
VST D ++ G L+ +++ P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.5 bits (195), Expect = 2e-17
Identities = 35/240 (14%), Positives = 65/240 (27%), Gaps = 66/240 (27%)
Query: 63 YYESLLKATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQC-QGASKSF 116
SL + + IG G+F V+Q +VA+K+L + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 117 MAECKALKNICHRNLVRFI----------------------------------------- 135
E + + N+V+ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 136 ----------SIAIDVASALDYLHHHCQEL-------ILHCDPKPSNVLLDNDLFAHIGD 178
+ A L + +H D N L+ ++ I D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 179 FELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
F L+R S + I + + + +T D + YG++L E+ +
Sbjct: 184 FGLSRNIY--SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 2e-17
Identities = 41/246 (16%), Positives = 75/246 (30%), Gaps = 61/246 (24%)
Query: 72 DGFPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLSI-QCQGASKSFMAECKALKN 125
+ +G G+F V + VA+K+L ++ M+E K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 126 IC-HRNLVRFI---------------------------------------------SIAI 139
+ H N+V + +A+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 140 DVASALDYLHHHCQEL-------ILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192
D+ L + + + + +H D N+LL + I DF LAR + SN
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNF 252
+ R + + A + + D ++YGI L E+ + D +
Sbjct: 203 VKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 253 ARMAFP 258
+ F
Sbjct: 261 IKEGFR 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.7 bits (193), Expect = 3e-17
Identities = 45/243 (18%), Positives = 78/243 (32%), Gaps = 53/243 (21%)
Query: 68 LKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127
L+ + + L IG GSF +Y G VAIK+ ++ + E K K +
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ 60
Query: 128 HRNLVRFI--------------------------------------SIAIDVASALDYLH 149
+ I +A + S ++Y+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 150 HHCQELILHCDPKPSNVL---LDNDLFAHIGDFELARFRQEVSNPTQS---SSNGVRRTI 203
+H D KP N L +I DF LA+ ++ + + T
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 204 GYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN----LHNFARMAFPN 259
Y +++ LG E S D + G +L+ P + + +M+ P
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 260 RVM 262
V+
Sbjct: 238 EVL 240
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 4e-17
Identities = 49/236 (20%), Positives = 85/236 (36%), Gaps = 61/236 (25%)
Query: 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRA-VVAIKVLSIQC--QGASKSFMAECKALKN 125
+A + + IG G++ V++ N VA+K + +Q +G S + E L++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 126 IC---HRNLVRFI-------------------------------------------SIAI 139
+ H N+VR +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 140 DVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGV 199
+ LD+LH H ++H D KP N+L+ + + DF LAR T V
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-----V 175
Query: 200 RRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
T+ Y A + L S +T D ++ G + EM R+ F G ++ ++
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKI 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 77.9 bits (191), Expect = 9e-17
Identities = 41/235 (17%), Positives = 73/235 (31%), Gaps = 59/235 (25%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS---IQCQGASKSFMAECKALKNICH 128
D F I +G GSF V + A+K+L + + + E + L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 129 RNLVRFI-------------------------------------SIAIDVASALDYLHHH 151
LV+ A + +YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
+++ D KP N+L+D + + DF A+ + + + T A +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------KGRTWTLCGTPEALAPEII 210
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-----LNLHNFARMAFPNRV 261
L + D + G+L+ EM P F D ++ FP+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 77.2 bits (189), Expect = 1e-16
Identities = 33/218 (15%), Positives = 64/218 (29%), Gaps = 51/218 (23%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRFI 135
+ IG GSF +++G LN VAIK + + E + K + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNV 66
Query: 136 --------------------------------------SIAIDVASALDYLHHHCQELIL 157
A + + + +H ++
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 158 HCDPKPSNVLLDNDLFAHIG-----DFELARFRQEVSNPTQS---SSNGVRRTIGYTALD 209
+ D KP N L+ + DF + +F ++ + T Y +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 210 YDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDL 247
LG E S D G + + + P +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 1e-16
Identities = 39/218 (17%), Positives = 70/218 (32%), Gaps = 58/218 (26%)
Query: 74 FPLINLIGVGSFDAVYQGVF-----DLNRAVVAIKVLS-IQCQGASKSFMAECKALKNIC 127
+ +G GSF VY+GV D VAIK ++ F+ E +K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 128 HRNLVRF-----------------------------------------------ISIAID 140
++VR I +A +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 141 VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVR 200
+A + YL+ + +H D N ++ D IGDF + R E
Sbjct: 142 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGL 196
Query: 201 RTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
+ + + + +T D +++G++L E+ T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 4e-16
Identities = 40/229 (17%), Positives = 74/229 (32%), Gaps = 62/229 (27%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVR 133
+ +IG GSF VYQ + +VAIK + + E + ++ + H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 134 FI----------------------------------------------SIAIDVASALDY 147
+ +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 148 LHHHCQELILHCDPKPSNVLLDNDLFAH-IGDFELARFRQEVSNPTQSSSNGVRRTIGYT 206
+H I H D KP N+LLD D + DF A+ + + + +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ----LVRGEPNVSYICSRYYRA 190
Query: 207 ALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
++ +++ D ++ G +L E++ + F GD + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 7e-16
Identities = 36/228 (15%), Positives = 68/228 (29%), Gaps = 53/228 (23%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVL------SIQCQGASKSFMAECKALKN 125
D + +G G F V + A K + S + + + E LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 126 ICHRNLVRFISIAID----------------------------------VASALDYLHHH 151
I H N++ + + + L+ +++
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 152 CQELILHCDPKPSNVLLDND----LFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTA 207
I H D KP N++L + I DF LA + + T + A
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-----GNEFKNIFGTPEFVA 184
Query: 208 LDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
+ + D ++ G++ +++ P F GD A +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANV 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 1e-15
Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 51/229 (22%)
Query: 72 DGFPLINLIGVGSFDAVYQGVFDLNR---AVVAIKVLS----IQCQGASKSFMAECKALK 124
+ F L+ ++G G++ V+ + A+KVL +Q ++ E + L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 125 NICHRNLVRFI-----------------------------------SIAIDVASALDYLH 149
+I + + + I V + L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 150 HHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALD 209
H + I++ D K N+LLD++ + DF L++ G TI Y A D
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG---TIEYMAPD 200
Query: 210 YDLGSEVSTNG--DAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256
G + + D ++ G+L+ E++T P F D ++ A ++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEIS 245
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 1e-15
Identities = 48/237 (20%), Positives = 77/237 (32%), Gaps = 60/237 (25%)
Query: 63 YYESLLKATDGFP----LINLIGVGSFDAVYQGVFDLNRAVVAIKVL--SIQCQGASKSF 116
Y + + K + +G G++ AV V A VAIK L Q + +K
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 117 MAECKALKNICHRNLVRFI----------------------------------------- 135
E + LK++ H N++ +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 136 SIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195
+ + L Y+H H D KP N+ ++ D I DF LAR S
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ-------ADSE 174
Query: 196 SNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHN 251
G T Y A + L + D ++ G ++ EM+T + F L+
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQLK 229
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 7e-15
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 8/134 (5%)
Query: 135 ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQS 194
I + VA +++L +H D N+LL I DF LAR +P
Sbjct: 137 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDYV 191
Query: 195 SSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFAR 254
R + + A + + D +++G+LL E+ + + G F R
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR 248
Query: 255 MAFPNRVMDIVNLV 268
M +
Sbjct: 249 RLKEGTRMRAPDYT 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 1e-14
Identities = 44/234 (18%), Positives = 73/234 (31%), Gaps = 62/234 (26%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC------QGASKSFMAECKALKNI--C 127
+ L+G G F +VY G+ + VAIK + E LK +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 128 HRNLVRFI--------------------------------------SIAIDVASALDYLH 149
++R + S V A+ + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 150 HHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTAL 208
+ +LH D K N+L+D N + DF ++ + T Y+
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD------TVYTDFDGTRVYSPP 178
Query: 209 DYDLGSEVSTNG-DAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV 261
++ ++ GILL +MV P FE D + ++ F RV
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIR-GQVFFRQRV 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 2e-14
Identities = 45/239 (18%), Positives = 83/239 (34%), Gaps = 58/239 (24%)
Query: 61 KEYYESLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQGASKSFMA 118
+E +++ + + + ++ +G G++ +V VA+K LS Q +K
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 119 ECKALKNICHRNLVRFI-----------------------------------------SI 137
E + LK++ H N++ + +
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197
+ L Y+H H D KPSN+ ++ D I DF LAR T
Sbjct: 127 IYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH-------TDDEMT 176
Query: 198 GVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
G T Y A + L + D ++ G ++ E++T R F G ++ +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLI 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 69.9 bits (170), Expect = 4e-14
Identities = 52/240 (21%), Positives = 86/240 (35%), Gaps = 56/240 (23%)
Query: 60 PKEY--YESLLKAT---DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASK 114
P+EY YES + D + L+ +G G + V++ + N V +K+L K
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKK 74
Query: 115 SFMAECKALKNI-CHRNLVRFI------------------------------------SI 137
E K L+N+ N++
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY 134
Query: 138 AIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARFRQEVSNPTQSSS 196
++ ALDY H I+H D KP NV++D++ + D+ LA F +P Q +
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----HPGQEYN 187
Query: 197 NGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMA 256
V + D ++ G +L M+ R++P F G N R+A
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLVRIA 244
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 6e-14
Identities = 46/224 (20%), Positives = 75/224 (33%), Gaps = 54/224 (24%)
Query: 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLS--IQCQGASKSFMAECKALKNICHRNL 131
+ + IG G+ V + VAIK LS Q Q +K E +K + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 132 VRFI----------------------------------------SIAIDVASALDYLHHH 151
+ + + + + +LH
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
H D KPSN+++ +D I DF LAR T T Y A +
Sbjct: 139 GII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-----YVVTRYYRAPEVI 190
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
LG N D ++ G ++ EMV + F G + + ++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKV 230
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 6e-14
Identities = 35/239 (14%), Positives = 66/239 (27%), Gaps = 71/239 (29%)
Query: 59 IPKEYYESLLKATDGFPLINLIGVGSFDAVYQGV-------FDLNRAVVAIKVLSIQ-CQ 110
+P++ L +G G+F V VA+K+L +
Sbjct: 10 LPRDRLV----------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 111 GASKSFMAECKALKNIC-HRNLVRFISIAID----------------------------- 140
++E + +K I H+N++ +
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 141 ---------------------VASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDF 179
+ + + +H D NVL+ D I DF
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 180 ELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKP 238
LAR + R + + A + + D +++G+LL E+ T
Sbjct: 180 GLARDIHH--IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 1e-13
Identities = 35/224 (15%), Positives = 63/224 (28%), Gaps = 64/224 (28%)
Query: 79 LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRFI-- 135
++G+G V Q + A+K+L E + ++VR +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 136 -----------------------------------------SIAIDVASALDYLHHHCQE 154
I + A+ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 155 LILHCDPKPSNVLLD---NDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYD 211
I H D KP N+L + + DF A+ +S T Y A +
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-----HNSLTTPCYTPYYVAPEVL 185
Query: 212 LGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARM 255
+ + D ++ G+++ ++ P F + L M
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGM 225
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.5 bits (153), Expect = 7e-12
Identities = 39/243 (16%), Positives = 82/243 (33%), Gaps = 63/243 (25%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNI--------- 126
L+ +G G F V+ +N VA+K++ + +++ E K L+ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 127 --CHRNLVRFI------------------------------------------SIAIDVA 142
++++ + I+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 143 SALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSNPTQSSSNGVRR 201
LDY+H C I+H D KP NVL++ D ++ ++A + +
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN--ACWYDEHYTNSIQ 191
Query: 202 TIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV 261
T Y + + LG+ D ++ L+ E++T FE D ++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQI 247
Query: 262 MDI 264
+++
Sbjct: 248 IEL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.0 bits (129), Expect = 3e-09
Identities = 19/152 (12%), Positives = 34/152 (22%), Gaps = 49/152 (32%)
Query: 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSI----------QCQGASKSFMAECKALKN 125
+ L+G G AV+ +K + + F
Sbjct: 4 IGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 126 ICHRNLVRF----------------------------------ISIAIDVASALDYLHHH 151
R L + + + + +H
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 152 CQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183
I+H D NVL+ + I DF +
Sbjct: 123 G---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 356 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.77 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.61 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=363.45 Aligned_cols=228 Identities=27% Similarity=0.419 Sum_probs=175.0
Q ss_pred hhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
...++|++.+.||+|+||.||+|++. ..||||+++.. .....+.|.+|+.+|++++|||||++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEE
Confidence 34578999999999999999999864 45999998644 23445789999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 568999999999999999 9999999999999999999999999998664332
Q ss_pred CCCccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CCchHHHh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PNRVMDIV 265 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 265 (356)
. ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+........ +....
T Consensus 159 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~--- 232 (276)
T d1uwha_ 159 G--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLS--- 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCCCGG---
T ss_pred C--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCcch---
Confidence 2 223345678999999999864 358899999999999999999999997532211 1111111111 11100
Q ss_pred hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 266 NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 266 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.....++..+.+|+.+||+.||++||||++|++.|+.+.++++
T Consensus 233 ------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 233 ------------------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ------------------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------------------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0011345578899999999999999999999999999987764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=355.01 Aligned_cols=217 Identities=21% Similarity=0.262 Sum_probs=171.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.+|++++|||||++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4689999999999999999999999999999999975432 334568899999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~-- 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 158 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc--
Confidence 569999999999999999 99999999999999999999999999987654321
Q ss_pred ccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||....................
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------------ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------ 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Confidence 223345789999999999988876 5779999999999999999999975433322222111110000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ......+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPW------------------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTG------------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Ccc------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 022235678999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=358.65 Aligned_cols=240 Identities=20% Similarity=0.254 Sum_probs=185.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+|++++||||+++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999743 23345678999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc-
Confidence 458899999999999999 99999999999999999999999999987643322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....+..
T Consensus 164 -~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~------------~~~i~~~ 225 (288)
T d1uu3a_ 164 -QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLI------------FQKIIKL 225 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH------------HHHHHTT
T ss_pred -ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHH------------HHHHHcC
Confidence 1223346799999999999999999999999999999999999999974211 111 1111111
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCCcCCccccc
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLTNNRAPKLK 349 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~~~~~~~~~ 349 (356)
.... +......+.+|+.+||+.||.+|||++|++..-.=..+.......++.+.++.+|.++
T Consensus 226 ~~~~----------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 226 EYDF----------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp CCCC----------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred CCCC----------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 1100 0022335689999999999999999999876533223334444567788888777664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=355.57 Aligned_cols=214 Identities=19% Similarity=0.225 Sum_probs=174.5
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|+.+|++++|||||++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999999999999999999987666666789999999999999999987
Q ss_pred -------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccC
Q 039228 135 -------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSS 195 (356)
Q Consensus 135 -------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 195 (356)
..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~----~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SK 172 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----CC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc----cc
Confidence 568999999999999999 9999999999999999999999999998764322 22
Q ss_pred CCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccccc
Q 039228 196 SNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKV 275 (356)
Q Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 275 (356)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+........+. +
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~---------~------ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE---------L------ 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC---------C------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC---------C------
Confidence 344679999999999999999999999999999999999999996422111 011111110000 0
Q ss_pred ccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 276 LAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 237 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 --------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000123345789999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-50 Score=361.95 Aligned_cols=226 Identities=21% Similarity=0.334 Sum_probs=180.9
Q ss_pred HHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 67 LLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
|+...++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|+.+|++++|||||++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567999999999999999999999999999999987543 345789999999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 558899999999999999 99999999999999999999999999987644
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.. ........|++.|+|||++.+..++.++|||||||++|||++|..||.... ..... .+.+..
T Consensus 168 ~~---~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~~---------~~~i~~ 231 (287)
T d1opja_ 168 DT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQV---------YELLEK 231 (287)
T ss_dssp SS---SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHH---------HHHHHT
T ss_pred CC---ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHHH---------HHHHhc
Confidence 32 222334568899999999999999999999999999999999777654211 11111 111211
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
....... ..++..+.+|+.+||+.||++||||++|++.|+.+.+.
T Consensus 232 ~~~~~~~------------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 232 DYRMERP------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TCCCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCC------------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111111 13445688999999999999999999999999887654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=353.58 Aligned_cols=233 Identities=20% Similarity=0.360 Sum_probs=171.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCC----eEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR----AVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
.+.|++.++||+|+||.||+|.+..++ ..||||+++.... .....|.+|+.++++++|||||++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 356889999999999999999987554 5799999975433 334578999999999999999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 568999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.... ........||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...+.. ..+..
T Consensus 163 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~---------~~i~~ 228 (283)
T d1mqba_ 163 DPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVM---------KAIND 228 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHH---------HHHHT
T ss_pred CCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHH---------HHHhc
Confidence 3221 222334568999999999999999999999999999999999766654221 111111 11111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccccccccCC
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPETVFKSLT 341 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~ 341 (356)
...... +..++..+.+|+.+||+.||++||||.+|++.|+.+.+. ++++++++
T Consensus 229 ~~~~~~------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~---p~~l~~l~ 281 (283)
T d1mqba_ 229 GFRLPT------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA---PDSLKTLA 281 (283)
T ss_dssp TCCCCC------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS---GGGGGSBC
T ss_pred cCCCCC------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC---cccccccc
Confidence 111111 113445688999999999999999999999999887653 44455443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=350.93 Aligned_cols=220 Identities=20% Similarity=0.361 Sum_probs=166.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++.. ++.||||+++... ...+.+.+|+.++++++|||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3579999999999999999999874 5789999997543 345789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 568999999999999999 99999999999999999999999999987644322
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcC-CCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......||+.|+|||++.+..++.++|||||||++|||+|+ .+||.... ...+...+.... ..
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~------------~~ 221 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF------------RL 221 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTC------------CC
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcC------------CC
Confidence 223346789999999999999999999999999999999995 55554211 111111111110 00
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.. +..++..+.+|+.+||+.||++||||++|++.|++|.++
T Consensus 222 ~~------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YK------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00 013344678999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=355.49 Aligned_cols=224 Identities=21% Similarity=0.359 Sum_probs=164.9
Q ss_pred cCCCCccccceecCceEEEEEEECCCCe---EEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRA---VVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||+||+|++..+++ .||||.+.... ....+.|.+|+.+|++++|||||++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568889999999999999999976543 68999886543 3345679999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 568999999999999999 999999999999999999999999999876543
Q ss_pred CCC-CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 189 SNP-TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 189 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~------------ 247 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIE------------ 247 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH------------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHH------------
Confidence 321 1222334567899999999999999999999999999999998 89999743211 1111111
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
....... +..++..+.+|+.+||+.||++||||.+|++.|+++.+
T Consensus 248 ~~~~~~~------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QDYRLPP------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTCCCCC------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1110000 11345578899999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=350.61 Aligned_cols=222 Identities=22% Similarity=0.344 Sum_probs=175.8
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|+++ +++.||||+++... ...+.+.+|+.+|++++|||||++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence 3467999999999999999999986 45889999997543 345789999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
+.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-- 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-- 163 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc--
Confidence 568999999999999999 9999999999999999999999999998765322
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
........||+.|+|||++.++.++.++|||||||++|||+||..|+..... .......+.. ....
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~------------~~~~ 229 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLER------------GYRM 229 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHT------------TCCC
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHh------------cCCC
Confidence 2233456789999999999988999999999999999999996555432111 1111111111 1000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.. +..++..+.+|+.+||+.||++||||++|++.|+.+-.+
T Consensus 230 ~~------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 VR------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 00 013444678999999999999999999999999887543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=348.54 Aligned_cols=210 Identities=19% Similarity=0.238 Sum_probs=171.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|+.+++.++|||||++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999998643 23345678899999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 568999999999999999 999999999999999999999999999765432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~------------i~~ 218 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKR------------ISR 218 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHH------------HHT
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHH------------HHc
Confidence 2234679999999999999999999999999999999999999996421 1111111 111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..... +...+..+.+|+.+||+.||++|||++|+++
T Consensus 219 ~~~~~----------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VEFTF----------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCCCC----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC----------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11000 0022345789999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=350.08 Aligned_cols=216 Identities=20% Similarity=0.260 Sum_probs=162.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999999999999999997543 2334678899999999999999987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCC--CcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQ--ELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~--~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+.++.||+.||.|||+.+. .+||||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 4588999999999998652 349999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...
T Consensus 163 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~----------- 225 (269)
T d2java1 163 ILNHDT----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGK----------- 225 (269)
T ss_dssp HC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-----------
T ss_pred ecccCC----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHH-----------
Confidence 764322 2234577899999999999999999999999999999999999999743211 11111
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+....... . +...+..+.+|+.+||+.||.+|||+.||++
T Consensus 226 i~~~~~~~-~------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGKFRR-I------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTCCCC-C------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCC-C------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111100 0 0123346789999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=355.66 Aligned_cols=222 Identities=22% Similarity=0.355 Sum_probs=172.6
Q ss_pred CCCCccccceecCceEEEEEEECCCCe----EEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA----VVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
++|++++.||+|+||+||+|.+..+++ .||+|.++.. .....+.+.+|+.++++++|||||++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 469999999999999999999987765 5888888643 33456789999999999999999997
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 568999999999999999 9999999999999999999999999998765433
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
. ........||+.|+|||++.++.++.++|||||||++|||+| |.+||...... .+...+...
T Consensus 166 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~------------ 229 (317)
T d1xkka_ 166 K--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG------------ 229 (317)
T ss_dssp C----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHT------------
T ss_pred c--cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC------------
Confidence 2 222334568999999999999999999999999999999999 88998753221 122222111
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
..... +..++..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus 230 ~~~~~------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ERLPQ------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCCCC------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCC------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11000 113445678999999999999999999999999888643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=351.68 Aligned_cols=214 Identities=21% Similarity=0.279 Sum_probs=172.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH-----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF----------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l----------------- 134 (356)
+.|++++.||+|+||.||+|++..+++.||||+++.......+.+.+|+.+|++++|||||++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 468999999999999999999999999999999987766777889999999999999999997
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 458899999999999999 9999999999999999999999999997653221
Q ss_pred cCCCCccccccccchhhhc-----CCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 194 SSSNGVRRTIGYTALDYDL-----GSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||....... .+........+ .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~-~-------- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP-T-------- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC-C--------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC-C--------
Confidence 1223467899999999984 4568899999999999999999999997532211 11111110000 0
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
+ ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~--------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L--------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C--------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 001133446789999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=341.66 Aligned_cols=217 Identities=21% Similarity=0.354 Sum_probs=176.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 468999999999999999999986 568999999986543 45789999999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 568999999999999999 99999999999999999999999999986654322
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+... ...
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~------------~~~ 220 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQG------------LRL 220 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTT------------CCC
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhC------------CCC
Confidence 23334678999999999999999999999999999999998 89999754321 111111110 000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
.. +..++..+.+|+.+||+.||++|||+++|++.|..|
T Consensus 221 ~~------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YR------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CC------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CC------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 00 013334678999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=345.35 Aligned_cols=226 Identities=22% Similarity=0.338 Sum_probs=178.9
Q ss_pred CCCCcccc-ceecCceEEEEEEECC--CCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 72 DGFPLINL-IGVGSFDAVYQGVFDL--NRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
++|.+.+. ||+|+||.||+|.+.. ++..||||+++... ....+.|.+|+.+|++++|||||++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 45777774 9999999999998754 35689999997543 3345789999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 568999999999999999 99999999999999999999999999987654332
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+...+....
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~------------ 229 (285)
T d1u59a_ 165 Y-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK------------ 229 (285)
T ss_dssp E-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTC------------
T ss_pred c-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC------------
Confidence 1 223344568999999999998999999999999999999998 9999975321 11111111110
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhcc
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLP 333 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~ 333 (356)
... .+..++..+.+|+.+||+.||++||||.+|++.|+.+..++..
T Consensus 230 ~~~------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 230 RME------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp CCC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCC------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 000 0113445678999999999999999999999999988766543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=353.60 Aligned_cols=164 Identities=26% Similarity=0.365 Sum_probs=144.5
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
..++|++++.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+|++++|||||++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999999999999999999999999997553 3335678999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.|++.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 4588999999999997 48 999999999999999999999999999865432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCcc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFM 242 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 242 (356)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223468999999999999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=342.22 Aligned_cols=210 Identities=24% Similarity=0.301 Sum_probs=163.9
Q ss_pred CccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 75 PLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
++.+.||+|+||+||+|++..+++.||+|.+.... ....+.+.+|+++|++++|||||++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999999999999999987542 3344678999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC-CCCceEEcccccccccccCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD-NDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 458899999999999874 4599999999999996 578999999999975432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...........+... ..+.
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~~i~~~~~~----~~~~ 235 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKP----ASFD 235 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCC----GGGG
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cHHHHHHHHHcCCCC----cccC
Confidence 12234679999999999875 59999999999999999999999996432 111111111100000 0000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
......+.+|+.+||+.||++|||++|+++
T Consensus 236 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ----------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 012235689999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-47 Score=347.55 Aligned_cols=208 Identities=26% Similarity=0.335 Sum_probs=167.2
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.|+.++.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+|++++|||||++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 38999999999999999999999999999999975532 234568899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 568999999999999999 99999999999999999999999999975432
Q ss_pred ccCCCCccccccccchhhhcC---CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLG---SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||....... .+........+ .+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~---------~~ 234 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------AL 234 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------CC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC---------CC
Confidence 223678999999999864 458999999999999999999999996422110 01111110000 00
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. ...+..+.+|+.+||+.||++|||++++++
T Consensus 235 ~~---------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QS---------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00 022346789999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-47 Score=348.21 Aligned_cols=227 Identities=21% Similarity=0.300 Sum_probs=177.3
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCcc-chHHHHHHHHHHhhcCCCChHHH-----
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQG-ASKSFMAECKALKNICHRNLVRF----- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l----- 134 (356)
+++...++|++.+.||+|+||.||+|+++. +++.||||+++..... ..+++.+|+.+|++++||||+++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344556789999999999999999999753 4689999999754333 35679999999999999999986
Q ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEe
Q 039228 135 --------------------------------------------------------ISIAIDVASALDYLHHHCQELILH 158 (356)
Q Consensus 135 --------------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH 158 (356)
+.++.|++.||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 447889999999999999 999
Q ss_pred cCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCC-C
Q 039228 159 CDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRR-K 237 (356)
Q Consensus 159 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~-~ 237 (356)
|||||+|||++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc--ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999986644322 22334466889999999999999999999999999999999985 5
Q ss_pred CCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCCh
Q 039228 238 PIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNV 317 (356)
Q Consensus 238 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 317 (356)
||...... .+...+. +.... . .+..++..+.+|+.+||+.||++||||
T Consensus 242 p~~~~~~~--e~~~~v~-----------~~~~~-~------------------~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 242 PYYGMAHE--EVIYYVR-----------DGNIL-A------------------CPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp TTTTSCHH--HHHHHHH-----------TTCCC-C------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCHH--HHHHHHH-----------cCCCC-C------------------CCccchHHHHHHHHHHcCCChhHCcCH
Confidence 66532111 1111111 10000 0 011344567899999999999999999
Q ss_pred HHHHHHHHHhhh
Q 039228 318 PNAVHDLQSVNN 329 (356)
Q Consensus 318 ~~vl~~L~~i~~ 329 (356)
.+|+++|++|.+
T Consensus 290 ~ev~~~L~~i~~ 301 (301)
T d1lufa_ 290 CSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHHHTTC
T ss_pred HHHHHHHHHhcC
Confidence 999999998853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=349.97 Aligned_cols=219 Identities=23% Similarity=0.307 Sum_probs=172.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCC-----eEEEEEEeecc-CccchHHHHHHHHHHhhc-CCCChHHH---------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNR-----AVVAIKVLSIQ-CQGASKSFMAECKALKNI-CHRNLVRF--------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l--------- 134 (356)
.++|++.+.||+|+||+||+|++..++ ..||+|.+... .......+.+|+.+|.++ +|||||++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 467999999999999999999986543 37999998643 333456789999999998 89999987
Q ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 039228 135 ---------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKP 163 (356)
Q Consensus 135 ---------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp 163 (356)
+.++.||+.||.|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 237889999999999999 99999999
Q ss_pred CCeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCcc
Q 039228 164 SNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFM 242 (356)
Q Consensus 164 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~ 242 (356)
+|||++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987654332 222345678999999999999999999999999999999998 89999753
Q ss_pred ccCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 243 FEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ..+........ ..+. +..++..+.+|+.+||+.||++||||+||++
T Consensus 271 ~~~-~~~~~~~~~~~------------~~~~------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 271 PVD-ANFYKLIQNGF------------KMDQ------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp CCS-HHHHHHHHTTC------------CCCC------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH-HHHHHHHhcCC------------CCCC------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 322 12222221111 1111 1134456889999999999999999999999
Q ss_pred HHH
Q 039228 323 DLQ 325 (356)
Q Consensus 323 ~L~ 325 (356)
.|.
T Consensus 320 ~L~ 322 (325)
T d1rjba_ 320 FLG 322 (325)
T ss_dssp HHH
T ss_pred HHh
Confidence 985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=340.21 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=168.7
Q ss_pred ccceecCceEEEEEEECC--CCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH-------------------
Q 039228 78 NLIGVGSFDAVYQGVFDL--NRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF------------------- 134 (356)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l------------------- 134 (356)
+.||+|+||.||+|.+.. +++.||||+++... ....+.+.+|+.+|++++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 469999999999998753 45789999996432 3335679999999999999999987
Q ss_pred -----------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCccCCC
Q 039228 135 -----------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQSSSN 197 (356)
Q Consensus 135 -----------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 197 (356)
+.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...... .....
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 168 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQT 168 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EEC--
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc-ccccc
Confidence 568999999999999999 999999999999999999999999999876443321 22334
Q ss_pred CccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccccccc
Q 039228 198 GVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVL 276 (356)
Q Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 276 (356)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+...+. .......
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~------------~~~~~~~--- 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLE------------KGERMGC--- 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH------------TTCCCCC---
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHH------------cCCCCCC---
Confidence 4678999999999999999999999999999999998 89999743211 1111111 1100000
Q ss_pred cccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 277 AGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
+..++..+.+|+.+||+.||++|||+++|++.|+.....
T Consensus 232 ---------------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 232 ---------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 113445688999999999999999999999999876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-46 Score=347.94 Aligned_cols=216 Identities=17% Similarity=0.194 Sum_probs=173.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999999999999999987666666789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--CCCceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD--NDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 568999999999999999 99999999999995 46889999999998764322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+......... +.
T Consensus 181 ----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~----------~~ 245 (350)
T d1koaa2 181 ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWN----------MD 245 (350)
T ss_dssp ----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC----------SC
T ss_pred ----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC----------CC
Confidence 223467899999999999999999999999999999999999999643111 001111110000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ........+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DS------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CG------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 001223457899999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=340.98 Aligned_cols=222 Identities=19% Similarity=0.280 Sum_probs=167.0
Q ss_pred cCCCCccccceecCceEEEEEEECCC---CeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF------------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l------------ 134 (356)
.++|++.+.||+|+||.||+|++..+ +..||||.++... ....+.+.+|+.+|++++||||+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 45799999999999999999998654 3578999886443 3334679999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+++ ||||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 568899999999999999 9999999999999999999999999998764322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
........||+.|+|||++.+..++.++|||||||++|||+| |.+||...... .+...+.....
T Consensus 163 ---~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~---------- 227 (273)
T d1mp8a_ 163 ---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER---------- 227 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC----------
T ss_pred ---ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 122334567899999999999999999999999999999998 89998754322 11111111100
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.. .+..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 228 --~~------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 --LP------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00 0113445688999999999999999999999999988654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=340.40 Aligned_cols=223 Identities=22% Similarity=0.332 Sum_probs=171.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++..+ +.||||+++... ...+.|.+|+.++++++|||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEec
Confidence 46799999999999999999999866 679999997543 345789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
+.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~--- 167 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--- 167 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC---
Confidence 568999999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
........||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+...+. ......
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~------------~~~~~~ 234 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE------------RGYRMP 234 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH------------TTCCCC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHH------------hcCCCC
Confidence 1223346689999999999999999999999999999999997666542211 111111111 111101
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
. ...++..+.+++.+||+.||++||||++|+++|+.+.....
T Consensus 235 ~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 C------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp C------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred C------------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 0 11344568899999999999999999999999988765543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.2e-46 Score=334.75 Aligned_cols=226 Identities=22% Similarity=0.268 Sum_probs=171.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc---cchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ---GASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++.++||||+++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999975432 334578999999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQ 186 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 186 (356)
..++.||+.||.|||+++ ||||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 568999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 187 EVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
.... .........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....
T Consensus 163 ~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~------------ 224 (277)
T d1o6ya_ 163 DSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAY------------ 224 (277)
T ss_dssp -----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH------------
T ss_pred cccc-cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHH------------
Confidence 3322 123344578999999999999999999999999999999999999999742211 1110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-ChHHHHHHHHHhhh
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-NVPNAVHDLQSVNN 329 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~vl~~L~~i~~ 329 (356)
..+...... .. ......+..+.+++.+||+.||.+|| |++++++.|.++.+
T Consensus 225 ~~~~~~~~~-----~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 225 QHVREDPIP-----PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHCCCCC-----GG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHhcCCCC-----Cc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 001000000 00 00012334678999999999999999 89999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=343.08 Aligned_cols=215 Identities=22% Similarity=0.254 Sum_probs=155.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
.+.|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|++++|||||++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3569999999999999999999999999999999975432 234567899999999999999997
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 458999999999999999 99999999999994 57899999999998654322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVL 269 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (356)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .+
T Consensus 165 -----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~---------------i~ 222 (307)
T d1a06a_ 165 -----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQ---------------IL 222 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH---------------HH
T ss_pred -----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHH---------------Hh
Confidence 223467999999999999999999999999999999999999999742211 11111 11
Q ss_pred ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 223 KAEYEFD------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTCCCCC------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCCCC------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1000000 0000123345789999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-46 Score=346.13 Aligned_cols=215 Identities=19% Similarity=0.212 Sum_probs=173.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++++.||+|+||.||+|++..+++.||||+++.......+.+.+|+.+|++++|||||++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3569999999999999999999999999999999987665556778899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC--CCCceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD--NDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 568999999999999999 99999999999998 67899999999998765322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......||+.|+|||++.+..++.++|||||||++|+|+||..||....... .+......... ..
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~----------~~ 248 (352)
T d1koba_ 184 ----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE----------FD 248 (352)
T ss_dssp ----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC----------CC
T ss_pred ----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC----------CC
Confidence 2233668999999999999999999999999999999999999996422110 01111110000 00
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 ED------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SS------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00123345789999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=338.45 Aligned_cols=224 Identities=21% Similarity=0.318 Sum_probs=176.2
Q ss_pred cccceecCceEEEEEEECCCC---eEEEEEEeecc-CccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 77 INLIGVGSFDAVYQGVFDLNR---AVVAIKVLSIQ-CQGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
.++||+|+||+||+|++..++ ..||||.++.. .....++|.+|+++|++++||||+++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 46999999743 34455789999999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
+.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 568999999999999999 99999999999999999999999999987755444334
Q ss_pred cCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLNDN 273 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 273 (356)
.......||..|+|||.+....++.++||||||+++|||+||..||....... .+......... ..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~------------~~- 254 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR------------LL- 254 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC------------CC-
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC------------CC-
Confidence 44455678999999999999999999999999999999999888875432211 11111111100 00
Q ss_pred ccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhccc
Q 039228 274 KVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILLPE 334 (356)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~~~ 334 (356)
.+..++..+.+|+.+||+.||++||||.||++.|+++.+++...
T Consensus 255 -----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 255 -----------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 00133446789999999999999999999999999998876554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-46 Score=340.21 Aligned_cols=209 Identities=22% Similarity=0.242 Sum_probs=170.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.+|+.++|||||++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35799999999999999999999999999999999743 23345778999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 447889999999999999 999999999999999999999999999875432
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .. ++...+.
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~------------~~~~i~~ 215 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MK------------TYEKILN 215 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HH------------HHHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HH------------HHHHHHc
Confidence 2346799999999999999999999999999999999999999974211 11 1111111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
..... +...+..+.+++.+||..||.+|| |++++++
T Consensus 216 ~~~~~----------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 AELRF----------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCC----------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC----------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11100 002233578999999999999996 8899876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=333.29 Aligned_cols=215 Identities=17% Similarity=0.151 Sum_probs=170.2
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC------ccchHHHHHHHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC------QGASKSFMAECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+|++++|||||++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356999999999999999999999999999999996432 1235679999999999999999997
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC----ceEEccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL----FAHIGDFELAR 183 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 558899999999999999 99999999999998776 59999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....
T Consensus 166 ~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~-------- 227 (293)
T d1jksa_ 166 KIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLAN-------- 227 (293)
T ss_dssp ECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------
T ss_pred hcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----HHHHHH--------
Confidence 764322 22346789999999999999999999999999999999999999974321 111110
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
........ ........+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ----i~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 228 ----VSAVNYEF------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----HHTTCCCC------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHhcCCCC------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00000123345789999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=338.18 Aligned_cols=229 Identities=21% Similarity=0.230 Sum_probs=168.7
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccC-ccchHHHHHHHHHHhhc-CCCChHHH----
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQC-QGASKSFMAECKALKNI-CHRNLVRF---- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l---- 134 (356)
.+....++|++.+.||+|+||.||+|++.. +++.||||+++... ....+.+..|..++.++ +|+||+.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 344445789999999999999999999753 45789999987543 33456788888888877 57888865
Q ss_pred --------------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCC
Q 039228 135 --------------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPS 164 (356)
Q Consensus 135 --------------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~ 164 (356)
+.++.||+.||.|||+++ ||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 347889999999999999 999999999
Q ss_pred CeEeCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcC-CCCCCccc
Q 039228 165 NVLLDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTR-RKPIDFMF 243 (356)
Q Consensus 165 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~ 243 (356)
|||++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+|| .+||....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeECCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999986543322 2233456799999999999999999999999999999999997 56775432
Q ss_pred cCCccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 244 EGDLNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.. ..+........ ..... ..++..+.+++.+||+.||++|||+.+|++.
T Consensus 242 ~~-~~~~~~~~~~~------------~~~~~------------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 ID-EEFCRRLKEGT------------RMRAP------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CS-HHHHHHHHHTC------------CCCCC------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH-HHHHHHHhcCC------------CCCCC------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21 11222111111 00100 1233467899999999999999999999999
Q ss_pred HHHhhhh
Q 039228 324 LQSVNNI 330 (356)
Q Consensus 324 L~~i~~~ 330 (356)
|+.+.++
T Consensus 291 L~~ilq~ 297 (299)
T d1ywna1 291 LGNLLQA 297 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=331.52 Aligned_cols=214 Identities=23% Similarity=0.368 Sum_probs=167.3
Q ss_pred hcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
..++|++.+.||+|+||.||+|+++ +..||||+++.. ...+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467899999999999999999985 688999999643 345789999999999999999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 568999999999999998 999999999999999999999999999864322
Q ss_pred CCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.....++..|+|||++.+..++.++|||||||++|||+| |++||...... .+...+....
T Consensus 157 ------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~----------- 217 (262)
T d1byga_ 157 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY----------- 217 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC-----------
T ss_pred ------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 223456889999999999999999999999999999998 78887643221 2222211110
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
... .+..++..+.+|+.+||+.||++||||.+|+++|+.++.
T Consensus 218 -~~~------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 -KMD------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCC------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 001 011333467899999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-45 Score=343.56 Aligned_cols=208 Identities=20% Similarity=0.181 Sum_probs=169.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999999999999999999743 23345678999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 458999999999999999 999999999999999999999999999865422
Q ss_pred CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...... .+......
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~--------~i~~~~~~- 256 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYE--------KIVSGKVR- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH--------HHHHCCCC-
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHH--------HHhcCCCC-
Confidence 234679999999999999999999999999999999999999996421 111111 01110000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCC-----ChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRM-----NVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~vl~ 322 (356)
. +......+.+++.+||+.||.+|+ |+++|++
T Consensus 257 -~------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -F------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -C------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -C------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 002233578999999999999994 8999886
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=340.63 Aligned_cols=212 Identities=20% Similarity=0.251 Sum_probs=171.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l------------- 134 (356)
.++|++++.||+|+||.||+|+++.+++.||||++++. .....+.+.+|+.+|++++||||+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999999999999999999753 23345778999999999999999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 458889999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .... .....
T Consensus 160 ---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~------------~~i~~ 219 (337)
T d1o6la_ 160 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLF------------ELILM 219 (337)
T ss_dssp ---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHHHH
T ss_pred ---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHH------------HHHhc
Confidence 233457899999999999999999999999999999999999999974321 1111 11111
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
..... +......+.+|+.+||+.||.+||+ +.++++
T Consensus 220 ~~~~~----------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 EEIRF----------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCC----------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCC----------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11000 0022335679999999999999995 777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=336.71 Aligned_cols=221 Identities=24% Similarity=0.305 Sum_probs=164.5
Q ss_pred CCCCccccceecCceEEEEEEECCC---CeEEEEEEeecc---CccchHHHHHHHHHHhhcCCCChHHH-----------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLN---RAVVAIKVLSIQ---CQGASKSFMAECKALKNICHRNLVRF----------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l----------- 134 (356)
++|++.+.||+|+||.||+|++... ...||||+++.. .....+.|.+|+.+|++++||||+++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 5699999999999999999987532 347899998643 23345679999999999999999987
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
+.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 568999999999999999 999999999999999999999999999876543
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCCccHHHHHHHhCCCchHHHhhh
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNL 267 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
... ........++..|+|||.+.+..++.++|||||||++|||+| |..||...... +.... +...
T Consensus 165 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~~~--------i~~~ 230 (273)
T d1u46a_ 165 DDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHK--------IDKE 230 (273)
T ss_dssp CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH--------HHTS
T ss_pred CCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHHHH--------HHhC
Confidence 321 223334567889999999999999999999999999999998 89999743211 11111 1111
Q ss_pred hhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHh
Q 039228 268 VLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSV 327 (356)
Q Consensus 268 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i 327 (356)
..... .+..++..+.+|+.+||+.||++||||.+|++.|++.
T Consensus 231 ~~~~~------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLP------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00000 0113344678999999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=332.64 Aligned_cols=238 Identities=25% Similarity=0.279 Sum_probs=172.3
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++++.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+|++++|||||++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999996543 2335788999999999999999987
Q ss_pred -----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCC
Q 039228 135 -----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNP 191 (356)
Q Consensus 135 -----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 191 (356)
..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 568999999999999999 9999999999999999999999999998654322
Q ss_pred CccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC-CC-chHHHhhhh
Q 039228 192 TQSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF-PN-RVMDIVNLV 268 (356)
Q Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~ 268 (356)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||......+ .+........ +. .....+...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccc
Confidence 2334467899999999887765 4789999999999999999999997532211 1111111111 11 100000000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... ......................+.+|+.+||+.||++|||++|+++
T Consensus 234 -~~~----~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 -PDY----KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp -TTC----CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -ccc----ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0000001111111111123346789999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=330.48 Aligned_cols=235 Identities=21% Similarity=0.247 Sum_probs=164.7
Q ss_pred ccccceecCceEEEEEEECCCCeEEEEEEeeccCcc-----chHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 76 LINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG-----ASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.+++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+|++++|||||++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999999999999999998644221 23568899999999999999987
Q ss_pred ---------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCCc
Q 039228 135 ---------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 ---------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---- 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---- 154 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC----
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc----
Confidence 568999999999999999 9999999999999999999999999998654322
Q ss_pred cCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhccc
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLND 272 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 272 (356)
.......||+.|+|||++.+. .++.++|||||||++|||+||.+||......+ .+..............+.+..-...
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccch
Confidence 223346789999999998754 57999999999999999999999997432211 1111111111111000000000000
Q ss_pred cccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 273 NKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..........-..... ......+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~----~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIF----SAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHC----TTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhc----ccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000000000 122346789999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=332.96 Aligned_cols=221 Identities=22% Similarity=0.311 Sum_probs=170.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCe--EEEEEEeecc-CccchHHHHHHHHHHhhc-CCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRA--VVAIKVLSIQ-CQGASKSFMAECKALKNI-CHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l------------- 134 (356)
++|++.+.||+|+||.||+|+++.++. .||||.++.. .....+.+.+|+.+|+++ +|||||++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 579999999999999999999987776 4677877543 333456799999999998 79999987
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCce
Q 039228 135 ----------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFA 174 (356)
Q Consensus 135 ----------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 174 (356)
+.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 347889999999999999 9999999999999999999
Q ss_pred EEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCC-CCCCccccCCccHHHHH
Q 039228 175 HIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRR-KPIDFMFEGDLNLHNFA 253 (356)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~-~Pf~~~~~~~~~~~~~~ 253 (356)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||... ...+..
T Consensus 167 kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHH
T ss_pred EEccccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHHHH
Confidence 999999997554322 223456899999999999999999999999999999999975 566532 111111
Q ss_pred HHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhhc
Q 039228 254 RMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNILL 332 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~~ 332 (356)
.. +....... .+..++..+.+|+.+||+.||++||||++|++.|+++.+...
T Consensus 237 ~~---------i~~~~~~~------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 237 EK---------LPQGYRLE------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HH---------GGGTCCCC------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HH---------HHhcCCCC------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11 11100000 011344568899999999999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=330.34 Aligned_cols=239 Identities=23% Similarity=0.263 Sum_probs=171.4
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHH--HHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFM--AECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l--------------- 134 (356)
++|.+.+.||+|+||.||+|++. |+.||||+++... .+.+. .|+..+..++||||+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45788899999999999999974 7999999986432 23333 45556668899999987
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcC-----CCcEEecCCCCCCeEeCCCCceEEcccccccc
Q 039228 135 -------------------------ISIAIDVASALDYLHHHC-----QELILHCDPKPSNVLLDNDLFAHIGDFELARF 184 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 184 (356)
+.++.+++.||+|||+.+ .++||||||||+||||+.++.+||+|||+++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 568899999999999741 12399999999999999999999999999987
Q ss_pred cccCCCCCccCCCCccccccccchhhhcCCC------CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC
Q 039228 185 RQEVSNPTQSSSNGVRRTIGYTALDYDLGSE------VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP 258 (356)
Q Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (356)
................||+.|+|||++.+.. ++.++|||||||++|||+||..||.............. ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~--~~~ 235 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV--PSD 235 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS--CSS
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc--ccc
Confidence 7654443333445678999999999987643 56789999999999999999988754332221111000 000
Q ss_pred CchHHHh----hhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhh
Q 039228 259 NRVMDIV----NLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNI 330 (356)
Q Consensus 259 ~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~ 330 (356)
.....+. +..+.+.... .....+++..+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~-------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCG-------------GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCc-------------ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1111111 1111111110 001125667789999999999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=329.01 Aligned_cols=238 Identities=23% Similarity=0.270 Sum_probs=169.0
Q ss_pred cCCCCccccceecCceEEEEEEECCC-CeEEEEEEeeccC--ccchHHHHHHHHHHhhc---CCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLN-RAVVAIKVLSIQC--QGASKSFMAECKALKNI---CHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l---------- 134 (356)
.++|++++.||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+|+.| +||||+++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 6789999986432 22334566788777665 79999986
Q ss_pred ---------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccc
Q 039228 135 ---------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFEL 181 (356)
Q Consensus 135 ---------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 181 (356)
..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 458899999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCch
Q 039228 182 ARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRV 261 (356)
Q Consensus 182 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ .+............
T Consensus 163 ~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 236 (305)
T ss_dssp CCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred hhhhccc-----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCch
Confidence 8754322 23345778999999999999999999999999999999999999997532211 12222211111110
Q ss_pred HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 262 MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 262 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
..+-......... .......-.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQA-FHSKSAQPIEKF----VTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGG-SCCCCCCCGGGT----CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhh-hccccccchhhc----cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000 000000000000 1122345678999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=331.97 Aligned_cols=245 Identities=20% Similarity=0.251 Sum_probs=171.1
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeecc--CccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ--CQGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46799999999999999999999999999999998644 23345678999999999999999975
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 458899999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC--CCc
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF--PNR 260 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~ 260 (356)
.................||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+........ +..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCChh
Confidence 7654433333344456799999999998765 68999999999999999999999997532211 1111111111 111
Q ss_pred h-HHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 261 V-MDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 261 ~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ....+......... ............. .......+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLEL-VKGQKRKVKDRLK--AYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------C-CSSCCBCHHHHHH--HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcc-cccccccchhhhc--cccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 00000000000000 0000000000000 0111235678999999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-44 Score=336.94 Aligned_cols=213 Identities=17% Similarity=0.196 Sum_probs=165.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHH---HHHHHhhcCCCChHHH----------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMA---ECKALKNICHRNLVRF---------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l---------- 134 (356)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+ ++.+++.++|||||++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999999999999999986432 112233334 4677788899999987
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 458899999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhh
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVN 266 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
. ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...... ............
T Consensus 160 ~------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~------- 224 (364)
T d1omwa3 160 K------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTM------- 224 (364)
T ss_dssp S------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSC-------
T ss_pred C------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccC-------
Confidence 2 2234679999999999974 56899999999999999999999999753322 121111111110
Q ss_pred hhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 267 LVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 267 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
.... +...+..+.+|+.+||+.||.+||| ++++++
T Consensus 225 -----~~~~----------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -----AVEL----------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCC----------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCC----------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000 0022335789999999999999999 577765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=331.02 Aligned_cols=224 Identities=22% Similarity=0.297 Sum_probs=172.2
Q ss_pred hcCCCCccccceecCceEEEEEEECCCC-------eEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFDLNR-------AVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF------ 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l------ 134 (356)
..++|++.+.||+|+||.||+|+...++ ..||||+++.... .....+.+|...+.++ +|||||++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3567999999999999999999975543 5799999976543 3346788999999888 79999987
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 135 -----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 135 -----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
+.++.||+.||.|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 458889999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
++.++.+||+|||+++....... ........+|+.|+|||.+.++.|+.++|||||||++|||++ |.+||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT--TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred ecCCCCeEeccchhhcccccccc--ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 99999999999999987654432 223345678999999999999999999999999999999998 78888642211
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
.... .+........+ ..++..+.+|+.+||+.||.+||||.||++.|++
T Consensus 245 -~~~~------------~i~~~~~~~~p------------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 245 -ELFK------------LLKEGHRMDKP------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp -HHHH------------HHHTTCCCCCC------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH------------HHHcCCCCCCC------------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1111 11111111110 1234467899999999999999999999999999
Q ss_pred hhhh
Q 039228 327 VNNI 330 (356)
Q Consensus 327 i~~~ 330 (356)
+.+.
T Consensus 294 i~a~ 297 (299)
T d1fgka_ 294 IVAL 297 (299)
T ss_dssp HHHH
T ss_pred Hhhc
Confidence 8654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=331.04 Aligned_cols=225 Identities=21% Similarity=0.276 Sum_probs=177.7
Q ss_pred hcCCCCccccceecCceEEEEEEEC-----CCCeEEEEEEeeccCc-cchHHHHHHHHHHhhc-CCCChHHH--------
Q 039228 70 ATDGFPLINLIGVGSFDAVYQGVFD-----LNRAVVAIKVLSIQCQ-GASKSFMAECKALKNI-CHRNLVRF-------- 134 (356)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l-------- 134 (356)
..++|++.+.||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++.+ +|||||++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3467999999999999999999873 4568999999975433 3445789999999999 69999987
Q ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeE
Q 039228 135 -----------------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVL 167 (356)
Q Consensus 135 -----------------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIl 167 (356)
..++.||+.||.|||+++ ||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 347899999999999999 999999999999
Q ss_pred eCCCCceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHc-CCCCCCccccCC
Q 039228 168 LDNDLFAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVT-RRKPIDFMFEGD 246 (356)
Q Consensus 168 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 246 (356)
++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||... ...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~ 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVD 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSS
T ss_pred ccccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHH
Confidence 99999999999999987654332 233445788999999999999999999999999999999999 55555432 222
Q ss_pred ccHHHHHHHhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHH
Q 039228 247 LNLHNFARMAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQS 326 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~ 326 (356)
..+...+... ...... ..++..+.+|+.+||+.||.+||||++|+++|++
T Consensus 255 ~~~~~~i~~~------------~~~~~~------------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 SKFYKMIKEG------------FRMLSP------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHHT------------CCCCCC------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcC------------CCCCCc------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222222222 111111 1233467899999999999999999999999998
Q ss_pred hhhh
Q 039228 327 VNNI 330 (356)
Q Consensus 327 i~~~ 330 (356)
+...
T Consensus 305 ~i~~ 308 (311)
T d1t46a_ 305 QISE 308 (311)
T ss_dssp HHHH
T ss_pred hhcc
Confidence 7554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=327.86 Aligned_cols=204 Identities=20% Similarity=0.227 Sum_probs=163.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc------chHHHHHHHHHHhhcC--CCChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG------ASKSFMAECKALKNIC--HRNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l-------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++...... ...++.+|+.+|++++ |||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999999999999999999743211 1234678999999997 8999987
Q ss_pred ------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-CCceEEccccccc
Q 039228 135 ------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-DLFAHIGDFELAR 183 (356)
Q Consensus 135 ------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 183 (356)
..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 458899999999999999 999999999999984 5799999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcCCCC-CCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEV-STNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .......
T Consensus 160 ~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~----- 221 (273)
T d1xwsa_ 160 LLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----- 221 (273)
T ss_dssp ECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC-----
T ss_pred ecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc-----
Confidence 64322 2234679999999999987765 567899999999999999999996321 1111000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.+.. ..+..+.+|+.+||+.||++|||++|+++
T Consensus 222 -----~~~~----------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQ----------------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSS----------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCC----------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000 12235689999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=333.58 Aligned_cols=224 Identities=21% Similarity=0.321 Sum_probs=176.1
Q ss_pred hhcCCCCccccceecCceEEEEEEECC-----CCeEEEEEEeeccCc-cchHHHHHHHHHHhhcCCCChHHH--------
Q 039228 69 KATDGFPLINLIGVGSFDAVYQGVFDL-----NRAVVAIKVLSIQCQ-GASKSFMAECKALKNICHRNLVRF-------- 134 (356)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l-------- 134 (356)
...++|++.+.||+|+||.||+|.+.. +++.||||+++.... .....+.+|+.++++++||||+++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 345679999999999999999998852 357899999975432 334568999999999999999987
Q ss_pred ---------------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceE
Q 039228 135 ---------------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAH 175 (356)
Q Consensus 135 ---------------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 175 (356)
+.++.+++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 348889999999999998 99999999999999999999
Q ss_pred EcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCC-CCCCccccCCccHHHHHH
Q 039228 176 IGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRR-KPIDFMFEGDLNLHNFAR 254 (356)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~-~Pf~~~~~~~~~~~~~~~ 254 (356)
|+|||+++.+..... ........+|+.|+|||.+.+..++.++||||||+++|||+||. +||... ...+...
T Consensus 174 l~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~ 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLR 246 (308)
T ss_dssp ECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHH
T ss_pred EeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence 999999987654432 22234457899999999999999999999999999999999985 676532 1111111
Q ss_pred HhCCCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 255 MAFPNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 255 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
. +.+..... .+..++..+.+|+.+||+.||++||||.+|+++|++..+
T Consensus 247 ~--------i~~~~~~~-------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 F--------VMEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H--------HHTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H--------HHhCCCCC-------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11111100 011344568999999999999999999999999977754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-44 Score=323.55 Aligned_cols=239 Identities=21% Similarity=0.231 Sum_probs=168.6
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++++.||+|+||+||+|+++ +++.||||+++... ....+.+.+|+.+|++++||||+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999986 66999999997543 2335789999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--- 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--- 154 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc---
Confidence 568999999999999999 9999999999999999999999999998654322
Q ss_pred ccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhcc
Q 039228 193 QSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLLN 271 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (356)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+..............+.+..-..
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhh
Confidence 222335678999999998764 56899999999999999999999997533211 122222222211111110000000
Q ss_pred ccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 272 DNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.... ....................+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDP---NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCT---TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccc---ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000001111123346789999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-43 Score=319.94 Aligned_cols=215 Identities=17% Similarity=0.211 Sum_probs=168.7
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCcc---------chHHHHHHHHHHhhcC-CCChHHH------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQG---------ASKSFMAECKALKNIC-HRNLVRF------ 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l------ 134 (356)
.++|++.+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999999999999999999754321 2246889999999997 9999987
Q ss_pred -------------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 135 -------------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 135 -------------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 568999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCccCCCCccccccccchhhhcC------CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhC
Q 039228 184 FRQEVSNPTQSSSNGVRRTIGYTALDYDLG------SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAF 257 (356)
Q Consensus 184 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (356)
...... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 159 ~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~ 232 (277)
T d1phka_ 159 QLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY 232 (277)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred EccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCC
Confidence 765422 2234678999999999853 357889999999999999999999997432111 0111111000
Q ss_pred CCchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 258 PNRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 258 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
. ... ......+..+.+|+.+||+.||.+|||+.||++
T Consensus 233 ~----------~~~------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q----------FGS------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C----------CCT------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C----------CCC------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 000 001133346789999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=329.85 Aligned_cols=211 Identities=23% Similarity=0.280 Sum_probs=167.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC---ccchHHHHHHHHHHh-hcCCCChHHH-------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC---QGASKSFMAECKALK-NICHRNLVRF------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l------------- 134 (356)
++|++.+.||+|+||+||+|++..+++.||||++++.. ....+.+..|..++. .++|||||++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999999999999999997432 334456777777765 6899999987
Q ss_pred ------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCC
Q 039228 135 ------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 558899999999999999 9999999999999999999999999998654322
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i---------------~~ 217 (320)
T d1xjda_ 158 ---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSI---------------RM 217 (320)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---------------HH
T ss_pred ---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH---------------Hc
Confidence 2233467899999999999999999999999999999999999999742211 111111 10
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChH-HHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVP-NAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~vl~ 322 (356)
..+.. +..++..+.+|+.+||..||++|||+. +|++
T Consensus 218 ~~~~~----------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 DNPFY----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCC----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCC----------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11000 002233578999999999999999985 6754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-43 Score=322.34 Aligned_cols=227 Identities=19% Similarity=0.229 Sum_probs=175.8
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||.||+|++..+++.||||++..... .+++..|+++++.++|+|++..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3579999999999999999999999999999999875432 3457889999999998876654
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeC---CCCceEEcccccccccccCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLD---NDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||+|||+++ ||||||||+|||++ .+..++|+|||+|+......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 568899999999999999 99999999999986 45579999999999775433
Q ss_pred CCC---ccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCcc--HHHHHHHhCCCchHHH
Q 039228 190 NPT---QSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLN--LHNFARMAFPNRVMDI 264 (356)
Q Consensus 190 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 264 (356)
... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||......... ..............
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh--
Confidence 221 22344578999999999999999999999999999999999999999754332211 11111100000000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNN 329 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~ 329 (356)
.+ ...++..+.+++..||+.||++||+++++.+.|+.+..
T Consensus 239 ---~~----------------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 ---VL----------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---HH----------------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---Hh----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00 01334567899999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=332.12 Aligned_cols=239 Identities=20% Similarity=0.195 Sum_probs=167.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|.+..+++.||||+++... ....+.+.+|+.+|+.++|||||++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999999999999999997542 2345678999999999999999986
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 458999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHHH
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMDI 264 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 264 (356)
. .....||+.|+|||++.+. .++.++||||+||++|+|++|++||...... ..+.......... .....
T Consensus 174 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 174 E-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp S-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHT
T ss_pred c-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHhh
Confidence 2 2346789999999998764 5689999999999999999999999753221 1111221111111 11000
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
.......... .....................+.+|+.+||..||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYM---KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHH---HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhh---ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0000000000001111223356799999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=331.30 Aligned_cols=247 Identities=21% Similarity=0.190 Sum_probs=171.3
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC-ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC-QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
+++|++++.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+|+.++||||+++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999999999999999997543 3345678999999999999999976
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 458999999999999999 9999999999999999999999999998764433
Q ss_pred CCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhh
Q 039228 190 NPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLV 268 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
.. ........||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+. ................ ...
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~-~~~ 240 (345)
T d1pmea_ 164 DH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDL-NCI 240 (345)
T ss_dssp CB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHH-HTC
T ss_pred cc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhh-hhh
Confidence 22 223345778999999999854 5678899999999999999999999975432111 1111111111111000 000
Q ss_pred hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 269 LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
...................+..........+.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000000000001122356899999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=325.90 Aligned_cols=214 Identities=21% Similarity=0.240 Sum_probs=169.5
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH----------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF---------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l---------------- 134 (356)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... ....+.+|+.+|+.++|||||++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4679999999999999999999999999999999976532 34568899999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC--CCceEEcccccccccccCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN--DLFAHIGDFELARFRQEVSN 190 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~ 190 (356)
..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 558899999999999999 999999999999984 4589999999998653321
Q ss_pred CCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc
Q 039228 191 PTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL 270 (356)
Q Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (356)
......+|+.|+|||...+..++.++|||||||++|+|++|..||...... .... .+......
T Consensus 159 ----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~-----------~i~~~~~~ 221 (321)
T d1tkia_ 159 ----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIE-----------NIMNAEYT 221 (321)
T ss_dssp ----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH-----------HHHHTCCC
T ss_pred ----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHH-----------HHHhCCCC
Confidence 223356789999999999999999999999999999999999999743211 1111 11111000
Q ss_pred cccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 NDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
... .........+.+|+.+||..||.+|||+.|+++
T Consensus 222 ~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCh----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000022335689999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=327.81 Aligned_cols=214 Identities=17% Similarity=0.162 Sum_probs=165.1
Q ss_pred cCCCCccc-cceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhh-cCCCChHHH--------------
Q 039228 71 TDGFPLIN-LIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKN-ICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l-------------- 134 (356)
.++|.+.+ .||+|+||.||+|++..+++.||||+++. ...+.+|+.++.+ .+|||||++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798875 69999999999999999999999999863 2567789998765 489999986
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC---CCceEEcccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN---DLFAHIGDFELA 182 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~a 182 (356)
..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 568999999999999999 999999999999985 567999999999
Q ss_pred cccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchH
Q 039228 183 RFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVM 262 (356)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||....... ........
T Consensus 162 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~------ 228 (335)
T d2ozaa1 162 KETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTR------ 228 (335)
T ss_dssp EECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C------
T ss_pred eeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHH------
Confidence 8654322 2334678999999999999999999999999999999999999996432211 10000000
Q ss_pred HHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 263 DIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 263 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
....... ............+.+|+.+||+.||++|||+.|+++
T Consensus 229 -----i~~~~~~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 -----IRMGQYE------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCSCSSS------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HhcCCCC------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 000011134456789999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=317.80 Aligned_cols=238 Identities=19% Similarity=0.240 Sum_probs=172.1
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH---------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF--------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l--------------- 134 (356)
++|++++.||+|+||+||+|++..+++.||||+++... .....++.+|+.+|+.++||||+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999999999999999997543 2345788999999999999999987
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCCCCC
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVSNPT 192 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 192 (356)
..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 568999999999999999 99999999999999999999999999987644322
Q ss_pred ccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH--Hhhhhh
Q 039228 193 QSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD--IVNLVL 269 (356)
Q Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l 269 (356)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||.........+........+..... ......
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223345678899999987665 689999999999999999999997532222222222222222111000 000000
Q ss_pred -ccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 270 -LNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
......... ..............+.+|+.+||+.||.+|||++||++
T Consensus 235 ~~~~~~~~~~------~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPA------TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCT------TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccc------cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00000011122335678999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-42 Score=313.40 Aligned_cols=231 Identities=16% Similarity=0.162 Sum_probs=177.4
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCC-CChHHH---------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICH-RNLVRF--------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l--------------- 134 (356)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+|++.++.++| +|++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 467999999999999999999999999999999986543 23456788999999876 777765
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCC-----CCceEEccccccccccc
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDN-----DLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~ 187 (356)
..++.|++.||.|||+.+ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 568999999999999999 999999999999974 57899999999987654
Q ss_pred CCCC---CccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 188 VSNP---TQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 188 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.... .........||+.|+|||.+.+..++.++|||||||++|||+||..||......... .... .+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~---------~i 228 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYE---------RI 228 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHH---------HH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HHHH---------HH
Confidence 3221 122344578999999999999999999999999999999999999999754332211 1100 00
Q ss_pred hhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHHHHHhhhhh
Q 039228 265 VNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHDLQSVNNIL 331 (356)
Q Consensus 265 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~L~~i~~~~ 331 (356)
.+........ .....++..+.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 229 ~~~~~~~~~~---------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 229 GEKKQSTPLR---------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHSCHH---------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhccCCCChH---------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000000000 000123456889999999999999999999999999887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-42 Score=318.87 Aligned_cols=240 Identities=20% Similarity=0.241 Sum_probs=170.0
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC-CCChHHH----------------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC-HRNLVRF---------------- 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l---------------- 134 (356)
++|++++.||+|+||+||+|++..+++.||||+++.. ..+++.+|+.+|+.++ ||||+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999998743 3467889999999996 9999987
Q ss_pred --------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCC-CceEEcccccccccccCCCCCc
Q 039228 135 --------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDND-LFAHIGDFELARFRQEVSNPTQ 193 (356)
Q Consensus 135 --------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~ 193 (356)
..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---- 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---- 184 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC----
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC----
Confidence 568999999999999999 9999999999999865 469999999998664332
Q ss_pred cCCCCccccccccchhhhcCC-CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHHhhhhhc--
Q 039228 194 SSSNGVRRTIGYTALDYDLGS-EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDIVNLVLL-- 270 (356)
Q Consensus 194 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-- 270 (356)
......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.............................-.
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 23346789999999998765 47999999999999999999999996433221111111111111111111111000
Q ss_pred -ccccccccc--ccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 271 -NDNKVLAGT--NSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 271 -~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
......... ...................+.+|+.+||..||.+|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 0000000000011123345789999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=320.29 Aligned_cols=237 Identities=19% Similarity=0.157 Sum_probs=169.0
Q ss_pred CCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChHHH------------------
Q 039228 73 GFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLVRF------------------ 134 (356)
Q Consensus 73 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l------------------ 134 (356)
+|+.+++||+|+||+||+|++..+++.||||++...... ..+|+.+|++++||||+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588999999999999999999999999999999754322 2469999999999999986
Q ss_pred ----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCC-ceEEccccccccc
Q 039228 135 ----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDL-FAHIGDFELARFR 185 (356)
Q Consensus 135 ----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 185 (356)
..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 347889999999999999 99999999999999765 8999999999865
Q ss_pred ccCCCCCccCCCCccccccccchhhhcC-CCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLG-SEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMDI 264 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..............+
T Consensus 174 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred cCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhh
Confidence 4322 2234678999999998765 56899999999999999999999999743221 112222222111111111
Q ss_pred hhh--h-hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH--HHHhh
Q 039228 265 VNL--V-LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD--LQSVN 328 (356)
Q Consensus 265 ~~~--~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~--L~~i~ 328 (356)
... . ....... .....+..... ......+.+|+.+||..||++|||+.|+++. ++++.
T Consensus 248 ~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQ--IKAHPWTKVFR----PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC---CCCCCC--CCCCCGGGTSC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccchhhccccc--cccCchhhhcc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 100 0 0000000 00000000000 1233357899999999999999999999863 44443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=320.23 Aligned_cols=244 Identities=20% Similarity=0.132 Sum_probs=167.6
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccC--ccchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQC--QGASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+++.+|+.+|++++||||+++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999999999999999997543 3334578899999999999999986
Q ss_pred --------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccC
Q 039228 135 --------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEV 188 (356)
Q Consensus 135 --------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 188 (356)
..++.|++.||.|||+.| |+||||||+|||++.++.++++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence 458999999999999999 999999999999999999999999998765432
Q ss_pred CCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCC----------
Q 039228 189 SNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFP---------- 258 (356)
Q Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 258 (356)
.......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...... ............
T Consensus 173 -----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 -----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSC
T ss_pred -----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhh
Confidence 2334467899999999999999999999999999999999999999743211 111111111111
Q ss_pred CchHHHhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHHH
Q 039228 259 NRVMDIVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVHD 323 (356)
Q Consensus 259 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~~ 323 (356)
........................................+.+|+.+||..||++|||++||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01111111110000000000000000000111223456678899999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=321.25 Aligned_cols=230 Identities=23% Similarity=0.240 Sum_probs=167.0
Q ss_pred cCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCc--cchHHHHHHHHHHhhcCCCChHHH--------------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ--GASKSFMAECKALKNICHRNLVRF-------------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l-------------- 134 (356)
.++|++++.||+|+||+||+|++..+|+.||||+++.... ...+++.+|+.+|++++|||||++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999999999999999999975432 334678899999999999999976
Q ss_pred ---------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccccc
Q 039228 135 ---------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQE 187 (356)
Q Consensus 135 ---------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 187 (356)
..++.||+.||+|||++| |+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 458899999999999999 99999999999999999999999999975432
Q ss_pred CCCCCccCCCCccccccccchhhhcCCC-CCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCC--chHH-
Q 039228 188 VSNPTQSSSNGVRRTIGYTALDYDLGSE-VSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPN--RVMD- 263 (356)
Q Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~- 263 (356)
......|+..|+|||...+.. ++.++|||||||++|+|++|+.||....... ............ ....
T Consensus 174 -------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 -------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred -------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhh
Confidence 233467899999999877654 6889999999999999999999997432111 111111111110 0000
Q ss_pred -------HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCChHHHHH
Q 039228 264 -------IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMNVPNAVH 322 (356)
Q Consensus 264 -------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~vl~ 322 (356)
.....+..... .............+.+|+.+||..||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPK-----------MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCC-----------CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCC-----------cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000 0000000122345689999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=314.09 Aligned_cols=217 Identities=21% Similarity=0.247 Sum_probs=166.2
Q ss_pred cCCCCccccceecCceEEEEEEE---CCCCeEEEEEEeeccC----ccchHHHHHHHHHHhhcCC-CChHHH--------
Q 039228 71 TDGFPLINLIGVGSFDAVYQGVF---DLNRAVVAIKVLSIQC----QGASKSFMAECKALKNICH-RNLVRF-------- 134 (356)
Q Consensus 71 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l-------- 134 (356)
.++|++++.||+|+||+||+|+. +.+|+.||||+++... ....+.+.+|+.+|++++| |||+++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999987 4468999999986432 2335678899999999987 799987
Q ss_pred -----------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEccccccccc
Q 039228 135 -----------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFR 185 (356)
Q Consensus 135 -----------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 185 (356)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 457889999999999999 999999999999999999999999999866
Q ss_pred ccCCCCCccCCCCccccccccchhhhcCC--CCCCccchHhHHHHHHHHHcCCCCCCccccCCccHHHHHHHhCCCchHH
Q 039228 186 QEVSNPTQSSSNGVRRTIGYTALDYDLGS--EVSTNGDAYNYGILLLEMVTRRKPIDFMFEGDLNLHNFARMAFPNRVMD 263 (356)
Q Consensus 186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.... ........|++.|++||.+.+. .++.++|||||||++|+|++|+.||........ .......
T Consensus 180 ~~~~---~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~-------- 247 (322)
T d1vzoa_ 180 VADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRR-------- 247 (322)
T ss_dssp CGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHH--------
T ss_pred cccc---cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh--------
Confidence 4332 2233456789999999998764 467899999999999999999999975433321 1111111
Q ss_pred HhhhhhccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC-----hHHHHH
Q 039228 264 IVNLVLLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN-----VPNAVH 322 (356)
Q Consensus 264 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~vl~ 322 (356)
....... .+......+.+++.+||++||++||| ++|+++
T Consensus 248 ----~~~~~~~----------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 ----ILKSEPP----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HHHCCCC----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----cccCCCC----------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1000000 00123446789999999999999995 677764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-38 Score=298.06 Aligned_cols=240 Identities=18% Similarity=0.163 Sum_probs=165.7
Q ss_pred CCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcCCCChH-----------HH------
Q 039228 72 DGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNICHRNLV-----------RF------ 134 (356)
Q Consensus 72 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-----------~l------ 134 (356)
++|++++.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++|+|++ ++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999999999999997542 2346778899999998776544 33
Q ss_pred ------------------------------------HHHHHHHHHHHHHHhh-cCCCcEEecCCCCCCeEeCCCC-----
Q 039228 135 ------------------------------------ISIAIDVASALDYLHH-HCQELILHCDPKPSNVLLDNDL----- 172 (356)
Q Consensus 135 ------------------------------------~~i~~~i~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~----- 172 (356)
..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4488999999999998 77 99999999999998654
Q ss_pred -ceEEcccccccccccCCCCCccCCCCccccccccchhhhcCCCCCCccchHhHHHHHHHHHcCCCCCCccccCC-c---
Q 039228 173 -FAHIGDFELARFRQEVSNPTQSSSNGVRRTIGYTALDYDLGSEVSTNGDAYNYGILLLEMVTRRKPIDFMFEGD-L--- 247 (356)
Q Consensus 173 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~--- 247 (356)
.++++|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||....... .
T Consensus 169 ~~~kl~dfg~s~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ceeeEeeccccccccc-------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 389999999975432 2234678999999999999999999999999999999999999997532211 0
Q ss_pred -cHHHHHHHhCCCchHHHhhh-----h-----hccccccccccccchhhhhchhhHHHHHHHHHHHHHhhcCCCcCCCCC
Q 039228 248 -NLHNFARMAFPNRVMDIVNL-----V-----LLNDNKVLAGTNSNMLRKTKMNSRLECLIFMVRIGAACSMGSSQDRMN 316 (356)
Q Consensus 248 -~~~~~~~~~~~~~~~~~~~~-----~-----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 316 (356)
.+...............-.. . ..............-...............+.+|+.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111111111000000000 0 000000000000000000111122356668899999999999999999
Q ss_pred hHHHHH
Q 039228 317 VPNAVH 322 (356)
Q Consensus 317 ~~~vl~ 322 (356)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=4e-22 Score=168.41 Aligned_cols=138 Identities=18% Similarity=0.108 Sum_probs=100.8
Q ss_pred CCccccceecCceEEEEEEECCCCeEEEEEEeeccCc------------------cchHHHHHHHHHHhhcCCCChHHH-
Q 039228 74 FPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQ------------------GASKSFMAECKALKNICHRNLVRF- 134 (356)
Q Consensus 74 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l- 134 (356)
+.+.+.||+|+||+||+|++. +|+.||||+++.... ........|...+.++.|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999986 578999998753210 011234568888999999887753
Q ss_pred -------------------------HHHHHHHHHHHHHHhhcCCCcEEecCCCCCCeEeCCCCceEEcccccccccccCC
Q 039228 135 -------------------------ISIAIDVASALDYLHHHCQELILHCDPKPSNVLLDNDLFAHIGDFELARFRQEVS 189 (356)
Q Consensus 135 -------------------------~~i~~~i~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 189 (356)
..++.|++.+|.|||+++ |+||||||+|||+++++ ++|+|||.|.......
T Consensus 81 ~~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~ 156 (191)
T d1zara2 81 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEG 156 (191)
T ss_dssp EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTSTT
T ss_pred EecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCCCC
Confidence 568999999999999999 99999999999999655 8899999996432111
Q ss_pred CCCccCCCCccccccccc------hhhhcCCCCCCccchHhHHHHH
Q 039228 190 NPTQSSSNGVRRTIGYTA------LDYDLGSEVSTNGDAYNYGILL 229 (356)
Q Consensus 190 ~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDiwSlG~~l 229 (356)
...|.. .+.+ ...|+.++|+||+.--+
T Consensus 157 ------------~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 157 ------------WREILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ------------HHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ------------cHHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 001111 1122 35678899999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.45 E-value=0.00023 Score=60.36 Aligned_cols=116 Identities=16% Similarity=0.106 Sum_probs=76.5
Q ss_pred HHHhhcCCCCccccceecCceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC----CCChHHH-------
Q 039228 66 SLLKATDGFPLINLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC----HRNLVRF------- 134 (356)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l------- 134 (356)
++....+.|.+.+..+-++.+.||+... +++.+++|+...........+.+|...+..+. -|-++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4445566787776655555678998763 45677889876554444445677888776653 2333211
Q ss_pred ----------------------HHHHHHHHHHHHHHhhcCC---------------------------------------
Q 039228 135 ----------------------ISIAIDVASALDYLHHHCQ--------------------------------------- 153 (356)
Q Consensus 135 ----------------------~~i~~~i~~aL~~LH~~~~--------------------------------------- 153 (356)
-.++.+++..|..||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 2355566666777765310
Q ss_pred -----------------CcEEecCCCCCCeEeCCCCceEEccccccc
Q 039228 154 -----------------ELILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 154 -----------------~~iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
..++|+|+.|.||++++++.+-|.||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 017899999999999987777799999885
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.72 E-value=0.0011 Score=57.67 Aligned_cols=28 Identities=29% Similarity=0.388 Sum_probs=25.9
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
+||+|+.++||+++.+...-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcccccceeEecccccc
Confidence 9999999999999988877899999884
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.98 E-value=0.009 Score=53.59 Aligned_cols=50 Identities=18% Similarity=0.052 Sum_probs=31.8
Q ss_pred cccceecCceEEEEEEECCCCeEEEEEEeecc-------CccchHHHHHHHHHHhhc
Q 039228 77 INLIGVGSFDAVYQGVFDLNRAVVAIKVLSIQ-------CQGASKSFMAECKALKNI 126 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l 126 (356)
.+.||.|....||+.....+++.|+||.-... ......+...|...|+.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~ 87 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ 87 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHH
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHh
Confidence 44689999999999988777788999975311 112334556677777655
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.89 E-value=0.0044 Score=51.70 Aligned_cols=28 Identities=21% Similarity=0.286 Sum_probs=25.1
Q ss_pred EEecCCCCCCeEeCCCCceEEccccccc
Q 039228 156 ILHCDPKPSNVLLDNDLFAHIGDFELAR 183 (356)
Q Consensus 156 iiH~Dlkp~NIll~~~~~~kl~Dfg~a~ 183 (356)
++|+|+.|.||+++++..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.77 E-value=0.0053 Score=53.63 Aligned_cols=41 Identities=15% Similarity=0.151 Sum_probs=29.3
Q ss_pred ceEEEEEEECCCCeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 85 FDAVYQGVFDLNRAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 85 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
-..||++... +|..|++|+.... ....+++..|...+..|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLV 75 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHH
T ss_pred cceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHH
Confidence 4689999875 4588999997643 223466778888877764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.61 E-value=0.093 Score=46.58 Aligned_cols=49 Identities=14% Similarity=0.118 Sum_probs=32.3
Q ss_pred cccceecCceEEEEEEECCC-------CeEEEEEEeeccCccchHHHHHHHHHHhhcC
Q 039228 77 INLIGVGSFDAVYQGVFDLN-------RAVVAIKVLSIQCQGASKSFMAECKALKNIC 127 (356)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 127 (356)
++.|+.|-...+|++..... ...|.+++.. .. ...-...+|..+++.+.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls 102 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLS 102 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHH
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHH
Confidence 35788899999999987542 3567777765 22 22234557877777664
|